Citrus Sinensis ID: 014585
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 422 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.952 | 0.815 | 0.824 | 0.0 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.959 | 0.826 | 0.789 | 0.0 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.739 | 0.760 | 0.667 | 1e-125 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.805 | 0.829 | 0.637 | 1e-123 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.744 | 0.762 | 0.663 | 1e-123 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.824 | 0.894 | 0.602 | 1e-123 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.746 | 0.797 | 0.620 | 1e-119 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.860 | 0.852 | 0.565 | 1e-118 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.736 | 0.730 | 0.629 | 1e-115 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.746 | 0.809 | 0.603 | 1e-115 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/415 (82%), Positives = 366/415 (88%), Gaps = 13/415 (3%)
Query: 8 ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNF 67
ESKS N+ S DQP V S+TTTSNAES+SST + EEL ++S LRKFTFNDLKL+TRNF
Sbjct: 83 ESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNF 142
Query: 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 127
RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLG+
Sbjct: 143 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGN 202
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+F
Sbjct: 203 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSF 262
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
LHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPE
Sbjct: 263 LHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPE 322
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307
YVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+D
Sbjct: 323 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLD 382
Query: 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQ 367
PRLEGHFSIKGAQK QLAA CLSRDPK RP MS+VVEALKPLP+LKDMASSSYYFQTMQ
Sbjct: 383 PRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQ 442
Query: 368 AERIGSSPNTRNGIRAQGGSLSRNGQ-----RSLSIPNGSYASPYHHQFPHPSPK 417
AER+ +NG G SRNGQ R+LS P+GS SPY HQ P P PK
Sbjct: 443 AERL------KNGSGRSQGFGSRNGQHQPVFRTLSSPHGS--SPYRHQIPSPKPK 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 661 bits (1705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/413 (78%), Positives = 357/413 (86%), Gaps = 8/413 (1%)
Query: 9 SKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFR 68
S+S S DQP V S+TTTSNAES+ ST + EEL + S L+KF+F DLKLATRNFR
Sbjct: 78 SQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFR 137
Query: 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 128
PESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LG+L
Sbjct: 138 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNL 197
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FL
Sbjct: 198 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFL 257
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 248
HEEA +PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEY
Sbjct: 258 HEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEY 317
Query: 249 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308
VMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+DP
Sbjct: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDP 377
Query: 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQA 368
RLEGHFS+KGAQK QLAA CLSRD K RP MSEVVE LKPLP+LKDMAS+SYYFQTMQA
Sbjct: 378 RLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQA 437
Query: 369 ERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSY-ASPYHHQFPHPSPK 417
ER+ + + +G SRNGQ R+LS P+G +SPY HQ P P PK
Sbjct: 438 ERLKAGSGSGSGRGFG----SRNGQPVFRTLSSPHGQAGSSPYRHQIPSPKPK 486
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 211/316 (66%), Positives = 258/316 (81%), Gaps = 4/316 (1%)
Query: 41 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 100
+ E E+ + L+ F+F +LK ATRNFRP+S+LGEGGFGCVFKGWI+E +PGTGL
Sbjct: 42 RTEGEILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGL 101
Query: 101 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 160
+AVK LN DG QGH+EWLAEVN+LG H +LVKLIGYC+ED+ RLLVYEFMPRGSLEN
Sbjct: 102 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLEN 161
Query: 161 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
HLFRR L PL W +R+K+ALGAAKGLAFLH R VIYRDFKTSNILLD++YNAKLS
Sbjct: 162 HLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETR-VIYRDFKTSNILLDSEYNAKLS 220
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
DFGLAKDGP GDK+HVSTRVMGT+GYAAPEY+ TGHLT++SDVYSFGVVLLE+L+GRR++
Sbjct: 221 DFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAV 280
Query: 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
DKNRP+GE NLVEWA+P+L +R+ +R+ID RL+ +S++ A K A L+ CL+ + K R
Sbjct: 281 DKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLR 340
Query: 338 PLMSEVVEALKPLPNL 353
P MSEVV L+ + +L
Sbjct: 341 PNMSEVVSHLEHIQSL 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/348 (63%), Positives = 268/348 (77%), Gaps = 8/348 (2%)
Query: 35 SNSSTSKLEEELKVA---SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 91
S+ ST + ++ + +++ FT +L+ T++FRP+ +LGEGGFG V+KG+I++N
Sbjct: 34 SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93
Query: 92 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 151
+K L VAVK LN +GLQGH+EWL EVNFLG L H NLVKLIGYC EDD RLLVYE
Sbjct: 94 VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150
Query: 152 FMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210
FM RGSLENHLFR++ PL WS RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209
Query: 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 270
DY AKLSDFGLAK GP+GD+THVSTRVMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEM
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269
Query: 271 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 330
LTGR+S+DK RP+ E NLV+WARP L ++R+ ++IDPRLE +S++ AQKA LA +CL
Sbjct: 270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329
Query: 331 SRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 378
S++PKARPLMS+VVE L+PL D A +G P+ R
Sbjct: 330 SQNPKARPLMSDVVETLEPLQCTGDALIPCATTTAGAAFAMGGVPDYR 377
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 211/318 (66%), Positives = 255/318 (80%), Gaps = 4/318 (1%)
Query: 41 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 100
+ E E+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+
Sbjct: 43 RTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGV 102
Query: 101 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 160
+AVK LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLEN
Sbjct: 103 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 162
Query: 161 HLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
HLFRR PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLS
Sbjct: 163 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLS 221
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
DFGLAKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++
Sbjct: 222 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 281
Query: 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
DKNRP GE LVEWARP L +R+ +R+ID RL+ +S++ A K A LA CL+ + K R
Sbjct: 282 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 341
Query: 338 PLMSEVVEALKPLPNLKD 355
P M+EVV L+ + L +
Sbjct: 342 PNMNEVVSHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 441 bits (1135), Expect = e-123, Method: Compositional matrix adjust.
Identities = 212/352 (60%), Positives = 269/352 (76%), Gaps = 4/352 (1%)
Query: 31 SNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 90
S+ S S + E E+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+
Sbjct: 32 SSTASFSYMPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESS 91
Query: 91 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 150
AP KPGTG+ +AVK LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVY
Sbjct: 92 LAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVY 151
Query: 151 EFMPRGSLENHLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207
EFM RGSLENHLFRR PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNIL
Sbjct: 152 EFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNIL 210
Query: 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 267
LD++YNAKLSDFGLA+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVL
Sbjct: 211 LDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVL 270
Query: 268 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 327
LE+L+GRR++DKN+P GEHNLV+WARP+L +RR R++DPRL+G +S+ A K A LA
Sbjct: 271 LELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLAL 330
Query: 328 HCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRN 379
C+S D K+RP M+E+V+ ++ L K+ + Q I SP N
Sbjct: 331 DCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQNPQISIDNIINKSPQAVN 382
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1098), Expect = e-119, Method: Compositional matrix adjust.
Identities = 198/319 (62%), Positives = 253/319 (79%), Gaps = 4/319 (1%)
Query: 37 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 96
++ K E E+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KP
Sbjct: 37 AAAQKTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKP 96
Query: 97 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 156
GTGL +AVK LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +G
Sbjct: 97 GTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKG 156
Query: 157 SLENHLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213
SLENHLFRR PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYN
Sbjct: 157 SLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYN 215
Query: 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
AKLSDFGLA+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL +RSDVYSFGV+LLE+L+G
Sbjct: 216 AKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSG 275
Query: 274 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 333
+R++D NRP E NLV+WARP+L +R+ ++D RL+ + + A + A +A CLS +
Sbjct: 276 KRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFE 335
Query: 334 PKARPLMSEVVEALKPLPN 352
PK+RP M +VV AL+ L +
Sbjct: 336 PKSRPTMDQVVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1091), Expect = e-118, Method: Compositional matrix adjust.
Identities = 216/382 (56%), Positives = 269/382 (70%), Gaps = 19/382 (4%)
Query: 39 TSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 98
T + E E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+
Sbjct: 55 TPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGS 114
Query: 99 GLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 158
G+ VAVK L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSL
Sbjct: 115 GIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSL 174
Query: 159 ENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
ENHLFRR + PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLS
Sbjct: 175 ENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLS 233
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
DFGLAK GP GDKTHVST+VMGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++
Sbjct: 234 DFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAV 293
Query: 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
DK++ E +LV+WA P+LG++R+ +R++D RL G + KGA AA LA CL+ D K R
Sbjct: 294 DKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLR 353
Query: 338 PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLS 397
P MSEV+ L L + K +G+ + R GS+ + R
Sbjct: 354 PKMSEVLAKLDQLESTK------------PGTGVGNRQAQIDSPRGSNGSIVQKSPRRY- 400
Query: 398 IPNGSYASPYHHQFPHPSPKPN 419
SY P H P SP P
Sbjct: 401 ----SYDRPLLHITPGASPLPT 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 197/313 (62%), Positives = 247/313 (78%), Gaps = 2/313 (0%)
Query: 39 TSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 98
T + E E+ + L+ FTFN+LK AT+NFR ++LLGEGGFGCVFKGWI++ +PG+
Sbjct: 58 TLRTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGS 117
Query: 99 GLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 158
G+ VAVK L +G QGHKEWL EVN+LG L H NLV L+GYC E + RLLVYEFMP+GSL
Sbjct: 118 GIVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSL 177
Query: 159 ENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
ENHLFRR + PL W+IRMK+A+GAAKGL FLHE A+ VIYRDFK +NILLDAD+NAKLS
Sbjct: 178 ENHLFRRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLS 236
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
DFGLAK GP GD THVST+V+GT+GYAAPEYV TG LT++SDVYSFGVVLLE+++GRR+M
Sbjct: 237 DFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAM 296
Query: 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
D + E++LV+WA P+LG++R+ +R++D +L G + KGA AA LA CL+ D K R
Sbjct: 297 DNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLR 356
Query: 338 PLMSEVVEALKPL 350
P MSEV+ L+ L
Sbjct: 357 PKMSEVLVTLEQL 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1066), Expect = e-115, Method: Compositional matrix adjust.
Identities = 193/320 (60%), Positives = 248/320 (77%), Gaps = 5/320 (1%)
Query: 37 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 96
++ K E E+ ++ ++ F+FN+LKLATRNFR +S++GEGGFGCVF+GW++E P K
Sbjct: 31 ATAHKTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKS 90
Query: 97 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 156
+GL +AVK LN DG QGH+EWL E+N+LG L H NLVKLIGYC+ED+QRLLVYEFM +G
Sbjct: 91 SSGLVIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKG 150
Query: 157 SLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212
SLENHLF + PL W +R+K+AL AAKGLAFLH + + VIYRD K SNILLD+D+
Sbjct: 151 SLENHLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDF 209
Query: 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
NAKLSDFGLA+DGP G++++VSTRVMGT+GYAAPEYV TGHL +RSDVYSFGVVLLE+L
Sbjct: 210 NAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLC 269
Query: 273 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 332
GR+++D NRP E NLV+WARP+L RR+ ++D RL + +GA + A +A CLS
Sbjct: 270 GRQALDHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSF 329
Query: 333 DPKARPLMSEVVEALKPLPN 352
+PK+RP M +VV AL L +
Sbjct: 330 EPKSRPTMDQVVRALVQLQD 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 422 | ||||||
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 0.983 | 0.862 | 0.935 | 0.0 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.981 | 0.843 | 0.928 | 0.0 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.981 | 0.850 | 0.932 | 0.0 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.981 | 0.853 | 0.925 | 0.0 | |
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.978 | 0.834 | 0.935 | 0.0 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.981 | 0.850 | 0.930 | 0.0 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 0.964 | 0.822 | 0.936 | 0.0 | |
| 357486605 | 492 | Serine/threonine protein kinase-like pro | 0.981 | 0.841 | 0.906 | 0.0 | |
| 53689728 | 603 | serine/threonine protein kinase-like [So | 0.981 | 0.686 | 0.914 | 0.0 | |
| 224100451 | 445 | predicted protein [Populus trichocarpa] | 0.978 | 0.928 | 0.937 | 0.0 |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/419 (93%), Positives = 405/419 (96%), Gaps = 4/419 (0%)
Query: 8 ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNF 67
E++STNDTSRDQP A V+SSTTTSNAESNSSTSKLEEELKVASRLRKF+FNDLK+ATRNF
Sbjct: 63 ENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASRLRKFSFNDLKMATRNF 122
Query: 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 127
RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD
Sbjct: 123 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 182
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRMKIALGAAKGLAF
Sbjct: 183 LIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRMKIALGAAKGLAF 242
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
LHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE
Sbjct: 243 LHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 302
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307
YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID
Sbjct: 303 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 362
Query: 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQ 367
PRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKDMASSSYYFQTMQ
Sbjct: 363 PRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMASSSYYFQTMQ 422
Query: 368 AERIGSSPNTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYHH-QFPHPSPKPNGKP 422
AERIGSSPN RNG+R Q G LSRNG QRSLSIPNGS+ASPYH Q+P+ SPKPNGKP
Sbjct: 423 AERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPYQSPKPNGKP 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2084), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/417 (92%), Positives = 402/417 (96%), Gaps = 3/417 (0%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
+ESKSTNDTSRDQP A +SSTTTSNAESNSSTSKLEEELK+ASRLRKF+FNDLK ATRN
Sbjct: 75 AESKSTNDTSRDQPTAPAVSSTTTSNAESNSSTSKLEEELKIASRLRKFSFNDLKSATRN 134
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
FRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG
Sbjct: 135 FRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
DLVH NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKIALGAAKGLA
Sbjct: 195 DLVHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPWSIRMKIALGAAKGLA 254
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP
Sbjct: 255 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 314
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
EYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWARPHLGERRRFYRLI
Sbjct: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLI 374
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 366
DPRLEGHFS+KGAQKAAQLAAHCLSRDPK+RPLMSEVVEALKPLP+LKDMASSSYYFQ M
Sbjct: 375 DPRLEGHFSVKGAQKAAQLAAHCLSRDPKSRPLMSEVVEALKPLPSLKDMASSSYYFQAM 434
Query: 367 QAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 421
QA+R G+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQFP PSPKPNGK
Sbjct: 435 QADRFGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQFPQPSPKPNGK 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2075), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/417 (93%), Positives = 401/417 (96%), Gaps = 3/417 (0%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
+ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEE KV+SRLRKFTFNDLKLATRN
Sbjct: 71 AESKSTIDTSRDQPTVPVVSSTTTSNAESNSSTSKLEEEFKVSSRLRKFTFNDLKLATRN 130
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN+LG
Sbjct: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNYLG 190
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
DLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA
Sbjct: 191 DLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
FLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP
Sbjct: 251 FLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI
Sbjct: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 370
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 366
DPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM
Sbjct: 371 DPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 430
Query: 367 QAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 421
QA+R +SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP PSPKPNGK
Sbjct: 431 QADRFSASPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFPQPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/418 (92%), Positives = 403/418 (96%), Gaps = 4/418 (0%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSS-TSKLEEELKVASRLRKFTFNDLKLATR 65
+ESKSTNDTSRDQP A +SSTTTSNAESNSS TSKLEEELK+ASRLRKF+FN+LKLATR
Sbjct: 68 AESKSTNDTSRDQPTAPAVSSTTTSNAESNSSSTSKLEEELKIASRLRKFSFNELKLATR 127
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
NFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL
Sbjct: 128 NFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 187
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
GDLVH NLVKL+GYCIE+DQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKIALGAAKGL
Sbjct: 188 GDLVHPNLVKLVGYCIEEDQRLLVYEFMPRGSLENHLFRRSIPLPWSIRMKIALGAAKGL 247
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
AFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA
Sbjct: 248 AFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 307
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWARPHLGERRRFYRL
Sbjct: 308 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRL 367
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQT 365
IDPRLEGHFS+KGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQ
Sbjct: 368 IDPRLEGHFSVKGAQKAALLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQA 427
Query: 366 MQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 421
MQA+RIG+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQFP PSPKPNGK
Sbjct: 428 MQADRIGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQFPQPSPKPNGK 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/416 (93%), Positives = 399/416 (95%), Gaps = 3/416 (0%)
Query: 8 ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNF 67
ESKSTNDTSRDQP A ISSTTTSNAESNSSTSKLEEELK+ASRLRKFTFNDLKLATRNF
Sbjct: 80 ESKSTNDTSRDQPTAPTISSTTTSNAESNSSTSKLEEELKIASRLRKFTFNDLKLATRNF 139
Query: 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 127
RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN+LGD
Sbjct: 140 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNYLGD 199
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
LVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF
Sbjct: 200 LVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 259
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE
Sbjct: 260 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 319
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307
YVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRP GEHNLVEWARPHLGERRRFYRLID
Sbjct: 320 YVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPIGEHNLVEWARPHLGERRRFYRLID 379
Query: 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQ 367
PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE LKPLPNLKDMASSSYYFQ+MQ
Sbjct: 380 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEVLKPLPNLKDMASSSYYFQSMQ 439
Query: 368 AERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 421
A++I SSPN ++ R QGG L RNG QRSLSIPNGS+ASPYHHQ+P SPKPNGK
Sbjct: 440 ADKIASSPNAKSSNRTQGG-LLRNGQQQRSLSIPNGSHASPYHHQYPFQSPKPNGK 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/417 (93%), Positives = 400/417 (95%), Gaps = 3/417 (0%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
+ESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEELKVASRLRKF FNDLKLATRN
Sbjct: 71 AESKSTIDTSRDQPTLRVVSSTTTSNAESNSSTSKLEEELKVASRLRKFAFNDLKLATRN 130
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN+LG
Sbjct: 131 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNYLG 190
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
DLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA
Sbjct: 191 DLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 250
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
FLHEEAERPVIYRDFKTSNILLDA+YN+KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP
Sbjct: 251 FLHEEAERPVIYRDFKTSNILLDAEYNSKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 310
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY+LI
Sbjct: 311 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYKLI 370
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 366
DPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM
Sbjct: 371 DPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 430
Query: 367 QAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPNGK 421
QA+R SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP PSPKPNGK
Sbjct: 431 QADRFSVSPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFPQPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/411 (93%), Positives = 396/411 (96%), Gaps = 4/411 (0%)
Query: 16 SRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGE 75
RDQP A V+SSTTTSNAESNSSTSKLEEELKVASRLRKF+FNDLK+ATRNFRPESLLGE
Sbjct: 85 CRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASRLRKFSFNDLKMATRNFRPESLLGE 144
Query: 76 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK 135
GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL+H NLVK
Sbjct: 145 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVK 204
Query: 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 195
LIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IRMKIALGAAKGLAFLHEEAERP
Sbjct: 205 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIRMKIALGAAKGLAFLHEEAERP 264
Query: 196 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 255
VIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT
Sbjct: 265 VIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 324
Query: 256 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 315
SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS
Sbjct: 325 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 384
Query: 316 IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSP 375
IKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSP
Sbjct: 385 IKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSP 444
Query: 376 NTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYHH-QFPHPSPKPNGKP 422
N RNG+R Q G LSRNG QRSLSIPNGS+ASPYH Q+P+ SPKPNGKP
Sbjct: 445 NARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQYPYQSPKPNGKP 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357486605|ref|XP_003613590.1| Serine/threonine protein kinase-like protein [Medicago truncatula] gi|355514925|gb|AES96548.1| Serine/threonine protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2034), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/417 (90%), Positives = 399/417 (95%), Gaps = 3/417 (0%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
+ESKSTNDTSR Q A VISSTTTSNAESNSST+KLEEELK+ASRLRKF+FN+LKLATRN
Sbjct: 76 AESKSTNDTSRGQRTAPVISSTTTSNAESNSSTTKLEEELKIASRLRKFSFNELKLATRN 135
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
FRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG
Sbjct: 136 FRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 195
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
DLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKIALGAAKGLA
Sbjct: 196 DLVHQNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPWSIRMKIALGAAKGLA 255
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP
Sbjct: 256 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 315
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
EYVMTGHLTS+SDVYSFGVVLLEM++GRRSMDK+RPNGEHNLVEWARPHLGERRRFYRLI
Sbjct: 316 EYVMTGHLTSKSDVYSFGVVLLEMISGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLI 375
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 366
DPRLEGHFS+KGAQKAAQLA HCLSRDPKARPLMSEVVEAL PLPNLKDMASSSYYFQ+M
Sbjct: 376 DPRLEGHFSVKGAQKAAQLAHHCLSRDPKARPLMSEVVEALMPLPNLKDMASSSYYFQSM 435
Query: 367 QAERIGSSPNTRNGIRAQGGSLSRNGQ--RSLSIPNGSYASPYHHQFPHPSPKPNGK 421
QAER G+SPN+R+ + AQG SL+RNGQ RSLSIPNG++ SPYHH++P SPKPN K
Sbjct: 436 QAERFGASPNSRS-VHAQGASLARNGQQRRSLSIPNGAHVSPYHHKYPQQSPKPNVK 491
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|53689728|gb|AAU89742.1| serine/threonine protein kinase-like [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2034), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/419 (91%), Positives = 399/419 (95%), Gaps = 5/419 (1%)
Query: 6 ISESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 65
++ESKSTN TSRDQP A +ISSTTTSNAESNSSTSKLEEELKV+SRLRKF FNDLKLATR
Sbjct: 186 LAESKSTN-TSRDQPVAPIISSTTTSNAESNSSTSKLEEELKVSSRLRKFAFNDLKLATR 244
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ W AEVNFL
Sbjct: 245 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQVLSIWQAEVNFL 304
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
GDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPWSIRMKIALGAAKGL
Sbjct: 305 GDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPWSIRMKIALGAAKGL 364
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA
Sbjct: 365 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 424
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL
Sbjct: 425 PEYVMTGHLTSKSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 484
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQT 365
+DPRLEGHFSIKGAQKAAQLAA CLSRDPKARP+MS+VVEALKPLPNLKDMASSSYYFQT
Sbjct: 485 VDPRLEGHFSIKGAQKAAQLAARCLSRDPKARPMMSDVVEALKPLPNLKDMASSSYYFQT 544
Query: 366 MQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSYASPYHHQFPHPSPKPNGK 421
MQA+R+GSSP+T+NG+R Q GS SRNGQ RSLSIPNGS+ASPYH QFP SPKPNGK
Sbjct: 545 MQADRVGSSPSTKNGVRTQ-GSFSRNGQQHPRSLSIPNGSHASPYHQQFPQNSPKPNGK 602
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100451|ref|XP_002311881.1| predicted protein [Populus trichocarpa] gi|222851701|gb|EEE89248.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2024), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/415 (93%), Positives = 402/415 (96%), Gaps = 2/415 (0%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
+ESKSTNDTS DQPAA V+S++TTSN ESNSSTSKLEEELKVASRLRKFTFNDLK ATRN
Sbjct: 31 TESKSTNDTSIDQPAALVVSTSTTSNTESNSSTSKLEEELKVASRLRKFTFNDLKFATRN 90
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG
Sbjct: 91 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 150
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
DLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA
Sbjct: 151 DLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 210
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
FLHEE ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP
Sbjct: 211 FLHEETERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 270
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
EYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI
Sbjct: 271 EYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 330
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM 366
DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV ALKPLPNLKDMAS+SYYFQTM
Sbjct: 331 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVNALKPLPNLKDMASTSYYFQTM 390
Query: 367 QAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPHPSPKPN 419
QAER+GSSPN RNG+R+Q G LSRNG QRSLSIP+GS+ASPYH+Q+PH SPKPN
Sbjct: 391 QAERVGSSPNARNGVRSQAGLLSRNGHQQRSLSIPHGSHASPYHYQYPHKSPKPN 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 422 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.950 | 0.813 | 0.798 | 1.1e-174 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.959 | 0.826 | 0.767 | 6.6e-168 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.872 | 0.812 | 0.8 | 8.4e-161 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.744 | 0.742 | 0.663 | 2.9e-112 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.691 | 0.712 | 0.720 | 3.6e-112 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.800 | 0.868 | 0.611 | 7.6e-112 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.732 | 0.782 | 0.632 | 3.9e-108 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.864 | 0.856 | 0.577 | 8.1e-108 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.819 | 0.812 | 0.581 | 1.5e-106 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.744 | 0.811 | 0.611 | 1.6e-104 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1697 (602.4 bits), Expect = 1.1e-174, P = 1.1e-174
Identities = 332/416 (79%), Positives = 355/416 (85%)
Query: 8 ESKSTNDTSRDQPAAAVIXXXXXXXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNF 67
ESKS N+ S DQP V + EEL ++S LRKFTFNDLKL+TRNF
Sbjct: 83 ESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNF 142
Query: 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 127
RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLG+
Sbjct: 143 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGN 202
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+F
Sbjct: 203 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSF 262
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
LHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPE
Sbjct: 263 LHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPE 322
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307
YVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+D
Sbjct: 323 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLD 382
Query: 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQ 367
PRLEGHFSIKGAQK QLAA CLSRDPK RP MS+VVEALKPLP+LKDMASSSYYFQTMQ
Sbjct: 383 PRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQ 442
Query: 368 AERIGSSPNTRNGI-RAQGGSLSRNGQ-----RSLSIPNGSYASPYHHQFPHPSPK 417
AER+ +NG R+QG SRNGQ R+LS P+GS SPY HQ P P PK
Sbjct: 443 AERL------KNGSGRSQGFG-SRNGQHQPVFRTLSSPHGS--SPYRHQIPSPKPK 489
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1633 (579.9 bits), Expect = 6.6e-168, P = 6.6e-168
Identities = 317/413 (76%), Positives = 346/413 (83%)
Query: 9 SKSTNDTSRDQPAAAVIXXXXXXXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNFR 68
S+S S DQP V + EEL + S L+KF+F DLKLATRNFR
Sbjct: 78 SQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFR 137
Query: 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 128
PESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LG+L
Sbjct: 138 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNL 197
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FL
Sbjct: 198 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFL 257
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 248
HEEA +PVIYRDFKTSNILLD +YNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEY
Sbjct: 258 HEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEY 317
Query: 249 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308
VMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+DP
Sbjct: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDP 377
Query: 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQA 368
RLEGHFS+KGAQK QLAA CLSRD K RP MSEVVE LKPLP+LKDMAS+SYYFQTMQA
Sbjct: 378 RLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQA 437
Query: 369 ERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIPNGSY-ASPYHHQFPHPSPK 417
ER+ + + +G R G SRNGQ R+LS P+G +SPY HQ P P PK
Sbjct: 438 ERLKAGSGSGSG-RGFG---SRNGQPVFRTLSSPHGQAGSSPYRHQIPSPKPK 486
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1566 (556.3 bits), Expect = 8.4e-161, P = 8.4e-161
Identities = 304/380 (80%), Positives = 335/380 (88%)
Query: 45 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 104
ELK +S+LR F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV
Sbjct: 81 ELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 140
Query: 105 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 164
KTLN DGLQGHKEWLAE+NFLG+LVH +LVKL+GYC+E+DQRLLVYEFMPRGSLENHLFR
Sbjct: 141 KTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFR 200
Query: 165 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224
R+LPLPWS+RMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKD
Sbjct: 201 RTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 260
Query: 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 284
P+ K+HVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLE+LTGRRS+DK+RPNG
Sbjct: 261 APDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNG 320
Query: 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344
E NLVEW RPHL +++RFYRL+DPRLEGH+SIKGAQKA Q+AA CL+RD KARP MSEVV
Sbjct: 321 EQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVV 380
Query: 345 EALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGS-LSRNG--QRSLSIPNG 401
EALKPLPNLKD ASSS FQTMQ P +NG+R QGG +SRNG RSLS N
Sbjct: 381 EALKPLPNLKDFASSSSSFQTMQ-------PVAKNGVRTQGGGFVSRNGPPMRSLSSLNL 433
Query: 402 SYASPYHHQFPHPSPKPNGK 421
ASPY ++ SPKP GK
Sbjct: 434 PQASPY--RYARQSPKPKGK 451
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 211/318 (66%), Positives = 255/318 (80%)
Query: 41 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 100
+ E E+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+
Sbjct: 54 RTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGV 113
Query: 101 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 160
+AVK LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLEN
Sbjct: 114 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 173
Query: 161 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
HLFRR PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLS
Sbjct: 174 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLS 232
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
DFGLAKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++
Sbjct: 233 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 292
Query: 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
DKNRP GE LVEWARP L +R+ +R+ID RL+ +S++ A K A LA CL+ + K R
Sbjct: 293 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 352
Query: 338 PLMSEVVEALKPLPNLKD 355
P M+EVV L+ + L +
Sbjct: 353 PNMNEVVSHLEHIQTLNE 370
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 214/297 (72%), Positives = 250/297 (84%)
Query: 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 114
FT +L+ T++FRP+ +LGEGGFG V+KG+I++N +K L VAVK LN +GLQG
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK---SLPVAVKVLNKEGLQG 113
Query: 115 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSI 173
H+EWL EVNFLG L H NLVKLIGYC EDD RLLVYEFM RGSLENHLFR++ PL WS
Sbjct: 114 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSR 173
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD+THV
Sbjct: 174 RMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 232
Query: 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293
STRVMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WAR
Sbjct: 233 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWAR 292
Query: 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
P L ++R+ ++IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL
Sbjct: 293 PKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
Identities = 209/342 (61%), Positives = 265/342 (77%)
Query: 41 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 100
+ E E+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+
Sbjct: 42 RTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGI 101
Query: 101 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 160
+AVK LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLEN
Sbjct: 102 VIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLEN 161
Query: 161 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
HLFRR PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLS
Sbjct: 162 HLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
DFGLA+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GRR++
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
DKN+P GEHNLV+WARP+L +RR R++DPRL+G +S+ A K A LA C+S D K+R
Sbjct: 281 DKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSR 340
Query: 338 PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRN 379
P M+E+V+ ++ L K+ + Q I SP N
Sbjct: 341 PTMNEIVKTMEELHIQKEASKEQQNPQISIDNIINKSPQAVN 382
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 3.9e-108, P = 3.9e-108
Identities = 198/313 (63%), Positives = 250/313 (79%)
Query: 41 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 100
K E E+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL
Sbjct: 41 KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100
Query: 101 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 160
+AVK LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLEN
Sbjct: 101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160
Query: 161 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
HLFRR PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYNAKLS
Sbjct: 161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLS 219
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
DFGLA+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL +RSDVYSFGV+LLE+L+G+R++
Sbjct: 220 DFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRAL 279
Query: 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
D NRP E NLV+WARP+L +R+ ++D RL+ + + A + A +A CLS +PK+R
Sbjct: 280 DHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSR 339
Query: 338 PLMSEVVEALKPL 350
P M +VV AL+ L
Sbjct: 340 PTMDQVVRALQQL 352
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 216/374 (57%), Positives = 267/374 (71%)
Query: 41 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 100
+ E E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 101 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 160
VAVK L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLEN
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 161 HLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219
HLFRR PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDF
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDF 235
Query: 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 279
GLAK GP GDKTHVST+VMGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++DK
Sbjct: 236 GLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 295
Query: 280 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 339
++ E +LV+WA P+LG++R+ +R++D RL G + KGA AA LA CL+ D K RP
Sbjct: 296 SKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPK 355
Query: 340 MSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSL-SI 398
MSEV+ L L + K QA+ SP NG Q + R L I
Sbjct: 356 MSEVLAKLDQLESTKPGTGVG----NRQAQI--DSPRGSNGSIVQKSPRRYSYDRPLLHI 409
Query: 399 PNGSYASPYHHQFP 412
G+ P H+ P
Sbjct: 410 TPGASPLPTHNHSP 423
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1054 (376.1 bits), Expect = 1.5e-106, P = 1.5e-106
Identities = 203/349 (58%), Positives = 257/349 (73%)
Query: 7 SESKSTNDTSRDQ-PAAAVIXXXXXXXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATR 65
S SK ++ TSR P+ + E E+ + L+ FTFN+LK AT+
Sbjct: 25 SGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKNATK 84
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
NFR ++LLGEGGFGCVFKGWI++ +PG+G+ VAVK L +G QGHKEWL EVN+L
Sbjct: 85 NFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLTEVNYL 144
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKG 184
G L H NLV L+GYC E + RLLVYEFMP+GSLENHLFRR PL W+IRMK+A+GAAKG
Sbjct: 145 GQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAVGAAKG 204
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L FLHE A+ VIYRDFK +NILLDAD+NAKLSDFGLAK GP GD THVST+V+GT+GYA
Sbjct: 205 LTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYA 263
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304
APEYV TG LT++SDVYSFGVVLLE+++GRR+MD + E++LV+WA P+LG++R+ +R
Sbjct: 264 APEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYLGDKRKLFR 323
Query: 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 353
++D +L G + KGA AA LA CL+ D K RP MSEV+ L+ L ++
Sbjct: 324 IMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESV 372
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
Identities = 195/319 (61%), Positives = 249/319 (78%)
Query: 43 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 102
E EL + L+ FTFN+LK ATRNF+P S++GEGGFGCV+KGWI E +P KPG+G+ V
Sbjct: 60 EGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVV 119
Query: 103 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 162
AVK L +G QGHKEWL EV++LG L H+NLVKLIGYC+E ++RLLVYE+MP+GSLENHL
Sbjct: 120 AVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHL 179
Query: 163 FRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221
FRR P+PW RMK+A AA+GL+FLHE VIYRDFK SNILLD D+NAKLSDFGL
Sbjct: 180 FRRGAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGL 236
Query: 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281
AK GP GD+THV+T+V+GT GYAAPEY+ TG LTS+SDVYSFGVVLLE+L+GR ++DK++
Sbjct: 237 AKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSK 296
Query: 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341
E NLV+WA P+L +RR+ +R++D +L G + KGA AA +A CL+ +PK RP M+
Sbjct: 297 VGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMA 356
Query: 342 EVVEALKPLP-NLKDMASS 359
+V+ L+ L + K M S+
Sbjct: 357 DVLSTLQQLETSSKKMGST 375
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8240 | 0.9526 | 0.8154 | yes | no |
| Q9SRH7 | Y3130_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7893 | 0.9597 | 0.8265 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 422 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 4e-54
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 66/278 (23%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 131
LGEGGFG V+ ++ G VA+K + + E L E+ L L H
Sbjct: 1 LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
N+VKL G +++ LV E+ GSL++ L L ++I L +GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109
Query: 192 AERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
+I+RD K NILLD+D KL+DFGL+K ++GT Y APE ++
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLL 166
Query: 251 -TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309
G+ + +SD++S GV+L E+
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL--------------------------------------- 187
Query: 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
+ L L +DP+ RP E++E L
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-53
Identities = 89/281 (31%), Positives = 128/281 (45%), Gaps = 30/281 (10%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 128
LGEG FG V+KG ++ + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H N+VKL+G C E++ +V E+M G L ++L + L S + AL A+G+ +L
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 248
+ I+RD N L+ + K+SDFGL++D + D + APE
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPES 174
Query: 249 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYRLI 306
+ G TS+SDV+SFGV+L E+ T P + E +L G R
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNGYRLPQPPNC 228
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
P L L C + DP+ RP SE+VE L
Sbjct: 229 PPEL------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 5e-53
Identities = 93/282 (32%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 128
LGEG FG V+KG ++ G + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 187
H N+VKL+G C E++ ++V E+MP G L ++L R L S + AL A+G+ +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
L + I+RD N L+ + K+SDFGL++D + D V + APE
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPE 174
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYRL 305
+ G TS+SDV+SFGV+L E+ T P + E +L G R
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKGYRLPKPPN 228
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
P L +L C + DP+ RP SE+VE L
Sbjct: 229 CPPEL------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-52
Identities = 90/284 (31%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 124
+ LG G FG V+K GTG VAVK L + + E+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184
L L H N+V+LI + D LV E+ G L R PL KIAL +G
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRG 110
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L +LH +I+RD K NILLD + K++DFGLAK + ++T V GT Y
Sbjct: 111 LEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYM 165
Query: 245 APEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
APE ++ G + DV+S GV+L E+LTG+ L + +
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIR 212
Query: 304 RLIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
R++ P LE G+++A L CL++DP RP E+++
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-51
Identities = 91/282 (32%), Positives = 134/282 (47%), Gaps = 37/282 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
LGEG FG V+KG ++ GT VAVKTL + +E+L E + + L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
N+V+L+G C + + +V E+MP G L + L + L +++AL AKG+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------RVMGTYGYAA 245
+ ++RD N L+ + K+SDFGL++D E D + M A
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------A 172
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PE + G TS+SDV+SFGV+L E+ T P + E L + YRL
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDG---YRL 223
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
PR E + +L C + DP+ RP SE+VE L
Sbjct: 224 --PRPEN-----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 6e-50
Identities = 94/295 (31%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 131
LGEG FG V+KG K G VAVKTL D + K++L E + L H
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPWSIRMKIALGAAK 183
N+V+L+G C E++ LV E+M G L ++L + L + A+ AK
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------RV 237
G+ +L + ++RD N L+ D K+SDFGL++D + D T R
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE---HNL-VEWAR 293
M APE + G TS+SDV+SFGV+L E+ T G L E
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVL 217
Query: 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
+L R+ YRL P + + +L C DP+ RP SE+VE L+
Sbjct: 218 EYL---RKGYRLPKPE---YCP----DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 84/282 (29%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 125
+ LGEG FG V+ TG VA+K + ++ +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKG 184
L H N+V+L ++D+ LV E+ G L + L R L R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L +LH + +++RD K NILLD D + KL+DFGLA+ G+K T V GT Y
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFY 303
APE ++ D++S GV+L E+LTG+ P G+ L+E + + F
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPF- 216
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
P E S +A L L +DP+ R E ++
Sbjct: 217 ----PPPEWDIS----PEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
F +G+GGFG V+K K TG VA+K + + + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKAR--------HKR-TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
H N+VK G ++ D+ +V EF GSL++ L + L S + KGL
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
+LH +I+RD K +NILL +D KL DFGL+ + + ++GT + AP
Sbjct: 113 YLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAP 166
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
E + ++D++S G+ +E+ G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 81/272 (29%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 129
LLG G FG V+ ++++ TG +AVK+ L+ D + + E+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKD--------TGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 130 HLNLVKLIGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRMKIALGAAKGLA 186
H N+V+ G ++++ L ++ E++ GSL + L ++ LP IR K +GLA
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR-KYTRQILEGLA 115
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
+LH +++RD K +NIL+D+D KL+DFG AK + + + V GT + AP
Sbjct: 116 YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
E + +D++S G ++EM TG+ P E A +G
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIG-----SSGE 221
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
P + H S ++A CL RDPK RP
Sbjct: 222 PPEIPEHLS----EEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHL 131
LGEG FG V + G TG VAVK+LNH G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 132 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
N+VK G C + R L+ E++P GSL ++L R + + + KG+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST--RVMGTYGYAAPE 247
+ I+RD NIL++++ K+SDFGLAK PE + + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLT 272
+ T +S SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 129
L+G G FG V+KG E TG VA+K L + K + E++ L +L
Sbjct: 7 LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 130 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H N+VK IG IE L ++ E+ GSL + ++ P P S+ +GLA+L
Sbjct: 58 HPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 248
HE+ VI+RD K +NIL D KL+DFG+A + K V+GT + APE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEV 170
Query: 249 V-MTGHLTSRSDVYSFGVVLLEMLTGR 274
+ M+G T+ SD++S G ++E+LTG
Sbjct: 171 IEMSGASTA-SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 99/377 (26%), Positives = 146/377 (38%), Gaps = 44/377 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 122
++R LGEG FG V+ + VA+K L KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 123 NFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIAL 179
L L H N+VKL + ++ LV E++ GSLE+ L R PL S + I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAK----DGPEGDKTHVS 234
L +LH + +I+RD K NILLD D KL DFGLAK G +
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 235 TRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291
+ +GT GY APE ++ + +S SD++S G+ L E+LTG + + + +
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-L 224
Query: 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-ALKPL 350
+ P S + A+ L L++DPK R S + L
Sbjct: 225 KIILELPTPSLASPLSPSNPELIS----KAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 351 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQ---------GGSLSRNGQRSLSIPNG 401
LK+ S A S P + + + L + PNG
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNG 340
Query: 402 SYASPYHHQFPHPSPKP 418
+SP++ S
Sbjct: 341 VSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 30/278 (10%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 130
+G+G FG V+KG ++ VAVKT K +L E L H
Sbjct: 2 KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
N+VKLIG C++ +V E +P GSL L ++ L ++++L AA G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE- 110
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
+ I+RD N L+ + K+SDFG++++ G T + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 251 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 310
G TS SDV+S+G++L E + + N + R + YR+ P+L
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPAPQL 219
Query: 311 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
+ +L C + DP+ RP SE+ L+
Sbjct: 220 CPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 84/293 (28%), Positives = 132/293 (45%), Gaps = 45/293 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 131
LG+G FG V++G VK VA+KT+N + + E+L E + + +
Sbjct: 14 LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 182
++V+L+G L+V E M +G L+++L L P + ++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
G+A+L A + ++RD N ++ D K+ DFG+ +D E D + +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----E 298
+ APE + G T++SDV+SFGVVL EM T L E +P+ G E
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQGLSNEE 229
Query: 299 RRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349
+F +ID GH K +L C +PK RP E+V +LK
Sbjct: 230 VLKF--VID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 28/209 (13%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 130
+ +G+G FG V G G VAVK L D +LAE + + L H
Sbjct: 12 ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLH 189
NLV+L+G ++ + +V E+M +GSL ++L R + + ++ AL +G+ +L
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHVSTRVMGTYGYAAP 246
E+ ++RD N+L+ D AK+SDFGLAK+ G + K V + AP
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAP 168
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLT-GR 274
E + +++SDV+SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 91/298 (30%), Positives = 135/298 (45%), Gaps = 28/298 (9%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 123
R + +LGEG FG V + P GTG VAVKTL + Q + W E+N
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L L H N+VK G C E + L+ E++P GSL ++L + L L + + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQI 116
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGT 240
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + + V
Sbjct: 117 CEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300
+ A E + + SDV+SFGV L E+LT ++ P ++ + + R
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVR 232
Query: 301 ------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352
R RL P+ Q+ L +C + K RP ++ LK + +
Sbjct: 233 LIELLERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 75/210 (35%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDL 128
LG+G FG V V K TG A+K L + KE L E N L +
Sbjct: 1 LGKGSFGKVLL----------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM--KIALGAAKG 184
H +VKL Y + +++L LV E+ P G L +HL + + +I L
Sbjct: 51 NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA---- 105
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L +LH +IYRD K NILLDAD + KL+DFGLAK+ + +T GT Y
Sbjct: 106 LEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYL 160
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
APE ++ D +S GV+L EMLTG+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 70/215 (32%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGDLVH 130
LGEG FG VF G ++P VAVKTL K++ E L + H
Sbjct: 13 LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL-------PLPWSIRMKI 177
N+VK G C E D ++V+E+M G L L L S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
A+ A G+ +L A + ++RD T N L+ D K+ DFG+++D D V
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
M + PE +M T+ SDV+SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 72 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV 129
LG+G FG V +G W G + VAVK L D L ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFL 188
H NL++L G + ++V E P GSL + L + +L S A+ A G+ +L
Sbjct: 55 HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST---RVMGTYGYAA 245
+ I+RD NILL +D K+ DFGL + P+ + +V +V + + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLT 272
PE + T + SDV+ FGV L EM T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 33/276 (11%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
+G G FG V+ G W+E+ VA+KT+ +G ++++ E + L H
Sbjct: 12 IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
LV+L G C E LV+EFM G L ++L + + + L +G+A+L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 251
VI+RD N L+ + K+SDFG+ + + D+ ST +++PE
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSF 175
Query: 252 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 311
+S+SDV+SFGV++ E+ + ++ +NR N E +VE +RL PRL
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TINAGFRLYKPRL- 225
Query: 312 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
+Q +L HC P+ RP S ++ L
Sbjct: 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVH 130
LGEG FG V+KG E G T +VA+KTL N + + +E+ E + DL H
Sbjct: 13 LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRM 175
N+V L+G C ++ +++E++ G L L R S L S +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
IA+ A G+ +L + ++RD N L+ K+SDFGL++D D V +
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 270
+ + + PE ++ G T+ SD++SFGVVL E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 130
LG G FG V+KG WI E VK + VA+K L + + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 184
++V+L+G C+ Q L+ + MP G L +++ L W +++ AKG
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
+++L E + +++RD N+L+ + K++DFGLAK +K + + +
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 290
A E ++ T +SDV+S+GV + E++T G + + +L+E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 67 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
F E LG G FG V++G W + VA+K L D L +++ EV L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGA 181
L H +L+ L C + ++ E M +GSL R + LP+ I M A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--ACQV 113
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
A+G+A+L E + I+RD NIL+ D K++DFGLA+ E ++ Y
Sbjct: 114 AEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PY 168
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE G +++SDV+SFG++L EM T
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 35/275 (12%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVH 130
+LG+G +G V+ G + VK V + T N + E L EV+ L L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
+N+V+ +G C++D+ + EF+P GS+ + L R PLP + K G+A+LH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRVMGTYGYAAP 246
V++RD K +N++L + KL DFG A+ G G +++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFY 303
E + +SD++S G + EM TG+ SMD+ A ++G R
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYIGAHRGLM 227
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
PRL FS A CL+RD RP
Sbjct: 228 ----PRLPDSFS----AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 42/273 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
+G+G FG VFK V+ A+K ++ + +E + E L L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRMKIALGAAKGL 185
+++ ++ + +V E+ G L L +R PLP W ++I LG L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
A LH + +++RD K+ N+ LDA N K+ D G+AK D T+ + ++GT Y +
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLS 169
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PE +SDV++ GVVL E TG+ D N + L+ + R
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRG 216
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
+ P + +S Q+ AQL CL++D + RP
Sbjct: 217 VFPPVSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 84/285 (29%), Positives = 128/285 (44%), Gaps = 48/285 (16%)
Query: 72 LLGEGGFGCVFKGWIEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 130
LLG G FG V++G ++G VK V++ G + K+ E+ L L H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---KIALGAAKGLA 186
N+V+ +G E+D + E +P GSL L ++ P IR+ +I LG L
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLG----LE 116
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-----GTY 241
+LH+ R ++RD K +NIL+D + KL+DFG+AK V G+
Sbjct: 117 YLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165
Query: 242 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300
+ APE + G +D++S G +LEM TG+ P + V A +G +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA-AVFKIGRSK 218
Query: 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
P + H S +A CL RDP RP +E++E
Sbjct: 219 EL-----PPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 90/278 (32%), Positives = 126/278 (45%), Gaps = 54/278 (19%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V+ G W NGT V AVKTL G + +L E + L H
Sbjct: 14 LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 188
LV+L C E++ +V E+M +GSL + L + L LP + M A A+G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTY 241
R I+RD NIL+ + K++DFGLA+ EG K +
Sbjct: 120 ES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------- 169
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERR 300
+ APE G T +SDV+SFG++L E++T R P G N R L +
Sbjct: 170 -WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN-----REVLEQVE 218
Query: 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
R YR+ PR ++ L C +DP+ RP
Sbjct: 219 RGYRM--PRPPNC-----PEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGD 127
E ++G G FG V +G ++ G + VA+KTL G + L E + +G
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
H N+++L G + +++ E+M GSL+ L + + G A G+ +
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAA 245
L +E ++RD NIL++++ K+SDFGL++ + E T ++ + A
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-LGERRRFYR 304
PE + TS SDV+SFG+V+ E+++ GE + + + YR
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGYR 226
Query: 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
L P QL C +D RP S++V L
Sbjct: 227 LPPPM-------DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 45/305 (14%)
Query: 53 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDG 111
+ T ND+ + + E+++ G G +KG +NG V VK +N +
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728
Query: 112 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 171
+ +E+ +G L H N+VKLIG C + L++E++ +L L L W
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSW 779
Query: 172 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
R KIA+G AK L FLH V+ + I++D L L+ G
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----L 832
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVE 290
T+ + Y APE T +T +SD+Y FG++L+E+LTG+ D G H ++VE
Sbjct: 833 CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVE 890
Query: 291 WAR-----PHLGERRRFYRLIDPRLEGHFSIKGAQ--KAAQLAAHCLSRDPKARPLMSEV 343
WAR HL IDP + G S+ + + LA HC + DP ARP ++V
Sbjct: 891 WARYCYSDCHLD------MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
Query: 344 VEALK 348
++ L+
Sbjct: 945 LKTLE 949
|
Length = 968 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 73/206 (35%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V KG K G + VAVKTL G KE+L E + + L H
Sbjct: 3 LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
+V+LIG C + +LV E P G L +L +R +P S ++A A G+A+L E
Sbjct: 57 CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYL--E 112
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG-----YAAP 246
++ V +RD N+LL + AK+SDFG+++ G + +T T G + AP
Sbjct: 113 SKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAP 167
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLT 272
E + G +S+SDV+S+GV L E +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 29/229 (12%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 124
N +G+G FG VF+ G P +P T VAVK L + ++ E
Sbjct: 6 NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------ 166
+ + H N+VKL+G C L++E+M G L L RS
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 167 ---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223
LPL + ++ IA A G+A+L +ER ++RD T N L+ + K++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ D S + PE + T+ SDV+++GVVL E+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 131
LG G G V K +P TG +AVKT+ + K+ L E++ L
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------GTYGY 243
+I+RD K SNIL+++ KL DFG VS +++ GT Y
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
APE + + +SD++S G+ L+E+ TGR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V G W + + VA+K + +G +++ E + L H
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
NLV+L G C + +V E+M G L N+L R L + + + + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEY 248
I+RD N L+ D K+SDFGLA+ D D+ S +A PE
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPPEV 172
Query: 249 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308
+S+SDV+SFGV++ E+ + + + N E +VE G YRL P
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG-----YRLYRP 223
Query: 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
+L + + C P+ RP +++ L
Sbjct: 224 KL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 50/280 (17%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV 129
+LG+G G V+K TG A+K ++ DG + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAP 246
+R +I+RD K SN+L+++ K++DFG++K + + T V GT Y +P
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSP 169
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
E + + +D++S G+ LLE G+ F+ L+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELM 212
Query: 307 D-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 338
P L FS + + CL +DPK RP
Sbjct: 213 QAICDGPPPSLPAEEFS----PEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 129
+LGEG FG V +G + ++ + +K VAVKT+ D +E+L+E + D
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 130 HLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 178
H N++KLIG C E +++ FM G L + L L LP +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVST 235
+ A G+ +L + R I+RD N +L D ++DFGL+K GD + ++
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295
+ + A E + TS+SDV++FGV + E+ T R H + ++
Sbjct: 177 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL--- 228
Query: 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
R RL P + L C DPK RP +++ E L+ +
Sbjct: 229 ----RHGNRLKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 5e-24
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 64/297 (21%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 123
+ +G+G FG V+ + +G +K L++ + ++ L EV
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVK 51
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP----WSIRM 175
L L H N++K E+ +L V E+ G L + ++ P P +
Sbjct: 52 ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
++ L L +LH R +++RD K NI L ++ KL DFG++K T
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKT 162
Query: 236 RVMGTYGYAAPE------YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289
V GT Y +PE Y +SD++S G VL E+ T + + L
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE---L- 211
Query: 290 EWARPHLGERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
+++ P + +S + L + L +DP+ RP ++++
Sbjct: 212 ------------ALKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 9e-24
Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LGEG FG VF E +P K + VAVK L L K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 176
+VK G C + D ++V+E+M G L N R P L S +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
M + PE +M T+ SDV+SFGV+L E+ T
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-23
Identities = 73/217 (33%), Positives = 110/217 (50%), Gaps = 26/217 (11%)
Query: 72 LLGEGGFGCVFKGW---IEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGD 127
LG G FG V++G I G+ P++ VAVKTL Q KE+L E + + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIR------VAVKTLRKGATDQEKKEFLKEAHLMSN 55
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALG 180
H N+VKL+G C+ ++ + ++ E M G L ++L F L L + I L
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLD 114
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGPEGDKTHVST 235
AKG +L + I+RD N L+ DAD K+ DFGLA+D + D
Sbjct: 115 VAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ + APE ++ G T++SDV+SFGV++ E+LT
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 4e-23
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 43/300 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 124
LGEG FG V + P V+ G L VAVK L D + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 169
L L N+++L+G C+++D ++ E+M G L L L L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 170 P---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226
P +S + +AL A G+ +L + ++RD T N L+ + K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 285
GD + R + + A E ++ G T+ SDV++FGV L E+L + K +P GE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245
Query: 286 --HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
++E A ++ R L P Q +L C SRD + RP S++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 124
R+ + LG+G FG V E P++ TG VAVK L H + +++ E+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 125 LGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
L L H N+VK G C +R LV E++P GSL ++L + L + A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--- 239
KG+ +L + ++RD T NIL++++ K+ DFGL K P+ DK + R G
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESP 174
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ Y APE + + SDV+SFGVVL E+ T
Sbjct: 175 IFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 9e-23
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 62 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 119
L R LLG G FG V KG WI E + + VA+KT+ + G Q +E
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
+ +G L H +V+L+G C LV + P GSL +H+ + L + +
Sbjct: 58 DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
AKG+ +L E +++R+ NILL +D +++DFG+A DK + +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ A E ++ G T +SDV+S+GV + EM++
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 66/207 (31%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 129
LG+GGFG V A TG A K L+ L +G + L E L + V
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKV 50
Query: 130 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAF 187
+ + Y E L LV M G L+ H++ P P + + A GL
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
LH+ R ++YRD K N+LLD N ++SD GLA + G K GT GY APE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGR 274
+ D ++ G L EM+ GR
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V++G W N T PV AVKTL + K++LAE + L H
Sbjct: 14 LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 188
L++L C ++ +V E M GSL +L R+L LP I M A A G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTY 241
+ I+RD N+L+ + K++DFGLA+ + EG K +
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK------- 169
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 274
+ APE + + +SDV+SFG++L E++T GR
Sbjct: 170 -WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 74/224 (33%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 131
LG G FG V++G V+ L VAVKTL Q ++L E + H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMK----IALGAAKG 184
N+V+LIG E R ++ E M G L++ L R + P P S+ MK A AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 185 LAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+L E I+RD N LL AK++DFG+A+D R M
Sbjct: 129 CKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 285
+ PE + G TS++DV+SFGV+L E+ + R N E
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 79/275 (28%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 129
S LGEG G V K + TG+ A+KT+ D K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 130 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAKG 184
+VK G +++ + E+ GSL++ + +R + + KIA KG
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGY 243
L++LH R +I+RD K SNILL KL DFG++ + T GT Y
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFY 169
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
APE + + SDV+S G+ LLE+ R P GE L
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVNMPNP 226
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
L D E IK +++ CL +DP RP
Sbjct: 227 ELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 39/233 (16%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 122
+F+ ++GEG F V + T A+K L+ L + K E
Sbjct: 2 DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52
Query: 123 NFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIAL 179
L L H ++KL Y +D++ L V E+ P G L ++ SL R A
Sbjct: 53 EVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE 110
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM- 238
L +LH + +I+RD K NILLD D + K++DFG AK +
Sbjct: 111 -ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 239 -----------------GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
GT Y +PE + SD+++ G ++ +MLTG+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 73 LGEGGFG----CVFKGWIEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 126
LGEG FG C +G E G AP G + VAVK L D + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--------- 177
L + N+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 178 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
A+ A G+ +L A ++RD T N L+ Y K++DFG++++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
R + + A E ++ G T+ SDV++FGV L EM T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 19/208 (9%)
Query: 72 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGDLV 129
++G+G FGCV+ G I+ +G + AVK+LN L+ +++L E + D
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQK-------IHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 130 HLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLA 186
H N++ L+G C+ + L+V +M G L N F RS +++ I G AKG+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYA 244
+L A + ++RD N +LD + K++DFGLA+D E H T +
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLT 272
A E + T T++SDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 5e-22
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 122
+ LGEG +G V+K ++ G VA+K + +G+ L E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
+ L +L H N+VKL+ + + LV+E+ L+ +L +R PL ++ I
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+GLA+ H +++RD K NIL++ D KL+DFGLA+ +T+ + V+ T
Sbjct: 109 RGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLW 163
Query: 243 YAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
Y APE ++ S + D++S G + EM+TG+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LGEG FG VF E P + + VAVKTL K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 179
+VK G C+E D ++V+E+M G L N R P L S + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
A G+ +L A + ++RD T N L+ + K+ DFG+++D D V M
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ PE +M T+ SDV+S GVVL E+ T
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGDL 128
+GEG G VFK E TG TVA+K + G+ + L E+ L
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H +VKL+ +LV E+MP L L PLP + KG+A++
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 248
H +++RD K +N+L+ AD K++DFGLA+ E + S +V T Y APE
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE- 170
Query: 249 VMTG--HLTSRSDVYSFGVVLLEMLTGR 274
++ G D+++ G + E+L G
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 81/284 (28%), Positives = 112/284 (39%), Gaps = 48/284 (16%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGDLVH 130
+G G FG V+ V TG +AVK + D KE E+ L L H
Sbjct: 8 IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
NLVK G + ++ + E+ G+LE L L + L +GLA+LH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV---MGTYGYAAPE 247
+++RD K +NI LD + KL DFG A T + V GT Y APE
Sbjct: 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPE 173
Query: 248 YVMTGHLTSR---SDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEWA---RPHLGE 298
+ G +D++S G V+LEM TG+R +D E+ G
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGAGH 223
Query: 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 342
+ + EG + CL DPK RP SE
Sbjct: 224 KPPIPDSLQLSPEGKDFLD----------RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 84/278 (30%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 130
LLG+G FG VFKG +++ VAVKT D Q K ++L+E L H
Sbjct: 2 LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
N+VKLIG C + +V E +P G + L ++ L +K AL AA G+A+L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT-YGYAAPEYV 249
+ I+RD N L+ + K+SDFG+++ E D + S+ + + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEAL 166
Query: 250 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309
G +S SDV+S+G++L E S+ G N + AR + + YR+ P+
Sbjct: 167 NYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV---EKGYRMSCPQ 217
Query: 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
K ++ C P+ RP SE+ + L
Sbjct: 218 -------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-21
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+GEG FG V +G TG VAVK + D + +L E + L H N
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIALGAAKGLAFLHEE 191
LV+L+G I + +V E M +G+L N L R L I++ + +L A+G+ +L
Sbjct: 61 LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVM 250
+ +++RD NIL+ D AK+SDFGLA+ G G D + + + + APE +
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170
Query: 251 TGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 279
+S+SDV+S+GV+L E+ + GR K
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGDLVH 130
+GEG G V+K TG VA+K + L+ + L E+ + D H
Sbjct: 27 IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
N+V + D+ +V E+M GSL + + + + + + +GL +LH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
+ VI+RD K+ NILL D + KL+DFG A + S V+GT + APE V+
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VI 188
Query: 251 TGHL-TSRSDVYSFGVVLLEMLTG 273
+ D++S G++ +EM G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 73 LGEGGFGCV-------FKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 124
LGEG FG V + + E+ + VAVK L D +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIR 174
L L N+ +L+G C D ++ E+M G L L + S L +S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
+ +A A G+ +L ++RD T N L+ +Y K++DFG++++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
R + A E V+ G T++SDV++FGV L E+LT
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-21
Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 37/286 (12%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 121
L+G+G +G V+ + N T TG +AVK + HD Q K +E
Sbjct: 8 LIGKGTYGRVY---LALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
+ L DL HLN+V+ +G+ ++ + E++P GS+ + R +
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+GLA+LH + +++RD K N+L+DAD K+SDFG++K + + + G+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 242 GYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
+ APE + + +++ D++S G V+LEM GR RP + + A LG +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFKLGNK 227
Query: 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
R P + S+ + A C + +P RP E+++
Sbjct: 228 RS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKI 177
+V+ G C E L+V+E+M G L N R P L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
A A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
M + PE ++ T+ SD++SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVHL 131
LGEG FG V E P TG VAVK+L + H L E+ L +L H
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 132 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
N+VK G C ED L+ EF+P GSL+ +L R + ++K A+ KG+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPE 247
R ++RD N+L+++++ K+ DFGL K E DK + + + + + APE
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLT 272
++ SDV+SFGV L E+LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 120
N+R LLG+G FG V+ TG +AVK + D KE A
Sbjct: 3 NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
E+ L +L H +V+ G C+ DD+ L ++ E+MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 237
+G+ +LH +++RD K +NIL D+ N KL DFG +K T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167
Query: 238 MGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLT 272
GT + +PE V++G R +DV+S G ++EMLT
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 33/210 (15%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G +G V++G W + + LTVAVKTL D ++ E+L E + ++ H
Sbjct: 14 LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLH 189
NLV+L+G C + ++ EFM G+L ++L R + + + +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE 121
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 242
++ I+RD N L+ ++ K++DFGL++ G K +
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------- 170
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + + +SDV++FGV+L E+ T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 73 LGEGGFG----CVFKG---WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 124
LGEG FG C +G +++++ + V + VAVK L D + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP----------WSIR 174
+ L N+++L+ CI D ++ E+M G L L R +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
+ +A A G+ +L + ++RD T N L+ +Y K++DFG++++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
R + + + E ++ G T+ SDV++FGV L E+LT
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 47/293 (16%)
Query: 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 121
L + + +G+G FG V G G VAVK + +D + +LAE
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 179
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
+ + +L ++RD N+L+ D AK+SDFGL K E T + ++
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL-- 161
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
+ APE + +++SDV+SFG++L E+ + R V + R L +
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD- 207
Query: 300 RRFYRLIDPRLEGHFSIKGAQKAA----QLAAHCLSRDPKARPLMSEVVEALK 348
+ PR+E + + + C D RP ++ E L+
Sbjct: 208 ------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 101 TVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 159
VA+K ++ + Q E EV + H N+VK + D+ LV ++ GSL
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 160 NHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216
+ + S P L +I + KGL +LH + I+RD K NILL D + K+
Sbjct: 88 -DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKI 143
Query: 217 SDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEM 270
+DFG LA G V +GT + APE VM ++D++SFG+ +E+
Sbjct: 144 ADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIEL 200
Query: 271 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA-AQLAAHC 329
TG K P L P P LE K K+ ++ + C
Sbjct: 201 ATGAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADYKKYSKSFRKMISLC 247
Query: 330 LSRDPKARPLMSEVVE 345
L +DP RP E+++
Sbjct: 248 LQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGH-KEWLAEVNFLGDLVH 130
+GEG +G V+K + TG VA+K + +G K L E+ L +L H
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH 57
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
N++KL+ L LV+EFM L + R LP S+ +GLAF H
Sbjct: 58 PNIIKLLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGYAAP 246
+++RD K N+L++ + KL+DFGLA+ P TH V TR Y AP
Sbjct: 116 SHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAP 167
Query: 247 EYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
E ++ ++ D++S G + E+L+ R
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-20
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 16/211 (7%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 128
+ ++G G FG VF+G ++ G V VA+KTL + + ++L+E + +G
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H N+++L G + +++ E+M G+L+ +L + + G A G+ +L
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAA 245
++ ++RD NIL++++ K+SDFGL++ D PEG T ++ + A
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
PE + TS SDV+SFG+V+ E+++ G R
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 75/299 (25%), Positives = 110/299 (36%), Gaps = 51/299 (17%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDL 128
++GEG +G V K + TG VA+K + D K L EV L L
Sbjct: 7 GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAF 187
H N+V L + LV+E++ R LE LP P ++R + +A+
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
H +I+RD K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 116 CHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
Query: 248 ----YVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSMDKNRPNGEHN 287
G DV++ G ++ E+L G + + P H
Sbjct: 172 LLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQ 226
Query: 288 LVEWARPHLGERRRFYRLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 342
+ + P +P LE + K + A CL DPK R E
Sbjct: 227 ELFSSNPRF----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 7e-20
Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 131
LG+G FG V++G + G +P T VA+KT+N ++ E+L E + + +
Sbjct: 14 LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 180
++V+L+G + L++ E M RG L+++L RSL P +++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 128 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-ER 299
+ +PE + G T+ SDV+SFGVVL E+ T L E +P+ G
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGMSN 227
Query: 300 RRFYRLIDPRLEGHFSIKG---AQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
+ R + +EG K +L C +PK RP E++ ++K
Sbjct: 228 EQVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 122
+F ++G+G FG V +++ T A+K +N + L E
Sbjct: 1 HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L +L H LV L Y +D++ + LV + + G L HL ++ ++ I
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EI 109
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
L +LH + +I+RD K NILLD + ++DF +A T T GT
Sbjct: 110 VLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281
GY APE + + D +S GV E L G+R +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
F LGEG +G V+K +E G VA+K + + +E + E++ L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
+VK G ++ +V E+ GS+ + + + L I KGL
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
+LH I+RD K NILL+ + AKL+DFG++ G D V+GT + AP
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAP 168
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
E + +++D++S G+ +EM G+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 3e-19
Identities = 69/232 (29%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 123
N LGEG FG V K +K G T VAVK L + ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---------------FRRSLP 168
L + H +++KL G C +D LL+ E+ GSL + L R S
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 169 L------PWSIRMKI--ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220
L ++ I A ++G+ +L AE +++RD N+L+ K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
L++D E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 71/227 (31%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 129
LGEG FG V K E G P TVAVK L D + K+ L DLV
Sbjct: 19 PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATE--KD-------LSDLVSE 65
Query: 130 ---------HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSI 173
H N++ L+G C ++ +V E+ G+L + L R S P
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 174 RMKI--------ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225
+ A A+G+ FL A + I+RD N+L+ D+ K++DFGLA+D
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
D +T + APE + T +SDV+SFGV+L E+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-19
Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 12/203 (5%)
Query: 72 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 129
+LG G FG V+KG W+ E T + VA+K LN G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
H +LV+L+G C+ +L V + MP G L +++ + + + + AKG+ +L
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 249
E R +++RD N+L+ + + K++DFGLA+ +K + + + A E +
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 250 MTGHLTSRSDVYSFGVVLLEMLT 272
T +SDV+S+GV + E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 8e-19
Identities = 81/293 (27%), Positives = 123/293 (41%), Gaps = 62/293 (21%)
Query: 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 117
LKL + LG G FG V+ G+ + VA+K+L G +
Sbjct: 6 ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47
Query: 118 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIR 174
+LAE N + L H LV+L + + ++ E+M GSL + L L + I
Sbjct: 48 FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPE 227
M A A+G+AF+ + I+RD + +NIL+ K++DFGLA+ E
Sbjct: 107 M--AAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161
Query: 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 285
G K + + APE + G T +SDV+SFG++L E++T R N E
Sbjct: 162 GAKFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
Query: 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
NL R YR+ P ++ +L C P+ RP
Sbjct: 214 QNL-----------ERGYRMPRPD-------NCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 8e-19
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 31/286 (10%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 128
E ++G G FG V +G ++ G + VA+KTL + +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H N++ L G + +++ EFM G+L++ L + + + G A G+ +L
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAA 245
+E ++RD NIL++++ K+SDFGL++ + T +G + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304
PE + TS SDV+S+G+V+ E+++ G R N +E + YR
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----------QDYR 229
Query: 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
L P + QL C +D ARP ++V L +
Sbjct: 230 LPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 131
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 181
++V+L+G + L+V E M G L+++L RSL P P +++ I + A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126
Query: 182 --AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
+ APE + G T+ SD++SFGVVL E+ + L E L
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228
Query: 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
+ ++D ++ L C +PK RP E+V LK
Sbjct: 229 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+F+ LG+G +G V+K + A+K ++ G KE VN +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDL-GSMSQKEREDAVNEI 50
Query: 126 GDLVHLNLVKLIGY--CIEDDQRL-LVYEFMPRGSLENHLFRRSL---PLPWSIRMKIAL 179
L +N +I Y D +L +V E+ P G L + +R +P +I +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
+GL LHE + +++RD K++NILL A+ K+ D G++K K +++ +G
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
T Y APE + +SD++S G +L EM T + AR R
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDLR 210
Query: 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
+ R P + +S Q L PK RP ++
Sbjct: 211 YKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 130
+GEG FG V++G + VAVKT + +E +L E + H
Sbjct: 13 CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
++VKLIG ++ +V E P G L ++L L + + + + LA+L
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
+ ++RD N+L+ + KL DFGL++ E + + +++ + APE +
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESIN 181
Query: 251 TGHLTSRSDVYSFGVVLLEML 271
TS SDV+ FGV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 41/218 (18%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 122
+LG+G FG V A +K GT AVK L D K LA
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIA 178
L L+ C + RL V E++ G L H+ R P + +I
Sbjct: 53 GKHPFLTQLHS------CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 237
LG L FLHE R +IYRD K N+LLD++ + K++DFG+ K+G G T +
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STF 156
Query: 238 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
GT Y APE +++ + D ++ GV+L EML G+
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 55/284 (19%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGDLV 129
+G+G FG V K V+ G + K +++ + K+ L +EVN L +L
Sbjct: 8 IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 130 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP----WSIRMKIAL 179
H N+V+ I+ + L V E+ G L L ++ + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 180 GAAKGLAFLH--EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVS 234
L H + V++RD K +NI LDA+ N KL DFGLAK KT+V
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294
GT Y +PE + +SD++S G ++ E+ P AR
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-------SPPFT------ARN 214
Query: 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
L + R+ +S + ++ L+ DP RP
Sbjct: 215 QLQLASKIKEGKFRRIPYRYS----SELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 41/222 (18%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGHKE---WLA 120
+F LG G FG V V+ G+G A+K L+ + K+ L
Sbjct: 1 DDFEFIKTLGTGSFGRVML----------VRHKGSGKYYALKILSKAKIVKLKQVEHVLN 50
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM--- 175
E L + H LV L G +DD L LV E++P G L +HL + P P + R
Sbjct: 51 EKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA 108
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
++ L L +LH ++YRD K N+LLD+D K++DFG AK V
Sbjct: 109 QVVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKG 153
Query: 236 RVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 273
R GT Y APE ++ G+ D ++ G+++ EML G
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 45/273 (16%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V+ G W NG VAVKTL G + +L E + L H
Sbjct: 14 LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 188
LV+L + ++ +V E+M +GSL + L R+L LP + M A A G+A++
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 118
Query: 189 HEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAA 245
ER I+RD +++NIL+ K++DFGLA+ + + T R + + A
Sbjct: 119 ----ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTA 171
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PE + G T +SDV+SFG++L E++T R N R L + R YR+
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRM 222
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
P+ +L C +DP+ RP
Sbjct: 223 PCPQ-------DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
+GEG +G V+K N TG VA+K + ++ KE + E+ L
Sbjct: 7 IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54
Query: 128 LVHLNLVKLIGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR--MKIALG 180
L H N+V+L + +V+E+M G L++ + + I+ MK L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLL- 110
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
+GL +LH +++RD K SNIL++ D KL+DFGLA+ + T + T
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVIT 164
Query: 241 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
Y PE ++ D++S G +L E+ G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG G FG V G K + VA+K +N +G ++++ E + L H
Sbjct: 12 LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 192
LV+L G C + +V EFM G L N+L +R L + + + +G+ +L +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 252
I+RD N L+ + K+SDFG+ + + D+ S+ ++ PE
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 253 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 312
+S+SDV+SFGV++ E+ T + + + N E +VE R +RL P+L
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVE-------MISRGFRLYRPKLAS 227
Query: 313 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
+ + C P+ RP +E++ A+
Sbjct: 228 MTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 55/284 (19%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 125
F +G+G FG V+K + T VA+K ++ + + E + E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
+ K G ++ + ++ E+ GS + L + L + I GL
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGL 111
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYG 242
+LHEE I+RD K +NILL + + KL+DFG++ G T ++ +GT
Sbjct: 112 EYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPF 163
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRR 301
+ APE + ++D++S G+ +E+ G P + H + R
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG------EPPLSDLHPM------------R 205
Query: 302 FYRLID----PRLEGH-FS--IKGAQKAAQLAAHCLSRDPKARP 338
LI P LEG+ FS K + CL++DPK RP
Sbjct: 206 VLFLIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDL-VH 130
LG G FG V +E K + VAVK L +E L +E+ + L H
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLH 189
N+V L+G C L++ E+ G L N L R R L + + AKG+AFL
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAP 246
A + I+RD N+LL K+ DFGLA+D D +V + R+ + AP
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKWMAP 212
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLT 272
E + T SDV+S+G++L E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 75/291 (25%), Positives = 118/291 (40%), Gaps = 32/291 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 124
N + + LG G FG VF + G V VK L E+ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIA 178
L H N+V+L+G C E + ++ E+ G L+ L + P P S + K+A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 179 LGA--AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
L A G+ L + ++RD N L+ + K+S L+KD + +
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRN 177
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
+ + APE V +++SDV+SFGV++ E+ T E L
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELPFYGL 222
Query: 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
+ RL +LE + +L C + +PK RP SE+V AL
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 117
+L L+ F E LGE FG ++KG + G + VA+KTL + + Q E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53
Query: 118 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 166
+ E + + +L H N+V L+G ++ +++E++ +G L L RS
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 167 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221
L + IA+ A G+ +L + +++D NIL+ + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+++ D V + + + PE +M G +S SD++SFGVVL E+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGD 127
E +LG G FG + +G ++ L VA+ TL G + +LAE LG
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRE------LPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
H N+V+L G + ++V E+M G+L++ L + L M + G A G+ +
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHVSTRVMGTYGYAAP 246
L +E +++ +L+++D K+S F L +D E T +S + +AAP
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAP 177
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
E + H +S SDV+SFG+V+ E+++ G R
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 19/190 (10%)
Query: 97 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 150
TG +AVK + N Q + E+ + L H ++++++G ED L
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 151 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210
E+M GS+ +HL + ++ + +GL++LH E +I+RD K +N+L+D+
Sbjct: 83 EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDS 138
Query: 211 D-YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFG 264
+++DFG LA G + +++GT + APE V+ G RS DV+S G
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVG 195
Query: 265 VVLLEMLTGR 274
V++EM T +
Sbjct: 196 CVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 45/285 (15%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 119
++ + R + LG+G FG V+ G W NGT VA+KTL G + +L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 176
E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 50 QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM- 107
Query: 177 IALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
A A G+A++ ER I+RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 108 -AAQIADGMAYI----ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---A 159
Query: 236 RVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293
R + + APE + G T +SDV+SFG++L E++T R N R
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------R 210
Query: 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
L + R YR+ P+ + +L C +DP RP
Sbjct: 211 EVLEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 66 NFRPESL-----LGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQG-HKEW 118
+ R E L LG G G V K VK TG +A K ++ K+
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSK----------VKHIPTGTVMAKKVVHIGAKSSVRKQI 50
Query: 119 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
L E+ + + +V G + ++ + EFM GSL+ ++++ P+P I KIA
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIA 109
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRV 237
+ +GL +L+ +++RD K SNIL+++ KL DFG++ G+ + ++
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTF 162
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
+GT Y +PE + G T +SDV+S G+ ++E+ G+
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 130
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 175
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 120
+ LGEG + V+K +E G VA+K + + K+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGINFTALR 51
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--MKI 177
E+ L +L H N++ L+ LV+EFM LE + +S+ L P I+ M +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VS 234
L +GL +LH +++RD K +N+L+ +D KL+DFGLA+ P TH V
Sbjct: 111 TL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 235 TRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
TR Y APE + H D++S G + E+L
Sbjct: 165 TRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG+G FG V+K TGL A K + + + ++++ E++ L + H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 192
+V L +++ ++ EF G+L++ + L + + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 251
VI+RD K NILL D + KL+DFG+ AK+ K +GT + APE V
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177
Query: 252 GHLTS-----RSDVYSFGVVLLEMLTGR 274
++D++S G+ L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 7e-17
Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 52/222 (23%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 127
LG+G FG V+ +E G VA+K + + W L EV L
Sbjct: 7 LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53
Query: 128 L-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIRMKIALGA 181
L H N+VKL E+D+ V+E+M E +L+ R+ P S+ I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRV 237
+GLA +H+ +RD K N+L+ K++DFGLA++ P D +VSTR
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR- 162
Query: 238 MGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 274
Y APE + L S S D+++ G ++ E+ T R
Sbjct: 163 ----WYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 120
+ E ++G G FG V G ++ G + VA+KTL G+ E +L+
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLK----AGYTEKQRRDFLS 54
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
E + +G H N++ L G + ++V E+M GSL+ L + + + G
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG 114
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRV 237
A G+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T ++
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + TS SDV+S+G+V+ E+++
Sbjct: 172 --PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 77/241 (31%), Positives = 106/241 (43%), Gaps = 40/241 (16%)
Query: 46 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 105
L + + NDL+ +G G G V+K ++ G +AVK
Sbjct: 3 LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46
Query: 106 TLNHDGLQGHKEWLAEVNFLGDL-VHL------NLVKLIGYCIEDDQRLLVYEFMPRGSL 158
+ G +KE + L DL V L +VK GY I D + E M L
Sbjct: 47 QMRRTG---NKEENKRI--LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CL 100
Query: 159 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218
+ L R P+P I K+ + K L +L E+ VI+RD K SNILLDA N KL D
Sbjct: 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCD 158
Query: 219 FGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYVMTGHLTS----RSDVYSFGVVLLEMLTG 273
FG++ G D K TR G Y APE + R+DV+S G+ L+E+ TG
Sbjct: 159 FGIS--GRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214
Query: 274 R 274
+
Sbjct: 215 Q 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 130
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 175
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 71/303 (23%), Positives = 125/303 (41%), Gaps = 58/303 (19%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 120
NF+ E +G+G F V+K +G VA+K + + K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 173
E++ L L H N++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+++ L +H + +++RD K +N+ + A KL D GL + KT
Sbjct: 112 FVQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293
+ ++GT Y +PE + +SD++S G +L EM
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204
Query: 294 PHLGERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
P G++ Y L P H+S ++ L + C++ DP+ RP +S V++
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYS----EELRDLVSRCINPDPEKRPDISYVLQ 260
Query: 346 ALK 348
K
Sbjct: 261 VAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 130
LGEG FG V + E G +P +TVAVK L + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIRM 175
N++ L+G C ++ ++ E+ +G+L L R P P + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
A A+G+ +L R I+RD N+L+ D K++DFGLA+ + D ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + T +SDV+SFG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 83/280 (29%), Positives = 129/280 (46%), Gaps = 45/280 (16%)
Query: 66 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 124
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 181
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 111
Query: 182 AKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
A G+A++ ER ++RD + +NIL+ + K++DFGLA+ + + T R
Sbjct: 112 ASGMAYV----ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAK 164
Query: 241 Y--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
+ + APE + G T +SDV+SFG++L E+ T R N R L +
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQ 215
Query: 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
R YR+ P + + L C ++P+ RP
Sbjct: 216 VERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 129
+G G FG V+ N T VAVK +++ G Q +++W + EV FL L
Sbjct: 29 IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
H N ++ G +++ LV E+ GS + L PL I GA +GLA+LH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 249
+I+RD K NILL KL+DFG A K+ + +GT + APE +
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVI 189
Query: 250 MT---GHLTSRSDVYSFGVVLLEM 270
+ G + DV+S G+ +E+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-17
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 121
+L+G G FG V+ G + +G +AVK +++ + L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
+ L +L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQI 115
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR----- 236
KGL +LH R +I+RD K +NIL+D K+SDFG++K E + T
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPS 171
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
+ G+ + APE V T ++D++S G +++EMLTG+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 77/299 (25%), Positives = 124/299 (41%), Gaps = 51/299 (17%)
Query: 60 LKLATRNFRPESLL------GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ 113
L+L P S L GEG G V TG VAVK ++ Q
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58
Query: 114 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 173
+ EV + D H N+V++ + D+ +V EF+ G+L + + +
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--- 115
Query: 174 RMKIA---LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGP 226
+IA L K L+FLH + VI+RD K+ +ILL +D KLSDFG ++K+ P
Sbjct: 116 --QIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286
++GT + APE + + D++S G++++EM+ G P
Sbjct: 171 R------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---- 220
Query: 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
L +R + P+L+ K + + L RDP R +E++
Sbjct: 221 ---------LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 69/209 (33%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 130
+GEG +G VFK E TG VA+K + D K L E+ L L H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
NLV LI ++L LV+E+ ++ N L + +P + KI + + F H
Sbjct: 60 PNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 246
+ I+RD K NIL+ KL DFG A+ GP D T +V+TR Y AP
Sbjct: 118 KHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 247 EYVMTGHLT--SRSDVYSFGVVLLEMLTG 273
E ++ G DV++ G V E+LTG
Sbjct: 170 E-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 56/157 (35%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 140 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 193
C + + RL V EF+ G L H+ R R LP +S + +AL FLHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHE--- 114
Query: 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTG 252
R +IYRD K N+LLDA+ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 253 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 287
D ++ GV++ EM+ GR D N + N
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG G FG V+ G+ N T VAVKTL G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 189
LV+L +++ ++ E+M +GSL + L + LP I + A+G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 242
+ I+RD + +N+L+ K++DFGLA+ EG K +
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------- 169
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + G T +SDV+SFG++L E++T
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 73/245 (29%), Positives = 100/245 (40%), Gaps = 57/245 (23%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 122
+F ++G G FG V+ TG A+K L + + AE
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MK 176
+ L D +VKL Y +D++ L LV E+MP G L N L R+ + + R +
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----- 231
+AL + L F+H RD K NIL+DAD + KL+DFGL K +
Sbjct: 112 LALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 232 -----------------HVSTRVM-----GTYGYAAPEYVMTGH-LTSRSDVYSFGVVLL 268
H RV GT Y APE V+ G D +S GV+L
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILY 221
Query: 269 EMLTG 273
EML G
Sbjct: 222 EMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 51/290 (17%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 121
LG G FGCV+K + NG +A+K +N K+ ++E
Sbjct: 7 HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 122 VNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----WSI 173
V + + L H N+V+ +E+D+ +V + + P G N L + W+I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+++ L L +LH+E + +++RD +NI+L D ++DFGLAK K
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170
Query: 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293
T V+GT Y+ PE V ++DV++FG +L +M T P N++ A
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA- 222
Query: 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
+ + +P EG +S + + CL+ D +ARP + +V
Sbjct: 223 -----TKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 140 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 198
C + RL LV E++ G L H+ +R LP A L FLHE R +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119
Query: 199 RDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 257
RD K N+LLDAD + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFS 176
Query: 258 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 317
D ++ GV++ EM+ GR D N + N ++ + E+ R+ S+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPRFLSV- 228
Query: 318 GAQKAAQLAAHCLSRDPKAR 337
KA+ + L++DPK R
Sbjct: 229 ---KASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 83/282 (29%), Positives = 121/282 (42%), Gaps = 47/282 (16%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 123
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 124 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAA 109
Query: 183 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
+ GL LH E +YRD K NILLD + ++SD GLA PEG+ + RV G
Sbjct: 110 EILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-G 163
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
T GY APE + T D + G ++ EM+ G+ P G +
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRK 205
Query: 300 RRFYR-LIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 337
+ R +D R+ E +S K +++A + L++DPK R
Sbjct: 206 EKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 76/282 (26%), Positives = 115/282 (40%), Gaps = 49/282 (17%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 125
++ L+G G +G V++G TG VA+K +N D + EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 126 GDLVHL---NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK----I 177
L N+ K G RL ++ E+ GS+ R+L I K I
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVI 106
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
L ++H+ VI+RD K +NIL+ N KL DFG+A + ST V
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV 162
Query: 238 MGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
GT + APE + G +++D++S G+ + EM TG L+ ++P
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-- 219
Query: 297 GERRRFYRLIDPRLEG-HFSIKGAQKAAQLAAHCLSRDPKAR 337
PRLE +S + + A CL +PK R
Sbjct: 220 -----------PRLEDNGYS----KLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 76 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLN 132
G +G VF K TG A+K + + + L E + L
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 133 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
+VKL Y + + L LV E++P G L L L + L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS------TRVMGTYGYAA 245
+I+RD K NIL+D++ + KL+DFGL+K G + +++ R++GT Y A
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 246 PEYVMTGHLTSRS-DVYSFGVVLLEMLTG 273
PE V+ G S++ D +S G +L E L G
Sbjct: 170 PE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 73/215 (33%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHD-----GLQGH----KEWLAEV 122
LG GGFG V VK T A+K + G Q H KE L E
Sbjct: 1 LGVGGFGRVEL----------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC 50
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
N H +VKL Y D++ +Y E+ G L L R L ++ R IA
Sbjct: 51 N------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA- 100
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
+LH R +IYRD K N+LLD++ KL DFG AK G KT G
Sbjct: 101 CVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCG 154
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
T Y APE ++ D +S G++L E+LTGR
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 82/276 (29%), Positives = 115/276 (41%), Gaps = 35/276 (12%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 123
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 124 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGA 181
L + V+ V + Y E D LV M G L+ H++ + A
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
GL LH+E ++YRD K NILLD + ++SD GLA PEG + RV GT
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTV 165
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
GY APE V T D ++ G +L EM+ G+ + + + VE
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 214
Query: 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
RL+ ++ +S K + A L L +DPK R
Sbjct: 215 --RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHL 131
LG G FGCV KG + + VA+K L ++ + E + E + L +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
+V++IG C E + +LV E G L L + + S +++ + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYV 249
+ ++RD N+LL + AK+SDFGL+K D ++ R G + + APE +
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 250 MTGHLTSRSDVYSFGVVLLEMLT 272
+SRSDV+S+G+ + E +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 87/283 (30%), Positives = 128/283 (45%), Gaps = 58/283 (20%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 124
+LG+GG+G VF+ + + A TG A+K L + H + AE N
Sbjct: 2 KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 125 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WSIRMKIA 178
L + H +V LI Y + +L L+ E++ G L HL R + + + + +A
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 237
L LH++ +IYRD K NILLDA + KL+DFGL K+ EG TH
Sbjct: 113 LE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---F 160
Query: 238 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
GT Y APE +M +GH D +S G ++ +MLTG A P
Sbjct: 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG------------------APPFT 201
Query: 297 GERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKAR 337
E R+ + ID L+G ++ +A L L R+P +R
Sbjct: 202 AENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 130
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM-------------- 175
N++ L+G C +D ++ E+ +G+L +L RR + +S +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVK----PGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFL 125
+LG+G FG VF V+ P G A+K L L+ E + L
Sbjct: 3 VLGQGSFGKVFL----------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL 52
Query: 126 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184
++ H +VKL Y + + +L L+ +F+ G L L + + ++ +A A
Sbjct: 53 AEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 245 APEYV-MTGHLTSRSDVYSFGVVLLEMLTG 273
APE V GH S +D +SFGV++ EMLTG
Sbjct: 166 APEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 124
NF+ LGEG + V+KG N T TG VA+K ++ D +G + E++
Sbjct: 1 NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGA 181
+ +L H N+V+L +++ +LV+E+M + ++ H R +L L
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
KG+AF HE V++RD K N+L++ KL+DFGLA+ T + V T
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TL 164
Query: 242 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
Y AP+ ++ S S D++S G ++ EM+TGR
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG+G FG V+K +E TG+ A K ++ + ++++ E++ L H N
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 192
+VKL+ ++ ++ EF G+++ + PL + + L +LHE
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 252
+I+RD K NIL D + KL+DFG++ + S +GT + APE VM
Sbjct: 124 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178
Query: 253 HLTSR-----SDVYSFGVVLLEM 270
R +DV+S G+ L+EM
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVH 130
LGEG FG V +G + ++ + L VAVKT+ +++L+E + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 131 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 179
N+++LIG C++ + +++ FM G L + L L LP + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
A G+ +L + + I+RD N +L+ + N ++DFGL+K GD
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ A E + T++SDV+SFGV + E+ T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 39/240 (16%)
Query: 119 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 175
L E+ L L H N++ + ++D+ L+ E+ G+L + + R+ +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
+ +A ++++H+ +++RD KT NI L KL DFG++K G + ++
Sbjct: 107 LFQIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAE 159
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 289
V+GT Y +PE +SD+++ G VL E+LT +R+ D P NLV
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQG 216
Query: 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349
+ P + + + + L L +DP+ RP EV++
Sbjct: 217 NYT---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 65/224 (29%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 130
++GEG +G V+K + TG VA+K ++ +E E N L H
Sbjct: 13 VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 131 LNLVKLIG------YCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIAL 179
N+ G DDQ LV E GS+ + + L W IA
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117
Query: 180 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 234
+GLA+LHE VI+RD K NILL + KL DFG++ D G + +
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTF 173
Query: 235 TRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG 273
GT + APE + +RSDV+S G+ +E+ G
Sbjct: 174 I---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLV 129
LG+GGFG E VK TG A K L+ L+ G K L E L +
Sbjct: 1 LGKGGFG--------EVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 130 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGL 185
+V L Y E L LV M G L+ H++ R L + I + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
LH ++YRD K N+LLD N +LSD GLA + +G T+ GT GY A
Sbjct: 109 LHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMA 162
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
PE + + D ++ G + EM+ GR
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 71/237 (29%), Positives = 102/237 (43%), Gaps = 43/237 (18%)
Query: 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 120
R++ LGEG FG V+K + TG VA+K L H+ G L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56
Query: 121 EVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLPL 169
E+ L L H N+V LI +E +R VY P G LEN + +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES- 115
Query: 170 PWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---- 223
I+ M L +G+ +LHE +++RD K +NIL+D K++DFGLA+
Sbjct: 116 --QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 224 -----DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
G G T T ++ T Y PE ++ T+ D++ G V EM T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 44/124 (35%), Positives = 73/124 (58%), Gaps = 7/124 (5%)
Query: 151 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210
E M GSL+ L +++ +P +I KI++ +GL +L E+ +++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS 135
Query: 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 270
KL DFG++ G D ++ +GT Y +PE + H T +SD++S G+ L+EM
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 271 LTGR 274
GR
Sbjct: 192 AIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 39/276 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG G FG V G K VA+K + +G E++ E + L H
Sbjct: 12 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEK 60
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 192
LV+L G C + +V E+M G L N+L S +++ +G+A+L
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--- 117
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPEYV 249
+ I+RD N L+D K+SDFGL++ D + S+ +G+ ++ PE +
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEVL 173
Query: 250 MTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308
+ +S+SDV++FGV++ E+ + G+ ++ N E VE + + R YR P
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KVSQGLRLYR---P 223
Query: 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344
L ++K + C + RP +++
Sbjct: 224 HL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 116
++ L+T F E LGE FG V+KG + GTAP + VA+KTL D +G +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53
Query: 117 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------- 166
E+ E L H N+V L+G ++ +++ + L L RS
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 167 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221
L + + I A G+ FL + V+++D T N+L+ N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
++ D + + + +PE +M G + SD++S+GVVL E+ +
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 26/220 (11%)
Query: 62 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 119
L F+ +LG G FG V+KG WI P + VA+K L + +KE L
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWS 172
E + + + ++ +L+G C+ +L + + MP G L ++++ + L L W
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWC 115
Query: 173 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 232
+++ AKG+ +L E R +++RD N+L+ + K++DFGLAK +K +
Sbjct: 116 VQI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ + A E ++ T +SDV+S+GV + E++T
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 69 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 121
PE L +G+G FG VFKG +N T V VA+K ++ + + E + E
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQE 52
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
+ L + K G ++D + ++ E++ GS + L PL + I
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREI 110
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
KGL +LH E + I+RD K +N+LL KL+DFG+A G D +GT
Sbjct: 111 LKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTP 165
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
+ APE + S++D++S G+ +E+ G + P L+ P
Sbjct: 166 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------- 218
Query: 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 354
P LEG++S + + CL+++P RP E+++ + K
Sbjct: 219 ------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 123
+ ++G G FG V + V +K + + + + A E
Sbjct: 1 KYEKIRVVGRGAFGIV---HLCRRKADQKL------VIIKQIPVEQMTKDERLAAQNECQ 51
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPWSIRMK 176
L L H N+++ +ED ++V E+ P G+L N L L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVST 235
+A LH + +++RD KT NILLD K+ DFG++K K+ T
Sbjct: 112 LA---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT 160
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 278
V+GT Y +PE +SD+++ G VL E+ + +R+ +
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 67/260 (25%), Positives = 111/260 (42%), Gaps = 34/260 (13%)
Query: 98 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLI--GYCIEDDQRLLVYEF 152
TG VA+K L D + + + E L H N+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 153 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---D 209
+P +L L LP ++ L LA H + +++RD K NI++
Sbjct: 61 VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 210 ADYNAKLSDFGLAKDGP---EGDKTHVS--TRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 264
+AK+ DFG+ P + D ++ T V+GT Y APE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 265 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 324
++ LE LTG+R + G ++ E L + P + GH Q
Sbjct: 177 LIFLECLTGQRVVQ-----GA-SVAEILYQQLSPVD---VSLPPWIAGH-------PLGQ 220
Query: 325 LAAHCLSRDPKARPLMSEVV 344
+ L++DP+ R + +
Sbjct: 221 VLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG+G FG V+K +E TG A K + + ++++ E+ L H
Sbjct: 20 LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 190
+VKL+G D + ++ EF P G+++ + R L P I++ I + L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
+I+RD K N+LL D + KL+DFG++ + + S +GT + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183
Query: 251 TGHLTS-----RSDVYSFGVVLLEM 270
+ ++D++S G+ L+EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 71/220 (32%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 117
FR ++LG G FG V A K TG A+K L + L K
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 118 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
N H LV L C + + + V E+ G L H+ P R
Sbjct: 52 IFETAN---SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAV 104
Query: 177 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVS 234
A GL +LHE ++YRD K N+LLD + K++DFGL K+G GD+T S
Sbjct: 105 FYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 273
T GT + APE V+T +R+ D + GV++ EML G
Sbjct: 160 T-FCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 129
+G G FG V+ VA+K +++ G Q +++W + EV FL L
Sbjct: 23 IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
H N ++ G + + LV E+ GS + L PL I GA +GLA+LH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 249
I+RD K NILL KL+DFG A + +GT + APE +
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPANSFVGTPYWMAPEVI 183
Query: 250 MT---GHLTSRSDVYSFGVVLLEM 270
+ G + DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 41/98 (41%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 240
A GL FLH + +IYRD K N++LDA+ + K++DFG+ K+ G KT TR GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGT 164
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 278
Y APE + D ++FGV+L EML G+ D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 36/223 (16%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 128
E ++GEG FG V + I+ K G + A+K L + H+++ E+ L L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 129 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR---------- 174
H N++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 175 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
++ A A G+ +L +E+ I+RD N+L+ + +K++DFGL++ G++
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEV 171
Query: 232 HVSTRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+V + MG + A E + T++SDV+SFGV+L E+++
Sbjct: 172 YVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 80/281 (28%), Positives = 119/281 (42%), Gaps = 45/281 (16%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 123
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 124 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAA 109
Query: 183 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
+ GL L E ++YRD K NILLD + ++SD GLA PEG+ V RV G
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-G 163
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
T GY APE + T D + G ++ EM+ G+ K + V+
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE------ 212
Query: 300 RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 337
+D R+ + +S K ++ A + L+++PK R
Sbjct: 213 ------VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 131
+G G FG V G G + + V VK L +L EV +L H
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 186
N+++ +G CIE LLV EF P G L+N+L + + ++A A GL
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
+LH+ I+ D N L AD + K+ D+GLA + D + AP
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 247 EYV-------MTGHLTSRSDVYSFGVVLLEMLT 272
E V + T +S+++S GV + E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-15
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 129
+LG+G FG V + ++ G+ VAVK L D +E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 130 HLNLVKLIGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PLPWSIRMKIA 178
H N++KLIG + RL ++ FM G L L + LP ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 238
+ A G+ +L + + I+RD N +L+ + ++DFGL+K GD
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ A E + T+ SDV++FGV + E++T
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 8e-15
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 203
D LV E++ G + L + LP + G+ LH+ R +I+RD K
Sbjct: 70 DYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKP 125
Query: 204 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 263
N+L+D + KL+DFGL+++G + + +GT Y APE ++ SD +S
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 264 GVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 291
G V+ E L G P N + W
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 68/212 (32%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 129
LG+GGFG V A TG A K LN L +G++ + E L V
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK-V 50
Query: 130 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GL 185
H + + Y + L LV M G L H++ P + A+ GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTYG 242
LH+ R +IYRD K N+LLD D N ++SD GLA KDG K + GT G
Sbjct: 111 EHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPG 162
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
+ APE + D ++ GV L EM+ R
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 131
+G G FG VF G + + T VAVK+ K ++L E L H
Sbjct: 3 IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES- 112
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEYV 249
+ I+RD N L+ K+SDFG++++ E D + ST M + APE +
Sbjct: 113 --KHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 250 MTGHLTSRSDVYSFGVVLLEMLT 272
G +S SDV+SFG++L E +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 72/208 (34%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGDL 128
+G+G FG V + G AVK L + KE +AE N L ++
Sbjct: 3 IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGL 185
H LV L Y + +L V +++ G L HL R RS P P R + A A L
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
+LH +IYRD K NILLD+ + L+DFGL K+G E KT ++ GT Y A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
PE + D + G VL EML G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 67 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 124
LL EG FG +F G I+E KPG V VKT+ +H L E
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 125 LGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK-- 176
L L H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQL 119
Query: 177 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPE-----G 228
+A+ A G+++LH+ R VI++D N ++D + K++D L++D P G
Sbjct: 120 VHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
D + + M A E ++ +S SDV+SFGV+L E++T
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
GL FLH+ + +IYRD K N+LLD D + K++DFG+ K+ G+ ++ GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
APE + D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 50/297 (16%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 122
NFR E +G G F V++ +G VA+K + L + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 179
+ L L H N++K IED++ +V E G L H ++ +P K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
L +H R V++RD K +N+ + A KL D GL + KT + ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
T Y +PE + +SD++S G +L EM P G++
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 210
Query: 300 RRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
Y L P H+S ++ QL C++ DP+ RP ++ V + K
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+G G +G V+K G VA+K + + + E++ L + H N
Sbjct: 11 IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIAL---GAAKGLAF 187
+V G + D+ +V E+ GSL++ + R L +IA KGLA+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAY 116
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYA 244
LHE I+RD K +NILL D + KL+DFG++ T + +GT +
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWM 168
Query: 245 APEYV---MTGHLTSRSDVYSFGVVLLEM 270
APE G + D+++ G+ +E+
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 32/207 (15%)
Query: 140 CIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 193
C + + RL V E++ G L H+ R R LP +S + +AL +LHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE--- 114
Query: 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG 252
R +IYRD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 253 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 310
D ++ GV++ EM+ GR D + N + N ++ + E++ R+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRI 224
Query: 311 EGHFSIKGAQKAAQLAAHCLSRDPKAR 337
S+ KAA + L++DPK R
Sbjct: 225 PRSLSV----KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 84/307 (27%), Positives = 119/307 (38%), Gaps = 65/307 (21%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLV 129
L+GEG +G V K +E TG VA+K + D K + E+ L L
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
H NLV LI + LV+EF+ L + L + L S K +G+ F H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 246
+I+RD K NIL+ KL DFG A+ P T +V+TR Y AP
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAP 169
Query: 247 EYVMTGHLTSRS-DVYSFGVVLLEMLTG---------------------------RRSMD 278
E ++ R+ D+++ G ++ EMLTG +
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 279 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
KN L E + +RF P+L G LA CL DP RP
Sbjct: 230 KNPLFAGMRLPE-VKEIEPLEKRF-----PKLSG--------LVLDLAKQCLRIDPDDRP 275
Query: 339 LMSEVVE 345
S+++
Sbjct: 276 SSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 129
E LG G FG V+ ++ VAVKT+ G + +LAE N + L
Sbjct: 11 EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLA 186
H LVKL + + ++ EFM +GSL + L PLP I + A+G+A
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMG 239
F+ + R I+RD + +NIL+ A K++DFGLA+ EG K +
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----- 168
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 275
+ APE + G T +SDV+SFG++L+E++T R
Sbjct: 169 ---WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 62 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 119
L + +LG G FG V+KG WI P + VA+K L + + +KE L
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 57
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
E + + + +L+G C+ +L V + MP G L +++ + + +
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPE--GDKTHV 233
AKG+++L E +++RD N+L+ + + K++DFGLA+ D E D V
Sbjct: 117 QIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173
Query: 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ M A E ++ T +SDV+S+GV + E++T
Sbjct: 174 PIKWM------ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
+LG+G FG VF A +K GT A+K L D V + D V
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKD-----------VVLMDDDVEC 41
Query: 132 NLV--KLIG-----------YCI--EDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSI 173
+V +++ YC + V E++ G L H+ + LP
Sbjct: 42 TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY 101
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+I G L FLH + ++YRD K NILLD D + K++DFG+ K+ GD
Sbjct: 102 AAEIICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152
Query: 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
+ GT Y APE ++ + D +SFGV+L EML G+
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 42/198 (21%)
Query: 161 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220
++ + L +P I KIA+ K L +LH + VI+RD K SN+L++ + KL DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 221 --------LAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLL 268
+AK G K Y APE + +SDV+S G+ ++
Sbjct: 150 ISGYLVDSVAKTIDAGCKP-----------YMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 269 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLAA 327
E+ TGR D W P + ++ P+L FS +
Sbjct: 199 ELATGRFPYDS-----------WKTP-FQQLKQVVEEPSPQLPAEKFSP----EFQDFVN 242
Query: 328 HCLSRDPKARPLMSEVVE 345
CL ++ K RP E+++
Sbjct: 243 KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 55/233 (23%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 124
+ +G G +G V V TG VA+K +++ D L K L E+
Sbjct: 2 YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 125 LGDLVHLNLVKLIGYCIEDDQRL------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
L L H N++ L+ + +V E M E L + I+
Sbjct: 53 LRHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHK-------VIKSPQP 99
Query: 179 LGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPE 227
L +GL +LH VI+RD K SNIL++++ + K+ DFGLA+ P+
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 228 GDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
D+ +V TR Y APE +++ +++ D++S G + E+LT +
Sbjct: 157 EDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-14
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
LG G FG V KG + + TVAVK L +D E L E N + L +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
+V++IG C E + +LV E G L L + +I ++ + G+ +L E
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEE 113
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEY 248
++RD N+LL + AK+SDFGL+K D+ + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 249 VMTGHLTSRSDVYSFGVVLLE 269
+ +S+SDV+SFGV++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 121
NF+ +GEG +G V+K + TG VA+K + D G+ + E
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 178
++ L +L H N+VKL+ +++ LV+EF+ + F + P +P +
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 238
+GLAF H + R V++RD K N+L++ + KL+DFGLA+ G T +
Sbjct: 107 FQLLQGLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 161
Query: 239 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSM 277
T Y APE ++ + ++ D++S G + EM+T RR++
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 123
+ + +G+G G V+ TA + TG VA+K +N Q KE + E+
Sbjct: 19 KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
+ + H N+V + + D+ +V E++ GSL + + + + +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQ 126
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 242
L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 127 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 180
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
+ APE V + D++S G++ +EM+ G
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 128
+ ++GEG FG V K I+ K G + A+K + + H+++ E+ L L
Sbjct: 12 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 129 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGA 181
H N++ L+G C L E+ P G+L + L R+S L IA L +
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 182 AKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
+ L F + A ++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179
Query: 235 TRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 180 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 139 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197
Y + D +L L+ +++ G L HL++R +R+ IA L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGII 127
Query: 198 YRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMT---G 252
YRD K NILLD++ + L+DFGL+K+ E ++ + GT Y APE + G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGG 184
Query: 253 HLTSRSDVYSFGVVLLEMLTG 273
H D +S GV+ E+LTG
Sbjct: 185 H-DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
LG G G V+K + T +AVK + D ++ K+ ++E+ L
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
++ G +++ + EFM GSL+ ++R+ +P + +IA+ KGL +L
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS- 113
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 251
+++RD K SN+L++ KL DFG++ ++ +GT Y APE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISG 167
Query: 252 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---P 308
SDV+S G+ +E+ GR + + N + L + ++D P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPP 218
Query: 309 RL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
L G FS +K C+ + PK RP +++
Sbjct: 219 VLPVGQFS----EKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 122
N+R LLG+G FG V+ + V G L + + + KE A E+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55
Query: 123 NFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
L +L H +V+ G C+ D ++ L ++ E+MP GS+++ L + L S+ K
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTR 113
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-VM 238
+G+++LH +++RD K +NIL D+ N KL DFG +K + R V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
GT + +PE + ++DV+S G ++EMLT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVH 130
++GEG FG V K I+ K G + A+K + + H+++ E+ L L H
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 131 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 174
N++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 175 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 234 STRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 167 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 9e-14
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 53 RKFTFNDLKLATRNFR--PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 104
R + D ++A F+ PE L +G G FG V+ + + T V VA+
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV-------VAI 55
Query: 105 KTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 161
K +++ G Q +++W + EV FL + H N ++ G + + LV E+ GS +
Sbjct: 56 KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDL 114
Query: 162 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221
L PL I GA +GLA+LH +I+RD K NILL KL+DFG
Sbjct: 115 LEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS 171
Query: 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 270
A + +GT + APE ++ G + DV+S G+ +E+
Sbjct: 172 ASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 40/284 (14%)
Query: 69 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 121
PE L +G+G FG VFKG +N T V VA+K ++ + + E + E
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
+ L + K G ++ + ++ E++ GS + L R+ P +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEI 110
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
KGL +LH E + I+RD K +N+LL + KL+DFG+A G D +GT
Sbjct: 111 LKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTP 165
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
+ APE + S++D++S G+ +E+ G P L+ P
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP------- 218
Query: 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
P L G FS + + CL++DP RP E+++
Sbjct: 219 ------PTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 131
+G+G FG V+KG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
+ + G ++ + ++ E++ GS + L + PL + I KGL +LH E
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 251
+ I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 252 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 311
++D++S G+ +E+ G P L+ P P LE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 222
Query: 312 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
G +S + + CL++DP+ RP E+++
Sbjct: 223 GQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L FLH VIYRD K NILLDA+ + KL+DFG+ K+G T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
APE + D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 73/256 (28%), Positives = 100/256 (39%), Gaps = 58/256 (22%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 125
+G+GG+G VF K TG VA+K + L L EV L
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 126 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIR 174
LVKL+ Y +DD+ L L E++P G L R +
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AE 109
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
M A+ A L ++H RD K N L+DA + KL+DFGL+K +
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA 292
V+G+ Y APE V+ G + D +S G +L E L G + PN NL W
Sbjct: 156 NSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK 214
Query: 293 ----RPHLGERRRFYR 304
RP + R
Sbjct: 215 ETLQRPVYDDPRFNLS 230
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 31/222 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 120
N+R LLG+G FG V+ + + TG +AVK + + + + KE A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
E+ L +L+H +V+ G + +R L E MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKTH 232
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS- 168
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
V GT + +PE + ++D++S G ++EMLT +
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 74/235 (31%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGL 112
FT DLK +G G FG V K + +GT +AVK D
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEK 44
Query: 113 QGHKEWLAEVNFLGDLVH-----LNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-----HL 162
+ K L ++ D+V +VK G + + E M SL+ +
Sbjct: 45 E-QKRLLMDL----DVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYE 98
Query: 163 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222
+S+ +P I KIA+ K L +L EE + +I+RD K SNILLD + N KL DFG++
Sbjct: 99 VLKSV-IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
Query: 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGR 274
G D TR G Y APE + RSDV+S G+ L E+ TG+
Sbjct: 156 --GQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 119
+L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
E+ L + +V G D + + E M GSL+ + +++ +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSI 110
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
KGL +L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
T Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 127
+GEG +G V+KG TG VA+K + L+ +E + E++ L +
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKIAL-GAAK 183
L H N+V L +++ + L++EF+ L+ +L SLP + +K L +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQ 112
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
G+ F H R V++RD K N+L+D KL+DFGLA+ G V T + T Y
Sbjct: 113 GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 244 AAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
APE ++ S D++S G + EM T +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 96/363 (26%), Positives = 143/363 (39%), Gaps = 68/363 (18%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 128
LLG+G FG V ++E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 185
H L L Y + RL V E+ G L HL R + +S GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 108
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
+LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + GT Y A
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 164
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PE + D + GVV+ EM+ GR L+ L E RF R
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPRT 218
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPK---------ARPLMS---------EVVEAL 347
+ P +A L + L +DPK A+ +M + V
Sbjct: 219 LSP------------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK 266
Query: 348 KPLPNLKDMASSS----YYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 403
K +P K +S Y+ + A+ I +P ++ + +R P SY
Sbjct: 267 KLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDN-----ERRPHFPQFSY 321
Query: 404 ASP 406
++
Sbjct: 322 SAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
GL FLH + +IYRD K N++LD D + K++DFG+ K+ GD ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
APE + T D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 69 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 119
PE L +G G FG V+ N VA+K +++ G Q +++W +
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
EV FL L H N ++ G + + LV E+ GS + L PL +
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
GA +GLA+LH +I+RD K NILL KL DFG A + +G
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVG 173
Query: 240 TYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 270
T + APE ++ G + DV+S G+ +E+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
++G GGFG V+ K TG A+K L+ ++ + E L + + L
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIML 48
Query: 132 NLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
+LV + Y +L + + M G L HL + + +R A
Sbjct: 49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEII 107
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+G
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHG 160
Query: 243 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288
Y APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 119
+L +F S LG G G V K KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
E+ L + +V G D + + E M GSL+ + + + +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSI 110
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
+GLA+L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
T Y +PE + H + +SD++S G+ L+E+ GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 83/278 (29%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLA--EVN 123
FR +LG+GGFG V A TG A K L ++ K E +A E
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 124 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAA 109
Query: 183 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
+ GL LH E ++YRD K NILLD + ++SD GLA + PEG+ + RV G
Sbjct: 110 EITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-G 163
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
T GY APE V T D + G ++ EM+ G+ + + + VE
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--------- 214
Query: 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
R + E +S K ++ A + L++DP R
Sbjct: 215 ----RRVKEDQE-EYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 50/145 (34%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 130 HLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H L +L C + RL V EF+ G L H+ ++S + A L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 248
H+ + +IYRD K N+LLD + + KL+DFG+ K+G KT ++ GT Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEI 167
Query: 249 VMTGHLTSRSDVYSFGVVLLEMLTG 273
+ D ++ GV+L EML G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 97 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFM 153
GTG A+K L + K+ E + L +L H +V ++ ++++ + EF+
Sbjct: 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100
Query: 154 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213
G L HL R++ P + +LH + +IYRD K N+LLD +
Sbjct: 101 VGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGH 156
Query: 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 272
K++DFG AK P+ T + GT Y APE + + GH D ++ GV+L E +
Sbjct: 157 VKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIA 210
Query: 273 G 273
G
Sbjct: 211 G 211
|
Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 36/217 (16%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 127
LG+G +G V+K + T VA+K + D + + A E+ FL +
Sbjct: 15 LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62
Query: 128 LV-HLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 181
L H N+VKL+ E+D+ + LV+E+M E L R ++ R I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVM 238
K L ++H VI+RD K SNILL++D KL+DFGLA+ + E + V T +
Sbjct: 117 LKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 239 GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
T Y APE ++ ++ D++S G +L EML G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 85/275 (30%), Positives = 112/275 (40%), Gaps = 48/275 (17%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 128
LLG+G FG V + E T G A+K L + + E + E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 185
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSAL 108
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
+LH R V+YRD K N++LD D + K++DFGL K+G T + GT Y A
Sbjct: 109 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRF 302
PE + D + GVV+ EM+ GR + D R L E L E RF
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIRF 214
Query: 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
R + P +A L A L +DPK R
Sbjct: 215 PRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 120
N+R LLG G FG V+ + + TG +AVK + + D + KE A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 121 EVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 177
E+ L +L H +V+ G C+ D +++L ++ E+MP GS+++ L + L ++ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKT 231
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
V GT + +PE + ++DV+S ++EMLT
Sbjct: 169 -----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 21/183 (11%)
Query: 98 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 157
+G VAVK ++ Q + EV + D H N+V++ + ++ ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 158 LENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214
L + + + L +IA + L +LH + VI+RD K+ +ILL D
Sbjct: 105 LTDIVSQTRLN-----EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRV 156
Query: 215 KLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 270
KLSDFG ++KD P+ ++GT + APE + + D++S G++++EM
Sbjct: 157 KLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 271 LTG 273
+ G
Sbjct: 211 VDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 46/297 (15%)
Query: 66 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 124
NF+ E +G G F V++ + + +K V+ + ++ + E++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGA 181
L L H N++K + IED++ +V E G L + ++ +P K +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+ +H R V++RD K +N+ + A KL D GL + KT + ++GT
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
Y +PE + +SD++S G +L EM P G++
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDKMN 212
Query: 302 FYRLID-------PRLEG-HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
+ L P L H+S +K +L + C+ DP RP + V + K +
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 32/228 (14%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 130
++G GGFG V+ K TG A+K L+ ++ + E LA L + +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLA----LNERIM 47
Query: 131 LNLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L+LV + Y +L + + M G L HL + + +R A
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEI 106
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+
Sbjct: 107 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTH 159
Query: 242 GYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288
GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 42/258 (16%)
Query: 98 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 157
TG VAVK ++ Q + EV + D H N+V + + D+ +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 158 LENHLFRRSLPLPWSIRMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211
L + + RM + L + L++LH + VI+RD K+ +ILL +D
Sbjct: 106 LTD--------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSD 154
Query: 212 YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 267
KLSDFG ++K+ P+ ++GT + APE + + D++S G+++
Sbjct: 155 GRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208
Query: 268 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 327
+EM+ G + P L RR + PR++ + +
Sbjct: 209 IEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLD 253
Query: 328 HCLSRDPKARPLMSEVVE 345
L R+P R E+++
Sbjct: 254 LMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 122
+F +LG+G FG V A K GT A+K L D + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMK 176
L + + C + RL V E++ G L H+ F+ + ++ +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
+ GL FLH R +IYRD K N++LD++ + K++DFG+ K E V+TR
Sbjct: 112 V------GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTR 159
Query: 237 VM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 278
GT Y APE + D +++GV+L EML G+ D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 27/162 (16%)
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSI 173
E L ++ H +++L + E DQR L + E++P G L ++L F S L ++
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+ AL +LH + ++YRD K NILLD + + KL+DFG AK K
Sbjct: 109 EIVCAL------EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRD 153
Query: 234 STRVM-GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 273
T + GT Y APE + GH + D ++ G+++ EML G
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 51/283 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+GEG G V A VK +G VAVK ++ Q + EV + D H N
Sbjct: 28 IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 186
+V++ + D+ +V EF+ G+L + + RM + L K L+
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 242
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPY 181
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302
+ APE + D++S G++++EM+ G P ++ R +L + +
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKN 238
Query: 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ P L+G L RDP R +E+++
Sbjct: 239 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 127
++G+G FG V + +G AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 128 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGL 185
+ H LV L Y + ++L V +F+ G L HL R RS P P + R A A L
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
+LH ++YRD K NILLD+ + L+DFGL K+G T +T GT Y A
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLA 164
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
PE + + D + G VL EML G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 241
+GL ++H V++RD K SN+LL+ + + K+ DFGLA+ PE D T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 242 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
Y APE ++ +++ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 87/275 (31%), Positives = 115/275 (41%), Gaps = 48/275 (17%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 128
LLG+G FG V + E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 185
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YGAEIVSAL 108
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYA 244
+LH V+YRD K N++LD D + K++DFGL K+G +G GT Y
Sbjct: 109 GYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYL 162
Query: 245 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRF 302
APE V+ + R+ D + GVV+ EM+ GR N +H L E L E RF
Sbjct: 163 APE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIRF 214
Query: 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
R + P +A L A L +DPK R
Sbjct: 215 PRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 68/207 (32%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 127
++G+G FG V + +G+ AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 128 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
L H LV L Y + ++L V +++ G L HL R L R A A +
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
+LH +IYRD K NILLD+ + L+DFGL K+G E ++T ++ GT Y AP
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTG 273
E + D + G VL EML G
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 187
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 188 LHEEAERPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDGPEGDKTHVSTR--VM 238
L ++ +++ + T NILL D + KLSD G+ V +R +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169
Query: 239 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
+ APE V + +L+ +D +SFG L E+ NGE L + L
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216
Query: 298 ERRRFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVV 344
E+ RFY EG + ++ A L HC++ DP RP ++
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 45/219 (20%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 127
+GEG +G V+K + TG VA+K + L+ E + E++ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54
Query: 128 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA---- 182
L H N+V+L+ + + +L LV+EF+ L+ + S P L
Sbjct: 55 LNHPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLDPPLIKS 103
Query: 183 ------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
+G+A+ H V++RD K N+L+D + KL+DFGLA+ G T
Sbjct: 104 YLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTH 158
Query: 237 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
+ T Y APE ++ S D++S G + EM+ R
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 139 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALGAAKGLAFLHEEAE 193
Y +DD+ L +V E+MP G L N + +P W+ + +AL A + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 251
RD K N+LLD + KL+DFG T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 252 --GHLTSRSDVYSFGVVLLEMLTG 273
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
+LG+G +G V+ A T + +A+K + + + E+ L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--KGLAFLH 189
N+V+ +G E+ + E +P GSL L + PL + + I +GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 190 EEAERPVIYRDFKTSNILLDADYNA--KLSDFG----LAKDGPEGDKTHVSTRVMGTYGY 243
+ +++RD K N+L++ Y+ K+SDFG LA P + GT Y
Sbjct: 126 DNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQY 175
Query: 244 AAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 274
APE + G + +D++S G ++EM TG+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 121
F + +GEG +G V++ +G VA+K + DG+ L E
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56
Query: 122 VNFLGDLVHLNLVKL---------------IGYCIEDDQRLLVYEFMPRGSLENHLFRRS 166
+ L +L H N+V+L + YC +D LL + MP
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103
Query: 167 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226
P S + L +GL +LHE +I+RD K SN+LL K++DFGLA+
Sbjct: 104 -PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR--T 157
Query: 227 EGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGR 274
G T + T Y APE + T + T+ D+++ G +L E+L +
Sbjct: 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 50/263 (19%)
Query: 20 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 79
P+++ SS+++S + S S +K EL+ R+ + +G G G
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELE---RVNR------------------IGSGAGG 88
Query: 80 CVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 137
V+K + TG A+K + NH+ ++ E+ L D+ H N+VK
Sbjct: 89 TVYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCH 138
Query: 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197
+ + ++ EFM GSLE L +A G+A+LH R ++
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RHIV 190
Query: 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTS 256
+RD K SN+L+++ N K++DFG+++ + D + S +GT Y +PE + T
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHG 247
Query: 257 R-----SDVYSFGVVLLEMLTGR 274
D++S GV +LE GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 238
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL- 238
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
+ APE + T++SDV+SFGV+L E+ + S P + N R G
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGT 294
Query: 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
R R P + + C DPK RP S +VE L L
Sbjct: 295 RMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 127
+GEG +G V+K T T+A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 182
+ H N+V+L + + LV+E++ L+ H+ F ++ L + +I
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----L 112
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+G+A+ H V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 242 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
Y APE ++ + H ++ D++S G + EM+ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 65/191 (34%), Positives = 81/191 (42%), Gaps = 26/191 (13%)
Query: 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207
LV F+ G L +HL R R A + L L + VIYRD K NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENIL 125
Query: 208 LDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 266
LD + L DFGL K + + DKT+ GT Y APE ++ T D ++ GV+
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 267 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 326
L EMLTG P + N+ E R L E RF D + A L
Sbjct: 183 LYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGFD------------RDAKDLL 224
Query: 327 AHCLSRDPKAR 337
LSRDP R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
+G G FG V G + +G P + V VK L +Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKG 184
NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A A G
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L LH+ I+ D N LL AD K+ D+GL+ + + D ++ +
Sbjct: 113 LLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 245 APEYV--MTGHL-----TSRSDVYSFGVVLLEML 271
APE V + G+L T S+V+S GV + E+
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+G+G G VF + TG VA+K +N + + E+ + +L + N
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLH 189
+V + + D+ +V E++ GSL + + + +IA + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCRECLQALEFLH 132
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEY 248
VI+RD K+ N+LL D + KL+DFG A+ PE K + ++GT + APE
Sbjct: 133 ANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 249 VMTGHLTSRSDVYSFGVVLLEMLTG 273
V + D++S G++ +EM+ G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 41/125 (32%), Positives = 57/125 (45%), Gaps = 4/125 (3%)
Query: 165 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224
RS PLP + I + LA+LH R +I+RD KT NI LD NA L DFG A
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK 234
Query: 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPN 283
T GT +PE + +++D++S G+VL EM ++ K +
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 284 GEHNL 288
L
Sbjct: 295 SSSQL 299
|
Length = 392 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 46/183 (25%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 102 VAVKTLNHDGLQGHKEWLA----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFM 153
V ++T +GHK + E+ L + N++K+ G+ I+ L L+ E+
Sbjct: 46 VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 154 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213
RG L L + L + ++ +A+ KGL L++ +P Y++ + + L+ +Y
Sbjct: 105 TRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYK 161
Query: 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 271
K+ GL K +V+ V Y + + + T + D+YS GVVL E+
Sbjct: 162 LKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
Query: 272 TGR 274
TG+
Sbjct: 217 TGK 219
|
Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)
Query: 140 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 193
C + RL V E++ G L + F+ + ++ + I GL FLH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG- 121
Query: 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTG 252
+IYRD K N++LD++ + K++DFG+ K E V+T+ GT Y APE +
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 253 HLTSRSDVYSFGVVLLEMLTGRRSMD 278
D ++FGV+L EML G+ +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 139 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 192
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 251
RD K N+LLD + KL+DFG E T V GT Y +PE + +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 252 ---GHLTSRSDVYSFGVVLLEMLTG 273
G+ D +S GV L EML G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 125
+GEG +G V+K TG VA+K + L KE + E+ L
Sbjct: 13 GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60
Query: 126 GDLVHLNLVKLIGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSLPLPWS 172
L H N+V L + L LV+E+M G LE+ L S S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 173 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 232
MK L +GL + H+ + ++RD K SNILL+ KL+DFGLA+ +
Sbjct: 121 F-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
+ +V+ T Y PE ++ + DV+S G +L E+ T +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 95 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 154
KPG V +K G +G L E L ++ H +++++ + +V +P
Sbjct: 87 KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137
Query: 155 --RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212
L +L +RS PLP + I +GL +LH A+R +I+RD KT NI ++
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQR-IIHRDVKTENIFINDVD 194
Query: 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ D G A+ P + + GT APE + S++D++S G+VL EML
Sbjct: 195 QVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
Query: 273 GRRSMDKNRPNGEHNLVEWARPHL 296
++ ++ P+ V+ HL
Sbjct: 252 YPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 1e-10
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 192
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 251
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 252 GHLTSRSDVYSFGVVLLEMLTG 273
+ D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+G+G G V+ + TG VA+K +N + + E+ + + + N
Sbjct: 27 IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 192
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSNQ 135
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 251
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189
Query: 252 GHLTSRSDVYSFGVVLLEMLTG 273
+ D++S G++ +EM+ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 58/252 (23%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGD 127
L+G+GG G V+ + P VA+K + D L K +L E D
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSIR------ 174
L+H +V + Y I D VY MP G L + SL + +
Sbjct: 59 LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTH 232
+ I + ++H + V++RD K NILL + D+G A K E D
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 233 VST--------------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT------ 272
+ +++GT Y APE ++ + +D+Y+ GV+L +MLT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 273 ---GRRSMDKNR 281
GR+ ++
Sbjct: 233 RKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 139 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197
Y + D +L L+ +++ G L HL +R +++ L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG---II 127
Query: 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHL 254
YRD K NILLD++ + L+DFGL+K+ E D+ + GT Y AP+ V GH
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGGH- 185
Query: 255 TSRSDVYSFGVVLLEMLTG 273
D +S GV++ E+LTG
Sbjct: 186 DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 139 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 193
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 251
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 252 --GHLTSRSDVYSFGVVLLEMLTG 273
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 75/285 (26%), Positives = 118/285 (41%), Gaps = 45/285 (15%)
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 178
+E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 238
L + + L E R +++RD K++NI L KL DFG +K + V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
GT Y APE + ++D++S GV+L E+LT RP G
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274
Query: 299 RRR------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV--EALKPL 350
+R Y DP F + L LS++P RP +++ E LK +
Sbjct: 275 SQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329
Query: 351 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRS 395
NL FQ + SP+ R I Q L +G+R+
Sbjct: 330 ANL---------FQDIVRHSETISPHDREEILRQ---LQESGERA 362
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+GL ++H +I+RD K SNI ++ D K+ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 243 YAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 274
Y APE +M H D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 173
EV L + H N+V E+ + +V E+ G L LF L W +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTH 232
+I+LG L +H+ R +++RD K+ NI L + AKL DFG+A+ D
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280
++ +GT Y +PE +++D++S G VL E+ T + + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 51/282 (18%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 128
LG+G F ++KG ++ V PG ++V +K L H++ LA + + L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H +LVKL G C+ D + ++V E++ G L+ L R + ++ +A A L +L
Sbjct: 59 SHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 189 HEEAERPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
++ +++ + NIL+ N KLSD G+ + R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 242 GYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
+ APE + G LT +D +SFG LLE+ + NGE L + E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS---SEK 215
Query: 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAA---HCLSRDPKARP 338
RFY+ + H A+LA C + DP RP
Sbjct: 216 ERFYQ------DQH--RLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 73 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 129
LGEG + VFKG + EN VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
H N+V L D LV+E++ + L+ ++ + +GLA+ H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 249
R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ +
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176
Query: 250 M-TGHLTSRSDVYSFGVVLLEMLTGR 274
+ + +++ D++ G + EM +GR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 45/184 (24%)
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
L LH+ ++YRD K NILLDA + L DFGL+K +KT + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 245 APEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302
APE ++ G+ T D +S GV++ EM G W+ + + ++
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQM 205
Query: 303 YRLID------PR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352
YR I P+ EG +KG L+R+P+ R LK P
Sbjct: 206 YRNIAFGKVRFPKNVLSDEGRQFVKG----------LLNRNPQHRLGAHRDAVELKEHPF 255
Query: 353 LKDM 356
D+
Sbjct: 256 FADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWL 119
NF +LG G +G VF + + TG A+K L L H
Sbjct: 1 NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM--- 175
E N L + + + Y + + +L L+ +++ G + HL++R +R
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
+I L L LH+ ++YRD K NILLD++ + L+DFGL+K+ +K +
Sbjct: 113 EIILA----LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 236 RVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTG 273
GT Y APE + GH D +S G+++ E+LTG
Sbjct: 166 -FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVH 130
LG+G +G V+K +P TG+T+A+K + + L K + + E++ L V
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF 187
+V G + + E+M GSL+ L+ + +P + +I KGL F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 246
L EE +I+RD K +N+L++ + KL DFG++ + KT++ G Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170
Query: 247 EYVMTGHLTSR------SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300
E + +G SDV+S G+ +LEM GR P N+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFA---------- 217
Query: 301 RFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ ++D P L +S A A CL++ P RP ++++E
Sbjct: 218 QLSAIVDGDPPTLPSGYS----DDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 130
+GEG +G VFK E T VA+K L+ D L E+ L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALG 180
N+V+L D + LV+E+ G ++ + + +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----------FQ 107
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
KGLAF H V++RD K N+L++ + KL+DFGLA+ G + + T
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVT 162
Query: 241 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 275
Y P+ + L S S D++S G + E+ R
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 128
LLG+G FG V + E + G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
H L L Y + RL V E++ G L HL R + R A L +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDY 110
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
LH ++YRD K N++LD D + K++DFGL K+G T + GT Y APE
Sbjct: 111 LHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGR 274
+ D + GVV+ EM+ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 24/160 (15%)
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGL 185
N+V L Y + +D LV + G L +H+ + L +P W+ M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA---- 100
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYA 244
LH E ++ RD +NILLD + +L+ F + D V Y
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 284
APE T D +S G +L E+LTG +++ + P+G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 52/161 (32%), Positives = 73/161 (45%), Gaps = 23/161 (14%)
Query: 184 GLAFL------HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
GL F+ H + +I+RD K++NILL ++ KL DFG +K V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
GT Y APE + ++D++S GV+L E+LT +R D GE N+ E L
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLA 259
Query: 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
R DP L S + ++ LS DPK RP
Sbjct: 260 GR------YDP-LPPSIS----PEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/175 (33%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 103 AVKTLNHDGLQGHKE---WLAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 158
AVK L + KE ++E N L ++ H LV L D+ V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 159 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218
HL R L R A A L +LH ++YRD K NILLD+ + L+D
Sbjct: 84 FYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTD 139
Query: 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
FGL K+ E + T ++ GT Y APE + D + G VL EML G
Sbjct: 140 FGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 33/219 (15%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 122
+ P + +G G +G V+K P +G VA+K++ N DGL + EV
Sbjct: 2 YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50
Query: 123 NFLGDLVHL---NLVKLIGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSI 173
L L N+V+L+ C D+ LV+E + + L +L + P LP
Sbjct: 51 ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQM 162
Query: 234 S-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 271
+ T V+ T Y APE ++ + D++S G + EM
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 91/350 (26%), Positives = 132/350 (37%), Gaps = 97/350 (27%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-- 130
LG G FG V IE + K T TVAVK L H E A ++ L L+H
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIG 68
Query: 131 --LNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHL----------------FRRSLP--- 168
LN+V L+G C + L+V EF G+L N+L FR+
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYG 128
Query: 169 -LPWSIRMKI----ALGAAKGLAFL---------HEEAERPVIYRDFKT----------- 203
+ ++ ++ + ++ F+ EEAE+ +Y+ T
Sbjct: 129 DISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQV 188
Query: 204 -------------------SNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVMGTY 241
NILL + K+ DFGLA+D + D +V R+
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL--PL 245
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGERR 300
+ APE + T +SDV+SFGV+L E+ S+ + G E+ R G R
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF----SLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
R P + Q C +P RP SE+VE L L
Sbjct: 302 RAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 119
+ + + +GEG +G VFK +NG G VA+K + +Q +E +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 120 ---AEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LP 170
A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 171 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 230
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSF 162
Query: 231 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
T V+ T Y APE ++ + D++S G + EM +
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 15/181 (8%)
Query: 98 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMP 154
TG VA+K + K E+ L L H N++ L I + + V E +
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 155 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214
+ H S PL +GL ++H V++RD K SNIL++ + +
Sbjct: 93 --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL 147
Query: 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTG 273
K+ DFGLA+ +VSTR Y APE ++T D++S G + EML G
Sbjct: 148 KICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 274 R 274
+
Sbjct: 203 K 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 46/282 (16%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
+GEG FG +E+G V +K +N + +E EV L ++ H
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 183
N+V+ E+ +V ++ G L LF L W +++ +AL
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
+H+ R +++RD K+ NI L D KL DFG+A+ ++ +GT Y
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYY 167
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
+PE ++SD+++ G VL EM T + + + NLV L R Y
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLV------LKIIRGSY 218
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
P + H+S +QL R+P+ RP ++ ++E
Sbjct: 219 ----PPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 62/240 (25%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 123
++P +G G +G V + +G VA+K + H D K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRR 165
L H N++ I D R +V + M L R
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111
Query: 166 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-- 223
L + + +GL ++H VI+RD K SN+L++ D ++ DFG+A+
Sbjct: 112 FL---YQL--------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 224 -DGPEGDKT----HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSM 277
P K +V+TR Y APE +++ + + D++S G + EML GRR +
Sbjct: 158 SSSPTEHKYFMTEYVATR-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/260 (23%), Positives = 120/260 (46%), Gaps = 39/260 (15%)
Query: 27 STTTSNAESNSSTSKLEEELKVASRLRKFTFNDL-KLATRNFRPESLLGEGGFGCVFKGW 85
N++ + E+E K+ ND+ + ++++ +++G G FG V++
Sbjct: 34 KLDEEERSHNNNAGEDEDEEKMID-------NDINRSPNKSYKLGNIIGNGSFGVVYEA- 85
Query: 86 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY----CI 141
+ T VA+K + D ++E L + +L H+N++ L Y C
Sbjct: 86 --------ICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYYTECF 133
Query: 142 EDDQRLL----VYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 195
+ +++ + V EF+P+ H R + LP + + + LA++H +
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--- 190
Query: 196 VIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGH 253
+ +RD K N+L+D + + KL DFG AK+ G + S + + Y APE ++ +
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATN 247
Query: 254 LTSRSDVYSFGVVLLEMLTG 273
T+ D++S G ++ EM+ G
Sbjct: 248 YTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+GL +LH +++RD K N+L++++ K+ DFGLA+ + H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 243 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
Y APE +M + H TS D++S G + E+L R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 131
LGEG + VFKG + T VA+K + + +G + EV+ L +L H
Sbjct: 13 LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
N+V L + LV+E++ L+ +L + +GL++ H+
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 250
R +++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177
Query: 251 TGHLTSRSDVYSFGVVLLEMLTGR 274
+ ++ D++ G +L EM TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 81/296 (27%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
F L+G G +G V+KG VK TG A+K ++ G + +E E+N L
Sbjct: 8 FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57
Query: 127 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 176
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
I +GL+ LH+ VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 168
Query: 237 --VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289
+GT + APE + +SD++S G+ +EM G + P L+
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
Query: 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
R PRL+ S K ++K CL ++ RP ++++
Sbjct: 229 P-------------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 26/145 (17%)
Query: 166 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225
S PL ++ + A+G+ FL A + I+RD N+LL AK+ DFGLA+D
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD- 261
Query: 226 PEGDKTHVSTRVMGT----YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281
D +V V G + APE + T +SDV+S+G++L E+ S+ K+
Sbjct: 262 IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGKS- 313
Query: 282 PNGEHNLVEWARPHLGERRRFYRLI 306
P + +FY+++
Sbjct: 314 ----------PYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 126
+ +GEG +G V+K TG VA+K L+ +G+ L E+ L
Sbjct: 5 AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53
Query: 127 DLV---HLNLVKLIGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR- 174
L H N+V+L+ C D+ L LV+E + + L + LP P +I+
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKD 111
Query: 175 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
M+ L +G+ FLH +++RD K NIL+ +D K++DFGLA+
Sbjct: 112 LMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMA 162
Query: 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 270
T V+ T Y APE ++ + D++S G + E+
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 131
LGEG + V+KG NG VA+K ++ +G + E + L L H
Sbjct: 13 LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 190
N+V L + V+E+M L ++ + L P+++R+ +GLA++H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG 121
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
+ +++RD K N+L+ KL+DFGLA+ +T+ S V T Y P+ ++
Sbjct: 122 ---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 251 -TGHLTSRSDVYSFGVVLLEMLTGR 274
+S D++ G + +EML G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 75 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGDLV 129
EG +G V++ TG VA+K L + KE L E+N L L
Sbjct: 15 EGTYGVVYRA---------RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62
Query: 130 HLNLVKL----IGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIR-----MKI 177
H N+V + +G + D+ +V E++ + +E P+ M
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQSEVKCLMLQ 114
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
L G+A LH+ +++RD KTSN+LL+ K+ DFGLA+ G T++
Sbjct: 115 LL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQL 166
Query: 238 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
+ T Y APE ++ ++ D++S G + E+LT +
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 243 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 274
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 62/228 (27%), Positives = 90/228 (39%), Gaps = 26/228 (11%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 118
K+ +F LG G FG V A K VA+K + K+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 119 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 177
+E L + H V L G ++ LV EF+ G L RR+ P +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG--- 133
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR- 236
AA+ + ++YRD K N+LLD D K++DFG AK V TR
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRT 185
Query: 237 --VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282
+ GT Y APE ++ +D ++ G+ + E+L G N P
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 243 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 274
Y APE ++ H T D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 67/259 (25%), Positives = 99/259 (38%), Gaps = 76/259 (29%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEV-- 122
+F ++G G FG V K TG A+K L + L+ KE +A V
Sbjct: 2 DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50
Query: 123 --NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-- 177
+ L + + +VKL Y +D+ L L+ E++P G + L ++ R I
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 178 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHV 233
A+ + L ++H RD K N+LLDA + KLSDFGL G K+H
Sbjct: 110 TILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHR 156
Query: 234 ST----------------------------------RVM-----GTYGYAAPEYVMTGHL 254
+ R + GT Y APE +
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216
Query: 255 TSRSDVYSFGVVLLEMLTG 273
D +S GV++ EML G
Sbjct: 217 NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 73 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 129
LGEG + V+KG + +N VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
H N+V L + LV+E++ + L+ +L + +GL + H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 249
R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ +
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 250 M-TGHLTSRSDVYSFGVVLLEMLTGR 274
+ + +++ D++ G + EM TGR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 62/232 (26%)
Query: 74 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVH 130
G G +G V+K G A+K D Q + E+ L +L H
Sbjct: 9 GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 131 LNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLF----------RRSLP------LPWS 172
N+V L+ +E + L++++ E+ L+ R S+P L W
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 173 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGP 226
I G+ +LH V++RD K +NIL+ + K+ D GLA+ + P
Sbjct: 117 I--------LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 227 -----EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 272
+ D V+ T Y APE ++ H T D+++ G + E+LT
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGDLV 129
LGEG + V+KG + G VA+K L H+ +G + E + L DL
Sbjct: 13 LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM---KIAL-GAA 182
H N+V L LV+E++ +++ + M ++ L
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHNVRLFLFQLL 113
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+GLA+ H+ R V++RD K N+L+ KL+DFGLA+ KT+ + V T
Sbjct: 114 RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLW 168
Query: 243 YAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 274
Y P+ ++ T + TS D++ G + EM TGR
Sbjct: 169 YRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 69/240 (28%), Positives = 101/240 (42%), Gaps = 46/240 (19%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 127
+G+G FG VFK A K T VA+K + ++ KE L E+ L
Sbjct: 20 IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 128 LVHLNLVKLIGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 176
L H N+V LI C LV+EF G L N + +L + MK
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 234
+ L GL ++H +++RD K +NIL+ D KL+DFGLA+ + K +
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289
T + T Y PE + L R D++ G ++ EM T M N + L+
Sbjct: 181 TNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
GL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 243 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 274
Y APE ++ H D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
F ++G G +G V+KG VK TG A+K ++ + +E E+N L
Sbjct: 18 FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67
Query: 127 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 176
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AY 125
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
I +GLA LH VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 126 ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 178
Query: 237 --VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 273
+GT + APE + RSD++S G+ +EM G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
AKG++FL A + I+RD NILL K+ DFGLA+D V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
+ APE + T SDV+S+G++L E+ + L P + +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325
Query: 302 FYRLIDPRLEGH--FSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVE 345
FY++I EG+ S + A + + C DP RP ++V+
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 59/245 (24%)
Query: 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 118
DL + RP LG G G VF + V VAVK + Q K
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49
Query: 119 LAEVNFLGDLVHLNLVKL--------------IGYCIEDDQRLLVYEFMP--------RG 156
L E+ + L H N+VK+ +G E + +V E+M +G
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 157 SL-ENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DY 212
L E H LF L +GL ++H V++RD K +N+ ++ D
Sbjct: 110 PLSEEHARLFMYQL--------------LRGLKYIHSAN---VLHRDLKPANVFINTEDL 152
Query: 213 NAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 269
K+ DFGLA+ D K ++S ++ + Y +P +++ + T D+++ G + E
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAE 211
Query: 270 MLTGR 274
MLTG+
Sbjct: 212 MLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLV-H 130
+G+G +G V+K +++G+ AVK L D + E + AE N L L H
Sbjct: 30 IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78
Query: 131 LNLVKLIGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGAA 182
N+VK G + D Q LV E GS L L L ++ I GA
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----- 237
GL LH +I+RD K +NILL + KL DFG++ STR+
Sbjct: 139 LGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTS 188
Query: 238 MGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 273
+GT + APE + +R DV+S G+ +E+ G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
+ P +G G +G V + T VA+K + + D K L E
Sbjct: 4 DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENH-LFRRSLPLPWSIR 174
+ L L H N++ + + R +VYE M + H + R S L
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
+GL ++H V++RD K SN+LL+A+ + K+ DFGLA+ +K
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFM 165
Query: 235 TRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
T + T Y APE ++ T+ DV+S G + E+L +
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 68/217 (31%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLV- 129
+G+G +G VFK ++NG+ AVK L+ HD +E AE N L L
Sbjct: 26 IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73
Query: 130 HLNLVKLIG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGA 181
H N+VK G Y +D DQ LV E GS L +R + I I A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
GL LH I+RD K +NILL + KL DFG++ +GT
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTP 188
Query: 242 GYAAPEYV-----MTGHLTSRSDVYSFGVVLLEMLTG 273
+ APE + + +R DV+S G+ +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 238
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL- 237
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + T++SDV+SFGV+L E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 65/247 (26%), Positives = 92/247 (37%), Gaps = 55/247 (22%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 121
++F+ LLG+G G VF + GT + A+K L+ + + L E
Sbjct: 1 KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 178
L L H L L + LV ++ P G L + P L +
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEV---AR 106
Query: 179 LGAAK---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------ 223
AA+ L +LH ++YRD K NILL + LSDF L+K
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 224 --DGPEGDKTH----------VSTRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVL 267
G + S R GT Y APE + GH S D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222
Query: 268 LEMLTGR 274
EML G
Sbjct: 223 YEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 36/258 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 130
+G G FG V I TG+ V VK L + + E+L + + L H
Sbjct: 3 IGNGWFGKVLLSEI--------YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 184
N+++ +G C+E LLV+E+ G L+++L R S L + ++A A G
Sbjct: 55 PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAG 111
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
+ +H+ ++ D N L +D K+ D+G+ + D +
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 245 APEYV-------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
APE V +T T S+V++ GV L E+ +N +L + +
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVLNHV 221
Query: 298 ERRRFYRLIDPRLEGHFS 315
+ + +L P+LE +S
Sbjct: 222 IKDQQVKLFKPQLELPYS 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 124
F ++GEG +G V K +E T VA+K + + + KE L E+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGA 181
L L N+V+L + LV+E++ + LE +P P +R I
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQL 109
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
K + + H+ +++RD K N+L+ + KL DFG A++ EG + T + T
Sbjct: 110 IKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATR 165
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
Y +PE ++ D++S G +L E+ G+
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 14 DTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLL 73
++ D P+ A S + + + + L A K +D LA +FR L
Sbjct: 103 ASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQA----KLKHDDEFLA--HFRVIDDL 156
Query: 74 GEGGFG----CVFKGWIEE-------NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 122
G FG C + EE N T KP +A + E E+
Sbjct: 157 PAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE--NEI 214
Query: 123 NFLGDLVHLNLVKL--------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 174
LG L H N++K+ Y I +Y FM + + + PL R
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQTR 270
Query: 175 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 232
MK L A + ++H+ + +I+RD K NI L+ D L DFG A E ++
Sbjct: 271 AIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREA 323
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+GT +PE + +D++S G++LL+ML+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGT 240
GL ++H V++RD K N+L++AD K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 241 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNR 281
Y APE +++ +++ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 43/143 (30%), Positives = 62/143 (43%), Gaps = 11/143 (7%)
Query: 139 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197
Y +D L LV E+ P G L + L R + A+ + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124
Query: 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY--VMTGHLT 255
+RD K N+L+D + KL+DFG A +K S +GT Y APE M G
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 256 SRSDV----YSFGVVLLEMLTGR 274
V +S GV+ EM+ GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 121 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 178
E L L H N+V + ED +V F G L + L ++ LP + ++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 238
+ A L +LHE+ +++RD KT N+ L K+ D G+A+ ++ +++ ++
Sbjct: 109 VQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLI 163
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
GT Y +PE +SDV++ G + EM T + + + N +LV
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV--------- 211
Query: 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344
YR+I+ +L + + +L A LS+ P+ RP + ++
Sbjct: 212 ----YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 124
++ + ++G+G +G V + + TG VA+K +N + + L E+
Sbjct: 2 YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 125 LGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
L L H ++V++ + +R +V+E M S + + + + L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVST 235
+ L ++H V +RD K NIL +AD K+ DFGLA+ D P T
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWT 164
Query: 236 RVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 274
+ T Y APE + T D++S G + E+LTG+
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 69/252 (27%), Positives = 99/252 (39%), Gaps = 65/252 (25%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 124
+F ++G G FG V K TG A+K L D L+ KE +A +
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHIYAMKILRKADMLE--KEQVAHIRA 50
Query: 125 LGD-LVHLN---LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-- 177
D LV + +VK+ Y +D + L L+ EF+P G + L ++ + + I
Sbjct: 51 ERDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE 109
Query: 178 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------------ 222
A+ A L F+H RD K N+LLDA + KLSDFGL
Sbjct: 110 TVLAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 223 ---KDGPEGD------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 261
P D + ++ +GT Y APE M D +
Sbjct: 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 262 SFGVVLLEMLTG 273
S GV++ EML G
Sbjct: 221 SLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 66/252 (26%), Positives = 96/252 (38%), Gaps = 65/252 (25%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ----GHKEWLA 120
+F ++G G FG V K TG A+K L D L+ GH A
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA- 178
E + L + L +VK+ Y +D L L+ EF+P G + L ++ + IA
Sbjct: 51 ERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 179 ----LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--- 231
+ + L F+H RD K N+LLD+ + KLSDFGL + +T
Sbjct: 110 TVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 232 ------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 261
++ +GT Y APE M D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 262 SFGVVLLEMLTG 273
S GV++ EML G
Sbjct: 221 SLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 243 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 274
Y APE ++ H D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 42/221 (19%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
++ +GEG F V K + G A+K + H + L +VN L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46
Query: 127 DLV-------HLNLVKLIGYCIEDDQ--RL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
++ H N+++LI + D + RL LV+E M +L + R PLP
Sbjct: 47 EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS 104
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTH 232
K L +H + +RD K NIL+ D KL+DFG + P + +
Sbjct: 105 YMYQLLKSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--Y 158
Query: 233 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 272
+STR Y APE ++T G+ + D+++ G V E+L+
Sbjct: 159 ISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGDL 128
+GEG +G V+K TG VA+K ++ +G+ L E++ L L
Sbjct: 9 IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 129 VHLN-LVKLIGYCIEDDQR-------LLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 177
+V+L+ +E + LV+E++ + ++++ PLP
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG--PEGDKTHVS 234
KG+A H+ V++RD K N+L+D K++D GL + P TH
Sbjct: 116 MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170
Query: 235 TRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 273
+ T Y APE ++ H ++ D++S G + EM
Sbjct: 171 --EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 51/204 (25%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 131
LGEG + V+KG + NG VA+K + +G + E + L L H
Sbjct: 13 LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 190
N+V L + LV+E++ L ++ + L P ++++ + +GL+++H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
R +++RD K N+L+ KL+DFGLA+ + +H + + T Y P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 251 -TGHLTSRSDVYSFGVVLLEMLTG 273
+ ++ D++ G + +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+G G +G V+K TG A+K + + + E+ + D H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 192
+V G + D+ + EF GSL++ ++ + PL S ++ +GL +LH +
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 251
+ ++RD K +NILL + + KL+DFG++ S +GT + APE
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVE 181
Query: 252 --GHLTSRSDVYSFGVVLLEM 270
G D+++ G+ +E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 240
A+G+ FL A + ++RD N+LL K+ DFGLA+D D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGSTFLP 302
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300
+ APE + T+ SDV+S+G++L E+ + L P +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDS 347
Query: 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEALKP 349
FY I Q+ + C + +P+ RP +S++VE+L P
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 73 LGEGGFGCVFKGWIEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGD 127
LGEG +G V K + G VK K G+ G H L E+ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
+ H N++ L+ +E D LV + M L+ + R + L S I L GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGLNV 134
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DGPEGDKTHVSTRVMG 239
LH+ ++RD +NI +++ K++DFGLA+ D D+T M
Sbjct: 135 LHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 240 ----TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
T Y APE +M D++S G + E+LTG+
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
APE ++ D++S G ++ EM+ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 52 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 111
LR+ +D +L R +G G +G V+K TG AVK + +
Sbjct: 3 LRRNPQHDYELIQR-------VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEP 46
Query: 112 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 171
E+ + + H N+V G + ++ + E+ GSL++ ++ + PL
Sbjct: 47 GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSE 105
Query: 172 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
+ +GLA+LH + + ++RD K +NILL + + KL+DFG+A
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162
Query: 232 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEM 270
S +GT + APE G D+++ G+ +E+
Sbjct: 163 RKS--FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 51/185 (27%), Positives = 78/185 (42%), Gaps = 36/185 (19%)
Query: 134 VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 186
+ + Y +D+ L LV ++ G L L + LP + M IA+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 242
++H RD K NIL+D + + +L+DFG L +DG T S+ +GT
Sbjct: 123 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 168
Query: 243 YAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
Y +PE + G D +S GV + EML G P +LVE +
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMN 222
Query: 298 ERRRF 302
+ RF
Sbjct: 223 HKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 60/208 (28%)
Query: 133 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 186
+VKL Y +D L V +++P G + + L F L + + A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL---------AKDGPEGDKTHVS--- 234
F+H RD K NIL+D D + KL+DFGL +K +GD
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 235 ------------------------TRVM-----GTYGYAAPEYVM-TGHLTSRSDVYSFG 264
R + GT Y APE ++ TG+ T D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVG 231
Query: 265 VVLLEMLTGRRSMDKNRPNG-EHNLVEW 291
V+L EML G+ + P + ++ W
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 173
E L + H N+V D +V E+ G L LF L W +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT 231
+M + G+ +HE + V++RD K+ NI L + KL DFG A+ P
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280
+ T V GT Y PE ++SD++S G +L E+ T + N
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG+G F +FKG E G T V +K L+ + + + + L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEE 191
LV G C+ D+ ++V E++ GSL+ +L + + S ++++ AK LA+ LH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFL 116
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEYV 249
++ + + + N+LL + + K + K G V + + + PE +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 250 MTG-HLTSRSDVYSFGVVLLEMLTG 273
+L+ +D +SFG L E+ +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 25/192 (13%)
Query: 98 TGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 154
T VAVK +N D ++ E+ L H N++ + I D + +V M
Sbjct: 24 TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 155 RGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212
GS E+ L + P LP I L ++H + I+R K S+ILL D
Sbjct: 83 YGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDG 138
Query: 213 NAKLSDFGLAKDGPEGDKTHV--------STRVMGTYGYAAPEYV---MTGHLTSRSDVY 261
LS + + K S + + + +PE + + G+ +SD+Y
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIY 194
Query: 262 SFGVVLLEMLTG 273
S G+ E+ G
Sbjct: 195 SVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 240
A G+ FL A + ++RD N+L+ K+ DFGLA+D D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLP 304
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ APE + T+ SDV+SFG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 287
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 288 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 337
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 302
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
APE ++ D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 66/264 (25%), Positives = 96/264 (36%), Gaps = 77/264 (29%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+F ++G+G FG V K TG A+KTL + K+ LA V
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAE 51
Query: 126 GDLVHLN----LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-- 178
D++ + +V L Y +D Q L L+ EF+P G L L + R +A
Sbjct: 52 RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110
Query: 179 ---LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-------------- 221
+ A L F+H RD K NIL+D + KLSDFGL
Sbjct: 111 VLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 222 -------AKDGPEGDKTHV-------------------STRVM-----GTYGYAAPEYVM 250
K+ + + + R+M GT Y APE +
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IF 220
Query: 251 TGHLTSRS-DVYSFGVVLLEMLTG 273
+ D +S G ++ E L G
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 66/256 (25%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLV 129
LG G FG V K T A+KTL + + AE + L +
Sbjct: 9 LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 130 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAK 183
+ +VKL Y +D L V +++P G + + L R L + + +A+ +
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-------------------KD 224
+ F+H RD K NIL+D D + KL+DFGL +D
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 225 GPE-------------GD----------KTH---VSTRVMGTYGYAAPEYVMTGHLTSRS 258
E GD K H ++ ++GT Y APE ++ T
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229
Query: 259 DVYSFGVVLLEMLTGR 274
D +S GV+L EML G+
Sbjct: 230 DWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 139 YCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSI-RMKIALGAAKGLAFLHEEAERP 195
+C + +R L V E++ G L + LP + RM A L +LH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG--- 121
Query: 196 VIYRDFKTSNILLDADYNAKLSDFGLAKDG--------PEGD-----KTHVSTRVMGTYG 242
+++RD K N+L+ + + KL+DFGL+K G EG + + +V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
Y APE ++ D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 44/151 (29%), Positives = 65/151 (43%), Gaps = 30/151 (19%)
Query: 139 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEE 191
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 247
RD K N+LLD + + +L+DFG L DG T S +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPE 173
Query: 248 YVM-----TGHLTSRSDVYSFGVVLLEMLTG 273
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRM 175
E L L H +VK +E D ++ E+ L+ L ++L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
I L G+ ++H+ R +++RD K NI L + K+ DFG+++ ++T
Sbjct: 112 FIQL--LLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLAT 163
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 270
GT Y +PE + S+SD++S G +L EM
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 189
H++L + G C+ + ++V EF+ G L+ L + +P + ++ +A A L++L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 190 EEAERPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+ + +++ + NILL A+ + KLSD G++ ++ RV
Sbjct: 135 D---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-----RV-ERIP 185
Query: 243 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
+ APE V G L++ +D +SFG LLE+ +GE L E E+ R
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EKER 232
Query: 302 FY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
FY RL +P ++ A L + CL+ +P RP
Sbjct: 233 FYEKKHRLPEP---------SCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 30/151 (19%)
Query: 139 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 191
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 247
RD K N+LLD + + +L+DFG + +DG T S+ +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPE 173
Query: 248 YVMT-----GHLTSRSDVYSFGVVLLEMLTG 273
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 61/206 (29%)
Query: 120 AEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHL-----FRRSLPLPWSI 173
AE + L + + +V+L Y +D D V +++P G + + L F L +
Sbjct: 50 AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL------------ 221
+ A+ + + F+H RD K NIL+D D + KL+DFGL
Sbjct: 109 ELTCAVESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 222 --AKDGPEGDKTHVSTR-------------------------------VMGTYGYAAPEY 248
+ D D S ++GT Y APE
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219
Query: 249 VMTGHLTSRSDVYSFGVVLLEMLTGR 274
++ T D +S GV+L EML G+
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 12/160 (7%)
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKI 177
E + L + H ++++L G + L+ +PR + + + +R++ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI--CDILAI 187
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
+ + +LHE +I+RD K NI ++ + L DFG A P +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
GT APE + D++S G+VL EM T S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 3/115 (2%)
Query: 155 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214
R L +L R PL + +A + ++H E +I+RD KT N+L++ +
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDI 299
Query: 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 269
L DFG A T + GT APE + T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 128
LG G FG V +E K +TVAVK L +E L +++LG+
Sbjct: 43 LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 165
H+N+V L+G C L++ E+ G L N L R+
Sbjct: 98 -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 21/136 (15%)
Query: 152 FMPRGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209
FM GS N L + P + ++ I GA +GL +LH+ I+R+ K S+IL+
Sbjct: 80 FMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 210 ADYNAKLSD----FGLAKDGPEG----DKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 258
D LS + L ++G + D ST V+ + +PE + + G+ +S
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKS 191
Query: 259 DVYSFGVVLLEMLTGR 274
D+YS G+ E+ TGR
Sbjct: 192 DIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 35/206 (16%)
Query: 105 KTLNHDGLQGHK--EWLAEVNFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLEN 160
K +++ GL+ + + + EVN + +L H N+V+ I + + +Q+L ++ EF G L
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 161 HL---FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP----VIYRDFKTSNILLD---- 209
++ ++ + + I LA+ H + P V++RD K NI L
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 210 ------ADYN-------AKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPEYVM--TGH 253
A N AK+ DFGL+K+ G E ++ +GT Y +PE ++ T
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKS 219
Query: 254 LTSRSDVYSFGVVLLEMLTGRRSMDK 279
+SD+++ G ++ E+ +G+ K
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 70 ESLLGEGGFGCVFK------GWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
+ L+G GGFGCV++ I A ++ T+ ++TL ++ + + +A
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIY-DIDKIALWK 75
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL---ENHLFRRSLPLPWSIRMKIALG 180
+ ++ HL + K G C + + Y F+ L +F+R + I
Sbjct: 76 NIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGP--EGDKTHVS 234
L ++HE + + D K NI++D + + D+G+A G E K
Sbjct: 135 MLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 269
GT YA + +T R D+ S G +L+
Sbjct: 192 LH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 26/171 (15%)
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMP----------RGSLENHLFRRSLP 168
E+ L +L H N++ L + R L++++ R S N ++ +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQ 104
Query: 169 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAK- 223
LP S+ + G+ +LH V++RD K +NIL+ + K++D G A+
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
Query: 224 -DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 272
+ P + V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 162 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 422 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.77 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.7 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.61 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.61 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.39 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.36 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.31 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.31 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.13 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.13 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.11 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.88 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.87 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.75 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.6 | |
| PLN02236 | 344 | choline kinase | 97.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.37 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.28 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.08 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.06 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.9 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.74 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.65 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.52 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.39 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.23 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.19 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.04 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.98 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-53 Score=405.26 Aligned_cols=290 Identities=58% Similarity=0.993 Sum_probs=252.6
Q ss_pred hccccchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC
Q 014585 51 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 130 (422)
Q Consensus 51 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 130 (422)
....|++.++..++++|....+||+|+||.||+|...+ |..||||++.........+|.+|+.++.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 45679999999999999999999999999999998854 47899998876554314569999999999999
Q ss_pred CcceeeEeEEEecC-ceEEEEEecCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 131 LNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 131 ~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
+|+|+++|||.+.+ +.+||+||+++|+|.++++.... .++|..+++|+.++++||+|||....++|||||||++||||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 99999999999998 49999999999999999987665 89999999999999999999999887789999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
|+++.+||+|||+|+..... .........||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+...+.....+
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999999765431 11111111799999999999999999999999999999999999999987766666678
Q ss_pred HHhhhhhhhcccccccccCcccC-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 289 VEWARPHLGERRRFYRLIDPRLE-GHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
..|....+.+. .+.+++|+.+. ..+.. .....+..++.+|++.+|.+||+|.++++.|+.+..
T Consensus 290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88887776665 88899999987 56664 577889999999999999999999999999965544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=413.15 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=214.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.+|...++||+|||+.||.+.+.. +|+.||+|++.+... ...+.+.+||+|+++|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 579999999999999999999876 888999999976433 23467899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+++|||+|+|..++|..++. ..+.+++..+..++.||+.||.|||+++ |||||||..|+||+++.+|||+|||+
T Consensus 89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence 9999999999999999999885 6678999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|......... ..+.||||.|.|||++.....+..+||||+||+||.||.|++||+...-.+..+.+...
T Consensus 165 At~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--------- 233 (592)
T KOG0575|consen 165 ATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--------- 233 (592)
T ss_pred eeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc---------
Confidence 9987654333 34589999999999999999999999999999999999999999865322211111100
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+. .++...+.++.+||.++|+.||.+|||+++|+.+
T Consensus 234 --~Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 --EY-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --Cc-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 1222456789999999999999999999999974
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=386.22 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=211.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+.+.++.||+|..|+||++.++. |++.+|+|++..... ...+++.+|+++++.++|||||.+||.|..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 456677899999999999999987 889999999954432 3457799999999999999999999999999
Q ss_pred Cc-eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 144 DQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 144 ~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+. +.|+||||++|+|++++... +.+++.....|+.+|++||.|||+ ++ ||||||||+||||+..|.|||||||.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 95 99999999999999998544 679999999999999999999996 66 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC--CcchhHHhhhhhhhcc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN--GEHNLVEWARPHLGER 299 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~ 299 (422)
+...... ...+++||..|||||.+.+..|+.++||||||++++||.+|+.||....+. ....+..++.. +
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~- 297 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---E- 297 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---C-
Confidence 9886543 456789999999999999999999999999999999999999999865221 11112221111 0
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..|.+... .++.++++|+..||+.||.+||++.++++|
T Consensus 298 ------ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 ------PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ------CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222211 367899999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-54 Score=392.06 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=208.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-------cHHHHHHHHHHhcccCCCccee
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-------GHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~ 135 (422)
..+.|.+.+.||+|+||.|-+|..+. +|+.||||++++.... ....+.+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 45678899999999999999998876 8999999999754322 2234679999999999999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC---C
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---Y 212 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~---~ 212 (422)
++++|...+..||||||++||+|.+.+..+ +.+.+..-+.+++|++.||.|||++| |+||||||+|||+..+ .
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 999999999999999999999999999654 46788888999999999999999999 9999999999999765 7
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCC---CchhhhhhHHHHHHHHHhCCCCCCCCCCCC-cchh
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNL 288 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~ 288 (422)
.+||+|||+|+..... ....++|||+.|.|||++.+..+ ..++|+||+||+||-+|+|.+||....... ....
T Consensus 317 llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred EEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 7999999999987533 33456899999999999986543 348899999999999999999998654332 1111
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.... -.+ -+ ......++++.+||.+||..||++||++.|+|++
T Consensus 394 I~~G~------y~f----~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ILKGR------YAF----GP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HhcCc------ccc----cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11111 001 01 1123567899999999999999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-53 Score=387.83 Aligned_cols=204 Identities=31% Similarity=0.526 Sum_probs=183.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..+|.+.+.||.|+||+||+|+++. ++..||||.+.+.. ....+.+..|+.+|+.++|||||++++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 3578899999999999999999987 67899999998774 334556889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC------CCeE
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------YNAK 215 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~------~~~k 215 (422)
.++.+|||||||+||+|.++|++++ .+++..+..++.||+.||++||+++ ||||||||.||||+.+ -.+|
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 9999999999999999999996554 7999999999999999999999999 9999999999999764 4589
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 283 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 283 (422)
|+|||+|+.+..+. ...+.||++.|||||++..+.|+.|+|+||+|+|+|+|++|+.||....+.
T Consensus 156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred ecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 99999999986443 345689999999999999999999999999999999999999999866543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=385.41 Aligned_cols=263 Identities=29% Similarity=0.371 Sum_probs=217.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|+++++||+|+||+||+++.++ +++.+|+|++++..... .+....|..+|.+++||.||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 4689999999999999999999875 88999999998765433 45688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+.+|||+||+.||.|..+|+ +.+.+++..+..++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 99999999999999999999994 4557999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+++....... ...++|||+.|||||++.+.+|+..+|+|||||++|||++|.+||...+... +.......+
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k- 241 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGK- 241 (357)
T ss_pred cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCc-
Confidence 9996443322 2345899999999999999999999999999999999999999998754321 111111111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 358 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 358 (422)
....+...+.+++++++++|..||++|.....=.+.++.++.++.+.+
T Consensus 242 ----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 242 ----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred ----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 011122245789999999999999999753333444677777776654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=373.80 Aligned_cols=267 Identities=26% Similarity=0.325 Sum_probs=214.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-c-HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-G-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|+.+.++|+|+||.||++++++ ||+.||||++...... . .+-.++|+++|++|+|+|+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 368888999999999999999987 9999999999755432 2 3447899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
...++||+|||+. ++.+-+.+....++...+..+++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhh
Confidence 9999999999977 555666677778999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh----
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---- 297 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---- 297 (422)
+...... ...+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+....+....+......+.
T Consensus 149 R~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 149 RTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred HhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 9876422 23455788999999999987 6899999999999999999999999998776554443332222111
Q ss_pred ----cccccccccCcccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ----ERRRFYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ----~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....|..+.-|.... .--+..+.-+.+|+++||..||++|++.++++.+
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111111111 1112345688999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=371.41 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=208.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEe-EE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG-YC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~-~~ 140 (422)
..+|+++++||+|.||+||++.+.. +|..||.|.+...... ..+.+..|+.+|++|+|||||++++ .+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 3568889999999999999999877 7889999999855443 3456899999999999999999999 55
Q ss_pred EecCc-eEEEEEecCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeccCCCCcEEEcCCCCeE
Q 014585 141 IEDDQ-RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAE-RPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 141 ~~~~~-~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~-~~iiHrDlkp~Nill~~~~~~k 215 (422)
.++.. ++||||||.+|+|..+++ +....+++..+|+++.|++.||..+|+.-+ .-|+||||||.||||+.+|.+|
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence 55555 789999999999999885 335679999999999999999999999432 2399999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
|+|||+++.+.... ....+++|||.||+||.+.+.+|+.|+||||+||++|||+...+||.+..-. +... .
T Consensus 169 LGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~------~L~~-K 239 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL------SLCK-K 239 (375)
T ss_pred eccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH------HHHH-H
Confidence 99999999875432 3345689999999999999999999999999999999999999999876221 1110 0
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
+ -+-.........++.++..||..|+..||+.||+...++..+
T Consensus 240 I---------~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 240 I---------EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred H---------HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 0 000011111146688999999999999999999855555443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-51 Score=388.07 Aligned_cols=256 Identities=35% Similarity=0.574 Sum_probs=211.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcE-EEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+.+.||.|+||+||+|.+. |.. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4445566999999999999984 456 9999997654332 4589999999999999999999999998
Q ss_pred cC-ceEEEEEecCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEEeec
Q 014585 143 DD-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 219 (422)
Q Consensus 143 ~~-~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl~DF 219 (422)
.. ..+|||||+++|+|.+++.. ....+++..++.|+.||++||.|||++++ |||||||++|||++.++ ++|||||
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCC
Confidence 87 79999999999999999987 47789999999999999999999999874 99999999999999998 9999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCccc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||..||....+......+ .
T Consensus 189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v---~---- 259 (362)
T KOG0192|consen 189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV---V---- 259 (362)
T ss_pred ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---H----
Confidence 9998754321 2233367999999999999 669999999999999999999999999876541111100 0
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.......++..++..+..|+..||..||..||++.+++..|+.+..
T Consensus 260 ---------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 260 ---------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ---------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 0011111222366889999999999999999999999999986543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=384.95 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=219.5
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhccc-CCCcceee
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKL 136 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~ 136 (422)
+....+|.+++.||.|+|++|++|..+. +++.||||++.+.... ..+.+..|-.+|.+| .||.|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 4455789999999999999999999876 8889999999765432 234577888999999 89999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
+..|.++..+|+|+||+++|+|.++|.+. +.|++.....++.||+.||+|||++| ||||||||+|||||+||++||
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEE
Confidence 99999999999999999999999999555 58999999999999999999999999 999999999999999999999
Q ss_pred eeccCcccCCCCCcc---------ce--eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 014585 217 SDFGLAKDGPEGDKT---------HV--STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 285 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 285 (422)
+|||.|+.+...... .. ...++||..|.+||+|..+..+..+|||+||||||+|+.|.+||.+.++...
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 999999886543222 11 1458999999999999999999999999999999999999999987643211
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCCCCCCc
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSS 360 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (422)
+.+++. +.-.|+...++.+.+|++++|..||.+|++..+| +.++++.++.+..
T Consensus 296 ----------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI----k~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 296 ----------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQI----KAHPFFEGVDWEN 348 (604)
T ss_pred ----------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHH----hhCcccccCChhh
Confidence 111111 1112333445789999999999999999999665 4566777766544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=357.89 Aligned_cols=264 Identities=27% Similarity=0.347 Sum_probs=221.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH---HHHHHHHHHhcccCCCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
..++|++++.||.|+||+|.+++.+. +|..+|+|++.....-.. +...+|.++|+.+.||.++++++.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t 112 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT 112 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence 44689999999999999999999987 788999999987655443 457899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
|.+.+.+||||||++||.|..++ ++.+++++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+||
T Consensus 113 ~~d~~~lymvmeyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 113 FKDNSNLYMVMEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eccCCeEEEEEeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEec
Confidence 99999999999999999999999 55568999999999999999999999999 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|.|+..... +.+.||||.|+|||++...+|..++|+|||||++|||+.|.+||...++..... ..+...
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~------KI~~~~ 257 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE------KILEGK 257 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH------HHHhCc
Confidence 999986432 455899999999999999999999999999999999999999998876522111 111111
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCCCCCCCCCCCccc
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLKDMASSSYY 362 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~~~~~~~~~~~~~ 362 (422)
. .|+...+.++++|++++|+.|-.+|- ++..=.+.++.+++++...+...+
T Consensus 258 v------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~ 309 (355)
T KOG0616|consen 258 V------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL 309 (355)
T ss_pred c------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence 1 13444567899999999999999994 444345566677777665544333
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=376.79 Aligned_cols=267 Identities=27% Similarity=0.336 Sum_probs=216.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHH-HHHHHHHHhcccC-CCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV-HLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~ 140 (422)
.-++|.++++||.|+||.||+|+... +|..||||.++.......+ .-++|++.|++|. |||||++.+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi 78 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI 78 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence 34689999999999999999999877 7888999999765433222 2468999999998 99999999999
Q ss_pred EecC-ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 141 IEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 141 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
.+.+ .+|+||||| ..+|.+++..++..|++..++.|+.||++||+|+|.+| +.||||||+|||+..+..+||+||
T Consensus 79 ~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 79 RDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred hccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccc
Confidence 9988 999999999 45999999888889999999999999999999999999 999999999999998889999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh---
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH--- 295 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--- 295 (422)
|+|+...... -.+..+.|.+|+|||++. .+.|+.++|+||+|||++|+.+-++.|.+....+...-+..+...
T Consensus 155 GLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 155 GLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK 231 (538)
T ss_pred ccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence 9999764332 234567899999999986 678899999999999999999999999987654433222111100
Q ss_pred --hhcc--------cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 --LGER--------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 --~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.+. -++.......+...++. .+.++.++|.+||++||.+|||+.+++++
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 11111222222223333 67899999999999999999999999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=377.65 Aligned_cols=269 Identities=26% Similarity=0.330 Sum_probs=220.6
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEe
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
+..++|+++++||+|+||.||+|+-+. ||..+|+|++++..... .+.+..|-.+|...+++.||+++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 346789999999999999999998776 89999999998776543 455788999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
.|.+.+.+||||||++||++..+|.+. ..|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+|
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecc
Confidence 999999999999999999999999554 57999999999999999999999999 99999999999999999999999
Q ss_pred ccCcccCCCC----------------------Ccc------c-----------------eeeccccCccccCCCcccCCC
Q 014585 219 FGLAKDGPEG----------------------DKT------H-----------------VSTRVMGTYGYAAPEYVMTGH 253 (422)
Q Consensus 219 FG~a~~~~~~----------------------~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~ 253 (422)
||++...... +.. . .....+|||.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 9998532110 000 0 011368999999999999999
Q ss_pred CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCC
Q 014585 254 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRD 333 (422)
Q Consensus 254 ~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 333 (422)
|+..+|+||||||+||||.|.+||....+...-..+...+..+.... ....+.++.+||.+||. |
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-C
Confidence 99999999999999999999999998877654333322222221110 11234799999999998 9
Q ss_pred CCCCCCHHHHHHHhCCCCCCCCCCCC
Q 014585 334 PKARPLMSEVVEALKPLPNLKDMASS 359 (422)
Q Consensus 334 p~~Rps~~ell~~L~~~~~~~~~~~~ 359 (422)
|++|.. ..=+++++.+++++++.+.
T Consensus 430 ~~~RLG-~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 430 PENRLG-SKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHhcC-cccHHHHhcCCccccCCcc
Confidence 999997 4455667778888777653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=369.31 Aligned_cols=258 Identities=30% Similarity=0.431 Sum_probs=208.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|...+.||+|+||.||++.+.+ +|..+|||.+........+.+.+|+++|++|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 467788999999999999999976 57899999997664444567899999999999999999999755444
Q ss_pred --ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-CCCeEEeeccC
Q 014585 145 --QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGL 221 (422)
Q Consensus 145 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~~~~kl~DFG~ 221 (422)
.++|+|||+++|+|.+++.+.+..+++..+..+++||++||+|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 588999999999999999777668999999999999999999999988 999999999999999 79999999999
Q ss_pred cccCCC-CCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 222 AKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 222 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
+..... ...........||+.|||||++..+ ....++|||||||++.||+||++||... .. ...+.......
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~---~~~~~~~ig~~- 238 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE---EAEALLLIGRE- 238 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc---hHHHHHHHhcc-
Confidence 987653 1111223347899999999999853 3345999999999999999999999864 11 11111100000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.....++...+.++.+|+.+|+..||.+|||+.++|++...
T Consensus 239 ---------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 239 ---------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ---------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 01113344567899999999999999999999999987543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=342.51 Aligned_cols=266 Identities=26% Similarity=0.383 Sum_probs=216.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.+|...++||+|.||.||+|++.+ +|+.||||+++...... ....++||+.|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 468888999999999999999877 88999999998765432 3457899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+.+.||+||++ .+|+..+..+...++...+..++.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+|
T Consensus 73 ~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 73 KSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred CCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccch
Confidence 999999999994 5999999888889999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--h-----
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--P----- 294 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~----- 294 (422)
+.+........ ..+-|.+|+|||.+.| ..|+..+|+||.|||+.||+.|.+-|.+.+..+....+-... +
T Consensus 149 r~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 99876544332 2367999999999885 579999999999999999999998888765543332221111 1
Q ss_pred ----hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 ----HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+++..++.....+.... +-..++.++.+|+.+||..||.+|+++.|++++
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111122222222222222 333556778999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=371.94 Aligned_cols=269 Identities=25% Similarity=0.305 Sum_probs=216.0
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
....|+.+++||+|+||.||+|++.. +|+.||+|+++.+.. ....-..+||.||++|+||||+++.+..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 34678889999999999999999987 889999999987653 3345678999999999999999999998
Q ss_pred Eec--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 141 IED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 141 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
.+. +.+|||+|||++ +|.-++......|++.++..++.||+.||.|||..+ |+|||||.+|||||.+|.+||+|
T Consensus 186 t~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred EecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecc
Confidence 876 789999999976 999999777888999999999999999999999999 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--h
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--H 295 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~ 295 (422)
||+|+.+....... .++.+-|.+|+|||++.| ..|+.++|+||.||||.||++|++.|.+.........+-.... .
T Consensus 262 FGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 262 FGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred ccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 99999876544332 445677999999999986 5799999999999999999999999998776544333221110 0
Q ss_pred hhcc--cccc--cccCc------ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGER--RRFY--RLIDP------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~~--~~~~--~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+ .++. ..+.+ .+.+. ....+..+.+|+..+|..||.+|.|+.++|+.
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0000 0111 11111 11111 11235678899999999999999999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=377.53 Aligned_cols=261 Identities=32% Similarity=0.468 Sum_probs=213.6
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+.+..+.+++++.||+|.||.||.|.+.. ...||+|.++... ...+.|.+|+++|++|+|+|||+++++
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcC----------CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEE
Confidence 34445556677889999999999999964 2369999998764 345789999999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
|..++.++|||||++.|+|.++|.. .+..+.....+.++.|||+||+||++++ +|||||..+||||+++..+||+|
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsD 346 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISD 346 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcc
Confidence 9998899999999999999999986 5677999999999999999999999999 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
||+|+...+ +.........-...|.|||.+..+.++.|+|||||||+||||+| |+.|+......+ .++. +.
T Consensus 347 FGLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~----le 418 (468)
T KOG0197|consen 347 FGLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLEL----LE 418 (468)
T ss_pred cccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHH----Hh
Confidence 999995433 33323333334678999999999999999999999999999999 677776543221 1111 11
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. -+++.. +..|+.++.+||..||..+|++|||+..+...|+.+..
T Consensus 419 ~---GyRlp~-------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 419 R---GYRLPR-------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred c---cCcCCC-------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1 122222 33577899999999999999999999999998876543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=375.25 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=216.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
...|....+||+|+.|.||.|.... +++.||||++........+-+++|+.+|+..+|+|||.+++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 3578888999999999999998766 7789999999887766667789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+.+|+||||++||+|.|.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++.
T Consensus 343 deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeee
Confidence 9999999999999999998544 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
.+..... .....+||++|||||++....|++|+||||||++++||+-|.+||-...+.....++.. -
T Consensus 418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~----n------- 484 (550)
T KOG0578|consen 418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----N------- 484 (550)
T ss_pred ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh----c-------
Confidence 8765443 34457899999999999999999999999999999999999999986544322211110 0
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....-..+...+..+++|+.+||+.|+.+|+++.|||++
T Consensus 485 ----g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 ----GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 011111234567899999999999999999999999984
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=373.55 Aligned_cols=251 Identities=27% Similarity=0.361 Sum_probs=209.3
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC----c-ccHHHHHHHHHHhcccC-CCcceee
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----L-QGHKEWLAEVNFLGDLV-HLNLVKL 136 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~-~~~~~~~~E~~~l~~l~-h~niv~~ 136 (422)
...+|.+.+.||+|+||+|++|.+.. +|..||+|++.... . ...+.+.+|+.+++++. ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 45689999999999999999999877 77899999876641 1 22345678999999998 9999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CCeE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAK 215 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~~k 215 (422)
++++.....+++|||||.||+|.+++.+ .+.+.+..+..+++||+.|++|||+.+ |+||||||+|||++.+ +++|
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999999999999999977 778999999999999999999999999 9999999999999999 9999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCC-CC-chhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
|+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||....... + ..
T Consensus 162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l---~~ 233 (370)
T KOG0583|consen 162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---L---YR 233 (370)
T ss_pred EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---H---HH
Confidence 99999999874 1222344579999999999999877 85 78999999999999999999998732211 1 11
Q ss_pred hhhhcccccccccCcccCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKG-AQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
......-. ++... +.++.+|+.+||..||.+|+++.+++++
T Consensus 234 ki~~~~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 234 KIRKGEFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHhcCCcc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11111111 11122 6789999999999999999999999853
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=376.96 Aligned_cols=269 Identities=26% Similarity=0.428 Sum_probs=221.5
Q ss_pred cchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCc
Q 014585 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN 132 (422)
Q Consensus 55 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n 132 (422)
...++|.+..+.+.+...||+|.||+||+|.+.. .||||+++..... ..+.|.+|+.++++-+|.|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 3446677777888899999999999999999976 5999999876543 4567999999999999999
Q ss_pred ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 133 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
|+-++|+|..+.. .||+.+|+|-+|+.+++.....|.....+.|++||++||.|||.++ |||||||..|||+.+++
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDL 525 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCC
Confidence 9999999998777 9999999999999999888888999999999999999999999998 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
+|||+|||++................|...|||||+++ ..+|+..+|||||||++|||++|..||...........+
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV 605 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV 605 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe
Confidence 99999999998754443333334456889999999987 458999999999999999999999999844332211111
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. .. +...|. . ....++++++++|+..||..++++||.+.+|+..|+.++.
T Consensus 606 G-------rG---~l~pd~--s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 G-------RG---YLMPDL--S-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred c-------cc---ccCccc--h-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0 00 011111 1 1233678899999999999999999999999997766544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=364.27 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=216.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..|+..++||+|.||.||+|.+.. +++.||+|++..+.... .+++.+|+.+|.+++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 467778999999999999999877 88899999998765543 56789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..++++||||.||++.+++ +.+..+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+.
T Consensus 84 ~~LwiiMey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred ccHHHHHHHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence 9999999999999999998 44555688889999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
......... ..++||+.|||||++.+..|+.|+||||||++.+||.+|.+||....+.....++ .
T Consensus 160 ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------p 224 (467)
T KOG0201|consen 160 QLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------P 224 (467)
T ss_pred eeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------c
Confidence 775544332 5689999999999999999999999999999999999999999887764332221 1
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+-..|.+.+ .++..+++|+..||..||+.||++.+++++
T Consensus 225 k~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 KSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 223344444 455789999999999999999999999974
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=353.88 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=215.2
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++..+||.|.-++||+|+... +++.||||++..+.... .+.+.+|+..|+.++||||++++..|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 45789999999999999999999876 67899999998776554 478999999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+..+|+||.||.+|++.+++... ...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence 999999999999999999999654 445999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcc-cee-eccccCccccCCCccc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 221 LAKDGPEGDKT-HVS-TRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 221 ~a~~~~~~~~~-~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
.+..+...... ... ..++||+.|||||++. ...|+.|+||||||++.+||.+|..||....+....- ..+
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl------~tL 245 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL------LTL 245 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH------HHh
Confidence 87665443322 222 4578999999999965 4589999999999999999999999998776543211 111
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+... ...-..+...-....+..++.++..||+.||.+|||+++++++
T Consensus 246 qn~pp--~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 246 QNDPP--TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCCCC--CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11110 0000011111222345688999999999999999999999964
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=362.14 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=211.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|.+.+.||+|+||+||+|+.+. +.+.||+|.+.+... ...+.+.+|++|++.++|||||.++++|..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 468888999999999999998765 888999999976543 234568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
..++|+|.|||.| +|..++. ..+.++++.+..++.|++.||.|||+.+ |+|||+||.|||++++|++|+||||+|
T Consensus 73 ~~~~~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred cceEEEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhh
Confidence 9999999999966 9999984 4557999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
+.... ...+.+...|||.|||||++.+++|+..+|+||+|||+|||++|++||.... +.........+.
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~--- 216 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP--- 216 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC---
Confidence 98654 4455677899999999999999999999999999999999999999997532 111111111111
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..+...+..+..|+..+|..||..|.+-.+++.+
T Consensus 217 ------v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 ------V---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------C---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1 1233567889999999999999999999999864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=378.41 Aligned_cols=264 Identities=24% Similarity=0.310 Sum_probs=215.5
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGY 139 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 139 (422)
.+...+++|.+.|.+|||+.||+|.+.. .|..||+|++...+....+.+.+||.+|++|. |+|||.+++.
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 4556788999999999999999999876 44789999998777778889999999999996 9999999993
Q ss_pred -EEe---c---CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 140 -CIE---D---DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 140 -~~~---~---~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
... + -+++|+||||.||.|.|+|..+ ...|++..+++|+.|+++||++||... .+|||||||-+||||+.+
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSAD 182 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCC
Confidence 221 1 2567999999999999999644 445999999999999999999999987 779999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccce-------eeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~ 281 (422)
|..||||||.|......-.... .-...-|+.|+|||++. +.++++|+|||||||+||-|+....||+...
T Consensus 183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 9999999999875322211100 00134699999999875 7889999999999999999999999998653
Q ss_pred CCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCC
Q 014585 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 354 (422)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 354 (422)
.. .+++..+.-.-...++..+.+||+.||+.||.+||++-+++..+..+....
T Consensus 263 ~l--------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 KL--------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ce--------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22 222222222223467889999999999999999999999999887666543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=349.19 Aligned_cols=269 Identities=26% Similarity=0.342 Sum_probs=213.0
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEec--CCCcccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
...+|...+.||.|+||.|..|.+.. +|+.||||++. -......++.++|+++|+.++|+||+.+++++
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~ 90 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF 90 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence 44667778999999999999999887 78899999997 33444567889999999999999999999998
Q ss_pred Ee-----cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 141 IE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 141 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
.. -..+|+|+|+| +.+|.+.+ +.+..++...+..++.||++||+|+|+.+ |+||||||.|+|++.++.+|
T Consensus 91 ~p~~~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 91 RPPSRDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred ccccccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEE
Confidence 75 35789999999 66998888 55556999999999999999999999999 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|||||+|+...........+..+-|.+|+|||++. ...|+.+.||||+|||+.||++|++.|.+.+......++.....
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999999875432222335567899999999886 57899999999999999999999999998765544333221111
Q ss_pred hhhc--------------ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGE--------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.-.+ -..+.......+...|+ .....+.+|+.+||.+||.+|+|++|+|++
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1000 00011111111112222 456789999999999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.94 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=217.7
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhccc-CCCccee
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVK 135 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~ 135 (422)
..+..++|.++++||+|.||+|+++..+. +++.+|||++++...-. .+..+.|.+|+... +||.+++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~ 433 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVN 433 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEee
Confidence 34566889999999999999999999877 78899999999876543 34577899988887 5999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
++++|...+++|+||||+.||++..+ .+...|++..+..++..|+.||.|||+++ |||||||.+|||||.+|.+|
T Consensus 434 L~~~fQT~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 434 LFSCFQTKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred cccccccCCeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEE
Confidence 99999999999999999999995443 34457999999999999999999999999 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
|+|||+++....... .+.++|||+.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+.-+.+.
T Consensus 509 iADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----- 581 (694)
T KOG0694|consen 509 IADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----- 581 (694)
T ss_pred ecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-----
Confidence 999999997543222 4567999999999999999999999999999999999999999999765433222211
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhCCCCCCCCCCC
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE-VVEALKPLPNLKDMAS 358 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~~~~~~ 358 (422)
.+ .-.++...+.++..|++++|..||++|..+.+ =.+.++..++++.+.+
T Consensus 582 -~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 582 -ND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred -cC------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 11 12244566789999999999999999996621 1223344566655543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.51 Aligned_cols=249 Identities=28% Similarity=0.393 Sum_probs=210.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.-|++++.||.|+-|.|.+|++.. ||+.+|||++...... ....+.+||-+|+.+.||||+++|+++.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 358889999999999999999987 9999999999765221 1345889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
...++|+|.||++||.|.+++.++ +++++..+.++++||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 999999999999999999999665 47999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
|..-..+. ...+-||++.|.|||++.|.+| +.++||||.|||||.||+|+.||++.+-. .+...+. .
T Consensus 159 AsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV~------~ 226 (786)
T KOG0588|consen 159 ASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKVQ------R 226 (786)
T ss_pred eecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHHH------c
Confidence 98754433 2345799999999999999999 57899999999999999999999854321 1111111 0
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
..++ ++...+.++++||.+||..||.+|.++.||++|.
T Consensus 227 G~f~---------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 GVFE---------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred Cccc---------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 0111 2224467899999999999999999999999874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.06 Aligned_cols=274 Identities=27% Similarity=0.331 Sum_probs=224.6
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH---HHHHHHHHHhcccCCCcce
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLV 134 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv 134 (422)
.+..+..++|++++.||+|.-|+||+++... ++..+|+|++.+...... .+...|-.||..++||.++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlP 140 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLP 140 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccc
Confidence 4445666789999999999999999999876 667999999987665443 4567899999999999999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
.+|+.|..+...|||||||+||+|..+.++. +..+++..+..++.+++-||+|||..| ||+|||||+||||.++|+
T Consensus 141 TLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGH 217 (459)
T KOG0610|consen 141 TLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGH 217 (459)
T ss_pred hhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCc
Confidence 9999999999999999999999999998765 567999999999999999999999999 999999999999999999
Q ss_pred eEEeeccCcccCCC---------------------------------CCcc---------------------ceeecccc
Q 014585 214 AKLSDFGLAKDGPE---------------------------------GDKT---------------------HVSTRVMG 239 (422)
Q Consensus 214 ~kl~DFG~a~~~~~---------------------------------~~~~---------------------~~~~~~~g 239 (422)
|.|.||.++..+.. .... .....++|
T Consensus 218 IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVG 297 (459)
T KOG0610|consen 218 IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVG 297 (459)
T ss_pred EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccc
Confidence 99999988653311 0000 01124889
Q ss_pred CccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHH
Q 014585 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA 319 (422)
Q Consensus 240 t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (422)
|-.|+|||++.|...+.++|+|+|||++||||.|..||.+.........+. .+...+.. ....+
T Consensus 298 ThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv------~~~l~Fp~----------~~~vs 361 (459)
T KOG0610|consen 298 THEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV------GQPLKFPE----------EPEVS 361 (459)
T ss_pred ccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh------cCCCcCCC----------CCcch
Confidence 999999999999999999999999999999999999998875543322211 11111111 11446
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCCCCCC
Q 014585 320 QKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASS 359 (422)
Q Consensus 320 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 359 (422)
..++|||+++|..||.+|.....=...++.+++++++.+.
T Consensus 362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred hHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 7899999999999999999977667777888888887764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=363.41 Aligned_cols=267 Identities=30% Similarity=0.444 Sum_probs=206.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+..++|++.++||+|+||.||+|.+.... +..++..||||++..... .....+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 34578999999999999999999864211 112566899999975432 2245688999999999 89999999998
Q ss_pred EEec-CceEEEEEecCCCChhhhhccCC----------------------------------------------------
Q 014585 140 CIED-DQRLLVYEFMPRGSLENHLFRRS---------------------------------------------------- 166 (422)
Q Consensus 140 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------- 166 (422)
+... +.+++||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 45789999999999999885421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeecc
Q 014585 167 ---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237 (422)
Q Consensus 167 ---------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 237 (422)
..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..............
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 24778888999999999999999988 999999999999999999999999999865432222222234
Q ss_pred ccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCH
Q 014585 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 316 (422)
Q Consensus 238 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (422)
.++..|+|||++.+..++.++|||||||++|||++ |..||....... .... .+..... .. .+.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~~------~~----~~~ 300 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ----RLKDGTR------MR----APE 300 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----HHhcCCC------CC----CCC
Confidence 56788999999999999999999999999999997 999997643211 0111 1111000 00 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 317 KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 317 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
..+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33567899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=351.61 Aligned_cols=263 Identities=25% Similarity=0.323 Sum_probs=209.0
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--------------cHHHHHHHHHHhc
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKEWLAEVNFLG 126 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~ 126 (422)
....+.|++.+.||+|.||.|-+|++.. +++.||||++.+.... ..+.+.+||.+|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 4456889999999999999999999877 7889999999754321 1246889999999
Q ss_pred ccCCCcceeeEeEEEe--cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 127 DLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 127 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
+|+|+|||+++++..+ .+.+|||+|||..|.+...- .....+++.++++++++++.||+|||.++ ||||||||+
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs 239 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS 239 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence 9999999999999876 56899999999999886543 22333999999999999999999999999 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCc---cceeeccccCccccCCCcccCCC----CCchhhhhhHHHHHHHHHhCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf 277 (422)
|+||+.+|++||+|||.+.....+.. .......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 99999999999999999986533211 11122368999999999887632 367899999999999999999999
Q ss_pred CCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.+....... ..+++..+.-.-..+...++++||++||..||+.|.+..+|..+..-...
T Consensus 320 ~~~~~~~l~----------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 320 FDDFELELF----------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccchHHHHH----------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 865322111 12233333322233456789999999999999999999999887754433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=338.39 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=212.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|+.+..|++|+||.||+|+++. |++.||+|+++.+.... --.-++||.+|.+++|||||.+-.+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 4578889999999999999999877 88899999998765221 123579999999999999999998876
Q ss_pred e--cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 142 E--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 142 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
. -+.+|||||||++ +|..++.....+|....+..++.|++.||+|||.+. |+|||||++|+|++..|.+||+||
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 4 4579999999966 999999888889999999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh------
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA------ 292 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~------ 292 (422)
|+|+.+...- ...+..+-|.+|+|||++.+ ..|++++|+||+|||+.||+++++.|.+.......+.+-..
T Consensus 222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 9999876542 23445678999999999886 57999999999999999999999999887654433322111
Q ss_pred --hhhhhcc-----cccccccCcccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 --RPHLGER-----RRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 --~~~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
++.+... ..+....-..+...|... .+....+|+..+|..||.+|.|+.+.|++
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111100 001111111122223222 45788999999999999999999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=347.82 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=212.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHH---HHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..+|++.+.||.|.||+|-+|.... .|+.||||.++++.....+ .+.+||+||..|+||||+.+|++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 4689999999999999999998765 7899999999987765544 467999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...+.+.|||||..+|.|+|++.+ .+.+++..+..+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 999999999999999999999954 457999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++..+.... ...++||++.|.+||++.+.+| ++.+|-|||||+||.|+.|..||++.+.. .++..+...
T Consensus 199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~G---- 268 (668)
T KOG0611|consen 199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISRG---- 268 (668)
T ss_pred hhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhcc----
Confidence 998875433 3456899999999999999999 57899999999999999999999875421 222211100
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
... .+..+..+.-||++||..||++|.|+.+|..+.
T Consensus 269 ----aYr--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 ----AYR--------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----ccc--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 001 112345778999999999999999999998875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=348.98 Aligned_cols=272 Identities=28% Similarity=0.438 Sum_probs=209.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCC-------CCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCccee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~ 135 (422)
.++|++.++||+|+||.||+|.+...... ..+.+++..||+|.+...... ...++.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 46899999999999999999987543211 123345668999998765322 3456899999999999999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~ii 197 (422)
+++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999884321 24678889999999999999999988 99
Q ss_pred eccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh--CCC
Q 014585 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRR 275 (422)
Q Consensus 198 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~ 275 (422)
||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987644433333334556889999999998899999999999999999987 456
Q ss_pred CCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 276 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 276 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
||...... ................ . ....+..++..+.+|+.+||+.||.+||++.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGRQ--V-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhcccc--c-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77654321 1111111111100000 0 00011234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=323.24 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=211.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++++.||+|.||.||+|+.+. ++..||+|++.+.... ....+.+|+.|...|+||||+++|++|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred hhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 4689999999999999999999887 6779999999765432 235688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
.+....||++||..+|.|...|.. ....+++...+.++.|++.||.|+|..+ +|||||||+|+|++.+|.+||+||
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 999999999999999999999964 3556999999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|.+...... .....|||..|.+||+..+..++..+|+|++|++.||++.|.+||..........-+.
T Consensus 169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--------- 235 (281)
T KOG0580|consen 169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--------- 235 (281)
T ss_pred CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---------
Confidence 999875422 2345799999999999999999999999999999999999999998654211110000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
+. ++ .++...+.++.++|.+||..+|.+|....|++++-
T Consensus 236 -k~-~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 236 -KV-DL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -Hc-cc-------cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 00 11 12234567899999999999999999999998763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=357.36 Aligned_cols=245 Identities=28% Similarity=0.453 Sum_probs=205.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+....++.||.|+.|.||+|+. .++.||||+++.- -..+|+.|++|+|+||+.|.|+|....
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-----------~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-----------HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-----------cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 3444567899999999999998 4568999988532 135789999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
-+|||||||..|-|..+| +.+..+.......|..+|+.|+.|||.++ |||||||.-||||+.+..|||+|||-++.
T Consensus 186 cyCIiMEfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred eeEEeeeccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999999999 55567889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
..+. ...-.++||..|||||++.+.+.+.|+|||||||+|||||||..||.+.... .+.|...
T Consensus 262 ~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVG---------- 324 (904)
T KOG4721|consen 262 LSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVG---------- 324 (904)
T ss_pred hhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEecc----------
Confidence 6543 2334589999999999999999999999999999999999999999754321 1111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
...+.-..+..+++.++-|++.||.-.|.+||+|++++.+|.-.
T Consensus 325 --sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 325 --SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred --CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 11122224456788899999999999999999999999998743
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=355.49 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=215.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.+|.+++.+|+|+||.+++++++. .+..|++|.+....... .+...+|+.+++++.|||||.+.+.|.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~---------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKS---------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhcc---------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 578899999999999999998877 55689999998665433 3457899999999999999999999999
Q ss_pred cCc-eEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 143 DDQ-RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 143 ~~~-~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
++. ++|||+||+||+|.+.|.+.. ..++++.++.|+.|++.|+.|||+.. |+|||||+.|||+++++.|||+|||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence 988 999999999999999997654 67999999999999999999999888 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+|+...... ....+.+||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.... +....
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i~ki~------- 219 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---ILKIN------- 219 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---HHHHh-------
Confidence 999876543 134457899999999999999999999999999999999999999987643221 11111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......+..++.++..+++.||..+|..||++.++|.+
T Consensus 220 -------~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 -------RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -------hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 011122344667899999999999999999999999976
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=350.43 Aligned_cols=246 Identities=25% Similarity=0.312 Sum_probs=202.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 368999999999999999999876 678999999865432 23356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence 99999999999999999999854 447899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
++..... .....|++.|+|||++.+..++.++|||||||++|+|++|..||........ .. .......
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~---~i~~~~~- 215 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YE---KILAGKL- 215 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhCCc-
Confidence 9865432 1235689999999999999999999999999999999999999976432111 11 0000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~~ 346 (422)
.++...+..+.+|+++||+.||.+||+ +.+++++
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111223467899999999999999995 6666643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=355.79 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=204.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.+|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 578999999999999999999876 678999999975422 23456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999999854 457899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.. ... ........
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~---~i~~~~~~ 233 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYE---KILAGRLK 233 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHH---HHhcCCcC
Confidence 98754322 23579999999999999999999999999999999999999997543211 111 00000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-HHHHHHhCCCCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-SEVVEALKPLPNLKD 355 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~~~ 355 (422)
++...+..+.+|+.+||+.||.+|++. .+.++.|..++++.+
T Consensus 234 ------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 234 ------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 111234678899999999999999962 223333334455543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=373.74 Aligned_cols=266 Identities=30% Similarity=0.454 Sum_probs=222.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...+.+..+.||+|+||+||+|+...-.. -.....||||.++..... .+++|.+|++.+..|+|||||+++|+|.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p----~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLP----GQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCC----CccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 34566778899999999999998765221 124568999999887766 5778999999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
+++..++|+|||..|||.++|..+. .+++..+.+.|+.||+.||.||-++. +|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence 9999999999999999999996321 23888999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 287 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 287 (422)
.++..|||+|||+++.....+.........-.++|||||.+..++|++++|||||||+|||+++ |..||.+....+.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-- 714 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-- 714 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--
Confidence 9999999999999998766666665545556789999999999999999999999999999998 8889987654332
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
++.... + .+ -..+..++.+++.||..||+.+|.+||+++||-..|+....
T Consensus 715 -Ie~i~~----g---------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 -IECIRA----G---------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -HHHHHc----C---------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 222211 1 11 22344678999999999999999999999999999876544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=344.35 Aligned_cols=250 Identities=29% Similarity=0.410 Sum_probs=202.8
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
|++.+.||+|+||.||+|.+.. +|+.||+|.+...... ....+.+|+.++++++|+||+++++++.++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~ 72 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence 7788999999999999999876 7789999998754322 234578999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999998887543 346899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ .....||..|+|||++.+..++.++|||||||++|+|++|+.||............. .....
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~---- 219 (285)
T cd05631 150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKE---- 219 (285)
T ss_pred EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhc----
Confidence 87543221 233578999999999999999999999999999999999999998654322111110 00000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 345 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~ 345 (422)
....++...+.++.+|+.+||+.||.+||+ +.++++
T Consensus 220 -------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 -------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 001122234578899999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.40 Aligned_cols=243 Identities=30% Similarity=0.377 Sum_probs=198.3
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (422)
++||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++++++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 469999999999999876 778999999975422 22345788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCC
Q 014585 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 227 (422)
|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 72 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 99999999999998854 457899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccC
Q 014585 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307 (422)
Q Consensus 228 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (422)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .....
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~---~~~~~-------- 211 (323)
T cd05571 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILMEE-------- 211 (323)
T ss_pred CCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH---HHcCC--------
Confidence 211 1234679999999999999999999999999999999999999997543211 1110 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 308 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
. .++...+.++.+||.+||+.||.+|| ++.+++++
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 11223457889999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=344.49 Aligned_cols=267 Identities=23% Similarity=0.329 Sum_probs=205.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+|++.++||.|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 579999999999999999998876 6789999998754322 334678999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||++ ++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 99999999996 5999988766667899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 294 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~ 294 (422)
....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... +
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 6432221 1233568999999998875 568999999999999999999999997654322211111000 0
Q ss_pred hhhcccccccccCcccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......+.....+.... ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000001111111111000 0011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=344.49 Aligned_cols=268 Identities=23% Similarity=0.293 Sum_probs=205.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||.||+|++.. +++.||+|++..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 478999999999999999999876 678999999875432 224568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||++++.|..+. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999887665443 44557999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh------
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL------ 296 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------ 296 (422)
......... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+......+
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 875432221 1223568999999999998899999999999999999999999998654322111111100000
Q ss_pred --hcccccccccCcccC------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 --GERRRFYRLIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 --~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.....+.....+... ..+....+..+.+|+++||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 01111245679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=353.47 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=206.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368999999999999999999876 678999999975422 23456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..+|||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcC
Confidence 99999999999999999999854 446899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------- 214 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-------- 214 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--------
Confidence 986543 2234579999999999999999999999999999999999999997654322111111000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+............+.++.+|+.+||..+|.+||++.+++++
T Consensus 215 --~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 --ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000000012345788999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=350.63 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=207.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||++.+.. +|..||+|.+..... .....+.+|++++++++|+||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4789999999999999999999876 678999999876532 224568999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 9999999999999999999854 346899999999999999999999852 2999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc--
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-- 300 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 300 (422)
....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||............. ........
T Consensus 152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~ 225 (331)
T cd06649 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGE 225 (331)
T ss_pred ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCC
Confidence 7653321 233578999999999999999999999999999999999999996543211100000 00000000
Q ss_pred ------------------------------ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 301 ------------------------------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 301 ------------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
.+..+.............+.++.+||.+||+.||++||++.+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000000001113457899999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=357.34 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=206.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+... ....++..||||+++.... ...+.+.+|+.++..+ +||||+++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 345799999999999999999975321 1122567899999975432 2345688999999999 899999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC------------------------------------------------------
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 166 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 166 (422)
...+..++|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999885421
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 167 --------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 167 --------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 24778889999999999999999988 9999999999999999999999999998764
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
............++..|+|||++.+..++.++|||||||++|||++ |..||....... ....... ... ..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~---~~ 336 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGY---RM 336 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCc---cC
Confidence 4332222223445678999999999999999999999999999998 888886543211 1111111 000 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
. .+...+.++.+|+.+||+.||++||++.++++.|+.
T Consensus 337 ~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 L-------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0 111224689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=358.63 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=208.4
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
...++|++.+.||+|+||.||+|.+...+. ..++..||||++...... ....+.+|+.+++.+ +|+||++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 344679999999999999999998754221 124567999999754322 345688999999999 89999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC-----------------------------------------------------
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 166 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 166 (422)
+...+..++|||||++|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999875321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCc
Q 014585 167 ----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 230 (422)
Q Consensus 167 ----------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 230 (422)
..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 24788889999999999999999988 99999999999999999999999999987544332
Q ss_pred cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcc
Q 014585 231 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309 (422)
Q Consensus 231 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (422)
........++..|+|||++.+..++.++|||||||++|||++ |..||........ ...... ..
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~----~~---------- 331 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVK----RG---------- 331 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHH----cc----------
Confidence 222223345678999999999999999999999999999997 9999975432111 111000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 310 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.....+...+.++.+++.+||+.||.+||++.++++.|+.+
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00001112246899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=341.73 Aligned_cols=245 Identities=20% Similarity=0.320 Sum_probs=199.7
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEEEe----c
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE----D 143 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~ 143 (422)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5799999999999987 57799999997654333 3567899999999999999999999877 3
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
...++||||+++|+|.+++.+ ...+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchH
Confidence 467899999999999999955 45789999999999999999999984 6 889999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+...... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||....... ..... .....
T Consensus 171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i---~~~~~ 239 (283)
T PHA02988 171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLI---INKNN 239 (283)
T ss_pred hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhcCC
Confidence 8653321 22468899999999876 689999999999999999999999998653211 11110 00000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
...++..++..+.+|+.+||+.||++||++.++++.|+.+.
T Consensus 240 ----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 ----------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01122245678999999999999999999999999987654
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=343.67 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=217.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH--HHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..-|.+.+.||+|.|+.|-+|++.- +|..||||++.+...... ..+.+|++.|+.++|||||++|++..
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 3568899999999999999998865 899999999988766543 46899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE-cCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill-~~~~~~kl~DFG 220 (422)
....+|||+|+-++|+|.++|.++...+.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ .+-|-|||.|||
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence 999999999999999999999999989999999999999999999999999 9999999999876 566999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++..+..+.. ....||+..|-|||++.+..|+ +++||||||||||.|++|++||+..+..+...+
T Consensus 165 FSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----------- 230 (864)
T KOG4717|consen 165 FSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----------- 230 (864)
T ss_pred ccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-----------
Confidence 9998876654 3457999999999999999986 689999999999999999999987654333222
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
++|-. -..+...+.++++||..||..||.+|.+.+||...
T Consensus 231 -----ImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 231 -----IMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -----hhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 12211 12345678999999999999999999999999754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=337.10 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=208.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|++..... .+..||+|.+...... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSK------RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCC------ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 4578999999999999999998764322 5678999999765332 23568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+++|+|.+++......+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999766667999999999999999999999988 999999999999999999999999987
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~- 225 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDGF- 225 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCC-
Confidence 65422211 11112345678999999999999999999999999999775 999997643221 11111 0100
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. ..+..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 226 -----~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 01223457889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.08 Aligned_cols=243 Identities=30% Similarity=0.366 Sum_probs=197.7
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (422)
+.||+|+||.||++.+.. +|..||+|++..... .....+.+|+++++.++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 469999999999999866 678999999975422 22345778999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCC
Q 014585 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 227 (422)
|||||+++|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 72 lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 72 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 99999999999988854 447899999999999999999999988 99999999999999999999999999875322
Q ss_pred CCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccC
Q 014585 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307 (422)
Q Consensus 228 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (422)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ... ......
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~---~~~~~~------- 212 (323)
T cd05595 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FEL---ILMEEI------- 212 (323)
T ss_pred CCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHH---HhcCCC-------
Confidence 211 12335799999999999999999999999999999999999999975432111 110 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 308 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
.++...+.++.+++.+||+.||.+|+ ++.+++++
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11223357889999999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.20 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=202.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 4689999999999999999999876 6779999999754332 23457899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+ .++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 99999999999 46888888776677999999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc---
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 298 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 298 (422)
....... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .........+..
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 226 (303)
T cd07869 151 RAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNE 226 (303)
T ss_pred eeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCCh
Confidence 7543221 11233568999999998875 468999999999999999999999997643211 111110000000
Q ss_pred --cc---cccccc--------CcccCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 --RR---RFYRLI--------DPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 --~~---~~~~~~--------~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ...... ...+...+. ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 000000 000000000 0123578899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.03 Aligned_cols=271 Identities=28% Similarity=0.448 Sum_probs=218.0
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcce
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLV 134 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv 134 (422)
..|++..++..+.++||+|+||.||+|........ ....||||..+... .....++++|+++|++++|||||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 44556667778889999999999999998763221 11128999998532 34567899999999999999999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
++||++.....++||||+|+||+|.++|++....++......++.+.+.||+|||+++ +|||||..+|+|++.++.+
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeE
Confidence 9999999999999999999999999999887778999999999999999999999999 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceee-ccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
||+|||+++.... ..... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.........+.
T Consensus 302 KISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-- 376 (474)
T KOG0194|consen 302 KISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-- 376 (474)
T ss_pred EeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH--
Confidence 9999999987531 11111 1234679999999999999999999999999999999 788987654321111110
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 355 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 355 (422)
........+...+.++..++.+||..||++||+|.++.+.|+.+.....
T Consensus 377 --------------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 377 --------------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 0011111222456889999999999999999999999999987655433
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=337.53 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=210.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||+|+||.||+|.+..... ......||+|.+...... ....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 478899999999999999998765321 114467999998754332 245688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
+..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 99999999999999999986431 45788999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 287 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 287 (422)
+.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--- 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--- 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986544333233334567889999999998899999999999999999998 999997654321
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
...... .. .....+..++.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 235 ~~~~i~----~~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIR----SR----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHH----cC----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 00 0011223456889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=330.95 Aligned_cols=264 Identities=26% Similarity=0.361 Sum_probs=206.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCc-ceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN-LVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~~~~~~~ 141 (422)
..|..+++||+|+||+||+|+... +|+.||+|+++....+ ......+|+.+|+.|+|+| ||.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 346667789999999999999887 7889999999866542 2345789999999999999 999999999
Q ss_pred ecC------ceEEEEEecCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 142 EDD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 142 ~~~------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
..+ .+++||||+ ..+|.+++.... ..++...++.+++||+.||+|||+++ |+||||||.||||+++|
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSG 157 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCC
Confidence 877 788999999 569999997655 46888999999999999999999999 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
.+||+|||+|+....... ..+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+.........+
T Consensus 158 ~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I-- 233 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI-- 233 (323)
T ss_pred cEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH--
Confidence 999999999997653332 24456789999999999876 7999999999999999999999999887653221111
Q ss_pred hhhhhhc--cccccccc---C-----cccC--CCCCH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 ARPHLGE--RRRFYRLI---D-----PRLE--GHFSI---KGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 ~~~~~~~--~~~~~~~~---~-----~~~~--~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...++. ...+.... + +... ..+.. .......+++.+||+.+|.+|.|+..++.+
T Consensus 234 -f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 234 -FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred -HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111110 01110000 0 0000 00111 112478899999999999999999999975
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=347.54 Aligned_cols=243 Identities=28% Similarity=0.364 Sum_probs=198.5
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (422)
+.||+|+||.||++.+.. +|..||+|++..... .....+.+|+++++.++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 469999999999999876 678999999975422 23456789999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCC
Q 014585 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 227 (422)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 72 FVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 99999999999988854 457899999999999999999999988 99999999999999999999999999876432
Q ss_pred CCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccC
Q 014585 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307 (422)
Q Consensus 228 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (422)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... ......
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~---~~~~~~-------- 211 (328)
T cd05593 148 DAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---LILMED-------- 211 (328)
T ss_pred ccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH---HhccCC--------
Confidence 211 1234579999999999999999999999999999999999999997543211 111 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 308 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
. .++...+.++.+|+.+||+.||.+|+ ++.+++++
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 I----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred c----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 11223356889999999999999997 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.26 Aligned_cols=253 Identities=25% Similarity=0.306 Sum_probs=215.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccC-CCcceeeEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV-HLNLVKLIG 138 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~ 138 (422)
....|++.+.||+|.||.||++.... +|+.+|+|.+.+..... ...+.+|+.+|+++. |||||.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34678999999999999999999876 78899999998765543 357899999999998 999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC----CCCe
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DYNA 214 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~----~~~~ 214 (422)
+|.+...+++|||+|.||.|.+.+... .+++..+..++.|++.|+.|||+.+ |+||||||+|+|+.. ++.+
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence 999999999999999999999999776 3999999999999999999999998 999999999999943 3579
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.........+....
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~- 254 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD- 254 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-
Confidence 9999999998765 223455799999999999999999999999999999999999999998766443322111111
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+....-...+..+.++++.||..||.+|+++.++|++
T Consensus 255 -------------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 -------------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 012222233557899999999999999999999999996
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=317.20 Aligned_cols=266 Identities=26% Similarity=0.345 Sum_probs=213.1
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++.++|++.+.||+|||+.||++++.. ++..||+|++.....+..+..++|++..++++||||++++++.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 3466899999999999999999998766 7779999999888777788899999999999999999999887
Q ss_pred EecC-----ceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 141 IEDD-----QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 141 ~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
..+. ..||++.|+..|+|.+.+... +..+++..++.|+.+|++||++||+.. .++.||||||.|||+++.+
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSG 166 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCC
Confidence 6544 489999999999999998643 446999999999999999999999987 5799999999999999999
Q ss_pred CeEEeeccCcccCCCCCccce-------eeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 213 NAKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
.++|.|||.++...-.-.... ......|..|+|||.+. +...+.++|||||||+||+|+.|..||+....
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 999999999886532211110 11234688999999886 45678999999999999999999999975433
Q ss_pred CCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.+.--. ....++.+.-.-....++.+.+++++||+.||.+||++.+++..+..+
T Consensus 247 ~GgSla--------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 QGGSLA--------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cCCeEE--------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 221000 001111111111112568899999999999999999999999988765
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=345.59 Aligned_cols=267 Identities=25% Similarity=0.370 Sum_probs=205.0
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||.||+|.+.. +|..+|+|.+...... ....+.+|++++++++|+||+++++++.
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 34789999999999999999998875 6778999998764322 2356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 74 SDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred ECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCC
Confidence 99999999999999999999854 44689999999999999999999974 5 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-hhhc-
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-HLGE- 298 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~- 298 (422)
++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||................. ....
T Consensus 150 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 150 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred cchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 987653221 2235689999999999988999999999999999999999999975432111100000000 0000
Q ss_pred -----cc-----------------ccccccCc---ccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 -----RR-----------------RFYRLIDP---RLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 -----~~-----------------~~~~~~~~---~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ....+.+. ...... ....+.++.+|+.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 00000000 000000 01134678999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=361.64 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=206.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
..|.+.+.||+|+||.||+|..... .+..||+|.+..........+.+|+.+++.++|||||++++++..++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 3489999999999999999987652 25678999876554444456788999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 145 QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..||||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcC
Confidence 99999999999999988753 2456899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
++..............+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... ....
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~---~~~~--- 286 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQ---VLYG--- 286 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHhC---
Confidence 98765433322344567999999999999999999999999999999999999999754321 11110 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
..+ .++...+.++.+||.+||..||.+||++.+++.
T Consensus 287 ---~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 ---KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 112234568999999999999999999999875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=349.70 Aligned_cols=254 Identities=25% Similarity=0.295 Sum_probs=204.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+... .+..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 35799999999999999999987542 23579999986432 22345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence 9999999999999999999998544 46899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+... ... ......
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~---i~~~~~ 245 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQK---ILEGII 245 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHH---HhcCCC
Confidence 99865322 1235799999999999998999999999999999999999999976433111 000 000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHhCCCCCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLPNLKDM 356 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~L~~~~~~~~~ 356 (422)
.++...+..+.+++++||+.||.+|+ ++.++++ ++++.+.
T Consensus 246 ------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~----hp~f~~~ 290 (340)
T PTZ00426 246 ------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE----HPWFGNI 290 (340)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc----CCCcCCC
Confidence 01122346788999999999999996 6777664 4455443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=344.56 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=198.3
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHh---cccCCCcceeeEeEE
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFL---GDLVHLNLVKLIGYC 140 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~ 140 (422)
|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|++++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6788999999999999998876 77899999997532 12234566666554 677899999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...+..|+||||+++++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence 999999999999999999888743 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+++....... .....+|++.|+|||++.+..++.++|||||||++|+|++|..||........ .. .......
T Consensus 147 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~---~i~~~~~ 218 (324)
T cd05589 147 LCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FD---SIVNDEV 218 (324)
T ss_pred CCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhCCC
Confidence 9875432211 22346799999999999999999999999999999999999999976432111 11 0000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhCCCCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE-VVEALKPLPNLKD 355 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~~~ 355 (422)
.++...+..+.++|.+||+.||.+||++.+ .++.+...+++.+
T Consensus 219 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 219 ------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 011233577889999999999999995332 2333334445444
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=341.91 Aligned_cols=256 Identities=29% Similarity=0.362 Sum_probs=201.1
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
+|++.+.||+|+||.||+++..... .+|..||+|++..... ...+.+..|+.+++.+ .|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH------DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 4888999999999999999875422 2678999999864321 2234578899999999 599999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..++..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998543 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+. .....
T Consensus 151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~-- 225 (332)
T cd05614 151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK-- 225 (332)
T ss_pred CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc--
Confidence 99865432222 12346799999999998865 47899999999999999999999997543222111111 00000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
.++. ++...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 226 ------~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ------CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ------CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 1122356789999999999999999 66666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=344.55 Aligned_cols=240 Identities=32% Similarity=0.344 Sum_probs=195.4
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
||+|+||.||+|.+.. +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999999876 67799999986432 22345678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 72 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 72 LAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 999999999999855 446899999999999999999999988 9999999999999999999999999997643222
Q ss_pred ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcc
Q 014585 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309 (422)
Q Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (422)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...........
T Consensus 148 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~~--------- 210 (312)
T cd05585 148 D--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEPL--------- 210 (312)
T ss_pred C--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC---------
Confidence 1 223467999999999999999999999999999999999999999754221 11111111100
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 014585 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVE 345 (422)
Q Consensus 310 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 345 (422)
.++...+.++.+++.+||..||.+||+ +.+++.
T Consensus 211 ---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 ---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 112234578899999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=352.58 Aligned_cols=254 Identities=25% Similarity=0.305 Sum_probs=199.7
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.|++++.||+|+||+||+|.+.. ++..||||++..... .....+.+|+.++++++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58889999999999999998876 778999999975432 223568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 99999999999999999998544 46899999999999999999999988 999999999999999999999999997
Q ss_pred ccCCCCCc---------------------------------------------cceeeccccCccccCCCcccCCCCCch
Q 014585 223 KDGPEGDK---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTSR 257 (422)
Q Consensus 223 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 257 (422)
........ .......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 64311000 000123579999999999999999999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcc--cCCCC
Q 014585 258 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL--SRDPK 335 (422)
Q Consensus 258 ~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dp~ 335 (422)
+|||||||++|||++|..||...........+ . ..... ... ......+.++.+||.+|| ..++.
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i--~--~~~~~---~~~-------~~~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKV--I--NWENT---LHI-------PPQVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHH--H--ccccc---cCC-------CCCCCCCHHHHHHHHHHccCccccc
Confidence 99999999999999999999765432111000 0 00000 000 001123568889998844 55666
Q ss_pred CCCCHHHHHHH
Q 014585 336 ARPLMSEVVEA 346 (422)
Q Consensus 336 ~Rps~~ell~~ 346 (422)
.|+++.+++.+
T Consensus 295 ~R~~~~~~l~h 305 (381)
T cd05626 295 GRNGADDIKAH 305 (381)
T ss_pred CCCCHHHHhcC
Confidence 69999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.66 Aligned_cols=254 Identities=24% Similarity=0.265 Sum_probs=204.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|.+.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+.+|+.+++.+.|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 468999999999999999998876 678999999975432 23345788999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCC
Confidence 999999999999999999999776668999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCccc------CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
+......... ......||+.|+|||++. ...++.++|||||||++|||++|..||........ .. ..
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~---~i 221 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---YN---NI 221 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---HH---HH
Confidence 9876433222 223357899999999986 45678999999999999999999999976432111 00 00
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ......... .....+..+.+|+.+||. +|.+||++.+++.+
T Consensus 222 ~-~~~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 222 M-NFQRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred H-cCCCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 000000000 011235678999999998 99999999998764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=349.29 Aligned_cols=263 Identities=19% Similarity=0.198 Sum_probs=200.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+|++.+.||+|+||.||+|.+.. +++.||+|... ...+.+|++++++++||||+++++++..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 34689999999999999999999876 78899999753 2356799999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
....++|||++ +++|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 155 ~~~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 155 NKFTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred CCeeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 99999999999 56888887543 46899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc----hhHHhhhhhhhc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----NLVEWARPHLGE 298 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~~ 298 (422)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..||......... ..+.........
T Consensus 230 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred cccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 75432211 1123467999999999999999999999999999999999999887543221100 000000000000
Q ss_pred -c--------ccccc---------ccCcccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 -R--------RRFYR---------LIDPRLEGH--FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 -~--------~~~~~---------~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..+.. ...+..... .....+.++.+||.+||+.||.+|||+.|++++
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00000 000000000 011345689999999999999999999999963
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=345.85 Aligned_cols=266 Identities=25% Similarity=0.360 Sum_probs=198.8
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|+||.||+|.+.. +|..||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 58889999999999999999876 67899999986432 22345688999999999999999999988643
Q ss_pred C-----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 144 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 144 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
. ..|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEcc
Confidence 2 479999999 5689888854 446999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCcc-ceeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 014585 219 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 293 (422)
Q Consensus 219 FG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-- 293 (422)
||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999864322211 11233579999999998875 678999999999999999999999997643211111000000
Q ss_pred ------hhhh--cccccccccC----cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 ------PHLG--ERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ------~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ....+...+. ..+...+ ...+..+.+++.+||+.||++||++.+++++
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0000000000 0000000 1234678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=350.67 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=199.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++++.||.|+||.||+|.+.. +|+.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 478999999999999999998876 778999999865321 23356788999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..||||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999854 457899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcc---------------------------------------------ceeeccccCccccCCCcccCCCCCc
Q 014585 222 AKDGPEGDKT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTS 256 (422)
Q Consensus 222 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 256 (422)
++........ ......+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9643211000 0001246999999999999999999
Q ss_pred hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 014585 257 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 336 (422)
Q Consensus 257 ~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 336 (422)
++|||||||++|||++|..||...........+ . .......+.+ ....+.++.+||.+||. +|.+
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~-~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKI------I-NWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH------H-ccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhh
Confidence 999999999999999999999754431110000 0 0000000000 01234678999999997 7776
Q ss_pred C---CCHHHHHHH
Q 014585 337 R---PLMSEVVEA 346 (422)
Q Consensus 337 R---ps~~ell~~ 346 (422)
| +++.+++.+
T Consensus 293 r~~r~~~~~~l~h 305 (377)
T cd05629 293 RLGRGGAHEIKSH 305 (377)
T ss_pred cCCCCCHHHHhcC
Confidence 5 599888874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=342.27 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=207.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|++.+.||+|+||.||+|.+...+.. .+..||||.+..... ...+++.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 46799999999999999999987653221 234599999875432 334678899999999999999999999876
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
. ..++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccc
Confidence 4 578999999999999999776667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||....... .... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~ 229 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGER 229 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HhCCCC
Confidence 87654333222222345678999999999999999999999999999997 999997543211 1110 001000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.. .+..++.++.+++.+||..||.+||++.+++..|..+.
T Consensus 230 ---~~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 ---LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---CC-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 01123457889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=353.27 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=201.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||.|+||+||+|.+.. +|+.||||++.... ......+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 478999999999999999999876 67899999997532 122345788999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccc
Confidence 999999999999999999998554 46999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccc------------------------------------eeeccccCccccCCCcccCCCCCchhhhhhHHH
Q 014585 222 AKDGPEGDKTH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 265 (422)
Q Consensus 222 a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 265 (422)
+.......... .....+||+.|+|||++.+..++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87543211000 011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHH
Q 014585 266 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSE 342 (422)
Q Consensus 266 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~e 342 (422)
++|||++|..||........ .... . .......... ....+.++.+||.+||. +|.+|++ +.+
T Consensus 228 il~el~~G~~Pf~~~~~~~~---~~~i---~-~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQET---YRKI---I-NWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHH---HHHH---H-cCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 99999999999976543211 0000 0 0000000000 01235688899999996 9999998 888
Q ss_pred HHHH
Q 014585 343 VVEA 346 (422)
Q Consensus 343 ll~~ 346 (422)
++++
T Consensus 293 ll~h 296 (364)
T cd05599 293 IKSH 296 (364)
T ss_pred HhcC
Confidence 7764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.75 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=202.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
-.|...+++|.|+||.||+|...+ +++.||||+.-.+.. .-.+|+++|+.++|||||++.-+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 357778899999999999999987 677999999865432 2247999999999999999998887532
Q ss_pred -----ceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CCeE
Q 014585 145 -----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAK 215 (422)
Q Consensus 145 -----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~~k 215 (422)
...+||||++. +|.+.+.. .+..++.-.++-+.+||++||.|||+.+ |+||||||.|+|+|.+ |.+|
T Consensus 91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEE
Confidence 23489999965 99988853 3567888999999999999999999988 9999999999999977 9999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|||||.|+....+... .....|..|+|||.+.+ ..|+.+.||||.||++.||+.|++.|.+.+.......+.....
T Consensus 167 icDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG 243 (364)
T ss_pred eccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence 9999999998665544 23456889999998885 6899999999999999999999999998654433222111110
Q ss_pred --hhh-------c--ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 --HLG-------E--RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 --~~~-------~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... . ..++..+....+...+....+.++.+|+.++|..+|.+|.++.|++.+
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 000 0 011112222222222344567899999999999999999999999863
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=351.02 Aligned_cols=266 Identities=23% Similarity=0.365 Sum_probs=208.8
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccC-CCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~ 139 (422)
...++|+++++||+|+||.||+|.+..... ...+..||||++...... ..+.+.+|+.+++++. ||||++++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSR----SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCC----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 345789999999999999999998753211 124557999999754332 2456899999999996 9999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC-----------------------------------------------------
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 166 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 166 (422)
+.+.+..+||||||++|+|.+++.+..
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999998875421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 167 ------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 167 ------------------------------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
..+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 24778888999999999999999988 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 283 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 283 (422)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999986543332222233457788999999999999999999999999999997 88998754221
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. .... .... ... ..+...+.++.+++.+||+.||++||++.+|.+.|+.+
T Consensus 347 ~~--~~~~----~~~~------~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 347 ST--FYNK----IKSG------YRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HH--HHHH----HhcC------CCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 10 0000 0000 000 11223457899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=351.72 Aligned_cols=254 Identities=25% Similarity=0.287 Sum_probs=200.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|+++.|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 369999999999999999999876 678999999864322 22356789999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..+||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999999999998554 46899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCC-----------------------------------------ccceeeccccCccccCCCcccCCCCCchhhh
Q 014585 222 AKDGPEGD-----------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 260 (422)
Q Consensus 222 a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 260 (422)
+..+.... ........+||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 75321000 0000123579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC--
Q 014585 261 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-- 338 (422)
Q Consensus 261 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-- 338 (422)
|||||++|||++|..||....+......+. .......+ + .....+.++.++|.+|+ .+|.+|+
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~~~~~--~-----~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKVI-------NWETTLHI--P-----SQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHHh-------ccCccccC--C-----CCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 999999999999999998654321111000 00000000 0 01123467888999876 5999999
Q ss_pred -CHHHHHHH
Q 014585 339 -LMSEVVEA 346 (422)
Q Consensus 339 -s~~ell~~ 346 (422)
++.+++++
T Consensus 293 ~t~~ell~h 301 (376)
T cd05598 293 NGADEIKAH 301 (376)
T ss_pred CCHHHHhCC
Confidence 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=346.98 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=206.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-C-----Ccceee
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H-----LNLVKL 136 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~ 136 (422)
...+|.+.+.||+|+||.|.+|++.. |++.||||+++... .-..+...|+++|..|+ | -|||++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 34588999999999999999999987 88999999997653 33456678999999996 4 379999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC--CC
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YN 213 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~--~~ 213 (422)
+++|...++.|||+|.+ ..+|.+++..+ -..++...+..++.||+.||.+||+.+ |||+||||+||||..- ..
T Consensus 254 ~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred eeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCc
Confidence 99999999999999999 67999999765 456999999999999999999999999 9999999999999543 47
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
|||+|||.|........ ..+.+..|+|||++.|.+|+.+.|+||||||++||++|.+.|.+....+....+....
T Consensus 330 vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred eeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 99999999987543322 4567889999999999999999999999999999999999998776543322111110
Q ss_pred h--------hhhccccccc------------------------------cc---Cc----ccCCCCCHHHHHHHHHHHHH
Q 014585 294 P--------HLGERRRFYR------------------------------LI---DP----RLEGHFSIKGAQKAAQLAAH 328 (422)
Q Consensus 294 ~--------~~~~~~~~~~------------------------------~~---~~----~~~~~~~~~~~~~l~~li~~ 328 (422)
. .......+.. .. .| .+...+.......+.+++++
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 0 0000000000 00 00 00111112334678999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 014585 329 CLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 329 ~l~~dp~~Rps~~ell~~ 346 (422)
||.+||.+|+|..+++++
T Consensus 485 ~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNH 502 (586)
T ss_pred HhccCchhcCCHHHHhcC
Confidence 999999999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=349.02 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=198.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++..... .....+.+|+.++.+++|+||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 478999999999999999998876 778999999975322 22346788999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+....||||||+++|+|.+++.+ ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence 99999999999999999999855 457999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc---------------------------------ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHH
Q 014585 222 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 268 (422)
Q Consensus 222 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ 268 (422)
++........ ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 014585 269 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS--RDPKARPLMSEVVEA 346 (422)
Q Consensus 269 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dp~~Rps~~ell~~ 346 (422)
||++|..||....+......+. . ..... .+.+. ...+.++.+++.+++. .++..||++.+|+++
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~---~-~~~~~----~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVM---N-WKETL----IFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHH---c-CcCcc----cCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999999997654321111000 0 00000 00110 1134678888888654 233356899988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=342.49 Aligned_cols=252 Identities=29% Similarity=0.361 Sum_probs=197.6
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HhcccCCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
+.||+|+||+||+|.+.. +|+.||||++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 469999999999999876 778999999965322 12234555554 56789999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 72 YFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 999999999999998854 457899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~------ 213 (323)
T cd05575 148 EHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNKPL------ 213 (323)
T ss_pred cCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCCC------
Confidence 2221 2234579999999999999999999999999999999999999997543211 1111111000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCC
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 355 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 355 (422)
. .....+..+.+++.+||+.||.+||++.+.+..+...+++..
T Consensus 214 --~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 214 --R----LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred --C----CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 0 111235788999999999999999998654444444555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=342.52 Aligned_cols=247 Identities=29% Similarity=0.386 Sum_probs=197.3
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----ccHHHHHHHHHHhcccCCCcceeeEeEEEecCc
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (422)
++.||+|+||.||+++..... .+++.||||++..... .....+.+|+.+++.++||||+++++++..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 367999999999999875422 2678999999875321 223457789999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
.++||||+++++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 75 LYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999999999998854 446888999999999999999999988 999999999999999999999999998754
Q ss_pred CCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ... ......
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~---~~~~~~------ 216 (323)
T cd05584 151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TID---KILKGK------ 216 (323)
T ss_pred ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHH---HHHcCC------
Confidence 32221 1233579999999999999899999999999999999999999997643211 111 000000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
..++...+..+.+++.+||+.||++|| ++.+++++
T Consensus 217 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 ------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011122346789999999999999999 67777653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.49 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=210.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+...+. +...||||.+...... ...++.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 3578999999999999999998865321 3457999998755433 24568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence 99999999999999999999776668999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~ 226 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVE----DGYR 226 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCCC
Confidence 87652222222222345678999999998899999999999999999998 99998653221 1111110 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ..+..++..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 227 ---~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ---L-------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 01123456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=344.20 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=195.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+|+..+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+++++.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 456778899999999999998865 6779999998654322 245688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|.+.. ...+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999986532 3567788899999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
....... ......||..|+|||++.. ...+.++|||||||++|||++|+.||................ ...
T Consensus 217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~ 292 (353)
T PLN00034 217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQ 292 (353)
T ss_pred ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccC
Confidence 6543211 1223579999999998743 234568999999999999999999997432211111111000 000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........+.++.+||.+||..||++||++.|++++
T Consensus 293 ------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122345789999999999999999999999974
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=352.34 Aligned_cols=252 Identities=26% Similarity=0.306 Sum_probs=198.3
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
+|+++++||+|+||+||+|.+.. +++.||+|++..... .....+.+|+.++++++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 68899999999999999999876 678999999975432 223468899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCC
Confidence 99999999999999999998554 46899999999999999999999998 999999999999999999999999997
Q ss_pred ccCCCCC---------------------------------------------ccceeeccccCccccCCCcccCCCCCch
Q 014585 223 KDGPEGD---------------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSR 257 (422)
Q Consensus 223 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 257 (422)
....... ........+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0000123579999999999999999999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 014585 258 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337 (422)
Q Consensus 258 ~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 337 (422)
+|||||||++|||++|..||....+......+ ..... .+........+.++.++|.+|+ .+|.+|
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~--------~~~~p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKV------INWQT--------SLHIPPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHH------HccCC--------CcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence 99999999999999999999765432111000 00000 0000001123467889998876 599999
Q ss_pred CC---HHHHHH
Q 014585 338 PL---MSEVVE 345 (422)
Q Consensus 338 ps---~~ell~ 345 (422)
++ +.++++
T Consensus 294 ~~~~~~~ei~~ 304 (382)
T cd05625 294 LGKNGADEIKA 304 (382)
T ss_pred CCCCCHHHHhc
Confidence 97 777665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.58 Aligned_cols=255 Identities=29% Similarity=0.359 Sum_probs=201.5
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 148 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 148 (422)
+.||+|+||.||+++..... .+|+.||+|++...... ....+..|+.++++++|+||+++++++..++..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP------DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999999864321 26889999999754322 23457789999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 149 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
||||+++|+|.+++.+ ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 76 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999999998854 446899999999999999999999998 999999999999999999999999998865332
Q ss_pred CccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 229 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .... ......
T Consensus 152 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~---i~~~~~-------- 215 (318)
T cd05582 152 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTM---ILKAKL-------- 215 (318)
T ss_pred CC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHH---HHcCCC--------
Confidence 11 2234679999999999998899999999999999999999999997543211 1110 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhCCCCCCCC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE-VVEALKPLPNLKD 355 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~~~ 355 (422)
.++...+..+.+|+.+||+.||.+||++.+ .++.+...+++..
T Consensus 216 ----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 216 ----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 111223567899999999999999999665 2444444555444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=344.22 Aligned_cols=265 Identities=29% Similarity=0.420 Sum_probs=206.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.....+ ...+++.||+|++...... ..+.+..|+.++.++ +|+||+++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3468999999999999999999764321 1125678999998754322 235678899999999 899999999988
Q ss_pred Ee-cCceEEEEEecCCCChhhhhccCC-----------------------------------------------------
Q 014585 141 IE-DDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 166 (422)
Q Consensus 141 ~~-~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 166 (422)
.. +..+++||||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 75 456789999999999998885321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeecccc
Q 014585 167 -------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239 (422)
Q Consensus 167 -------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 239 (422)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++................+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 25789999999999999999999988 99999999999999999999999999987644332222233456
Q ss_pred CccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHH
Q 014585 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 318 (422)
Q Consensus 240 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (422)
+..|+|||++.+..++.++|||||||++|||++ |..||........ ... .+..... ...+...
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~----------~~~~~~~ 301 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTR----------MRAPEYA 301 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCC----------CCCCccC
Confidence 778999999999999999999999999999998 9999975432111 101 1111000 0011123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 319 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 319 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
+.++.+++.+||+.+|++||++.+++++|+.+
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 46789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=345.69 Aligned_cols=243 Identities=30% Similarity=0.372 Sum_probs=197.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (422)
+.||+|+||.||+|.+.. +|..||+|++..... .....+.+|++++..++|+||+++++++...+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 469999999999998866 778999999975422 22345778999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
|||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 72 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99999999999988854 4478999999999999999999997 67 9999999999999999999999999987543
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~i---~~~~~------ 213 (325)
T cd05594 148 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI---LMEEI------ 213 (325)
T ss_pred CCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHHH---hcCCC------
Confidence 2211 12235799999999999999999999999999999999999999975432111 1100 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
. ++...+.++.+|+.+||+.||.+|+ ++.+++++
T Consensus 214 --~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 --R----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --C----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 1112346789999999999999997 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.18 Aligned_cols=254 Identities=29% Similarity=0.365 Sum_probs=205.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 478999999999999999999876 678999999975422 23456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence 999999999999999999999655 57999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCC---------------------------ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCC
Q 014585 222 AKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274 (422)
Q Consensus 222 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 274 (422)
+....... .........||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 98654332 001123357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 014585 275 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 346 (422)
Q Consensus 275 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~ 346 (422)
.||...........+ . .... ...-+. ....+.++.+||.+||. ||.+||+ +.+++++
T Consensus 228 ~Pf~~~~~~~~~~~i------~-~~~~--~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTLQETYNKI------I-NWKE--SLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCHHHHHHHH------h-ccCC--cccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999865421110000 0 0000 000000 01135788999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=335.12 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=197.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhccc---CCCcceeeEeE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGY 139 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~~~~~ 139 (422)
++|++.+.||+|+||.||+|.+... .|..||+|.+...... ....+.+|+.+++.+ .||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 4799999999999999999987542 4678999998654322 223456677666655 79999999998
Q ss_pred EEe-----cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 140 CIE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 140 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
+.. ....++||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence 852 456899999995 6898888654 345899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...........+....
T Consensus 149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred EEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 9999999998654321 2234568999999999998899999999999999999999999998654322111110000
Q ss_pred hhhhcccccc-------cccCccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFY-------RLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ......+. ..+.... ........+..+.+|+.+||+.||++||++.+++++
T Consensus 226 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 226 G-LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred C-CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00000000 0000000 000111345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=327.96 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=215.1
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCc
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (422)
-|.++.+||+|+||.||+|.+++ +|..+|||.+..+ ...+++.+|+.+|.+++.++||++||.+.....
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 36677889999999999999987 8899999998765 456889999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
+|||||||..|++.+.+..+++++.+..+..+++..+.||+|||... -||||||..|||++.+|..||+|||.|..+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh
Confidence 99999999999999999888899999999999999999999999988 899999999999999999999999999876
Q ss_pred CCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
.+. ........||+.|||||++..-.|+.++||||||++..||..|++||.+..+.-...++. ..
T Consensus 180 TDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------------T~ 244 (502)
T KOG0574|consen 180 TDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------------TK 244 (502)
T ss_pred hhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------------CC
Confidence 432 222345789999999999999999999999999999999999999998766543222111 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..|. -..+...+.++.++++.||..+|++|-++.+++++
T Consensus 245 PPPT--F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 245 PPPT--FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCC--CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1111 11234557889999999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=325.91 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=199.4
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
+.||+|+||.||+|.+.. +|+.||+|.+..... .....+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 469999999999999876 677899998865432 2345689999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999999999766667899999999999999999999988 9999999999999999999999999987654321
Q ss_pred ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||........ .. ....
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~~----~~~~---------- 211 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---RE----AIEQ---------- 211 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---HH----HHHc----------
Confidence 1111111123457999999998899999999999999999997 8888864322110 00 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
......+...+..+.+|+.+||+.+|++||++.++++.|+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0001112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=341.26 Aligned_cols=242 Identities=29% Similarity=0.420 Sum_probs=193.1
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|.+.. +++.||||+++.... ...+.+..|..++..+ .||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999999876 677999999975421 2234456677777654 899999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999999999999998854 447999999999999999999999988 9999999999999999999999999997643
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~---i~~~~------- 212 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDS---ILNDR------- 212 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHcCC-------
Confidence 322 12234679999999999999999999999999999999999999997643211 1110 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 345 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~ 345 (422)
..++...+.++.+++.+||+.||.+||++. ++++
T Consensus 213 -----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 213 -----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 011223356788999999999999999875 4444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=332.65 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=206.5
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
+..++|++.+.||+|+||.||+|.+... ....++..||||.+..... ....++.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 3567899999999999999999987532 1223567899999864332 2345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
......++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence 99999999999999999999985422 23577889999999999999999988 9999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 290 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 290 (422)
+.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~ 232 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLR 232 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence 9999999999876543332222222345788999999998899999999999999999999 688886543211 111
Q ss_pred hhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
... .. ... ..+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 233 ~~~----~~-~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FVM----EG-GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHH----cC-CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 100 00 000 011123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=321.19 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=208.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.+.|++.+.||+|.|+.||++.+.. +|+.+|+|+++.... ...+++.+|++|.+.|+|||||++++.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 4578888899999999999998766 899999999865433 34678999999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc---CCCCeEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~---~~~~~kl~D 218 (422)
+....|||+|++.|++|..-|..+ -.+++..+-.+++||++||.|+|.++ |||||+||+|+++. ...-+||+|
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecc
Confidence 999999999999999998766444 45788899999999999999999999 99999999999994 334589999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||+|.....+ .....++|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+.. .+.+.+...
T Consensus 157 FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g--- 227 (355)
T KOG0033|consen 157 FGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAG--- 227 (355)
T ss_pred cceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhcc---
Confidence 9999987632 2345578999999999999999999999999999999999999999864321 111111110
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
.-.++++.+. ..++++++|+++||..||.+|.|+.|.|++-
T Consensus 228 ----~yd~~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 228 ----AYDYPSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ----ccCCCCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 0111222222 3457899999999999999999999999753
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=346.77 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=207.3
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEEE
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 151 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 151 (422)
+||+|.||+||.|++.+ +...+|||.+........+-+.+||...++|+|.|||+++|.+.+++.+-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 69999999999999987 677899999987766666779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-CCCeEEeeccCcccCCCC
Q 014585 152 FMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 152 ~~~~g~L~~~l~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~~~~kl~DFG~a~~~~~~ 228 (422)
.++||+|.+++...=+++ .+..+-.+.+||++||.|||++. |||||||-+||||+. .|.+||.|||-++.+...
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 999999999998776677 78889999999999999999998 999999999999964 689999999999887543
Q ss_pred CccceeeccccCccccCCCcccCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 229 DKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 229 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
. ..+.++.||.-|||||++..+ .|+.++|||||||++.||.||++||........ .+.. ..+++
T Consensus 730 n--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----AMFk------VGmyK-- 795 (1226)
T KOG4279|consen 730 N--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----AMFK------VGMYK-- 795 (1226)
T ss_pred C--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----hhhh------hccee--
Confidence 3 345568899999999999854 689999999999999999999999975322111 0000 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
.-...+...+.+++.+|.+|+..||.+||++.++|.
T Consensus 796 ---vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 ---VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ---cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 122345678899999999999999999999999986
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=342.07 Aligned_cols=258 Identities=26% Similarity=0.335 Sum_probs=203.3
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCC-cceeeEeEEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHL-NLVKLIGYCI 141 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~ 141 (422)
+|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+..|++++..+.|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 58889999999999999998866 67789999997532 22345678899999999765 5888999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCc
Confidence 99999999999999999998854 346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ...
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~---~~~-- 217 (324)
T cd05587 148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIM---EHN-- 217 (324)
T ss_pred ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH---cCC--
Confidence 875322221 1234579999999999999999999999999999999999999997543211 111100 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHhCCCCCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDM 356 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~~~~~ 356 (422)
..++...+.++.+++.+||..||.+|++.. +..+.+..++.+...
T Consensus 218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 218 ----------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 011123356889999999999999999762 334445555555443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.45 Aligned_cols=261 Identities=30% Similarity=0.447 Sum_probs=208.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|.+.+.||+|+||.||+|.+.... ...++..||||.+...... ..+.+.+|+++++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 356888999999999999999875421 0124678999999765444 34678999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEc
Confidence 999999999999999999986432 34788899999999999999999988 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 288 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 288 (422)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~ 233 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---V 233 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence 999999999999976433222222233456788999999999999999999999999999998 999986543211 1
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
..... . .. ....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 234 ~~~~~----~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECIT----Q-GR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHH----c-CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 0 00 00111234578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=358.14 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=206.5
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
...++|++.+.||+|+||+||+|.+.. +|+.||||++...... ....+.+|+.++..++|+||+++++.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 345799999999999999999998876 6789999999765432 23467899999999999999999887
Q ss_pred EEecC--------ceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 140 CIEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 140 ~~~~~--------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
+...+ ..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl 176 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILL 176 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEE
Confidence 75432 367999999999999988542 356899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
+.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----- 251 (496)
T PTZ00283 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----- 251 (496)
T ss_pred eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----
Confidence 999999999999998754432222334467999999999999999999999999999999999999999754321
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
......... .. ..++...+.++.+++.+||..||.+||++.+++++
T Consensus 252 -~~~~~~~~~------~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 -EVMHKTLAG------RY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -HHHHHHhcC------CC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111100 00 01122345789999999999999999999999875
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.21 Aligned_cols=267 Identities=23% Similarity=0.245 Sum_probs=205.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+|.+++.||+|+||.||+|..... .++..||+|.+... ....+|++++++++|+||+++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 446799999999999999999976432 15678999988643 345689999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
....++|||++ +++|.+++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 158 ~~~~~lv~e~~-~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 158 KSTVCMVMPKY-KCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred CCEEEEEehhc-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence 99999999999 46888888 44567999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc-cc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-RR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 301 (422)
................||+.|+|||++.+..++.++|||||||++|||++|+.||.+................+... ..
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 87654433333344679999999999999999999999999999999999999997655433211111111100000 00
Q ss_pred ---------------cccccCcccC--CC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 ---------------FYRLIDPRLE--GH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ---------------~~~~~~~~~~--~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.....+... .. .....+.++.++|++||..||.+||++.|++.+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00 001234678899999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=370.38 Aligned_cols=265 Identities=31% Similarity=0.455 Sum_probs=217.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.......+.||+|+||.||.|......... ....||||.+..... +...+|++|..+|+.++|||||+++|++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 455677789999999999999987632210 134699999976543 445679999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
....+|++|||+||+|..+|++. ...+.....+.++.||++|+.||++++ +|||||..+|+||+....+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence 99999999999999999999876 567999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
+|||+|+.....+.........-...|||||.+..+.++.|+|||||||+|||+++ |..||...+........
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------ 917 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------ 917 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------
Confidence 99999997655555544444345679999999999999999999999999999999 77888765443221111
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
+ +.. ++ ..+..|+..+.++|..||+.+|++||++..|++.+..+.+
T Consensus 918 ~-~gg---RL-------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 918 L-EGG---RL-------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred H-hCC---cc-------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 0 101 11 1234677899999999999999999999999997765543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=341.13 Aligned_cols=238 Identities=29% Similarity=0.399 Sum_probs=193.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|.+.. +++.||||++.... ......+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 469999999999999876 67899999987532 22345577888888876 799999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 9999999999999988544 57999999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~---i~~~~~------ 213 (320)
T cd05590 148 FNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEA---ILNDEV------ 213 (320)
T ss_pred cCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHH---HhcCCC------
Confidence 2211 2234579999999999999999999999999999999999999997643211 1111 111000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 341 (422)
.++...+.++.+++.+||+.||.+||++.
T Consensus 214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 01112356889999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=339.99 Aligned_cols=250 Identities=27% Similarity=0.333 Sum_probs=194.1
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HhcccCCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|++.. +|..||+|++..... .....+..|.. +++.++|+||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 469999999999999876 678999999865322 12334555554 67889999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 72 YFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 999999999999888854 456889999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~------- 212 (321)
T cd05603 148 EPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHKP------- 212 (321)
T ss_pred CCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcCC-------
Confidence 2211 223467999999999999989999999999999999999999999764311 1111111000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 353 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 353 (422)
..++...+..+.+++.+||+.||.+||++..-+..+...+++
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 011122346789999999999999999865333333334444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=330.64 Aligned_cols=260 Identities=27% Similarity=0.462 Sum_probs=206.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+|++.+.||+|+||.||+|.+...+. .++..||+|.+..... .....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 468888999999999999998644221 2567899999975432 2335688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR----------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
...++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence 9999999999999999988422 124788899999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 286 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 286 (422)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--- 233 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--- 233 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999987544332222333456778999999988889999999999999999998 88898754321
Q ss_pred hhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
...+.... .. . . ..+..++..+.+++.+||+.||.+||++.+++++|+.
T Consensus 234 ~~~~~~~~----~~-~---~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRK----RQ-L---L------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHc----CC-c---C------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111110 00 0 0 0111234688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=317.39 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=207.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc----c----HHHHHHHHHHhccc-CCCcce
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----G----HKEWLAEVNFLGDL-VHLNLV 134 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~h~niv 134 (422)
-..|...+.||+|..+.|.++.++. +|..+|+|++...... . .++-..|+.||+++ -||||+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II 86 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII 86 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence 3578888999999999999988766 8889999998643221 1 23456899999999 699999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
++.+++..+..+++|+|.|+.|.|.|++. ..-.+++.....|++|+++|+.|||..+ |+||||||+|||++++.++
T Consensus 87 ~l~D~yes~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 87 DLQDVYESDAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI 162 (411)
T ss_pred EeeeeccCcchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence 99999999999999999999999999994 4457999999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccC------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
||+|||++.....+... ...||||+|+|||.+.+ ..|+..+|+||+|||+|.|+.|.+||.....
T Consensus 163 ~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ 233 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ 233 (411)
T ss_pred EEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------
Confidence 99999999998766543 45899999999999864 3688899999999999999999999975422
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.+.+..+... +++-.+.+ .+.+..+++||.+||+.||.+|.|++|+|.+
T Consensus 234 mlMLR~ImeGk---yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 MLMLRMIMEGK---YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHHhcc---cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11111111111 11112222 2456789999999999999999999999975
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.01 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=217.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+.|.|+..||-|+||.||+|.++. ++...|-|++........++++-||.||..++||+||++++.|..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 468888999999999999999876 66678889998777777888999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.+||+.|||.||-.+.++..-+..+.+..+..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999999999888889999999999999999999999998 99999999999999999999999999865
Q ss_pred CCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
... .......+.|||+|||||++. ..+|++++||||||++|.||..+.+|.....+.-. ++....
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaK------ 249 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK------ 249 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhh------
Confidence 322 223345689999999999876 46899999999999999999999999876554321 111111
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCCCCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASS 359 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 359 (422)
..-..++. +...+..+.+|+++||..||..||++.+|+++ +++.+.++.
T Consensus 250 SePPTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H----pfv~~~~Sn 298 (1187)
T KOG0579|consen 250 SEPPTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH----PFVQNAPSN 298 (1187)
T ss_pred cCCCcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC----cccccCCcc
Confidence 00111222 23456788999999999999999999999984 444444443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.79 Aligned_cols=269 Identities=22% Similarity=0.331 Sum_probs=196.6
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC------CC
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV------HL 131 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~ 131 (422)
+++.....+|++.++||+|+||+||+|.+.. +++.||||+++... .....+..|+.+++.+. |.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~ 191 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRF 191 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCc
Confidence 3344556889999999999999999999876 67799999996432 22234556666666654 45
Q ss_pred cceeeEeEEEec-CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEc
Q 014585 132 NLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 132 niv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~ 209 (422)
+++++++++... +..|||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ .+ ||||||||+|||++
T Consensus 192 ~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~ 266 (467)
T PTZ00284 192 PLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILME 266 (467)
T ss_pred ceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEe
Confidence 688999988764 5788999998 78899888554 579999999999999999999997 47 99999999999998
Q ss_pred CCC----------------CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhC
Q 014585 210 ADY----------------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273 (422)
Q Consensus 210 ~~~----------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 273 (422)
.++ .+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 765 499999998864322 12346799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhhcc----------cccc-------cccCccc----C---CCCCHHHHHHHHHHHHHc
Q 014585 274 RRSMDKNRPNGEHNLVEWARPHLGER----------RRFY-------RLIDPRL----E---GHFSIKGAQKAAQLAAHC 329 (422)
Q Consensus 274 ~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~-------~~~~~~~----~---~~~~~~~~~~l~~li~~~ 329 (422)
+.||...........+......++.. ..+. ...++.. . ..........+.+||.+|
T Consensus 342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 99998654322222111111000000 0000 0000000 0 000011235678999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 014585 330 LSRDPKARPLMSEVVEA 346 (422)
Q Consensus 330 l~~dp~~Rps~~ell~~ 346 (422)
|+.||.+||++.|++++
T Consensus 422 L~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 422 LHYDRQKRLNARQMTTH 438 (467)
T ss_pred CCcChhhCCCHHHHhcC
Confidence 99999999999999974
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=353.18 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=196.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+|++.++||+|+||.||+|.+.. +++.||||++.... ....+|+.+++.++|+||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 34689999999999999999999866 67899999885432 234579999999999999999988753
Q ss_pred c--------CceEEEEEecCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 143 D--------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 143 ~--------~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
. ..+++||||++ ++|.+++. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~ 206 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPN 206 (440)
T ss_pred cccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCC
Confidence 2 24668999996 47777664 24567999999999999999999999988 9999999999999866
Q ss_pred C-CeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 212 Y-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 212 ~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
+ .+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.........+
T Consensus 207 ~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred CCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4 699999999987643322 223578999999998875 46899999999999999999999999865432211111
Q ss_pred Hhhh--hhhhc---------ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 290 EWAR--PHLGE---------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 290 ~~~~--~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... +.... ...+.......+...++...+.++.+||.+||..||.+||++.+++++
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 00000 000000011111111222345789999999999999999999999865
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=328.43 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=207.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....++.+|+++++.++|+||+++++++..+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 3568889999999999999999876 67789999987543 3356788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccc
Confidence 9999999999999999998654 346899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...... .
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----~--- 220 (263)
T cd05052 152 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----K--- 220 (263)
T ss_pred cccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----C---
Confidence 876433211 1112234668999999999999999999999999999998 889987543211 111000 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
......+...+..+.+++.+||..||++||++.++++.|+.+
T Consensus 221 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 -------GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 001111223457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.70 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=193.2
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|.+.. +++.||||++..... .....+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 469999999999999876 678999999975432 2234578899999888 799999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.+ ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 999999999999988854 357999999999999999999999998 9999999999999999999999999987532
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC--cchhHHhhhhhhhccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG--EHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 304 (422)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 220 (329)
T cd05588 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----- 220 (329)
T ss_pred cCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-----
Confidence 2111 1234679999999999999999999999999999999999999997432211 111111111111000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 340 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 340 (422)
... ++...+.++.+++.+||+.||.+|+++
T Consensus 221 --~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 221 --QIR----IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred --CCC----CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 000 111234678999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.25 Aligned_cols=252 Identities=26% Similarity=0.325 Sum_probs=198.2
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HhcccCCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
+.||+|+||+||+|.+.. +++.||+|++..... .....+..|.. +++.+.|+||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 469999999999999876 677899999865321 12234444444 56788999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 72 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999999999998854 446888999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---i~~~~~------ 213 (325)
T cd05602 148 EHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDN---ILNKPL------ 213 (325)
T ss_pred cCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHH---HHhCCc------
Confidence 2221 1234679999999999999999999999999999999999999997543211 1110 000000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCC
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 355 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 355 (422)
.+....+..+.+++.+||+.||.+||++.+.+..+.....+..
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 214 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 0112335688999999999999999998876666666555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=340.19 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=194.6
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|.+.. +|+.||||++..... .....+..|.+++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 469999999999998865 678999999875422 2234577888888866 899999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999988854 456899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... ..... .
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~---i~~~~-----~- 213 (321)
T cd05591 148 LNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFES---ILHDD-----V- 213 (321)
T ss_pred cCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHH---HHcCC-----C-
Confidence 2221 1234579999999999999999999999999999999999999997653211 1111 00000 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-------LMSEVVE 345 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------s~~ell~ 345 (422)
.++...+.++.+++.+||+.||.+|| ++.++++
T Consensus 214 ------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 214 ------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 01112346889999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=340.25 Aligned_cols=257 Identities=24% Similarity=0.314 Sum_probs=202.1
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
+|++.+.||+|+||.||+|.+.. ++..||||++..... .....+..|..++..+ .|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 58889999999999999998866 677999999975432 2234567788888777 5889999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCC
Confidence 999999999999999999988544 46899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ...
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~---~~~-- 217 (323)
T cd05616 148 CKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM---EHN-- 217 (323)
T ss_pred ceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHH---hCC--
Confidence 975432111 1234679999999999999999999999999999999999999997643211 111100 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHhCCCCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKD 355 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~~~~ 355 (422)
..++...+.++.+++.+||+.||.+|++.. +..+.+...+.+..
T Consensus 218 ----------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 218 ----------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 011223457889999999999999999852 22333444455443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.34 Aligned_cols=242 Identities=28% Similarity=0.422 Sum_probs=193.8
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcc-cCCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~ 146 (422)
+.||+|+||+||+|.+.. +++.||||++..... .....+..|..++.. ++||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999999876 677999999975421 223456677888876 4999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 999999999999998854 456899999999999999999999988 9999999999999999999999999987542
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... . .
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~----~-------~ 211 (316)
T cd05619 148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR----M-------D 211 (316)
T ss_pred CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----h-------C
Confidence 2221 1234579999999999999999999999999999999999999997643211 111110 0 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 345 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~ 345 (422)
.+. ++...+.++.+++.+||+.||.+||++. ++++
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 011 1112346789999999999999999996 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.26 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=202.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 468889999999999999997743 3479999886443 33467889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999999999998765567899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....... ..
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~----~~--- 218 (256)
T cd05114 150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISR----GF--- 218 (256)
T ss_pred cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----CC---
Confidence 5332211 1122345678999999998899999999999999999999 899997543211 1111110 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
....+. ..+..+.+++.+||+.+|.+||++.++++.|
T Consensus 219 ~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 RLYRPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011111 1245789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.66 Aligned_cols=265 Identities=29% Similarity=0.445 Sum_probs=210.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|.+.+.||+|+||.||++...... ...++..+|+|.+..........+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 457899999999999999999764311 1125567999998766544556789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999999985332 24899999999999999999999988 9999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 290 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 290 (422)
+.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE 233 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999986543322222223446788999999998899999999999999999998 899986543211 111
Q ss_pred hhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
... .. .. .... ...+.++.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 234 ~i~----~~-~~-----~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 CIT----QG-RV-----LQRP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHH----cC-Cc-----CCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 110 00 00 0001 1234678999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.37 Aligned_cols=252 Identities=30% Similarity=0.414 Sum_probs=203.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.|++.++||+|+||+||++.+.. +++.||+|++...... ....+.+|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47888999999999999998865 6779999998654322 22457789999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999887543 346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ .....|+..|+|||++.+..++.++|||||||++|||++|..||...........+. .....
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~--- 219 (285)
T cd05605 149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKE--- 219 (285)
T ss_pred ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhh---
Confidence 987543221 123578999999999998899999999999999999999999997643221111110 00000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
....++...+..+.+|+.+||..||.+|| ++.+++++
T Consensus 220 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 --------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00112223457889999999999999999 77777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=331.04 Aligned_cols=254 Identities=35% Similarity=0.572 Sum_probs=197.6
Q ss_pred CCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCceE
Q 014585 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 69 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (422)
+.+.||.|.||.||+|.+... ....+..|+||.+...... ..+.+.+|++.+++++||||++++|++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 456899999999999999831 1225678999999654332 3578999999999999999999999999888899
Q ss_pred EEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 148 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
+||||+++|+|.+++... ...+++..++.|+.||+.||.|||+.+ ++|+||+++|||++.++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999999999776 667999999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
............+...|+|||.+.+..++.++||||||+++|||++ |+.||..... ........ +... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~----~~~~---~ 224 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLK----QGQR---L 224 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHH----TTEE---T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----cccc---c
Confidence 3333333333456789999999998889999999999999999999 6788765421 11111111 1110 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
..+..++..+.+++..||..||.+||++.+|++.|
T Consensus 225 -------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01112356789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=336.70 Aligned_cols=242 Identities=29% Similarity=0.407 Sum_probs=193.8
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|.+.. +|..||+|++..... .....+..|..++..+ +|+||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 469999999999999876 778999999975421 2334567788888754 899999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 999999999999998854 456899999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+.... .
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~---~-------- 211 (316)
T cd05620 148 FGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRV---D-------- 211 (316)
T ss_pred cCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---C--------
Confidence 2221 223467999999999999999999999999999999999999999754321 11111100 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 345 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~ 345 (422)
.+. ++...+.++.+++.+||+.||.+||++. ++++
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 212 TPH----YPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 011 1112346789999999999999999974 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=347.16 Aligned_cols=256 Identities=22% Similarity=0.275 Sum_probs=203.7
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEe
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
....+|++.+.||+|+||.||+|.+.. +|..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 445789999999999999999999876 778999999964321 22345778999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++.+++..++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999999999988543 5888999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCC----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
||++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|..||........ .. .
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~ 258 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS---K 258 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HH---H
Confidence 999986543221 112345799999999998653 478999999999999999999999976532111 00 0
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~ell~~ 346 (422)
.......+ .. . .....+.++.+||.+||..+|.+ |+++.+++++
T Consensus 259 i~~~~~~~-~~-----~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSL-TF-----P--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcC-CC-----C--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00000000 00 0 01123578899999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.57 Aligned_cols=253 Identities=28% Similarity=0.357 Sum_probs=200.4
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HhcccCCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|.+.. +|+.||+|++..... .....+..|.. +++.++||||+++++++..++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 469999999999999876 678999999865321 22334555554 56788999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 999999999999988854 457999999999999999999999988 9999999999999999999999999987542
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ....... ..
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~~~----~~- 214 (325)
T cd05604 148 AQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILHKP----LV- 214 (325)
T ss_pred CCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHcCC----cc-
Confidence 2211 1234679999999999999999999999999999999999999997543211 11 1011000 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCCC
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 356 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 356 (422)
+....+..+.+++.+||+.||.+||++.+.++.+..++++...
T Consensus 215 -------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 215 -------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 1112346788999999999999999998767666667766554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=328.72 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=204.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+|++.+.||+|+||+||+|.+..++.. ....|++|.+..... ....++..|+.+++++.|+||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 5788899999999999999998653221 122578888754332 22356788899999999999999999875 4
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...++|+||+++|+|.+++......+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 5678999999999999999776678999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
...............++..|+|||.+.+..++.++|||||||++|||++ |..||....+......+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~-- 228 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGE-- 228 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCC--
Confidence 7544332222333557788999999998899999999999999999998 999997654321111110 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
....+. .++..+.+++.+||..||.+||++.|+++.|..+.
T Consensus 229 -~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 229 -RLAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -cCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 001111 12356789999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=331.50 Aligned_cols=264 Identities=29% Similarity=0.442 Sum_probs=211.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|.+.+.||+|+||.||+|.+..... ..++..+++|.+........+.+.+|+.++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 468888999999999999998643211 1245679999987666555567899999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 9999999999999999985432 34889999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 288 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 288 (422)
.++.++|+|||++................|+..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V 234 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999976544332222333557889999999999999999999999999999998 999986543211 1
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
..... .. .. .......+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 235 ~~~~~----~~-~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECIT----QG-RV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHh----CC-CC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11110 00 00 00111235678999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=329.20 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=195.6
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
||+|+||+||+|.+.. +|+.||+|.+...... ..+.+..|+++++.++|+||+++++++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 7999999999998876 6789999998754322 234577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 150 YEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999887743 3456899999999999999999999988 9999999999999999999999999997654
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .... ..
T Consensus 149 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~----------~~ 214 (280)
T cd05608 149 DGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQR----------IL 214 (280)
T ss_pred CCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH--HHHh----------hc
Confidence 33221 2335789999999999999999999999999999999999999975432211100 0000 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 345 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~ 345 (422)
... ..++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 215 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 215 NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 000 012223457889999999999999999 4555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=335.45 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=192.7
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
+.||+|+||.||+|.+.. +++.||+|++..... .....+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 469999999999999876 678999999975422 2334577899888777 899999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 999999999999988754 457999999999999999999999998 9999999999999999999999999987532
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc--chhHHhhhhhhhccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 304 (422)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 220 (329)
T cd05618 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 220 (329)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-----
Confidence 2111 12346799999999999999999999999999999999999999964221111 11111111110000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 340 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 340 (422)
...++...+.++.+++.+||+.||.+||++
T Consensus 221 ------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 001122335678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=338.06 Aligned_cols=263 Identities=23% Similarity=0.287 Sum_probs=198.4
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
....+|++.+.||+|+||.||+|.+.. ++..||+|+.... ....|+.++++++|+||+++++++.
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE
Confidence 345689999999999999999999865 6678999975432 2357999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+ .++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 128 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 128 SGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred eCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcc
Confidence 999999999999 56898888777778999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHH-------hhhh
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-------WARP 294 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~-------~~~~ 294 (422)
++...... ......||+.|+|||++.+..++.++|||||||++|||+++..++....+........ ....
T Consensus 204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 204 AQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred ccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 97532211 1223568999999999999999999999999999999998665553332221111000 0000
Q ss_pred hhh-cccccc---------cccC------cccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLG-ERRRFY---------RLID------PRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~-~~~~~~---------~~~~------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+. ....+. .+++ ..... .-....+.++.+||.+||+.||.+|||+.|++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 000000 0000 00000 0001224566789999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=344.67 Aligned_cols=246 Identities=28% Similarity=0.411 Sum_probs=208.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.|.-++.||-|+||.||.|++.. +.+.||||.+.....+. .+++++|++.|+++.|||+|.+-|+|..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 45557789999999999999876 67789999998766554 4578999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+...||||||| -|+-.|++.-..+++.+..+..|..+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccch
Confidence 99999999999 67999999888889999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
....+ ..+++|||+|||||++. .+.|+.++||||||++..||.-.++|+...+.......+.
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA--------- 238 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--------- 238 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH---------
Confidence 77543 34589999999999986 5789999999999999999999999986543322111111
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..-.|.+. ..+.+..+++|+..||+.-|.+|||..+++++
T Consensus 239 ----QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 239 ----QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 00111221 34667889999999999999999999999875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=326.98 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=202.7
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
||+|+||.||++.... +|+.||+|.+...... ....+..|+.++++++||||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999999876 7889999998643322 223456799999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 150 YEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
|||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999887543 345889999999999999999999988 999999999999999999999999998875432
Q ss_pred CccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 229 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
. ......|+..|+|||++.+..++.++|||||||++|||++|..||......... ..........
T Consensus 149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~---------- 213 (277)
T cd05607 149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLED---------- 213 (277)
T ss_pred c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhcc----------
Confidence 2 122356899999999999888999999999999999999999999754322111 1111111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 355 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 355 (422)
.... .....+.++.+|+.+||+.||.+||++.|+++.+..++.++.
T Consensus 214 ~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 214 EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 0000 001235678999999999999999999988877777766644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.30 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=202.5
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceee
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKL 136 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~ 136 (422)
+....++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+|+.+++.++||||+++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeE
Confidence 34456789999999999999999999876 678999999864321 223457789999999999999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
++++..++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL 183 (370)
T cd05621 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKL 183 (370)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999988543 5889999999999999999999988 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCC----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+|||++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ .
T Consensus 184 ~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~--- 256 (370)
T cd05621 184 ADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---Y--- 256 (370)
T ss_pred EecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---H---
Confidence 99999987543221 112346799999999998754 378899999999999999999999976432111 0
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 346 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~ell~~ 346 (422)
......... .. +. .....+..+.+++.+||..++.+ |+++.+++++
T Consensus 257 ~~i~~~~~~-~~-----~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 SKIMDHKNS-LN-----FP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHhCCcc-cC-----CC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000000000 00 00 01123577889999999855543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=337.60 Aligned_cols=243 Identities=28% Similarity=0.391 Sum_probs=196.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||+||+|.+.. ++..||||++.... ......+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999999866 67799999997542 12334577888998887 799999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 9999999999999888544 47999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... .....+|++.|+|||++.+..++.++|||||||++|+|++|..||....... .... .....
T Consensus 148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~---i~~~~------- 212 (318)
T cd05570 148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQS---ILEDE------- 212 (318)
T ss_pred cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHH---HHcCC-------
Confidence 2221 1233578999999999999999999999999999999999999997543211 1110 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 346 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~~ 346 (422)
. .++...+..+.+||.+||..||.+||++ .+++++
T Consensus 213 -~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 -V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0 1112335688999999999999999998 666653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=324.30 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=206.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 4567999999999999999999864 34579999987654 335678899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcce
Confidence 999999999999999999986543 56899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... ......
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~ 221 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQGY 221 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCC
Confidence 9876432111 1111223457999999998899999999999999999999 999997543211 111 000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 222 ---~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 ---R-------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---C-------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 011123457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.95 Aligned_cols=272 Identities=26% Similarity=0.395 Sum_probs=211.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCC-------CCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCccee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~ 135 (422)
..+|++++.||+|+||.||+|.+...+.. ......+..||+|.+...... ....+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 46899999999999999999988653321 122234567999998765432 3456889999999999999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
+++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 26899999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPN 283 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~ 283 (422)
|+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986544333333334557789999999988889999999999999999998 66777543221
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
............. ........+..++.++.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111110000 000001112234578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=325.53 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=203.7
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
|++.+.||+|+||.||+|....+.. ++..||+|.+...... ....+.+|+..++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5788999999999999998865322 4568999998754332 2356889999999999999999999887655
Q ss_pred c------eEEEEEecCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 145 Q------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 145 ~------~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
. .++||||+++|+|..++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT 151 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence 4 78999999999999887432 236899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05035 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL 228 (273)
T ss_pred EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999987644332222222345678999999988899999999999999999999 88888654321 111111
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ... .. ..+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 229 ~----~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 R----HGN------RL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H----cCC------CC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 000 00 11223456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=326.53 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=209.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 34578999999999999999998853 45799999987765556778999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccc
Confidence 99999999999999999999653 456899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........ .
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~---~-- 220 (261)
T cd05148 151 ARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITA---G-- 220 (261)
T ss_pred hhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHh---C--
Confidence 9775432211 123346778999999988899999999999999999998 88999654321 11111110 0
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.....+..++..+.+++.+||+.||.+||++.++++.|+.
T Consensus 221 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 ---------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0011122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=324.74 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=205.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|++.+.||+|+||.||+|.+.. +|+.||+|++..........+.+|+.++++++|+||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3579999999999999999998865 6778999999765544456688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999998854 347899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
....... ......|+..|+|||.+. ...++.++|||||||++|||++|..||....+....... .. .
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~------~ 224 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SK------S 224 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ec------C
Confidence 6532211 122356889999999874 455788999999999999999999998654322110000 00 0
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
....+... .....+..+.+++.+||..+|++||++.+++++|
T Consensus 225 ---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 ---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00001110 0113356889999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=327.49 Aligned_cols=275 Identities=26% Similarity=0.361 Sum_probs=206.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
..+|++.+.||+|+||.||+|.... ....++..||+|.+........+.+.+|++++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 3578999999999999999997642 1122678999999976655556678999999999999999999998754
Q ss_pred -cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
....++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcc
Confidence 34678999999999999999766667899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccce-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc--
Q 014585 222 AKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-- 298 (422)
Q Consensus 222 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 298 (422)
+........... .....++..|+|||++.+..++.++|||||||++|||++|..++....... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~~~ 230 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF----MRMMGNDKQGQM 230 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh----hhhccccccccc
Confidence 987644322111 111234456999999998899999999999999999999887664322110 0000000000
Q ss_pred -ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 299 -RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 299 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
...+...+............+.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000000011123456899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.23 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=199.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||++.+.. +++.||+|++..... ...+.+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 478999999999999999999876 677999999864221 22345788999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..++||||+++|+|.+++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence 999999999999999999999765667999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
+......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||........ .....
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~ 221 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIM 221 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHH
Confidence 8765432221 1222469999999999863 4578899999999999999999999975432111 00000
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK--ARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~--~Rps~~ell~~ 346 (422)
.. .....+ .+ .....+..+.+++.+||..++. .|+++.+++++
T Consensus 222 ~~-~~~~~~-~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 222 NH-KEHFQF-PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC-CCcccC-CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 000000 00 0112456788999998865443 37899888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=327.52 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=207.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.++||+|+||.||+|..... ....++..+|+|.+..........+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35788899999999999999975431 11225678999998766555556799999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 99999999999999999986432 34889999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 288 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 288 (422)
+++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--- 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---
Confidence 999999999999976543322222223345788999999999999999999999999999998 8999865332111
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
..... .... . ..+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 234 ~~~~~----~~~~------~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECIT----QGRE------L----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHH----cCcc------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11000 0000 0 011123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=345.29 Aligned_cols=265 Identities=23% Similarity=0.256 Sum_probs=201.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+|.+.+.||+|+||.||+|.+.. +++.||||.... ..+.+|+++|++|+|+|||++++++..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~ 231 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVV 231 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 34579999999999999999999876 677899996432 345789999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++|||++ .++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 232 ~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 232 GGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred CCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCc
Confidence 99999999999 57898888766667999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC-Cc----chhHHhhhhhhh
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-GE----HNLVEWARPHLG 297 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~----~~~~~~~~~~~~ 297 (422)
+...............||..|+|||++.+..++.++|||||||+||||++|..++...... .. ..+.........
T Consensus 308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~ 387 (461)
T PHA03211 308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV 387 (461)
T ss_pred eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence 8654332222233467999999999999999999999999999999999988765432211 00 011111110000
Q ss_pred cccccccc----------------cCcccCC-CCC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRL----------------IDPRLEG-HFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~----------------~~~~~~~-~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+... ..+.... .+. ...+.++.+||.+||+.||.+|||+.|+|++
T Consensus 388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 0000000 000 0223578899999999999999999999985
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=327.29 Aligned_cols=263 Identities=23% Similarity=0.380 Sum_probs=206.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||+||+|.+..++.. ....||+|++...... ....+.+|+.++..+.|+||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 346789999999999999999987653221 1235899998754332 3456889999999999999999999987
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
. ...+++|||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCc
Confidence 5 4578999999999999999776667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~ 228 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGE 228 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCC
Confidence 987643322211222335678999999998899999999999999999998 889986543211 111111 000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
. . .....++..+.+++.+||..||++||++.++++.|+.+.
T Consensus 229 ~------~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 R------L----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred c------C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 0 011134567899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=332.15 Aligned_cols=266 Identities=29% Similarity=0.405 Sum_probs=209.8
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEe
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIG 138 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (422)
.+..++|++.+.||+|+||.||+|.+..... ......||+|.+..... ....++.+|+.+++++ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4455789999999999999999998765321 12456899999875432 2234688999999999 8999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 203 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 203 (422)
++..++..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp 160 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA 160 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence 999999999999999999999998532 346889999999999999999999988 99999999
Q ss_pred CcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCC
Q 014585 204 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 282 (422)
Q Consensus 204 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 282 (422)
+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999987644332222222345678999999998999999999999999999997 8888865432
Q ss_pred CCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... . ...... ....+...+..+.+|+.+||..||.+|||+.++++.|+.+
T Consensus 241 ~~~~---~----~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 EELF---K----LLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH---H----HHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1110 0 000000 0011223456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=336.12 Aligned_cols=272 Identities=26% Similarity=0.409 Sum_probs=225.5
Q ss_pred ccchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCc
Q 014585 54 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLN 132 (422)
Q Consensus 54 ~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~n 132 (422)
.-+..++.+..+...+.++||.|.||.||+|.+.... ++....||||..+.+. ....+.|+.|.-+|++++|||
T Consensus 378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHph 452 (974)
T KOG4257|consen 378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPH 452 (974)
T ss_pred CCCCCcceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcc
Confidence 3344555666777888899999999999999987632 3355679999998743 445677999999999999999
Q ss_pred ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 133 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
||+++|+|.+ ...|||||.++-|.|..+++.+...++......++.||+.||+|||+.. +|||||..+|||+....
T Consensus 453 IikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~ 528 (974)
T KOG4257|consen 453 IIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQ 528 (974)
T ss_pred hhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcc
Confidence 9999999975 5689999999999999999988888999999999999999999999988 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 291 (422)
.+||+|||+++...+....... ...-...|||||.+.-..++.++|||.|||++||++. |..||.+-...+....++
T Consensus 529 CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE- 606 (974)
T KOG4257|consen 529 CVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE- 606 (974)
T ss_pred eeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-
Confidence 9999999999998776655433 3344678999999999999999999999999999876 899998765433221111
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
+. -....++.|+..+..|+.+||+.+|.+||.+.+|...|..+..
T Consensus 607 ------nG----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 ------NG----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ------CC----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 1112345678899999999999999999999999988876544
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=334.96 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=194.8
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhccc-CCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 146 (422)
++||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.++.++ .|+||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 469999999999999876 677999999975432 2234578899999888 699999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 999999999999988854 346999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||......................
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 218 (327)
T cd05617 148 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------- 218 (327)
T ss_pred CCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------
Confidence 2111 2234679999999999999999999999999999999999999997543322222211111111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 341 (422)
.. .++...+..+.+++.+||..||.+|+++.
T Consensus 219 ~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 219 PI----RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00 01112346788999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=321.63 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=208.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.+|++.+.||+|+||.||+|.+.. +|..||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 579999999999999999999876 677999998864322 22346889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
..+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999988742 3345889999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||++........ ......|+..|+|||.+.+..++.++|+||||+++|||++|..||....... ........ .
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~----~ 222 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIE----Q 222 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHh----c
Confidence 999887543221 1123468899999999988889999999999999999999999986432211 11111100 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
...+ .......+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 223 ------~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 ------CDYP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------CCCC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000 1112234578999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.09 Aligned_cols=273 Identities=32% Similarity=0.441 Sum_probs=205.4
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec--
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 143 (422)
|++.+.||+|+||+||++..... ...++..||+|.+..... .....+.+|+.++++++|+||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 48899999999999998865431 122677899999976533 2345688999999999999999999988763
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 3578999999999999998543 5899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
......... ......++..|+|||++.+..++.++|||||||++|||++|..||........ .......... ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhh
Confidence 764432211 11223456779999999888999999999999999999999999865432110 0000000000 00001
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
....+.......+...+.++.+++.+||+.||++||+++++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111111122334578999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.50 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=202.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.++..++|+||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 368889999999999999999876 77899999996432 223456788999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..+|||||+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999999854 446899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc---------------------------------ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHH
Q 014585 222 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 268 (422)
Q Consensus 222 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ 268 (422)
+......... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754321100 0112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 014585 269 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVE 345 (422)
Q Consensus 269 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 345 (422)
||++|..||....+......+. ...... .+.+. ...+.++.++|.+|+ .||.+|++ +.+++
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i~-------~~~~~~-~~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~- 291 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKVM-------NWKETL-VFPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIK- 291 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHHH-------cCCCce-ecCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh-
Confidence 9999999997654322111000 000000 00110 013467889999987 49999996 44544
Q ss_pred HhCCCCCCCCC
Q 014585 346 ALKPLPNLKDM 356 (422)
Q Consensus 346 ~L~~~~~~~~~ 356 (422)
.++++.+.
T Consensus 292 ---~hp~f~~~ 299 (360)
T cd05627 292 ---SHPFFEGV 299 (360)
T ss_pred ---cCCCCCCC
Confidence 35555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=336.78 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=202.9
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccC-CCcceeeEeEEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 141 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 141 (422)
+|++.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+..|+.++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 47788999999999999999876 778999999875421 22345778899988885 567888999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccc
Confidence 99999999999999999998854 346999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ....
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i---~~~~-- 217 (323)
T cd05615 148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSI---MEHN-- 217 (323)
T ss_pred ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC--
Confidence 875432211 1233569999999999999999999999999999999999999997643211 11111 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHhCCCCCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDM 356 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~~~~~ 356 (422)
..++...+.++.+++.+||+.||.+|++.. +..+.+..++.+...
T Consensus 218 ----------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 218 ----------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ----------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 011223356789999999999999999754 234455555555443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=330.79 Aligned_cols=266 Identities=26% Similarity=0.377 Sum_probs=209.7
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
...++|.+.+.||+|+||.||+|.+.... ...++..||||++..... ...+.+.+|+.+++++ +|+||++++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLS----KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCC----CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 34467999999999999999999864211 112566899999875532 2245688999999999 79999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+...+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECC
Confidence 999999999999999999999986543 34899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ......
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~---- 258 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK---- 258 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----
Confidence 999986544332222223456788999999999999999999999999999998 9999875432111 111000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. .....+...+.++.+++.+||..+|++||++.++++.|+.+
T Consensus 259 ~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EG----------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 00001112346899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.34 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=204.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+.|.+.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 468999999999999999998765 6789999998654321 23467889999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999999999988543 46899999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCCccce-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 220 GLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 220 G~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
|+++.......... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .. . ..
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~--~-~~-- 220 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IF--K-IA-- 220 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HH--H-Hh--
Confidence 99876533221111 1234678899999999998899999999999999999999999975422110 00 0 00
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......++...+..+.+++.+||..+|.+||++.+++++
T Consensus 221 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 --------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000111222345788999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=339.04 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=210.0
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhccc-CCCcceee
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKL 136 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~ 136 (422)
+++....|++++.||+||.+.||++...+ ...||+|.+..... +...-+.+|+..|.+| .|.+||++
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL 425 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQL 425 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEE
Confidence 34556789999999999999999998754 34577777654332 3345689999999999 58999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
++|-..++.+||||||- ..+|..+|.+.....+...++.+..|++.|+.++|.++ |||.||||.|+|+- .|.+||
T Consensus 426 ~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKL 500 (677)
T KOG0596|consen 426 YDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKL 500 (677)
T ss_pred eeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEe
Confidence 99999999999999987 55999999877766776689999999999999999999 99999999999984 578999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCCC-----------CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-----------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 285 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 285 (422)
+|||+|...............+||+.||+||.+.... .+.++||||||||||+|+.|++||....
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---- 576 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---- 576 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----
Confidence 9999999988888777788899999999999886432 4678999999999999999999997421
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHH-HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....++..+.+|.-.-.|+.-.. .++.++++.||++||.+||++.|||++
T Consensus 577 -----------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 -----------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11223445556544444432222 339999999999999999999999974
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=343.16 Aligned_cols=267 Identities=24% Similarity=0.380 Sum_probs=207.7
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccC-CCcceeeEe
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV-HLNLVKLIG 138 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~ 138 (422)
.+..++|.+.+.||+|+||.||+|.+.... ...++..||||++....... .+.+.+|+.+|.++. |+||+++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 344457888999999999999999875421 11255689999997653332 346889999999997 999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCC----------------------------------------------------
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRS---------------------------------------------------- 166 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------- 166 (422)
++...+..++||||+++|+|.+++.+..
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999885421
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014585 167 ---------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 201 (422)
Q Consensus 167 ---------------------------------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 201 (422)
..+++..++.++.||+.||.|||+.+ ++||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccC
Confidence 13567788899999999999999988 999999
Q ss_pred CCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCC
Q 014585 202 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 280 (422)
Q Consensus 202 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 280 (422)
||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986533222222233457889999999998899999999999999999998 88888654
Q ss_pred CCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
..... ... .+.... .. ..+...+.++.+|+.+||..+|.+||++.+|++.|+.+
T Consensus 346 ~~~~~--~~~----~~~~~~------~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 346 PMNEQ--FYN----AIKRGY------RM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CchHH--HHH----HHHcCC------CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 32111 000 000000 00 01122357899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.70 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=203.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 568889999999999999997643 3359999987543 33467899999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+.+++|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999999999765557899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...... ....
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~-- 219 (256)
T cd05113 150 VLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS----QGLR-- 219 (256)
T ss_pred cCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh----cCCC--
Confidence 543221 11122345678999999988889999999999999999998 999986543211 111110 0000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.. .....+..+.+++.+||+.||.+||++.++++.|+
T Consensus 220 ----~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 ----LY----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 01112468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.03 Aligned_cols=261 Identities=27% Similarity=0.393 Sum_probs=205.3
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+|++.+.||+|+||.||+|....... ......+++|.+...... ....+.+|+.+++.+.||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 47889999999999999998754221 113357899988755432 2456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014585 145 QRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 201 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 201 (422)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 999999999999999987532 134788999999999999999999988 999999
Q ss_pred CCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCC
Q 014585 202 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 280 (422)
Q Consensus 202 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 280 (422)
||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999986533322211222346778999999988889999999999999999998 99999754
Q ss_pred CCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.+... ..... .. .....+...+.++.+++.+||+.+|.+||++.++++.|+.+
T Consensus 234 ~~~~~---~~~~~----~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 234 APERL---FNLLK----TG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CHHHH---HHHHh----CC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 32211 11110 00 00011123346889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=323.89 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=206.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.++||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN----------NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec----------CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3467999999999999999999864 34579999986543 235678999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCcc
Confidence 99999999999999999998653 456889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...... ..
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~- 220 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RG- 220 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cC-
Confidence 9875432211 1222346778999999988889999999999999999998 999997543211 111110 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
..... ....+.++.+++.+||..+|++||+++++++.|+.+
T Consensus 221 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 -----YRMPR----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----CCCCC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00000 112346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=328.22 Aligned_cols=272 Identities=27% Similarity=0.433 Sum_probs=205.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCC-----CCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTA-----PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-----~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
.++|++.+.||+|+||.||+|.+...+.. ....+....||+|.+...... ....+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987542110 011123346899998754322 245688999999999999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885421 24688899999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCCC
Q 014585 207 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNG 284 (422)
Q Consensus 207 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~ 284 (422)
+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999986543332222233455778999999998899999999999999999998 55677653321
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
..+............. .. ...+...+..+.+|+.+||+.||.+||++.++++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 --QVIENTGEFFRNQGRQ--IY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHhhhhcccc--cc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111000000 00 0001123468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=331.41 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=203.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++++++|+||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 579999999999999999998865 6778999998754332 234578999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||++ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 99999999996 4888888666667899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 294 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~ 294 (422)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... +
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 6433221 1223467899999998865 568999999999999999999999997654322211111000 0
Q ss_pred hhhcccccccccCcccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......+...-.+.... ......+.++.+|+.+||..||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000000000 0011245678999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=332.86 Aligned_cols=268 Identities=27% Similarity=0.390 Sum_probs=208.1
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+...+|.+.+.||+|+||.||+|.+...... ...++..||+|.+..... ....++.+|+.+++.+ +|+||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKE--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCc--ccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3346799999999999999999987542211 111345799999975432 2345688899999999 79999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
+...+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 999999999999999999999996532 24888999999999999999999988 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 283 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 283 (422)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999876543222111122234578999999998899999999999999999998 88888643221
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
. .... ..... ....+...+.++.+|+.+||..+|.+||++.++++.|+.+.
T Consensus 250 ~---~~~~----~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 250 E---LFKL----LKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred H---HHHH----HHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 1110 00000 00112234578899999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.19 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=206.2
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
+..++|++.+.||+|+||.||+|...... ....+..||+|.+..... .....+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45678999999999999999999765321 111456899999865432 2234578899999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence 99999999999999999999996421 33567788999999999999999988 9999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 290 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 290 (422)
+.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~ 232 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK 232 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999986543322222222345778999999998899999999999999999998 788886533211 111
Q ss_pred hhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... ... . ...+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 233 ~~~----~~~----~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVM----DGG----Y------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHH----cCC----C------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 110 000 0 001112346899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=328.36 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=206.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+|++.+.||+|+||.||+|.+..... ...+..||||++....... ...+.+|+.++..++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 457778899999999999998754211 1145689999997554322 35688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
+..++++||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEe
Confidence 9999999999999999987421 234788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 287 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 287 (422)
++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~ 234 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D 234 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999887544333222333456789999999988889999999999999999998 88888654321 1
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
...... ... ...++..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 235 ~~~~i~----~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIR----NRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHH----cCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 000 001122455778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=341.03 Aligned_cols=266 Identities=25% Similarity=0.348 Sum_probs=201.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|+||.||+|.+.. +|+.||||.+.... ....+++.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 47889999999999999998865 67899999986532 22345788999999999999999999999877
Q ss_pred C-----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 144 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 144 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+ ..++||||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence 6 7899999995 688887743 457999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--h
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--H 295 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~ 295 (422)
||+++........ ......++..|+|||++.+. .++.++|||||||++|||++|+.||....+......+..... .
T Consensus 147 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~ 225 (372)
T cd07853 147 FGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225 (372)
T ss_pred ccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999865432211 12234678999999998864 579999999999999999999999986654322111110000 0
Q ss_pred hh-------c-ccccc-cccC-cccCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LG-------E-RRRFY-RLID-PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~-------~-~~~~~-~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. . ...+. .... +.... .+....+.++.+||.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 0 00000 0000 00000 0111235688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=320.64 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=202.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 46889999999999999999874 234699999865432 3456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...... .
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~----- 216 (256)
T cd05059 150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVS----A----- 216 (256)
T ss_pred ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHH----c-----
Confidence 5432211 1111224567999999999999999999999999999999 789987543221 111110 0
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
.... ..+...+.++.+++.+||..+|++||++.++++.|
T Consensus 217 -~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 -GYRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0000 01112457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=342.05 Aligned_cols=262 Identities=23% Similarity=0.268 Sum_probs=204.1
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcc
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 133 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni 133 (422)
+.++....++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+|+.+++.++||||
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i 105 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC
Confidence 44455667899999999999999999999876 778999999864321 223457789999999999999
Q ss_pred eeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 134 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 134 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
+++++++..++..++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCC
Confidence 99999999999999999999999999988543 5889999999999999999999998 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCC----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
+||+|||+++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus 181 ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---- 255 (371)
T cd05622 181 LKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---- 255 (371)
T ss_pred EEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH----
Confidence 99999999987543221 122346799999999998754 378999999999999999999999976432111
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 347 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~ell~~L 347 (422)
.......... ..+. .....+..+.++|.+||..++.+ |+++.+++++.
T Consensus 256 --~~~i~~~~~~-~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 256 --YSKIMNHKNS-LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --HHHHHcCCCc-ccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1100000000 0000 01134578899999999844433 67888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=325.93 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=208.2
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||.||+|.+..... ..++..||+|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45689999999999999999998865321 12557899999865432 22356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
.....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence 9999999999999999999985421 24688899999999999999999988 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 291 (422)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~ 233 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF 233 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH
Confidence 999999999986544332222233456789999999988889999999999999999998 888986543221 1111
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.. ... . ...+...+.++.+++.+||+.+|++||++.++++.|+
T Consensus 234 ~~----~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VI----DGG-H---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred Hh----cCC-C---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 000 0 0011123578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.14 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=198.8
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEec-
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 143 (422)
|.+.+.||+|+||.||+|.+...+ ....||+|.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 456789999999999999886521 11368999987543 22345688999999999999999999987532
Q ss_pred -----CceEEEEEecCCCChhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 144 -----DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 144 -----~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
...++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 150 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN 150 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence 246899999999999988742 2345899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 227 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL 227 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999987644332222222346778999999999999999999999999999999 78888653221 111111
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ..... . .....+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 228 ~----~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 R----QGNRL------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred H----cCCCC------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 10000 0 1112346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.32 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=207.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|+..+.||+|+||.||+|.+...+. ....+|+|.+..... ...+.+..|++++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 3578888999999999999999865321 234799999875532 234568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999776677999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcccee-eccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 223 KDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 223 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
............ .....+..|+|||++.+..++.++|||||||++|||++ |..||...... ....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i~----~~~ 227 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAIN----DGF 227 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHh----cCC
Confidence 765432221111 11223567999999998889999999999999999997 99999654321 1111110 000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
........+..+.+++.+||..+|++||++.++++.|+++
T Consensus 228 ----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001113456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.70 Aligned_cols=265 Identities=24% Similarity=0.314 Sum_probs=199.3
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.+++.++|+||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 34789999999999999999998866 778999999965422 2345688999999999999999999998
Q ss_pred EecC------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
...+ ..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 6543 46899999954 6766653 24788999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-----
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV----- 289 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~----- 289 (422)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999997643221 123357899999999999999999999999999999999999999865321110000
Q ss_pred -------H----hhhhhhhccccc-----ccccCccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 290 -------E----WARPHLGERRRF-----YRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 290 -------~----~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ............ .+...... ........+..+.+||.+||..||.+||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000000 00000000 000111234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.73 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=204.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|.+.+.||+|+||.||+|.+..... ..++..||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4678999999999999999998864211 114568999988654332 23468899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC---C
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 213 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~---~ 213 (422)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence 999999999999999999986543 25899999999999999999999988 99999999999998765 5
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... .....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~ 234 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV 234 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 89999999987633222111122334568999999998999999999999999999997 999997543221 11110
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
. ... ...++...+..+.+++.+||+.+|++||++.+++++|+
T Consensus 235 ~----~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T----GGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H----cCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 000 00112233568899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.79 Aligned_cols=260 Identities=25% Similarity=0.432 Sum_probs=206.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+|++.+.||+|+||.||+|.+...+. .+..||||.+.... .....++..|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 458889999999999999999876332 23469999987543 22345789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence 9999999999999999999766667899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccc---cCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 224 DGPEGDKTHVSTRVM---GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
............... ++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~ 227 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QD 227 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cC
Confidence 654322211111111 2457999999999999999999999999999886 99999754321 1111111 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. ...+..++..+.+++.+||..+|.+||++.+++..|+.+
T Consensus 228 ------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------Cc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 001123456789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.78 Aligned_cols=251 Identities=26% Similarity=0.309 Sum_probs=192.5
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhccc---CCCcceeeEeEEEecCce
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 146 (422)
||+|+||+||+|++.. +|+.||||++...... ....+..|..++..+ .||||+++++++...+..
T Consensus 1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999999876 6789999998643221 123345666666655 699999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++|+|.+++.+ ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 72 YLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 999999999999988854 457899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ .. ....... .+
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~---~i~~~~~---~~ 216 (330)
T cd05586 148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YR---NIAFGKV---RF 216 (330)
T ss_pred CCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HH---HHHcCCC---CC
Confidence 2221 12346799999999998754 589999999999999999999999975432111 00 0000000 00
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCC
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 355 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 355 (422)
.. ...+.++.+++.+||..||.+||++.+.++.+..++++..
T Consensus 217 ~~--------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 217 PK--------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CC--------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 00 1234678899999999999999965444444444555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.09 Aligned_cols=269 Identities=26% Similarity=0.396 Sum_probs=210.0
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+...+|.+.+.||+|+||.||+|.+..... .....+..||+|.+.... ......+.+|+.+++.+ .|+||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 445789999999999999999998643111 011245679999987543 23346788999999999 89999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
+......++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 999999999999999999999986532 34788889999999999999999988 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 283 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 283 (422)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999987644332222223446778999999998899999999999999999998 77888654221
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. .... +..... ...+..++..+.+|+.+||..+|.+||++.++++.|+.+..
T Consensus 247 ~---~~~~----~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 E---LFKL----LKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred H---HHHH----HHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1 1111 111000 00112345789999999999999999999999999977644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=321.72 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=201.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.++||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 368889999999999999998866 678999999865432 2345688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 9999999999999986542 4788899999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhhhccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 302 (422)
...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ...........
T Consensus 144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 215 (279)
T cd06619 144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---- 215 (279)
T ss_pred eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----
Confidence 653321 223578999999999999999999999999999999999999997533221111 00100000000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
..+.+ .....+.++.+++.+||+.||.+||++.+++++.
T Consensus 216 ---~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 216 ---DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred ---CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 00000 0112346789999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.27 Aligned_cols=265 Identities=29% Similarity=0.462 Sum_probs=221.1
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
...+...++++||+|-||.|.++... .+..||||+++...... .++|.+|+++|.+|+|||||+++|+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve----------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE----------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec----------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 44567888999999999999999864 25789999998766544 47899999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
..++.+++|+||+++|+|.+++.++..+. .......|+.||+.||+||.+.+ +|||||.++|||++.++++||+||
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence 99999999999999999999998775443 56667789999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|+++.+..++........+-..+|||+|.+..++++.++|||+||+++||+++ ...||...... ..++.....+.
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~ 758 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFR 758 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcC
Confidence 99998888888888888888999999999999999999999999999999865 66788654332 22222222222
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.... ......+.-++.++.+++..||..|-.+||+++++..+|+.
T Consensus 759 ~~~~-------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 759 DQGR-------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCCc-------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 2111 11112234567899999999999999999999999998864
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=327.14 Aligned_cols=266 Identities=25% Similarity=0.367 Sum_probs=204.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||+|+||.||+|.+.. +|..||+|.+...... ....+.+|++++++++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368999999999999999998866 6778999998754322 235688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++.+. ..+++..+..++.|+++||.|||+ .+ ++||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999999998554 578999999999999999999997 46 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc--
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-- 300 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 300 (422)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......................
T Consensus 148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 7643221 2335789999999999888899999999999999999999999965432211111100000000000
Q ss_pred --------------ccccccCccc---CCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 301 --------------RFYRLIDPRL---EGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 301 --------------~~~~~~~~~~---~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
...+..+... .... ....+.++.+|+.+||..||++||++.+++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 0000 012456799999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=327.84 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=202.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||.||+|.....+ ....+++|.++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 47899999999999999999886522 12357888886432 22345688999999999 79999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
.+..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 999999999999999999985432 34888999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 286 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 286 (422)
++.++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-- 226 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-- 226 (297)
T ss_pred ECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 9999999999999986432111 1111223557999999998899999999999999999997 999997543211
Q ss_pred hhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 014585 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 353 (422)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 353 (422)
..... .. .... ..+..++..+.+|+.+||+.+|.+||++.++++.|+.+...
T Consensus 227 -~~~~~----~~------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 227 -LYEKL----PQ------GYRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -HHHHH----hc------CCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11100 00 0000 11123456889999999999999999999999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=321.82 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=208.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|++.+.||+|+||.||+|.+...+. .+..+|+|.+...... ..+.+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3578899999999999999998765322 3447999998754332 24578899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence 99999999999999999999776667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccce-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 223 KDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 223 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
........... .....++..|+|||.+.+..++.++|||||||++||+++ |..||....... ...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~ 226 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EGY 226 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CCC
Confidence 87644322111 111234568999999998899999999999999999886 999997543221 111111 000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. . ......+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 227 ~---~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 R---L-------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred c---C-------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0 01123356789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.37 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=208.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.+|++.+.||+|+||.||+|.+.. +|..||||.+..... ....++.+|+.+++.+.|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468889999999999999999866 677899998865332 22356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
.++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999998853 2456899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... .......
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~------ 220 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI------ 220 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhh------
Confidence 999876543322 1223568999999999998899999999999999999999999996532210 0110000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.....+.. .....+..+.+++.+||..||.+|||+.+|++.++++.
T Consensus 221 ----~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 221 ----EQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----hcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00000111 11235678999999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=324.24 Aligned_cols=272 Identities=26% Similarity=0.428 Sum_probs=206.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCC-------CCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCccee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 135 (422)
.++|++.+.||+|+||.||++.+...... .....++..||+|.+..... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 35799999999999999999875432110 01223456799999975432 23457899999999999999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
+++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986432 23677889999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPN 283 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~ 283 (422)
||++.++.++|+|||+++...............++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986543332222223445678999999888899999999999999999998 67788654322
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.. +............ ....+ .+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 241 ~~---~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV---IENTGEFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 1111000000000 00000 01123468899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=317.61 Aligned_cols=252 Identities=34% Similarity=0.514 Sum_probs=206.6
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
+.||+|+||.||+|.+.... ..+..||+|.+....... .+.+.+|+++++.++|+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999987521 136789999998665443 56789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 150 YEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 9999999999999765 467999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+................++..|+|||.+....++.++|||||||++|+|++ |..||...... ....... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~- 223 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLR----KG- 223 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cC-
Confidence 987655432222334567889999999988899999999999999999999 59999765321 1111111 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.....+...+.++.+++.+||..||.+||++.+++++|+
T Consensus 224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001112233678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=317.57 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=209.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||.|+||.||+|.+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 578999999999999999998865 56789999998765556678999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..+++|||+++++|.+++......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999999999998766567999999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccCccccCCCcccCC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
...... ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||....+..... .... .
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~~~~------~- 219 (262)
T cd06613 151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--LISK------S- 219 (262)
T ss_pred hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh------c-
Confidence 543211 12235688899999998776 88999999999999999999999997543221110 0000 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+. .......+.++.+++.+||..+|.+||++.+++.+
T Consensus 220 --~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 --NFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 11223456789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=318.13 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=205.8
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|.+.+.||+|+||.||+|.+.. +|..|++|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788999999999999999876 677999999865432 2345688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999999998764 457899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...... ....... .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~---~----- 215 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKII---R----- 215 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---c-----
Confidence 86543322 123356889999999999999999999999999999999999999754311 1111000 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ...+....+..+.+++.+||+.+|++||++.+++++
T Consensus 216 -~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 -GV-----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CC-----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 011112345789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=325.03 Aligned_cols=263 Identities=25% Similarity=0.349 Sum_probs=196.4
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhccc---CCCcceeeEeEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGYC 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~~~~~~ 140 (422)
+|++.+.||+|+||+||+|.+.. +|+.||+|.+...... ....+.+|+.+++.+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 58899999999999999999876 7889999998754322 123456677766655 799999999988
Q ss_pred Ee-----cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~-----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
.. ....++||||++ ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV 147 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 64 245789999996 5888888654 345899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-HHhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWAR 293 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~ 293 (422)
||+|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|.+||........... .....
T Consensus 148 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 148 KLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred EECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 9999999986543221 2235689999999999988999999999999999999999999975433211110 00000
Q ss_pred hhhhccccccc-------ccCc---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYR-------LIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
......+.. ...+ ..........+.++.+++.+||+.||.+||++.+++.+
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 225 --LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred --CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 0000 00001112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=322.72 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=203.5
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCce
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
|++.+.||.|+||.||+|.+.. ++..+++|.+........+.+.+|+.+++.++|+||+++++++...+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 6778899999999999998866 6778999999766555566788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++++|..++.+....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999999999988665667999999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
... .......|+..|+|||++. +..++.++|||||||++|+|++|..||........ ...... ..
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~----~~-- 224 (282)
T cd06643 155 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK----SE-- 224 (282)
T ss_pred ccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhh----cC--
Confidence 221 1123356899999999874 45678899999999999999999999975432111 011000 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.. ..+...+.++.+|+.+||+.||.+||++.+++++
T Consensus 225 -----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 -----PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0112345688999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=336.18 Aligned_cols=265 Identities=23% Similarity=0.298 Sum_probs=199.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +++.||||.+..... .....+.+|+.+++.++|+||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 45789999999999999999998765 678899999975432 2345678999999999999999999988
Q ss_pred Eec------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
... ...++||||+++ +|.+.+.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 653 346899999954 67766632 4889999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-HHh--
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEW-- 291 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~-- 291 (422)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+......... +..
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999998653321 12335789999999999999999999999999999999999999976542111000 000
Q ss_pred -------------hhhhhhcccccc-----cccCccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 -------------ARPHLGERRRFY-----RLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 -------------~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
............ ....... ........+.++.+||.+||..||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 0000000 001111234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=316.96 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=197.2
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
.||+|+||.||+|.+... .++..||+|++...... ..+++.+|+.+++.+.|+||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 589999999999976432 15678999998654322 3457889999999999999999999875 4567899
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||.|||++.++.+||+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 74 MELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 999999999999854 346899999999999999999999988 9999999999999999999999999998754332
Q ss_pred ccce-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccC
Q 014585 230 KTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307 (422)
Q Consensus 230 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (422)
.... .....++..|+|||.+....++.++|||||||++|||++ |..||....... ...... ...
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~----~~~------- 215 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIE----SGE------- 215 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCC-------
Confidence 2111 112234678999999988889999999999999999998 999997543221 111111 000
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 308 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
....+...+.++.++|.+||+.||.+||++.+|.+.|+.
T Consensus 216 ---~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 ---RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 001122345789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=329.47 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=199.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.++||+|+||.||++.+.. +++.||+|++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 378999999999999999999876 677899999864321 12234778999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence 999999999999999999999766667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
+........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||........ .....
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~ 221 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIM 221 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHh
Confidence 876433221 1223357999999999886 34688999999999999999999999975432111 11000
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~ell~~ 346 (422)
.....+ . + + ......+.++.+|+.+||..++.+ |+++.+++++
T Consensus 222 ~~~~~~-~-~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 222 NHKERF-Q-F-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccc-c-C-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000000 0 0 0 001134578899999998655444 6788888864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.40 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=203.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||+|+||.||+|.+.. +++.||+|.+..........+.+|+.+++.++|+||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 478888999999999999998866 67799999987665444556889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999999999998854 447999999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
..... .......|+..|+|||++. ...++.++|||||||++|+|++|..||....+....... ...
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~------- 224 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKS------- 224 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hcc-------
Confidence 53221 1123357899999999874 456889999999999999999999998654332111000 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+.... ....+..+.+++.+||+.+|++||++.+++++
T Consensus 225 --~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 --NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000011100 01234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=316.95 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=208.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +|+.||+|.++.... .....+.+|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 579999999999999999999875 678999999864322 22457889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
..+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence 99999999999999999998853 2455899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....... ........ .
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~ 222 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE----K 222 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-HHHHhhhh----c
Confidence 999876543221 1223568899999999998899999999999999999999999996543110 00111000 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
....+ ......+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 223 -----~~~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 -----CDYPP----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----CCCCC----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00000 001134568899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=323.57 Aligned_cols=252 Identities=31% Similarity=0.415 Sum_probs=202.2
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.|++.+.||+|+||.||+|.+.. +++.||+|.+....... ...+.+|+.++++++|+||+.+++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 36778899999999999999876 77899999986543222 2457789999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999988543 345899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||...................
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----- 220 (285)
T cd05630 149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----- 220 (285)
T ss_pred eeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----
Confidence 876533221 123468999999999999999999999999999999999999997643221111111000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~~ 346 (422)
...+....+.++.+|+.+||+.||.+||+ +.+++++
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 ---------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00111233467899999999999999999 7788763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=323.24 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=205.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+.|++++.||.|+||.||+|.+.. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 3679999999999999999998876 6779999999876555567788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|..++.+....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999888666667999999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
...... .......++..|+|||++. ...++.++|||||||++|+|++|..||....+... ......
T Consensus 159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----- 229 (292)
T cd06644 159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK----- 229 (292)
T ss_pred eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhc-----
Confidence 543211 1122356889999999885 34578899999999999999999999975432110 111000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+.. ..+...+.++.+++.+||..||++||++.+++++
T Consensus 230 ------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 230 ------SEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ------CCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0112344678999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=324.11 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=206.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.+.|+||+++++.+..+.
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 689999999999999999998765 67799999998766555677889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 99999999999999998853 35789999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+.... ..... . ..
T Consensus 166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~----~--~~-- 233 (296)
T cd06654 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIAT----N--GT-- 233 (296)
T ss_pred cccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhc----C--CC--
Confidence 533221 122346889999999999888999999999999999999999999754432110 00000 0 00
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+ ....+...+..+.+++.+||..||.+||++.+++++
T Consensus 234 ---~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 ---P--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---C--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 001122345678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=317.30 Aligned_cols=249 Identities=29% Similarity=0.486 Sum_probs=205.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 46789999999999999999976 466899999976643 456789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999999986543 36899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... ....
T Consensus 150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~~- 216 (256)
T cd05039 150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKGY- 216 (256)
T ss_pred cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcCC-
Confidence 87632211 2234668999999988889999999999999999997 999986542211 11100 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
....+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 ---------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 001112335788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=317.82 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=204.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+|++.+.||.|+||.||++.+.. ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 57889999999999999998866 67789999986543 233456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence 999999999999999988543 456899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ...... .. .
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~---~~--~-- 216 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKVC---QG--S-- 216 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHHh---cC--C--
Confidence 6543221 1233568999999999998889999999999999999999999997543211 110000 00 0
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ...+...+..+.+|+.+||+.||.+||++.+++..
T Consensus 217 --~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 --Y-----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --C-----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 01122345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=316.45 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=198.8
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEE
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 150 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 150 (422)
.||+|+||.||+|.+.... .+..||+|++...... ..+.+.+|+.++++++|+||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCC-------CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 3899999999999875321 4557999998765432 2456889999999999999999999875 45789999
Q ss_pred EecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCc
Q 014585 151 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 230 (422)
Q Consensus 151 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 230 (422)
||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 999999999999766667999999999999999999999988 99999999999999999999999999986543322
Q ss_pred cce-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 231 THV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 231 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||........ ..... ...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~-------- 215 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFIE----QGK-------- 215 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHH----CCC--------
Confidence 111 111233578999999988889999999999999999996 9999975432211 11110 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
....+..++.++.+++.+||..||++||++.++.+.|+.+
T Consensus 216 --~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 --RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0112223457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.31 Aligned_cols=254 Identities=31% Similarity=0.522 Sum_probs=203.1
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHH--HHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
|++.+.||+|+||+||++.+.. +++.||+|++......... ...+|+.++++++|+||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 6778999999999999999877 6778999999877644332 3456999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++. ....+++..++.++.||++||.+||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999999996 4457899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
.. ..........++..|+|||++. +..++.++||||||+++|+|++|..||............. ......
T Consensus 148 ~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~---- 218 (260)
T PF00069_consen 148 LS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRP---- 218 (260)
T ss_dssp ST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTH----
T ss_pred cc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccccc----
Confidence 41 1122234467899999999998 8889999999999999999999999998651111111111 110000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....... .......+.+++.+||+.||++||++.+++++
T Consensus 219 -~~~~~~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 219 -LPSSSQQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -HHHHTTS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -ccccccc---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00012789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=335.77 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=199.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++|+||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 34689999999999999999998866 677899999975432 2345688999999999999999999987
Q ss_pred Eec------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
... ...|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcE
Confidence 643 35799999995 577777632 4788999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh---
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW--- 291 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~--- 291 (422)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999998653321 12335789999999999999999999999999999999999999976543211110000
Q ss_pred ---------h----hhhhhccccccc-----ccCc---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 ---------A----RPHLGERRRFYR-----LIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 ---------~----~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .........+.. +... .............+.+||.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000000000 0000 00000111224578999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=319.70 Aligned_cols=249 Identities=23% Similarity=0.422 Sum_probs=194.0
Q ss_pred ccccccCcEEEEEEeccCCCCC---------------CCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceee
Q 014585 72 LLGEGGFGCVFKGWIEENGTAP---------------VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 136 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~---------------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 136 (422)
.||+|+||.||+|.....+... ........||+|++..........+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999865422111 1222345689999875544444578899999999999999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC----
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---- 212 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~---- 212 (422)
++++......++||||+++|+|..++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766677999999999999999999999988 99999999999997654
Q ss_pred ---CeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHH-hCCCCCCCCCCCCcch
Q 014585 213 ---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHN 287 (422)
Q Consensus 213 ---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~ 287 (422)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999988654221 12357788999998875 56899999999999999985 6889987654322111
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
. ...... ... ....++.+++.+||+.+|.+||++.++++.|.
T Consensus 233 ~-------~~~~~~--------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 F-------YEKKHR--------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-------HHhccC--------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 000000 001 11246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.22 Aligned_cols=266 Identities=30% Similarity=0.414 Sum_probs=203.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.... ...+++.||||++...... ....+.+|+.++.++ +|+||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 3468999999999999999999864311 1126778999999754322 345688999999999 689999999988
Q ss_pred Eec-CceEEEEEecCCCChhhhhccCC-----------------------------------------------------
Q 014585 141 IED-DQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 166 (422)
Q Consensus 141 ~~~-~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 166 (422)
... ...++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46789999999999999885421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccce
Q 014585 167 -------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233 (422)
Q Consensus 167 -------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 233 (422)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 23677888999999999999999988 99999999999999999999999999986533222222
Q ss_pred eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCC
Q 014585 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 312 (422)
Q Consensus 234 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (422)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .... ....... . .
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~~---~---~--- 302 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTR---M---R--- 302 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----HHhccCC---C---C---
Confidence 222345678999999999999999999999999999997 889986542211 1111 0101000 0 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 313 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 313 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.+...+.++.+++.+||+.||.+||++.+|+++|+.+.
T Consensus 303 -~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 303 -APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112357899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=317.51 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=203.0
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~- 71 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN----------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS- 71 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec----------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence 3467999999999999999999764 345699999876543 3467899999999999999999999875
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCcee
Confidence 55689999999999999998654 345899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....... ..
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~- 219 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVE----RG- 219 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cC-
Confidence 9865432211 1122345678999999988899999999999999999999 88899654321 1111110 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
. ....+...+..+.+|+.+||..+|.+||++.++++.|+.
T Consensus 220 -----~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -----Y----RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----C----CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 001122345689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=317.90 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=204.7
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+..++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 34568999999999999999999864 456899999876543 3467899999999999999999999864
Q ss_pred ecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCc
Confidence 56789999999999999988643 456899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||....... ..... ...
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~ 219 (260)
T cd05067 148 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL----ERG 219 (260)
T ss_pred ceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----HcC
Confidence 9977543221 11222346778999999988889999999999999999999 999997543211 11111 000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.... .+...+.++.+++.+||..+|++||++++++..|+.
T Consensus 220 ------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 ------YRMP----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000 111234679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=331.00 Aligned_cols=271 Identities=27% Similarity=0.397 Sum_probs=209.9
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEe
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIG 138 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (422)
.+...+|++.+.||+|+||.||+|.+...... ....+..||+|.+..... ....++.+|+.+++++ .|+||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKD--KPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCc--cCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 44456899999999999999999987542211 111345799998875432 2346788999999999 8999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 203 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 203 (422)
++...+..++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 9999999999999999999999986432 24788889999999999999999988 99999999
Q ss_pred CcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCC
Q 014585 204 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 282 (422)
Q Consensus 204 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 282 (422)
+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999986543322222222334578999999999999999999999999999998 8888865432
Q ss_pred CCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 014585 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 353 (422)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 353 (422)
... ... +.... ....+..++.++.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 243 ~~~---~~~----~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 EEL---FKL----LKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHH---HHH----HHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111 110 00000 0011123356889999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=328.13 Aligned_cols=267 Identities=26% Similarity=0.406 Sum_probs=206.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
...+|.+.+.||+|+||.||+|.+..... .....+..||+|.+..... .....+.+|+.+++++ +|+||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34678899999999999999998643211 1112455799999875432 2345688999999999 699999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
...+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 99999999999999999999985432 34888999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 284 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 284 (422)
||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543222211122234568999999998899999999999999999999 888886543211
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
...... .... ...+..++.++.+++.+||..||.+||++.++++.|+.+.
T Consensus 245 ---~~~~~~----~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ---LFKLLR----EGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHHH----cCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111110 1000 0111233568889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=331.77 Aligned_cols=256 Identities=21% Similarity=0.254 Sum_probs=198.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||++.+.. +++.||+|++..... .....+.+|+.++..+.|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 478999999999999999998876 677899999864321 12334778999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..|+||||++||+|.+++.+....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccc
Confidence 999999999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
+......... ......||+.|+|||++.+ +.++.++|||||||++|+|++|+.||........ .. ...
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~---~i~ 221 (331)
T cd05624 149 CLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YG---KIM 221 (331)
T ss_pred eeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HH---HHH
Confidence 9765432221 1223579999999998875 5678899999999999999999999975432111 10 000
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~ell~~ 346 (422)
.....+ . +... ....+.++.+++.+||..++.+ |+++.+++++
T Consensus 222 ~~~~~~-~-~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 222 NHEERF-Q-FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCcc-c-CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000000 0 0000 1123578899999999865543 3567666653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=324.62 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=203.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||.|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 579999999999999999998865 6779999998754322 234678999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999999996 5999888766667899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------h
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 294 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~ 294 (422)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+.... .
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 153 AKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred ccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 6433221 1223457889999998875 457889999999999999999999997654321110000000 0
Q ss_pred hhhcccccccccCcccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......+...-.+.... ......+..+.+||.+||..||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000000000000 0111235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=322.12 Aligned_cols=268 Identities=28% Similarity=0.390 Sum_probs=205.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+.|++.+.||+|+||.||+|.+...+ ..++..||+|.+..... .....+.+|+.+++.+.|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCC-----CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 45788999999999999999864321 22678999999875432 2345788999999999999999999998875
Q ss_pred --CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 144 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 144 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
...++||||+++++|.+++.+....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcc
Confidence 5688999999999999998665557899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC--------cchhHHhh
Q 014585 222 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG--------EHNLVEWA 292 (422)
Q Consensus 222 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--------~~~~~~~~ 292 (422)
++........ .......|+..|+|||++.+..++.++|||||||++|||+++..|+....... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 9876433221 11223456778999999988889999999999999999999876653211100 00000000
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
........ .......++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 236 ~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000 0001113457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=322.54 Aligned_cols=265 Identities=27% Similarity=0.423 Sum_probs=209.4
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
+..++|++.+.||+|+||.||+|.+.... ..++..|++|++..... .....+.+|+.+++++.|+||+++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34578999999999999999999987522 12467899999875432 2345688999999999999999999987
Q ss_pred Ee-cCceEEEEEecCCCChhhhhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 141 IE-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 141 ~~-~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
.. +...++++||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~ 154 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEEL 154 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCC
Confidence 76 567889999999999999985432 45899999999999999999999988 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 291 (422)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |..||....+.. ...+
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~ 231 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY 231 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH
Confidence 999999999986544332222223446778999999998899999999999999999998 999997643321 1111
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
... .. .. .....++..+.+++.+||..||++||++.++++.|+.+.
T Consensus 232 ~~~----~~---~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 232 LKD----GY---RL-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHc----CC---CC-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 110 00 00 011123568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.09 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=202.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|++.++||+|+||.||+|.+.. + ..||+|++..... ..+.+.+|+.++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~---------~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG---------T-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC---------C-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 4679999999999999999998753 2 3599999975432 3467899999999999999999999874 4
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCce
Confidence 5689999999999999999653 345899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ..... ..
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~----~~-- 219 (262)
T cd05071 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVE----RG-- 219 (262)
T ss_pred eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHh----cC--
Confidence 765433221 1122346778999999988899999999999999999999 8888865432111 11000 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ........+..+.+|+.+||+.||.+||++.++++.|+..
T Consensus 220 ----~----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 ----Y----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----C----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 0011224557889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=314.17 Aligned_cols=242 Identities=29% Similarity=0.374 Sum_probs=203.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHH---HHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
-++|..+++||+|.||+|.+++.+. +|+.+|+|++++.......+ -+.|-++|...+||.+..+.-.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 3578889999999999999998765 89999999998876554443 56799999999999999998889
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...+++|+||||+.||.|.-++. +...+++.....+..+|+.||.|||+.+ ||+||||.+|+|+|++|++||+|||
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred ccCceEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence 99999999999999999998884 4567999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+++.... .......+||||.|+|||++....|+.++|+|.+||++|||++|+.||...+....-.++ +.+..
T Consensus 314 LCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------l~ed~ 385 (516)
T KOG0690|consen 314 LCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------LMEDL 385 (516)
T ss_pred cchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------Hhhhc
Confidence 9986432 223345699999999999999999999999999999999999999999865432211111 11111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 338 (422)
.|+...+++++.|+..+|..||.+|.
T Consensus 386 ------------kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 ------------KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 13334567899999999999999996
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=321.96 Aligned_cols=246 Identities=30% Similarity=0.414 Sum_probs=197.5
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
|+..+.||.|+||+||+|.+.. +|+.||+|.+...... ....+.+|+.+++.++|+||+.+++.+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 6777899999999999999876 6789999998654322 224577899999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999999888543 346999999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ .....|+..|+|||++.+..++.++|+|||||++|+|++|..||............. .....
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~~~~---- 219 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLE---- 219 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhhhc----
Confidence 76533221 123468999999999998899999999999999999999999997543211111110 00000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 341 (422)
. ...+....+.++.+|+.+||+.||.+||++.
T Consensus 220 --~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 220 --T-----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --c-----ccccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 0 0011223456788999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.56 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=208.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||.|+||.||+|.+.. ++..|++|.+..... .+.+.+|++++++++|+||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 579999999999999999999875 567899999875532 568999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++++||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence 999999999999999999766778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+....... . .
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~----------~ 213 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---P----------N 213 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---c----------c
Confidence 644321 122345888999999999889999999999999999999999999754332111000 0 0
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+ ....+...+.++.+++.+||+.||.+||++.+++++
T Consensus 214 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 KPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000 001122345689999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=327.05 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=201.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+..++ ....+|+|.+..... .....+.+|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 357889999999999999999986521 113467887764322 2345688999999999 8999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
.++..++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+.+ ++||||||+||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Ni 155 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 155 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheE
Confidence 9999999999999999999986432 35789999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 014585 207 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 285 (422)
Q Consensus 207 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 285 (422)
|++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 231 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 231 (303)
T ss_pred EecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-
Confidence 99999999999999986432111 1111234667999999988889999999999999999998 999996543211
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
..... ... .....+...+..+.+|+.+||+.+|++||++.+++..|+.+.
T Consensus 232 --~~~~~----~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 232 --LYEKL----PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred --HHHHH----hcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100 000 000011123467899999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=320.50 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=209.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|++.+.||+|+||.||+|.+..++.. ....||+|.+...... ...++.+|+.+++++.|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 35789999999999999999998653321 2346899988765432 34568899999999999999999999887
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
...++||||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccc
Confidence 7889999999999999999777667999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...............++..|+|||.+....++.++|||||||++|||++ |..||........ ..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~~ 229 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDLLE----KGER 229 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHh----CCCC
Confidence 87654332222222234678999999988899999999999999999998 9999976533211 11110 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. ..+..++..+.+++.+||..||.+||++.++++.|+.+..
T Consensus 230 ---~-------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ---L-------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---C-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0111233578899999999999999999999999886533
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=321.05 Aligned_cols=276 Identities=29% Similarity=0.381 Sum_probs=210.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
++|++.+.||+|+||.||+|.+...+ ..++..||||.+...... ....+.+|+.+++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 56888899999999999999875422 126789999999766543 35679999999999999999999999887
Q ss_pred -cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
....++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccc
Confidence 55789999999999999999776667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+.......... ......++..|+|||.+.+..++.++|||||||++|||++|..||............. . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHH
Confidence 98765332211 1112334567999999988899999999999999999999999986532211100000 0 0000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.+...+........+..++.++.+|+.+||..+|.+||++.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000000011111223457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=322.20 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=206.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||.|+||.||+|.+.. ++..||+|.+........+.+..|+.++++++|+||+++++++..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 3568999999999999999998865 6778999999766555566788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...++||||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence 9999999999999999998776667999999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
....... ......|+..|+|||++. ...++.++|||||||++|+|++|..||........ ..... .
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~-----~ 222 (280)
T cd06611 152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKIL-----K 222 (280)
T ss_pred hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHh-----c
Confidence 6433221 123356899999999875 34578899999999999999999999976432111 10000 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+.+ ..+...+.++.+++.+||..+|.+||++.+++++
T Consensus 223 ------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 ------SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000000 0112345678999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=314.66 Aligned_cols=253 Identities=31% Similarity=0.493 Sum_probs=200.1
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
++||+|+||.||+|.+.... +++..||+|.+...... ..+++.+|+.+++.+.|+||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999875522 13468999999766543 3456889999999999999999999876 4568999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++.... .+++..++.++.|++.||.|||..+ ++||||||+|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999996544 7899999999999999999999988 9999999999999999999999999998764333
Q ss_pred ccce-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccC
Q 014585 230 KTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307 (422)
Q Consensus 230 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (422)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ........ ... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~----~~~---~-- 217 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES----GER---L-- 217 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----CCc---C--
Confidence 2211 111223568999999998899999999999999999998 99999754321 11111111 000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 308 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
..+..++..+.+++.+||..+|.+||++.++++.|+.+.
T Consensus 218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011123468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.85 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=202.8
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---------HHHHHHHHHHhcccCCCcceee
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLVHLNLVKL 136 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~ 136 (422)
+|.+.+.||.|+||.||+|.+.. ++..||+|.+....... .+.+.+|+.++++++|+||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 47888999999999999998765 56789999886543321 2457889999999999999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEe
Confidence 99999999999999999999999998543 56899999999999999999999988 999999999999999999999
Q ss_pred eeccCcccCCCCCc----cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 217 SDFGLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 217 ~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+|||+++....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||....... .+.
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~-- 222 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIF-- 222 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHH--
Confidence 99999887642211 111123468899999999998889999999999999999999999997542211 000
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. . .....+ .++...+..+.+++.+||+.||.+||++.+++++
T Consensus 223 ~--~------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 K--I------GENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred H--H------hccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 0 000111 1222345788999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=322.14 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=205.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+... ....++..||+|++..... ....++.+|+.+++++.|+||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 46799999999999999999987431 1112567899999875433 224568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 201 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 201 (422)
++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 999999999999999999986321 24788889999999999999999988 999999
Q ss_pred CCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCC
Q 014585 202 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 280 (422)
Q Consensus 202 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 280 (422)
||+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876533222211222345678999999998899999999999999999997 87888644
Q ss_pred CCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.... ..... ... . .. ..+...+.++.+|+.+||+.||.+||++.|+++.|+.
T Consensus 237 ~~~~---~~~~~----~~~-~---~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEE---VIYYV----RDG-N---VL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHH---HHHHH----hcC-C---CC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3211 11110 000 0 00 0111335789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=314.51 Aligned_cols=252 Identities=30% Similarity=0.464 Sum_probs=202.4
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
++||+|+||.||+|.+.... +....||||.+..... ...+.+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 46899999999999886521 1334699999987766 456679999999999999999999999988 889999
Q ss_pred EEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 150 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999997654 57899999999999999999999988 999999999999999999999999999876442
Q ss_pred Ccc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 229 DKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 229 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....... ... ..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~---~~- 220 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGE---RL- 220 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCC---cC-
Confidence 221 11123457789999999998899999999999999999998 999996543211 1111100 000 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
..+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus 221 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011133568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.23 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=206.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|++.+.||+|+||.||+|.+.. +|..||+|.+........+.+.+|+.+++.++|+||+++++++..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 789999999999999999998765 67799999997665555567889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 99999999999999998854 35789999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+........ .
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~--~----------- 229 (297)
T cd06656 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T----------- 229 (297)
T ss_pred ccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec--c-----------
Confidence 533221 1223468899999999999889999999999999999999999997644321110000 0
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........+...+..+.+++.+||..||.+||++.+++++
T Consensus 230 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 --NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000122345678899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.66 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=200.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE-e
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-E 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~ 142 (422)
..+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-----------~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-----------cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 35789999999999999999976 45679999986543 3457889999999999999999999765 4
Q ss_pred cCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
++..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCcc
Confidence 567899999999999999986543 34889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...... ....... ..
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~- 215 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KG- 215 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cC-
Confidence 87643321 12334668999999998899999999999999999997 99998643211 1111110 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
..+ .....++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 216 -----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -----YKM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----CCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 000 11123457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=314.84 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=194.5
Q ss_pred CccccccCcEEEEEEeccCCCC---CCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTA---PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~---~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (422)
+.||+|+||.||+|........ .........|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986432110 0111234568999887655444557889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC-------eEEeecc
Q 014585 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-------AKLSDFG 220 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-------~kl~DFG 220 (422)
+||||+++++|..++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999888766667999999999999999999999988 999999999999987664 8999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
++...... ....|+..|+|||++. +..++.++|||||||++|||+ .|..||........ ... ...
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~----~~~ 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---ERF----YEG 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---HHH----Hhc
Confidence 98764321 1245788999999887 567899999999999999998 57777764322111 000 000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
..... .....++.+|+.+||+.||.+||++.+|++.|+
T Consensus 225 ---~~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 ---QCMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---CccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 112367899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=320.47 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=200.1
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|+||.||+|.+.. +|..||||.+...... ....+.+|+.++++++|+||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 47889999999999999999866 6779999998654322 235688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+..++||||++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 6888887543 256899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-HHhhh------
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWAR------ 293 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~------ 293 (422)
+....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 97653221 11223457889999998865 4578999999999999999999999976432111000 00000
Q ss_pred -hhhhcccccccccCc---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 -PHLGERRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 -~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........+....+. ..........+.++.++|.+||..||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000 00000011245788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.25 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=201.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
....|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+..|+.+++++ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 34678889999999999999998866 67799999987553 3345788999999998 7999999999987
Q ss_pred ec------CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 142 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 142 ~~------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
.. ...++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence 53 4578999999999999998653 346899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
+|+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|..||....+......
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~- 227 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL- 227 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-
Confidence 9999999876533211 123356899999999886 34688899999999999999999999965432111000
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .. .. .... .....+.++.+|+.+||..||.+||++.+++++
T Consensus 228 ---~---~~-~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 ---I---PR-NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---H---hc-CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 00 00 0000 111234678999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=316.90 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=205.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||.|+||.||+|.+.. +|..||+|.+.... ......+.+|+.+++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 368889999999999999999866 67899999987654 23345688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...++|+||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccce
Confidence 9999999999999999998544 7899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
...... .......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+...... ..
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~---------- 211 (274)
T cd06609 147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL---IP---------- 211 (274)
T ss_pred eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH---hh----------
Confidence 764332 112335688899999999988899999999999999999999999975442211000 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+.+... ..+.++.+++.+||..+|++||++.+++++
T Consensus 212 ~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 212 KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0011111111 145678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=324.38 Aligned_cols=262 Identities=24% Similarity=0.409 Sum_probs=205.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|+..+.||+|+||.||+|.+...+.. ....||+|.+....... ..++.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 46788899999999999999988763221 12358999887543322 3468899999999999999999999875
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
. ..++|+||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccc
Confidence 4 567999999999999999776667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLE----KGER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCCC
Confidence 87643332222222345778999999999999999999999999999997 889986543211 111110 1000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.. ....++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 230 ---~~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 ---LP-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ---CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 01123457889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.07 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=189.9
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe--cCceE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRL 147 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 147 (422)
.++||+|+||+||+|.+... .+++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 46899999999999987532 1567899999865432 3457899999999999999999999864 45678
Q ss_pred EEEEecCCCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE----cCCCCeE
Q 014585 148 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAK 215 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill----~~~~~~k 215 (422)
+||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence 999999 45888776422 235899999999999999999999998 9999999999999 4567899
Q ss_pred EeeccCcccCCCCCcc-ceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc------h
Q 014585 216 LSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N 287 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~------~ 287 (422)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......... .
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~ 232 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence 9999999875432211 11234578999999999876 46899999999999999999999999754322110 0
Q ss_pred hHHhhhhhhh--------------cccccccccCc------ccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014585 288 LVEWARPHLG--------------ERRRFYRLIDP------RLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344 (422)
Q Consensus 288 ~~~~~~~~~~--------------~~~~~~~~~~~------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 344 (422)
........+. ........... .+.. ......+.++.+||.+||+.||.+|||+.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l 312 (317)
T cd07868 233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 312 (317)
T ss_pred HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence 0000000000 00000000000 0000 00001134688999999999999999999998
Q ss_pred HH
Q 014585 345 EA 346 (422)
Q Consensus 345 ~~ 346 (422)
++
T Consensus 313 ~h 314 (317)
T cd07868 313 QD 314 (317)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=357.62 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=202.5
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCccee
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~ 135 (422)
.+......+|++++.||.|+||+||+|.+.. ++..||+|.+...... ....+..|+.++++|+|||||+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVr 76 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCe
Confidence 3344556799999999999999999999876 6778999998754332 2456889999999999999999
Q ss_pred eEeEEEe--cCceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeccCCCCcE
Q 014585 136 LIGYCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE----RPVIYRDFKTSNI 206 (422)
Q Consensus 136 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~----~~iiHrDlkp~Ni 206 (422)
++++|.. ...+||||||+++|+|.++|... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||
T Consensus 77 l~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI 156 (1021)
T PTZ00266 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI 156 (1021)
T ss_pred EEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence 9998865 35689999999999999998642 3569999999999999999999998541 3499999999999
Q ss_pred EEcC-----------------CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC--CCCCchhhhhhHHHHH
Q 014585 207 LLDA-----------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVL 267 (422)
Q Consensus 207 ll~~-----------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 267 (422)
||+. .+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||||
T Consensus 157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred EeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 9964 2458999999998654322 1233579999999999864 4588999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 268 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 268 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
|||++|..||....... .+.. .+... ....+ ...+.++.+||..||..+|.+||++.++|.
T Consensus 234 YELLTGk~PF~~~~~~~--qli~----~lk~~------p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 234 YELCSGKTPFHKANNFS--QLIS----ELKRG------PDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHCCCCCCcCCcHH--HHHH----HHhcC------CCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999999997543211 1111 11000 00000 123468899999999999999999999985
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=313.95 Aligned_cols=255 Identities=28% Similarity=0.372 Sum_probs=194.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
+.||+|+||.||+|..... .++..+|+|.+..... .....+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 4689999999999986432 1456799999876543 2234688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 150 YEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
|||+++|+|.+++... ....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence 9999999999998643 234667788899999999999999988 999999999999999999999999999764
Q ss_pred CCCCccceeeccccCccccCCCcccCC-------CCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
.............|+..|+|||++.+. .++.++|||||||++|||++ |..||........ ..... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~--~~ 225 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV--RE 225 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh--hc
Confidence 333222222335678899999988642 35789999999999999996 9999975432211 11100 00
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
......++.+.. ..+..+.+++..|| .+|++||++.+|+..|.
T Consensus 226 ---~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 226 ---QQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---ccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 001111222111 23456888999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=311.06 Aligned_cols=247 Identities=31% Similarity=0.450 Sum_probs=197.9
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
++||+|+||.||+|... .+..||+|.+....... ...+.+|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 36899999999999753 35689999987654332 34688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999998766667899999999999999999999988 9999999999999999999999999987543321
Q ss_pred ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ...... .. ..
T Consensus 148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~~----~~------~~- 212 (250)
T cd05085 148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQVE----KG------YR- 212 (250)
T ss_pred cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----cC------CC-
Confidence 11 1112234677999999998899999999999999999998 999997543211 111000 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
...+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 213 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 ---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.56 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=202.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.++||+|+||.||+|.+.. +|+.||||++...... ..+++.+|++++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 579999999999999999999866 6789999999754322 2356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
+++..++||||++||+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d 149 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF 149 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence 999999999999999999988531 123566778899999999999999988 9999999999999999
Q ss_pred CCeEEeeccCcccCCCCCc----------------cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCC
Q 014585 212 YNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 275 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 275 (422)
+.+||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 9999999999986521110 011123579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCC
Q 014585 276 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 350 (422)
Q Consensus 276 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~ 350 (422)
||........... .. ..++.... .....+..+.+++.+||+.||++|+ ++.++++.|+..
T Consensus 230 PF~~~~~~ki~~~-----~~---------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 230 PYRRKKGRKISYR-----DV---------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCCCcchhhhhhh-----hh---------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9975332111000 00 00000000 0013346788999999999999997 566676666543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=318.81 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=206.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||+||+|.+.. +|..||+|++..... ...+.+.+|+++++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 4678889999999999999999876 677899999865432 234678999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+..++||||+++++|.+++.+ .+.+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999999998854 4568999999999999999999997 46 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc-----hhHHhhhhhh
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-----NLVEWARPHL 296 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-----~~~~~~~~~~ 296 (422)
+....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||......... ..........
T Consensus 151 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd06620 151 SGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226 (284)
T ss_pred ccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence 87542211 12357899999999998889999999999999999999999999865432110 1111111111
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
... .+.+ .....+.++.+|+.+||..||.+||++.|++++..
T Consensus 227 ~~~-------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 227 QEP-------PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred hcc-------CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000 0011 01124568999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=311.10 Aligned_cols=248 Identities=29% Similarity=0.442 Sum_probs=199.8
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
++||.|+||.||+|.+.. ++.||+|.+...... ....+.+|++++++++|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 469999999999998743 568999998765443 345789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 9999999999999766667899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
.........++..|+|||.+.++.++.++|||||||++|+|++ |..||........... .. ..
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~----~~--------- 211 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IE----SG--------- 211 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---Hh----cC---------
Confidence 1111112234567999999988899999999999999999999 8888865532111111 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.....+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 212 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 -YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 000112234568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.13 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=202.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+.+.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 34455556689999999999998765 677899999877665556778999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-CCCeEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~~~~kl~DF 219 (422)
++..++||||+++++|.+++......+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 999999999999999999997654455 88889999999999999999988 999999999999976 679999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|++........ ......|+..|+|||++.+. .++.++||||||+++|+|++|..||........ ..+......
T Consensus 154 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~ 228 (268)
T cd06624 154 GTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK 228 (268)
T ss_pred hhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc
Confidence 99876533221 12224588999999998754 378899999999999999999999965322110 001000000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....++...+.++.+++.+||..+|.+||++.+++++
T Consensus 229 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111222345788999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=329.30 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=197.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.++++++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 34789999999999999999998866 677999999875432 2235677999999999999999999987
Q ss_pred Eec------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
... ...+++||++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence 543 3568999998 789988774 346999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 292 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~ 292 (422)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ...
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999865432 223568999999999876 57899999999999999999999999754321110000 000
Q ss_pred hh-------hhhc--cccc----ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 RP-------HLGE--RRRF----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~~-------~~~~--~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .... ...+ .......+.. .....+..+.+|+.+||..||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000 0000 0000000000 000123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.67 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.3
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||.|+||.||.+.... ++..+++|.+.... .....++.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 58899999999999999998776 67789999986543 23345688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999999998654 456899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........ .. ..... .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~~---~~~~~--~- 217 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---VV---KIVQG--N- 217 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHcC--C-
Confidence 86543321 22345689999999999888899999999999999999999999975432111 10 00000 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
..+ .....+.++.+++.+||..+|.+||++.++++++
T Consensus 218 ---~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 ---YTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 000 1123457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=320.13 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=200.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|+||.||+|.+.. +|..||+|.+...... ....+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 58889999999999999999876 6789999998654322 234578899999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++|+||++ ++|.+++......+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999999995 5888888666667999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---------
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------- 293 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------- 293 (422)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ......
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 223 (284)
T cd07839 148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEE 223 (284)
T ss_pred ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChH
Confidence 6533221 12234578899999988764 478999999999999999999988653322110 000000
Q ss_pred --hhhhcccccc--cccCccc-CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 --PHLGERRRFY--RLIDPRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 --~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+......... ....... ........+.++.+++.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000000 0000000 001112345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.17 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=210.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
...+.++||+|.||.|++|.|..... +-..||||.++.+... ...+|++|+.+|.+|+|+|++++||+..+ .
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 34455789999999999999976322 2346999999887765 56789999999999999999999999887 6
Q ss_pred ceEEEEEecCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...+|||++++|+|.+.|.+ ....|.......++.||+.||.||..++ +|||||..+|+||.....|||||||+.+
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence 78899999999999999987 4567888999999999999999999988 9999999999999989999999999999
Q ss_pred cCCCCCccceee-ccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 224 DGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 224 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
.+..++...... ...-...|+|||.+....++.++|||+|||+||||++ |..||-+........
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~-------------- 326 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK-------------- 326 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH--------------
Confidence 887665443322 2344678999999999999999999999999999998 678997764422211
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+|..-.-.-+..|+++++++++.||..+|.+||+|..|.+.
T Consensus 327 ---~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 327 ---NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ---hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 122111112345688999999999999999999999999743
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=320.76 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=206.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|++.+.||.|+||.||+|.+.. +|+.||+|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 569999999999999999998765 67899999997665555677899999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999999999999999988543 5899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+...... .. ... ...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~---~~~--~~~ 234 (296)
T cd06655 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA---TNG--TPE 234 (296)
T ss_pred cccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---hcC--Ccc
Confidence 543221 12234688999999999988899999999999999999999999976543211100 00 000 000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+ ..+...+..+.++|.+||..||.+||++.+++.+
T Consensus 235 ~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 L-------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred c-------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 0112345678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=313.92 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=195.4
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEE-ecCceEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-EDDQRLL 148 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l 148 (422)
+.||+|+||.||+|.+..... .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDG------QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCC------ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999998754221 44679999985432 233467889999999999999999999876 4556889
Q ss_pred EEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 149 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
||||+.+++|.+++.+....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999999766556788888999999999999999988 999999999999999999999999999765332
Q ss_pred Ccc--ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 229 DKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 229 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
... .......++..|+|||.+.+..++.++|||||||++|||++| .+||...... ....... ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~----~~~----- 219 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL----QGR----- 219 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----cCC-----
Confidence 111 111123467789999999888999999999999999999995 5556543211 1111110 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... +...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 220 -~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 220 -RLLQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000 112246789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.40 Aligned_cols=256 Identities=29% Similarity=0.423 Sum_probs=206.4
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+..++|++.+.||.|+||.||+|.+.. +..||||.+.... ....++.+|+.++++++|+||+++++++.
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 345789999999999999999998643 3579999987554 34567899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccc
Confidence 8899999999999999999996643 56899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...... .........
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~---- 220 (261)
T cd05034 149 LARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG---- 220 (261)
T ss_pred cceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC----
Confidence 99876432111 1112234668999999998899999999999999999998 99999654321 111111000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
... ..+...+.++.+++.+||..+|.+||++.++++.|+.
T Consensus 221 ------~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 ------YRM----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------CCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000 0111225688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.13 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=206.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|.+.++||+|+||.||+|.+.... +....||||...... ....+.+.+|+.+++++.|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 457889999999999999999876421 133468999987654 2344578999999999999999999998875
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence 5678999999999999999766667899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ ......++..|+|||.+....++.++|||||||++|||++ |..||........ .... .....
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~----~~~~~ 226 (270)
T cd05056 155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI----ENGER 226 (270)
T ss_pred eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HcCCc
Confidence 865433211 1122334568999999988889999999999999999986 9999975532211 1110 00000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. ..+..++..+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 227 ---~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 227 ---L-------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 0112345689999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=318.39 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=201.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||+|+||.||+|.+.. +|..||+|.+..... .....+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368899999999999999998865 677999999875422 2245788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
+..++||||+++++|..++... ...+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence 9999999999999999888553 3468999999999999999999996 46 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCC------CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
++....... .....|+..|+|||++.+. .++.++|||||||++|+|++|..||..............
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--- 221 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA--- 221 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH---
Confidence 987653221 2234678899999988643 358899999999999999999999975432211111100
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.+. ....++...+.++.+|+.+||+.+|.+||++.+++.+
T Consensus 222 ----------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 ----------IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----------Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0000 0011223456788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=324.16 Aligned_cols=264 Identities=19% Similarity=0.229 Sum_probs=197.1
Q ss_pred CCCccccc--cCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 69 PESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 69 ~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++++||+| +|++||++.+.. +|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 56789999 788999998876 788999999976532 22345778999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999999998654 345899999999999999999999988 9999999999999999999999998754
Q ss_pred cCCCCCccc-----eeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 224 DGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 224 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
......... ......++..|+|||++.+ ..++.++|||||||++|||++|..||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence 432211100 0112356778999999875 4689999999999999999999999975332110 000000000
Q ss_pred hc---------------------cccccc---------ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GE---------------------RRRFYR---------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~---------------------~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ...+.. .........+....+..+.+|+.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 000000 000000011222345689999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=312.47 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=201.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+++++++.|+|++++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 3568999999999999999998753 2368999886543 23467889999999999999999999875 5
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccc
Confidence 5688999999999999998654 345889999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....... .
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~-- 219 (260)
T cd05069 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER----G-- 219 (260)
T ss_pred eEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C--
Confidence 765432211 1122346778999999988899999999999999999999 889987543211 1111100 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
... ..+...+..+.+++.+||..||.+||++.++++.|+.
T Consensus 220 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 ----YRM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 1122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=315.85 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=194.5
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 150 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 150 (422)
+.||.|+||.||+|.+...+.. .......||+|.+........+.+.+|+.+++.+.|+||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 3699999999999987653221 01134468889886554444567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--------eEEeeccCc
Q 014585 151 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLA 222 (422)
Q Consensus 151 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~--------~kl~DFG~a 222 (422)
||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999776667899999999999999999999988 999999999999987765 699999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCC-CCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
...... ....++..|+|||++.+ ..++.++|||||||++|+|++|. .||....+... .. ......
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~----~~~~~~ 222 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ----FYEDRH 222 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH----HHHccc
Confidence 754321 22467889999999886 45799999999999999999995 55543322110 00 000100
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.++.....++.+|+.+||+.||++||++.++++.|+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011122357899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=321.49 Aligned_cols=261 Identities=28% Similarity=0.338 Sum_probs=205.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ..+.+.+|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 368899999999999999998866 6789999999765433 3456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..+..++||||+.+++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence 999999999999999999998653 356899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcc---------------------------ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhC
Q 014585 221 LAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273 (422)
Q Consensus 221 ~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 273 (422)
++......... .......|+..|+|||++.+..++.++|||||||++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98754322110 011124689999999999988899999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 014585 274 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 353 (422)
Q Consensus 274 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 353 (422)
..||........ ... .... ...-......+..+.+++.+||+.||++||+....++.+..++++
T Consensus 229 ~~pf~~~~~~~~--~~~----~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 229 TTPFKGSNRDET--FSN----ILKK----------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred CCCCCCCchHHH--HHH----HhcC----------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 999975432111 000 0000 000000111467899999999999999999944433333334444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=313.11 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=206.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..|+..+.||.|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++++.|+||+++++++.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 467788999999999999998876 677899999875432 3345688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccce
Confidence 999999999999999998853 36889999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......++..|+|||++.+..++.++|+|||||++|||++|..||....+.......
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------------- 213 (277)
T cd06640 150 QLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------------- 213 (277)
T ss_pred eccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh--------------
Confidence 6543221 122346788999999999888999999999999999999999999754432111000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
............+..+.+++.+||..+|.+||++.+++.+
T Consensus 214 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 214 ---PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0001112334567889999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=314.34 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=195.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhccc-CCCcceeeEeEEEecCceEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLL 148 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 148 (422)
++||+|+||.||+|.+..++ ....+++|.+.... ....+.+.+|+.++.++ .||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 36899999999999986521 12357888887433 23345788999999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 149 VYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~ 150 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 150 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence 999999999999986432 24789999999999999999999988 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||....... .....
T Consensus 151 ~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~ 224 (270)
T cd05047 151 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL 224 (270)
T ss_pred EEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH
Confidence 9999999986422111 1111234567999999988899999999999999999997 999996543211 11100
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... ........+.++.+++.+||..||.+||++.+++..|+.+
T Consensus 225 ----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 ----PQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----hCCC----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0000 0001112346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=314.88 Aligned_cols=255 Identities=30% Similarity=0.473 Sum_probs=200.2
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
+.||+|+||.||+|.+..... ....+..||||.+..... .....+.+|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 368999999999998765221 011346799998865432 3345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-----CeEEee
Q 014585 150 YEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-----NAKLSD 218 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-----~~kl~D 218 (422)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999998642 234788999999999999999999988 99999999999999877 899999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...... .......
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~---- 227 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVT---- 227 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHh----
Confidence 999976543332222223456788999999999999999999999999999998 99998644321 1111110
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
... ........+..+.+++.+||..+|.+||++.++++.|+
T Consensus 228 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 00112234578899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.34 Aligned_cols=268 Identities=27% Similarity=0.357 Sum_probs=204.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ...+.+.+|++++++++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 368899999999999999998876 677999999865432 234678999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||++++.|..++ .....+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecc
Confidence 99999999999876665554 44556899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc---
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 298 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 298 (422)
........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||..................+..
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 87654332 122335688999999999887 8899999999999999999999999754322111100000000000
Q ss_pred -----ccccc--cccCcc----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 -----RRRFY--RLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 -----~~~~~--~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+. +..+.. +...++...+.++.+|+++||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 000000 0001222336789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=311.25 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=202.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
+|++.+.||.|+||.||++.+.. +++.||+|.+..... ...+.+.+|+.++++++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48899999999999999999866 667899999865433 234568899999999999999999998764
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence 44678999999999999988653 446899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... .........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~--- 217 (257)
T cd08223 149 ARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEG--- 217 (257)
T ss_pred eEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc---
Confidence 976533221 223356899999999999999999999999999999999999998743211 110000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ...+...+..+.+++.+||+.||.+||++.+++++
T Consensus 218 ---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 ---KL-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CC-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 01122445789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=316.46 Aligned_cols=264 Identities=26% Similarity=0.341 Sum_probs=204.8
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||.|+||.||+|.+.. +|..||+|++..... .....+.+|+.++++++|+||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 58889999999999999999866 677899999976542 2245788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 9999999999 99999998766677999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh-----
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----- 297 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----- 297 (422)
....... .......|+..|+|||++.+. .++.++|||||||++|+|++|.++|....... ........+.
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~ 223 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEE 223 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChH
Confidence 7644322 112235689999999988754 56899999999999999999988886543211 1111110000
Q ss_pred ------cccccccccCccc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ------ERRRFYRLIDPRL----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......+..+.. ........+.++.+++.+||..||.+||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 000111235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=316.51 Aligned_cols=267 Identities=28% Similarity=0.332 Sum_probs=203.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+.+|+.++++++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 468899999999999999998865 677999999864432 223567899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
....++||||++++.|..++. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999999888877663 4446899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh-hhhhhc--
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGE-- 298 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~-- 298 (422)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+... ......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 87644321 1223457889999999876 56789999999999999999999999765432211111100 000000
Q ss_pred ----cccc-ccccCcccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 ----RRRF-YRLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ----~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+ .....+...... ....+..+.+|+.+||+.+|++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 000000000000 01235778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=310.71 Aligned_cols=252 Identities=28% Similarity=0.486 Sum_probs=202.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++|+||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 46888899999999999999874 245799998875433 3457889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
...... .......++..|+|||.+.++.++.++||||||+++|||++ |..||...... ...... ... .
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~---~ 218 (256)
T cd05112 150 VLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETI----NAG---F 218 (256)
T ss_pred cccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH----hCC---C
Confidence 533211 11122335678999999998899999999999999999998 89998753321 111110 000 0
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
....+. ..+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 RLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111111 12468999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=312.07 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=204.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+|+..+.||+|+||.||+|.+.. +|..||+|.+...... ..+.+.+|++++++++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999998765 6789999998754321 23568899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl~D 218 (422)
+.+.+..++||||+++++|.+++.+ ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcc
Confidence 9999999999999999999999854 447899999999999999999999998 99999999999998776 599999
Q ss_pred ccCcccCCCCCcc--ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 219 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 219 FG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
||++......... .......|+..|+|||.+.+..++.++|||||||++|+|++|..||..............
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----- 222 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK----- 222 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH-----
Confidence 9998775432111 112235688999999999888899999999999999999999999965432211111100
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.........++...+.++.+++.+||..+|.+||++.+++++
T Consensus 223 --------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 223 --------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000001112333456789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=312.51 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=200.4
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+|++.+.||.|+||.||+|... +|..+|+|.+...... ....+.+|+.++++++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 5888999999999999999753 5678999998644221 12457889999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+.+.+..++||||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccc
Confidence 99999999999999999999998544 46899999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCC----ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 220 GLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 220 G~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
|++....... .........|+..|+|||.+.+..++.++|||||||++|+|++|..||.............
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----- 221 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG----- 221 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-----
Confidence 9987642211 1111223568999999999998899999999999999999999999997543211100000
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
.. ....+. .+...+.++.+++.+||..+|.+||++.+++.
T Consensus 222 --~~----~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 222 --AH----RGLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --hc----cCCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000111 12234578899999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=298.59 Aligned_cols=254 Identities=30% Similarity=0.428 Sum_probs=204.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
.++.+.+..||.|+.|.|+++.+.. +|..+|||.+.... .+..++++..+.++... ++|+||+.+|+|.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 3456667789999999999999987 78899999997654 34456788888877666 5899999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+..++|.||.| ...++.++.+-.+++++..+-++...++.||.||..++ +|||||+||+|||+|+.|++||||||+
T Consensus 162 ~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 162 TNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence 999999999999 66788888777788999999999999999999998754 399999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+-.+.+.. ..+...|-+.|||||-+. ...|+.++||||||++++||.||+.||.+....-. .......
T Consensus 239 sGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkvln---- 309 (391)
T KOG0983|consen 239 SGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKVLN---- 309 (391)
T ss_pred cceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHHHh----
Confidence 98764432 234457899999999886 45789999999999999999999999986432111 1111111
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
-..|.+..+. ..+..+.+|+..||..|+.+||.+.+++++
T Consensus 310 ------~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 ------EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 0112222221 256788999999999999999999999975
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=313.07 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=201.6
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc----------cHHHHHHHHHHhcccCCCccee
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~ 135 (422)
+|.+.+.||.|+||.||+|.... +|+.||+|.+...... ..+.+.+|+.++++++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 57888999999999999998765 6779999988532111 1235778999999999999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
+++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEE
Confidence 999999999999999999999999998654 57899999999999999999999988 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
|+|||++................|+..|+|||.+.... ++.++|+||||+++|+|++|..||...... .....
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~ 223 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFK 223 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHH
Confidence 99999997654322211223356889999999987654 889999999999999999999999643211 00000
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .. .....+........+..+.+++.+||..+|.+||++.+++++
T Consensus 224 -~~-~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 224 -LG-NK-----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -hh-cc-----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 00 000111111222345789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=311.71 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=198.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
.+|++.+.||+|+||.||+|.+.. +|..||+|.+..... .....+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 368999999999999999998765 678999999864422 123457889999999999999999998
Q ss_pred EEe--cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 140 CIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 140 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+.. ....+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 875 35678999999999999998543 46899999999999999999999988 9999999999999999999999
Q ss_pred eccCcccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||++......... .......|+..|+|||++.+..++.++|||||||++|||++|..||........ +. ...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~~---~~~ 222 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---IF---KIA 222 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---HH---HHh
Confidence 99998764321111 111224588999999999988899999999999999999999999975422110 00 000
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......++...+..+.+++ .||..+|++||++++++++
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 223 ----------TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----------cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00001122233456778888 6777899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=316.54 Aligned_cols=261 Identities=27% Similarity=0.357 Sum_probs=203.4
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCccee
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVK 135 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 135 (422)
++.+....++|++.+.||+|+||.||+|.+.. ++..+|+|++.... .....+.+|+.+++.+ +|+||++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~ 79 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK 79 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence 34444567899999999999999999998876 67789999886532 2235688899999999 7999999
Q ss_pred eEeEEE-----ecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 136 LIGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 136 ~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
+++++. .++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil 156 (286)
T cd06638 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL 156 (286)
T ss_pred eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence 999874 34568999999999999988742 3456889999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
++.++.+||+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|..||....+
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 99999999999999876543221 1223468999999998753 4578899999999999999999999975432
Q ss_pred CCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
.... .. .... ......+ +...+..+.+|+.+||+.||++||++.|+++++
T Consensus 235 ~~~~--~~-----~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 235 MRAL--FK-----IPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hHHH--hh-----cccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1110 00 0000 0000111 112345789999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=309.16 Aligned_cols=255 Identities=33% Similarity=0.515 Sum_probs=204.2
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCc
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (422)
+++.+.||.|+||.||+|.+...+. ..+..||+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 4677899999999999999876321 13478999999765543 45678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.++||||+++++|.+++...... +++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999999999655434 899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
.......... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ....... ...
T Consensus 153 ~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~--- 221 (258)
T smart00219 153 LYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK----KGY--- 221 (258)
T ss_pred cccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCC---
Confidence 6543222111 2336789999999988889999999999999999998 78888653211 1111110 000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
.. ......+.++.+++.+||..||.+||++.++++.|
T Consensus 222 ~~-------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RL-------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC-------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 01112457899999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=315.77 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=202.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.++++++|+||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 46667789999999999998865 677899999875432 23456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999999999998843 46899999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... ......|+..|+|||++.+..++.++|||||||++|||++|..||....+..... . ...
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~------ 215 (277)
T cd06642 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPK------ 215 (277)
T ss_pred ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhc------
Confidence 543221 1223468889999999999899999999999999999999999987543221100 0 000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+ ......+..+.+++.+||..+|++||++.+++++
T Consensus 216 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 216 NSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011 1122345778999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=308.66 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=194.1
Q ss_pred CccccccCcEEEEEEeccCCCCCC-CCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
+.||+|+||.||+|.+...+.... .......|++|.+...... ...+.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999876431110 0112245888887655433 5778999999999999999999999988 778999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-------CeEEeeccCc
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-------NAKLSDFGLA 222 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-------~~kl~DFG~a 222 (422)
|||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999766557899999999999999999999988 99999999999999887 7999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCC--CCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||........ ..+.. ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~~----~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFYQ----DQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHHh----cC
Confidence 86533 1223567789999998876 78999999999999999999 5777765432111 11000 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
. .... .....+.+++.+||..+|.+||++.++++.|+
T Consensus 223 ~---~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H---RLPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C---CCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0000 01167889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=329.90 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=217.8
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceee
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 136 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 136 (422)
.+.|+....+.....+||-|.||.||.|.|+. -...||||.++.+. ...++|+.|..+|+.++|||+|++
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk---------yslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqL 328 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 328 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeec---------cceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHH
Confidence 35667777788888999999999999999987 34579999998765 446789999999999999999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
+|+|..+..+|||+|||..|+|.++|.+.+ ..++.-..++++.||..||.||...+ +|||||..+|+|+.++..||
T Consensus 329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEE
Confidence 999999999999999999999999997653 45777888999999999999999988 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 294 (422)
++|||+++.+.....+. .....-.+.|.|||-+.-..++.|+|||+|||+|||+.| |..||.+.+....
T Consensus 406 vADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV--------- 475 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------- 475 (1157)
T ss_pred eeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH---------
Confidence 99999999876544322 222223678999999999999999999999999999988 7778876432111
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
+.++...+.-.-+..|+..+.+|++.||+++|.+||++.|+-+.++.+
T Consensus 476 --------Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 476 --------YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred --------HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 122222222223446788999999999999999999999998877643
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=313.21 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=205.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||.|+||.||+|....... ......|++|.+...... ...++.+|++++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 678999999999999999999865322 224567999998655433 346789999999999999999999999998
Q ss_pred CceEEEEEecCCCChhhhhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 99999999999999999986433 15899999999999999999999988 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ......
T Consensus 158 l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~- 232 (275)
T cd05046 158 VSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ- 232 (275)
T ss_pred EcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH-
Confidence 999999875432211 11223456778999999988889999999999999999998 788886433211 111100
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
. ... ........+..+.+++.+||+.+|.+||++.+++..|.
T Consensus 233 ---~-~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 ---A-GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---c-CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 000 00011133468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=317.93 Aligned_cols=251 Identities=28% Similarity=0.391 Sum_probs=204.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+|++++++++|+||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 468899999999999999999876 677899999865432 23456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999999998554 57999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... .... .....
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~~~-- 214 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEK---ILEGK-- 214 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HhcCC--
Confidence 9876443 223568999999999988889999999999999999999999997544210 0000 00000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHhCCCCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLPNLKD 355 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~L~~~~~~~~ 355 (422)
. .++...+..+.+++.+||..||.+|+ ++.++++ ++++..
T Consensus 215 ------~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~----~~~~~~ 259 (290)
T cd05580 215 ------V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN----HPWFAG 259 (290)
T ss_pred ------c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc----Cccccc
Confidence 0 01112357889999999999999999 5555554 455444
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.47 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=207.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||.|+||+||+|.... ++..+|+|++..... .....+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 478999999999999999998765 667899999875432 2456789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+..++|||++++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence 9999999999999999998654 246899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc--eeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+.......... ......|+..|+|||++... .++.++|+|||||++|+|++|..||........ ....... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~ 223 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---D 223 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---C
Confidence 87765433221 22335689999999998876 789999999999999999999999976543211 1110000 0
Q ss_pred ccccccccCcccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.+.... ....+..+.+++.+||..||++||++.+++++
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 --------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111100 12345788999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=310.51 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=199.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
.+|++.+.||+|+||.||+|.+.. +|..||||.+..... ...+.+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 468899999999999999998866 778999999864321 123467889999999999999999998
Q ss_pred EEec--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 140 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 140 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+.+. ...++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence 8763 4678999999999999988544 45889999999999999999999988 9999999999999999999999
Q ss_pred eccCcccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|..||....... .... ..
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~-~~ 222 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AIFK-IA 222 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HHHH-Hh
Confidence 99998865321111 11123468899999999988889999999999999999999999997532111 0000 00
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........+...+..+.+++.+|| .+|.+||++++++++
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 ----------TQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred ----------cCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 000111223345678889999999 499999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=319.01 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=189.5
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe--cCceE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRL 147 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 147 (422)
..+||+|+||.||+|..... .++..||+|.+..... ...+.+|+.++++++|+||+++++++.. +...+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 35799999999999987542 1457899999875432 3467899999999999999999998864 55778
Q ss_pred EEEEecCCCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE----cCCCCeE
Q 014585 148 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAK 215 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill----~~~~~~k 215 (422)
+||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEE
Confidence 9999995 5777776421 235889999999999999999999988 9999999999999 5668999
Q ss_pred EeeccCcccCCCCCcc-ceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc------h
Q 014585 216 LSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N 287 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~------~ 287 (422)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||......... .
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~ 232 (317)
T cd07867 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232 (317)
T ss_pred EeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHH
Confidence 9999999875433221 11233568999999999876 45899999999999999999999999754321110 0
Q ss_pred hHHhhhhhhh-----------ccccccccc---------Cccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014585 288 LVEWARPHLG-----------ERRRFYRLI---------DPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344 (422)
Q Consensus 288 ~~~~~~~~~~-----------~~~~~~~~~---------~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 344 (422)
........+. ....+.... ...+ ...........+.+|+.+||+.||.+|||+.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 233 QLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred HHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 0000000000 000000000 0000 0000111235688999999999999999999998
Q ss_pred HH
Q 014585 345 EA 346 (422)
Q Consensus 345 ~~ 346 (422)
++
T Consensus 313 ~h 314 (317)
T cd07867 313 QD 314 (317)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=315.39 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=199.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||+|+||.||+|.+.. +++.||||.+...... ....+.+|+.++++++|+||+++++++..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 679999999999999999998865 6778999998754322 234577899999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||++ ++|.+++......+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 99999999996 5999988766667899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc--cc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--RR 300 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 300 (422)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||....... .........+.. ..
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 152 AKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEE 227 (291)
T ss_pred ccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChh
Confidence 5432111 1122346889999998875 568999999999999999999999997543111 000000000000 00
Q ss_pred cc---------c----ccc-CcccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RF---------Y----RLI-DPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~---------~----~~~-~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+ . ... ...+.... ......++.+++.+||+.+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0 000 00000000 00112678899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=310.87 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=203.6
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+...+|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.++++++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 345789999999999999999997542 3469999887543 23457889999999999999999999988
Q ss_pred ecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
. ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCc
Confidence 7 7889999999999999999653 445788999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++......... ......++..|+|||++....++.++|+|||||++|++++ |..||....... ...... ..
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~ 219 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE----RG 219 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----CC
Confidence 99765432221 1222345678999999998889999999999999999998 899997543211 111111 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
. .. ......+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~------~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 Y------RM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C------CC----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 00 0111334678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=314.87 Aligned_cols=258 Identities=29% Similarity=0.398 Sum_probs=202.8
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceee
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKL 136 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 136 (422)
.+.......|++.+.||.|+||.||+|.+.. +++.||+|.+.... .....+..|+.+++++ +|+||+++
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~ 78 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATY 78 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEE
Confidence 3444456789999999999999999999876 67789999986543 2335688899999998 79999999
Q ss_pred EeEEEe------cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 137 IGYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 137 ~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
++++.. ....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++
T Consensus 79 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~ 155 (282)
T cd06636 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLT 155 (282)
T ss_pred eeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 999863 45779999999999999988653 345889999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 284 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 284 (422)
.++.++|+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|..||....+..
T Consensus 156 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 156 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred CCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999999999876432111 122356899999999876 3468889999999999999999999997543221
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... ....+.. .....+..+.+||.+||..||.+||++.+|+++
T Consensus 234 ~~~~~~-------------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 234 ALFLIP-------------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhhhHh-------------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111000 0000000 111345789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=318.11 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=202.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||++.+.. +++.||+|.+..... .....+.+|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368899999999999999999876 677999999875532 22346789999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.++..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999999999999998544 56899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCc-------------cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 222 AKDGPEGDK-------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 222 a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
++....... ........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+..... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~ 224 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L 224 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 864211100 001112457889999999988899999999999999999999999997543211 1
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
... .... ....+... ...+.++.+++.+||+.||++||++.++++.|+.
T Consensus 225 ~~~---~~~~-----~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 FGQ---VISD-----DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHH---HHhc-----ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 0000 00001100 1235678999999999999999997666655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=309.57 Aligned_cols=255 Identities=29% Similarity=0.393 Sum_probs=191.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
+.||+|+||.||+|..... .....+|+|.+...... ....+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3699999999999975431 13457899987654322 234688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 150 YEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
|||+++|+|.+++.... ...++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999999999986543 23467888999999999999999988 999999999999999999999999998764
Q ss_pred CCCCccceeeccccCccccCCCcccC-------CCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
.............++..|+|||++.. ..++.++|||||||++|||++ |..||....... ...... .
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~---~ 224 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVV---R 224 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHh---h
Confidence 33222211223446778999998742 456889999999999999999 778886543211 111000 0
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
. ....+..+.+ ....+..+.+++..|| .||++||++.+|++.|.
T Consensus 225 ~--~~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 E--QDIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c--cCccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 0011112221 2234467788999998 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=312.09 Aligned_cols=255 Identities=31% Similarity=0.414 Sum_probs=205.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||.|+||.||+|.+.. +++.||+|.+..... ....++.+|+.+++++.|+||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 367888999999999999999876 677899999876543 3345688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++......+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999999999997655789999999999999999999999 88 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ ....|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ............
T Consensus 149 ~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~---- 219 (265)
T cd06605 149 GQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE---- 219 (265)
T ss_pred hhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC----
Confidence 76532211 115688999999999988999999999999999999999999975432111 111111111000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+.+. ....+.++.++|.+||..||.+||++.+++.+
T Consensus 220 ---~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 ---PPPRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---CCCCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000111 11156789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=308.69 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=202.4
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
+|+..+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 57888999999999999998865 577899999865432 2345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..+...++||||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999998544 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........ .... . ..
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~--~---~~ 217 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKI--G---RS 217 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHH--H---hc
Confidence 987754332 123356899999999987766 89999999999999999999999975432110 0000 0 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ..++...+..+.+++.+||..+|.+||++.+++.+
T Consensus 218 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 218 KEL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ccC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 000 01122345788999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.27 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=200.7
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
|.+.+.||+|+||.||+|.+.... +++..||||++..... ...+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 667889999999999999876532 2678999999875432 23456889999999999999999999886532
Q ss_pred ------ceEEEEEecCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 145 ------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 145 ------~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
..++++||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~ 151 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT 151 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence 236889999999998876422 234788999999999999999999988 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+++...............++..|++||.+.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05074 152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL 228 (273)
T ss_pred EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence 99999999987543322222223445678999999998899999999999999999999 88888654321 111111
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ..... . .....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 229 ~----~~~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 I----KGNRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H----cCCcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00000 0 1112346899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=308.41 Aligned_cols=246 Identities=31% Similarity=0.479 Sum_probs=198.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||+|+||.||++.. ++..||+|.+.... ....+.+|+.++++++|+||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5689999999999999999864 56689999986543 345788999999999999999999998754
Q ss_pred ceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence 5799999999999999986543 35899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
...... .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||........ ... .....
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~-- 214 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KEC----VEKGY-- 214 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH----HhCCC--
Confidence 643221 11234567999999988899999999999999999997 9999975432211 110 00000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
. .......+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 215 -~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -R-------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -C-------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 00112345788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.19 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=200.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|++.+.||+|+||.||+|.+.. +|..||+|.+....... ...+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 4689999999999999999998866 67789999986543332 3467899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+. ++|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccc
Confidence 999999999995 6887777665566888999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh----
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---- 297 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---- 297 (422)
+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ........+.
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~ 226 (291)
T cd07870 151 RAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTE 226 (291)
T ss_pred cccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCCh
Confidence 76432221 1223457889999998875 4588999999999999999999999975443111 1100000000
Q ss_pred -------ccccc-ccccCcccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 -------ERRRF-YRLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 -------~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... ............ ....+..+.+++.+||..||.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 000000000000 00124678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.83 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=202.1
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
+|++.+.||+|+||.||+|.+.. +|+.||||.+...... ....+..|+.++++++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 47888999999999999999866 6779999999765433 234567899999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||+ +++|.+++......+++..++.++.||++||.|||+.+ ++|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999999 89999998655447999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhhhh---
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPH--- 295 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~--- 295 (422)
++......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.++|............ ......
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 148 LARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred eeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence 99876443211 222356788999998864 56789999999999999999998888654332111000 000000
Q ss_pred -hhcccccccccCccc-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 -LGERRRFYRLIDPRL-----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 -~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
............... ........+.++.+++.+||..||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 000112335788999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=315.60 Aligned_cols=267 Identities=28% Similarity=0.349 Sum_probs=201.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.++||+|+||.||+|.+.. +|+.||+|.+...... ..+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368899999999999999999865 6778999998654322 24568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+++++|.++... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeee
Confidence 9999999999999888876643 345899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc--
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-- 299 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 299 (422)
........ ......++..|+|||++.+ ..++.++|||||||++|||++|.+||...........+......+...
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 76543221 1223567899999998875 457889999999999999999999997543211100000000000000
Q ss_pred ------cccccccCcccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 ------RRFYRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........+.... ......+..+.+|+.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0011345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=317.23 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=201.0
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCce
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
|.....||+|+||.||++.+.. ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 4445679999999999998765 6778999998765544556788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999999999998743 35889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......|+..|+|||.+.+..++.++||||||+++|||++|..||........ ..... ...
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~----------~~~ 234 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIR----------DNL 234 (292)
T ss_pred cccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----------hcC
Confidence 2221 12235689999999999888999999999999999999999999975432111 11000 011
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.+.. ....+..+.+++.+||..||.+||++.+++++
T Consensus 235 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 PPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111 11234678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.82 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=202.9
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
+|++.+.||.|+||.||+|.+.. +|..||+|.+...... ..+.+..|+.++++++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 58889999999999999998876 6778999998754332 24568899999999999999999998764
Q ss_pred -cCceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeccCCCCcEEEcCCCC
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH-----EEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH-----~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
....+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+ ++|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence 45678999999999999998643 457899999999999999999999 666 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+||+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .......
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 223 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK 223 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh
Confidence 99999999987654332 122356899999999999888999999999999999999999999764311 1111110
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .....++...+..+.+++.+||+.+|.+||++.+|+++
T Consensus 224 ----~----------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 ----E----------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----c----------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00111222445789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=325.20 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=211.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
....|.+.+.||+|.|+.|.+|.+.. +|..||||.+.+..... ...+.+|+++|+.|+|||||+++.+.
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 44679999999999999999999987 88899999998776544 34588999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.....+|+||||+.+|.+.+++.+++ ...+..+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 99999999999999999999996665 5666899999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++..+..+ .....++|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-.....-+ +..+
T Consensus 201 fS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------l~gk 271 (596)
T KOG0586|consen 201 FSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------LRGK 271 (596)
T ss_pred cceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------eeee
Confidence 99987533 34556899999999999998877 67899999999999999999999976433221110 0000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+ .+...+.++.++|+++|..+|.+|++++++.++
T Consensus 272 ~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ec------------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 00 112234678899999999999999999999865
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.64 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=202.8
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 58889999999999999998876 677899999875532 2345788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CCeEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~~kl~DFG~ 221 (422)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.+ +.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999999999664 345899999999999999999999988 9999999999999865 4579999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ...... .. .
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~---~~--~ 217 (256)
T cd08220 149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM---SG--T 217 (256)
T ss_pred ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHH---hc--C
Confidence 987643321 223568899999999998889999999999999999999999997543221 111100 00 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..+....+.++.+++.+||..||.+||++.+++.+
T Consensus 218 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 F---------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C---------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 00111245678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=313.36 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=203.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||.|+||.||+|.+.. +++.||+|.++..... ....+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 478899999999999999998865 6778999999754322 22356789999999999999999999988
Q ss_pred c--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 143 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 143 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
. +..++||||++ ++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 7 89999999996 5999988665557999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh-----
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR----- 293 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~----- 293 (422)
++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+ ....
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9987644321 12234578899999988754 4689999999999999999999999765432111100 0000
Q ss_pred --h---hhh--cccccccccCcccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 --P---HLG--ERRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 --~---~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .+. ....+.......+...++.. .+..+.++|.+||+.||++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000 00000000111111222222 36778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.89 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=203.9
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|+||.||++.... +|+.||+|.+..... ....++.+|+.++++++|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 58889999999999999998876 677899999875432 2345788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999999988654 346899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...... .... .....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~---~~~~~---- 216 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVL---KIIRG---- 216 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHH---HHhcC----
Confidence 76543221 122345888999999999889999999999999999999999998643211 1110 00000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ...+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 217 --~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 --SY-----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CC-----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 01122345688999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=305.76 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=191.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
+.||+|+||.||+|...... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+......++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv 73 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence 35999999999999764321 233567787765432 3346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 150 YEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
|||+++|+|.+++.+. ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccC
Confidence 9999999999998653 234677788899999999999999988 9999999999999999999999999986432
Q ss_pred CCCccceeeccccCccccCCCcccC-------CCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
............|+..|+|||++.. ..++.++|||||||++|||++ |..||...... ...... ..
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~- 223 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---IK- 223 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hh-
Confidence 2221122234568899999998753 245789999999999999997 46677543221 111111 10
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.......++.+... .+..+.+++..|| .+|++||++.++++.|.
T Consensus 224 -~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 -DQQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -hcccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11112223332222 3467788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=311.69 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=205.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|.+.+.||+|+||.||+|.... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 689999999999999999998765 66789999987554445567889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++|+||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 999999999999999988543 5789999999999999999999988 99999999999999999999999998876
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||............. .
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-------~------ 229 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------T------ 229 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------c------
Confidence 543322 1223468899999999988889999999999999999999999997644321110000 0
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
............+..+.+++.+||..+|.+||++.+++.+
T Consensus 230 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 --NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000112335678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=316.30 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=200.8
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCce
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
|.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.+.||||+++++++..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3345579999999999998865 6779999998765545556788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 999999999999987743 45899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......|+..|+|||++.+..++.++|||||||++|||++|..||....+... ..... .. .
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~----~~------~ 233 (297)
T cd06659 169 KDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLR----DS------P 233 (297)
T ss_pred cccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHh----cc------C
Confidence 3221 12235689999999999988999999999999999999999999975432111 11000 00 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.. ......+..+.+++.+||+.+|.+||++.+++++
T Consensus 234 ~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0011234678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=311.37 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=195.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHH-hcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||.||+|.+.. +|..||+|++..... .....+..|+.+ ++.++|+||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 368899999999999999999876 788999999876532 223455666665 566799999999999999
Q ss_pred cCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 143 DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++..++||||++ |+|.+++.. ....+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence 999999999995 688777643 345689999999999999999999986 6 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccC----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
||++....... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||....... .... .
T Consensus 148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~---~ 219 (283)
T cd06617 148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLK---Q 219 (283)
T ss_pred ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHH---H
Confidence 99988653221 1223468889999998864 456889999999999999999999996432110 0000 0
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ..+.+ .....+.++.+++.+||..+|.+||++.+++++
T Consensus 220 ~~~~-------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVEE-------PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhc-------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000 011245789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=310.16 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=204.4
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
+|++.+.||.|+||.||+|.+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 48889999999999999998865 678999999975432 234678899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+.+++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccc
Confidence 99999999999999999998554 57899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||............. ....
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~---- 216 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET---- 216 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc----
Confidence 8764432 1233568889999999988889999999999999999999999998654321111111 0000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM--SEVVE 345 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~ell~ 345 (422)
....++...+..+.++|.+||..||.+||++ .++++
T Consensus 217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0111222345789999999999999999999 65553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=306.15 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=208.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||.|++|.||+|.+.. +|+.|+||++..... .....+.+|+.++.+++|+||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 368889999999999999998876 678999999876654 3356789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+++++|.+++... ..+++..++.++.|+++||.|||+ .+ ++||||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999654 579999999999999999999999 88 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.................
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------- 217 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-------- 217 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc--------
Confidence 876433222 1234678999999999988999999999999999999999999976543111111111110
Q ss_pred ccccCcccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ...+.. .+..+.+++.+||..+|++||++.+++++
T Consensus 218 --~~~----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 218 --GPP----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCC----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 111122 45789999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.40 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=196.5
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC----CcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+...+||+|+|-+||+|.+.. +|..||--.++.. .....++|..|+.+|+.|+|+|||++|++|.+.
T Consensus 43 k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 455689999999999999876 7888875444322 223357899999999999999999999999986
Q ss_pred Cc--eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CCeEEeecc
Q 014585 144 DQ--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG 220 (422)
Q Consensus 144 ~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~~kl~DFG 220 (422)
.. ..+|+|.+..|+|..++.+. +.+....++.|++||++||.|||++. ++|||||||.+||||+.+ |.|||+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchh
Confidence 65 67899999999999999554 47889999999999999999999987 789999999999999765 999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc--
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-- 298 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 298 (422)
+|+...... .....|||.|||||+.. ..|+..+||||||++++||+|+..||..-. +..+........
T Consensus 192 LAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 192 LATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIK 261 (632)
T ss_pred HHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCC
Confidence 999865433 22368999999999776 899999999999999999999999996322 111111111111
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+.+. ...++++||.+||.. ..+||++.|||+.
T Consensus 262 P~sl~kV------------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 262 PAALSKV------------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhhcc------------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1111111 236889999999999 9999999999973
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.99 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=219.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
......|.++||.|.||.|++|+.+..++ ....||||.++....+. +.+|+.|+.||.+++||||+++.|+..
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 34556788999999999999999987654 33579999998776554 457999999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
....++||.|||++|+|+.+|.++.+.|.+.+..-+++.|+.||+||-+++ +|||||..+|||++.+..+|++|||+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999999999888999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeecc--ccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTHVSTRV--MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
++...++.... .+.. .-..+|.|||.+.-.+++.++|||||||+|||.++ |..||.+....+..+.++ .
T Consensus 778 SRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---~---- 849 (996)
T KOG0196|consen 778 SRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---Q---- 849 (996)
T ss_pred eeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH---h----
Confidence 99875544221 2222 22579999999999999999999999999999876 888987654332222211 1
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.+.-..+.+|+..|.+|+..||+.|..+||.+.+|+..|.++.
T Consensus 850 ----------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 850 ----------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ----------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 1111234578899999999999999999999999999997653
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.49 Aligned_cols=253 Identities=30% Similarity=0.407 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +++.|++|++..... ....+.+|+.+++++ .|+||+++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 4789999999999999999999865 567899999876543 346788999999999 79999999999976
Q ss_pred cC------ceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 143 DD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 143 ~~------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
.. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAE 151 (275)
T ss_pred cCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCe
Confidence 54 489999999999999988542 357899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
+||+|||++........ ......|+..|+|||++.. ..++.++|||||||++|+|++|..||........ .
T Consensus 152 ~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 227 (275)
T cd06608 152 VKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--L 227 (275)
T ss_pred EEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--H
Confidence 99999999876533221 1233568999999998753 3467899999999999999999999974322111 1
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ....+.+ ......+.++.+|+.+||..||.+||++.+++++
T Consensus 228 ~~~~-----------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 228 FKIP-----------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHhh-----------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1000 0000011 1112345789999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.69 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=202.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCc
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (422)
.|...+.||+|++|.||+|.+.. ++..|++|.+........+.+.+|+.+++.+.|+||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 45556789999999999998765 677899999876554555678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
.++|+||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+...
T Consensus 91 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 9999999999999998865 46899999999999999999999988 999999999999999999999999988754
Q ss_pred CCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
..... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+... ...... .
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~~----------~ 230 (285)
T cd06648 166 SKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIRD----------N 230 (285)
T ss_pred ccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHh----------c
Confidence 33221 12235689999999999888899999999999999999999999975432111 110000 0
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+... .....+..+.+++.+||..+|++||++.+++++
T Consensus 231 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 231 LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000110 011244689999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=305.82 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=201.1
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----------ccHHHHHHHHHHhcc-cCCCcce
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGD-LVHLNLV 134 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv 134 (422)
.|++.+.||+|+||.||+|.+... ++..+|+|.+..... ....++..|+.++.+ ++|+||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 478889999999999999998652 456899998864321 123457788888865 7999999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcC
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDA 210 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~ 210 (422)
++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~ 149 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE 149 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence 999999999999999999999999988742 34568999999999999999999996 56 999999999999999
Q ss_pred CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 014585 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 290 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 290 (422)
++.+||+|||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ..
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~ 223 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT 223 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH
Confidence 9999999999998754432 22345689999999999988899999999999999999999999965432111 10
Q ss_pred hhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
... .. ...+.. ....+..+.+++.+||+.||++||++.|+..+++
T Consensus 224 ~~~----~~-----~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 KIV----EA-----VYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHh----hc-----cCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 00 000000 1123468899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=312.17 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=200.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.+|++.+.||+|+||.||+|.+.. +|+.||+|.+...... ..+++.+|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 568999999999999999998865 6779999998654322 2346889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||++ |+|.+++......+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCc
Confidence 9999999999996 6787777655667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+...... ....|+..|+|||++. ...++.++||||||+++|||++|..||........... ...
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-------~~~ 228 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------IAQ 228 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-------Hhc
Confidence 8765322 2246788999999874 45688999999999999999999999965432111000 000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
. . .+. ......+..+.+++.+||..||.+||++.+++.+.
T Consensus 229 ~-~-----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 229 N-D-----SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred C-C-----CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 0 000 01123457899999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.51 Aligned_cols=267 Identities=29% Similarity=0.403 Sum_probs=218.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
..+.|+.-++||+||||.||-++... ||+.||.|.+.+..... ....++|-.+|.+++.+.||.+--.
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred cccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 34678889999999999999998776 89999999986544322 2347899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
|...+.+|+||..|+||+|.-+|.+.+ ..|++..+..++.+|+.||++||+.. ||+|||||+|||+|+.|+++|+|
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeec
Confidence 999999999999999999999987654 56999999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+|+|..+..+... ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-++ ...+.
T Consensus 331 LGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~- 404 (591)
T KOG0986|consen 331 LGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLE- 404 (591)
T ss_pred cceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhc-
Confidence 9999988665432 23489999999999999999999999999999999999999997543322211111 00000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHhCCCCCCCCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDMAS 358 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~~~~~~~ 358 (422)
....++...++++++|.+.+|..||.+|.... +=.+.++.++.++.+.+
T Consensus 405 -----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 405 -----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred -----------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 12234556778999999999999999998766 44555666777766554
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=320.19 Aligned_cols=265 Identities=24% Similarity=0.300 Sum_probs=200.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|..||||.+.... ......+.+|+.++++++|+||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 45789999999999999999999876 67899999986432 22345678899999999999999999988
Q ss_pred Eec------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
... ...++||||+. ++|.+.+... +++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 643 35699999995 5888877432 889999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-H---
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E--- 290 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~--- 290 (422)
||+|||+++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999987543221 22346789999999999999999999999999999999999999754321110000 0
Q ss_pred --------hh----hhhhhcc-----cccccccCcc----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 291 --------WA----RPHLGER-----RRFYRLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 291 --------~~----~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ....... ..+....... .........+..+.++|.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000 0000111000 0000112345678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.29 Aligned_cols=260 Identities=28% Similarity=0.365 Sum_probs=203.2
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCccee
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVK 135 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 135 (422)
+.++....++|.+.+.||+|+||.||+|.... +++.+|+|.+.... .....+.+|+.+++++ +|+||++
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~ 83 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVK 83 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEE
Confidence 34444456889999999999999999998866 67799999986542 2235678899999999 8999999
Q ss_pred eEeEEEec-----CceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 136 LIGYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 136 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
+++++... +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 84 ~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nil 160 (291)
T cd06639 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNIL 160 (291)
T ss_pred EEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEE
Confidence 99998754 357999999999999998753 3456899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-----CCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
++.++.+||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....+
T Consensus 161 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 161 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 99999999999999886543221 11234688999999987643 368899999999999999999999975432
Q ss_pred CCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ...... .....+.+ .......+.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~--~~~~~~------~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 VKT--LFKIPR------NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHH--HHHHhc------CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 111000 00000111 11234578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=307.22 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=201.2
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccC---CCcceeeEeEEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV---HLNLVKLIGYCI 141 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 141 (422)
.|++.+.||.|+||.||+|.+.. +|..||+|.+..... ....++.+|+.+++++. |+|++++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47788999999999999999865 677999999875432 33456888999999986 999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCc
Confidence 999999999999999999988543 6899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............ .
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~--- 215 (277)
T cd06917 148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------P--- 215 (277)
T ss_pred eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------c---
Confidence 987654332 1233568999999998865 45789999999999999999999999764332111000 0
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+.+... ..+.++.+++.+||..||.+||++.+++++
T Consensus 216 ---~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 ---KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0001111110 134688999999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=304.62 Aligned_cols=254 Identities=30% Similarity=0.433 Sum_probs=204.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 58889999999999999998765 6778999999766543 456789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence 9999999999999999998553 45889999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccce--eeccccCccccCCCcccCCC---CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 224 DGPEGDKTHV--STRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 224 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
.......... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||....... ...+.... ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~~~-~~ 223 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHVGA-GH 223 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHHhc-CC
Confidence 7644332211 11246788999999988766 8899999999999999999999997543111 11110000 00
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.+.. ....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 224 --------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 --------KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --------CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000100 11235678899999999999999999998863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.42 Aligned_cols=259 Identities=29% Similarity=0.369 Sum_probs=203.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|+..+.||.|++|.||+|.+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 367888999999999999999876 677999999875433 2345689999999999999999999988653
Q ss_pred --CceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 144 --DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 144 --~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence 468999999999999887642 3456899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC--CcchhHHhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN--GEHNLVEWARPHL 296 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~ 296 (422)
||++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+....
T Consensus 149 fg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 223 (287)
T cd06621 149 FGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM- 223 (287)
T ss_pred ccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-
Confidence 99987643222 12345788999999999999999999999999999999999999865321 111111111100
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
. ...+.+ ... .....+..+.+++.+||..+|.+||++.|++++-
T Consensus 224 -~---~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 224 -P---NPELKD-EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred -C---chhhcc-CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0 000000 000 0012457889999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.04 Aligned_cols=255 Identities=28% Similarity=0.391 Sum_probs=207.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.+-+|+-...||.|.||.||-|.+.+ +|...|+|-++-... ...+.+.+|..+|..++|||+|+++|+-
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE 1303 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee
Confidence 34578888999999999999998877 788899999864332 2345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..+|.||||++|+|.+++ +.+.-.++.....+..|++.|++|||++| ||||||||+|||++.+|.+|++|||
T Consensus 1304 vHRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred ecHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccc
Confidence 9999999999999999999998 55656778888889999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccc--eeeccccCccccCCCcccCC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 221 LAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 221 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
.|.......... .....+||+.|||||++.+. .-..+.|||||||++.||+||+.||...+..- .+-+. ..
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~-V~ 1455 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYH-VA 1455 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhH-Hh
Confidence 998765542111 11246899999999999753 45679999999999999999999997543211 11110 01
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+. ...++...+.+-.+||.+||..||..|+++.||+++
T Consensus 1456 ~gh------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGH------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccC------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111 112344567889999999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=313.87 Aligned_cols=268 Identities=26% Similarity=0.337 Sum_probs=201.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..+|++.+.||+|+||.||+|.+.. +|..||+|.+....... ...+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 3679999999999999999999876 77899999987543221 234678999999999999999999987
Q ss_pred ec--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 142 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 142 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
.. +..++||||+. ++|.+++......+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 65 46899999995 5888888665667999999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh----
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP---- 294 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---- 294 (422)
|++......... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 999876433211 122345788999998875 5689999999999999999999999976543222111110000
Q ss_pred ----hhhcccc--cccccCcccCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 ----HLGERRR--FYRLIDPRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ----~~~~~~~--~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....... ........... ......+.++.++|.+||+.||.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00000000000 0001135678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.12 Aligned_cols=278 Identities=18% Similarity=0.236 Sum_probs=189.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCC------CCCCcE----EEEEEecCCCcccHHHHHHHHHHhcccCCCc
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK------PGTGLT----VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~------~~~g~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 132 (422)
...+|++++.||+|+||+||+|........... ...+.. ++.|.+... ......+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCCC
Confidence 457899999999999999999876542110000 000011 111211111 122345789999999999999
Q ss_pred ceeeEeEEEecCceEEEEEecCCCChhhhhccCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 133 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
||++++++...+..|+|+|++ +++|.+++.... .......+..|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 557777764321 22345677889999999999999988 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCC-CCCCCCCCcch
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHN 287 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p-f~~~~~~~~~~ 287 (422)
+.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876433221 22336799999999999999999999999999999999998754 43322211111
Q ss_pred hHHhhhhh------hhc-ccccccccCcc-c---CCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 288 LVEWARPH------LGE-RRRFYRLIDPR-L---EGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 288 ~~~~~~~~------~~~-~~~~~~~~~~~-~---~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+....... +.. ...+...++.. + ...+ ....+.++.+++.+||+.||.+||++.|++.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000 000 00000000000 0 0000 00123567888999999999999999999874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=313.43 Aligned_cols=269 Identities=25% Similarity=0.323 Sum_probs=199.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||.||+|.+.. +|..||||.+...... ....+.+|+.++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 579999999999999999998866 6789999998654322 23356789999999999999999999876
Q ss_pred cCc--------eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 143 DDQ--------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 143 ~~~--------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
.+. .++||||+. ++|.+++......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL 158 (310)
T ss_pred ccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence 543 499999995 5888888666667999999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCcc--ceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 215 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
||+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999765432211 112234678899999988754 478899999999999999999999976543322222211
Q ss_pred hhhhhhcc-----cc---cccccCc-ccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 ARPHLGER-----RR---FYRLIDP-RLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 ~~~~~~~~-----~~---~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........ .. +.....+ ...... .......+.+||.+||..||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11100000 00 0000000 000000 00123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=306.50 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=202.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+-|++.+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.++++++|+||+++++++..+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 74 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 74 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence 347788899999999999998765 677899999865432 2335688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccce
Confidence 999999999999999998853 35899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ ... ....
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~----~~~~---- 216 (277)
T cd06641 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFL----IPKN---- 216 (277)
T ss_pred ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHH----HhcC----
Confidence 6543221 12234688899999999888899999999999999999999999975432111 000 0000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+....+.++.+++.+||..+|.+||++.+++++
T Consensus 217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 ------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011122345778999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=310.78 Aligned_cols=274 Identities=23% Similarity=0.298 Sum_probs=212.7
Q ss_pred ccchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-C-C
Q 014585 54 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H-L 131 (422)
Q Consensus 54 ~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~ 131 (422)
.+.+........+|.+++++|+|.||.|-.+++.. ++..||||+++.-. ...+..+-|+++|.++. + |
T Consensus 78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP 147 (415)
T KOG0671|consen 78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDP 147 (415)
T ss_pred eEEEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCC
Confidence 35555556668999999999999999999999877 57799999986432 23455778999999993 2 2
Q ss_pred c----ceeeEeEEEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 132 N----LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 132 n----iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
+ +|++.+||...++.|||+|.+ |-++.++|.++ -.+++...+..+++||+++++|||+.+ ++|.||||+||
T Consensus 148 ~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENI 223 (415)
T KOG0671|consen 148 NGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENI 223 (415)
T ss_pred CCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheE
Confidence 2 788889999999999999999 77999999764 467999999999999999999999999 99999999999
Q ss_pred EEc--------------------CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHH
Q 014585 207 LLD--------------------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 266 (422)
Q Consensus 207 ll~--------------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 266 (422)
|+. ++..|+|+|||.|+...... ...+.|..|+|||++.+-+|+..+||||+|||
T Consensus 224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCI 298 (415)
T KOG0671|consen 224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCI 298 (415)
T ss_pred EEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeE
Confidence 982 13458999999998754433 33567999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc------------------------ccCcccC----CCCCHHH
Q 014585 267 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR------------------------LIDPRLE----GHFSIKG 318 (422)
Q Consensus 267 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~----~~~~~~~ 318 (422)
|+||.+|...|+..+..+...+.+.+...++....... ..++... -......
T Consensus 299 L~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e 378 (415)
T KOG0671|consen 299 LVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLE 378 (415)
T ss_pred EEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHH
Confidence 99999999999987654444444433332222100000 0000000 0011234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 319 AQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 319 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+.+|+++||..||.+|+|+.|++.+
T Consensus 379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 379 HVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HhHHHHHHHHHHccCccccccHHHHhcC
Confidence 5679999999999999999999999874
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=346.84 Aligned_cols=269 Identities=25% Similarity=0.280 Sum_probs=215.9
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcc
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNL 133 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~ni 133 (422)
+.++.....+|.++++||+|+||.|.+++++. +++.||+|++++..... ..-|..|-.+|..-+.+=|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi 137 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI 137 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence 45566778899999999999999999999987 88899999998643322 2347788888888888889
Q ss_pred eeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 134 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 134 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
++++-.|.++.++|+||||++||+|..++.+.. .+++..+..++..|+-||..||+.| +|||||||+|||||..|+
T Consensus 138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 999999999999999999999999999997766 8999999999999999999999999 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCccc----C-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----T-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
+||+|||.+-.+...+ .......+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||....-
T Consensus 214 ikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------ 286 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------ 286 (1317)
T ss_pred EeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------
Confidence 9999999988765433 23345578999999999986 3 6789999999999999999999999975432
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHhCCCCCCCCCCC
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEALKPLPNLKDMAS 358 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~L~~~~~~~~~~~ 358 (422)
++.....+.- +....+.+ ..+.+.++.+||.+.+ .+|+.|.. +.++ +.+++|.+..|
T Consensus 287 veTY~KIm~h-k~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedi----k~HpFF~g~~W 346 (1317)
T KOG0612|consen 287 VETYGKIMNH-KESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDI----KNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHhch-hhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHH----HhCccccCCCh
Confidence 2211111111 00111110 1246789999999988 68888887 6555 45667766655
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=307.23 Aligned_cols=260 Identities=24% Similarity=0.318 Sum_probs=197.4
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccC-CCcceeeEeEEEec-
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYCIED- 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~- 143 (422)
|++.+.||+|+||.||+|.+.. ++..||+|.+...... ......+|+.++.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 6778899999999999998866 6778999998754322 2234568999999885 99999999999987
Q ss_pred -CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||++ ++|.+.+......+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccc
Confidence 88999999996 5888888665567999999999999999999999988 999999999999999 99999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc---
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 298 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 298 (422)
......... ....++..|+|||++. +..++.++|||||||++|||++|..||........ ..........
T Consensus 147 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~ 220 (282)
T cd07831 147 RGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDA 220 (282)
T ss_pred cccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 865432221 2245789999999765 45678899999999999999999999976543211 1111000000
Q ss_pred ----ccccccccCcccCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 ----RRRFYRLIDPRLEG-------HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ----~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........+..... ......+..+.++|.+||..+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0112346889999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=309.79 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=199.2
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||.|+||.||+|.+.. +|..||||.+..... .....+.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 47889999999999999998865 677999999865432 2235688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence 99999999995 6888887543 456899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhh-----
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPH----- 295 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~----- 295 (422)
........ ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||......... .........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 76533221 122345788999999887644 688999999999999999999999754321110 000000000
Q ss_pred -----hhc-ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 -----LGE-RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 -----~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ...+.......+. ......+.++.++|.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0000000000000 0011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=309.54 Aligned_cols=266 Identities=18% Similarity=0.219 Sum_probs=191.7
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHhcccCC
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGDLVH 130 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h 130 (422)
+..++|++.++||+|+||+||+|.+..... .+..+|+|+......... .....++..+..+.|
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h 82 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH 82 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC
Confidence 345789999999999999999998765311 145677776543322111 112344556677899
Q ss_pred CcceeeEeEEEecC----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 131 LNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 131 ~niv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
+||+++++++.... ..+++||++ ..++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 83 LGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred CCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 99999999766543 346788887 4577666633 334678889999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 014585 207 LLDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281 (422)
Q Consensus 207 ll~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 281 (422)
|++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999865432211 11122469999999999999999999999999999999999999998653
Q ss_pred CCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
..... +......+.. .+...... ...++..+.+++..|+..+|++||++.++++.|+
T Consensus 238 ~~~~~--~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 238 HNGNL--IHAAKCDFIK-----RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred cchHH--HHHhHHHHHH-----Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 22211 1000000000 00000000 1123578999999999999999999999998763
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=300.62 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=207.7
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCc
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (422)
+|.+.+.||+|++|.||++.+.. ++..|++|++..........+.+|+.++++++|+||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47888999999999999999865 577899999987665456789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
.++++||+++++|.+++......+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 99999999999999998766567999999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........... ... ......
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~-----~~~~~~ 217 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IAT-----NGPPGL 217 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHh-----cCCCCc
Confidence 54332 2335688999999999888899999999999999999999999975432111100 000 000011
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ....+..+.+++.+||..||.+||++.+++++
T Consensus 218 ~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Cc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11125689999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.71 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=207.2
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|++|.||+|.+.. ++..|++|++..... ...+.+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 47788999999999999998875 677999999876543 3356788999999999999999999999988
Q ss_pred --CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 144 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 144 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+..++||||+++++|.+++.+.. .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccccc
Confidence 88999999999999999986554 8999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+................++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-------- 216 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKI-------- 216 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhc--------
Confidence 98765543211123356889999999998888999999999999999999999999765410 0000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.........+...+..+.+++.+||..||.+||++.+++.+
T Consensus 217 ----~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 217 ----GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ----cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00001111222336789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.15 Aligned_cols=266 Identities=23% Similarity=0.346 Sum_probs=201.7
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+|++.+.||.|++|.||+|.+.. +|..||||.+...... ....+.+|+.++++++|+||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 58889999999999999999876 6789999999765432 2456778999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 99999999974 8888876543 46899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhh------
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP------ 294 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~------ 294 (422)
........ ......++..|++||++.+ ..++.++|||||||++|+|++|..||.......... .......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 76433211 1123457889999998865 457899999999999999999999997654321111 0000000
Q ss_pred -hhhcccccccccCc---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 -HLGERRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 -~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.....+...... .....+....+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000000 00001112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=307.04 Aligned_cols=254 Identities=29% Similarity=0.404 Sum_probs=198.6
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
||+|+||+||+|.+.. +|+.||+|.+...... ....+.+|+.++++++|+||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6999999999998766 6779999998654322 234567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 150 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
|||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999999986543 36899999999999999999999988 999999999999999999999999998765432
Q ss_pred CccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 229 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
. ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.. .....
T Consensus 149 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~---------- 213 (277)
T cd05577 149 K---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RTLEM---------- 213 (277)
T ss_pred C---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--ccccc----------
Confidence 1 12234578899999999888899999999999999999999999976543211111110 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhCCCCCCCC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE-VVEALKPLPNLKD 355 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~~~ 355 (422)
...++...+..+.+++.+||+.||.+||++.+ ....|..++++..
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 214 --AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred --cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 00112233578899999999999999995555 4444444555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.33 Aligned_cols=243 Identities=26% Similarity=0.346 Sum_probs=189.1
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHH---hcccCCCcceeeEeEEEecCc
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF---LGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~ 145 (422)
+||+|+||.||++.+.. +|..||+|.+....... ...+.+|..+ +....|+||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999998865 67899999986543221 1223444433 334579999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 99999999999999888544 46999999999999999999999988 999999999999999999999999998754
Q ss_pred CCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
.... .....|+..|+|||.+. +..++.++|||||||++|+|++|..||.............. ..
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~-------- 212 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL-------- 212 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh--------
Confidence 3321 12346899999999886 45689999999999999999999999975433221111100 00
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
.. ...++...+.++.+++.+||..||.+|| ++.+++++
T Consensus 213 ~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 TV----NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cC----CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00 1112233457899999999999999999 58777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.89 Aligned_cols=264 Identities=28% Similarity=0.406 Sum_probs=201.8
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec--
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 143 (422)
|...+.||+||||.||+|+++. +|+.||||.++.... ...+...+|+++|++|+|+|||+++++-...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4456789999999999999987 899999999986543 3356688999999999999999999975543
Q ss_pred ----CceEEEEEecCCCChhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE--cCCCC--
Q 014585 144 ----DQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYN-- 213 (422)
Q Consensus 144 ----~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill--~~~~~-- 213 (422)
....+|||||.||+|...+.+ +...+++...+.++.++..||.|||+++ |+||||||.||++ ..+|.
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence 356799999999999999974 4567999999999999999999999998 9999999999998 33344
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
.||+|||.|+...++. ...+++||..|++||++. .+.|+.-+|.|||||++|++.||..||..........-+.|.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 5999999999886655 456789999999999998 488999999999999999999999999754332211111111
Q ss_pred hhhh-------------hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHh
Q 014585 293 RPHL-------------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP--LMSEVVEAL 347 (422)
Q Consensus 293 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--s~~ell~~L 347 (422)
.-.- .....+-..+ ....+.+......+-.++..+|..+|.+|. .+.+....+
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~l--P~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTL--PQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccC--CCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 1000 0000110111 112233344456677888999999999999 555554444
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.85 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=201.3
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.|...+.||+|+||.||+|.+.. +|..||+|.+...... ....+.+|+.++++++|+|++++++++..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 37778899999999999998866 6778999998754322 23468899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 999999999996 5888887666667999999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
...... ....|+..|+|||++. .+.++.++|||||||++|+|++|..||.......... .... .
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~----~- 239 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ----N- 239 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHh----c-
Confidence 754321 2346888999999874 4568899999999999999999999986542111100 0000 0
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
..........+..+.+++.+||+.+|.+||++.++++++..+.
T Consensus 240 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 ---------ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---------cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000011134567899999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.79 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=206.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+.|++.+.||+|+||.||+|.+.. ++..|++|++..... ....+.+|+.+++.++|+||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 34678889999999999999999865 567899999976543 45678899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++|+||+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchh
Confidence 99999999999999999999765557999999999999999999999988 999999999999999999999999988
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ ......++..|+|||++.+..++.++|+|||||++|+|++|..||....+.... ..... ...
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~~------~~~ 233 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLITT------KGI 233 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh------cCC
Confidence 76433221 112345788999999998888999999999999999999999999754322110 00000 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .. .....+..+.+++.+||+.+|.+||++.+++++
T Consensus 234 ~~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 PP-----LK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CC-----Cc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 00 011245789999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.42 Aligned_cols=243 Identities=26% Similarity=0.349 Sum_probs=196.7
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
||.|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus 1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 6999999999999865 677999999975432 2335688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 9999999999998554 46899999999999999999999988 9999999999999999999999999998764432
Q ss_pred ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcc
Q 014585 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309 (422)
Q Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (422)
......|+..|++||.+.+..++.++|+||||+++|+|++|..||....... ........ ...
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~----------~~~ 210 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL----------KGN 210 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh----------ccC
Confidence 1223568899999999988889999999999999999999999997654211 11111000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014585 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 345 (422)
Q Consensus 310 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~ 345 (422)
....++...+.++.+++.+||+.||.+||+ +.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011122223578999999999999999998 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.94 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=199.8
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
+|++.+.||+|+||.||+|.+... +++..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 488889999999999999998652 146789999998643 2334567899999999999999999999998
Q ss_pred c--CceEEEEEecCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC----CC
Q 014585 143 D--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DY 212 (422)
Q Consensus 143 ~--~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~----~~ 212 (422)
. ...++||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence 8 78999999996 4777766422 236899999999999999999999988 999999999999999 89
Q ss_pred CeEEeeccCcccCCCCCc-cceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc----
Q 014585 213 NAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH---- 286 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~---- 286 (422)
.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 229 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence 999999999987543322 111223567899999998876 46899999999999999999999999865443210
Q ss_pred --hhHHhhhhhhh-----------cccccccccCcccCCCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHHH
Q 014585 287 --NLVEWARPHLG-----------ERRRFYRLIDPRLEGHFS---------I--KGAQKAAQLAAHCLSRDPKARPLMSE 342 (422)
Q Consensus 287 --~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~dp~~Rps~~e 342 (422)
.........+. ....+....+......++ . ..+.++.+++.+||+.||.+||++.+
T Consensus 230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 00000000000 000000000000000000 0 23457899999999999999999999
Q ss_pred HHHH
Q 014585 343 VVEA 346 (422)
Q Consensus 343 ll~~ 346 (422)
++++
T Consensus 310 il~~ 313 (316)
T cd07842 310 ALEH 313 (316)
T ss_pred HhcC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.40 Aligned_cols=253 Identities=28% Similarity=0.361 Sum_probs=196.4
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccC-CCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 143 (422)
+|...+.||+|+||.||++.+.. +|..||+|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 56667889999999999999876 678999999875432 23456889999999996 99999999999999
Q ss_pred CceEEEEEecCCCChhhhhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 144 DQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+..+++|||+. ++|.++.. .....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEee
Confidence 99999999985 46655432 2245799999999999999999999974 6 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
||++........ .....|+..|+|||++.+. .++.++|||||||++|+|++|..||..... ........
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~ 223 (288)
T cd06616 152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV 223 (288)
T ss_pred cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh
Confidence 999976533221 1224588999999998765 689999999999999999999999975431 11111100
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ...+.+........+.++.+|+.+||+.||.+||++.+++++
T Consensus 224 ~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 VK-------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cC-------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 001111111222356789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.09 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=206.9
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|.+.+.||.|+||.||++.+.. ++..||+|++..... .....+.+|+++++.++|+|++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 58888999999999999999865 677899999976544 3456788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence 9999999999999999998654 367999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
.+....... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ..... . . .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~-~-~ 218 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI---L-K-G 218 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHH---h-c-C
Confidence 998764432 12333578999999999988889999999999999999999999997543211 11100 0 0 0
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. . ..++...+..+.+++.+||..+|++||++.+++++
T Consensus 219 ~----~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 219 Q----Y-----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C----C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 01111345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.83 Aligned_cols=266 Identities=24% Similarity=0.302 Sum_probs=202.1
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEec-
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 143 (422)
|++.+.||.|+||.||+|.+.. +|+.||+|.+.... ......+.+|+.+++.+.|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 6778899999999999998876 67799999998653 23345688999999999999999999999988
Q ss_pred -CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++||||++ ++|.+++......+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccce
Confidence 88999999996 5899888666567999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-h-hhcc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-H-LGER 299 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~-~~~~ 299 (422)
......... ......++..|+|||.+.+ ..++.++||||||+++|||++|..||...........+..... . ....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 876443211 1223456888999998764 4678999999999999999999999976543211111100000 0 0000
Q ss_pred ccccc-----------ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYR-----------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+.. .....+...+...++..+.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 000000001111126788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.45 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=200.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-----cccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
.+|++.+.||+|+||.||+|.+.. +|..||+|.+.... ......+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 478999999999999999998865 67899999875321 1223468899999999999999999999
Q ss_pred EEec--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 140 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 140 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+.+. ...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 8764 4578999999999999998544 45889999999999999999999988 9999999999999999999999
Q ss_pred eccCcccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||+++........ .......|+..|+|||++.+..++.++|+|||||++|+|++|..||....... .... ..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~ 222 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFK----IA 222 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHH----HH
Confidence 99999865321111 11123568999999999998889999999999999999999999997542211 0000 00
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......++...+..+.+++.+||. +|..||++.+++.+
T Consensus 223 ----------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 ----------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0001112233455789999999998 57999999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=306.04 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
|++.+.||.|++|.||+|.+.. +|..||+|++...... ....+.+|+.+++.++|+||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 6788999999999999999866 6779999998754322 2356889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..++||||++ ++|.+++.... ..+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999994 68999885543 46899999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhh------
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH------ 295 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~------ 295 (422)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.......... ........
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 6432211 11223568899999987654 57899999999999999999999997643321100 00000000
Q ss_pred ----hhc-ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 ----LGE-RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ----~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.+ ...+....... ........+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000000000 001112234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=315.03 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=197.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||.+..... .....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999998866 778999999864322 234568899999999999999999998765
Q ss_pred cC-----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 143 DD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 143 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
.. ..++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 43 5789999995 588877733 46899999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccc-eeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 218 DFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 218 DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
|||++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .......
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~ 225 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGV 225 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence 999987654322111 1123568999999998754 5789999999999999999999999975432110 0000000
Q ss_pred hhc--ccccc-----------cccCcccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGE--RRRFY-----------RLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~--~~~~~-----------~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.. ...+. ......... ......+.++.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000 000000000 0001235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.68 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=197.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccC-CCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +|+.||||.+..... .....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368899999999999999999876 678999999865432 22356888999999995 699999999998
Q ss_pred ecCc-----eEEEEEecCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-C
Q 014585 142 EDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-D 211 (422)
Q Consensus 142 ~~~~-----~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~ 211 (422)
..+. .++||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. +
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~ 147 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK 147 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence 7666 8999999975 888887543 245899999999999999999999988 999999999999998 8
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hH
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LV 289 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~ 289 (422)
+.+||+|||++......... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..
T Consensus 148 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 148 GLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred CeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999998765332111 122356889999998865 467999999999999999999999997643221100 00
Q ss_pred Hhhhhhhhccccccccc-----------CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 290 EWARPHLGERRRFYRLI-----------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ......+.... .+..........+.++.++|.+||..||.+||++.+++.+
T Consensus 226 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 226 KLLG--TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHhC--CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000000000 0000000112345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.30 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=204.1
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
|++.+.||.|++|.||+|.+.. +|+.+++|.+...... ....+.+|+.++++++|+||+++++++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 6778899999999999998865 6778999998755433 3456889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 99999999964 888888776678999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc--ccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--RRR 301 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 301 (422)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........... ....+.. ...
T Consensus 148 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 222 (283)
T cd05118 148 FGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEV 222 (283)
T ss_pred cCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHh
Confidence 65433 112234578899999998876 789999999999999999999999976543211100 0000000 000
Q ss_pred cccccC-------------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLID-------------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+..+.+ ...........+.++.++|.+||..||.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 000011122456889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=302.17 Aligned_cols=250 Identities=21% Similarity=0.356 Sum_probs=201.9
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|.+.+.||.|+||.||+|.+.. +|..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 57888999999999999999876 677899999865432 2335678999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC-eEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-~kl~DFG~ 221 (422)
+..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++. +||+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999999986543 35899999999999999999999988 999999999999988864 69999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...... ......... .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~--~ 218 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQG--Y 218 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhcc--c
Confidence 987543221 122346899999999998888999999999999999999999999654221 111111000 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .......+..+.+++.+||..+|++||++.+++++
T Consensus 219 ----~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 ----F-----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----C-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 01112334679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=298.59 Aligned_cols=274 Identities=23% Similarity=0.298 Sum_probs=201.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..|++.+.||+|.||.||+|.-.+.... -.+.+|||.++..... ......+|+..++.++|+||+.+..++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k-----r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK-----RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcc-----cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 4688999999999999999965542210 1337999999755321 12457799999999999999999999988
Q ss_pred -cCceEEEEEecCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC----CC
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YN 213 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~----~~ 213 (422)
+..+++++||+++ +|...|+-+ ...++...+..|++||+.|+.|||++- |+||||||.||||..+ |.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 7889999999976 888888532 346899999999999999999999988 9999999999999877 99
Q ss_pred eEEeeccCcccCCCCCccc-eeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc-----
Q 014585 214 AKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----- 286 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~----- 286 (422)
|||+|||+++.+...-... .....+-|.+|+|||.+.+ ..|+.+.||||+|||+.||++-.+.|.+.......
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999876543332 2234567999999999986 57899999999999999999999988765432111
Q ss_pred -hhHHhhhhhhh--cccccccc---cC---------cccCCCCCH--------HHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014585 287 -NLVEWARPHLG--ERRRFYRL---ID---------PRLEGHFSI--------KGAQKAAQLAAHCLSRDPKARPLMSEV 343 (422)
Q Consensus 287 -~~~~~~~~~~~--~~~~~~~~---~~---------~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~el 343 (422)
+....+...++ ....+..+ .+ .......+. .-++...+|+.++|..||.+|.|+.+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11111111111 00011000 00 000000000 012347899999999999999999999
Q ss_pred HHHh
Q 014585 344 VEAL 347 (422)
Q Consensus 344 l~~L 347 (422)
+++.
T Consensus 335 leh~ 338 (438)
T KOG0666|consen 335 LEHP 338 (438)
T ss_pred hccc
Confidence 9864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.09 Aligned_cols=266 Identities=25% Similarity=0.327 Sum_probs=200.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|.+.+.||+|+||+||+|.+.. +|..||||.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 3579999999999999999998865 78899999986532 223456778999999999999999999876
Q ss_pred ec-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 142 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 142 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
.. ...++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 54 34799999994 789888854 457999999999999999999999988 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP- 294 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~- 294 (422)
+|||++....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998754322 11233467889999998764 5689999999999999999999999975432111000000000
Q ss_pred -------hhh--cccc----cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 -------HLG--ERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 -------~~~--~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... .... .....+.... ......+.++.+++.+||+.+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 0000 0000000000 0112345788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.72 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=197.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||.|+||.||+|.+.. +|+.||+|.+..... .....+.+|+.++++++|+||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 478999999999999999998865 677899999865432 223568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-CCCeEEeecc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFG 220 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~~~~kl~DFG 220 (422)
.+..++||||++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999995 5888777543 334688889999999999999999988 999999999999985 5679999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhhhhh--
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHL-- 296 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~-- 296 (422)
++........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||............ .......
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9976433211 1123457889999998875 46789999999999999999999999764332111000 0000000
Q ss_pred --------hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 --------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
......................+.++.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000000112235678999999999999999999999973
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.81 Aligned_cols=245 Identities=21% Similarity=0.224 Sum_probs=191.8
Q ss_pred hcCCCCCCcc--ccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 64 TRNFRPESLL--GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~l--g~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
.++|.+.+.+ |.|+||.||++.... +|..+|+|.+........ |+.....+ +|+||+++++++
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence 4567777766 999999999998876 677899999865432211 22222222 799999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEEeec
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 219 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl~DF 219 (422)
...+..++||||+++++|.+++... ..+++..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 9999999999999999999998554 38999999999999999999999988 99999999999999998 9999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|++...... ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... .....+.... ..
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~- 225 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK- 225 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc-
Confidence 998765322 12458899999999999899999999999999999999999997443221 1111111100 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~ 346 (422)
........+..+.++|.+||+.+|.+||+ +++++++
T Consensus 226 -----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 -----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111235678999999999999999995 6888853
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=314.42 Aligned_cols=269 Identities=22% Similarity=0.324 Sum_probs=201.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||.|+||.||+|.... +|..||+|++..... .....+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 3689999999999999999998876 678999999875432 23456788999999999999999999876
Q ss_pred e----cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 142 E----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 142 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
. ....++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence 3 346799999995 689888854 446999999999999999999999988 9999999999999999999999
Q ss_pred eccCcccCCCCCcc--ceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 218 DFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 218 DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 99999765332211 11123578999999998865 5689999999999999999999999976543211110000000
Q ss_pred h----hh---cccccccc---cCcccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 H----LG---ERRRFYRL---IDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~----~~---~~~~~~~~---~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .. ........ ...... .......+.++.++|++||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00 00000000 000000 00112346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=305.84 Aligned_cols=270 Identities=26% Similarity=0.319 Sum_probs=201.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
...++|++.+.||+|+||.||+|.+.. +|+.||+|.+..... .....+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 456789999999999999999999876 677999999975432 223467789999999999999999999
Q ss_pred EEecC----------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 140 CIEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 140 ~~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
+.+.. ..++||||+++ +|.+.+......+++..++.++.||+.||+|||+.+ |+||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~ 150 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLN 150 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 87654 78999999965 777777665567999999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999876443321 1122346788999998865 4578999999999999999999999975432211111
Q ss_pred HHhhh-h-------hhhcccccc-----cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWAR-P-------HLGERRRFY-----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~-~-------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.... . .+.....+. ..........+ ...+..+.+++..||..||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000 0 000000000 00000000000 1235788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=292.11 Aligned_cols=253 Identities=24% Similarity=0.285 Sum_probs=200.4
Q ss_pred HhcCCCCC-CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
.+++|.+. ++||-|-.|.|..+.++. ||+.+|+|++... ....+|++..-.. .|+|||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 34566665 489999999999998877 8889999998643 3456788876665 699999999998
Q ss_pred Ee----cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CC
Q 014585 141 IE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DY 212 (422)
Q Consensus 141 ~~----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~ 212 (422)
.. ..-+.+|||.++||.|...++.+ ...+++..+..|+.||+.|+.|||+.+ |.||||||+|+|... |.
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence 64 33456899999999999999765 456999999999999999999999999 999999999999954 56
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
.+||+|||+|+...... ...+.+-|+.|.|||++....|+..+|+||+||++|-|++|.+||.........
T Consensus 202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais------ 272 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------ 272 (400)
T ss_pred ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC------
Confidence 79999999998754322 223467799999999999999999999999999999999999999765432110
Q ss_pred hhhhhcc--cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 293 RPHLGER--RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 293 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
+.+..+ ...+++.++.+ ...++.++++|+++|..+|.+|.++.+++++-
T Consensus 273 -pgMk~rI~~gqy~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 273 -PGMKRRIRTGQYEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred -hhHHhHhhccCccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 001000 11122333322 25678999999999999999999999998753
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=311.29 Aligned_cols=268 Identities=28% Similarity=0.351 Sum_probs=199.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC--CcccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
..++|++.+.||+|+||.||+|.+.. +|..||+|.+... .......+.+|+.+++++ +|+||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 35689999999999999999998865 6778999988543 223345677899999999 99999999999
Q ss_pred EEec--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 140 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 140 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+... ...++||||++ ++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 8654 35799999996 5998888543 6889999999999999999999988 9999999999999999999999
Q ss_pred eccCcccCCCCCcc---ceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 218 DFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 218 DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999875443321 12233568999999998764 567899999999999999999999997543221100000000
Q ss_pred hh--------h--hccccccccc----CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PH--------L--GERRRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~--------~--~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. + .....+...+ ...... .....+.++.+++.+||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 0 0000000000 000000 111245788999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=300.82 Aligned_cols=242 Identities=27% Similarity=0.364 Sum_probs=189.4
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHH---HHhcccCCCcceeeEeEEEecCc
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEV---NFLGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~ 145 (422)
+||+|+||.||+|.+.. +|+.||+|.+....... ...+..|. +.++...|+||+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 48999999999998865 67899999987543221 11233343 34555689999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
.++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 72 ~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 9999999999999988854 457999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
.... .....|+..|+|||++.++ .++.++||||+||++|+|++|..||.............. ..
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~-------- 212 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL-------- 212 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---hh--------
Confidence 3221 1234689999999998754 689999999999999999999999976533221111100 00
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 345 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~ 345 (422)
..... ++...+.++.+++.+||..+|.+|| ++.++++
T Consensus 213 ~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 TMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00111 1112357899999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=305.41 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=198.8
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
..+||+|+||.||++.+.. +|..||||.+..........+.+|+.+++.++|+||+++++++...+..++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 3579999999999998876 6789999998655444456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 96 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 999999999987743 35899999999999999999999988 9999999999999999999999999987653322
Q ss_pred ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcc
Q 014585 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309 (422)
Q Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (422)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ........ ...
T Consensus 171 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~----------~~~ 235 (292)
T cd06657 171 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNL----------PPK 235 (292)
T ss_pred c--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhC----------Ccc
Confidence 1 12335688999999999888899999999999999999999999975432111 11111000 011
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 310 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.. ....+..+.+++.+||..||.+||++.+++++
T Consensus 236 ~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 LKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 100 01234678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=308.27 Aligned_cols=262 Identities=22% Similarity=0.261 Sum_probs=194.1
Q ss_pred Cccccc--cCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecCce
Q 014585 71 SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
..||.| +||+||+|.+.. +|+.||+|++...... ..+.+.+|+.+++.++|+||+++++++..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 356666 999999999876 7889999998754322 235688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 147 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
++||||+.+++|.+++.+. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+...
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999999999999988654 345899999999999999999999988 999999999999999999999999865432
Q ss_pred CCCCccc-e----eeccccCccccCCCcccCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-h-
Q 014585 226 PEGDKTH-V----STRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-L- 296 (422)
Q Consensus 226 ~~~~~~~-~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~- 296 (422)
....... . .....++..|+|||++.+. .++.++|||||||++|+|++|..||........ ........ .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~ 229 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYS 229 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCC
Confidence 2111100 0 0112346679999998763 578999999999999999999999975432111 00000000 0
Q ss_pred -------hc--------c--------------cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 -------GE--------R--------------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 -------~~--------~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. . ..........+.......++..+.+|+++||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0 00000001111112233466789999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=295.67 Aligned_cols=248 Identities=31% Similarity=0.500 Sum_probs=204.8
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||+|++|.||+|.+.. +++.|++|.+..... .....+.+|++++++++|+|++++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 57889999999999999998865 677899999977654 3446789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccce
Confidence 9999999999999999998554 57999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
........ .....|+..|+|||.+.+..++.++|||+||+++|+|++|..||...... ....... ....
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~---~~~~- 216 (254)
T cd06627 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIV---QDDH- 216 (254)
T ss_pred ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHh---ccCC-
Confidence 76543321 22356889999999998888899999999999999999999999754311 0000000 0000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
+ .++...+..+.+++.+||..+|++||++.+++.
T Consensus 217 ----~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ----P----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----C----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 112233578899999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=298.06 Aligned_cols=243 Identities=26% Similarity=0.319 Sum_probs=189.4
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHH-hcccCCCcceeeEeEEEecCce
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF-LGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~ 146 (422)
+.||.|+||.||+|.+.. +|+.||+|++....... ...+..|..+ .....|+||+++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 569999999999998866 67799999987543222 2234445444 4455899999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 73 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999999999999998543 46899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... .... .......
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~~~~~----- 211 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDN---ILSRRIN----- 211 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhcccC-----
Confidence 2 223468889999999988889999999999999999999999997543211 1100 0000000
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........++..+.+++.+||+.||++||++.++.+.
T Consensus 212 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ---CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 0111111345789999999999999999977554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=298.34 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=204.4
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||.|+||.||++.+.. ++..+|+|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 58889999999999999998765 677899999875432 2234678999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence 9999999999999999988552 356899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..... ..
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~-----~~- 215 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKV-----QR- 215 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH-----hc-
Confidence 99876443 1223458889999999999899999999999999999999999997543211 00000 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
......+...+.++.+++.+||..+|++||++.+++++
T Consensus 216 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 --------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00111223456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=294.24 Aligned_cols=265 Identities=26% Similarity=0.337 Sum_probs=206.5
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCccee
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVK 135 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 135 (422)
|.+....+. +.||+|+|+.|--+.... +|.+||||++.+...-.+.++.+|+.++.++ .|+||++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilq 140 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQ 140 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHH
Confidence 555544443 479999999999998877 8889999999887666778899999999999 5999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 213 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-- 213 (422)
++++|.++...|||||-+.||.|..+|+++ ..|++..+.++.++|+.||.|||.+| |.||||||+|||......
T Consensus 141 LiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 141 LIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVS 216 (463)
T ss_pred HHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcC
Confidence 999999999999999999999999999655 46999999999999999999999999 999999999999965543
Q ss_pred -eEEeeccCcccCCCCCc-----cceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 214 -AKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 214 -~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
+|||||.+..-...... +....+.+|+..|||||++. ...|+.++|.||||||||-||+|.+||.+.-.
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 79999988754322111 11223478999999999874 34689999999999999999999999986543
Q ss_pred CCcch-------h-HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 283 NGEHN-------L-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 283 ~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.-. . -......+.+ .-+++.+..+ ...+.++.+++..+|..|+.+|.++.+++.+
T Consensus 297 ~dCGWdrGe~Cr~CQ~~LFesIQE--GkYeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 297 ADCGWDRGEVCRVCQNKLFESIQE--GKYEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CcCCccCCCccHHHHHHHHHHHhc--cCCcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 22110 0 0000001111 1122222221 2457889999999999999999999998873
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.56 Aligned_cols=245 Identities=29% Similarity=0.413 Sum_probs=197.1
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
|...+.||+|+||+||+|.+.. +|..|++|.+...... ....+.+|+.+++.++|+|++++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 6667789999999999998765 6789999998754332 234678999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...++||||+. ++|.+++......+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99999999995 5888888666667999999999999999999999988 9999999999999999999999999986
Q ss_pred cCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
.... .....|+..|+|||++. ...++.++|||||||++|+|++|..||............. . .
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~------~--~ 235 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------Q--N 235 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------h--c
Confidence 5322 12356889999999874 4568889999999999999999999987643221111000 0 0
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... .....+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSPTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 111234578999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.95 Aligned_cols=269 Identities=28% Similarity=0.331 Sum_probs=198.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.++||.|+||.||+|.+.. ++..||||++...... ....+.+|+.+++.++|+||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 4689999999999999999999866 6778999998654322 2245778999999999999999999876
Q ss_pred ecC--------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 142 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 142 ~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
... ..++||||+. ++|...+......+++..+..++.||++||.|||+.+ |+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 543 4589999995 5787777666667999999999999999999999998 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccc---------eeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 014585 214 AKLSDFGLAKDGPEGDKTH---------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 283 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 283 (422)
++|+|||++.......... ......|++.|+|||.+.+ ..++.++|||||||++|||++|.+||.+....
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999997653322111 1123467889999998765 45889999999999999999999999765432
Q ss_pred CcchhHHhhhhh-----hhcccccccc--------cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 284 GEHNLVEWARPH-----LGERRRFYRL--------IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 284 ~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.....+...... .......... ..+.+...+ ......+.+++.+||..||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 211111000000 0000000000 000000000 1123678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=334.17 Aligned_cols=256 Identities=29% Similarity=0.410 Sum_probs=191.3
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...+|+.+++||+||||.||+++++- +|+.||||++..... .....+.+|++.|.+|+|||||+++..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWV 547 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWV 547 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence 44678888999999999999999987 788999999986642 22356889999999999999999987432
Q ss_pred ec------------------------------------------------------------------------------
Q 014585 142 ED------------------------------------------------------------------------------ 143 (422)
Q Consensus 142 ~~------------------------------------------------------------------------------ 143 (422)
+.
T Consensus 548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg 627 (1351)
T KOG1035|consen 548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG 627 (1351)
T ss_pred ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence 00
Q ss_pred -----------------------------------------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHH
Q 014585 144 -----------------------------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182 (422)
Q Consensus 144 -----------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~ 182 (422)
-.+||-||||+...|.+++.++...-.....|.+++||+
T Consensus 628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREIL 707 (1351)
T ss_pred cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHH
Confidence 013788999988777777754432225788999999999
Q ss_pred HHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC----------------CCCccceeeccccCccccCC
Q 014585 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP----------------EGDKTHVSTRVMGTYGYAAP 246 (422)
Q Consensus 183 ~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~----------------~~~~~~~~~~~~gt~~y~aP 246 (422)
+||+|+|+++ ||||||||.|||++.++.|||+|||+|+... .+......+..+||..|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999 9999999999999999999999999998721 00111123457899999999
Q ss_pred CcccCC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHH
Q 014585 247 EYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAA 323 (422)
Q Consensus 247 E~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 323 (422)
|++.+. .|+.|+|+|||||||+||+. ||...- +....+...+ ...+... ..|.......-.
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR-----~g~iP~~------~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLR-----KGSIPEP------ADFFDPEHPEEA 848 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcc-----cCCCCCC------cccccccchHHH
Confidence 998754 59999999999999999995 365321 1111111111 0001000 112222334567
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014585 324 QLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 324 ~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+|.+||+.||.+|||+.|+|..
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhc
Confidence 89999999999999999999963
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=310.79 Aligned_cols=267 Identities=25% Similarity=0.326 Sum_probs=203.1
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|++.+.||.|+||.||+|.+.. +|..||||.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 58899999999999999999865 67799999987643 23446789999999999999999999998877
Q ss_pred C-----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 144 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 144 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
. ..|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 5 7899999996 5898888543 48999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCcc-ceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 219 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 219 FG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
||++......... .......++..|+|||++.+. .++.++|||||||++|+|++|..||...........+.......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999876543210 112234678999999999877 88999999999999999999999997654321111000000000
Q ss_pred h-------cccccccccC---ccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 G-------ERRRFYRLID---PRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~-------~~~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ........+. ... ........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0000000000 000 000111245788999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.55 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=196.2
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
||.|+||.||+|.+.. +|+.|++|.+..... .....+.+|++++++++|+||+++++.+......++|
T Consensus 1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999999865 678999999976543 2345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++.+.. .+++..++.++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999986544 7899999999999999999999988 9999999999999999999999999987653321
Q ss_pred c------cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 230 K------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 230 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
. ........++..|+|||.+....++.++||||||+++|+|++|..||........ .... ......+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~---~~~~~~~- 220 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNI---LNGKIEW- 220 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---hcCCcCC-
Confidence 1 1122335678899999999888899999999999999999999999975432111 1000 0000000
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
+ . ....+..+.+++.+||+.+|.+||++.++.+.|
T Consensus 221 ----~---~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 221 ----P---E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ----C---c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 0 001257889999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=308.45 Aligned_cols=267 Identities=25% Similarity=0.306 Sum_probs=198.0
Q ss_pred cCCC-CCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--------------HHHHHHHHHHhcccC
Q 014585 65 RNFR-PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGDLV 129 (422)
Q Consensus 65 ~~y~-~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~ 129 (422)
++|. +.+.||.|+||+||+|.+.. +|+.||||.+....... ...+.+|+.+++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 4665 45779999999999998765 67799999986543221 124779999999999
Q ss_pred CCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 130 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
|+||+++++++...+..++||||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~ 153 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN 153 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence 9999999999999999999999995 68998884 4456899999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCc------------cceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCC
Q 014585 210 ADYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 276 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p 276 (422)
.++.++|+|||++........ ........++..|+|||.+.+. .++.++|||||||++|+|++|..|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999976541110 0111223568889999998764 468999999999999999999999
Q ss_pred CCCCCCCCcchhH-Hhhhhhh----hccc------ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 277 MDKNRPNGEHNLV-EWARPHL----GERR------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 277 f~~~~~~~~~~~~-~~~~~~~----~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
|...........+ ....... .... .+.......... .....+.++.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 9765432111100 0000000 0000 000000000000 01123567899999999999999999999997
Q ss_pred H
Q 014585 346 A 346 (422)
Q Consensus 346 ~ 346 (422)
+
T Consensus 313 ~ 313 (335)
T PTZ00024 313 H 313 (335)
T ss_pred C
Confidence 4
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=269.12 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=205.9
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+|.-.++||+|.||+||+|++.+ +++.||+|.++.+... .....++|+.+|+.++|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 45667789999999999999887 7889999999765432 235688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..+-+|+||| ..+|..+...-++.++.+.+..++.|+++||.|+|+++ +.||||||.|+||+.+|.+||+|||+++
T Consensus 74 kkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 9999999999 56999998777889999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhh--hhhcc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP--HLGER 299 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~--~~~~~ 299 (422)
.+.-.. ......+-|.+|.+|.++.+ .-|++..|+||.|||+.|+.. |++.|.+.+-.+...-+-+... ....+
T Consensus 150 afgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 875432 22333567999999999986 468999999999999999987 5566665443222111111111 11111
Q ss_pred cccccccCcccCCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHF---------SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+-.+.|-.....+ .+.....-++++.++|..+|..|.++++.+++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 222222222211111 12233456899999999999999999998864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.29 Aligned_cols=263 Identities=25% Similarity=0.326 Sum_probs=197.0
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhccc---CCCcceeeEeEEE
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDL---VHLNLVKLIGYCI 141 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~h~niv~~~~~~~ 141 (422)
|++.+.||+|+||.||+|.+.. ++..||+|.+....... ...+.+|+.+++++ .|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 6778899999999999999865 57799999997543222 23466777766655 6999999999999
Q ss_pred ecCc-----eEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~~-----~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
..+. .+++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence 8776 899999996 58988886543 36899999999999999999999988 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-HHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~ 294 (422)
|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++|.+||........... ......
T Consensus 148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence 999999977643321 1223578899999999999999999999999999999999999976443211100 000000
Q ss_pred hhh-c--------ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLG-E--------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... . ...+....... ........+..+.+++.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 0 00000000000 011122445788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.28 Aligned_cols=251 Identities=27% Similarity=0.339 Sum_probs=204.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccC-CCcceeeEeEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYC 140 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 140 (422)
++|.+.+.||+|+||.||+|.... +|..||+|++..... .....+.+|+.+++++. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 478899999999999999999876 678999999875332 22356789999999998 99999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..++..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999999999999998554 47999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcc------------------ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 221 LAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 221 ~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
++......... .......|+..|+|||++.+..++.++||||||+++++|++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98865433211 122235678999999999888899999999999999999999999986542
Q ss_pred CCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 014585 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM----SEVVEA 346 (422)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~ell~~ 346 (422)
.. ..... ... ...++...+..+.+++.+||..+|.+||++ .+++++
T Consensus 228 ~~---~~~~~---~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YL---TFQKI---LKL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH---HHHHH---Hhc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11 00000 000 011122335788999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=302.60 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=210.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHH---HHHHHHHhccc-CCCcceeeEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL-VHLNLVKLIG 138 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~h~niv~~~~ 138 (422)
...+|.++.+||.|+||+|.+|..+. +.+.+|||+++++...+..+ -+.|-++|... +-|.+++++.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkg---------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred eecccceEEEeccCccceeeeecccC---------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 34678999999999999999997654 77789999998775543332 45788888777 4678899999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+|..-+.+|+||||+.||+|.-+|++- +.+.+..+..++.+|+-||-|||+.+ ||+||||.+|||++.+|++||+|
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 999999999999999999999988654 46889999999999999999999999 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||+++....... .+.+++||+.|+|||++.-++|+..+|+||+||+||||+.|++||++.+..+.-.
T Consensus 494 FGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~----------- 560 (683)
T KOG0696|consen 494 FGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----------- 560 (683)
T ss_pred cccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----------
Confidence 999987543332 3456899999999999999999999999999999999999999999765432211
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHhCCCCCCCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDMA 357 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~~~~~~ 357 (422)
.+.+. .-.++...+.++..+.+..|..+|.+|.... +--+.++.++.++...
T Consensus 561 -----aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 561 -----AIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred -----HHHHc--cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 11111 1224556678999999999999999997432 2224444555554443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.38 Aligned_cols=263 Identities=30% Similarity=0.510 Sum_probs=206.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
...|...++||+|+||.||+|.+.. +|..||||.+...... ...|++++++++|||||++++++.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3567788899999999999998865 6779999998644321 23568899999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++|+|.+++. .+++..+..++.|+++||+|||....++|+||||||+||+++.++..++. ||...
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999999999999984 38899999999999999999996544559999999999999999888875 66554
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+|....... ....
T Consensus 831 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~ 902 (968)
T PLN00113 831 LLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLD 902 (968)
T ss_pred cccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchh
Confidence 3211 1123678999999999999999999999999999999999999964322 222344444332221 1223
Q ss_pred cccCcccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 304 RLIDPRLEGH--FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 304 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
..+++.+... .......++.+++.+||+.||++||++.++++.|+.+..
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3444444332 334556788899999999999999999999999986533
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=303.72 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=199.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..|...+.||.|+||.||+|.+.. ++..||+|.+..... ....++.+|+.+++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 447778899999999999999866 677899999864322 22346789999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.....++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccc
Confidence 9999999999995 6888877655667899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+...... ....|+..|+|||.+. ...++.++|||||||++|+|++|..||.......... ... .
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~-----~ 228 (308)
T cd06634 162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA-----Q 228 (308)
T ss_pred ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHh-----h
Confidence 8764321 2346888999999874 3567889999999999999999999986542211100 000 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
. . .+.. .....+..+.+||.+||..+|.+||++.+++++..-
T Consensus 229 ~-~-----~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 229 N-E-----SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred c-C-----CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 0 0 0000 112345678999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.55 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=202.6
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHhcccCCCcce
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLVHLNLV 134 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv 134 (422)
...++|-++.+||+|||+.||+|.+.. ..+.||||+-..... ...+...+|.+|.+.|+||.||
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV 530 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV 530 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence 445688899999999999999998876 567999998643321 1124467899999999999999
Q ss_pred eeEeEEE-ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc---C
Q 014585 135 KLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---A 210 (422)
Q Consensus 135 ~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~---~ 210 (422)
++|++|. +.+.+|-|+|||+|.+|+-+| +....+++..+..|+.||+.||.||.+.. .+|||-||||.|||+- .
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcc
Confidence 9999986 466788999999999998888 44557999999999999999999999887 7799999999999994 3
Q ss_pred CCCeEEeeccCcccCCCCCcc-----ceeeccccCccccCCCcccCC----CCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 014585 211 DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~ 281 (422)
-|.+||.|||+++.+.+.... ..+....||.+|++||++.-+ .++.|+||||+|||+|.++.|+.||....
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 478999999999987665443 233457899999999998633 46889999999999999999999998643
Q ss_pred CCCcchhHHhhhhhhhcccccccccCcc-cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 282 PNGEHNLVEWARPHLGERRRFYRLIDPR-LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
.. .++.+... ++... ..-..-+..+.++.+||++||+.--++|.+.-++..
T Consensus 689 sQ--QdILqeNT-----------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 689 SQ--QDILQENT-----------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hH--HHHHhhhc-----------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22 11111110 00000 000011234678999999999999999998877764
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=298.67 Aligned_cols=255 Identities=27% Similarity=0.360 Sum_probs=197.7
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
+|++.+.||.|+||.||+|...... .+|..||+|++..... ...+.+.+|+++++++ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 4788899999999999999875321 2678899999875322 2235678899999999 699999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..+...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998544 46889999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
++......... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ...........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~ 227 (290)
T cd05613 151 LSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS 227 (290)
T ss_pred cceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc
Confidence 99865432211 1223568999999999875 3468899999999999999999999964322111 11111111000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 345 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~ 345 (422)
.+ .++...+..+.+++.+||+.||.+|| ++.+++.
T Consensus 228 --------~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 --------EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 11223456788999999999999997 5555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.49 Aligned_cols=268 Identities=25% Similarity=0.312 Sum_probs=194.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
+|++.+.||+|+||.||+|.+.... .+..||+|.+..... ...+.+.+|+.+++++ .|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 4788899999999999999986520 167899999864322 2245678999999999 59999999987543
Q ss_pred c----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 143 D----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 143 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
. ...++++||+. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCc
Confidence 2 45788999984 68988884 3457899999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCcc--ceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 014585 219 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 293 (422)
Q Consensus 219 FG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-- 293 (422)
||+++........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||................
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 9999865432211 11223578999999998765 578999999999999999999999997643211100000000
Q ss_pred ------hhhhc-c-ccc----ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 ------PHLGE-R-RRF----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ------~~~~~-~-~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+.. . ..+ .......+. ......+..+.+++.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 0 000 000000000 0001124678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=309.74 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=198.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|.+.+.||.|+||.||+|.+.. +|..||+|.+........+.+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 3689999999999999999998876 7789999999776666667789999999999999999999876543
Q ss_pred --------------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 144 --------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 144 --------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
...++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence 35789999996 588887743 35899999999999999999999988 99999999999997
Q ss_pred C-CCCeEEeeccCcccCCCCCccc-eeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 014585 210 A-DYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286 (422)
Q Consensus 210 ~-~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 286 (422)
. ++.+||+|||++.......... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....+....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 5678999999997653221111 1122357889999998754 56889999999999999999999999765432211
Q ss_pred hhHHhhhhhhh--cccccccccC-----cccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 287 NLVEWARPHLG--ERRRFYRLID-----PRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 287 ~~~~~~~~~~~--~~~~~~~~~~-----~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.......+... ....+..... ..... .+....+.++.+|+.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11100000000 0000000000 00000 0011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.37 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=197.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|..||||.+..... .....+..|+.++.++ .|+||+++++++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 34678999999999999999999865 678999999975432 2334567788777666 599999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
......++||||+ +++|.+++......+++..+..++.|++.||+|||+ .+ |+||||+|+||+++.++.+||+||
T Consensus 84 ~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 84 ITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred ecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence 9999999999998 557888776655689999999999999999999997 46 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCC----CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
|++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ...... .
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~---~ 231 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK---I 231 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH---H
Confidence 99876533221 12235788999999987543 788999999999999999999999643211 011110 0
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
+.... +... ....++.++.+|+.+||..||.+||++.+++++.
T Consensus 232 ~~~~~-------~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 232 LQEEP-------PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred hcCCC-------CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 10000 0000 0012346789999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=301.62 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=189.8
Q ss_pred cCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEEEecC
Q 014585 77 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 154 (422)
Q Consensus 77 ~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 154 (422)
++|.||.+.... +|+.||||++.... ......+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus 12 ~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 12 DLMIVHLAKHKP---------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred CCceEEEEEecC---------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 344555555443 67899999997652 2344678999999999999999999999999999999999999
Q ss_pred CCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCcc--
Q 014585 155 RGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-- 231 (422)
Q Consensus 155 ~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-- 231 (422)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999998654 346899999999999999999999988 999999999999999999999999988754322211
Q ss_pred ---ceeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc---c----
Q 014585 232 ---HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE---R---- 299 (422)
Q Consensus 232 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~---- 299 (422)
.......++..|+|||++.+ ..++.++|||||||++|||++|..||....... ...+........ .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 11122457788999999875 468899999999999999999999997543211 111110000000 0
Q ss_pred ---ccccc----ccCc----ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 ---RRFYR----LIDP----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ---~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... ..++ ..........+.++.+|+.+||..||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0000 01111223446788999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.42 Aligned_cols=264 Identities=27% Similarity=0.389 Sum_probs=202.1
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+..|+.++++++|+||+++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 5677899999999999998876 67899999997653 223456789999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++||||++ ++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999999996 5999999766567999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh-------hh
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR-------PH 295 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~-------~~ 295 (422)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|..||...........+ .... ..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 543221 12224567889999998766 8899999999999999999999999764422111000 0000 00
Q ss_pred hhc----ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ...+...........+ ...+..+.+++.+||..||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000 0000000000000001 1225689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=296.92 Aligned_cols=259 Identities=27% Similarity=0.346 Sum_probs=201.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
+|++.+.||+|+||.||++....... ++..||||++..... ...+.+.+|+.++.++ +|+||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHD------AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEecccc------CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 47788999999999999998654222 567899999875322 2234578999999999 699999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..+...++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECc
Confidence 9999999999999999999988543 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+++........ ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........ ...........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~ 227 (288)
T cd05583 151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS 227 (288)
T ss_pred ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc
Confidence 98775433221 122356899999999987654 78899999999999999999999964322111 11111111000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.+ ..+...+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 228 --------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01 1112234678999999999999999998888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=305.80 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=194.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..+|.+.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.+++.++|+||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 3689999999999999999998765 678999999865322 22346789999999999999999999987
Q ss_pred ecC------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
... ..++||||+. .+|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 543 4589999995 4776654 236899999999999999999999988 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR- 293 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~- 293 (422)
|+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998764322 123467889999998876 568999999999999999999999998653221111000000
Q ss_pred -------hhhhcc--cccccccCcccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 -------PHLGER--RRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 -------~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... ..............+ ....+.++.+||.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 000000000000000 01234678899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.69 Aligned_cols=264 Identities=27% Similarity=0.376 Sum_probs=198.3
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccC-CCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 144 (422)
|++.+.||.|+||.||+|.... +++.||||.+...... ......+|+..++++. |+||+++++++.+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6778899999999999999865 5778999998654322 2234567999999998 999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..++||||+ +|+|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999 789998886553 57899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhhhh----hh
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPH----LG 297 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~----~~ 297 (422)
....... .....|+..|+|||++. +..++.++|+||||+++|+|++|.+||............ ...... ..
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 6543221 12345788999999875 456789999999999999999999999765432111000 000000 00
Q ss_pred cccccccccCcccC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLE-------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+...+....+..+. .......+.++.+++.+||+.||.+||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000000 00001124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.26 Aligned_cols=263 Identities=23% Similarity=0.284 Sum_probs=216.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..+++++..||.||||.|=++.... ....+|+|++++...- ..+.+..|-+||..++.+.||++|-.|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~---------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNS---------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecc---------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 4566777889999999999887755 2224899998765443 345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.++..+|++||-|-||.|...|. ..+.|+......++..+++|++|||+++ ||+|||||+|++++.+|-+||.|||
T Consensus 490 rd~kyvYmLmEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence 99999999999999999999984 4557999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+|+....+.. +.++|||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++....+++......+
T Consensus 566 FAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---- 638 (732)
T KOG0614|consen 566 FAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---- 638 (732)
T ss_pred hHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----
Confidence 9998866554 445899999999999999999999999999999999999999999888765555443222111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhCCCCCCCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALKPLPNLKDMAS 358 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L~~~~~~~~~~~ 358 (422)
+++......+.+||++++..+|.+|.. -..=+..++.+.++.++.+
T Consensus 639 ------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 639 ------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 123344577889999999999999985 2223344555666655443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=303.51 Aligned_cols=266 Identities=24% Similarity=0.288 Sum_probs=199.7
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEe
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
....++|++.+.||.|+||.||+|.+.. +|..||||.+..... ...+.+.+|+.+++.++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 3467889999999999999999998876 678999998864322 23456889999999999999999999
Q ss_pred EEEe-cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 139 YCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 139 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
++.. ....++||||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||+|+|||++.++.++|+
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeC
Confidence 9876 56788999999 6689887743 35788889999999999999999988 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH- 295 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 295 (422)
|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..................
T Consensus 151 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 151 DFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999987643211 22457889999998765 57899999999999999999999999765431111000000000
Q ss_pred -------hhcccccccccCcccCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 -------LGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 -------~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
............-......+ ...+..+.++|.+||+.+|++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000001 1235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.92 Aligned_cols=256 Identities=27% Similarity=0.334 Sum_probs=199.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
.+.+-+..||.|+||+|++-.++. +|+..|||+++.... ..+++++.|.....+- +.||||++||.+..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 344456679999999999998876 889999999987765 4456788888875554 79999999999999
Q ss_pred cCceEEEEEecCCCChhhhhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 143 DDQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++..||.||+| ..+|+.+.. .....+++..+-.|....+.||.||-...+ |||||+||+|||++..|.+||||
T Consensus 135 EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 135 EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeec
Confidence 99999999999 568876543 134569999999999999999999987543 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCccc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
||++-.+.+. ...+...|-..|||||-+. +..|+.++||||||++|||+.||..|+..+.. ..+......
T Consensus 212 FGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv 283 (361)
T KOG1006|consen 212 FGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV 283 (361)
T ss_pred ccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH
Confidence 9999765332 2233456888999999987 34699999999999999999999999987643 111111111
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ...+.. ..-....+..+.++|..||..|..+||.+.+++++
T Consensus 284 ~gd--pp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGD--PPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCC--CCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 110 011111 11122456789999999999999999999998763
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.06 Aligned_cols=268 Identities=24% Similarity=0.339 Sum_probs=200.0
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCccee
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~ 135 (422)
.++....++|.+.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+.+|+.++++++|+||++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~ 80 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccc
Confidence 3445566899999999999999999998765 678999999875432 22356788999999999999999
Q ss_pred eEeEEEec------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 136 LIGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 136 ~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
+++++... ...+++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~ 154 (345)
T cd07877 81 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 154 (345)
T ss_pred eeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEc
Confidence 99988643 3467888887 7899887743 35899999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
.++.+||+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........
T Consensus 155 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 155 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred CCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999998764322 123467899999998866 5788999999999999999999999975432211110
Q ss_pred HHhhh--------hhhhcc--ccc----ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWAR--------PHLGER--RRF----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~--------~~~~~~--~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.... ..+... ..+ .......+.. .....+.++.++|.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 000000 000 0000000000 000235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.59 Aligned_cols=270 Identities=26% Similarity=0.362 Sum_probs=205.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..|.-..+||+|.||.||+|+... +|+.||+|++..+... --...++|+++|..|.|+|++.++++|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 456667889999999999998876 7888999887543321 23457899999999999999999988764
Q ss_pred --------cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 143 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 143 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
...+|+||.+|++ +|..++.+....++...+..++.+++.||.|+|... |+|||+|++|+||+++|.+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence 2357999999966 899999777788999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCc--cceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 215 KLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
||+|||+++.+..... ....++.+-|.+|++||.+.+ ..|+.+.|||..|||+.||++|.+.|++.........+..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999999987543322 122334566999999999886 5799999999999999999999999988765544433332
Q ss_pred hhhhhhc-------cccccccc--CcccCCCC--------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 292 ARPHLGE-------RRRFYRLI--DPRLEGHF--------SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 292 ~~~~~~~-------~~~~~~~~--~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
....... ...+.+.+ .|-..+.+ +..-.+++.+|+.++|..||.+|+++++++.+-
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2211110 00011111 00000000 111135788999999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=327.21 Aligned_cols=146 Identities=25% Similarity=0.320 Sum_probs=131.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|.+.++||+|+||+||+|.+.. +++.||||++....... ...+..|+.++..++|+||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 579999999999999999999876 67899999997543322 356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..||||||+.+++|.+++... ..+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999999999998543 46889999999999999999999988 99999999999999999999999998
Q ss_pred cc
Q 014585 222 AK 223 (422)
Q Consensus 222 a~ 223 (422)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 85
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=307.83 Aligned_cols=267 Identities=25% Similarity=0.292 Sum_probs=210.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH---HHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..-|..++.||-|+||.|.++.-.+ |...||+|.+++...... ..++.|-.||..-+.+-||++|-.|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 4567788899999999999997655 667899999987654333 3467899999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+++.+|+||+|++||++..+|.+.+ -|++..+..++.++..|+++.|..| +|||||||+|||||.+|+|||.|||
T Consensus 699 QDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 699 QDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred ccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecc
Confidence 99999999999999999999997765 6899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCC---------CCCcc-------------------------------ceeeccccCccccCCCcccCCCCCchhhh
Q 014585 221 LAKDGP---------EGDKT-------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDV 260 (422)
Q Consensus 221 ~a~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 260 (422)
+++-+. .++-. ...-.++||+.|+|||++....|+..+|+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 986321 11000 00113789999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014585 261 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 340 (422)
Q Consensus 261 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 340 (422)
||.|||||||+.|+.||....+.+....+..+ ...++-. +..+.+.++.++|.+++ .++++|..
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~----~~~~ls~e~~~li~kLc-~sad~RLG- 918 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQYKVINW----------RNFLHIP----YQGNLSKEALDLIQKLC-CSADSRLG- 918 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcceeeeeeh----------hhccccc----cccccCHHHHHHHHHHh-cChhhhhc-
Confidence 99999999999999999988876553322211 1122222 22344577888887765 57777874
Q ss_pred HHHHHHhCCCCCCCCCCCC
Q 014585 341 SEVVEALKPLPNLKDMASS 359 (422)
Q Consensus 341 ~ell~~L~~~~~~~~~~~~ 359 (422)
+...+.++.+++++.+..+
T Consensus 919 kng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred ccchhhhhcCccccccchH
Confidence 2233356677777766543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=303.49 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=197.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|..||||.+...... ....+.+|+.++++++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 35689999999999999999998766 6789999998643222 234688999999999999999999998
Q ss_pred EecC------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
..+. ..++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 7654 358999999 7799888743 46899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hHHhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 292 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~ 292 (422)
+|+|||++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.......... .....
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999865332 123467889999998875 468899999999999999999999997543211100 00000
Q ss_pred h-------hhhhc--ccc----cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 R-------PHLGE--RRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~-------~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..+.. ... +.......+ .......+..+.+++.+||+.||.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000 000 000000000 00111234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=291.89 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=196.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---c--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---L--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
+|.+.+.||+|+||.||++.+.. .+..+++|.++... . .....+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 58889999999999999998765 33345555554321 1 2233567899999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
.+....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence 999999999999999999988853 3456899999999999999999999988 999999999999975 579999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .........
T Consensus 148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~ 219 (260)
T cd08222 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE 219 (260)
T ss_pred ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc
Confidence 9999876543221 22235688899999999888899999999999999999999999964321 111110000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+ ..+...+.++.++|.+||..||++||++.+++++
T Consensus 220 -------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -------GPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0011 1223456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=288.58 Aligned_cols=237 Identities=32% Similarity=0.393 Sum_probs=193.6
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
||.|+||.||++.+.. +++.||+|.+...... ....+..|+.++++++|+||+++++.+..++..++|
T Consensus 1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6999999999998865 5778999998765433 334688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 229 (422)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 9999999999998544 46899999999999999999999988 9999999999999999999999999998754332
Q ss_pred ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcc
Q 014585 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309 (422)
Q Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (422)
.......|+..|++||.+.+..++.++|+||||+++|+|++|..||..... ........ ...
T Consensus 148 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~~~---------- 209 (250)
T cd05123 148 --SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---KDP---------- 209 (250)
T ss_pred --CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---cCC----------
Confidence 122335688899999999888889999999999999999999999965432 11111100 000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 014585 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 342 (422)
Q Consensus 310 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 342 (422)
..++...+..+.+++.+||..||++||++.+
T Consensus 210 --~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 --LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0112223578899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=306.94 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=199.3
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+++++.|+||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 35689999999999999999999876 677899999865322 2335677899999999999999999988
Q ss_pred EecCc------eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 141 IEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 141 ~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
...+. .++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 76554 89999999 6799998854 46899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999999875432 123467889999998865 467899999999999999999999997654321111000000
Q ss_pred hh----hhcc------cccccccCcccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PH----LGER------RRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~----~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. +... ..+...+.......+ ....+.++.+++.+||..||.+||++.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 0000 000000000000000 01235789999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=303.46 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=201.8
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecCceE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 147 (422)
.++||+|.||+||-|.++. +|+.||||++.+.... ....+.+|+.||.++.||.||.+...|...+.++
T Consensus 569 devLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 3689999999999999987 8999999999765433 3356889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC---CCeEEeeccCcc
Q 014585 148 LVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAK 223 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~---~~~kl~DFG~a~ 223 (422)
.|||-+ +|+..+.|. ...+.+++.....++.||+.||.|||.++ |+|+||||+|||+... -.+||||||+|+
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccccee
Confidence 999999 556666654 44678999999999999999999999998 9999999999999654 468999999999
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
...+.. .....+||+.|+|||++.++.|....|+||+|||+|--+.|..||...... .+.++.+.-
T Consensus 716 iIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaF--------- 781 (888)
T KOG4236|consen 716 IIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAF--------- 781 (888)
T ss_pred ecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcccc---------
Confidence 875533 234578999999999999999999999999999999999999999765432 122221111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+..+..+. +.+.++.+||..+|+..-.+|.+.+..+.+
T Consensus 782 -MyPp~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 782 -MYPPNPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -ccCCCchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11122222 445788999999999999999999988764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=283.66 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=205.0
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhccc-CCCccee
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVK 135 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~ 135 (422)
+.+..++|+++++||+|+|++|.+++++. |.+.||+|++++.-... ..-+..|-.+..+. +||.+|-
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEe
Confidence 44567899999999999999999999876 78899999998654333 33466777777776 7999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
++.+|..+..+++|.||++||+|.-++++ ...++++.+..+..+|+-||.|||+.| ||+||||.+|||+|..|++|
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence 99999999999999999999999988854 457999999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-CCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR-PNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~-~~~~~~~~~~~~~ 294 (422)
|.|+|+++...... ..+.++|||+.|.|||++.+..|+..+|+|+|||+++||+.|+.||+.-. .+...+...+...
T Consensus 392 ltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq 469 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ 469 (593)
T ss_pred ecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence 99999998754322 23456899999999999999999999999999999999999999997432 1222233333332
Q ss_pred hhhcc-cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014585 295 HLGER-RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 340 (422)
Q Consensus 295 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 340 (422)
.+-++ .++ +-..+-.+..+++..|..||.+|...
T Consensus 470 vilekqiri------------prslsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 470 VILEKQIRI------------PRSLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred HHhhhcccc------------cceeehhhHHHHHHhhcCCcHHhcCC
Confidence 22211 111 11223456688999999999999643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=314.96 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=215.0
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
..+..++||+|+||+||+|.+.-.++. -+..||||++.... .+...++++|+-+|.+|+|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 344567899999999999998765432 34579999986544 345678999999999999999999999998765
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
+.||++|+++|+|.++++.+...+.....+.|..||++||.|||.+. ++||||..+||||..-..+||.|||+++.
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 88999999999999999988889999999999999999999999988 99999999999999999999999999998
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
..............-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+..++.+...
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge---------- 917 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE---------- 917 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc----------
Confidence 876655444444445678999999999999999999999999999998 888998766544444333111
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
++ ..++.++.++..++.+||..|+..||+++++...+.
T Consensus 918 RL-------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 918 RL-------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred cC-------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 11 123456789999999999999999999999987664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.34 Aligned_cols=241 Identities=27% Similarity=0.309 Sum_probs=197.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
...|.+...+|.|+|+.|-.+.+.. +++..++|++.... .+..+|+.++... .|+||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccc---------cccchhheeccccc----cccccccchhhhhcCCCcceeecceecC
Confidence 4678888889999999999998876 78899999997652 2344677666655 89999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE-cCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill-~~~~~~kl~DFG~ 221 (422)
..+.|+|||.+.|+-|.+.+.... .+. ..+..|+.+|+.|+.|||++| ++||||||+|||+ +..|+++|+|||.
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEech
Confidence 999999999999998888775443 233 777789999999999999998 9999999999999 6889999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
++..... ....+-|..|.|||++...+|+.++||||||++||+||+|+.||...... ..+..
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----------- 524 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----------- 524 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH-----------
Confidence 9876543 22245688999999999999999999999999999999999999865432 01000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
++ ....+....+..+++|+.+||+.||.+||++.+++.+
T Consensus 525 --~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 525 --RI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --hh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 01 1112234567899999999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.67 Aligned_cols=254 Identities=28% Similarity=0.375 Sum_probs=209.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
.+..|++...||.|.+|.||++.+.+ +|+.+|+|+..... ...+++..|.++|+.+ +|||++.++++|.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 45678999999999999999999887 67789999887664 3446788999999888 7999999999987
Q ss_pred e-----cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 E-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~-----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
. ++.+|||||||.||+.-|++..- +..+.|..+..|++.++.||.+||... ++|||||-.|||++.++.||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 4 56899999999999999998643 567999999999999999999999988 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCC-----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 290 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 290 (422)
|+|||++....... .......||+.|||||++.+. .|+..+|+||||++..||.-|.+|+.+..+.-....+
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I- 240 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI- 240 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-
Confidence 99999998764322 223457899999999999753 4778999999999999999999999876553221110
Q ss_pred hhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.-+|.....-+...++++.++|..||..|..+||++.+++++
T Consensus 241 --------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 --------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111222222345677899999999999999999999999874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=320.51 Aligned_cols=270 Identities=29% Similarity=0.443 Sum_probs=212.3
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeE
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLI 137 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~ 137 (422)
+++..++..+.+.||+|.||.|++|......... ......||||.++..... ..+.+..|+.+|+.+ .|+||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 4444555667779999999999999876532211 112568999999865544 456799999999999 799999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 202 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlk 202 (422)
|+|...+..++|+||+..|+|.+++..+. ..++....+.++.||+.|++||++.. +|||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 99999999999999999999999997655 34889999999999999999999988 9999999
Q ss_pred CCcEEEcCCCCeEEeeccCcccCCCCCccceeecc-ccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCC
Q 014585 203 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV-MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 280 (422)
Q Consensus 203 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 280 (422)
.+|||+.++..+||+|||+|+.............. .-...|||||.+....|+.++|||||||+|||+++ |..||.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999976554443322111 12456999999999999999999999999999998 77788652
Q ss_pred CCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... ..+.++. ... ..-..+..++.++.++++.||+.+|++||++.++.+.++.+
T Consensus 526 ~~~--~~l~~~l----~~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPT--EELLEFL----KEG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcH--HHHHHHH----hcC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 211 1111111 111 11122335578999999999999999999999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=282.35 Aligned_cols=220 Identities=24% Similarity=0.243 Sum_probs=178.3
Q ss_pred ccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEEEecCC
Q 014585 76 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 155 (422)
Q Consensus 76 G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 155 (422)
|.||.||++++.. +|+.||+|.+.... .+.+|...+....||||+++++++...+..++||||+++
T Consensus 4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999999876 78899999997543 233455555566799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceee
Q 014585 156 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235 (422)
Q Consensus 156 g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 235 (422)
|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+...... ..
T Consensus 70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence 9999988554 46899999999999999999999988 999999999999999999999999987665332 12
Q ss_pred ccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCC
Q 014585 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 315 (422)
Q Consensus 236 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (422)
...++..|+|||.+.+..++.++||||+||++|||++|..||........ . ... ..++
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~------~~~----~~~~ 198 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T------HTT----LNIP 198 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c------ccc----cCCc
Confidence 23467789999999888899999999999999999999988753211000 0 000 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 014585 316 IKGAQKAAQLAAHCLSRDPKARPLM 340 (422)
Q Consensus 316 ~~~~~~l~~li~~~l~~dp~~Rps~ 340 (422)
...+..+.+++.+||+.||.+||++
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 2234678999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=288.69 Aligned_cols=269 Identities=29% Similarity=0.436 Sum_probs=198.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcc--cCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~ 141 (422)
....++.++||+|.||.||+|.. +++.||||++.... .+.+.+|-.|.+. +.|+||+++++.-.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-----------~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-----------DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-----------cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 34566778899999999999988 45789999997543 3457777777654 58999999999876
Q ss_pred ecC----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeccCCCCcEEEcCC
Q 014585 142 EDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 142 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~------~~~iiHrDlkp~Nill~~~ 211 (422)
... .++||+||.+.|+|.++|..+ .++|....+|+..+++||+|||+.. +++|+|||||..||||..|
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 655 789999999999999999655 5899999999999999999999764 3469999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCC-----chhhhhhHHHHHHHHHhCCCCCCC-CCCCC
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SRSDVYSFGVVLLEMLTGRRSMDK-NRPNG 284 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwslG~il~elltg~~pf~~-~~~~~ 284 (422)
++..|+|||+|..+..+......-..+||.+|||||++.+. .+. .+.||||+|.+||||+++..-+.. ..+..
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 99999999999987655443334457899999999999763 222 368999999999999997655431 11111
Q ss_pred cch---------hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 285 EHN---------LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 285 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
... ..+......-..+....+.+ .+..+ ....-+.+.+..||..|++.|.|+.=+-+.+..+..
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD-AWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChh-hhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 110 01111111111111111111 11111 234678899999999999999999877777665544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=280.31 Aligned_cols=268 Identities=28% Similarity=0.392 Sum_probs=201.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcc--cCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~ 140 (422)
..+...+.+.||+|.||.||+|.+ -|+.||||++..... ..+.+|.+|... |+|+||+.+++.-
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-----------rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-----------RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-----------cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 456788889999999999999999 577999999976542 456777777765 4999999999876
Q ss_pred EecC----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeccCCCCcEEEcCC
Q 014585 141 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-----AERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 141 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~-----~~~~iiHrDlkp~Nill~~~ 211 (422)
..+. ++|||++|.+.|+|.|+|.+ ..++....++++..++.||++||.. |++.|.|||||..|||+.++
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 6543 57899999999999999965 4689999999999999999999953 56779999999999999999
Q ss_pred CCeEEeeccCcccCCCCCcc--ceeeccccCccccCCCcccCCC----C--CchhhhhhHHHHHHHHHhC----------
Q 014585 212 YNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGH----L--TSRSDVYSFGVVLLEMLTG---------- 273 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~il~elltg---------- 273 (422)
|...|+|+|+|......... ......+||.+|||||++...- + -..+||||||.++||+.-.
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999876544221 1223468999999999986431 2 2369999999999999863
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 274 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 274 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
+.||.+..+.+... .++.. ... ..++...++.++ .+...-..+.++++.||..||.-|.++-.+.+.|.++.+
T Consensus 433 ~~Pyyd~Vp~DPs~-eeMrk-VVC-v~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSF-EEMRK-VVC-VQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCcccCCCCCCCH-HHHhc-cee-ecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 46776554433211 11100 000 011111222222 223556788899999999999999999999988876654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=280.05 Aligned_cols=264 Identities=21% Similarity=0.305 Sum_probs=198.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-----C---Ccceee
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----H---LNLVKL 136 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~ 136 (422)
.+|.+.++||.|.|++||+|++.+ ..+.||+|+.+... ...+..+.||++|++++ | .+||++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 899999999999999999999988 66799999987553 23456789999999883 3 359999
Q ss_pred EeEEEe----cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 137 IGYCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 137 ~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
++.|.. +.++|+|+|++ |.+|..+|... -..++...+++|++||+.||.|||... +|||-||||+|||+..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 999986 35889999999 88999999765 457999999999999999999999865 49999999999998200
Q ss_pred --------------------------------------------------------------------------------
Q 014585 212 -------------------------------------------------------------------------------- 211 (422)
Q Consensus 212 -------------------------------------------------------------------------------- 211 (422)
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 014585 212 -------------------------------------------------------------------------------- 211 (422)
Q Consensus 212 -------------------------------------------------------------------------------- 211 (422)
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence
Q ss_pred ------CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC-
Q 014585 212 ------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG- 284 (422)
Q Consensus 212 ------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~- 284 (422)
.++||+|||-|...... .+....|..|+|||++.+..|+..+||||++|++|||+||...|+......
T Consensus 385 ~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 01455555555443221 122346888999999999999999999999999999999999987543321
Q ss_pred --cchhHHhhh------------------hhhhcccccccccCcccCC---------CCCHHHHHHHHHHHHHcccCCCC
Q 014585 285 --EHNLVEWAR------------------PHLGERRRFYRLIDPRLEG---------HFSIKGAQKAAQLAAHCLSRDPK 335 (422)
Q Consensus 285 --~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~ 335 (422)
..+.+..+. ..+.....+..+-.-..+. .++.+...++.+|+.-||+++|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 111111111 1111111121111111111 35667788999999999999999
Q ss_pred CCCCHHHHHHH
Q 014585 336 ARPLMSEVVEA 346 (422)
Q Consensus 336 ~Rps~~ell~~ 346 (422)
+|||+.+++++
T Consensus 540 KR~tA~~cl~h 550 (590)
T KOG1290|consen 540 KRPTAAQCLKH 550 (590)
T ss_pred ccccHHHHhcC
Confidence 99999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.80 Aligned_cols=270 Identities=26% Similarity=0.355 Sum_probs=221.6
Q ss_pred chhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcce
Q 014585 56 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLV 134 (422)
Q Consensus 56 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv 134 (422)
...++.+...+++...++-+|.||.||.|.+.+... ..+.+.|-+|.++....+ ....++.|-..+..+.|||+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt----~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDT----YNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCC----cchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 456777788899999999999999999998875322 124456778888655433 345688999999999999999
Q ss_pred eeEeEEEe-cCceEEEEEecCCCChhhhhcc-----C--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 135 KLIGYCIE-DDQRLLVYEFMPRGSLENHLFR-----R--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 135 ~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~-----~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
.+.+++.+ .+..+.++.+..-|+|..++.. . ...++..+...++.|++.|++|||+++ +||.||..+|+
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNC 427 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNC 427 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcc
Confidence 99999876 4567888999999999999972 1 234667778899999999999999999 99999999999
Q ss_pred EEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 014585 207 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 285 (422)
Q Consensus 207 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 285 (422)
+||+...+||+|=.+++...+.+......+......||+||.+.+..|+.++|||||||+||||+| |+.|+...+|.+.
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 999999999999999999888777766666667889999999999999999999999999999998 8889887666443
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
...+. +.. ++. -+..|++++..++..||+.+|++||++.+++..|.+
T Consensus 508 ~~ylk-------dGy---Rla-------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 EHYLK-------DGY---RLA-------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHh-------ccc---eec-------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22221 111 111 234678999999999999999999999999998864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.49 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=171.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeE---
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY--- 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~--- 139 (422)
..++|.+.++||+|+||.||+|.+..+.. ..+..||||++...... +....| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45789999999999999999999876211 12778999988643211 111111 1112222222222211
Q ss_pred ---EEecCceEEEEEecCCCChhhhhccCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014585 140 ---CIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------------LPWSIRMKIALGAAKGLAFLHEEAERPVI 197 (422)
Q Consensus 140 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~qi~~al~~LH~~~~~~ii 197 (422)
.......+|||||+++++|.+++...... .....+..++.||+.||.|||+.+ |+
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 24566789999999999999988643211 123446689999999999999988 99
Q ss_pred eccCCCCcEEEcC-CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC----------------------CC
Q 014585 198 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----------------------HL 254 (422)
Q Consensus 198 HrDlkp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 254 (422)
||||||+|||++. ++.+||+|||+++....... .......|++.|+|||.+... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999986 58999999999986543222 223446789999999966422 23
Q ss_pred CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCC----CCC--HHHHHHHHHHHHH
Q 014585 255 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG----HFS--IKGAQKAAQLAAH 328 (422)
Q Consensus 255 ~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~l~~li~~ 328 (422)
+.++|||||||+||||+++..++.... ................+.....+.... .+. ........+||.+
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 456799999999999998766543210 000000000000000000111111000 000 0012345689999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 014585 329 CLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 329 ~l~~dp~~Rps~~ell~~ 346 (422)
||+.||.+|||+.+++++
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=267.20 Aligned_cols=239 Identities=31% Similarity=0.421 Sum_probs=194.1
Q ss_pred cCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEEEecCC
Q 014585 77 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 155 (422)
Q Consensus 77 ~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 155 (422)
+||.||+|.+.. +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999999865 67799999998765544 67899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceee
Q 014585 156 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235 (422)
Q Consensus 156 g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 235 (422)
++|.+++.... .+++..++.++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 99999985543 3899999999999999999999988 9999999999999999999999999998765432 223
Q ss_pred ccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCC
Q 014585 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 315 (422)
Q Consensus 236 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (422)
...++..|++||.+.+..++.++|||+||+++|+|++|..||...... ............ ... ...
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~------~~~------~~~ 210 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKP------PFP------PPE 210 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCC------CCc------ccc
Confidence 356888999999998888999999999999999999999999753111 111111110000 000 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 316 IKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 316 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
...+.++.+++.+||..+|++||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 004468899999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.71 Aligned_cols=270 Identities=20% Similarity=0.277 Sum_probs=185.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCC-------CCCCCCcEEEEEEecCCCcccHHH--------------HHHH
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHKE--------------WLAE 121 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~-------~~~~~g~~vavK~~~~~~~~~~~~--------------~~~E 121 (422)
..++|++.++||+|+||+||+|.....+... .....++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4578999999999999999999764322111 122356789999987543322222 3346
Q ss_pred HHHhcccCCCcc-----eeeEeEEEe--------cCceEEEEEecCCCChhhhhccCC----------------------
Q 014585 122 VNFLGDLVHLNL-----VKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS---------------------- 166 (422)
Q Consensus 122 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 166 (422)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766554 667777653 356899999999999999885321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccC
Q 014585 167 -LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245 (422)
Q Consensus 167 -~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 245 (422)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 12456778899999999999999988 999999999999999999999999999765332211 1112345889999
Q ss_pred CCcccCCC--------------------C--CchhhhhhHHHHHHHHHhCCC-CCCCCCCCCc------chhHHhhhhhh
Q 014585 246 PEYVMTGH--------------------L--TSRSDVYSFGVVLLEMLTGRR-SMDKNRPNGE------HNLVEWARPHL 296 (422)
Q Consensus 246 PE~~~~~~--------------------~--~~~~DvwslG~il~elltg~~-pf~~~~~~~~------~~~~~~~~~~~ 296 (422)
||.+.... | ..+.||||+||++|+|++|.. ||........ .....|..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--- 455 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--- 455 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---
Confidence 99875322 1 134799999999999999875 6653221110 00111110
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHHh
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP---KARPLMSEVVEAL 347 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~ell~~L 347 (422)
.......-......+....+|+.+||..+| .+|+|+.|+|+|-
T Consensus 456 --------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 456 --------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred --------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 000000000112345788999999999766 6899999999853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=251.08 Aligned_cols=205 Identities=27% Similarity=0.356 Sum_probs=171.6
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEe
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIG 138 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (422)
.+..++...+..||+|++|.|=+-++.. +|...|+|.+...-. +.++++++|+.+..+. .+|.+|.+||
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyG 112 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYG 112 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence 3444555666789999999998888877 788999999976543 3456788999987665 7999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
.+...+.+||.||.+ ..+|+.+.. +.+..+++..+-+|+..+++||.|||++-. +||||+||+||||+.+|.+|
T Consensus 113 a~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 113 ALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred hhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEE
Confidence 999999999999999 568877653 467789999999999999999999998754 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCccc----CCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~elltg~~pf~~~ 280 (422)
+||||++-.+.+.- ..+...|-..|||||.+. ...|+.++||||||+++.||.+++.||+..
T Consensus 190 iCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 190 ICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred Ecccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99999997764322 122245778899999886 347999999999999999999999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.85 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=199.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 141 (422)
..++|++.+++|+|.++.||.|.+.. +++.++||+++.- ..+.+.+|++||..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 45789999999999999999998766 5668999999753 2367889999999996 999999999988
Q ss_pred ec--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CCeEEee
Q 014585 142 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSD 218 (422)
Q Consensus 142 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~~kl~D 218 (422)
+. ....||+||+++.+...+. ..++...+..++.+++.||.|+|++| |+|||+||.|++||.. -.++|+|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred CccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeee
Confidence 74 4567999999888776655 35777889999999999999999999 9999999999999865 5699999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh---
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--- 294 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--- 294 (422)
+|+|..+..+....+ .+.+..|..||.+.. ..|+...|+|||||++..|+..+.||.....+..+ ++..+..
T Consensus 177 WGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt 252 (338)
T KOG0668|consen 177 WGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGT 252 (338)
T ss_pred cchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhCh
Confidence 999998866544332 356778899998874 67899999999999999999999999766544321 1111110
Q ss_pred ----------------hh------hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 ----------------HL------GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ----------------~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+ ..++.+..++.+.-.. -.++++.+|+.++|..|-.+|+|++|++.+
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00 0012222222221111 124788999999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=266.08 Aligned_cols=268 Identities=23% Similarity=0.346 Sum_probs=202.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC--CcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.+.+..+.||.|+||.||.+.+.. +|+.||+|++..- ....-+.+.+|+++|..++|.|++..+++..-
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPR---------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPR---------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCC---------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 466778899999999999987655 7889999998643 23345678999999999999999998887653
Q ss_pred c-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 143 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 143 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
. .++|.|+|.+ ..+|..+|. ....++...++-++.||++||+|||+.+ |.||||||.|+|++.|..+|||
T Consensus 124 ph~dfFqEiYV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred CCchHHHHHHHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEec
Confidence 2 3467889999 558988874 4457899999999999999999999999 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH- 295 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 295 (422)
|||+++.-...+... .+..+-|.+|+|||++.+ ..|+.++||||+|||+.||+..+..|+...+....+++......
T Consensus 199 DFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 199 DFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 999999754433333 233456889999999986 57999999999999999999999999887776554443221110
Q ss_pred -h------hcccc---ccc-ccCcccCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 296 -L------GERRR---FYR-LIDPRLEGHF----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 296 -~------~~~~~---~~~-~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
+ .+.-+ ++. ...|.+.-.+ +.....+...++.++|.+||++|.+..+.+.++
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 00000 000 0011111100 112335678899999999999999999988765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=279.85 Aligned_cols=276 Identities=23% Similarity=0.280 Sum_probs=211.6
Q ss_pred cccchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC---
Q 014585 53 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--- 129 (422)
Q Consensus 53 ~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--- 129 (422)
..|.+.-.++...+|.+....|+|-|++|.+|.+.. .|..||||++...... .+.=+.|+.||++|+
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD 489 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDAD 489 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccC
Confidence 445666677888999999999999999999998876 5669999999866432 345578999999995
Q ss_pred ---CCcceeeEeEEEecCceEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 130 ---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 130 ---h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
--|+++++-.|...+++|||+|-+ ..+|.++|.+.+ ..+....+..++.|++-||..|-..+ |+|.||||.
T Consensus 490 ~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPD 565 (752)
T KOG0670|consen 490 PEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPD 565 (752)
T ss_pred chhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCcc
Confidence 247999999999999999999999 779999997653 45888999999999999999999988 999999999
Q ss_pred cEEEcCC-CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 014585 205 NILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 283 (422)
Q Consensus 205 Nill~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 283 (422)
|||+++. ..+||||||.|........+. +.-+..|.|||++.|.+|+...|+||+||+||||.||+..|.+...+
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred ceEeccCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 9999876 557999999998765543221 23466799999999999999999999999999999999999876544
Q ss_pred CcchhHHhhh---------------hhhhcc----------------cccccccCc------ccCC--CC---CHHHHHH
Q 014585 284 GEHNLVEWAR---------------PHLGER----------------RRFYRLIDP------RLEG--HF---SIKGAQK 321 (422)
Q Consensus 284 ~~~~~~~~~~---------------~~~~~~----------------~~~~~~~~~------~~~~--~~---~~~~~~~ 321 (422)
....+.-... .++... ..+...+.| .+.. .+ .......
T Consensus 642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 3221111111 111100 000001111 0000 01 1234567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 322 AAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 322 l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.+|+.+||..||++|.+..++|.+
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhcC
Confidence 8999999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=284.28 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=208.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|..+..+|.|.||.||+|+++. +++..|+|+++........-+.+|+-+++..+|+|||.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 4689999999999999999999987 7889999999887767777788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..||+||||.||+|.+.-+ -.+++++.++..+.+..++||+|||+.+ -+|||||-.|||+++.|.+||+|||.+-
T Consensus 85 dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 99999999999999998764 4568999999999999999999999998 8999999999999999999999999987
Q ss_pred cCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
.+...- .....+.||+.|||||+.. .+.|...+|||++|++..|+--.++|.....+.....+.. ...+.
T Consensus 161 qitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~q--- 233 (829)
T KOG0576|consen 161 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGFQ--- 233 (829)
T ss_pred hhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCCC---
Confidence 653321 1234588999999999874 6789999999999999999998888876554432221111 00000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
-..+-|+. .....+.+|++.||..+|.+||++..+|.
T Consensus 234 -pp~lkDk~-------kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 -PPTLKDKT-------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -CCcccCCc-------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00111111 23467889999999999999999987764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=288.17 Aligned_cols=245 Identities=28% Similarity=0.396 Sum_probs=188.5
Q ss_pred CCCCCccccccCcE-EEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGC-VFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~-Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 144 (422)
|.-.+++|.|+-|+ ||+|.+ .|+.||||++-... ..-..+|+..|+.- +|||||++++.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-----------e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-----------EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-----------CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44456789999986 899998 57799999986432 23467999999888 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCC---CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---C--CCeEE
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---D--YNAKL 216 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~--~~~kl 216 (422)
..||+.|.| ..+|.+++......+ .....+.++.|++.||++||+.+ ||||||||.||||+. + .+++|
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence 999999999 559999996631111 11345788999999999999998 999999999999965 3 46899
Q ss_pred eeccCcccCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhh
Q 014585 217 SDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~ 294 (422)
+|||+++....+.... ......||-+|+|||++....-+.++|||||||++|+.++| ..||...-.... +++
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl----- 726 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NIL----- 726 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhh-----
Confidence 9999999876554332 23446799999999999988888899999999999999997 789976432211 111
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.....+..+.. ..++ ++.+||.+|+..+|..||++.+++.|
T Consensus 727 --~~~~~L~~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 727 --TGNYTLVHLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --cCccceeeecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 01111111100 0111 88999999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=272.32 Aligned_cols=199 Identities=24% Similarity=0.329 Sum_probs=171.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--------HHHHHHHHHHhcccC---CC
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLV---HL 131 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---h~ 131 (422)
...+|..++.||+|+||.|++|.++. ....|+||.+.+...-. .-.+-.||+||..|+ |+
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~ 629 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHE 629 (772)
T ss_pred ccccceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCcc
Confidence 34579999999999999999999987 45589999997654321 112457999999997 99
Q ss_pred cceeeEeEEEecCceEEEEEec-CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC
Q 014585 132 NLVKLIGYCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210 (422)
Q Consensus 132 niv~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~ 210 (422)
||++++++|.+++.+||+||-- +|-+|.++| +....+++..+..|++|++.|+++||+++ |||||||-+||.++.
T Consensus 630 NIlKlLdfFEddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 630 NILKLLDFFEDDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDS 705 (772)
T ss_pred chhhhhheeecCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEec
Confidence 9999999999999999999975 456899998 55567999999999999999999999999 999999999999999
Q ss_pred CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCC
Q 014585 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 278 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~ 278 (422)
+|-+||+|||.+.....+ ....++||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus 706 ~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999998764332 2345789999999999999888 567999999999999999988885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=253.97 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=197.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..+|.-++.+|.|.- .|..|.+.. +++.||+|.+.... ....++..+|+..+..+.|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 357888888999988 676776654 67899999986542 233467889999999999999999999986
Q ss_pred ec------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
-. ...|+|||++ ..+|...+. ..++-..+..|+.|++.|++|||+.+ |+||||||+||++..++.+|
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhhee
Confidence 43 3568999999 669999886 35677889999999999999999999 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH------
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 289 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~------ 289 (422)
|+|||+|+..... ...+..+.|..|.|||++.+..|...+||||+||++.||++|.-.|.+....+.-..+
T Consensus 159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 9999999875332 2344567899999999999988999999999999999999999988754322111100
Q ss_pred ----------Hhhhhhhhcc-----cccccccCc-ccCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 290 ----------EWARPHLGER-----RRFYRLIDP-RLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 290 ----------~~~~~~~~~~-----~~~~~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..++...... ..+.+.+.. .+.. ..+......+.+++.+||..||++|-+++++|++
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000000 111111111 1110 0111224568899999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=245.84 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=189.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeE-EE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY-CI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~ 141 (422)
.+.|.+.+.||+|.||.+.++.++. ++..+++|.+.... ....+|.+|+..--.| .|.||+.-|++ |.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 3578999999999999999999987 77899999987664 4467899999877666 58899987765 55
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE-c-CCCCeEEeec
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-D-ADYNAKLSDF 219 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill-~-~~~~~kl~DF 219 (422)
..+.+++++||++.|+|..-+.. ..+.+.....++.|++.||.|||+.+ +||||||.+|||| + +..++|||||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence 66778899999999999988754 35788899999999999999999998 9999999999999 2 3357999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccC---C--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---G--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+.+....... ...-+..|.+||.... + ...+.+|+|.||+++|.++||..||+... ..+....+|...
T Consensus 168 G~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w 241 (378)
T KOG1345|consen 168 GLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQW 241 (378)
T ss_pred ccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHH
Confidence 99986432211 1234567999997652 2 23678999999999999999999998432 222333333322
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVE 345 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~ell~ 345 (422)
.-.... .+...|. ..+..+.++.++-|..++++| .+.+....
T Consensus 242 ~~rk~~--------~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 242 LKRKNP--------ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hcccCc--------cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 211111 2222221 234678899999999999999 44444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=239.83 Aligned_cols=212 Identities=36% Similarity=0.570 Sum_probs=184.6
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 151 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 151 (422)
||+|++|.||++.... +|+.+++|++...... ....+.+|++.++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999998865 5778999999866543 34578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-CCCeEEeeccCcccCCCCCc
Q 014585 152 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDK 230 (422)
Q Consensus 152 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~~~~kl~DFG~a~~~~~~~~ 230 (422)
|+++++|.+++......+++..++.++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 99989999998655456899999999999999999999998 999999999999999 89999999999987644321
Q ss_pred cceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcc
Q 014585 231 THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309 (422)
Q Consensus 231 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (422)
......+...|++||.+... .++.+.|+|++|+++++|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence 12224578899999998877 888999999999999999
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 310 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
..+.+++.+|+..||.+||++.+++++|
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=237.47 Aligned_cols=200 Identities=33% Similarity=0.418 Sum_probs=174.1
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCc
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 145 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 145 (422)
|.+.+.||.|++|.||+|.+.. ++..+|+|.+...... ..+.+.+|+..+++++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5677899999999999998865 5678999999876554 56778899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
.++++||+++++|.+++......+++..++.++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||.+...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 99999999999999998654433899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccceeeccccCccccCCCcc-cCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 279 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~ 279 (422)
...... ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 543211 12235678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=248.93 Aligned_cols=272 Identities=25% Similarity=0.325 Sum_probs=201.9
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeE
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLI 137 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 137 (422)
.+....+.|.++++||+|.|++||++.+... ...++.||+|.+..... ..++.+|+++|..+ -+.||+++.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~ 101 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLN 101 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcch
Confidence 3445667899999999999999999988763 22567899999976643 35789999999999 589999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-CCCeEE
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKL 216 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~~~~kl 216 (422)
+++..++...+||||+++....++.. .++...+..+++.++.||.++|.+| ||||||||.|+|.+. .+.-.|
T Consensus 102 ~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 102 GCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred hhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence 99999999999999999998888773 3668889999999999999999999 999999999999975 477899
Q ss_pred eeccCcccCCCCC------------------------------------------ccceeeccccCccccCCCcccC-CC
Q 014585 217 SDFGLAKDGPEGD------------------------------------------KTHVSTRVMGTYGYAAPEYVMT-GH 253 (422)
Q Consensus 217 ~DFG~a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~ 253 (422)
+|||+|....... .........||++|.|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999987210000 0001113579999999999874 56
Q ss_pred CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh----------hhhhcc---------------cccccccC-
Q 014585 254 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----------PHLGER---------------RRFYRLID- 307 (422)
Q Consensus 254 ~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----------~~~~~~---------------~~~~~~~~- 307 (422)
.++++||||.|||++-++++..||........ .+.+.+. ..+... ..-++-++
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 78999999999999999999999975433211 1111000 000000 00000000
Q ss_pred cc---------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 308 PR---------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 308 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .........+..+.+|+.+||..||.+|.++++.|++
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 0001111234578999999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=226.52 Aligned_cols=263 Identities=19% Similarity=0.224 Sum_probs=209.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 143 (422)
-.|+++++||+|.||.++.|.+.- +++.||||...... ...++..|.+..+.| ..++|..++-+...+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecccccc---------cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 479999999999999999999877 67899999876443 224577888888888 578999999888888
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-----CCeEEee
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNAKLSD 218 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-----~~~kl~D 218 (422)
.+..||||++ |.+|+|++.-.+..|+...+..++.|++.-++|+|++. +|.|||||+|+||... ..|.|+|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence 8889999999 88999999778889999999999999999999999999 9999999999999654 3488999
Q ss_pred ccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 219 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 219 FG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
||+|+.+.+.... ....+..||.+||+-....+.+.+.+.|+-|||-+++++|-|..||++........--+
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe--- 249 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE--- 249 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---
Confidence 9999987654322 22345789999999999999999999999999999999999999999876543322111
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.+++.++. .-...++...+.++..-+.-.-..+..+-|+++-+...+..+..
T Consensus 250 -KIGe~Kr~------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 250 -KIGETKRS------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred -Hhcccccc------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11111111 11112233456777788888888889999999887776655443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=275.10 Aligned_cols=197 Identities=20% Similarity=0.256 Sum_probs=141.4
Q ss_pred ccCC-CcceeeEeEE-------EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 014585 127 DLVH-LNLVKLIGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 198 (422)
Q Consensus 127 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiH 198 (422)
.+.| .||++++++| .....++++|||+ +++|.+++......+++..++.++.||++||.|||+++ |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4455 5788888877 2334567889988 67999999765667999999999999999999999988 999
Q ss_pred ccCCCCcEEEcCC-------------------CCeEEeeccCcccCCCCCc--------------cceeeccccCccccC
Q 014585 199 RDFKTSNILLDAD-------------------YNAKLSDFGLAKDGPEGDK--------------THVSTRVMGTYGYAA 245 (422)
Q Consensus 199 rDlkp~Nill~~~-------------------~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~a 245 (422)
|||||+||||+.. +.+||+|||+++....... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4455666666553211000 000112468999999
Q ss_pred CCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHH
Q 014585 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 325 (422)
Q Consensus 246 PE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 325 (422)
||++.+..|+.++|||||||+||||++|.+|+..... ...... . ..+++.. ......+.++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~----~-----~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR----H-----RVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH----H-----hhcChhh-----hhcCHHHHHH
Confidence 9999999999999999999999999998887653210 000000 0 0111110 0112345688
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 014585 326 AAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 326 i~~~l~~dp~~Rps~~ell~~ 346 (422)
+.+||+.||.+||++.+++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 999999999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=216.01 Aligned_cols=264 Identities=20% Similarity=0.211 Sum_probs=210.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC-CcceeeEeEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYC 140 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~ 140 (422)
+....|+++++||+|+||.+|+|.... +|..||||+..... ....+..|.++.+.|++ ..|..+..+.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 345789999999999999999999877 78899999986553 23467889999999965 6788888888
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC---CCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~---~~~kl~ 217 (422)
.+.....+||+.+ |.+|++++.-....++...++.++.|++.-++|+|.++ +|||||||+|+|..-+ ..+.|+
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEE
Confidence 8889999999999 89999999777788999999999999999999999999 9999999999999543 468999
Q ss_pred eccCcccCCCCCc-----cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 218 DFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 218 DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
|||+|+.+.+... ........||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||++..+.......+.+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 9999998754332 22234578999999998888888999999999999999999999999987665443322221
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. ..-......++...+.++.-.+.-|-..--++-|+..-+.+.+..+
T Consensus 237 ~E----------kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 237 SE----------KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HH----------hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 11 1111111223334567888899999999999999988877766544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=230.48 Aligned_cols=262 Identities=23% Similarity=0.231 Sum_probs=200.3
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC----CcceeeEeEE-
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH----LNLVKLIGYC- 140 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~- 140 (422)
+|.+.++||+|+||.||+|.+.... ...+|+|............+..|+.++..+.. .++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 8999999999999999999986521 35789999876544333367888888888863 5899999998
Q ss_pred EecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-----CCe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNA 214 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-----~~~ 214 (422)
..+...+|||+.+ |.+|.++..... ..++...+..|+.|++.+|.+||+.| ++||||||+|+++... ..+
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence 4777889999999 889999885554 78999999999999999999999999 9999999999999765 468
Q ss_pred EEeeccCcc--cCCCCCcc----c-e-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 014585 215 KLSDFGLAK--DGPEGDKT----H-V-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286 (422)
Q Consensus 215 kl~DFG~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 286 (422)
.|.|||+++ .+...... . . ...+.||..|+++.+..+...+.+.|+||++.++.||+.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999999 43222211 1 1 12356999999999999999999999999999999999999999765433221
Q ss_pred hhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
........ . ..... +....+.++.++...+-..+..++|.+..+...|+....
T Consensus 247 ~~~~~~~~----~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 247 SKFEKDPR----K----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHHHHhh----h----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11110000 0 00000 111234567777777778999999999999988765443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=210.00 Aligned_cols=166 Identities=25% Similarity=0.253 Sum_probs=126.5
Q ss_pred CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceee
Q 014585 156 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235 (422)
Q Consensus 156 g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 235 (422)
|+|.+++..+...+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999766677999999999999999999999865 999999999999999 99988654321
Q ss_pred ccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCC
Q 014585 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 315 (422)
Q Consensus 236 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (422)
..||+.|+|||++.+..++.++|||||||++|||++|..||....... ............ . .+. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~------~-~~~-~~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA------D-DPR-DRSNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc------C-Ccc-ccccH
Confidence 258999999999999999999999999999999999999996543211 111111100000 0 000 00011
Q ss_pred HHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 316 IKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 316 ~~~~~--~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
..... ++.+++.+||..||.+||++.++++++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 12223 68999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=224.24 Aligned_cols=177 Identities=18% Similarity=0.159 Sum_probs=134.3
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-----cccHHHHHHHHHHhcccCCCccee-
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVK- 135 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~- 135 (422)
....+|.+.+.||+|+||+||+|.+... +++.||||++.... ......+.+|+++|++++|+|++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 4457899999999999999999987642 45678999875331 112456889999999999999985
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCcEEEcCCCCe
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNA 214 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl-kp~Nill~~~~~~ 214 (422)
+++ .+..+|||||++|++|.. +... . ...++.|+++||.|||+.+ |+|||| ||+|||++.++.+
T Consensus 87 l~~----~~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 87 LLA----TGKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred EEE----cCCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence 443 256899999999999963 2111 1 1467889999999999988 999999 9999999999999
Q ss_pred EEeeccCcccCCCCCccce------eeccccCccccCCCcccCCC------CCchhhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVMTGH------LTSRSDVY 261 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 261 (422)
||+|||+|+.......... .....+++.|+|||.+.... .+...|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999987654331111 12467889999999886322 23346766
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-27 Score=239.36 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=188.9
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEec----CC-Cccc-HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HD-GLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
....++|.|++|.|+.+..... ...++.|.+. .. .... ...+..|+.+-..|.|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~---------~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD---------LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCC---------CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 4567899999998877765542 2223333332 11 1111 112667888999999999988777776
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.....-+||||++ +|..++... ..+....+..++.|++.||.|||..| |.|||||++|++++.+|.+||+|||.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCc
Confidence 66555556999999 999988544 46888889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcc--ceeeccccCccccCCCcccCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+..+...... ......+|+..|+|||++.+..|+. ..||||.|++++.|.+|+.||............. ....
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~ 542 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSD 542 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----cccc
Confidence 9876555444 5566789999999999999999976 6999999999999999999997654433321000 0000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
... ... -........+.+.+.+|.+||+.||.+|.++.+|++
T Consensus 543 ~~~---~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 QRN---IFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc---ccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 000 000112244677889999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=206.90 Aligned_cols=259 Identities=32% Similarity=0.420 Sum_probs=197.7
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCC-cceeeEeEEEe
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHL-NLVKLIGYCIE 142 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~-niv~~~~~~~~ 142 (422)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +|+++++++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 677889999999999999875 368999987655433 56789999999999988 79999999977
Q ss_pred cCceEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl~DF 219 (422)
....+++++++.+++|.+++.... ..+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence 777899999999999997664443 27899999999999999999999999 99999999999999988 6999999
Q ss_pred cCcccCCCCCccc----eeeccccCccccCCCcccC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC-CcchhHHh
Q 014585 220 GLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEW 291 (422)
Q Consensus 220 G~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~ 291 (422)
|++.......... ......|+..|+|||.+.+ ..+....|+|++|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9998654433221 2345789999999999987 57889999999999999999999997655431 00111111
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....... .................+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1100000 000000000001223578899999999999999998877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=198.09 Aligned_cols=174 Identities=9% Similarity=0.076 Sum_probs=135.2
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHH---------HHHHHHHhcccCCC
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGDLVHL 131 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~ 131 (422)
+....+|++.++||.|+||.||++.. ++..+|||++.......... +.+|++.+.++.|+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 35678999999999999999998644 24469999997554333222 57899999999999
Q ss_pred cceeeEeEEEec--------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 014585 132 NLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 203 (422)
Q Consensus 132 niv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 203 (422)
+|..+.+++... +..+|||||++|.+|.++. .++. ....+++.+|..||..+ ++||||||
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp 163 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHK 163 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCCh
Confidence 999999886643 3578999999999998763 2232 34568999999999999 99999999
Q ss_pred CcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh
Q 014585 204 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272 (422)
Q Consensus 204 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 272 (422)
+||+++.+| ++|+|||............ .++....|..++|+|+||+++..+..
T Consensus 164 ~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 164 GNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred HHEEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence 999999988 9999999887653211100 03445567789999999999887653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=196.48 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=191.3
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
..+..+|.+...|..|+|++.. ..+++|++....... .++|..|.-.|+-+.||||+.+++.|....
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 3445678999999999999954 457788886554332 357999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe--eccC
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS--DFGL 221 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~--DFG~ 221 (422)
++.++..|++.|+|+..++... -..+-.++.+++.++++|++|||+..+ -|.---|....++||++.+.+|. |--+
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccccee
Confidence 9999999999999999997653 346778889999999999999999873 24444689999999999887763 3222
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCC---CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+.. .....-.+.||+||.+...+- -.++|+|||.+++|||.|..-||....+.+.-..+
T Consensus 340 sfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--------- 401 (448)
T KOG0195|consen 340 SFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--------- 401 (448)
T ss_pred eee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------
Confidence 211 111233789999999986554 34799999999999999999999987765432111
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.-..+.-+.++..+..+.+|+.-|+..||.+||.++.++-.|+++
T Consensus 402 -------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 402 -------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 111223344556677889999999999999999999999888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=185.29 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=108.3
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--c-------H-----------------HHHHHHHH
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--G-------H-----------------KEWLAEVN 123 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~ 123 (422)
...||+|+||.||+|.+. +|+.||||+++..... . . .....|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 468999999999999873 5779999999754221 1 0 11245999
Q ss_pred HhcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccCC
Q 014585 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRDFK 202 (422)
Q Consensus 124 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~~~~iiHrDlk 202 (422)
++.++.++++.....+.. ...+|||||++|++|...+.. ...+++..+..++.|++.+|.|| |+.+ |+|||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlk 145 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLS 145 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999998877644333322 234899999988777655433 35789999999999999999999 6888 9999999
Q ss_pred CCcEEEcCCCCeEEeeccCcccC
Q 014585 203 TSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 203 p~Nill~~~~~~kl~DFG~a~~~ 225 (422)
|+|||++ ++.++|+|||+|...
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccC
Confidence 9999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-25 Score=213.21 Aligned_cols=241 Identities=27% Similarity=0.348 Sum_probs=187.3
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH--HHHHHHHHHhcccC-CCcceeeEeEEEecCceEE
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 148 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 148 (422)
.+|+|+||.|+++.-... ...|..+|+|+.++...... .....|-.++..++ ||.+|+++-.+..+...++
T Consensus 1 vlg~g~~gkvfLvrk~~g------~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGG------ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhcc------ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 379999999998754331 12567799999876543221 13456777888886 9999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 149 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
++++..||.|...+.+ ...+.+.....+...++-++.++|+.+ |+|||+|++||+++.+|++++.|||+++.....
T Consensus 75 ~ld~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9999999999888744 445777777788888999999999999 999999999999999999999999999876443
Q ss_pred CccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCc
Q 014585 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 308 (422)
Q Consensus 229 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (422)
... |||..|||||++. ....++|.||||++++||++|..||.. .... . ++
T Consensus 151 ~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~---~----------Il-- 200 (612)
T KOG0603|consen 151 KIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMK---R----------IL-- 200 (612)
T ss_pred hhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHH---H----------Hh--
Confidence 322 8999999999988 677899999999999999999999976 1110 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHhCCCCC
Q 014585 309 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPN 352 (422)
Q Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~ 352 (422)
...-.++......+.+++..++..+|.+|.-.. +.+..++....
T Consensus 201 ~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f 245 (612)
T KOG0603|consen 201 KAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEF 245 (612)
T ss_pred hhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccch
Confidence 011223446678899999999999999998653 34444443333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=192.69 Aligned_cols=232 Identities=21% Similarity=0.276 Sum_probs=150.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCC----------Cc
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVH----------LN 132 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~n 132 (422)
.+...+.||.|+|+.||.+.+.+ ||+.+|||++..... ...+.+.+|.-....+.+ -.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 34556789999999999999987 899999999865442 224556666655544322 12
Q ss_pred ceeeEeEEE---------ec---C-----ceEEEEEecCCCChhhhhc---cCC---CCCCHHHHHHHHHHHHHHHHHHH
Q 014585 133 LVKLIGYCI---------ED---D-----QRLLVYEFMPRGSLENHLF---RRS---LPLPWSIRMKIALGAAKGLAFLH 189 (422)
Q Consensus 133 iv~~~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~---~~~~~~~~~~i~~qi~~al~~LH 189 (422)
++..++... .. . ..+++|+-+ .++|.+++. ... ..+....+..+..|+++.+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 332223222 11 1 236788888 568888763 111 12344556777899999999999
Q ss_pred hcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC--------CCCCchhhhh
Q 014585 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVY 261 (422)
Q Consensus 190 ~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvw 261 (422)
..| ++|+||+|+|+|++.+|.++|+||+......... .. ...+..|.+||.... -.++.+.|.|
T Consensus 163 ~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW 234 (288)
T PF14531_consen 163 SYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAW 234 (288)
T ss_dssp HTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred hcc---eEecccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence 999 9999999999999999999999999887643211 11 234577999997643 2578899999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 014585 262 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337 (422)
Q Consensus 262 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 337 (422)
+||+++|.|++|..||....+...... ...... +.++.++.||..+|+.||.+|
T Consensus 235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 235 QLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999999999986543221110 112233 677899999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=177.74 Aligned_cols=141 Identities=17% Similarity=0.134 Sum_probs=110.7
Q ss_pred CCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--------------------------HHHHHHHH
Q 014585 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------------------HKEWLAEV 122 (422)
Q Consensus 69 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~E~ 122 (422)
+.+.||+|+||.||+|.+. +|+.||||+++...... ...+..|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 70 (190)
T cd05145 1 INGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF 70 (190)
T ss_pred CCceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence 3578999999999999863 47799999997653110 11235789
Q ss_pred HHhcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccC
Q 014585 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDF 201 (422)
Q Consensus 123 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDl 201 (422)
+.+.++.|++|.....+... ..+|||||++|+++...... ...++...+..++.|++.+|.+||. .+ |+||||
T Consensus 71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDl 144 (190)
T cd05145 71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDL 144 (190)
T ss_pred HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 99999999987554444332 34899999988755443222 3457888999999999999999999 88 999999
Q ss_pred CCCcEEEcCCCCeEEeeccCcccCC
Q 014585 202 KTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 202 kp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
||+|||++ ++.++|+|||++....
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999 8899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=212.01 Aligned_cols=201 Identities=19% Similarity=0.214 Sum_probs=162.1
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC---CCcce
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLV 134 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv 134 (422)
.++++....|.|.+.||+|+||+||+|... .|+.||+|+-+....-. |.-=.+++.+|+ -+-|.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~----------~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~ 757 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHS----------NGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIM 757 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecC----------CCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchH
Confidence 345566788999999999999999999875 36789999987655322 222222233333 34566
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC----
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---- 210 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---- 210 (422)
.+...+...+..+||+||.+.|+|.+++. ..+.+++..++.+..|++..|+.||..+ |||+||||+|+||..
T Consensus 758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 758 HISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICA 833 (974)
T ss_pred HHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCC
Confidence 67777777888899999999999999994 6678999999999999999999999999 999999999999942
Q ss_pred ---CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCC
Q 014585 211 ---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 275 (422)
Q Consensus 211 ---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 275 (422)
...++|+|||.+..+..--........++|-.+-.+|+..|.+|++.+|.|.|+.+++-||.|+.
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 34589999999977543333334555788999999999999999999999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=174.27 Aligned_cols=187 Identities=18% Similarity=0.081 Sum_probs=138.1
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc----HHHHHHHHHHhcccC-CCcceeeEeEEEe
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGDLV-HLNLVKLIGYCIE 142 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 142 (422)
.+...|++|+||+||++.. .+..++.+.+.....-. ...+.+|+++|++|. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 4567899999999997654 45577777776543311 124789999999995 5789999886
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl-kp~Nill~~~~~~kl~DFG~ 221 (422)
+..+++|||+.|.+|...+.. . ...++.|++.+|.++|+.| |+|||| ||+|||++.++.++|+|||+
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCC
Confidence 456999999999888654311 1 1357789999999999999 999999 79999999999999999999
Q ss_pred cccCCCCCcc----ce-------eeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCC
Q 014585 222 AKDGPEGDKT----HV-------STRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280 (422)
Q Consensus 222 a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~ 280 (422)
+......... .. ..-...++.|++|+...- ..--...++++.|+-+|.++|+..++...
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9865433210 00 001235677777775432 22235789999999999999999877544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=187.17 Aligned_cols=262 Identities=20% Similarity=0.245 Sum_probs=171.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCC-------CC----CC---------------CCcEEEEEEecCCCccc-H-
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VK----PG---------------TGLTVAVKTLNHDGLQG-H- 115 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~-------~~----~~---------------~g~~vavK~~~~~~~~~-~- 115 (422)
.++|+++..||+|.-..||.|....++... .. +. ..-..|||++-.-...+ .
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 457999999999999999999876532210 00 00 01145677664322221 1
Q ss_pred ---HHHHHHHH--------------Hhcc--------cCCCcceeeEeEEEe---------------------------c
Q 014585 116 ---KEWLAEVN--------------FLGD--------LVHLNLVKLIGYCIE---------------------------D 143 (422)
Q Consensus 116 ---~~~~~E~~--------------~l~~--------l~h~niv~~~~~~~~---------------------------~ 143 (422)
+.+.+|+- ..+. -.|||||+++++|.+ .
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 11222210 1111 259999999988753 2
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE--cCCC--CeEEeec
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADY--NAKLSDF 219 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill--~~~~--~~kl~DF 219 (422)
..+|+||..++. +|..++-.+ ..+.....-++.|+++|+.|||.++ |.|||||.+|||| ++|+ .++|+||
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccc
Confidence 356899999854 999988544 3556667788899999999999999 9999999999999 4443 3689999
Q ss_pred cCcccCCCCCcc----ceeeccccCccccCCCcccCCC------CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 220 GLAKDGPEGDKT----HVSTRVMGTYGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 220 G~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
|++-........ ...-..-|.-.-||||+....+ --.|+|.|+.|.+.||++....||...-.... +.-
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r 468 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTR 468 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chh
Confidence 987543321111 0111245778899999886422 12489999999999999999999986321110 000
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
.+ .+.--| .++..++..+++++..+|+.||.+|++..-....|
T Consensus 469 ~Y-----------qe~qLP----alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 469 TY-----------QESQLP----ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hh-----------hhhhCC----CCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 01 011111 12334567889999999999999999876555444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-23 Score=210.56 Aligned_cols=212 Identities=26% Similarity=0.384 Sum_probs=151.0
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+|..+++|..|+||.||+++++. +.+.+|+| +++... +++- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~---------trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV-------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccc---------cccchhhc-ccccch-----hhhc--cccccCCccee--------
Confidence 34689999999999999999999876 67789984 433321 1111 22233333333
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
|+-...+ +..+.++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||++
T Consensus 136 -------------gDc~tll-k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 -------------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred -------------chhhhhc-ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhh
Confidence 3444444 3334555443 67899999998 999999999999999999999999998
Q ss_pred ccCCCCCcc-------------ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 223 KDGPEGDKT-------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 223 ~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
+........ ......+||+.|.|||++....|+..+|+|++|+|+||++.|..||.+..+......+
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 754221111 0112368999999999999999999999999999999999999999988664332111
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 339 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 339 (422)
+.+...+.+- ....+.++++++.++|+.+|..|.-
T Consensus 271 ------isd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 271 ------ISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ------hhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1111111111 1123478999999999999999973
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=173.80 Aligned_cols=137 Identities=19% Similarity=0.192 Sum_probs=107.0
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-----CCCcceeeEeEEEe
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-----VHLNLVKLIGYCIE 142 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~ 142 (422)
.-.++||+|+||.||. +.. ++.. +||++........+.+.+|+++++.+ .||||++++|++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 3356899999999995 433 3334 69998765545567799999999999 57999999999988
Q ss_pred cC---ceE-EEEEe--cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeccCCCCcEEEcCC----
Q 014585 143 DD---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL-AFLHEEAERPVIYRDFKTSNILLDAD---- 211 (422)
Q Consensus 143 ~~---~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al-~~LH~~~~~~iiHrDlkp~Nill~~~---- 211 (422)
+. .++ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++.+
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESE 145 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCC
Confidence 63 334 78999 5579999999543 36655 35677888777 9999999 9999999999999743
Q ss_pred CCeEEeeccCcc
Q 014585 212 YNAKLSDFGLAK 223 (422)
Q Consensus 212 ~~~kl~DFG~a~ 223 (422)
+.++|+||+.+.
T Consensus 146 ~~~~LiDg~G~~ 157 (210)
T PRK10345 146 VIPVVCDNIGES 157 (210)
T ss_pred CcEEEEECCCCc
Confidence 479999955443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-23 Score=210.03 Aligned_cols=251 Identities=23% Similarity=0.270 Sum_probs=179.5
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHH---HHHHHHHHhcccCCCcceeeEeEEE
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHK---EWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. .-... +.+.|++ ...++|||++.+.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 57778899999999999998754 44 8899986543 22333 4445555 55669999999988877
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+...|||-+|..+ +|+|.+ .-+..+..-..+.|+.||+.||.-+|..+ |+|||||.+||||+.=.=+.|+||..
T Consensus 92 t~kAAylvRqyvkh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccc
Confidence 77888999999955 999988 34445777788889999999999999999 99999999999998877789999987
Q ss_pred cccC--CCCCccc---eeeccccCccccCCCcccCC----------C-CCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 014585 222 AKDG--PEGDKTH---VSTRVMGTYGYAAPEYVMTG----------H-LTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 284 (422)
Q Consensus 222 a~~~--~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 284 (422)
-+.. +..+... ...+-..-..|.|||-+... . .+++-||||+||+++||++ |+++|.-.
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---- 242 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---- 242 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence 6542 2211111 11111123469999977531 2 5678999999999999998 67888532
Q ss_pred cchhHHhhhhhhhcc-cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 285 EHNLVEWARPHLGER-RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.+..+........ ..+.++-| ..++.++..|++.||.+|.++++.|+.-..+.
T Consensus 243 --QL~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 243 --QLLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred --HHHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1122111100000 11111112 35789999999999999999999998755443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=192.29 Aligned_cols=219 Identities=25% Similarity=0.382 Sum_probs=167.3
Q ss_pred hcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 125 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+......+++.....++++|+.||+|||...- ..|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeeccc
Confidence 467899999999999999999999999999999999998878889999999999999999999998661 399999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC---C----CCchhhhhhHHHHHHHHHhCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---H----LTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DvwslG~il~elltg~~pf 277 (422)
|++++....+||.|||+.................-...|.|||.+.+. . .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776431111111112235579999998763 1 466799999999999999999999
Q ss_pred CCCCCCCcc-hhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 014585 278 DKNRPNGEH-NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 353 (422)
Q Consensus 278 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 353 (422)
......... .++..... .....+.|.+.... ....++..++..||..+|.+||++..+-..++.+...
T Consensus 159 ~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 865433332 22222111 01111222222111 3344789999999999999999999999988776553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=168.62 Aligned_cols=143 Identities=18% Similarity=0.165 Sum_probs=111.2
Q ss_pred CCCCCCccccccCcEEEEEE-eccCCCCCCCCCCCcEEEEEEecCCCcc------------------------cHHHHHH
Q 014585 66 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------------GHKEWLA 120 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~-~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------------~~~~~~~ 120 (422)
.|.+.+.||+|+||.||+|. +.. +|+.||||++...... ....+..
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 48899999999999999998 433 6789999998754311 0123568
Q ss_pred HHHHhcccCCCc--ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 014585 121 EVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 198 (422)
Q Consensus 121 E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiH 198 (422)
|+.++.++.+.+ +.+++++ ...+|||||++|++|...+.. ...+....+..++.|++.+|.+||..+. |+|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH 172 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGE--LVH 172 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEe
Confidence 999999997533 3444443 235899999998888766533 2346666778999999999999998653 999
Q ss_pred ccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 199 RDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 199 rDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
|||||+||+++ ++.++|+|||.+...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-20 Score=164.46 Aligned_cols=134 Identities=18% Similarity=0.260 Sum_probs=112.6
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--------HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
+.||+|++|.||+|.+ .|..|++|+........ ...+.+|+.++..+.|++|.....++..
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 5799999999999986 45578999865432211 1357789999999999998887777777
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||++|++|.+++.... . .+..++.+++.+|.+||+.+ ++||||+|.|||++ ++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcc
Confidence 888999999999999999885432 2 77899999999999999998 99999999999999 789999999988
Q ss_pred cc
Q 014585 223 KD 224 (422)
Q Consensus 223 ~~ 224 (422)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 65
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=187.13 Aligned_cols=173 Identities=25% Similarity=0.406 Sum_probs=130.2
Q ss_pred ceEEEEEecCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 145 QRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+||.|++|...+|.++|..+ ....++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999533 4557888999999999999999 56 999999999999999999999999999
Q ss_pred ccCCCCC----ccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 223 KDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 223 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
....... .....+..+||..||+||++.+..|+.++||||||++|+||+. -...|...... . .+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~------~----d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL------T----DIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh------h----hhh
Confidence 8765543 1222345789999999999999999999999999999999997 22222211000 0 000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 343 (422)
...+++.....+ ++-..|+.++|...|.+||++.+.
T Consensus 474 -----~g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 -----DGIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -----cCCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 012222222222 244589999999999999955443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=160.84 Aligned_cols=130 Identities=21% Similarity=0.318 Sum_probs=106.3
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.||+|+||.||+|.+ .|..|++|........ ...++.+|++++..+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999985 4567999986543211 124577899999999988766555556667
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||++|++|.+++..... .++.+++.+|.+||+.+ ++|||++|+||+++ ++.++++|||++.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 778999999999999988743221 78899999999999998 99999999999999 8899999999987
Q ss_pred c
Q 014585 224 D 224 (422)
Q Consensus 224 ~ 224 (422)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 5
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-19 Score=158.35 Aligned_cols=139 Identities=17% Similarity=0.068 Sum_probs=109.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc----------------------cHHHHHHHH
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEV 122 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~ 122 (422)
..|.+.+.||+|+||.||+|... +|+.||||++...... .......|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 84 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF 84 (198)
T ss_pred chhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence 34888999999999999999763 5778999987643210 011256789
Q ss_pred HHhcccCCCc--ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 014585 123 NFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 200 (422)
Q Consensus 123 ~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrD 200 (422)
.++..+.|.+ +...++ ....++||||++|++|.++... .....++.+++.++.++|+.+ |+|||
T Consensus 85 ~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 85 AALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 9999998774 444443 3456899999999998775421 335678899999999999988 99999
Q ss_pred CCCCcEEEcCCCCeEEeeccCcccCCC
Q 014585 201 FKTSNILLDADYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 201 lkp~Nill~~~~~~kl~DFG~a~~~~~ 227 (422)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=182.74 Aligned_cols=138 Identities=22% Similarity=0.287 Sum_probs=111.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--c------ccHHHHHHHHHHhcccCCCccee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--L------QGHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~ 135 (422)
...|...++||+|+||+||+|.+.. ..+++|+..... . ...+++.+|+++++.++|++++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 400 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence 3456778999999999999998743 234444432111 1 11245789999999999999998
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
...++......++||||++|++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ .++.++
T Consensus 401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred eEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEE
Confidence 8888777778899999999999998874 35678999999999999988 9999999999999 678999
Q ss_pred EeeccCcccC
Q 014585 216 LSDFGLAKDG 225 (422)
Q Consensus 216 l~DFG~a~~~ 225 (422)
|+|||+++..
T Consensus 468 liDFGla~~~ 477 (535)
T PRK09605 468 LIDFGLGKYS 477 (535)
T ss_pred EEeCcccccC
Confidence 9999999763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-20 Score=187.50 Aligned_cols=256 Identities=25% Similarity=0.289 Sum_probs=195.2
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccC-CCcceeeEeEEEe
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 142 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 142 (422)
.|.+.+.||+|+|+.|-+.....+ ....+|+|.+.... .........|..+-..+. |.|++.+++....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 466777799999999988776543 33467777776553 222344556888888886 9999999999999
Q ss_pred cCceEEEEEecCCCChhhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeccCCCCcEEEcCCC-CeEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY-NAKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~~~~iiHrDlkp~Nill~~~~-~~kl~DF 219 (422)
.+..+++++|..|+++.+.+ .......+......++.|+..++.|+| ..+ +.||||||+|.+++..+ .++++||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence 99999999999999999988 444436777788889999999999999 877 99999999999999999 9999999
Q ss_pred cCcccCCC-CCccceeecccc-CccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 220 GLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 220 G~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|+|..+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||......... ...|...
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~-- 246 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN-- 246 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc--
Confidence 99998776 444444555788 9999999998885 4467899999999999999999999865433211 1111110
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
...+ .............+++.+++..+|..|.+.+++..
T Consensus 247 --~~~~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 247 --KGRF--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccc--------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000 00111123456778999999999999999877643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-17 Score=139.47 Aligned_cols=135 Identities=21% Similarity=0.132 Sum_probs=113.8
Q ss_pred CCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC--CcceeeEeEEEecCce
Q 014585 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQR 146 (422)
Q Consensus 69 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 146 (422)
+++.||.|.++.||++... +..+++|....... ...+..|+.+++.+.| .+++++++++...+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4578999999999999873 34799999865543 4578899999999976 5899999988888889
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
+++|||++++.+..+ +......++.+++++|++||.....+++|+||+|+||++++.+.++++|||.+..
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999988877654 5566778899999999999986434599999999999999989999999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=145.56 Aligned_cols=139 Identities=20% Similarity=0.147 Sum_probs=98.8
Q ss_pred CCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHH----------------------HHHHHHH
Q 014585 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNF 124 (422)
Q Consensus 69 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~ 124 (422)
+.+.||+|+||+||+|.+. +|+.||||++....... ... ...|...
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 70 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN 70 (187)
T ss_pred CCcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH
Confidence 3578999999999999764 46789999987543211 111 1356666
Q ss_pred hcccCCCc--ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccC
Q 014585 125 LGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDF 201 (422)
Q Consensus 125 l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDl 201 (422)
+.++.+.+ +.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+||||
T Consensus 71 l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl 141 (187)
T cd05119 71 LKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG---LVHGDL 141 (187)
T ss_pred HHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCC
Confidence 66664433 4444443 346899999998554322111110 11 5678899999999999999 88 999999
Q ss_pred CCCcEEEcCCCCeEEeeccCcccCCC
Q 014585 202 KTSNILLDADYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 202 kp~Nill~~~~~~kl~DFG~a~~~~~ 227 (422)
||+||+++ ++.++|+|||.+.....
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred ChhhEEEE-CCcEEEEECcccccccC
Confidence 99999999 89999999999976533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=4e-17 Score=148.53 Aligned_cols=135 Identities=22% Similarity=0.238 Sum_probs=103.4
Q ss_pred Cccc-cccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHhcccCCCcc--e
Q 014585 71 SLLG-EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLVHLNL--V 134 (422)
Q Consensus 71 ~~lg-~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni--v 134 (422)
..|| .||.|+||.+.. .+..++||.+..... .....+.+|+.++.+|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~-----------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEe-----------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4577 888888888876 355789998854221 122457889999999998875 6
Q ss_pred eeEeEEEecCc----eEEEEEecCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 135 KLIGYCIEDDQ----RLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 135 ~~~~~~~~~~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
..+++...... .++|||+++| .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+||||||+|||++
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~ 176 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLD 176 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEc
Confidence 77776544322 2599999997 688888743 245544 3568999999999999 99999999999999
Q ss_pred CCCCeEEeeccCcccC
Q 014585 210 ADYNAKLSDFGLAKDG 225 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~ 225 (422)
.++.++|+|||.+...
T Consensus 177 ~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 177 PDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCEEEEECCCcccC
Confidence 9999999999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-16 Score=155.51 Aligned_cols=252 Identities=25% Similarity=0.292 Sum_probs=190.8
Q ss_pred HhcCCCCCCcccc--ccCcEEEEEEe--ccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhccc-CCCccee
Q 014585 63 ATRNFRPESLLGE--GGFGCVFKGWI--EENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL-VHLNLVK 135 (422)
Q Consensus 63 ~~~~y~~~~~lg~--G~fg~Vy~~~~--~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~ 135 (422)
....|.+.+.+|. |.+|.||.+.. .. ++..+|+|.-+... ......=++|+...+.+ .|+|.++
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~---------s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~ 182 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSE---------SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVR 182 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCccc---------CCcccccccccCCCCCccccccccchhhcccccCccccccc
Confidence 4467888899999 99999999987 44 67789998843222 22233445777777777 5999999
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~----al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
.+..+...+..++-+|+| +.+|..+.......++...++..+.+... ||..+|... ++|-|+||+||++..+
T Consensus 183 ~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 183 DSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSD 258 (524)
T ss_pred cCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccc
Confidence 999999999999999999 67898888777777999999999999999 999999988 9999999999999999
Q ss_pred -CCeEEeeccCcccCCCCCcc---ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 212 -YNAKLSDFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 212 -~~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
...+++|||+........-. ....+..|...|++||. ..+-++.+.|+|++|.++.+..++..++......
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---- 333 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNS---- 333 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCC----
Confidence 88999999999887655422 12223467889999994 4567889999999999999999987665432100
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
.|. .+... .+...+....+.++...+..|++.+|..|+++..+..
T Consensus 334 --~W~--------~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 --SWS--------QLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --Ccc--------ccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 00000 1122222233455666999999999999999887764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.7e-16 Score=138.46 Aligned_cols=204 Identities=23% Similarity=0.298 Sum_probs=141.8
Q ss_pred HHHhcccCCCcceeeEeEEEecC-----ceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 014585 122 VNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAE 193 (422)
Q Consensus 122 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~ 193 (422)
+..|-++.|.|||+++.++.+.. ...++.||+..|+|..+|++ +...+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 44455678999999999987543 46789999999999999964 3456888888999999999999999987
Q ss_pred CCeEeccCCCCcEEEcCCCCeEEeeccCcccCC--CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHH
Q 014585 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP--EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 271 (422)
Q Consensus 194 ~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 271 (422)
++|+|++|..+.|++..+|-+|++--.-..... ............|.++|.+||.-.....+.++|||+||.+..||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 779999999999999999989875211100000 000001111234678899999877777788999999999999998
Q ss_pred hCCCCCCCCCCC-CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 272 TGRRSMDKNRPN-GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 272 tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
.+.---...... .....+.... ..+-++ .-+.++.+|++..|..||++++++.+.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i---------~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVI---------IGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhhhhhhhe---------eeccCc------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 876422111110 0000000000 001111 113688999999999999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.1e-15 Score=145.16 Aligned_cols=141 Identities=21% Similarity=0.152 Sum_probs=97.7
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH------------------------------H---
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH------------------------------K--- 116 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~------------------------------~--- 116 (422)
.+.||.|++|.||+|... +|+.||||+.+....... +
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 367999999999999874 578999999865421110 0
Q ss_pred -------HHHHHHHHhcccC----CCcceeeEeEE-EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHH-
Q 014585 117 -------EWLAEVNFLGDLV----HLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK- 183 (422)
Q Consensus 117 -------~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~- 183 (422)
++.+|.+.+.++. |.+-+.+-.++ ......+|||||++|++|.++......... ...++.+++.
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS 268 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence 1344555555542 32223222222 224557899999999999887643222222 3445666665
Q ss_pred HHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 184 al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
.+..+|..+ ++|+|+||.||+++.++.++|+|||++....
T Consensus 269 ~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 467889888 9999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.9e-14 Score=122.26 Aligned_cols=131 Identities=19% Similarity=0.051 Sum_probs=97.1
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcce-eeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~l 148 (422)
++.|+.|.++.||++.. .|..|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++
T Consensus 3 ~~~l~~G~~~~vy~~~~-----------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEE-----------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 35689999999999976 456799999765432 123467899999988665544 455443 334689
Q ss_pred EEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 149 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
||||++|.++.+.. .....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 69 v~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 69 ITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99999998876531 111345678999999999977 22359999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.1e-13 Score=133.35 Aligned_cols=164 Identities=16% Similarity=0.181 Sum_probs=126.1
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHH
Q 014585 98 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 177 (422)
Q Consensus 98 ~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i 177 (422)
++..|.|+..............+-++.|+.++||||+++++.+..++..|||+|-+ ..|..++.+.+ ...+...
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~~G 109 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVCLG 109 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHHHH
Confidence 67789998887665543455778899999999999999999999999999999998 46766664433 6667778
Q ss_pred HHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCch
Q 014585 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 257 (422)
Q Consensus 178 ~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 257 (422)
+.||+.||.|||+.+. ++|++|.-..|+|+..|..||++|-++......... .....--..|..|+.+.... -.
T Consensus 110 l~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cc
Confidence 8999999999986543 999999999999999999999999988654332210 01111122356666544322 35
Q ss_pred hhhhhHHHHHHHHHhC
Q 014585 258 SDVYSFGVVLLEMLTG 273 (422)
Q Consensus 258 ~DvwslG~il~elltg 273 (422)
.|.|-|||++++++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 7999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-14 Score=143.84 Aligned_cols=145 Identities=17% Similarity=0.120 Sum_probs=96.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-----------------------------
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----------------------------- 114 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~----------------------------- 114 (422)
-..|+. +.||+|++|.||+|+... +|+.||||+.+......
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~ 188 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE 188 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence 345776 789999999999999865 58899999997542110
Q ss_pred -----HH------HHHHHHHHhcccC----CCcceeeEeEEEe-cCceEEEEEecCCCChhhhh--ccCCC---CCCHHH
Q 014585 115 -----HK------EWLAEVNFLGDLV----HLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSI 173 (422)
Q Consensus 115 -----~~------~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~ 173 (422)
.+ ++.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.++- ...+. .+....
T Consensus 189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~ 268 (537)
T PRK04750 189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG 268 (537)
T ss_pred HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence 01 1334444444442 3333443333332 45678999999999998742 22221 133333
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC----CeEEeeccCcccCCCC
Q 014585 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAKDGPEG 228 (422)
Q Consensus 174 ~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~----~~kl~DFG~a~~~~~~ 228 (422)
+..++.|++ ..| ++|+|+||.||+++.+| .++++|||++......
T Consensus 269 v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 269 VEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 444444443 456 99999999999999888 9999999999876443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-12 Score=114.53 Aligned_cols=145 Identities=14% Similarity=0.093 Sum_probs=101.7
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----------------------ccHHHH----HHHHH
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHKEW----LAEVN 123 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------------------~~~~~~----~~E~~ 123 (422)
...||.|--+.||.|....... ....+..+|||+.+.... ...+.+ .+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 4579999999999997542100 011356899999863210 001122 37999
Q ss_pred HhcccCC--CcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecc
Q 014585 124 FLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRD 200 (422)
Q Consensus 124 ~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~~~~iiHrD 200 (422)
.|.++.. -++.+++++ ...+|||||+.++.+..-..+. ..++......+..+++.+|..| |..+ |+|+|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999953 466677764 4678999999665442211121 2355566778889999999999 8888 99999
Q ss_pred CCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 201 FKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 201 lkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3e-12 Score=108.00 Aligned_cols=131 Identities=23% Similarity=0.300 Sum_probs=100.1
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-----cc---cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+++|+-+.+|.+.+ -|..+++|.=.... .. ...+..+|++++.++.--.|...+=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~-----------~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-----------LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeec-----------cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 4689999999999966 34456666532211 11 12346789999999976666655556677
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+...|+|||++|..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..++ +.++|||++
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcc
Confidence 88889999999998998888544 2456777778888999999 99999999999997664 999999999
Q ss_pred cc
Q 014585 223 KD 224 (422)
Q Consensus 223 ~~ 224 (422)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 75
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=132.83 Aligned_cols=248 Identities=21% Similarity=0.158 Sum_probs=176.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHH--HHHHHHHhccc-CCCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
...+|..+..||.|.|+.|+...... .++..|++|.+.........+ -+.|+.+...+ .|.+++.++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~--------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRP--------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecC--------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 44678889999999999999876331 155678999886554443333 24566666666 68899998888
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~~kl~D 218 (422)
|......||=.|||+++++...+ .-...+.+..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 88888888999999999887665 33345778888999999999999999988 9999999999999886 7789999
Q ss_pred ccCcccCCCCCccceeeccccCcccc--CCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYA--APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
||+...+.... ....+.-+++ +++......+-.++|+++||..+.+.+++...-..... |.
T Consensus 411 ~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~---- 473 (524)
T KOG0601|consen 411 FGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL---- 473 (524)
T ss_pred cccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce----
Confidence 99987532211 1122333444 45555567888999999999999999997643221100 00
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.+... .....+ .....+..+.+.+...++..||.+.++..+.+
T Consensus 474 -------~i~~~-~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 -------TIRSG-DTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -------eeecc-cccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000 000111 11266778899999999999999988876554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.7e-12 Score=106.89 Aligned_cols=142 Identities=22% Similarity=0.223 Sum_probs=108.4
Q ss_pred CCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecC-----CCcc---cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-----DGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 69 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~-----~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.+.+|-+|+-+.|+++.+ .|+.++||.-.. .... ...+.++|++.|.++.--.|....=++
T Consensus 11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 567899999999999987 567777776422 1111 234678999999999766776666677
Q ss_pred EecCceEEEEEecCC-CChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC---CeE
Q 014585 141 IEDDQRLLVYEFMPR-GSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAK 215 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~---~~k 215 (422)
.+...-.|+|||++| .++.+++..... .........++..|-+.+.-||..+ |||+||..+||++..++ .+.
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence 788888899999966 378888765432 3333444788999999999999999 99999999999996544 358
Q ss_pred EeeccCccc
Q 014585 216 LSDFGLAKD 224 (422)
Q Consensus 216 l~DFG~a~~ 224 (422)
|+|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1e-13 Score=142.39 Aligned_cols=249 Identities=21% Similarity=0.197 Sum_probs=169.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..+.+.+-+-+|.|+.++.+.-.. +|...++|+...... ...+....+-.++-...+|-++...-.+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~---------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAG---------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccCCccc---------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 456666778899999998775433 454455555433221 11112222323333334566665555555
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.....+||++|+.+++|...++... ..+.+........+.++++|||... +.|+|++|.|+++..+|..++.|||.
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 5677899999999999999886554 4555556666667889999999977 89999999999999999999999984
Q ss_pred cccCCCC-----------------------------CccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh
Q 014585 222 AKDGPEG-----------------------------DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272 (422)
Q Consensus 222 a~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 272 (422)
....... +.........||+.|.+||.+.+......+|+|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 3221100 00011233679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014585 273 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341 (422)
Q Consensus 273 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 341 (422)
|.+||....+......+. ... +. +..-+...+.++.+++...+..+|.+|..+.
T Consensus 1031 g~pp~na~tpq~~f~ni~------~~~-----~~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENIL------NRD-----IP----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhhhhccc------cCC-----CC----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999998776543211110 000 00 0111223456788999999999999998776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-11 Score=110.09 Aligned_cols=142 Identities=20% Similarity=0.228 Sum_probs=109.1
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCC--CcceeeEeEEEec---C
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVH--LNLVKLIGYCIED---D 144 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~ 144 (422)
+.|+.|.++.||++... .|..+++|+...... .....+..|+.+++.+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999999763 245799999865432 134568899999999965 3457777776653 3
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------- 192 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-------------------------------- 192 (422)
..++||||++|.+|.+.+.. ..++......++.+++++|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 66899999999988876532 35777788888889999999888531
Q ss_pred ---------------------CCCeEeccCCCCcEEEcC--CCCeEEeeccCccc
Q 014585 193 ---------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKD 224 (422)
Q Consensus 193 ---------------------~~~iiHrDlkp~Nill~~--~~~~kl~DFG~a~~ 224 (422)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999988 56789999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-10 Score=112.12 Aligned_cols=212 Identities=17% Similarity=0.212 Sum_probs=150.5
Q ss_pred cEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE----ecCceEEEEEecC
Q 014585 79 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMP 154 (422)
Q Consensus 79 g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~ 154 (422)
.+.|+++... +|..|++|++.............-+++++++.|.|||++.++|. .+..+++|++|++
T Consensus 290 ~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 290 ITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred ceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 5689998876 67799999995544443334456678899999999999999887 3557789999997
Q ss_pred C-CChhhhhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 155 R-GSLENHLFR--------------RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 155 ~-g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+ ++|.++... .+...++..+|.++.||..||.++|+.| +..+-|.+.+|+++.+.+++|...
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecc
Confidence 6 477765532 1235788999999999999999999999 999999999999999999999888
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCC-CCCCCCCcchhHHhhhhhhhc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~ 298 (422)
|.......... |.+.+ -.+-|.=.||.+++.|.||..-- ..... .....
T Consensus 438 ~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~------~~s~~----- 487 (655)
T KOG3741|consen 438 GIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST------QSSHL----- 487 (655)
T ss_pred cceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch------HHHHH-----
Confidence 87665433220 11211 23579999999999999986421 11000 00000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
......++.++++++.-+...++++ -+..+++.+
T Consensus 488 -------------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 488 -------------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -------------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 0011244567778888888777776 566666654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-09 Score=100.61 Aligned_cols=124 Identities=15% Similarity=0.096 Sum_probs=91.4
Q ss_pred CCcEEEEEEecCCCccc-H----------HHHHHHHHHhcccCCCc--ceeeEeEEEe-----cCceEEEEEecCCC-Ch
Q 014585 98 TGLTVAVKTLNHDGLQG-H----------KEWLAEVNFLGDLVHLN--LVKLIGYCIE-----DDQRLLVYEFMPRG-SL 158 (422)
Q Consensus 98 ~g~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~~~~~lv~e~~~~g-~L 158 (422)
.|+.|.||......... . ..+.+|++.+.+|..-+ +...+++... ....+||||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 46689999774433110 1 13778999988885433 3455555543 23468999999876 78
Q ss_pred hhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-------CCCeEEeeccCccc
Q 014585 159 ENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-------DYNAKLSDFGLAKD 224 (422)
Q Consensus 159 ~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-------~~~~kl~DFG~a~~ 224 (422)
.+++... ....+......++.+++..+.-||..| |+|+||++.|||++. ++.+.|+||+.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 8887432 234566777899999999999999999 999999999999975 46799999998854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.6e-09 Score=99.59 Aligned_cols=262 Identities=16% Similarity=0.134 Sum_probs=158.6
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeE------
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY------ 139 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~------ 139 (422)
....+.||+|+-+.+|-.-.. + ..+-|++.........+. +..|... .||-+-.-+.|
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-----------~-d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~ 77 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-----------R-DQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLH 77 (637)
T ss_pred cCCCccccCCccceeeecchh-----------h-chhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhh
Confidence 455678999999999965321 1 234588765543322222 2223333 45533221111
Q ss_pred EEe-cCceEEEEEecCCCCh-hhhhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 140 CIE-DDQRLLVYEFMPRGSL-ENHLF-----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 140 ~~~-~~~~~lv~e~~~~g~L-~~~l~-----~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
.-. .....++|..+.|..- ..++. +......|...++.++.|+.+.+.||..| .+-+|+.++|+|+++++
T Consensus 78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~ 154 (637)
T COG4248 78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDS 154 (637)
T ss_pred CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCc
Confidence 011 2225678888876522 22221 22345889999999999999999999999 89999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhC-CCCCCCCCCCCcc
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEH 286 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~ 286 (422)
.+.|.|=..-... .........+|...|.+||... +-.-+...|.|.||+++++++.| +.||.+.......
T Consensus 155 ~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a 231 (637)
T COG4248 155 KVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA 231 (637)
T ss_pred eEEEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence 9999984433222 2223344568999999999654 33456789999999999999987 8999764322110
Q ss_pred -hhHH--hhhhhhhcc-cccccccCcccCCCCCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHhCCC
Q 014585 287 -NLVE--WARPHLGER-RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR--DPKARPLMSEVVEALKPL 350 (422)
Q Consensus 287 -~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dp~~Rps~~ell~~L~~~ 350 (422)
...+ .....+..- ........+.....+ .-.+..+..+..+|+.. ++.-||+++.++..|..+
T Consensus 232 p~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 232 PNPLETDIAHGRFAYASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred CCcchhhhhcceeeechhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0000 000000000 000111111111111 12356777888888854 367899999888766543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=94.38 Aligned_cols=126 Identities=21% Similarity=0.216 Sum_probs=80.3
Q ss_pred EEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---------------------c-----HHHHHHHHHHhcccCCC--
Q 014585 80 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---------------------G-----HKEWLAEVNFLGDLVHL-- 131 (422)
Q Consensus 80 ~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~-- 131 (422)
.||.|... .|..+|||+.+..... . .....+|++.|.++..-
T Consensus 1 ~Vy~~~~~----------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv 70 (188)
T PF01163_consen 1 DVYHAIDP----------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV 70 (188)
T ss_dssp EEEEEEEC----------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-
T ss_pred CEEEEECC----------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc
Confidence 37888763 4678999998642100 0 12356899999999765
Q ss_pred cceeeEeEEEecCceEEEEEecC--CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeccCCCCcEEE
Q 014585 132 NLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 132 niv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~-LH~~~~~~iiHrDlkp~Nill 208 (422)
++.+++++. ..+|||||++ |..+..+. ... ++......++.+++..+.. +|..| |+|+||.+.|||+
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv 140 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILV 140 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEE
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEe
Confidence 566776542 4579999997 54454433 221 1133456677788885555 57888 9999999999999
Q ss_pred cCCCCeEEeeccCcccCC
Q 014585 209 DADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~ 226 (422)
+++ .+.|+|||.+....
T Consensus 141 ~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 141 DDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ETT-CEEE--GTTEEETT
T ss_pred ecc-eEEEEecCcceecC
Confidence 887 99999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=91.69 Aligned_cols=136 Identities=18% Similarity=0.084 Sum_probs=97.9
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHHH
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVNF 124 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~ 124 (422)
+.+...||.|.-+.||.|... .|..+|||.-+..... ......+|+++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 566789999999999999874 4778999986532110 11235689999
Q ss_pred hcccCCC--cceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014585 125 LGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 202 (422)
Q Consensus 125 l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlk 202 (422)
|.+|.-. .|.+.+++ +...+||||++|-.|...-. .......++..|++-+.-+-..| |||+|+.
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 9999654 67776664 45689999998876654321 22333444555555554444667 9999999
Q ss_pred CCcEEEcCCCCeEEeeccCcccC
Q 014585 203 TSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 203 p~Nill~~~~~~kl~DFG~a~~~ 225 (422)
+-||+++++|.+.++||--+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999876654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=90.87 Aligned_cols=106 Identities=24% Similarity=0.213 Sum_probs=83.9
Q ss_pred HHHHHHHHHhcccCCC--cceeeEeEEEecC----ceEEEEEecCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 014585 116 KEWLAEVNFLGDLVHL--NLVKLIGYCIEDD----QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188 (422)
Q Consensus 116 ~~~~~E~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~L 188 (422)
....+|+..+..|..- .+.+.+++..... ..+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4578888888888533 3456666665532 347999999874 78888854332 66777889999999999999
Q ss_pred HhcCCCCeEeccCCCCcEEEcCCC---CeEEeeccCcccC
Q 014585 189 HEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 225 (422)
Q Consensus 189 H~~~~~~iiHrDlkp~Nill~~~~---~~kl~DFG~a~~~ 225 (422)
|..| |+|+||++.|||++.++ .+.|+||+-++..
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 99999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.1e-09 Score=109.12 Aligned_cols=150 Identities=23% Similarity=0.317 Sum_probs=103.9
Q ss_pred HHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCcccee-------eccccCccccCCCcccCC
Q 014585 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS-------TRVMGTYGYAAPEYVMTG 252 (422)
Q Consensus 180 qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 252 (422)
+++.|+.|+|..- .+||++|.|++|.++.++..||+.|+.+............ ....-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999864 4999999999999999999999999988665442211100 012235689999999998
Q ss_pred CCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHccc
Q 014585 253 HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 331 (422)
Q Consensus 253 ~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 331 (422)
..+.++|+||+||++|.+.. |+.-+........ +.. ....+..-...++...+.++++-+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSF---------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch-----hhh---------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 88999999999999999994 5444443211110 000 00111111122334567899999999999
Q ss_pred CCCCCCCCHHHHHH
Q 014585 332 RDPKARPLMSEVVE 345 (422)
Q Consensus 332 ~dp~~Rps~~ell~ 345 (422)
.+..-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997776653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.83 E-value=8e-08 Score=86.71 Aligned_cols=138 Identities=16% Similarity=0.144 Sum_probs=85.4
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc--ceeeEeEEEecCceEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIEDDQRLL 148 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~l 148 (422)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 46899999999984 23357788876432 3355789999999986433 4677888877778889
Q ss_pred EEEecCCCC-hhhhh---------------------ccCC-CCCCHHHH-HHHHH----------HHHHH-HHHHHhc-C
Q 014585 149 VYEFMPRGS-LENHL---------------------FRRS-LPLPWSIR-MKIAL----------GAAKG-LAFLHEE-A 192 (422)
Q Consensus 149 v~e~~~~g~-L~~~l---------------------~~~~-~~~~~~~~-~~i~~----------qi~~a-l~~LH~~-~ 192 (422)
|||+++|.. +...+ +.-. ........ ..+.. .+.+. ..+|... .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998863 21111 0000 01111110 00000 01111 1222211 1
Q ss_pred CCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 193 ~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23479999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.7e-08 Score=100.65 Aligned_cols=143 Identities=15% Similarity=0.126 Sum_probs=94.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH------------------------------H----
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH------------------------------K---- 116 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~------------------------------~---- 116 (422)
..|+.++-|.||+|+.. +|+.||||+.+..-.... +
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 68999999999999986 488999999875321110 0
Q ss_pred ------HHHHHHHHhcccC-----CCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHH
Q 014585 117 ------EWLAEVNFLGDLV-----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185 (422)
Q Consensus 117 ------~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al 185 (422)
++.+|...+.++. .++|.--.=++...+...|+|||++|-.+.+...-....++...+.....++.--.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q 280 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQ 280 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1234555444442 23332222223335677899999999999888533334556444433333332222
Q ss_pred HHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 186 ~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
-+ ..| ++|.|..|.||+++.+|.+.+.|||+.......
T Consensus 281 ~~--~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LL--RDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HH--hcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 22 245 999999999999999999999999998876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.5e-07 Score=82.54 Aligned_cols=138 Identities=17% Similarity=0.118 Sum_probs=100.4
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC---C---cccHHHHHHHHHHhcccCCC--cceeeEeEEEe--
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---G---LQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE-- 142 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~-- 142 (422)
-|+||.+-|++.... |..+=+|.-... . ......|.+|+..|.+|..- .+.+.......
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~ 94 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI 94 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc
Confidence 477999999998763 345667775311 0 22456799999999998533 34444422211
Q ss_pred c--CceEEEEEecCC-CChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--eEE
Q 014585 143 D--DQRLLVYEFMPR-GSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKL 216 (422)
Q Consensus 143 ~--~~~~lv~e~~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~--~kl 216 (422)
. -..+||+|-++| .+|.+++.+. -.+.+......++.+|+.++.-||..+ +.|+|+.+.|||++.+|. +++
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEE
Confidence 1 135799998853 4888887543 234677778899999999999999999 999999999999987777 999
Q ss_pred eeccCccc
Q 014585 217 SDFGLAKD 224 (422)
Q Consensus 217 ~DFG~a~~ 224 (422)
+||--++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99987664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.2e-08 Score=84.46 Aligned_cols=139 Identities=12% Similarity=0.067 Sum_probs=92.7
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHH---------HHHHHHhcccCC--
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---------LAEVNFLGDLVH-- 130 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h-- 130 (422)
....+|.+.+++-......|.+-.. .|..+++|..+.......+.| .+++..+.++..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g 96 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG 96 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence 4567888888888887777776654 567899999876543322222 233444444432
Q ss_pred -CcceeeEeEEE-----ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 131 -LNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 131 -~niv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
...+.++.+.. .....+|||||++|..|.++.. +++ .++..+.+++.-||..| +.|+|..|.
T Consensus 97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpg 164 (229)
T PF06176_consen 97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPG 164 (229)
T ss_pred ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcC
Confidence 22223222222 2234568999999988876541 222 24456778899999999 999999999
Q ss_pred cEEEcCCCCeEEeeccCccc
Q 014585 205 NILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~ 224 (422)
|+++++++ ++++||+..+.
T Consensus 165 NFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 165 NFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred cEEEECCc-EEEEECccccc
Confidence 99998654 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.8e-07 Score=81.12 Aligned_cols=154 Identities=19% Similarity=0.116 Sum_probs=101.6
Q ss_pred ccchhHHHHHhcCCCCCCccc---cccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc----------------
Q 014585 54 KFTFNDLKLATRNFRPESLLG---EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------------- 114 (422)
Q Consensus 54 ~~~~~~~~~~~~~y~~~~~lg---~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------------- 114 (422)
..+...+....++..+....| .|.-+.||+|... .+..||||+++......
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~ 103 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNS 103 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcC
Confidence 344555666666666665544 5666689998652 46789999987432111
Q ss_pred ---HH-----HHHHHHHHhcccC--CCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHH
Q 014585 115 ---HK-----EWLAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184 (422)
Q Consensus 115 ---~~-----~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~a 184 (422)
.+ ...+|++.|+++. +-.+.+.+++. ...|||||+... ..-.=.-....+.......+..++++.
T Consensus 104 ~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 104 RSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEY 178 (268)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHH
Confidence 11 1346888888884 45566666654 357999999443 111000011123333566777788888
Q ss_pred HHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 185 LAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 185 l~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
+.-|-. .+ +||+||..-|||+. ++.+.|+|||-|....
T Consensus 179 ~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 179 MRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 877766 56 99999999999999 8899999999887654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.7e-09 Score=103.57 Aligned_cols=186 Identities=17% Similarity=0.103 Sum_probs=135.3
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc-ceeeEeEEEecCc
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQ 145 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~ 145 (422)
+....-+++|+++++++.+... +. ....+.+... ....-+++.|.+++||| .+..++-+..++.
T Consensus 244 s~~fh~fvK~altknpKkRpta---------ek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTA---------EK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCCh---------hh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 3444557899999999876532 11 1224444322 34556888999999999 7888888888888
Q ss_pred eEEEEEecCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 146 RLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 146 ~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.+++|+++.++ +-...+......+.......+.+.-++++++||+.. -+|+| ||+..+ +..++.||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence 99999999777 333322222223444455566777778999999865 58999 777655 6799999999887
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 278 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 278 (422)
+.... ......+++.|+|||+...+.+..+.|+|++|+-..+|--|.+|-.
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 65543 3345779999999999999999999999999987777777766654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.2e-07 Score=82.10 Aligned_cols=139 Identities=19% Similarity=0.112 Sum_probs=84.1
Q ss_pred ccccccC-cEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEEecCceEEE
Q 014585 72 LLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 72 ~lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 149 (422)
.|..|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|
T Consensus 5 ~~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 70 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL 70 (244)
T ss_pred ecCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence 3455555 789988642 2467888876543 235678888888883 44466788877776778999
Q ss_pred EEecCCCChhhhhc-------------------cC---CCCCCHH--HHHHHHH--------------------HHHHHH
Q 014585 150 YEFMPRGSLENHLF-------------------RR---SLPLPWS--IRMKIAL--------------------GAAKGL 185 (422)
Q Consensus 150 ~e~~~~g~L~~~l~-------------------~~---~~~~~~~--~~~~i~~--------------------qi~~al 185 (422)
||+++|.+|..... .- ...+... ....... .+...+
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (244)
T cd05150 71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY 150 (244)
T ss_pred EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence 99999987764320 00 0011100 0000000 011111
Q ss_pred HHHHhc----CCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 186 AFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 186 ~~LH~~----~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..|-.. ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 222111 123489999999999999887788999997754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.3e-07 Score=80.68 Aligned_cols=140 Identities=18% Similarity=0.155 Sum_probs=81.9
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCC--cceeeEeEEEe---cCc
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE---DDQ 145 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~ 145 (422)
+.|+.|..+.||++... +..+++|..... .....+.+|..+++.+... .+.+++.+... ...
T Consensus 3 ~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 56899999999999863 347999997654 3446678898888888533 35567764432 334
Q ss_pred eEEEEEecCCCChhh----------------hh---ccC---CCCCCHHH---------HHHH------------HHHHH
Q 014585 146 RLLVYEFMPRGSLEN----------------HL---FRR---SLPLPWSI---------RMKI------------ALGAA 182 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~----------------~l---~~~---~~~~~~~~---------~~~i------------~~qi~ 182 (422)
.+++|++++|..+.. .+ +.. ...+.... .... ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 689999999988877 11 011 01111100 0000 11122
Q ss_pred H-HHHHHHhc----CCCCeEeccCCCCcEEEc-CCCCeEEeeccCcc
Q 014585 183 K-GLAFLHEE----AERPVIYRDFKTSNILLD-ADYNAKLSDFGLAK 223 (422)
Q Consensus 183 ~-al~~LH~~----~~~~iiHrDlkp~Nill~-~~~~~kl~DFG~a~ 223 (422)
+ .+..++.. ....++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 23333321 234599999999999999 56666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.4e-05 Score=69.75 Aligned_cols=102 Identities=28% Similarity=0.246 Sum_probs=80.9
Q ss_pred HHHHHHhcccCC-CcceeeEeEEEecCceEEEEEecCCCChhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014585 119 LAEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 195 (422)
Q Consensus 119 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~ 195 (422)
..|.-++..+.+ +++.+++|+|- .++|.||...+++..... ..-...+|..+.+|+.++++.+.+|+..-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888866 69999999983 367899998776643210 11124689999999999999999999855445
Q ss_pred eEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 196 VIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 196 iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
+.-.|++++|+-++.+|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.8e-06 Score=87.81 Aligned_cols=149 Identities=16% Similarity=0.191 Sum_probs=91.7
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccC-CCcc--eeeEeEEEec--
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNL--VKLIGYCIED-- 143 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~-- 143 (422)
++.|+.|.++.+|+......+ ....+++|+...... .....+.+|+++|+.+. |.+| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 467899999999998654311 113577787654322 23456889999999995 6654 7888887664
Q ss_pred -CceEEEEEecCCCChhhh-----------------------hccCC----------CCCC--HHHHHHHHH--------
Q 014585 144 -DQRLLVYEFMPRGSLENH-----------------------LFRRS----------LPLP--WSIRMKIAL-------- 179 (422)
Q Consensus 144 -~~~~lv~e~~~~g~L~~~-----------------------l~~~~----------~~~~--~~~~~~i~~-------- 179 (422)
+..|+||||++|..+.+. |+.-. .+.. ...+..|..
T Consensus 116 ~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~ 195 (822)
T PLN02876 116 IGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGE 195 (822)
T ss_pred CCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcc
Confidence 467899999988654321 01100 0000 111211111
Q ss_pred -------HHHHHHHHHHhcCC--------CCeEeccCCCCcEEEcCC-CC-eEEeeccCcccC
Q 014585 180 -------GAAKGLAFLHEEAE--------RPVIYRDFKTSNILLDAD-YN-AKLSDFGLAKDG 225 (422)
Q Consensus 180 -------qi~~al~~LH~~~~--------~~iiHrDlkp~Nill~~~-~~-~kl~DFG~a~~~ 225 (422)
.+...+.+|..+-+ ..+||+|+++.|||++.+ +. +-|.||.++...
T Consensus 196 ~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 196 GKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12233556644332 239999999999999853 34 468999988754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.2e-06 Score=70.07 Aligned_cols=132 Identities=18% Similarity=0.147 Sum_probs=92.6
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcce-eeEeEEEecC
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDD 144 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~ 144 (422)
..++.+.|++|.+|.||+|.+ .|..+|+|+-+.+. ....+..|+++|..+.-.++- +++.+..
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~-----------~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~--- 86 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEW-----------RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE--- 86 (201)
T ss_pred hhhhhhhhhcccccEEEEeec-----------cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech---
Confidence 345667899999999999988 45689999877664 346789999999999877664 4444433
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC-CCcEEEcCCCCeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK-TSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlk-p~Nill~~~~~~kl~DFG~a~ 223 (422)
.++.|||+.|-.|.+..... +..+ ...+++.---|-..| |-|+.|. |...+|..++.+.|+||..|+
T Consensus 87 -~~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 87 -DFIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred -hhhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 34569999888887654221 2222 234555555566667 9999886 444444455589999999887
Q ss_pred cC
Q 014585 224 DG 225 (422)
Q Consensus 224 ~~ 225 (422)
..
T Consensus 155 ~k 156 (201)
T COG2112 155 FK 156 (201)
T ss_pred hc
Confidence 43
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.7e-06 Score=83.18 Aligned_cols=140 Identities=16% Similarity=0.101 Sum_probs=90.5
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH-------------------------------H---
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-------------------------------K--- 116 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-------------------------------~--- 116 (422)
+.||.-+.|.||+|+.+ .|+.||||+-+..-.... +
T Consensus 167 ~piaaASlaQVhrA~L~----------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK----------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEec----------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 57999999999999886 478899999764321100 0
Q ss_pred ---HHHHHHHHhccc----CCCc------ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHH
Q 014585 117 ---EWLAEVNFLGDL----VHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183 (422)
Q Consensus 117 ---~~~~E~~~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~ 183 (422)
+|.+|.+...++ .|-+ |.+++- .......|+||||+|..+.|+-.-....++...+..-+.++..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL 314 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence 133444433332 3444 333332 2245678999999999887764323334665555444444333
Q ss_pred HHHHHHhcCCCCeEeccCCCCcEEEcC----CCCeEEeeccCcccCCC
Q 014585 184 GLAFLHEEAERPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 184 al~~LH~~~~~~iiHrDlkp~Nill~~----~~~~kl~DFG~a~~~~~ 227 (422)
-+-+.| | ++|+|=.|.||+++. ++.+.+.|||+......
T Consensus 315 ~qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 333333 4 999999999999984 67899999999887644
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.4e-06 Score=71.76 Aligned_cols=125 Identities=29% Similarity=0.408 Sum_probs=90.1
Q ss_pred cCCCCCCccccccC-cEEEEEEeccCCCCCCCCCCCcEEEEEEecC---CCc-------c-----------cHHHHHHHH
Q 014585 65 RNFRPESLLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---DGL-------Q-----------GHKEWLAEV 122 (422)
Q Consensus 65 ~~y~~~~~lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~---~~~-------~-----------~~~~~~~E~ 122 (422)
.+++.++.||.|.- |.||++.. .|+.||+|++.. ... . ...-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 78899999999999 99999988 677999999321 110 0 112377898
Q ss_pred HHhcccC---CCcc--eeeEeEEEecC------------------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHH
Q 014585 123 NFLGDLV---HLNL--VKLIGYCIEDD------------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179 (422)
Q Consensus 123 ~~l~~l~---h~ni--v~~~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~ 179 (422)
+...+|+ +.++ |+.+||..-.. ...||.||++... .+. ..-+.
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~ 171 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIP 171 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHH
Confidence 8888774 4455 89999875331 1247777765532 122 23345
Q ss_pred HHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 180 qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 172 ~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 6778889999999 999999999986 4589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.5e-06 Score=75.39 Aligned_cols=74 Identities=15% Similarity=0.133 Sum_probs=47.0
Q ss_pred CccccccCc-EEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCC---cceeeEeEEEec---
Q 014585 71 SLLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCIED--- 143 (422)
Q Consensus 71 ~~lg~G~fg-~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~--- 143 (422)
+.|+.|+.. .||+.. ..+++|...... ....+.+|++++..+... .+.++++.....
T Consensus 3 ~~~~~gG~~n~vy~~~--------------~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~ 66 (235)
T cd05155 3 EPVDSGGTDNATFRLG--------------DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY 66 (235)
T ss_pred eeccCCCcccceEEcC--------------CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence 457777776 588751 146778755422 235788999999887532 344555544332
Q ss_pred CceEEEEEecCCCChhh
Q 014585 144 DQRLLVYEFMPRGSLEN 160 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~ 160 (422)
+..++||++++|.++.+
T Consensus 67 ~~~~~l~~~i~G~~l~~ 83 (235)
T cd05155 67 PWPWSVYRWLEGETATA 83 (235)
T ss_pred CcceEEEEeecCCCCCc
Confidence 23488999999987753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.4e-05 Score=73.80 Aligned_cols=78 Identities=12% Similarity=0.058 Sum_probs=56.0
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC---CcceeeEeEEEe--
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIE-- 142 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~-- 142 (422)
.-.+.||.|..+.||+....+ + .+.+|..+.. .....+..|...|+.|.. ..+.++++++..
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~ 83 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ----------G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ 83 (297)
T ss_pred heeeecCCccceeEEEEEcCC----------C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence 335679999999999986422 2 4667775431 122578899999988843 367888888754
Q ss_pred -cCceEEEEEecCCCCh
Q 014585 143 -DDQRLLVYEFMPRGSL 158 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L 158 (422)
.+..+||||+++|+++
T Consensus 84 ~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 84 SPGPDVLLLERLRGVSV 100 (297)
T ss_pred cCCCeEEEEeccCCEec
Confidence 3668999999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.4e-05 Score=68.68 Aligned_cols=128 Identities=18% Similarity=0.255 Sum_probs=88.5
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC----------------cccHHHHHHHHHHhcccC----
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGDLV---- 129 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 129 (422)
...||+|+.=.||.- .. .....||+..... ....++..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H--P~----------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD----------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC--CC----------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 457999999999953 22 2246789987665 122345666776665555
Q ss_pred --CCcceeeEeEEEecCceEEEEEecCC--C----ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014585 130 --HLNLVKLIGYCIEDDQRLLVYEFMPR--G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 201 (422)
Q Consensus 130 --h~niv~~~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 201 (422)
+.+|.+++|+...+....+|+|.+.+ | +|.+++.+. .++. .... .+-+-..||-+.+ |+.+||
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQ---ALDEFKRYLLDHH---IVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHH---HHHHHHHHHHHcC---CeecCC
Confidence 78899999999999999999998643 2 567777332 3554 3333 3334456777777 999999
Q ss_pred CCCcEEEcCC--C--CeEEee
Q 014585 202 KTSNILLDAD--Y--NAKLSD 218 (422)
Q Consensus 202 kp~Nill~~~--~--~~kl~D 218 (422)
+|.||++..+ + .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 9999999543 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.7e-05 Score=73.15 Aligned_cols=137 Identities=17% Similarity=0.116 Sum_probs=78.3
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEEEE
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 150 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 150 (422)
.+..|-.+.+|+... .|..+++|........-.-...+|..+++.+...++ .+++... . .++||
T Consensus 3 ~~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 356677889998863 455788887654322211235678888888864433 3444432 2 36899
Q ss_pred EecCCCChhhh-------h----------ccC---CCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCC
Q 014585 151 EFMPRGSLENH-------L----------FRR---SLPLPWS-IRMKIALGA---------AKGLAFLHEE-----AERP 195 (422)
Q Consensus 151 e~~~~g~L~~~-------l----------~~~---~~~~~~~-~~~~i~~qi---------~~al~~LH~~-----~~~~ 195 (422)
||++|..+... + +.. ...++.. .+..+..++ ...+..+-.. .+..
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 99998766431 0 111 1112211 111211111 1112222111 1224
Q ss_pred eEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 196 VIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 196 iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
++|+|+.|.||++++++ +.|+||..+..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.13 E-value=8.8e-06 Score=86.13 Aligned_cols=196 Identities=20% Similarity=0.234 Sum_probs=138.8
Q ss_pred HHHHHHHhcccCCCcceeeEeEEEecCce----EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 014585 118 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 193 (422)
Q Consensus 118 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~ 193 (422)
...|+..+.++.|+|++.++.|....... .+..|+|...++...+ ..-..++....+.+..++.+||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 44577788888999999999987764332 2456788888888877 44557889999999999999999999976
Q ss_pred CCeEeccCCCC---cEEEcCCCCeEEe--eccCcccCCCCCccceeeccccCccccCCCcccCCCCCch--hhhhhHHHH
Q 014585 194 RPVIYRDFKTS---NILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR--SDVYSFGVV 266 (422)
Q Consensus 194 ~~iiHrDlkp~---Nill~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslG~i 266 (422)
+.|.-|... +.-.+.++.+.+. ||+.+........... ..-+..|.++|......+..+ .|+|.+|..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHH
Confidence 666655555 4445666777777 9998887655443322 234556888887776665544 799999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 267 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 267 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+..+..|..+-..... ...+++. .......+...+|+..++++|+++.+++.+
T Consensus 382 ~~~~~~~~~i~~~~~~-------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV-------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccccc-------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999988654321110 0001110 011156788999999999999999999875
Q ss_pred h
Q 014585 347 L 347 (422)
Q Consensus 347 L 347 (422)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 3
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.8e-05 Score=73.31 Aligned_cols=141 Identities=17% Similarity=0.100 Sum_probs=83.9
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc--ceeeEe------EEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIG------YCI 141 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~------~~~ 141 (422)
.+.|..|....+|+.... +..+++|+... .....+..|++++..+.+.+ +.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 456777888899987642 23588898764 22345677888887774332 444443 123
Q ss_pred ecCceEEEEEecCCCChhhh----h----------ccC----CC------CCCHHHH----------HHHHHHHHHHHHH
Q 014585 142 EDDQRLLVYEFMPRGSLENH----L----------FRR----SL------PLPWSIR----------MKIALGAAKGLAF 187 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~----l----------~~~----~~------~~~~~~~----------~~i~~qi~~al~~ 187 (422)
..+..++|++|++|..+... + +.. .. ...+... ......+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 34567899999998776430 0 000 00 0111110 0011112334445
Q ss_pred HHh----cCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 188 LHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 188 LH~----~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
+.. ..+..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 443 1224599999999999999887778999987754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.4e-05 Score=69.39 Aligned_cols=76 Identities=22% Similarity=0.155 Sum_probs=47.3
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv 149 (422)
+.|..|-...+|++..... .+..|++|+...... ......+|+.+++.+...++ .++++.+. ..+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence 4577788889998864310 135788997754322 11234578888888854333 44544332 2489
Q ss_pred EEecCCCChh
Q 014585 150 YEFMPRGSLE 159 (422)
Q Consensus 150 ~e~~~~g~L~ 159 (422)
|||++|.++.
T Consensus 71 ~e~i~G~~l~ 80 (235)
T cd05157 71 YEFIPGRTLE 80 (235)
T ss_pred EEeeCCCcCC
Confidence 9999987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00042 Score=66.06 Aligned_cols=32 Identities=31% Similarity=0.403 Sum_probs=26.6
Q ss_pred CCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 193 ~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 34699999999999998665558999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00041 Score=65.83 Aligned_cols=142 Identities=18% Similarity=0.170 Sum_probs=81.6
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc--ceeeEeE------EE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY------CI 141 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~ 141 (422)
.+.++.|....+|+.... .| .+++|+..... ....+..|+.++..|...+ +.+++.. ..
T Consensus 27 i~~~~~G~~n~~y~v~t~----------~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD----------VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ccccCCccccceEEEEeC----------CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 456777877899987642 23 57789875431 2345556777777764222 3444331 12
Q ss_pred ecCceEEEEEecCCCChhhh--------------hccCCCCC----------C-HHHHH------------HHHHHHHHH
Q 014585 142 EDDQRLLVYEFMPRGSLENH--------------LFRRSLPL----------P-WSIRM------------KIALGAAKG 184 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~--------------l~~~~~~~----------~-~~~~~------------~i~~qi~~a 184 (422)
..+..++||||++|..+... ++.....+ . |.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 24567899999988654311 11100000 0 10000 001123334
Q ss_pred HHHHHh----cCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 185 LAFLHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 185 l~~LH~----~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
++++.. ..+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 555543 1235699999999999999887778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00014 Score=68.72 Aligned_cols=146 Identities=23% Similarity=0.247 Sum_probs=83.8
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv 149 (422)
+.|..|-...+|+....... .....+..+++|+..... ....+..+|++++..+...++ .++++++. -.+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCch
Confidence 34566777789988653210 012245689999976543 223456788888888854333 35555543 2368
Q ss_pred EEecCCCChhhhh-----------------ccCCCC--------CC--HHHHHH--------------------------
Q 014585 150 YEFMPRGSLENHL-----------------FRRSLP--------LP--WSIRMK-------------------------- 176 (422)
Q Consensus 150 ~e~~~~g~L~~~l-----------------~~~~~~--------~~--~~~~~~-------------------------- 176 (422)
+||++|..+.... ++.... .+ +..+..
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 9999887764310 111000 01 101111
Q ss_pred HHHHHHHHHHHHHh------cCCCCeEeccCCCCcEEEcCC----CCeEEeeccCccc
Q 014585 177 IALGAAKGLAFLHE------EAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 224 (422)
Q Consensus 177 i~~qi~~al~~LH~------~~~~~iiHrDlkp~Nill~~~----~~~kl~DFG~a~~ 224 (422)
+...+...+..|-. ..+..++|+|+.+.|||++++ +.+.|+||..|..
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11122222334432 123459999999999999885 8899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00058 Score=66.55 Aligned_cols=77 Identities=19% Similarity=0.131 Sum_probs=52.8
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC------C-cccHHHHHHHHHHhcccC---CCcceeeEeE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDLV---HLNLVKLIGY 139 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~ 139 (422)
.+.||.|.+..||++.... .++.|+||.-... . ....+++..|.+.|..+. -.++.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 3578999999999998743 2247999985411 1 123456777888887762 2457777776
Q ss_pred EEecCceEEEEEecCCCC
Q 014585 140 CIEDDQRLLVYEFMPRGS 157 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~ 157 (422)
+.+..++||||+++..
T Consensus 102 --D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 --DEELAVTVMEDLSDHK 117 (401)
T ss_pred --CCCCCEEEEecCCCcc
Confidence 4466789999997643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0012 Score=62.19 Aligned_cols=122 Identities=20% Similarity=0.284 Sum_probs=75.0
Q ss_pred CCcEEEEEEecC--CCcccHHHHHHHHHHhcccCC--CcceeeEeEEEecC--ceEEEEEecCCCChhhhhccCCCCCCH
Q 014585 98 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPW 171 (422)
Q Consensus 98 ~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~ 171 (422)
+++.+++. ... ..........+|+++++.+.- .-+...+++|.++. ..|.||+|++|..+.+.+.... ..
T Consensus 47 ~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~--~~- 122 (321)
T COG3173 47 TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES--LG- 122 (321)
T ss_pred CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc--ch-
Confidence 35678887 331 223344567788888888743 33456667776655 6799999998854433221110 00
Q ss_pred HHHHHHH-HHHHHHHH--------------------------------------------------HHHhcC-----CCC
Q 014585 172 SIRMKIA-LGAAKGLA--------------------------------------------------FLHEEA-----ERP 195 (422)
Q Consensus 172 ~~~~~i~-~qi~~al~--------------------------------------------------~LH~~~-----~~~ 195 (422)
.+++ ..++..|+ +|+.+. ...
T Consensus 123 ---~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~ 199 (321)
T COG3173 123 ---RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV 199 (321)
T ss_pred ---HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence 0111 13333333 333322 123
Q ss_pred eEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 196 VIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 196 iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++|+|+.+.||+++.++-+=|.||+++....
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 9999999999999998889999999998653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.001 Score=64.15 Aligned_cols=144 Identities=17% Similarity=0.130 Sum_probs=82.5
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcce-eeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv 149 (422)
..|-.|-...+|++....... ..+..|++|+........ -...+|+.+++.+...++. ++++.+. ++ .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEEC-Cc---eE
Confidence 345558888999986533111 134678999886543222 2236789998888654443 5566553 22 58
Q ss_pred EEecCCCChhhh-----------------hccCCC-----CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 014585 150 YEFMPRGSLENH-----------------LFRRSL-----PLPWSIRMKIALGA-----------------AKGLAFL-- 188 (422)
Q Consensus 150 ~e~~~~g~L~~~-----------------l~~~~~-----~~~~~~~~~i~~qi-----------------~~al~~L-- 188 (422)
+||+++.+|... ++.... ...+..+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999988776421 011110 11122332332221 1112122
Q ss_pred --Hh-cCCCCeEeccCCCCcEEEcC-CCCeEEeeccCccc
Q 014585 189 --HE-EAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 224 (422)
Q Consensus 189 --H~-~~~~~iiHrDlkp~Nill~~-~~~~kl~DFG~a~~ 224 (422)
.. ..+..++|+||++.|||+++ ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 21 11234899999999999976 47899999988754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00075 Score=63.72 Aligned_cols=142 Identities=16% Similarity=0.095 Sum_probs=93.2
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----------------------ccHH----HHHHH
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHK----EWLAE 121 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------------------~~~~----~~~~E 121 (422)
.+-.+|..|.-+-||.|... .|..+|||+++.... ..++ ....|
T Consensus 147 ~inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE 216 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE 216 (520)
T ss_pred ecccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence 34457888999999998654 577899999863211 0011 13578
Q ss_pred HHHhcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014585 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 201 (422)
Q Consensus 122 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 201 (422)
++.|.+|+...|...--+.. ....|||+|+. ++=.-.-.-....++...+..+-.|++.-+.-|-+.+ .+||.||
T Consensus 217 ~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL 291 (520)
T KOG2270|consen 217 MRNLKRLNNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL 291 (520)
T ss_pred HHHHHHHHhcCCCCCCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence 88898887665532222222 23468999994 3322211122335666777777777877777665543 2999999
Q ss_pred CCCcEEEcCCCCeEEeeccCcccC
Q 014585 202 KTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 202 kp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
.-=|+|+. +|.+.|+|-+-+...
T Consensus 292 SEfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 292 SEFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhhhheEE-CCEEEEEEccccccC
Confidence 99999994 678999998877543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=8.4e-06 Score=88.23 Aligned_cols=174 Identities=14% Similarity=0.022 Sum_probs=122.3
Q ss_pred EEEEEecCCCcccHHH-----HHHHHHHhcccCCCcceeeEeEEEe--cCceEEEEEecCCCChhhhhccCC---CCCCH
Q 014585 102 VAVKTLNHDGLQGHKE-----WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRS---LPLPW 171 (422)
Q Consensus 102 vavK~~~~~~~~~~~~-----~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~ 171 (422)
+-+|+.+....+..-+ .+.|..-++...|+++.....-... ....+.+++|+.+|.+.+.|.+.. ..+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 3455555443333222 3445555566789988776654432 445689999999999999987543 33444
Q ss_pred HHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcc
Q 014585 172 SIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 249 (422)
Q Consensus 172 ~~~~~i~~qi~~al~~LH~~~--~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 249 (422)
..+.....+.+.+..-+|+.. ..-.+|++||+.|.+|..+..+|++++|+.+...+ .....+...+++.|+.+++.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHH
Confidence 444444444455666655443 23479999999999999999999999999984322 11223446788999999988
Q ss_pred cCCCCCchhhhhhHHHHHHHHHhCCCCC
Q 014585 250 MTGHLTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 250 ~~~~~~~~~DvwslG~il~elltg~~pf 277 (422)
..-.++.++|+|..|+-+|++.-|..+|
T Consensus 1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 8888999999999999999999887766
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00017 Score=66.79 Aligned_cols=135 Identities=16% Similarity=0.087 Sum_probs=93.6
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc----------------------cHHHHHHHHH
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVN 123 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~ 123 (422)
-+.+++.||-|.-+.||.+-+. .|...++|.-+..... ++-...+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 4678889999999999999775 4677888875421100 0112457888
Q ss_pred HhcccCC-C-cceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014585 124 FLGDLVH-L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 201 (422)
Q Consensus 124 ~l~~l~h-~-niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 201 (422)
.|+.|.. - -|.+.+++ +..++|||++.|-.|...-+-. ... .+...++.-+.-|-.+| +||+|.
T Consensus 163 fmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~~---~ly~~lm~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE----DPP---TLYDDLMGLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC----ChH---HHHHHHHHHHHHHHHcC---ceeccc
Confidence 8888843 2 24455543 4568999999888886643221 122 33344455566677777 999999
Q ss_pred CCCcEEEcCCCCeEEeeccCccc
Q 014585 202 KTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 202 kp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.-=||++++++.++++||--...
T Consensus 229 NEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred chheeEEecCCCEEEeechHhhc
Confidence 99999999999999999975543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.002 Score=60.20 Aligned_cols=73 Identities=22% Similarity=0.282 Sum_probs=46.7
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC---CCcceeeEeEEEecCce
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~ 146 (422)
.+.++.|....+|+... ++..+.||+-.. .....|..|..-|+.|. --.+.+++++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEET-----------TS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEEC-----------CCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 45688899999998863 566888998762 22346778888887773 34577899988888888
Q ss_pred EEEEEecCCC
Q 014585 147 LLVYEFMPRG 156 (422)
Q Consensus 147 ~lv~e~~~~g 156 (422)
+|||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0044 Score=57.74 Aligned_cols=31 Identities=32% Similarity=0.454 Sum_probs=25.9
Q ss_pred CeEeccCCCCcEEEcCCCCe-EEeeccCcccC
Q 014585 195 PVIYRDFKTSNILLDADYNA-KLSDFGLAKDG 225 (422)
Q Consensus 195 ~iiHrDlkp~Nill~~~~~~-kl~DFG~a~~~ 225 (422)
.++|+|+.+.|||++.++.+ -|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 38999999999999975654 59999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0011 Score=59.25 Aligned_cols=120 Identities=22% Similarity=0.171 Sum_probs=59.3
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEEEEEecCCCChhhh-h---------------
Q 014585 100 LTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVYEFMPRGSLENH-L--------------- 162 (422)
Q Consensus 100 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l--------------- 162 (422)
+.|+|++..... ...-....|..+++.+...++ .++++++.. .+|+||++|..|... +
T Consensus 3 ~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 3 EKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp SEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 468899887663 334556788888888865444 455555422 267799977665321 0
Q ss_pred -c---c--C-CCCCCHHHHHHH----------------------HHHHHHHHHHHHh----cC-CCCeEeccCCCCcEEE
Q 014585 163 -F---R--R-SLPLPWSIRMKI----------------------ALGAAKGLAFLHE----EA-ERPVIYRDFKTSNILL 208 (422)
Q Consensus 163 -~---~--~-~~~~~~~~~~~i----------------------~~qi~~al~~LH~----~~-~~~iiHrDlkp~Nill 208 (422)
+ . . ....-+..+..+ +..+..-+..+.. .+ +.-++|+||.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 0 0 0 000011111111 1111222222221 11 1238999999999999
Q ss_pred -cCCCCeEEeeccCccc
Q 014585 209 -DADYNAKLSDFGLAKD 224 (422)
Q Consensus 209 -~~~~~~kl~DFG~a~~ 224 (422)
+.++.++|+||..|..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0045 Score=59.28 Aligned_cols=142 Identities=17% Similarity=0.207 Sum_probs=79.6
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEEEE
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 150 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 150 (422)
.|..|-...+|+....... ..+..|++|+...... ..-.-.+|..+++.+..-++ .++++++ .++ +|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~ 89 (330)
T PLN02421 21 RISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQ 89 (330)
T ss_pred EeCCcccceEEEEEecCCC------CCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-CCc---Eee
Confidence 4555777889988653211 0234788998765432 22234578888888865555 3556555 222 589
Q ss_pred EecCCCChhhh-------h----------ccCC----C-CCCHHHHHHHHHHH----------------------HHHHH
Q 014585 151 EFMPRGSLENH-------L----------FRRS----L-PLPWSIRMKIALGA----------------------AKGLA 186 (422)
Q Consensus 151 e~~~~g~L~~~-------l----------~~~~----~-~~~~~~~~~i~~qi----------------------~~al~ 186 (422)
+|++|..|... + +... . ...+..+..+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 99987765321 1 1111 0 11122222222221 11122
Q ss_pred HHHh----cC-CCCeEeccCCCCcEEEcC-CCCeEEeeccCccc
Q 014585 187 FLHE----EA-ERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 224 (422)
Q Consensus 187 ~LH~----~~-~~~iiHrDlkp~Nill~~-~~~~kl~DFG~a~~ 224 (422)
.+.. .+ +.-++|+||.+.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 2211 11 223899999999999975 57899999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.00062 Score=66.82 Aligned_cols=166 Identities=23% Similarity=0.340 Sum_probs=92.7
Q ss_pred HHHHHHHHHHhcccCCCcceeeEeEEEe-cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 014585 115 HKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 193 (422)
Q Consensus 115 ~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~ 193 (422)
...++-.+++++.+.|+|.+.++++... .....+|||++ +.+|++.+.... +-... + + -| +
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~---~--~~--~- 87 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------L---L--AH--G- 87 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------h---c--cc--c-
Confidence 3567788999999999999999998765 34567899999 779999885443 11111 0 0 11 1
Q ss_pred CCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhC
Q 014585 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273 (422)
Q Consensus 194 ~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 273 (422)
+.|- | .++++| -++.. | |- +..+|+|||++|.++.++..|
T Consensus 88 --~~~~-----~-------~~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 88 --VLHL-----N-------IIYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred --ccee-----h-------hhhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHHHh
Confidence 3332 1 123333 11110 0 00 111499999999999999998
Q ss_pred CCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014585 274 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344 (422)
Q Consensus 274 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 344 (422)
...+...... ...+..............+ .....+...+++...++..+|+-..|..||...++.
T Consensus 128 ~~l~~~~~~s---~~l~~i~k~~~~d~~~~~~---a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 128 ISLEAELTES---EYLEILLKYYTDDQELLST---AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hHHHHHHHHH---HHHHHHHHhccCchhHHHH---HHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 7655422110 0001000000000000000 000012234567788999999999999998666554
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.01 Score=57.84 Aligned_cols=80 Identities=11% Similarity=0.026 Sum_probs=51.7
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHhcccC---CCcceeeEeE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLV---HLNLVKLIGY 139 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~~~~~ 139 (422)
.+.||-|....||+.... +..|+||.-..... -...+...|+..|+.+. -.++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 557899999999998752 23588998651111 12344455666666553 2477888887
Q ss_pred EEecCceEEEEEecCC--CChhhhh
Q 014585 140 CIEDDQRLLVYEFMPR--GSLENHL 162 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~--g~L~~~l 162 (422)
+. +..+++||++++ ..+.+.+
T Consensus 106 de--d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 106 DR--TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CC--CCCEEEEeecCCcceehhhhh
Confidence 75 557889999976 3444433
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.012 Score=55.90 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.6
Q ss_pred CCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 194 ~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 45999999999999987 6789999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.014 Score=55.29 Aligned_cols=31 Identities=16% Similarity=0.170 Sum_probs=28.0
Q ss_pred CCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 194 ~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..+||+|+.+.|||++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4599999999999999999999999988765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0049 Score=58.28 Aligned_cols=73 Identities=19% Similarity=0.179 Sum_probs=56.5
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
...|++|++- |++|.. + ....++++..++++.+..+.-+... .++-||||...||||+ +|+|-|+||-+++
T Consensus 299 ~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence 3456777775 556542 2 2345788889999988877777654 4599999999999999 9999999999999
Q ss_pred cC
Q 014585 224 DG 225 (422)
Q Consensus 224 ~~ 225 (422)
..
T Consensus 370 l~ 371 (488)
T COG5072 370 LS 371 (488)
T ss_pred cc
Confidence 54
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.02 Score=54.86 Aligned_cols=80 Identities=15% Similarity=0.111 Sum_probs=49.2
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecC------CC-cccHHHHHHHHHHhcccC--CC-cceeeEeEEE
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGDLV--HL-NLVKLIGYCI 141 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~ 141 (422)
.||-|-...||++.... .++.|+||.-.. .. .....+..-|...|+... -| .+.+++.+
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-- 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-- 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--
Confidence 47999999999998632 235799998531 11 223455667777776652 23 45555543
Q ss_pred ecCceEEEEEecCCC-Chhhhh
Q 014585 142 EDDQRLLVYEFMPRG-SLENHL 162 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g-~L~~~l 162 (422)
+.+...+|||+++.. .|.+.|
T Consensus 71 D~e~~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 71 DTEMAVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ccccceehHhhCccchHHHHHH
Confidence 455667999998543 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.023 Score=50.44 Aligned_cols=75 Identities=21% Similarity=0.257 Sum_probs=50.3
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC---CCcceeeEeEEEecCceE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQRL 147 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 147 (422)
+.+.-|..-..|...+ ....+-||+-... ....|..|+.-|+.|. .-+|.+++.+..+.++.|
T Consensus 22 ~~v~gG~inea~~v~d-----------g~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sy 87 (286)
T COG3001 22 EEVSGGDINEAWRLRD-----------GTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSY 87 (286)
T ss_pred cccCCccccceeEeec-----------CCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeE
Confidence 4455555555555443 2245777764322 2345777777776664 356788899999999999
Q ss_pred EEEEecCCCChh
Q 014585 148 LVYEFMPRGSLE 159 (422)
Q Consensus 148 lv~e~~~~g~L~ 159 (422)
+||||++-+.+.
T Consensus 88 lVle~L~~~~~d 99 (286)
T COG3001 88 LVLEYLPTGPLD 99 (286)
T ss_pred EEEeeccCCCCC
Confidence 999999987665
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.036 Score=52.78 Aligned_cols=139 Identities=22% Similarity=0.255 Sum_probs=79.4
Q ss_pred ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc------ceeeEeEE--Eec
Q 014585 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVKLIGYC--IED 143 (422)
Q Consensus 72 ~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~--~~~ 143 (422)
.|.+ .-..||+....+ | .+++|+.... ....++..|+..|..|.-.+ +...-|-. .-.
T Consensus 33 ~l~s-~eN~~f~~~~~~----------g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~ 98 (331)
T COG2334 33 GLNS-EENSNFRVQTED----------G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALS 98 (331)
T ss_pred cccc-ccCceEEEEecC----------C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhcc
Confidence 3444 556788887643 3 3488988766 34456777777777773222 12222211 113
Q ss_pred C--ceEEEEEecCCCChhh-hh--------------cc--------CC---CCCCHHH-------------HHHHHHHHH
Q 014585 144 D--QRLLVYEFMPRGSLEN-HL--------------FR--------RS---LPLPWSI-------------RMKIALGAA 182 (422)
Q Consensus 144 ~--~~~lv~e~~~~g~L~~-~l--------------~~--------~~---~~~~~~~-------------~~~i~~qi~ 182 (422)
+ ..+-|++|++|..+.. .- +. +. ....|.. -.....++.
T Consensus 99 ~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~ 178 (331)
T COG2334 99 GGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALL 178 (331)
T ss_pred CCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHH
Confidence 3 6778999999988872 11 00 00 0122220 011223333
Q ss_pred HHHHHHHhcC----CCC---eEeccCCCCcEEEcCCCC-eEEeeccCccc
Q 014585 183 KGLAFLHEEA----ERP---VIYRDFKTSNILLDADYN-AKLSDFGLAKD 224 (422)
Q Consensus 183 ~al~~LH~~~----~~~---iiHrDlkp~Nill~~~~~-~kl~DFG~a~~ 224 (422)
..+..+.+.- +.. +||+|+.|.||+++.+.. +-++||+-+..
T Consensus 179 ~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 179 AALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 4444444321 222 999999999999998875 88999997653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.016 Score=55.81 Aligned_cols=61 Identities=18% Similarity=0.145 Sum_probs=40.6
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~ 210 (422)
..||-+|..|-++..++...+ .+++....++.--.+|+--|---.+ ++|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEe
Confidence 356667888888888885443 4555666666655566543332221 999999999999943
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.024 Score=54.98 Aligned_cols=82 Identities=21% Similarity=0.229 Sum_probs=51.6
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecC-----CC-cccHHHHHHHHHHhcccC--CC-cceeeEeEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-----DG-LQGHKEWLAEVNFLGDLV--HL-NLVKLIGYC 140 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~ 140 (422)
.+.||-|--..||++.+.. .+..|+||.-.. .. .-..++..-|...|+.+. -| ++.+++.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 4578999999999998732 234688998531 11 223456677778777662 34 45556543
Q ss_pred EecCceEEEEEecCCC-Chhhhh
Q 014585 141 IEDDQRLLVYEFMPRG-SLENHL 162 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g-~L~~~l 162 (422)
+.+...+|||+++.. .|.+.|
T Consensus 104 -D~e~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 104 -DSVMNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred -CcHHhhHHHHhCcccHHHHHHH
Confidence 455667899998542 344433
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.016 Score=51.09 Aligned_cols=101 Identities=14% Similarity=0.079 Sum_probs=65.5
Q ss_pred EEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHH
Q 014585 102 VAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180 (422)
Q Consensus 102 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~q 180 (422)
..+|+++.-... ...-+.++.+++.++. .|+++..- ..-.+.++.|+|..... ... .+...
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~~----N~i~a 149 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NFS----NFITA 149 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------chh----HHHHH
Confidence 445666544333 3345678899988875 47777631 22244588999843111 111 11111
Q ss_pred HHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 181 i~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
=+.+|.-.|+.. ...+|+|-.|+|||-|+.|.+||.|=+.
T Consensus 150 gi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 150 GIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred hHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 246778889654 4599999999999999999999999654
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.16 Score=48.58 Aligned_cols=72 Identities=17% Similarity=0.092 Sum_probs=43.1
Q ss_pred ccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCC--cceeeE---e--EEEecCceEE
Q 014585 76 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLI---G--YCIEDDQRLL 148 (422)
Q Consensus 76 G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~---~--~~~~~~~~~l 148 (422)
+.-..||+.... .|..+++|+.+... ....++..|+..+..|... .++... | +...++..+.
T Consensus 36 s~eN~vy~v~~~----------~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~ 104 (325)
T PRK11768 36 SYENRVYQFGDE----------DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFA 104 (325)
T ss_pred cccceEEEEecC----------CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEE
Confidence 445678988653 35578999875432 2345677788877766321 222211 1 1223566788
Q ss_pred EEEecCCCCh
Q 014585 149 VYEFMPRGSL 158 (422)
Q Consensus 149 v~e~~~~g~L 158 (422)
|+++++|..+
T Consensus 105 l~~~~~G~~~ 114 (325)
T PRK11768 105 LFPRRGGRAP 114 (325)
T ss_pred EEeeeCCCCC
Confidence 9999987654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.06 Score=52.57 Aligned_cols=81 Identities=14% Similarity=0.065 Sum_probs=45.8
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcce-eeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv 149 (422)
+.|..|-...+|++......... -..+.|.++...... ...-+-.+|+++++.+...++- ++++.+. .++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~---~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDR---YPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCc---cccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 35555888899998754321000 001124444432211 1112335789999999665554 5555553 3689
Q ss_pred EEecCCCChh
Q 014585 150 YEFMPRGSLE 159 (422)
Q Consensus 150 ~e~~~~g~L~ 159 (422)
.||++|..|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999988764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.076 Score=52.85 Aligned_cols=84 Identities=12% Similarity=0.078 Sum_probs=49.8
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcce-eeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~l 148 (422)
++.|..|-.-.+|++....... ...+..++.|.+++.......- -.-..|..+++.+...+|- ++++.+. -+.
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 4456667778899987543211 0011135678899886543222 2345688888877655554 4555442 346
Q ss_pred EEEecCCCChh
Q 014585 149 VYEFMPRGSLE 159 (422)
Q Consensus 149 v~e~~~~g~L~ 159 (422)
|.||++|..|.
T Consensus 184 I~efi~g~~l~ 194 (442)
T PTZ00296 184 IEEWLYGDPLR 194 (442)
T ss_pred EEEeeCCccCC
Confidence 89999887543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 422 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-40 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 537 bits (1385), Expect = 0.0
Identities = 110/321 (34%), Positives = 172/321 (53%), Gaps = 31/321 (9%)
Query: 43 EEELKVAS-RLRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVK 95
+ L+V+ R F+F +LK T NF + +GEGGFG V+KG++
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------ 55
Query: 96 PGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 151
TVAVK L + + +++ E+ + H NLV+L+G+ + D LVY
Sbjct: 56 -----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 152 FMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209
+MP GSL + L + PL W +R KIA GAA G+ FLHE I+RD K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167
Query: 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 269
+ AK+SDFGLA+ + +T +++R++GT Y APE + G +T +SD+YSFGVVLLE
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLE 226
Query: 270 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 329
++TG ++D++R L++ E + ID ++ + +A+ C
Sbjct: 227 IITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQC 283
Query: 330 LSRDPKARPLMSEVVEALKPL 350
L RP + +V + L+ +
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 519 bits (1339), Expect = 0.0
Identities = 116/332 (34%), Positives = 181/332 (54%), Gaps = 17/332 (5%)
Query: 29 TTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEE 88
+ + +NS L V + DL+ AT NF + L+G G FG V+KG + +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 89 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 148
G VA+K + QG +E+ E+ L H +LV LIG+C E ++ +L
Sbjct: 63 ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112
Query: 149 VYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205
+Y++M G+L+ HL+ ++ + W R++I +GAA+GL +LH +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169
Query: 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 265
ILLD ++ K++DFG++K G E D+TH+ST V GT GY PEY + G LT +SDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 266 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 325
VL E+L R ++ ++ P NL EWA + +++DP L + +K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 326 AAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 357
A CL+ + RP M +V+ L+ L++
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-162
Identities = 119/304 (39%), Positives = 187/304 (61%), Gaps = 18/304 (5%)
Query: 51 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 110
+L++F+ +L++A+ NF +++LG GGFG V+KG + +GT VAVK L +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65
Query: 111 GLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 166
QG + ++ EV + VH NL++L G+C+ +RLLVY +M GS+ + L R
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 167 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226
PL W R +IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286
D THV+T V GT G+ APEY+ TG + ++DV+ +GV+LLE++TG+R+ D R +
Sbjct: 186 YKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 287 --NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344
L++W + L + ++ L+D L+G++ + ++ Q+A C P RP MSEVV
Sbjct: 245 DVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 345 EALK 348
L+
Sbjct: 304 RMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-87
Identities = 77/348 (22%), Positives = 129/348 (37%), Gaps = 50/348 (14%)
Query: 32 NAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 91
+ +S ++ +L + + + G FGCV+K +
Sbjct: 2 GHHHHHHSSGVD-----------LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---- 46
Query: 92 APVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLGDLVHLNLVKLIGYCIEDD----Q 145
VAVK +Q + W E V L + H N+++ IG
Sbjct: 47 -------NEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96
Query: 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER-------PVIY 198
L+ F +GSL + L + W+ IA A+GLA+LHE+ + +
Sbjct: 97 LWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 199 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-- 256
RD K+ N+LL + A ++DFGLA G + +GT Y APE +
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214
Query: 257 ---RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--WARPHLGERRRF--YRLIDPR 309
R D+Y+ G+VL E+ + + D E P L + + ++ P
Sbjct: 215 AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPV 274
Query: 310 LEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 356
L ++ G + C D +AR V E + + L ++
Sbjct: 275 LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-66
Identities = 69/332 (20%), Positives = 121/332 (36%), Gaps = 54/332 (16%)
Query: 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQ 113
++ L N + L+G G +G V+KG E VAVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47
Query: 114 GHKEWLAEVN--FLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS 166
+ ++ E N + + H N+ + I + LLV E+ P GSL +L +
Sbjct: 48 NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107
Query: 167 LPLPWSIRMKIALGAAKGLAFLHEEAER------PVIYRDFKTSNILLDADYNAKLSDFG 220
W ++A +GLA+LH E R + +RD + N+L+ D +SDFG
Sbjct: 108 SD--WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 221 LAK------DGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVL 267
L+ G++ + + +GT Y APE + + D+Y+ G++
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
Query: 268 LEMLTGRRSMDKNRPNGEHNL----VEWARPHLGERRRF-----YRLIDPRLEGHFSIKG 318
E+ + E+ + P + + R P S+
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-A 284
Query: 319 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
+ + C +D +AR E + L
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-63
Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 53/301 (17%)
Query: 57 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 115
+ ++++ +G G FG V K W VA+K + + +
Sbjct: 7 YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45
Query: 116 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSI 173
K ++ E+ L + H N+VKL G C+ LV E+ GSL N H +
Sbjct: 46 KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTH 232
M L ++G+A+LH + +I+RD K N+LL A K+ DFG A D
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQT 158
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292
T G+ + APE + + + DV+S+G++L E++T R +P E +
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFR 212
Query: 293 RP---HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349
H G R + + + L C S+DP RP M E+V+ +
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPI------------ESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 350 L 350
L
Sbjct: 261 L 261
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-62
Identities = 82/313 (26%), Positives = 138/313 (44%), Gaps = 62/313 (19%)
Query: 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 115
N+++ E +G+GGFG V KG + ++ + VA+K+L +G
Sbjct: 18 DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61
Query: 116 ------KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 169
+E+ EV + +L H N+VKL G +V EF+P G L + L ++ P+
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 170 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKLSDFGLAKD 224
WS+++++ L A G+ ++ + P+++RD ++ NI L A AK++DFGL++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ- 177
Query: 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281
H + ++G + + APE + T ++D YSF ++L +LTG
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------G 226
Query: 282 P----NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
P + G R PRL + C S DPK R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKR 274
Query: 338 PLMSEVVEALKPL 350
P S +V+ L L
Sbjct: 275 PHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-62
Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 57 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 115
+ DL + + +G G FG V + W +G+ VAVK L
Sbjct: 36 WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76
Query: 116 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPW 171
E+L EV + L H N+V +G + +V E++ RGSL L + L
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136
Query: 172 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
R+ +A AKG+ +LH P+++R+ K+ N+L+D Y K+ DFGL++ +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE- 290
S GT + APE + +SDVYSFGV+L E+ T + +P G N +
Sbjct: 196 --SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQV 247
Query: 291 -WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349
A +R R ++P++ A + C + +P RP + +++ L+P
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRP 295
Query: 350 L 350
L
Sbjct: 296 L 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-61
Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 56/309 (18%)
Query: 65 RNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 118
R FRP L LG+G FG K TG + +K L + + +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTF 54
Query: 119 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
L EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------DGP 226
A G+A+LH +I+RD + N L+ + N ++DFGLA+
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286
+ V+G + APE + + DV+SFG+VL E++ + P+
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLP 227
Query: 287 NLVEWARPHLGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341
+++ R F P + C DP+ RP
Sbjct: 228 RTMDFGLNV----RGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFV 271
Query: 342 EVVEALKPL 350
++ L+ L
Sbjct: 272 KLEHWLETL 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-60
Identities = 85/309 (27%), Positives = 131/309 (42%), Gaps = 58/309 (18%)
Query: 57 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 115
F +L L +G GGFG V++ W G VAVK HD +
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46
Query: 116 ----KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 171
+ E L H N++ L G C+++ LV EF G L L + +P
Sbjct: 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP 104
Query: 172 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--------ADYNAKLSDFGLAK 223
I + A+ A+G+ +LH+EA P+I+RD K+SNIL+ ++ K++DFGLA+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP- 282
E +T + G Y + APE + + SDV+S+GV+L E+LTG P
Sbjct: 165 ---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPF 214
Query: 283 NGEHNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341
G L V + A+L C + DP +RP +
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFT 262
Query: 342 EVVEALKPL 350
+++ L +
Sbjct: 263 NILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 67/312 (21%), Positives = 115/312 (36%), Gaps = 70/312 (22%)
Query: 57 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 115
F L T+ L E G ++KG W G + VK L
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49
Query: 116 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLP 170
+++ E L H N++ ++G C + +MP GSL N L + +
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 171 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 230
S +K AL A+G+AFLH E + + ++++D D A++S +
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------F 161
Query: 231 THVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286
+ S M + APE + +D++SF V+L E++T P +
Sbjct: 162 SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADL 214
Query: 287 NLVEWA--------RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
+ +E RP + I P + ++L C++ DP RP
Sbjct: 215 SNMEIGMKVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRP 256
Query: 339 LMSEVVEALKPL 350
+V L+ +
Sbjct: 257 KFDMIVPILEKM 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-58
Identities = 62/351 (17%), Positives = 123/351 (35%), Gaps = 69/351 (19%)
Query: 34 ESNSSTSKLEEELKVASRLRKFT------FNDLKLATRNFRPESLLGEGGFGCVFKG-WI 86
E N S + AS+ F F L++ +G+G FG V+ G W
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW- 54
Query: 87 EENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144
+G VA++ ++ + K + EV H N+V +G C+
Sbjct: 55 --HGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204
++ +L + + + L + +IA KG+ +LH + ++++D K+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159
Query: 205 NILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTG--------- 252
N+ D + ++DFGL G + G + APE +
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 253 HLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 309
+ SDV++ G + E+ ++ + W + +
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQ------MGTGMKPNLSQ 265
Query: 310 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSS 360
+ I + C + + + RP +++++ L+ LP K S
Sbjct: 266 IGMGKEIS------DILLFCWAFEQEERPTFTKLMDMLEKLP--KRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 9e-58
Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 42/301 (13%)
Query: 57 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 115
+ + R +G G FG V+KG W +G VAVK LN
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62
Query: 116 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 173
+ + EV L H+N++ +GY Q +V ++ SL +HL
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+ IA A+G+ +LH + +I+RD K++NI L D K+ DFGLA + +H
Sbjct: 122 LIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 234 STRVMGTYGYAAPE---YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 290
++ G+ + APE + + +SDVY+FG+VL E++TG+ P N +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRD 232
Query: 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
+G ++ + ++ +L A CL + RP ++ ++ L
Sbjct: 233 QIIEMVGRGSL--SPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
Query: 351 P 351
Sbjct: 287 A 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 9e-57
Identities = 68/313 (21%), Positives = 119/313 (38%), Gaps = 45/313 (14%)
Query: 70 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 126
+G+G +G V+ G W E VAVK W E+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86
Query: 127 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
+ H N++ I I+ Q L+ ++ GSL ++L +S L +K+A +
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 183 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 235
GL LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 236 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--H 286
+GT Y PE V+ L +D+YSFG++L E+ R + +
Sbjct: 205 TRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPY 262
Query: 287 NLVEWARPHLGERRRF--YRLIDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKARPLMSEV 343
+ + + P + R + + P +S + +L C + +P +R V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 344 VEALKPLPNLKDM 356
+ L + +D+
Sbjct: 323 KKTLAKMSESQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 71/311 (22%), Positives = 114/311 (36%), Gaps = 53/311 (17%)
Query: 70 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 126
+G+G +G V++G W G VAVK + + K W E +
Sbjct: 13 LECVGKGRYGEVWRGSW---QGE---------NVAVKIFSS---RDEKSWFRETELYNTV 57
Query: 127 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
L H N++ I + Q L+ + GSL ++L + L ++I L A
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 183 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 235
GLA LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 236 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRP------ 282
+GT Y APE V+ + R D+++FG+VL E+ S
Sbjct: 176 PRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 283 --NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 339
E R + ++ R I R A+L C ++P AR
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQ--RPNIPNRWFSD---PTLTSLAKLMKECWYQNPSARLT 289
Query: 340 MSEVVEALKPL 350
+ + L +
Sbjct: 290 ALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 73/317 (23%), Positives = 123/317 (38%), Gaps = 53/317 (16%)
Query: 70 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 126
+ +G+G FG V++G W E VAVK + + + W E +
Sbjct: 47 QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91
Query: 127 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
L H N++ I +D+ Q LV ++ GSL ++L + +K+AL A
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTA 149
Query: 183 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 235
GLA LH E + +RD K+ NIL+ + ++D GLA D
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 236 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRP------ 282
+GT Y APE V+ + R+D+Y+ G+V E+ +
Sbjct: 210 HRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 283 --NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 339
VE R + E++ R I R + +++ A++ C + AR
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKL--RPNIPNRWQSCEALR---VMAKIMRECWYANGAARLT 323
Query: 340 MSEVVEALKPLPNLKDM 356
+ + L L + +
Sbjct: 324 ALRIKKTLSQLSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
+G G FG VF G + + T VAVK+ ++L E L H
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 251
+ I+RD N L+ K+SDFG++++ +G + APE +
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 252 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPRL 310
G +S SDV+SFG++L E + S N N + VE + RL P
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRL--PCP 337
Query: 311 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
E +L C + +P RP S + + L+ +
Sbjct: 338 ELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-43
Identities = 88/302 (29%), Positives = 122/302 (40%), Gaps = 44/302 (14%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 123
R + LGEG FG V + P GTG VAVK L D G Q W E++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L L H +++K G C + LV E++P GSL ++L R S+ L + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQI 143
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 235
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + +
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 236 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 293
APE + SDV+SFGV L E+LT S E + +
Sbjct: 201 VFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254
Query: 294 PHLGERRRF----YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346
+ RL P E + L +C + RP ++
Sbjct: 255 MTVLRLTELLERGERLPRPDKCPAEVY----------HLMKNCWETEASFRPTFENLIPI 304
Query: 347 LK 348
LK
Sbjct: 305 LK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 82/306 (26%), Positives = 122/306 (39%), Gaps = 47/306 (15%)
Query: 65 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
R+ + S LG+G FG V + P+ TG VAVK L H G +++ E+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L L +VK G ++ LV E++P G L + L R L S + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 235
KG+ +L R ++RD NIL++++ + K++DFGLAK P +V
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 236 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 293
APE + + +SDV+SFGVVL E+ T +S + E
Sbjct: 194 IFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 294 PHLGERRRF----YRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344
P L RL P H +L C + P+ RP S +
Sbjct: 248 PALSRLLELLEEGQRL--PAPPACPAEVH----------ELMKLCWAPSPQDRPSFSALG 295
Query: 345 EALKPL 350
L L
Sbjct: 296 PQLDML 301
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 65 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 235
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ +
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 236 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-----V 289
APE + + SDV+SFGVVL E+ T +
Sbjct: 181 IFWY------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 290 EWARPHLGER-RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ HL E + RL P E + + C + + RP ++
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIY----------MIMTECWNNNVNQRPSFRDLAL 284
Query: 346 ALKPL 350
+ +
Sbjct: 285 RVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-41
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 65 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 235
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ + +
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 236 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
APE + + SDV+SFGVVL E+ T
Sbjct: 212 IFWY------APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 79/304 (25%), Positives = 119/304 (39%), Gaps = 42/304 (13%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 123
R + LGEG FG V + P TG VAVK+L + G + E+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L +L H N+VK G C ED L+ EF+P GSL+ +L + + ++K A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 235
KG+ +L R ++RD N+L+++++ K+ DFGL K + +
Sbjct: 136 CKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 236 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV---E 290
APE +M SDV+SFGV L E+LT + +
Sbjct: 193 VFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246
Query: 291 WARPHLGER-RRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346
L + RL P E + QL C P R ++E
Sbjct: 247 MTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSFQNLIEG 296
Query: 347 LKPL 350
+ L
Sbjct: 297 FEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 20/229 (8%)
Query: 50 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLN 108
+ LR + K LG G FG V+KG WI E + VA+K L
Sbjct: 7 ALLRILKETEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELR 53
Query: 109 HD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 167
+ +KE L E + + + ++ +L+G C+ L+ + MP G L +++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 168 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227
+ + + AKG+ +L +R +++RD N+L+ + K++DFGLAK
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+K + + + A E ++ T +SDV+S+GV + E++T G +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVH 130
LGEG FG V +G + GT L VAVKT+ D + +E+L+E + D H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 131 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IALG 180
N+++L+G CIE + +++ FM G L +L + R P I ++ +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRV- 237
A G+ +L + R ++RD N +L D ++DFGL+K GD + ++
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 238 ---MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ A E + TS+SDV++FGV + E+ T
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 33 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAA 182
++V+L+G + L++ E M RG L+++L P S +++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----- 237
G+A+L ++RD N ++ D+ K+ DFG+ +D E D +
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 238 -MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
M +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 64 TRNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 116
R F+ L LG G FG V KG WI E + + V +K + G Q +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60
Query: 117 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
+ +G L H ++V+L+G C LV +++P GSL +H+ + L + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
+ AKG+ +L E +++R+ N+LL + +++DFG+A P DK + +
Sbjct: 120 WGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+ A E + G T +SDV+S+GV + E++T G
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
+G G FGCV+ G T G + AVK+LN + ++L E + D H
Sbjct: 33 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 132 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
N++ L+G C+ + L+V +M G L N + + + L AKG+ +L
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG------TYGYA 244
A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM---- 199
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLT 272
A E + T T++SDV+SFGV+L E++T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 130
LG G FG V+KG WI E + VA+K L + +KE L E + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
++ +L+G C+ L+ + MP G L +++ + + + AKG+ +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
+R +++RD N+L+ + K++DFGLAK +K + + + A E ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 251 TGHLTSRSDVYSFGVVLLEMLT-GRR 275
T +SDV+S+GV + E++T G +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG+G F +FKG V +K L+ + + + + L H
Sbjct: 16 LGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 189
+LV G C+ D+ +LV EF+ GSL+ +L + + + W + + A A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129
Query: 190 EEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
E +I+ + NILL + + KLSD G++ D +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184
Query: 242 GYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRR 275
PE + +L +D +SFG L E+ + G +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 49 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------MKIA 178
+V+ G C E L+V+E+M G L L + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV- 237
A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 238 -----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
M PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LGEG FG VF E +P K VAVK L L K++ E L +L H +
Sbjct: 23 LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MKI 177
+VK G C + D ++V+E+M G L L + + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
A A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 238 ------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
M PE +M T+ SDV+SFGV+L E+ T
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
+G+G FG V+ G + + A+K+L+ +Q + +L E + L H
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 132 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFL 188
N++ LIG + + ++ +M G L + +R+ + I L A+G+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG------TYG 242
AE+ ++RD N +LD + K++DFGLA+D + + V T
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
A E + T T++SDV+SFGV+L E+LT
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVH 130
LG+G FG V + + G+ + VAVK L D + +E+L E + + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 131 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IAL 179
++ KL+G + + +++ FM G L L R P+++ ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRV 237
A G+ +L + R I+RD N +L D ++DFGL++ GD + ++++
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 238 ----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ A E + T SDV++FGV + E++T
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 69/275 (25%), Positives = 114/275 (41%), Gaps = 30/275 (10%)
Query: 15 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPE---- 70
S I +TS + S + + +L A ++
Sbjct: 30 GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89
Query: 71 -----SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNF 124
++G G FGCV+ G T G + AVK+LN + ++L E
Sbjct: 90 IVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143
Query: 125 LGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
+ D H N++ L+G C+ + L+V +M G L N + + + L AK
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---- 239
G+ FL A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 204 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 240 --TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
A E + T T++SDV+SFGV+L E++T
Sbjct: 261 KWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 70 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 127
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG----- 242
L E+ ++RD N+LL + AK+SDFGL+K D + +
Sbjct: 126 L---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPL 177
Query: 243 -YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+ APE + +SRSDV+S+GV + E L+ G++
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G +G V++G W LTVAVKTL D ++ +E+L E + ++ H
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 190
NLV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
++ I+R+ N L+ ++ K++DFGL++ GD + APE +
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 251 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR 309
+ +SDV++FGV+L E+ T S + + L+E + YR+ P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERPE 442
Query: 310 LEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQA 368
G + +L C +P RP +E+ +A + + SS +
Sbjct: 443 --------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----ESSISDEVEKEL 490
Query: 369 ERIGS 373
+ G+
Sbjct: 491 GKRGT 495
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 128
E ++G G G V G + G V VA+K L + + ++L+E + +G
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H N+++L G ++V E+M GSL+ L + + G G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPE 247
++ ++RD N+L+D++ K+SDFGL++ + D + +T + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+ +S SDV+SFGVV+ E+L G R
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 67/285 (23%), Positives = 95/285 (33%), Gaps = 43/285 (15%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVN 123
+F+ S LG G +G VFK G AVK G + LAEV
Sbjct: 58 SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 124 FLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
+ H V+L E L E SL+ H LP +
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
LA LH + +++ D K +NI L KL DFGL + V G
Sbjct: 168 LALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPR 221
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR- 301
Y APE + + + +DV+S G+ +LE+ PH GE +
Sbjct: 222 YMAPELLQGSY-GTAADVFSLGLTILEVACNME-----------------LPHGGEGWQQ 263
Query: 302 -FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ P S + + L DPK R ++
Sbjct: 264 LRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V G W G V AVK + +G E+ E + L H
Sbjct: 16 LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 189
LVK G C ++ +V E++ G L N+L + L + M +G+AFL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAP 246
I+RD N L+D D K+SDFG+ + + +GT ++AP
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAP 174
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
E +S+SDV++FG+++ E+ + G+
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 128
LG+G FG V +G W +G ++VAVK L D L + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLA 186
H NL++L G + +V E P GSL + L + L R A+ A+G+
Sbjct: 79 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGY 243
+L + I+RD N+LL K+ DFGL + P+ D +V + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
APE + T + SD + FGV L EM T G+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
+G G FG V G W V A+KT+ +G ++++ E + L H
Sbjct: 16 IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 189
LV+L G C+E LV EFM G L ++L R + M L +G+A+L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYA 244
E VI+RD N L+ + K+SDFG+ + + + T+
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------ 172
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+PE +S+SDV+SFGV++ E+ + G+
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 58 NDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGL--QG 114
L L + LG G FG V KG + + V AVK L ++
Sbjct: 16 KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61
Query: 115 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSI 173
E LAE N + L + +V++IG C E + +LV E G L +L R + I
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+ + G+ +L E ++RD N+LL + AK+SDFGL+K + +
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 234 STRVMGTYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+ + APE + +S+SDV+SFGV++ E + G++
Sbjct: 176 AQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVH 130
+G G FG V+KG +G V VA+KTL + ++L E +G H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 190
N+++L G + +++ E+M G+L+ L + + + G A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTYGY 243
A ++RD NIL++++ K+SDFGL+ +D PE T ++
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
APE + TS SDV+SFG+V+ E++T G R
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 122
R + + +G G F V+KG E T + VA L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 123 NFLGDLVHLNLVKLIGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIA 178
L L H N+V+ + + +++ E M G+L+ +L +R + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWC 135
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRV 237
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 136 RQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
+GT + APE + DVY+FG+ +LEM T E+ E
Sbjct: 191 IGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMAT-----------SEYPYSECQNAAQI 238
Query: 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
RR + + + ++ C+ ++ R
Sbjct: 239 YRRVTSGVKPASFDKVAI----PEVKEIIEGCIRQNKDERY 275
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 42/245 (17%)
Query: 50 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 109
+L++ + + ++ LGE FG V+KG G AP + VA+KTL
Sbjct: 1 GKLKEISLSAVRF-------MEELGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKD 49
Query: 110 D-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 168
+E+ E L H N+V L+G +D +++ + G L L RS
Sbjct: 50 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 169 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213
+ + A G+ +L + V+++D T N+L+ N
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLN 166
Query: 214 AKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 267
K+SD GL ++ D K ++ + M APE +M G + SD++S+GVVL
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVL 220
Query: 268 LEMLT 272
E+ +
Sbjct: 221 WEVFS 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 131
LGEG FG V++G G + VAVKT D +K ++++E + +L H
Sbjct: 20 LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 189
++VKLIG E+ ++ E P G L ++L + SL + + +L K +A+L
Sbjct: 74 HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGYA 244
++RD NIL+ + KL DFGL++ + D S + M
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+PE + T+ SDV+ F V + E+L+ G++
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-36
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 130
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 175
N++ L+G C +D ++ E+ +G+L +L R P +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHV 233
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 234 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 9e-36
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V G W G V A+K + +G E++ E + +L H
Sbjct: 32 LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 189
LV+L G C + ++ E+M G L N+L R + M + + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAP 246
+ ++RD N L++ K+SDFGL++ + + T +G+ ++ P
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPP 190
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
E +M +S+SD+++FGV++ E+ + G+
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL 128
+ ++G G FG V G ++ + VA+KTL + +++L E + +G
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H N+++L G + ++V E+M GSL++ L + + + G A G+ +L
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTY 241
++ ++RD NIL++++ K+SDFGL +D PE T ++
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT--- 217
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+PE + TS SDV+S+G+VL E+++ G R
Sbjct: 218 ---SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 64/313 (20%), Positives = 112/313 (35%), Gaps = 69/313 (22%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
+F ++LG+G FG V K A+K + H + L+EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRL-------------LVYEFMPRGSLENHLFRRSLPLP 170
L L H +V+ +E + + E+ G+L + + +L
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 171 ----WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 223
W + +I L+++H + +I+RD K NI +D N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 224 ----------DGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEML 271
G ++++ + GT Y A E V+ TGH + D+YS G++ EM+
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 272 TGRRSMDKNRPNGEHNLVE-WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 330
+ V + P + + + ++ +
Sbjct: 226 YP--------FSTGMERVNILKKLRSVSIE-----FPPDFDDNKM----KVEKKIIRLLI 268
Query: 331 SRDPKARPLMSEV 343
DP RP +
Sbjct: 269 DHDPNKRPGARTL 281
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 130
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 89 LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 175
N++ L+G C +D ++ E+ +G+L +L R P +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHV 233
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 234 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 128
+ ++GEG FG V K I+ K G + A+K + H+++ E+ L L
Sbjct: 30 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 129 V-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------------- 174
H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 141
Query: 175 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ K
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 232 HVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
R+ M A E + T+ SDV+S+GV+L E+++
Sbjct: 199 T-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 73/309 (23%), Positives = 113/309 (36%), Gaps = 58/309 (18%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 124
+F+ L+G GGFG VFK G T +K + ++ + +E V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNNEKAERE----VKA 57
Query: 125 LGDLVHLNLVKLIGYCIEDDQRL----------------LVYEFMPRGSLENHL-FRRSL 167
L L H+N+V G D + EF +G+LE + RR
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 168 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227
L + +++ KG+ ++H + +I RD K SNI L K+ DFGL
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---S 171
Query: 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSK 226
Query: 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
F L D + F +K L LS+ P+ RP SE++ L
Sbjct: 227 F-------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTL 269
Query: 348 KPLPNLKDM 356
+
Sbjct: 270 TVWKKSPEK 278
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 39/285 (13%)
Query: 70 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 128
E LG+G FG V+ G W NGT V A+KTL G + +L E + L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 187
H LV+L E+ +V E+M +GSL + L L + +A A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
+ ++RD + +NIL+ + K++DFGLA+ E ++ + APE
Sbjct: 296 V---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLI 306
+ G T +SDV+SFG++L E+ T R N E + VE R YR+
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMP 401
Query: 307 DPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 350
P ++ L C ++P+ RP + L+
Sbjct: 402 CPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 131
+GEG FG V +G L VA+KT + + ++L E + H
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 189
++VKLIG E+ ++ E G L + L + SL L I A + LA+L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGYA 244
+ ++RD N+L+ ++ KL DFGL++ + S + M
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
APE + TS SDV+ FGV + E+L G +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 130
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK--- 176
N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 177 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHV 233
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D K
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 234 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ R+ M APE + T +SDV+SFGV+L E+ T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 43/230 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
+GEG FG VF+ G P +P T VAVK L + ++ E + + +
Sbjct: 55 IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 174
N+VKL+G C L++E+M G L L S S+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 175 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228
+ IA A G+A+L +ER ++RD T N L+ + K++DFGL+++
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 229 D--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
D K + + M PE + T+ SDV+++GVVL E+ +
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 70 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 127
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYA 244
L E+ ++R+ N+LL + AK+SDFGL+K D + + +
Sbjct: 452 L---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWY 506
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
APE + +SRSDV+S+GV + E L+ G++
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 132 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 189
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----MGTYGYAA 245
++RD N+L+ D AK+SDFGL K+ T + ++ A
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------A 182
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
PE + +++SDV+SFG++L E+ + GR
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 71/316 (22%), Positives = 112/316 (35%), Gaps = 50/316 (15%)
Query: 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKE 117
+ + +++ LGEGGF V V+ G A+K + Q +E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQQDREE 72
Query: 118 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLP 170
E + H N+++L+ YC+ + L+ F RG+L N + R L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 171 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 230
+ + LG +GL +H + +RD K +NILL + L D G +
Sbjct: 133 EDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 231 THVSTRVM-------GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280
+ T Y APE + R+DV+S G VL M+ G D
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249
Query: 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-- 338
G+ L + + P S QL ++ DP RP
Sbjct: 250 FQKGDSVA-------LAVQNQLSIPQSP----RHS----SALWQLLNSMMTVDPHQRPHI 294
Query: 339 --LMSEVVEALKPLPN 352
L+S++ P P
Sbjct: 295 PLLLSQLEALQPPAPG 310
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG G +G V++G V LTVAVKTL + +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEE 191
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 192 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYAAP 246
++ I+RD N L+ ++ K++DFGL++ H + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------AP 181
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
E + + +SDV++FGV+L E+ T G
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 38 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSIRMKIALGAAKG 184
N+V+ IG ++ R ++ E M G L++ L R + P L + +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+L E I+RD N LL AK+ DFG+A+D M
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ PE M G TS++D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 201 IGKGEFGDVMLGDY---RGN---------KVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 132 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 189
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305
Query: 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 249
++RD N+L+ D AK+SDFGL K+ T + ++ + APE +
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKL--PVKWTAPEAL 358
Query: 250 MTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+++SDV+SFG++L E+ + GR
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 78/369 (21%), Positives = 123/369 (33%), Gaps = 55/369 (14%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
S S S+ A SS + T + E + + K + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETE--DNEGVLLTEKLKPVDYEYREEVHW 59
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
+ +G G FG V + TG AVK + L+ + E+
Sbjct: 60 MTHQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACA 105
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
L +V L G E + E + GSL L ++ LP + A +GL
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 187 FLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYG 242
+LH +++ D K N+LL +D A L DFG A G + GT
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 243 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
+ APE VM ++ D++S ++L ML G P W
Sbjct: 222 HMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH------P--------WT--QYFRGPL 264
Query: 302 FYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEALKPLPN 352
++ + + AQ L ++P R L +V +AL+ +
Sbjct: 265 CLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320
Query: 353 LKDMASSSY 361
LK Y
Sbjct: 321 LKSPWKGEY 329
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG G FG V+ G + NG V AVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 190
LV+L ++ ++ E+M GSL + L + L + + +A A+G+AF+
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYV 249
ER I+RD + +NIL+ + K++DFGLA+ + + + + APE +
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAI 182
Query: 250 MTGHLTSRSDVYSFGVVLLEMLT-GRR 275
G T +SDV+SFG++L E++T GR
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 79 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR--MKIALGAAKG 184
N+V+ IG ++ R ++ E M G L++ L R + P ++ + +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+L E I+RD N LL AK+ DFG+A+D M
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ PE M G TS++D +SFGV+L E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 128
+GEG FG V +G + VA+KT + +++L E +
Sbjct: 395 GRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 188
H ++VKLIG E+ ++ E G L + L R L + + A + LA+L
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYAA 245
+ ++RD N+L+ ++ KL DFGL++ + S + A
Sbjct: 508 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----A 560
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
PE + TS SDV+ FGV + E+L G +
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 66/348 (18%), Positives = 123/348 (35%), Gaps = 39/348 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 122
+ +GEG FG G +K +N + KE EV
Sbjct: 25 KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGA 181
L ++ H N+V+ E+ +V ++ G L + ++ + + +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
L +H+ R +++RD K+ NI L D +L DFG+A+ + GT
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTP 189
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
Y +PE ++SD+++ G VL E+ T + + + +
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------- 242
Query: 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE---ALKPLPNLKDMAS 358
P + H+S L + R+P+ RP ++ ++E K +
Sbjct: 243 ------PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 359 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 406
+ F + GS P + S+S + ++ P Y P
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-34
Identities = 65/309 (21%), Positives = 110/309 (35%), Gaps = 64/309 (20%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 124
+F P LG GGFG VF+ A+K + + +E + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 125 LGDLVHLNLVKLIGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR--SLPLP 170
L L H +V+ +E + ++ +Y + + +L++ + R
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 171 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 223
S+ + I L A+ + FLH + +++RD K SNI D K+ DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 224 ---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280
T +GT Y +PE + + + D++S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225
Query: 281 RPNGEHNLVEWARPHLGERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKA 336
+ + ER R + P L + LS P
Sbjct: 226 PFSTQM-----------ERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPME 270
Query: 337 RPLMSEVVE 345
RP ++E
Sbjct: 271 RPEAINIIE 279
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 68/231 (29%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 131
LGEG FG V K T TVAVK L + ++ L+E N L + H
Sbjct: 31 LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 174
+++KL G C +D LL+ E+ GSL L R S +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 175 -------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227
+ A ++G+ +L AE +++RD NIL+ K+SDFGL++D E
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 228 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
D R+ M A E + T++SDV+SFGV+L E++T
Sbjct: 203 EDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 50/292 (17%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 122
NFR E +G G F V++ G+ VA+K + L K + E+
Sbjct: 33 NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIAL 179
+ L L H N++K IED++ +V E G L + ++ +P K +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
L +H R V++RD K +N+ + A KL D GL + T + V G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-G 198
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299
T Y +PE + +SD++S G +L EM + P G++
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDK 240
Query: 300 RRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
Y L P H+S ++ QL C++ DP+ RP ++ V
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYV 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 73 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
LG+G FG V+ G W NGT V A+KTL G + +L E + L H
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 190
LV+L E+ +V E+M +GSL + L L + +A A G+A++
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379
Query: 191 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250
++RD + +NIL+ + K++DFGLA+ E ++ + APE +
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 251 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR 309
G T +SDV+SFG++L E+ T R N E + VE R YR+ P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMPCPP 487
Query: 310 LEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 350
++ L C ++P+ RP + L+
Sbjct: 488 --------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 70 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 128
E LG G FG V+ + N V AVKT+ G + +LAE N + L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240
Query: 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAF 187
H LVKL ++ ++ EFM +GSL + L P + + A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
+ +R I+RD + +NIL+ A K++DFGLA+ E ++ + APE
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275
+ G T +SDV+SFG++L+E++T GR
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 34/221 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 130
LG G FG V + G VAVK L + ++E+ + L H
Sbjct: 54 LGAGAFGKVVEA--TAFGLGKEDAVL--KVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKI 177
N+V L+G C L++ E+ G L N L R+S L +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-- 235
+ A+G+AFL A + I+RD N+LL + AK+ DFGLA+D V
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 236 ----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ M APE + T +SDV+S+G++L E+ +
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 39/225 (17%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 130
LG G FG V + + G TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 131 LNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 174
LN+V L+G C + +++ EF G+L +L R +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 175 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KT 231
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 232 HVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
R+ M APE + T +SDV+SFGV+L E+ +
Sbjct: 207 KGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 65/225 (28%), Positives = 91/225 (40%), Gaps = 38/225 (16%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 130
LG G FG V + G TVAVK L L + ++E+ L L H
Sbjct: 31 LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 174
+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 175 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D V
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 234 ST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ M APE + T SDV+S+G+ L E+ +
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 68/322 (21%), Positives = 118/322 (36%), Gaps = 60/322 (18%)
Query: 26 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 85
S +T + S + + E +LG+G +G V+ G
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41
Query: 86 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 145
+ +A+K + + + E+ L H N+V+ +G E+
Sbjct: 42 --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93
Query: 146 RLLVYEFMPRGSLENHLFRRSLPLPWS---IRMKIALGAAKGLAFLHEEAERPVIYRDFK 202
+ E +P GSL L + PL + I +GL +LH+ +++RD K
Sbjct: 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ---IVHRDIK 149
Query: 203 TSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 258
N+L++ K+SDFG +K + + GT Y APE + G+ +
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY-GKAA 206
Query: 259 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--HLGERRRFYRLIDPRLEGHFSI 316
D++S G ++EM TG+ P + L E +G + + P + S
Sbjct: 207 DIWSLGCTIIEMATGK------PPF--YELGEPQAAMFKVGMFK-----VHPEIPESMS- 252
Query: 317 KGAQKAAQLAAHCLSRDPKARP 338
+A C DP R
Sbjct: 253 ---AEAKAFILKCFEPDPDKRA 271
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 72/293 (24%), Positives = 112/293 (38%), Gaps = 45/293 (15%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 122
++ LG GG V+ VA+K + + +E L EV
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNI---------KVAIKAI-FIPPREKEETLKRFEREV 62
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
+ L H N+V +I EDD LV E++ +L ++ PL +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQIL 121
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
G+ H+ +++RD K NIL+D++ K+ DFG+AK E T + V+GT
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGE--- 298
Y +PE +D+YS G+VL EML G P NGE V A H+ +
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQDSVP 230
Query: 299 --RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 348
+ I L + +D R + E+ + L
Sbjct: 231 NVTTDVRKDIPQSLS------------NVILRATEKDKANRYKTIQEMKDDLS 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 57/230 (24%), Positives = 89/230 (38%), Gaps = 43/230 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 130
LG G FG V G + VAVK L + ++E+ + L H
Sbjct: 53 LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 174
N+V L+G C L++E+ G L N+L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 175 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228
+ A AKG+ FL + ++RD N+L+ K+ DFGLA+D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 229 D--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
+ R+ M APE + G T +SDV+S+G++L E+ +
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 58/213 (27%), Positives = 82/213 (38%), Gaps = 19/213 (8%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 122
+R L+G GG G V++ VA+K + + L + E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
G L ++V + + D Q + + L L RR PL + I
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIG 144
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
L H +RD K NIL+ AD A L DFG+A + T + +GT
Sbjct: 145 SALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 275
Y APE H T R+D+Y+ VL E LTG
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 66/338 (19%), Positives = 107/338 (31%), Gaps = 51/338 (15%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 130
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 131 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 185
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 186 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 242 GYAAPEYVMTGHLTSRS--------DVYSFGVVLLEMLTGRR-------------SMDKN 280
Y P+ L D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 340
+ + + D + S + A+ L D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 341 SEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 378
+ + + + + Q M A +I
Sbjct: 298 DQFFAETSDILHRMVIH--VFSLQQMTAHKIYIHSYNT 333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 37/290 (12%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 122
++ +G G +G K + G + K L++ + + ++EV
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56
Query: 123 NFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 177
N L +L H N+V+ + L +V E+ G L + + + L +++
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 178 ALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
L H + V++RD K +N+ LD N KL DFGLA+ D + T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295
V GT Y +PE + +SD++S G +L E+ + +
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 233
Query: 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
R+ +S + ++ L+ RP + E++E
Sbjct: 234 ------------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 48/286 (16%), Positives = 87/286 (30%), Gaps = 28/286 (9%)
Query: 8 ESKSTNDTSRDQPA----AAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLA 63
S T D +I + ++ SS E ++ T + +L
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT--EFQLG 63
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
++ LLGEG F V++ + K +K +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEA--TQGDLNDAK--NKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRMKIAL 179
L + +K + + +LV E G+L N + +P + + A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILL-----------DADYNAKLSDFGLAKDGPEG 228
+ +H+ +I+ D K N +L D L D G + D
Sbjct: 180 RMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
K + T T G+ E + + D + + ML G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 77/336 (22%), Positives = 132/336 (39%), Gaps = 54/336 (16%)
Query: 37 SSTSKLEEELKVASRLRKFTFNDLK---LATRNFRPESLLGEGGFGCVFKGWIEENGTAP 93
+LE + + RL F K L +F S LG G G VFK +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP----- 56
Query: 94 VKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 152
+GL +A K ++ + + + E+ L + +V G D + + E
Sbjct: 57 ----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112
Query: 153 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212
M GSL+ + +++ +P I K+++ KGL +L E+ +++RD K SNIL+++
Sbjct: 113 MDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 169
Query: 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
KL DFG++ + + ++ V GT Y +PE + H + +SD++S G+ L+EM
Sbjct: 170 EIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 273 GR-------------------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLID------ 307
GR P + R + +
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285
Query: 308 ----PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 338
P+L G FS + CL ++P R
Sbjct: 286 NEPPPKLPSGVFS----LEFQDFVNKCLIKNPAERA 317
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-30
Identities = 69/301 (22%), Positives = 105/301 (34%), Gaps = 43/301 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 124
+ + LG GGFG V + + TG VA+K + ++E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 125 LGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSLPLPWSIR 174
+ L H N+V + D + LL E+ G L +L + L
Sbjct: 66 MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPEGDKT 231
+ + L +LHE +I+RD K NI+L K+ D G AK+ +G+
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR---------SMDKNRP 282
V GT Y APE + T D +SFG + E +TG R
Sbjct: 181 T--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 342
+ + G + L P H S A K + L + R +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294
Query: 343 V 343
Sbjct: 295 N 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 62/297 (20%), Positives = 98/297 (32%), Gaps = 49/297 (16%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 130
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 131 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 185
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 186 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 242 GYAAPEYVMTGHL--------TSRSDVYSFGVVLLEMLTGRR-------------SMDKN 280
Y P+ L + D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
+ + + D + S + A+ L D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-30
Identities = 44/381 (11%), Positives = 84/381 (22%), Gaps = 64/381 (16%)
Query: 19 QPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGF 78
+ +I + ++ + + L R + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 79 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVK 135
VF A+K E L+ + +
Sbjct: 76 SVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 136 LIGYC-----------------------IEDDQRLLVYEFMPR--------GSLENHLFR 164
+D MP S + ++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 165 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224
+ + A L + +++ F N+ + D L D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRP 282
G + S+ YA E++ T + + G+ + + P
Sbjct: 243 -KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 342
+ W RP L + L L+ D + R L E
Sbjct: 299 GIKG---SWKRPSLRVPGTDS--LAFGSCTPLP----DFVKTLIGRFLNFDRRRRLLPLE 349
Query: 343 VVE--ALKPLPNLKDMASSSY 361
+E L N + S+
Sbjct: 350 AMETPEFLQLQNEISSSLSTG 370
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 64/308 (20%), Positives = 111/308 (36%), Gaps = 50/308 (16%)
Query: 53 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 112
F + + R + +G GG VF+ V A+K +N +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 113 QGH--KEWLAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 167
+ E+ +L L + ++L Y DQ + +V E L + L ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK- 122
Query: 168 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227
+ R + + +H+ +++ D K +N L+ D KL DFG+A
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178
Query: 228 GDKTHVSTRVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRS 276
+ V +GT Y PE + ++ +SDV+S G +L M G+
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT- 237
Query: 277 MDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 335
P N + + + +IDP E F + + CL RDPK
Sbjct: 238 -----PFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 336 ARPLMSEV 343
R + E+
Sbjct: 283 QRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 69/357 (19%), Positives = 124/357 (34%), Gaps = 64/357 (17%)
Query: 4 KLISESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLA 63
L+ +T+ + + S + + ++S E + V R
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR------------ 56
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 121
+ +G GG VF+ V A+K +N + Q + E
Sbjct: 57 --IYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 122 VNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
+ +L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 105 IAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 238
+ + +H+ +++ D K +N L+ D KL DFG+A + V +
Sbjct: 162 KNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 239 GTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEH 286
G Y PE + ++ +SDV+S G +L M G+ P
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQII 271
Query: 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
N + + + +IDP E F + + CL RDPK R + E+
Sbjct: 272 NQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 43/289 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+F P+ +LG G G + + VAVK + + EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 126 GDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184
+ H N+++ + + + E +L+ ++ ++ + + G
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 185 LAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAK--DGPEGDKTHVSTRV 237
LA LH +++RD K NIL+ A +SDFGL K + S
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 238 MGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294
GT G+ APE + + T D++S G V +++ P G+ +
Sbjct: 188 -GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ---- 237
Query: 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
L E H A +L ++ DP+ RP V
Sbjct: 238 -ANILLGACSLDCLHPEKHED----VIARELIEKMIAMDPQKRPSAKHV 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 48/373 (12%), Positives = 95/373 (25%), Gaps = 92/373 (24%)
Query: 19 QPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGF 78
Q S S A+S STS ++L R ++LG+
Sbjct: 33 QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE------SELGERPRTLVRGTVLGQEDP 86
Query: 79 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------------------- 112
+ TG + V
Sbjct: 87 YAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 113 --QGHKEWLAEVNFLGDLVHLNLVKLIGYC--IEDDQRLLVYEFMP-----RGSLENHLF 163
+ H ++ + + D ++++ + R +Y M G +
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 164 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223
L R+++ L + LA LH +++ + +I+LD L+ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLT 272
+ + G+ PE +T D ++ G+V+ +
Sbjct: 255 ------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 273 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 332
P + + + R + Q L L
Sbjct: 309 AD------LPITKDAALGGSEWIF------------RSCKNIP----QPVRALLEGFLRY 346
Query: 333 DPKARPLMSEVVE 345
+ R L + +E
Sbjct: 347 PKEDRLLPLQAME 359
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 49/328 (14%), Positives = 92/328 (28%), Gaps = 85/328 (25%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------------- 110
R ++LG+ + +E TG + V
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 111 ---------GLQGHKEWLAEVNFL--GDLVHLNLVKLIGYCIEDDQRLLV---YEFMPRG 156
G++ K+ + F+ DLV K + D++ + V + PR
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 157 SLENHLFRRSL--------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208
F L L R+++ L + LA LH +++ + +I+L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVL 244
Query: 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TGHLTSRS 258
D L+ F +G S G+A PE +T
Sbjct: 245 DQRGGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 259 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 318
D ++ G+ + + PN + + + + P+
Sbjct: 299 DTWTLGLAIYWIWCAD------LPNTDDAALGGSEWIFRSCKNI-----PQP-------- 339
Query: 319 AQKAAQLAAHCLSRDPKARPLMSEVVEA 346
L L + R L + +E
Sbjct: 340 ---VRALLEGFLRYPKEDRLLPLQAMET 364
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 81/292 (27%), Positives = 109/292 (37%), Gaps = 55/292 (18%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 118
+ FR +LG+GGFG V A TG A K L ++ K
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 119 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
L E L + +V L Y E L LV M G L+ H++ R
Sbjct: 231 ALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 177 -----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
I G L LH E ++YRD K NILLD + ++SD GLA PEG
Sbjct: 290 FYAAEICCG----LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNL 288
RV GT GY APE V T D ++ G +L EM+ G+ + + + +
Sbjct: 343 K--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ--QRKKKIKREEV 397
Query: 289 VEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
RL+ FS +A L + L +DP R
Sbjct: 398 --------------ERLVKEVPEEYSERFS----PQARSLCSQLLCKDPAER 431
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 66/347 (19%), Positives = 124/347 (35%), Gaps = 54/347 (15%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 129
+G GG VF+ A+K +N + + E+ +L L
Sbjct: 16 QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 130 HLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
+ ++L Y DQ + +V E L + L ++ + R + +
Sbjct: 66 QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
+H+ +++ D K +N L+ D KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 247 EYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARP 294
E + ++ +SDV+S G +L M G+ P N +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQIINQIS---- 228
Query: 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE----ALKPL 350
+ + +IDP E F + + CL RDPK R + E++ ++
Sbjct: 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 351 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLS 397
P + ++ + + + +G + A+ +G S +
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 329
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 80/335 (23%), Positives = 121/335 (36%), Gaps = 54/335 (16%)
Query: 20 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 79
PA A + + + ++ L + R + LG+GGF
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFA 55
Query: 80 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKL 136
F+ T A K + L + E++ L H ++V
Sbjct: 56 KCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 137 IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 195
G+ ED+ + +V E R SL RR R G +LH
Sbjct: 107 HGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NR 161
Query: 196 VIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 254
VI+RD K N+ L+ D K+ DFGLA K +G++ V GT Y APE V++
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKG 217
Query: 255 TS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI---DPRL 310
S DV+S G ++ +L G+ P L E Y I + +
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE-----------TYLRIKKNEYSI 260
Query: 311 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
H + AA L L DP ARP ++E++
Sbjct: 261 PKHIN----PVAASLIQKMLQTDPTARPTINELLN 291
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 67/302 (22%), Positives = 113/302 (37%), Gaps = 48/302 (15%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWLA---- 120
+ +LG GG V VAVK L L +
Sbjct: 14 YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFYLRFRR 61
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
E L H +V + + +V E++ +L + + P+ ++
Sbjct: 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIE 120
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST- 235
+ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ + + T
Sbjct: 121 VIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARP 294
V+GT Y +PE + +RSDVYS G VL E+LTG P G+ + V A
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SPVSVAYQ 230
Query: 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKP 349
H+ E L + + L+++P+ R + +++V
Sbjct: 231 HVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282
Query: 350 LP 351
P
Sbjct: 283 EP 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 46/281 (16%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 128
LG+G FG V+ + + +A+K L L+ + EV L
Sbjct: 16 PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
H N+++L GY D R+ L+ E+ P G++ L ++ A L++
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
H + VI+RD K N+LL + K++DFG + P + GT Y PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPE 177
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI- 306
+ + D++S GV+ E L G+ P + E Y+ I
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQE-----------TYKRIS 220
Query: 307 --DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ + +GA+ L + L +P RP++ EV+E
Sbjct: 221 RVEFTFPDFVT-EGARD---LISRLLKHNPSQRPMLREVLE 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 44/231 (19%), Positives = 86/231 (37%), Gaps = 49/231 (21%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 120
L +G F + E++ A+K L+ +++
Sbjct: 39 LNQGKFNKIILC--EKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 121 -----EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSL 167
E+ + D+ + + G I + + ++YE+M S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 168 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227
+P + I +++H E+ + +RD K SNIL+D + KLSDFG ++ +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 228 GD-KTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 274
K GTY + PE + + ++ D++S G+ L M
Sbjct: 205 KKIKG-----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 76/290 (26%), Positives = 111/290 (38%), Gaps = 48/290 (16%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 121
R + LG+GGF F+ T A K + L + E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
++ L H ++V G+ ED+ + +V E R SL RR R
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQ 123
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMG 239
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V G
Sbjct: 124 IVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---G 177
Query: 240 TYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
T Y APE V++ S DV+S G ++ +L G+ P L E
Sbjct: 178 TPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE-------- 222
Query: 299 RRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
Y I + + H + AA L L DP ARP ++E++
Sbjct: 223 ---TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 69/229 (30%), Positives = 91/229 (39%), Gaps = 38/229 (16%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 118
+ F +LG GGFG VF A TG A K LN L+ K +
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 119 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPW 171
+ E L + +V L Y E L LV M G + H++ P
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP- 289
Query: 172 SIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226
R I G L LH+ +IYRD K N+LLD D N ++SD GLA +
Sbjct: 290 --RAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
G GT G+ APE ++ G S D ++ GV L EM+ R
Sbjct: 341 AGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 59/289 (20%), Positives = 104/289 (35%), Gaps = 53/289 (18%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 125
+ + + GG G ++ G V +K L H G + +AE FL
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVN--------GRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 126 GDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
++VH ++V++ + D+ +V E++ SL+ + LP+ +I L
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAIA--YLLE 190
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
L++LH ++Y D K NI+L + KL D G + GT
Sbjct: 191 ILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYGT 240
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300
G+ APE ++ T +D+Y+ G L + + + +G P L
Sbjct: 241 PGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTYD 295
Query: 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 348
+ RL+ + DP+ R E+ L
Sbjct: 296 SYGRLL--------------------RRAIDPDPRQRFTTAEEMSAQLT 324
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 69/253 (27%), Positives = 100/253 (39%), Gaps = 45/253 (17%)
Query: 36 NSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK 95
S + K T ND F ++G GGFG V+ K
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMND-------FSVHRIIGRGGFGEVY---------GCRK 210
Query: 96 PGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLN---LVKLIGYCIEDDQRL-L 148
TG A+K L+ ++ + L E L + + +V + Y +L
Sbjct: 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSF 269
Query: 149 VYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFK 202
+ + M G L HL + M+ I LG L +H V+YRD K
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNRF---VVYRDLK 319
Query: 203 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVY 261
+NILLD + ++SD GLA D + K H V GT+GY APE + G S D +
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWF 375
Query: 262 SFGVVLLEMLTGR 274
S G +L ++L G
Sbjct: 376 SLGCMLFKLLRGH 388
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 61/302 (20%), Positives = 97/302 (32%), Gaps = 66/302 (21%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 121
T F +G G FG VFK VK G A+K G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 122 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 177
V L H ++V+ EDD L+ E+ GSL + + +R + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-------------------YNAKLSD 218
L +GL ++H +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRS 276
G V G + A E + HL +D+++ + ++
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPL 230
Query: 277 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 336
P +W G PR+ S Q+ +L + DP+
Sbjct: 231 -----PRNGD---QWHEIRQGRL--------PRIPQVLS----QEFTELLKVMIHPDPER 270
Query: 337 RP 338
RP
Sbjct: 271 RP 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 122
+F+ +LLG+G F V++ TGL VA+K ++ + EV
Sbjct: 12 DFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L H ++++L Y ED + LV E G + +L R P +
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGT 240
G+ +LH +++RD SN+LL + N K++DFGLA + +K + GT
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GT 175
Query: 241 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
Y +PE + H SDV+S G + +L GR
Sbjct: 176 PNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 22/207 (10%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGDL 128
LG+G FG V+ + +A+K L L+ L E+ L
Sbjct: 21 PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 129 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
H N++++ Y D +R+ L+ EF PRG L L ++ A L +
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 247
HE R VI+RD K N+L+ K++DFG + P + GT Y PE
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPE 182
Query: 248 YVMTGHLTSRSDVYSFGVVLLEMLTGR 274
+ + D++ GV+ E L G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 69/348 (19%), Positives = 129/348 (37%), Gaps = 64/348 (18%)
Query: 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 118
++L R +L EGGF V++ + G+G A+K L + + ++
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 119 LAEVNFLGDLV-HLNLVKLIGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--P 168
+ EV F+ L H N+V+ + L+ + +G L L + P
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 169 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDG 225
L +KI + + +H + P+I+RD K N+LL KL DFG A
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 226 PEGDKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSRSDVYSFGVVLLEMLTGRR 275
P+ + ++ T Y PE + + + + D+++ G +L + +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ- 250
Query: 276 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLS 331
P + + I + G +SI L L
Sbjct: 251 -----HPFEDGAKLR---------------I---VNGKYSIPPHDTQYTVFHSLIRAMLQ 287
Query: 332 RDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM-QAERIGSSPNTR 378
+P+ R ++EVV L+ + +++ S + + Q GS+ +R
Sbjct: 288 VNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 55/296 (18%)
Query: 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 118
+++ + P LG G +G V K +G +AVK + Q K
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52
Query: 119 LAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR 174
L +++ + + V G + + E M SL+ + + +P I
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
KIA+ K L LH + VI+RD K SN+L++A K+ DFG++
Sbjct: 112 GKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAK 166
Query: 235 TRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 290
G Y APE + + +SD++S G+ ++E+ R
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR-----------FPYDS 215
Query: 291 WARPHLGERRRFYRLID-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 338
W P ++ + P+L FS + + CL ++ K RP
Sbjct: 216 WGTP--------FQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 70/249 (28%), Positives = 107/249 (42%), Gaps = 39/249 (15%)
Query: 37 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 96
S ++ V K + F +LG+G FG VF +++
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQ-------FELLKVLGQGSFGKVFL--VKKISG----S 49
Query: 97 GTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFM 153
A+K L L+ E + L ++ H +VKL Y + + +L L+ +F+
Sbjct: 50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFL 108
Query: 154 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207
G L L + +K +AL L LH +IYRD K NIL
Sbjct: 109 RGGDLFTRLSKEVMFTEE---DVKFYLAELALA----LDHLHS---LGIIYRDLKPENIL 158
Query: 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGV 265
LD + + KL+DFGL+K+ + +K GT Y APE V+ ++S D +SFGV
Sbjct: 159 LDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGV 214
Query: 266 VLLEMLTGR 274
++ EMLTG
Sbjct: 215 LMFEMLTGT 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 77/276 (27%), Positives = 114/276 (41%), Gaps = 34/276 (12%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
E + T D + + + ++ E E+ +A + T N+
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE------- 149
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN 123
F LLG+G FG V + TG A+K L + + E L E
Sbjct: 150 FEYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALG 180
L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 201 VLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAE 256
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-G 239
L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + G
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCG 311
Query: 240 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
T Y APE V+ + R+ D + GVV+ EM+ GR
Sbjct: 312 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 76/315 (24%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 125
F +G+G FG VFKG + T VA+K ++ + + E + E+ L
Sbjct: 24 FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAA 182
+ K G ++D + ++ E++ GS + L L IA
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREIL 129
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMG 239
KGL +LH E I+RD K +N+LL KL+DFG+A G T + +G
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVG 181
Query: 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHN 287
T + APE + S++D++S G+ +E+ G + + KN P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----- 236
Query: 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE----- 342
P LEG++S + + CL+++P RP E
Sbjct: 237 --------------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 343 -VVEALKPLPNLKDM 356
++ K L ++
Sbjct: 273 FILRNAKKTSYLTEL 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 61/243 (25%), Positives = 93/243 (38%), Gaps = 47/243 (19%)
Query: 48 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKT 106
V F+ F +G+G FG V V K T A+K
Sbjct: 5 VFDENEDVNFDH-------FEILRAIGKGSFGKVCI----------VQKNDTKKMYAMKY 47
Query: 107 LNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL 162
+N E E+ + L H LV L Y +D++ + +V + + G L HL
Sbjct: 48 MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL 106
Query: 163 FR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216
+ +K + + L +L + +I+RD K NILLD + +
Sbjct: 107 QQNVHFKEE---TVKLFICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHI 156
Query: 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLT 272
+DF +A P + T + GT Y APE G+ + D +S GV E+L
Sbjct: 157 TDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLR 212
Query: 273 GRR 275
GRR
Sbjct: 213 GRR 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 47/313 (15%)
Query: 35 SNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 94
S+ S+ K L + + + NDL+ +G G G V+K +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48
Query: 95 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEF 152
TG +AVK + G + +K L +++ + +V+ G I + + E
Sbjct: 49 ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 153 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212
M E R P+P I K+ + K L +L E+ VI+RD K SNILLD
Sbjct: 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERG 162
Query: 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-----TSRSDVYSFGVVL 267
KL DFG++ R G Y APE + R+DV+S G+ L
Sbjct: 163 QIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 268 LEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 325
+E+ TG+ + + E +++ P L FS
Sbjct: 220 VELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG------------HMGFS----GDFQSF 263
Query: 326 AAHCLSRDPKARP 338
CL++D + RP
Sbjct: 264 VKDCLTKDHRKRP 276
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 78/343 (22%), Positives = 119/343 (34%), Gaps = 67/343 (19%)
Query: 16 SRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGE 75
AA S+ E + + K + F +LG
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-------FELLKVLGT 64
Query: 76 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAEVNFLGDLVHL 131
G +G VF + + TG A+K L + + E L +
Sbjct: 65 GAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 132 N-LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAK 183
LV L Y + + +L L+ +++ G L HL + ++ I L
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLA--- 171
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
L LH+ +IYRD K NILLD++ + L+DFGL+K+ + GT Y
Sbjct: 172 -LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226
Query: 244 AAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLG 297
AP+ V +GH + D +S GV++ E+LTG + E
Sbjct: 227 MAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAE------------ 273
Query: 298 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
R I +P S A L L +DPK R
Sbjct: 274 ----ISRRILKSEPPYPQEMS----ALAKDLIQRLLMKDPKKR 308
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 84/293 (28%), Positives = 116/293 (39%), Gaps = 62/293 (21%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 118
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 119 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 175
+ E L + H L L Y + RL V E+ G L HL R R R
Sbjct: 52 TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107
Query: 176 K-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 230
+ I L +LH R V+YRD K N++LD D + K++DFGL K+G
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
Query: 231 THVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288
T + GT Y APE V+ + R+ D + GVV+ EM+ G R
Sbjct: 161 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCG-------RL------ 203
Query: 289 VEWARPHLGE-RRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
P + R + LI + R S +A L A L +DPK R
Sbjct: 204 -----PFYNQDHERLFELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQR 247
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 39/255 (15%)
Query: 31 SNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 90
A + + + + RK D F+ +LGEG F V
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLA------ 49
Query: 91 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147
+ T A+K L + + E + + L H VKL + +DD++L
Sbjct: 50 ---RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105
Query: 148 -LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRD 200
+ G L ++ + S + I L +LH + +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155
Query: 201 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSD 259
K NILL+ D + +++DFG AK K + +GT Y +PE + SD
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSD 214
Query: 260 VYSFGVVLLEMLTGR 274
+++ G ++ +++ G
Sbjct: 215 LWALGCIIYQLVAGL 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 70/301 (23%), Positives = 105/301 (34%), Gaps = 59/301 (19%)
Query: 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 117
+ + +G G +G V K + +G +AVK + + K+
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66
Query: 118 WLAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWS 172
L +++ + +V+ G + + E M S + +P
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125
Query: 173 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 232
I KI L K L L E +I+RD K SNILLD N KL DFG++ + +
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180
Query: 233 VSTRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288
TR G Y APE + RSDV+S G+ L E+ TGR K
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------ 234
Query: 289 VEWARPHLGERRRFYRLID-------PRL----EGHFSIKGAQKAAQLAAHCLSRDPKAR 337
+ + P+L E FS CL++D R
Sbjct: 235 -------------VFDQLTQVVKGDPPQLSNSEEREFS----PSFINFVNLCLTKDESKR 277
Query: 338 P 338
P
Sbjct: 278 P 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/257 (22%), Positives = 97/257 (37%), Gaps = 38/257 (14%)
Query: 38 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 92
S+L ++ VA L+ +++L +F ++G G F V
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--------- 79
Query: 93 PV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 147
V TG A+K +N + E + E + L + + +L + +D+ L
Sbjct: 80 -VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLY 137
Query: 148 LVYEFMPRGSLENHLFR--RSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTS 204
LV E+ G L L + +P + R +A + A + +H ++RD K
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPD 191
Query: 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY--- 261
NILLD + +L+DFG V GT Y +PE + + Y
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 262 ----SFGVVLLEMLTGR 274
+ GV EM G+
Sbjct: 251 CDWWALGVFAYEMFYGQ 267
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 66/245 (26%), Positives = 101/245 (41%), Gaps = 41/245 (16%)
Query: 43 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 102
E V K F +LG+GG+G VF+ + + TG
Sbjct: 2 SSETSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIF 48
Query: 103 AVKTLNHDGLQGHK---EW-LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS 157
A+K L + + AE N L ++ H +V LI Y + +L L+ E++ G
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGE 107
Query: 158 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211
L L R I++ L LH++ +IYRD K NI+L+
Sbjct: 108 LFMQLEREGIFMED---TACFYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQ 157
Query: 212 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLE 269
+ KL+DFGL K+ T GT Y APE ++ +R+ D +S G ++ +
Sbjct: 158 GHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYD 213
Query: 270 MLTGR 274
MLTG
Sbjct: 214 MLTGA 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 47/283 (16%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
+ + + N+V + + D+ +V E++ GSL + + + I + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRECLQ 127
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 242
L FLH VI+RD K+ NILL D + KL+DFG A+ PE K T V GT
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPY 181
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--R 300
+ APE V + D++S G++ +EM+ G P P+L E R
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPLR 223
Query: 301 RFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 338
Y + P L+ S CL D + R
Sbjct: 224 ALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRG 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 52/306 (16%), Positives = 103/306 (33%), Gaps = 46/306 (15%)
Query: 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 118
+ R + + L G F W+E + + + ++ +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 119 LA--EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------ 170
++ + N V + + + + +L++ + RR
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 171 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------ 224
I ++IA + FLH + +++RD K SNI D K+ DFGL
Sbjct: 167 LHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 225 ----GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280
T +GT Y +PE + + + + D++S G++L E+L +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-- 277
Query: 281 RPNGEHNLVEWARPHLGERRRFYRLI-DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 339
ER R + + + F+ K + + LS P RP
Sbjct: 278 -----------------ERVRIITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTERPE 319
Query: 340 MSEVVE 345
++++E
Sbjct: 320 ATDIIE 325
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 71/316 (22%), Positives = 107/316 (33%), Gaps = 78/316 (24%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
E +LG G G V G VAVK + + L E+ L
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63
Query: 127 DLV-HLNLVKLIGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWSIRMKIA 178
+ H N+++ YC E R + E +L ++ +L L
Sbjct: 64 ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 179 L-GAAKGLAFLHEEAERPVIYRDFKTSNILLD-------------ADYNAKLSDFGLAK- 223
L A G+A LH +I+RD K NIL+ + +SDFGL K
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 224 --DGPEGDKTHVSTRVMGTYGYAAPE-------YVMTGHLTSRSDVYSFGVVLLEMLTG- 273
G +T+++ GT G+ APE LT D++S G V +L+
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 274 ------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 327
+ S + N G +L E H + +A L +
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLH---------------DRSLI----AEATDLIS 277
Query: 328 HCLSRDPKARPLMSEV 343
+ DP RP +V
Sbjct: 278 QMIDHDPLKRPTAMKV 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 74/322 (22%), Positives = 126/322 (39%), Gaps = 54/322 (16%)
Query: 32 NAESNSSTSKLEEELKVASRLRKFTFND-LKLATRNFRPESL------LGEGGFGCVFKG 84
+ S+ E + + F L++ P L +GEG G V
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 85 WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144
+ +G VAVK ++ Q + EV + D H N+V++ + +
Sbjct: 65 ---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204
+ ++ EF+ G+L + + + L + + LA+LH + VI+RD K+
Sbjct: 116 ELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170
Query: 205 NILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 263
+ILL D KLSDFG A+ + K + V GT + APE + + D++S
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISRSLYATEVDIWSL 227
Query: 264 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--RRFYRLID---PRLEG--HFSI 316
G++++EM+ G P P+ + + RL D P+L+ S
Sbjct: 228 GIMVIEMVDG-------EP-----------PYFSDSPVQAMKRLRDSPPPKLKNSHKVS- 268
Query: 317 KGAQKAAQLAAHCLSRDPKARP 338
L RDP+ R
Sbjct: 269 ---PVLRDFLERMLVRDPQERA 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-24
Identities = 63/289 (21%), Positives = 110/289 (38%), Gaps = 58/289 (20%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 126
+ LG+G FG V+K TG A K + + ++++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
H +VKL+G D + ++ EF P G+++ + L + + L
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGY 243
FLH + +I+RD K N+L+ + + +L+DFG++ + +GT +
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYW 183
Query: 244 AAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
APE VM + ++D++S G+ L+EM P PH
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-------EP-----------PHHEL 225
Query: 299 ---RRRFYRLID----PRLE--GHFSIKGAQKAAQLAAHCLSRDPKARP 338
R I P L +S + L ++P+ RP
Sbjct: 226 NPMRVLL--KIAKSDPPTLLTPSKWS----VEFRDFLKIALDKNPETRP 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 49/284 (17%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
F LGEG +G V+K +E TG VA+K + + +E + E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
+ ++VK G ++ +V E+ GS+ + + R+ L I K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 242
GL +LH I+RD K NILL+ + +AKL+DFG+ + K + V+GT
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPF 190
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--R 300
+ APE + +D++S G+ +EM G +P P+ R
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEG-------KP-----------PYADIHPMR 232
Query: 301 RFYRLID----PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 338
+ +I P +S CL + P+ R
Sbjct: 233 AIF-MIPTNPPPTFRKPELWS----DNFTDFVKQCLVKSPEQRA 271
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 83/343 (24%), Positives = 132/343 (38%), Gaps = 60/343 (17%)
Query: 15 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLG 74
+ TT N + EE K A R+ L ++F ++G
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 75 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-H 130
G + V T A++ + + + ++ E + H
Sbjct: 62 RGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAK 183
LV L C + + RL V E++ G L H+ R R LP + I+L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA--- 165
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYG 242
L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT
Sbjct: 166 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPN 218
Query: 243 YAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLG 297
Y APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 219 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------------ 265
Query: 298 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
+++I R+ S KAA + L++DPK R
Sbjct: 266 TEDYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 304
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 65/252 (25%), Positives = 105/252 (41%), Gaps = 33/252 (13%)
Query: 38 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 92
L + + + L ++ DL++ ++ ++G G FG V
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--------- 87
Query: 93 PVKP-GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 147
V+ T A+K L+ + + + E + + +V+L Y +DD+ L
Sbjct: 88 -VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLY 145
Query: 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTSNI 206
+V E+MP G L N + +P W+ R A + A L +H I+RD K N+
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNM 199
Query: 207 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYS 262
LLD + KL+DFG + T V GT Y +PE + + G+ D +S
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 258
Query: 263 FGVVLLEMLTGR 274
GV L EML G
Sbjct: 259 VGVFLYEMLVGD 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 63/256 (24%), Positives = 96/256 (37%), Gaps = 36/256 (14%)
Query: 37 SSTSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 91
+ S L E + L ++L +F ++G G FG V
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV-------- 92
Query: 92 APV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 147
V A+K LN + E + E + L + + L Y +DD L
Sbjct: 93 --VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNL 149
Query: 148 -LVYEFMPRGSLENHL--FRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKT 203
LV ++ G L L F LP + R +A + A + +H+ ++RD K
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQ---LHYVHRDIKP 203
Query: 204 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS----- 258
NIL+D + + +L+DFG E S V GT Y +PE +
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPEC 262
Query: 259 DVYSFGVVLLEMLTGR 274
D +S GV + EML G
Sbjct: 263 DWWSLGVCMYEMLYGE 278
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 62/289 (21%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
LG G +G V T + A+K + + + + L EV L L H
Sbjct: 45 LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 184
N++KL + ED + LV E G L + + R ++ +K L
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSG--- 148
Query: 185 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+ +LH+ +++RD K N+LL + D K+ DFGL+ K +GT
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTA 202
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERR 300
Y APE V+ + DV+S GV+L +L G P G+ + +
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------PPFGGQTD------------Q 243
Query: 301 RFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 343
R + +G ++ + A L L D + R +
Sbjct: 244 EILRKV---EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 73/300 (24%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------------HDGLQGHKEWLA 120
LG G +G V + A+K + + ++ E +
Sbjct: 44 LGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 121 -EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 174
E++ L L H N++KL ED + LV EF G L + R +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAAN 150
Query: 175 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 230
MK L + +LH + +++RD K NILL ++ N K+ DFGL+ + K
Sbjct: 151 IMKQILSG---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 231 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLV 289
+GT Y APE V+ + DV+S GV++ +L G P G+++
Sbjct: 205 LR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY------PPFGGQND-- 252
Query: 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 343
+ + + +G + +A +L L+ D R E
Sbjct: 253 ----------QDIIKKV---EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 66/249 (26%), Positives = 101/249 (40%), Gaps = 44/249 (17%)
Query: 39 TSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 98
T+ + + D F +LG+G FG V + GT
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVMLS---------ERKGT 44
Query: 99 GLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFM 153
AVK L D + + + E L L +L C + RL V E++
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYV 103
Query: 154 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207
G L H+ + P IA+G L FL + +IYRD K N++
Sbjct: 104 NGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVM 153
Query: 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGV 265
LD++ + K++DFG+ K+ T T+ GT Y APE ++ +S D ++FGV
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGV 209
Query: 266 VLLEMLTGR 274
+L EML G+
Sbjct: 210 LLYEMLAGQ 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 50/294 (17%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 124
++ + ++G G V VA+K +N + Q + L E+
Sbjct: 16 DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR-MKIAL- 179
+ H N+V + D+ LV + + GS+ + H+ + + IA
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 180 --GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTR 236
+GL +LH+ I+RD K NILL D + +++DFG+ A GD T R
Sbjct: 127 LREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 237 --VMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293
+GT + APE + ++D++SFG+ +E+ TG K P
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---------- 233
Query: 294 PHLGERRRFYRLI----DPRLEGHFSIKGAQKA-----AQLAAHCLSRDPKARP 338
+ L P LE K K ++ + CL +DP+ RP
Sbjct: 234 -------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 73/262 (27%), Positives = 102/262 (38%), Gaps = 44/262 (16%)
Query: 26 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 85
NA + ++ S +D F ++G+G FG V
Sbjct: 6 QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKVLLA- 57
Query: 86 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCI 141
+ AVK L + KE ++E N L V H LV L +
Sbjct: 58 --------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSF 108
Query: 142 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAER 194
+ +L V +++ G L HL R R P R + IA L +LH
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---L 158
Query: 195 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGH 253
++YRD K NILLD+ + L+DFGL K+ E + T T GT Y APE V+
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQ 214
Query: 254 LTSRS-DVYSFGVVLLEMLTGR 274
R+ D + G VL EML G
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGL 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 63/290 (21%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 129
LG+G FG V TG AVK ++ ++ + L EV L L
Sbjct: 34 LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 130 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAK 183
H N++KL + ED LV E G L + + R +S ++ L
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSG-- 138
Query: 184 GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
+ ++H+ +++RD K N+LL D N ++ DFGL+ K +GT
Sbjct: 139 -ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGT 191
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-R 299
Y APE V+ G + DV+S GV+L +L+G P G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------------------PPFNGANE 232
Query: 300 RRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 343
+ + +G ++ + + A L L+ P R +
Sbjct: 233 YDILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-23
Identities = 82/351 (23%), Positives = 128/351 (36%), Gaps = 72/351 (20%)
Query: 33 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESL------LGEGGFGCVFKGWI 86
N + + R D+ PE L +G G FG V+
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-- 73
Query: 87 EENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIED 143
VA+K +++ G Q +++W + EV FL L H N ++ G + +
Sbjct: 74 -------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 203
LV E+ GS + L PL + GA +GLA+LH +I+RD K
Sbjct: 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKA 182
Query: 204 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVMT---GHLTSRS 258
NILL KL DFG A + ++ +GT + APE ++ G +
Sbjct: 183 GNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 259 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE---RRRFYRLID----PRLE 311
DV+S G+ +E+ +P P + I P L+
Sbjct: 235 DVWSLGITCIELAER-------KP-----------PLFNMNAMSALY--HIAQNESPALQ 274
Query: 312 -GHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLPNLKDM 356
GH+S + CL + P+ RP L V +P + D+
Sbjct: 275 SGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 69/253 (27%), Positives = 105/253 (41%), Gaps = 29/253 (11%)
Query: 31 SNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 90
A+ T EE+ N ++ +F +LG+G FG V
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLS------ 360
Query: 91 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQR 146
+ GT AVK L D + + + E L L +L C + R
Sbjct: 361 ---ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR 416
Query: 147 L-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGLAFLHEEAERPVIYRDFKT 203
L V E++ G L H+ + P A A GL FL + +IYRD K
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQS---KGIIYRDLKL 470
Query: 204 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVY 261
N++LD++ + K++DFG+ K+ T T+ GT Y APE ++ +S D +
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWW 526
Query: 262 SFGVVLLEMLTGR 274
+FGV+L EML G+
Sbjct: 527 AFGVLLYEMLAGQ 539
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 72/245 (29%), Positives = 99/245 (40%), Gaps = 44/245 (17%)
Query: 43 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 102
E + S K D F +LG+G FG VF T
Sbjct: 2 ELNKERPSLQIKLKIED-------FILHKMLGKGSFGKVFLA---------EFKKTNQFF 45
Query: 103 AVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 157
A+K L D + + + E L H L + + + L V E++ G
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGD 104
Query: 158 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211
L H+ L R I LG L FLH + ++YRD K NILLD D
Sbjct: 105 LMYHIQSCHKFDLS---RATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKD 154
Query: 212 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLE 269
+ K++DFG+ K+ GD T GT Y APE ++ G + S D +SFGV+L E
Sbjct: 155 GHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYE 210
Query: 270 MLTGR 274
ML G+
Sbjct: 211 MLIGQ 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 56/295 (18%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 118
L ++F ++G G + V T A+K + + + ++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDW 55
Query: 119 -LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 174
E + H LV L C + + RL V E++ G L H+ R R LP + R
Sbjct: 56 VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113
Query: 175 M---KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
+I+L L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 232 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGE 285
T GT Y APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 167 ---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 286 HNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 337
+++I R+ S KAA + L++DPK R
Sbjct: 223 ------------TEDYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 127
+GEG +G VFK + TG VA+K L E+ L
Sbjct: 11 IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L H NLV L+ + LV+E+ ++ + L R +P + I + + F
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRVMGTYGYA 244
H+ I+RD K NIL+ KL DFG A+ GP V+TR Y
Sbjct: 118 CHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169
Query: 245 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
+PE ++ DV++ G V E+L+G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 37/260 (14%)
Query: 26 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 85
++ S + + K + T + F LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59
Query: 86 IEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCI 141
VK +G A+K L+ + K+ L E L + LVKL +
Sbjct: 60 --------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSF 110
Query: 142 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAFLHEEAERPV 196
+D+ L +V E++ G + +HL R P + R +I L +LH +
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDL 162
Query: 197 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLT 255
IYRD K N+L+D +++DFG AK T + GT APE +++ G+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY-- 215
Query: 256 SRS-DVYSFGVVLLEMLTGR 274
+++ D ++ GV++ EM G
Sbjct: 216 NKAVDWWALGVLIYEMAAGY 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 69/289 (23%), Positives = 107/289 (37%), Gaps = 62/289 (21%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 184
N++KL ED +V E G L + + +R +S +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG--- 133
Query: 185 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-RR 300
Y APE V+ G + DV+S GV+L +L+G P G+
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNEY 228
Query: 301 RFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 343
+ + G ++ A L L+ P R ++
Sbjct: 229 DILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 56/310 (18%), Positives = 91/310 (29%), Gaps = 64/310 (20%)
Query: 74 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHL 131
G V TG V V+ +N + E++ H
Sbjct: 36 GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 132 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFL 188
N+V I D++ +V FM GS + L + + IA G K L ++
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIAYILQGVLKALDYI 144
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHV----STRVMGTYGY 243
H ++R K S+IL+ D LS G + V + +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 244 AAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGR-------------------------- 274
+PE V+ +L ++SD+YS G+ E+ G
Sbjct: 202 LSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 275 ------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 328
+ ++ + + R FS
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQ 316
Query: 329 CLSRDPKARP 338
CL R+P ARP
Sbjct: 317 CLQRNPDARP 326
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 70/250 (28%), Positives = 100/250 (40%), Gaps = 44/250 (17%)
Query: 38 STSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 97
S E + + ++ F +LG+G FG V
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVMLA---------RVKE 46
Query: 98 TGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEF 152
TG AVK L D + + + E L H L +L C + RL V EF
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEF 105
Query: 153 MPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNI 206
+ G L H+ + R R + I L FLH+ + +IYRD K N+
Sbjct: 106 VNGGDLMFHIQKSRRFDEA---RARFYAAEIISA----LMFLHD---KGIIYRDLKLDNV 155
Query: 207 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFG 264
LLD + + KL+DFG+ K+G T T GT Y APE ++ L + D ++ G
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMG 211
Query: 265 VVLLEMLTGR 274
V+L EML G
Sbjct: 212 VLLYEMLCGH 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW- 118
K + ++F+ LG G FG V ++ G A+K L + + K+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVE 51
Query: 119 --LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 174
E L + H ++++ +D Q++ ++ +++ G L + L + + P P
Sbjct: 52 HTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---V 107
Query: 175 MK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229
K + L L +LH + +IYRD K NILLD + + K++DFG AK P+
Sbjct: 108 AKFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
Query: 230 KTHVSTRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 274
T + GT Y APE V T + ++S D +SFG+++ EML G
Sbjct: 161 YT-----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 120
+ L+GEG +G V K ++ TG VA+K + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
E+ L L H NLV L+ C + + LV+EF+ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 237
G+ F H +I+RD K NIL+ KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 238 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
Y APE ++ DV++ G ++ EM G
Sbjct: 189 ----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 62/258 (24%), Positives = 96/258 (37%), Gaps = 62/258 (24%)
Query: 50 SRLRKFTFNDLKLATRNFRPESL---------LGEGGFGCVFKGWIEENGTAPVKPGTGL 100
SR + F F DL + ++ P++L LG G G V + T
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161
Query: 101 TVAVKTLNHDGLQGHKEWLA--------EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 152
VA++ ++ A E+ L L H ++K+ + + + +V E
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220
Query: 153 MPRGSLENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFK 202
M G E LF + + L + +LHE +I+RD K
Sbjct: 221 MEGG--E--LFDK-------VVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266
Query: 203 TSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL----T 255
N+LL + D K++DFG +K E T GT Y APE V+
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYN 322
Query: 256 SRSDVYSFGVVLLEMLTG 273
D +S GV+L L+G
Sbjct: 323 RAVDCWSLGVILFICLSG 340
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 72/303 (23%), Positives = 112/303 (36%), Gaps = 52/303 (17%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 129
E +LGEG V + T AVK + EV L
Sbjct: 18 EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 130 -HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAA 182
H N+++LI + E++ R LV+E M GS+ +H+ +R ++ ++ A
Sbjct: 69 GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASA- 123
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 238
L FLH + + +RD K NIL + K+ DF L GD + +ST +
Sbjct: 124 --LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 239 ----GTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 288
G+ Y APE V + D++S GV+L +L+G P G
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGS 232
Query: 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSE 342
L + EG + A L + L RD K R ++
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292
Query: 343 VVE 345
V++
Sbjct: 293 VLQ 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-21
Identities = 81/323 (25%), Positives = 119/323 (36%), Gaps = 76/323 (23%)
Query: 49 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 108
A L + + L+ F L+G G +G V+KG + TG A+K ++
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58
Query: 109 HDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGSLE-- 159
G +E E+N L H N+ G DDQ LV EF GS+
Sbjct: 59 VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 160 -NHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215
+ +L W IA +GL+ LH+ VI+RD K N+LL + K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 216 LSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVL 267
L DFG++ R +GT + APE + +SD++S G+
Sbjct: 170 LVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 268 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGE---RRRFYRLID----PRLEG-HFSIKGA 319
+EM G P P R F LI PRL+ +S
Sbjct: 225 IEMAEG-------AP-----------PLCDMHPMRALF--LIPRNPAPRLKSKKWS---- 260
Query: 320 QKAAQLAAHCLSRDPKARPLMSE 342
+K CL ++ RP +
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQ 283
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 63/296 (21%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 121
N+R +G+G F V TG VA+K ++ L L E
Sbjct: 16 NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64
Query: 122 VNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
V + L H N+VKL + IE ++ L L+ E+ G + ++L RMK
Sbjct: 65 VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEKE 115
Query: 180 GAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 233
+K + + H+ + +++RD K N+LLDAD N K++DFG + + G K
Sbjct: 116 ARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
Query: 234 STRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291
G YAAPE + G DV+S GV+L +++G D NL E
Sbjct: 173 FC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE- 221
Query: 292 ARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ L G + I + L L +P R + ++++
Sbjct: 222 ----------LRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 72/292 (24%), Positives = 109/292 (37%), Gaps = 66/292 (22%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 131
LG G FG V + +GL +KT+N D Q E + E+ L L H
Sbjct: 30 LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 132 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----------MKIALG 180
N++K+ ED + +V E G E L R + + MK +
Sbjct: 81 NIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
A LA+ H + V+++D K NIL K+ DFGLA+ + +
Sbjct: 136 A---LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA 187
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
GT Y APE V +T + D++S GVV+ +LTG P G
Sbjct: 188 -GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------------LPFTG 227
Query: 298 E-RRRFYRLIDPRLEGHFSIKGA-----QKAAQLAAHCLSRDPKARPLMSEV 343
+ + +A L L++DP+ RP ++V
Sbjct: 228 TSLEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 74/403 (18%), Positives = 136/403 (33%), Gaps = 80/403 (19%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+G G +G V+K ++ A+K + G+ E+ L +L H N
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 133 LVKLIGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPWSIRMKIALGAAK 183
++ L + D+++ L++++ ++ H ++ + LP + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGPEGDKTHVSTRV 237
G+ +LH V++RD K +NIL+ + K++D G A+ + P + V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 238 MGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEH---- 286
+ T+ Y APE ++ G H T D+++ G + E+LT R D N H
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254
Query: 287 ----------NLVEW-----------ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 325
+W + +E H + KA L
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS-KAFHL 313
Query: 326 AAHCLSRDPKARPLMSEVVEALK-------PLPNLKDMASSSYYFQTMQAERIGSSPNTR 378
L+ DP R +A++ PLP A + + P+ +
Sbjct: 314 LQKLLTMDPIKRITSE---QAMQDPYFLEDPLPTSDVFAGCQIPYP-KREFLTEEEPDDK 369
Query: 379 NGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPKPNGK 421
+ Q N P + H P K
Sbjct: 370 GDKKNQQQQQGNNHTNGTGHPG-------NQDSSHTQGPPLKK 405
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 8e-20
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
+GEG +G V+K + G T A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 245
H+ R V++RD K N+L++ + K++DFGLA+ P TH ++ T Y A
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 246 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 274
P+ V+ G ++ D++S G + EM+ G
Sbjct: 169 PD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 48/288 (16%)
Query: 1 MYGKLISESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL 60
M G+ + S + + QP+A + S+ ++ KV + +
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAF-----------GSMKVSRDKDGSKVTTVVATPGQGPD 49
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 120
+ ++ ++G G FG V++ + + +G VA+K + LQ +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNR 96
Query: 121 EVNFLGDLVHLNLVKLIGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPW 171
E+ + L H N+V+L Y +D+ L LV +++P + H R LP
Sbjct: 97 ELQIMRKLDHCNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 172 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK 230
+ LA++H + +RD K N+LLD D KL DFG AK G+
Sbjct: 156 IYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 231 -TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 274
+ +R Y Y APE ++ G TS DV+S G VL E+L G+
Sbjct: 213 NVSYICSR----Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
+GEG +G VFK E T VA+K + L E L E+ L +
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L H N+V+L D + LV+EF + L+ + + L I KGL F
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 245
H R V++RD K N+L++ + KL++FGLA+ P + V+ T Y
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 246 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGRR 275
P+ V+ G ++ D++S G + E+ R
Sbjct: 170 PD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 120
+ LGEG + V+KG + T VA+K + + H+E +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVM 238
+GLA+ H + V++RD K N+L++ KL+DFGLA K P + V+
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 239 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 274
T Y P+ ++ G +++ D++ G + EM TGR
Sbjct: 163 -TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 70/295 (23%), Positives = 104/295 (35%), Gaps = 76/295 (25%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
+G G +G V V+ GT + A K + ++ + E+ + L H N
Sbjct: 17 IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 133 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKIA 178
+++L ED+ + LV E G E LF R + MK
Sbjct: 68 IIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVFRESDAARIMKDV 115
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVST 235
L A +A+ H+ V +RD K N L D KL DFGLA G + T
Sbjct: 116 LSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRT 167
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295
+V GT Y +P+ V+ G D +S GV++ +L G P
Sbjct: 168 KV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------------------PPF 207
Query: 296 LGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 343
I EG F+ +A L L++ PK R +
Sbjct: 208 SAPTDSEVMLKI---REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
+GEG +G V+K K G VA+K + L E + E++ L +
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L H N+V LI + LV+EFM + L+ L L S +G+A
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 245
H+ +++RD K N+L+++D KL+DFGLA+ P TH V+ T Y A
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRA 187
Query: 246 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 274
P+ V+ G ++ D++S G + EM+TG+
Sbjct: 188 PD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 62/295 (21%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 127
+G+G F V + + TG AVK ++ E +
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 128 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SIRMKIALG 180
L H ++V+L+ D L +V+EFM L + +R+ S M+ L
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
A L + H + +I+RD K +LL + KL FG+A E RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194
Query: 238 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
GT + APE V+ + DV+ GV+L +L+G P
Sbjct: 195 -GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------------------LPFY 234
Query: 297 GERRRFYRLIDPRLEGHFSIKGAQ------KAAQLAAHCLSRDPKARPLMSEVVE 345
G + R + I ++G + + Q A L L DP R + E +
Sbjct: 235 GTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 63/285 (22%), Positives = 108/285 (37%), Gaps = 41/285 (14%)
Query: 6 ISESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATR 65
+ S + S A V S+ + S + + + F +
Sbjct: 24 MKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQG 83
Query: 66 NFR------PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 119
+LG G FG V K + TGL +A K + G++ +E
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKIIKTRGMKDKEEVK 134
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLF--RRSLPLP 170
E++ + L H NL++L E + LV E++ G L E++ ++
Sbjct: 135 NEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF- 192
Query: 171 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEG 228
MK G+ +H + +++ D K NIL K+ DFGLA+
Sbjct: 193 ----MKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
+K V GT + APE V ++ +D++S GV+ +L+G
Sbjct: 243 EKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 130
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 183
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 184 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 243 YAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 274
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGD 127
LLGEG +G V + E T AVK L L+ A E+ L
Sbjct: 12 LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 128 LVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMKIALGAAK 183
L H N+++L+ E+ Q++ +V E+ G E + + + P+ + L
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL--ID 120
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGT 240
GL +LH + ++++D K N+LL K+S G+A D S G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GS 174
Query: 241 YGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 274
+ PE + G T + D++S GV L + TG
Sbjct: 175 PAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 56/295 (18%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF-TFNDLKLATR 65
+ ++ + RD P+ + + + + K +
Sbjct: 35 EQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ 94
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 120
+ P+ ++G G V + V TG AVK + + E L
Sbjct: 95 KYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 121 ---EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 175
E + L + H +++ LI E + LV++ M +G E LF +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG--E--LFDY-------LTE 193
Query: 176 KIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225
K+AL ++FLH +++RD K NILLD + +LSDFG +
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 273
G+K GT GY APE ++ + D+++ GV+L +L G
Sbjct: 251 EPGEKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 55/255 (21%), Positives = 90/255 (35%), Gaps = 68/255 (26%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 127
+G+G +G V ++ T A+K +N + ++ EV +
Sbjct: 34 IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 128 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------ 180
L H N+ +L ED+Q + LV E G L + L M +
Sbjct: 85 LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 181 --------------------------AAK-------GLAFLHEEAERPVIYRDFKTSNIL 207
+ L +LH + + +RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 208 LDADYNA--KLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSD 259
+ + KL DFGL+K G+ ++T+ GT + APE V+ S + D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNESYGPKCD 258
Query: 260 VYSFGVVLLEMLTGR 274
+S GV+L +L G
Sbjct: 259 AWSAGVLLHLLLMGA 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 55/277 (19%), Positives = 94/277 (33%), Gaps = 29/277 (10%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
+ ++ T + V +++ +++ +
Sbjct: 95 EPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDH 154
Query: 67 FRP----ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 122
LG G FG V + + TG A K + + E+
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEI 205
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
+ L H LV L +D++ +++YEFM G E LF + + A+
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKMSEDEAVEYM 261
Query: 183 K----GLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVSTR 236
+ GL +H E ++ D K NI+ KL DFGL V
Sbjct: 262 RQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--- 315
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
GT +AAPE + +D++S GV+ +L+G
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 74/292 (25%), Positives = 115/292 (39%), Gaps = 66/292 (22%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 128
LG G FG V G TG VAVK LN ++ E+ L
Sbjct: 18 TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 129 VHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 183
H +++KL Y I +V E++ G L +++ + R++
Sbjct: 69 RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQ 119
Query: 184 ---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173
Query: 241 YGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHV---------- 216
Query: 299 RRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
++ I G F I + L H L DP R + ++ E
Sbjct: 217 -PTLFKKI---RGGVFYIPEYLNRSVAT---LLMHMLQVDPLKRATIKDIRE 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 72/299 (24%), Positives = 107/299 (35%), Gaps = 78/299 (26%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 176
N++KL ED +V E G E LF I +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRFSEHDAARIIK 128
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHV 233
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K
Sbjct: 129 QVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180
Query: 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293
R+ GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------P 220
Query: 294 PHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 345
P G+ + + G ++ A L L+ P R ++ +E
Sbjct: 221 PFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
F+ E + G+G FG V G + TG++VA+K + D ++E L +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71
Query: 124 FLGDLVHLNLVKLI------GYCIEDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIR 174
L L H N+V+L G D L +V E++P + +RR + P +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 175 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKD-GPEGDKTH 232
+ + LH + V +RD K N+L++ AD KL DFG AK P
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 233 -VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 274
+ +R Y Y APE ++ G H T+ D++S G + EM+ G
Sbjct: 191 YICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
LGEG F V+K + T VA+K + K+ L E+ L +
Sbjct: 18 LGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L H N++ L+ LV++FM LE + SL L S L +GL +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGYA 244
LH+ +++RD K +N+LLD + KL+DFGLAK P TH V TR Y
Sbjct: 128 LHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYR 179
Query: 245 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 274
APE + + D+++ G +L E+L
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 56/226 (24%), Positives = 84/226 (37%), Gaps = 53/226 (23%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 124
LG G G V + T VA+K ++ A E+
Sbjct: 18 LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---A 181
L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLKEATC 116
Query: 182 AK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 231
+ +LHE +I+RD K N+LL + D K++DFG +K E
Sbjct: 117 KLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSR----SDVYSFGVVLLEMLTG 273
T GT Y APE V+ T+ D +S GV+L L+G
Sbjct: 174 --RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 54/219 (24%), Positives = 83/219 (37%), Gaps = 48/219 (21%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 131
+LG G F VF + TG A+K + E+ L + H
Sbjct: 16 VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 132 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------AAK- 183
N+V L E LV + + G E LF R I + G A+
Sbjct: 67 NIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I---LERGVYTEKDASLV 111
Query: 184 ------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVS 234
+ +LHE +++RD K N+L + + ++DFGL+K G +
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 235 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
+ GT GY APE + + D +S GV+ +L G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 39/263 (14%)
Query: 26 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 85
S T ++ + + L++ KV L + + ++G G FG VF+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAK 60
Query: 86 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI---- 141
+ E+ VA+K + LQ + E+ + + H N+V L
Sbjct: 61 LVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLK-AFFYSNG 105
Query: 142 --EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 196
+D+ L LV E++P H + +P + + LA++H +
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGI 162
Query: 197 IYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG- 252
+RD K N+LLD KL DFG AK G+ + +R Y Y APE ++ G
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPE-LIFGA 216
Query: 253 -HLTSRSDVYSFGVVLLEMLTGR 274
+ T+ D++S G V+ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
LG G + V+KG + TG+ VA+K + D +E + E++ + +
Sbjct: 13 LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMKIALGAAK 183
L H N+V+L +++ LV+EFM + +++ + L ++ +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVMGTY 241
GLAF HE +++RD K N+L++ KL DFGLA P + V+ T
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172
Query: 242 GYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 274
Y AP+ V+ G ++ D++S G +L EM+TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 130
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 183
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 184 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 243 YAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 274
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 52/258 (20%), Positives = 92/258 (35%), Gaps = 29/258 (11%)
Query: 26 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRP----ESLLGEGGFGCV 81
+ + + +K+ +++ + LG G FG V
Sbjct: 8 HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVV 67
Query: 82 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141
+ V+ TG K +N E++ + L H L+ L
Sbjct: 68 HRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-F 117
Query: 142 EDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFLHEEAERPVI 197
ED + L+ EF+ G L + + + M+ A GL +H E ++
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMH---EHSIV 171
Query: 198 YRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 255
+ D K NI+ + K+ DFGLA + V T +AAPE V +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVG 228
Query: 256 SRSDVYSFGVVLLEMLTG 273
+D+++ GV+ +L+G
Sbjct: 229 FYTDMWAIGVLGYVLLSG 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 68/366 (18%), Positives = 116/366 (31%), Gaps = 77/366 (21%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 120
+ S LG G FG V+ V V VK + + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 121 ---EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRM 175
E+ L + H N++K++ E+ LV E G L + R R+
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RL 127
Query: 176 KIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229
L + + +L + +I+RD K NI++ D+ KL DFG A G
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 230 KTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGE 285
+ GT Y APE V+ G+ +++S GV L ++ +
Sbjct: 185 LFYTFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
P S ++ L + L P+ R + ++V
Sbjct: 241 -----------------IHP--PY---LVS----KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 346 A--LKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 403
+ NL D Y ++ + S G + ++ + G
Sbjct: 275 DPWVTQPVNLAD-----YTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEG 329
Query: 404 ASPYHH 409
+HH
Sbjct: 330 HHHHHH 335
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 53/289 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHL 131
LGEG F K V + AVK ++ ++ E+ L H
Sbjct: 19 LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 132 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 185
N+VKL D LV E + G L + ++ +S M+ + A +
Sbjct: 67 NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSA---V 119
Query: 186 AFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+ +H+ V++RD K N+L + + K+ DFG A+ P ++ + T T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLH 174
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302
YAAPE + D++S GV+L ML+G+ P +
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLTCTSA 221
Query: 303 YRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 345
++ +G FS +G Q+A L L+ DP R MS +
Sbjct: 222 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 56/238 (23%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 115
N+ P+ +LG G V + + T AVK ++ + +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 116 KEWLA-EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 172
+E EV+ L + H N+++L E + LV++ M +G E LF
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY------- 114
Query: 173 IRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222
+ K+ L K + LH+ +++RD K NILLD D N KL+DFG +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 273
G+K GT Y APE ++ + D++S GV++ +L G
Sbjct: 172 CQLDPGEKL--REVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 67/361 (18%), Positives = 117/361 (32%), Gaps = 92/361 (25%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
S + +S P + ++ +A + + E
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES------------------Q 44
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 120
++ LLG GGFG V+ G ++ L VA+K + D + E
Sbjct: 45 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 121 EVNFLGDLVHL--NLVKLIGYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMK 176
EV L + +++L+ + E L+ E P L + + R ++
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERG-------ALQ 147
Query: 177 IALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLA---KDGP 226
L + + H V++RD K NIL+D + KL DFG KD
Sbjct: 148 EELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 284
GT Y+ PE++ H + V+S G++L +M+ G +
Sbjct: 205 Y--TDFD-----GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----H 251
Query: 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344
+ ++ + S + L CL+ P RP E+
Sbjct: 252 DEEIIRGQ----------VFF--RQ---RVS----SECQHLIRWCLALRPSDRPTFEEIQ 292
Query: 345 E 345
Sbjct: 293 N 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 121
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
L H N+V+L I+++ LV++ + G E LF I +A
Sbjct: 56 ARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGG--E--LFED-------I---VARE 100
Query: 181 ------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD 224
A+ +A+ H +++R+ K N+LL KL+DFGLA +
Sbjct: 101 FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157
Query: 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 273
+ + H GT GY +PE V+ + D+++ GV+L +L G
Sbjct: 158 VNDSEAWH--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 74/295 (25%), Positives = 117/295 (39%), Gaps = 60/295 (20%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 122
++ LG G FG V G TG VAVK LN ++ E+
Sbjct: 17 HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 123 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
L H +++KL Y I + +V E++ G L +++ + R+
Sbjct: 68 QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEKES 118
Query: 181 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
G+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S
Sbjct: 119 RRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 235 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292
G+ YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 176 C---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHV---- 221
Query: 293 RPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 345
++ I +G F L H L DP R + ++ E
Sbjct: 222 -------PTLFKKI---CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
LGEG +G V+K T TVA+K + L+ +E + EV+ L +
Sbjct: 42 LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L H N+++L + + L++E+ L+ ++ ++ + + G+ F
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--GPEGDKTHVSTRVMGT 240
H R ++RD K N+LL + K+ DFGLA+ P TH ++ T
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-T 200
Query: 241 YGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 274
Y PE ++ G H ++ D++S + EML
Sbjct: 201 LWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 33/238 (13%)
Query: 47 KVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 106
+ R +F N + N+ + LG+G F V + V TGL A K
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61
Query: 107 LNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF 163
+N L ++ E L H N+V+L I+++ LV++ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120
Query: 164 RRSLPLPWSIR-----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAK 215
R +S ++ L + +A+ H +++R+ K N+LL K
Sbjct: 121 ARE---FYSEADASHCIQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVK 171
Query: 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
L+DFGLA + + + H GT GY +PE + + D+++ GV+L +L G
Sbjct: 172 LADFGLAIEVNDSEAWH--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 37/288 (12%), Positives = 77/288 (26%), Gaps = 59/288 (20%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN 123
+R G ++ VA+ ++ G+ +E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
L + + +++ L+V E++ GSL+ + P P ++ A
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAMQSLAA 140
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
H V S + + D + L+
Sbjct: 141 AADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------T 175
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
+ D+ G L +L R + + G + + A +
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTAGQPIEP 225
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351
ID + S +AA + D R S ++ ++
Sbjct: 226 ADIDRDIPFQIS--------AVAARSVQGDGGIRSA-STLLNLMQQAT 264
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 126
LG G F V K + TGL A K + + + + EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 127 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 179
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 235
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 66/305 (21%), Positives = 104/305 (34%), Gaps = 78/305 (25%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWL 119
+R LLG+GGFG VF G + L VA+K + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 120 AEVNFL----GDLVHLNLVKLIGYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSI 173
EV L H +++L+ + E + LV E +P L +++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG------- 134
Query: 174 RMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLA---K 223
+ + H R V++RD K NIL+D KL DFG
Sbjct: 135 PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRP 282
D P GT Y+ PE++ + V+S G++L +M+ G
Sbjct: 192 DEPY--TDFD-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD-------- 236
Query: 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLM 340
P ++ I LE + L CL+ P +RP +
Sbjct: 237 ----------IPFERDQE-----I---LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSL 278
Query: 341 SEVVE 345
E++
Sbjct: 279 EEILL 283
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 71/298 (23%), Positives = 116/298 (38%), Gaps = 67/298 (22%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 122
+ LGEG FG V T VA+K ++ L+ + E+
Sbjct: 10 PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 123 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
++L L H +++KL Y I + +V E+ G L +++ + RM G
Sbjct: 61 SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTEDEG 110
Query: 181 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 234
+ + H +++RD K N+LLD + N K++DFGL+ +G+ S
Sbjct: 111 RRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 235 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292
G+ YAAPE V+ G L DV+S G+VL ML GR D + +
Sbjct: 168 C---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFI---- 213
Query: 293 RPHLGERRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
++ + + + GAQ L + DP R + E+
Sbjct: 214 -------PNLFKKV---NSCVYVMPDFLSPGAQS---LIRRMIVADPMQRITIQEIRR 258
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 40/218 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 126
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 127 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 179
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 235
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 61/294 (20%), Positives = 101/294 (34%), Gaps = 62/294 (21%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 130
+LG G G V + TG A+K L + EV+
Sbjct: 36 VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81
Query: 131 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALG 180
++V ++ E+ L++ E M G L + + R ++ R M+
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGT 139
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
A + FLH + +RD K N+L + D KL+DFG AK+ + + T
Sbjct: 140 A---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC 190
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
T Y APE + D++S GV++ +L G ++
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------------YSNTGQA 236
Query: 298 ERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 345
R I G + + A QL L DP R +++ +
Sbjct: 237 ISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
+GEG +G VFK +N G VA+K + +Q +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 128 L---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 176
L H N+V+L + + +L LV+E + L+ +P
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 235
+ +GL FLH V++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--- 178
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
V+ T Y APE ++ + D++S G + EM +
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 126
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 127 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---AA 182
++ H N++ L E+ + L+ E + G E LF + K +L A
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGG--E--LFDF-------LAEKESLTEDEAT 111
Query: 183 K-------GLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKT 231
+ G+ +LH + + + D K NI+L + KL DFG+A G++
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 169 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 42/207 (20%), Positives = 81/207 (39%), Gaps = 26/207 (12%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 132
LG G FG V + V+ + T K + G E++ L H N
Sbjct: 13 LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 133 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFL 188
++ L E + L +++EF+ + + + L + + L FL
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFL 118
Query: 189 HEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
H + + D + NI+ ++ K+ +FG A+ GD + + Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTG 273
E +++ +D++S G ++ +L+G
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 65/294 (22%), Positives = 103/294 (35%), Gaps = 67/294 (22%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 131
+G G + + + T + AVK ++ E E+ L H
Sbjct: 30 IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76
Query: 132 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 185
N++ L +D + + +V E M G L + + R+ +S R + +
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKT---V 129
Query: 186 AFLHEEAERPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+LH + V++RD K SNIL D N ++ DFG AK + + T T
Sbjct: 130 EYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTA 184
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHLG 297
+ APE + + D++S GV+L MLTG D
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--------------- 229
Query: 298 ERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 345
I G FS+ G A L + L DP R + V+
Sbjct: 230 ---EILARI---GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF-------- 124
+G G +G V+K +G VA+K++ + +
Sbjct: 17 IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64
Query: 125 ---LGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSI 173
L H N+V+L+ + + ++ LV+E + R L+ LP
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAET 121
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTH 232
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 122 IKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
V+ T Y APE ++ + D++S G + EM +
Sbjct: 179 ---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 38/216 (17%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
LG G F V + + TG A K L E L E+ L
Sbjct: 37 LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 131 L-NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW--------SIRMKIALG 180
++ L E+ + L+ E+ G E +F LP +K L
Sbjct: 88 CPRVINLHEV-YENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
G+ +LH + +++ D K NILL + K+ DFG+++ + +
Sbjct: 143 ---GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---I 193
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
MGT Y APE + +T+ +D+++ G++ +LT
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 159 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218
E L + + AKG+ FL A R I+RD NILL K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
FGLA+D + + APE + T +SDV+SFGV+L E+ +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 12/107 (11%)
Query: 67 FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLA 120
F + L LG G FG V + K T TVAVK L H+ ++
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMS 74
Query: 121 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRR 165
E+ L + HLN+V L+G C + L+V EF G+L +L +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 40/218 (18%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 126
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 127 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 179
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 70 EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TEFLKQIL 124
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 235
+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 125 NG---VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 67/365 (18%), Positives = 117/365 (32%), Gaps = 64/365 (17%)
Query: 1 MYGKLISESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL 60
M +S + P + A+ + + V S L+ +
Sbjct: 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII 60
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 120
+LG G G V + T A+K L +
Sbjct: 61 D---DYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARR 103
Query: 121 EVNFLGDLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR 174
EV ++V+++ E+ L+V E + G L + + R ++ R
Sbjct: 104 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTER 161
Query: 175 -----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDGP 226
MK A + +LH + +RD K N+L NA KL+DFG AK+
Sbjct: 162 EASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286
+ ++T T Y APE + D++S GV++ +L G P
Sbjct: 216 SHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF--- 263
Query: 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLM 340
++ L I G + ++ L + L +P R +
Sbjct: 264 ----YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316
Query: 341 SEVVE 345
+E +
Sbjct: 317 TEFMN 321
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 46/225 (20%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 127
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 25 IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72
Query: 128 LVHLNLVKLIGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 176
L H N+V LI C LV++F G L N L + +L + M+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-MQ 131
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------KDGPEGDK 230
+ L GL ++H +++RD K +N+L+ D KL+DFGLA K+
Sbjct: 132 MLL---NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 231 THVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 274
T+ RV+ T Y PE ++ D++ G ++ EM T
Sbjct: 186 TN---RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 130
LG+G F V + VK G A +N L H++ E L H
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 131 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 184
N+V+L I ++ L+++ + G L + R +S ++ L A
Sbjct: 70 PNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEA--- 122
Query: 185 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
+ H+ V++R+ K N+LL KL+DFGLA + EG++ GT
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFA-GTP 177
Query: 242 GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 273
GY +PE V+ D+++ GV+L +L G
Sbjct: 178 GYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 33/222 (14%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
+ ++ +G G G V VA+K L+ K E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 122 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 175
+ + + H N++ L+ +E+ Q + LV E M + + + L RM
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHERM 166
Query: 176 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--H 232
L G+ LH +I+RD K SNI++ +D K+ DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
V TR Y APE ++ D++S G ++ EM+ +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 55/238 (23%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 120
+G+G +G V A+K L+ L +
Sbjct: 20 EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 121 ---------------EVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENH 161
E+ L L H N+VKL + +D +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 162 LFRRSLPLPWSIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219
+ L + + G + +LH + +I+RD K SN+L+ D + K++DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 274
G++ + +G +S V GT + APE + DV++ GV L + G+
Sbjct: 182 GVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 65/297 (21%), Positives = 98/297 (32%), Gaps = 60/297 (20%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 124
+ +G G FG T VAVK + E + E+
Sbjct: 21 RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69
Query: 125 LGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
L H N+V+ I L ++ E+ G L + R
Sbjct: 70 HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG-------RFSEDEARF 120
Query: 183 K------GLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTHVS 234
G+++ H + +RD K N LLD K+ DFG +K +
Sbjct: 121 FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 175
Query: 235 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292
+ V GT Y APE V+ +DV+S GV L ML G + P +
Sbjct: 176 STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE--DPEEPRDY---- 227
Query: 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR----DPKARPLMSEVVE 345
R+ + I L +SI + + H +SR DP R + E+
Sbjct: 228 -------RKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 35/219 (15%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+++ LG G + VF+ N V VK L K+ E+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84
Query: 126 GDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIR--MKIALG 180
+L N++ L + R F + N F++ + IR M L
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG-PEGDKTH-VSTRV 237
K L + H +++RD K N+++D ++ +L D+GLA+ P + V++R
Sbjct: 141 --KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 238 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 275
+ PE ++ + S D++S G +L M+ +
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 79/368 (21%), Positives = 119/368 (32%), Gaps = 86/368 (23%)
Query: 1 MYGKLISESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL 60
M+ S T S ++ A + T+ L + + + +D
Sbjct: 1 MHHHHHHSSGVDLGTENLYF-----QSMSSVTASAAPGTASLVPDYWIDGS-NRDALSDF 54
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 120
F ES LG G V++ + GT A+K L K
Sbjct: 55 ------FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRT 97
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
E+ L L H N++KL E + LV E + G L F R I +
Sbjct: 98 EIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I---VEK 142
Query: 180 G------AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAK 223
G AA +A+LHE +++RD K N+L D K++DFGL+K
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199
Query: 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 283
V GT GY APE + D++S G++ +L G
Sbjct: 200 IVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF--------- 247
Query: 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKAR 337
P ER + L + A L + DPK R
Sbjct: 248 ---------EPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297
Query: 338 PLMSEVVE 345
+ ++
Sbjct: 298 LTTFQALQ 305
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 55/231 (23%), Positives = 89/231 (38%), Gaps = 40/231 (17%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 118
+ + + G +G V G+ VA+K + + G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 119 ------LAEVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 167
L E+ L H N++ L + + +L LV E M L + + +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 168 PLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDG 225
+ ++ GL LHE A V++RD NILL + + + DF LA +D
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 226 PEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
+ +KT +V+ R Y APE VM T D++S G V+ EM +
Sbjct: 186 ADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
+ ++ +G G G V VA+K L+ K E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 122 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 175
+ + + H N++ L+ +E+ Q + +V E M +L + + L RM
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQMEL---DHERM 129
Query: 176 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKT-H 232
L G+ LH +I+RD K SNI++ +D K+ DFGLA G T +
Sbjct: 130 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
V TR Y APE ++ D++S G ++ EM+ G
Sbjct: 187 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 49/253 (19%), Positives = 89/253 (35%), Gaps = 61/253 (24%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-----------------T 106
++ + LG G FG V + + E +G A+K
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPRYKNRELDIMKV 56
Query: 107 LNH----------------DGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LV 149
L+H + + N K + ++ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 150 YEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAERPVIYRDFKTSNI 206
E++P + R +P + I + + + F+H + +RD K N+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNL 172
Query: 207 LLDA-DYNAKLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG--HLTSRSDVY 261
L+++ D KL DFG AK + + +R + Y APE +M G T D++
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTPSIDLW 226
Query: 262 SFGVVLLEMLTGR 274
S G V E++ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 54/232 (23%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
+ + + +G G +G V + +G VA+K L+ K E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 122 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 175
+ L + H N++ L+ + + LV FM + L + + +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK-------IMGL 121
Query: 176 KIA-----------LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224
K + L KGL ++H A V++RD K N+ ++ D K+ DFGLA+
Sbjct: 122 KFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR- 174
Query: 225 GPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
+ + T V TR + Y APE +++ H D++S G ++ EMLTG+
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
++ S +G G +G V + + TGL VAVK L+ + K E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 122 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 173
+ L + H N++ L+ +E+ + LV M L + L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-H 232
+ +GL ++H A+ +I+RD K SN+ ++ D K+ DFGLA+ + T +
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGY 189
Query: 233 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
V+TR Y APE ++ H D++S G ++ E+LTGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 38/231 (16%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
+ LG GG G VF V VA+K + Q K L E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIK 60
Query: 124 FLGDLVHLNLVKLI-------------GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSL 167
+ L H N+VK+ + + + +V E+M E L
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115
Query: 168 PLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAK-D 224
PL + +GL ++H A V++RD K +N+ ++ D K+ DFGLA+
Sbjct: 116 PLL-EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 225 GPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
P + + T Y +P +++ + T D+++ G + EMLTG+
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
+R +G G +G V V TG VA+K L K E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 122 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 173
+ L + H N++ L+ ++D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 174 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-H 232
+ KGL ++H A +I+RD K N+ ++ D K+ DFGLA+ + + T +
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGY 185
Query: 233 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
V TR Y APE ++ T D++S G ++ EM+TG+
Sbjct: 186 VVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 35/225 (15%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 122
+ S +GEG +G V + VA+K ++ + + L E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREI 76
Query: 123 NFLGDLVHLNLVKLIG----YCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 175
L H N++ + IE + + +V + M E L++ ++ L + +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHI 130
Query: 176 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDK 230
L +GL ++H A V++RD K SN+LL+ + K+ DFGLA+ P+ D
Sbjct: 131 CYFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 231 THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 274
T T + T Y APE ++ T D++S G +L EML+ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 122
+ +F+ +SLLGEG +G V TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA---------THKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 123 NFLGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 175
L H N++ + E+ + ++ E M + L R + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHI 114
Query: 176 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPE 227
+ L + + LH + VI+RD K SN+L++++ + K+ DFGLA + +
Sbjct: 115 QYFIYQTL---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 228 GDKTHVSTRVMGTY----GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 274
+ M + Y APE ++T + DV+S G +L E+ R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 49/324 (15%), Positives = 97/324 (29%), Gaps = 85/324 (26%)
Query: 7 SESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 66
+ ++ N ++ + + S+ T+ + +
Sbjct: 7 AAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPR--------PHSDWQ----IPDR 54
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----E 121
+ L+G G +G V + VA+K + E
Sbjct: 55 YEIRHLIGTGSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDCKRILRE 102
Query: 122 VNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
+ L L H ++VK+ I +E L +V E ++ + R
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------LFRTP 150
Query: 177 IALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---- 222
+ L G+ ++H A +++RD K +N L++ D + K+ DFGLA
Sbjct: 151 VYLTELHIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 223 -----KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH------------LTSRS-----DV 260
++ + +TGH L + DV
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267
Query: 261 YSFGVVLLEMLTGRRSMDKNRPNG 284
+S G + E+L + +
Sbjct: 268 WSIGCIFAELLNMIKENVAYHADR 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 44/240 (18%), Positives = 79/240 (32%), Gaps = 46/240 (19%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 114
R ++ +S G +++ + ++K DG
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 115 HKEWLAEVNFLGDLVHLNLVKLIGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPW 171
+ + L L + +G+ +D R LV +P SL+ S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVL 156
Query: 172 SIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK---D 224
S R ++A L FLH E ++ + NI +D + ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 225 GPEGDKTHVSTR------VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 274
HV+ G + + M H + RSD+ S G +L+ L G
Sbjct: 214 ----SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 62/258 (24%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
N+ + L+G G +G V+ T VA+K +N + L K L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
+ L L +++L I DD +V E ++ L + +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK-------LFKTP 123
Query: 177 IALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---- 222
I L G F+HE + +I+RD K +N LL+ D + K+ DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-----------------SDVYSFGV 265
+ + + +T H+ +R D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 266 VLLEMLTGRRSMDKNRPN 283
+ E+L +S + N
Sbjct: 241 IFAELLNMLQSHINDPTN 258
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 52/277 (18%), Positives = 96/277 (34%), Gaps = 49/277 (17%)
Query: 26 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 85
+S+ L E+ V + ++ +G+GGFGC++
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAA-------AWKVGLPIGQGGFGCIYLAD 55
Query: 86 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGDLVHLNLVKLIG-- 138
+ + G+ VK D E A+ + + +K +G
Sbjct: 56 MNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111
Query: 139 ---YCIEDDQRLLVYEF--MPR-G-SLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 188
D+ Y F M R G L+ ++ + ++ ++L L ++
Sbjct: 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRFSRK-TVLQ-LSLRILDILEYI 168
Query: 189 HEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD-GPEGDKTHVSTR----VMGTY 241
H E ++ D K SN+LL+ + L D+GLA PEG + GT
Sbjct: 169 H---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI 225
Query: 242 GYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 274
+ + + H + R D+ G +++ LTG
Sbjct: 226 EFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 53/247 (21%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 130
LG G F V+ N T VA+K + D + E+ L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74
Query: 131 LNLVKLIG----YCIEDDQRLLVYEFMPRGSLENHLF------RRSL----------PLP 170
+ K + + +LL + F +G H+ +L +P
Sbjct: 75 ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 171 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD------ADYNAKLSDFGLAKD 224
+I+ GL ++H +I+ D K N+L++ K++D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-----RSMDK 279
E + TR Y +PE ++ +D++S ++ E++TG
Sbjct: 188 YDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 280 NRPNGEH 286
+ +H
Sbjct: 243 YTKDDDH 249
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 52/225 (23%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 129
++G+G FG V K + + VA+K + N H++ E+ L L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151
Query: 130 HL------NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPW 171
N++ ++ C+ E LL +YE + + + LP
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF------QGFSLP- 200
Query: 172 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA-KLSDFGLAKDGPEGD 229
+R K A + L LH+ +I+ D K NILL + K+ DFG + +
Sbjct: 201 LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 274
T++ +R Y APE ++ D++S G +L E+LTG
Sbjct: 257 YTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 46/239 (19%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 121
R + LG+G +G V+K + TG VAVK + + E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 122 VNFLGDL-VHLNLVKLIGYCI-EDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRMK 176
+ L +L H N+V L+ ++D+ + LV+++M E L R+ L + +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQ 112
Query: 177 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTH 232
+ K + +LH +++RD K SNILL+A+ + K++DFGL+ +
Sbjct: 113 YVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 233 VSTRVMGTYGYAAPEYVMTGH------------LTSRS-----DVYSFGVVLLEMLTGR 274
+ T + + ++T + L S D++S G +L E+L G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 56/243 (23%), Positives = 91/243 (37%), Gaps = 54/243 (22%)
Query: 54 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 112
+ R + +SL+G+G FG V K + VA+K + N
Sbjct: 45 IVKNGEK-WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF 93
Query: 113 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 154
+ EV L + +V L + C+ E +L +Y+
Sbjct: 94 --LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-- 145
Query: 155 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214
L N FR + ++ K A L FL +I+ D K NILL +
Sbjct: 146 ---LRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRS 198
Query: 215 --KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEML 271
K+ DFG + + ++ +R Y +PE V+ G + D++S G +L+EM
Sbjct: 199 AIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMH 252
Query: 272 TGR 274
TG
Sbjct: 253 TGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 51/230 (22%), Positives = 85/230 (36%), Gaps = 46/230 (20%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 123
+++ +GEG FG +F+G VA+K D Q E+
Sbjct: 11 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 180
G + + + E +LV + + SLE L R + ++ M A
Sbjct: 62 LAG---CTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQ 114
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTH 232
+ +H E+ ++YRD K N L+ + + DFG+ K D K H
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQH 169
Query: 233 VSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 274
+ R + GT Y + + HL + R D+ + G V + L G
Sbjct: 170 IPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 54/301 (17%), Positives = 92/301 (30%), Gaps = 98/301 (32%)
Query: 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 131
LG G G V + T A+K L + EV
Sbjct: 26 LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71
Query: 132 NLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG-----A 181
++V+++ E+ L+V E + G E LF R I+ + A
Sbjct: 72 HIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQDRGDQAFTEREA 119
Query: 182 A-------KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 231
+ + + +LH + +RD K N+L + KL+DFG A E
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE---- 169
Query: 232 HVSTRVMGT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 290
G Y + D++S GV++ +L G P
Sbjct: 170 -----TTGEKYDKSC-------------DMWSLGVIMYILLCGY------PPF------- 198
Query: 291 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVV 344
++ L I G + ++ L + L +P R ++E +
Sbjct: 199 YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255
Query: 345 E 345
Sbjct: 256 N 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 38/225 (16%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+R +G G FG ++ G G VA+K H + E
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58
Query: 126 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 181
+ + + E D ++V E + SLE LF R L ++ + +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR- 236
+ ++H + I+RD K N L+ + DFGLAK H+ R
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 237 ---VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 274
+ GT YA+ + HL + R D+ S G VL+ G
Sbjct: 172 NKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 55/229 (24%), Positives = 84/229 (36%), Gaps = 44/229 (19%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
NFR +G G FG + G T VA+K E F
Sbjct: 10 NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 126 GDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 181
L + ++ + +V E + SLE LF R+ L ++ M IA+
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQL 114
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHV 233
+ ++H + +IYRD K N L+ N + DF LAK D K H+
Sbjct: 115 ISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHI 169
Query: 234 STR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 274
R + GT Y + + HL + R D+ + G + + L G
Sbjct: 170 PYREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 41/278 (14%), Positives = 76/278 (27%), Gaps = 88/278 (31%)
Query: 148 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206
+V+E + L + + LP KI +GL +LH + +I+ D K NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 207 LLDAD-------------------------------------------------YNAKLS 217
LL + K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277
D G A + + TR Y + E ++ + +D++S + E+ TG
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 278 DKNRPNGEHN-------------------LVEWARPHL-----GERRRFYRLIDPRLEG- 312
+ + +V G+ + +L L
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 313 -----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+S + A L P+ R +E +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 41/238 (17%), Positives = 80/238 (33%), Gaps = 45/238 (18%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 119
+ +G GGFG ++ + VK + E +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 120 AEVNFLGDLVHLNLVKLIG-----YC-----IEDDQRLLVYEFMPR--GSLENHLFRRSL 167
A+ + + + + +G R +V M R L+ + ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNG 146
Query: 168 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD- 224
S +++ + L ++H E ++ D K +N+LL + L+D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 225 GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 274
P G+ GT + + + H + RSDV G +L L G+
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 36/224 (16%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
FR +G G FG ++ G + VA+K N H + L E
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56
Query: 126 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM--KIALGAA 182
L + + + +E D +LV + + SLE LF S++ +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLF-NFCSRKLSLKTVLMLADQMI 113
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR-- 236
+ F+H + ++RD K N L+ A + DFGLAK H+ R
Sbjct: 114 NRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 237 --VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 274
+ GT YA+ + HL + R D+ S G VL+ L G
Sbjct: 171 KNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 1e-07
Identities = 39/225 (17%), Positives = 59/225 (26%), Gaps = 63/225 (28%)
Query: 46 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 105
+ S+ F+ L T + +GEG FG VF+ VA+K
Sbjct: 2 MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIK 49
Query: 106 TLNHDGLQGH--------KEWLAEVNFLGDLVHL---------NLVKLIGYCI------- 141
+ +G +E L E+ +L L + L
Sbjct: 50 IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109
Query: 142 -----------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
+DDQ +V EF G + + + I
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSIL 167
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223
LA +RD N+LL KL K
Sbjct: 168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 60/259 (23%), Positives = 87/259 (33%), Gaps = 72/259 (27%)
Query: 54 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 112
D L R + LGEG FG V + VA+K + N
Sbjct: 10 VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59
Query: 113 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 154
+ E+N L + V + + CI E LL +EF
Sbjct: 60 --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111
Query: 155 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 213
L+ + F+ P P +A L FLHE + + D K NIL ++++
Sbjct: 112 ---LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162
Query: 214 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL- 254
+++DFG A E T V+TR Y PE V+
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELGW 216
Query: 255 TSRSDVYSFGVVLLEMLTG 273
DV+S G +L E G
Sbjct: 217 AQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 67/259 (25%), Positives = 95/259 (36%), Gaps = 72/259 (27%)
Query: 54 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 112
D+ L+ R + LGEG FG V + + G G VAVK + N D
Sbjct: 5 ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54
Query: 113 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 154
+ +E+ L L V+++ + CI E LL Y+F
Sbjct: 55 --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106
Query: 155 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 213
++ + F P K+A K + FLH + + D K NIL +DY
Sbjct: 107 ---IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157
Query: 214 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL- 254
K+ DFG A E T VSTR Y APE V+
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALGW 211
Query: 255 TSRSDVYSFGVVLLEMLTG 273
+ DV+S G +L+E G
Sbjct: 212 SQPCDVWSIGCILIEYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 5e-07
Identities = 44/249 (17%), Positives = 75/249 (30%), Gaps = 80/249 (32%)
Query: 2 YGKLISESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLK 61
Y L+S K+ QP+ + N + ++ + V SRL+ + L+
Sbjct: 91 YKFLMSPIKTEQR----QPSMMTRMYIEQRDRLYNDN--QVFAKYNV-SRLQPYL--KLR 141
Query: 62 LATRNFRPESLL---GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE- 117
A RP + G G G K W VA+ +Q +
Sbjct: 142 QALLELRPAKNVLIDGVLGSG---KTW----------------VALDVCLSYKVQCKMDF 182
Query: 118 ---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRG-SLENHLFRRSLP 168
WL + C + L L+Y+ P S +H L
Sbjct: 183 KIFWLN----------------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 169 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-LSDFGLAKDGPE 227
+ + E R + + ++ ++L NAK + F L
Sbjct: 227 IHS----------------IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL------ 264
Query: 228 GDKTHVSTR 236
K ++TR
Sbjct: 265 SCKILLTTR 273
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 1e-06
Identities = 63/385 (16%), Positives = 124/385 (32%), Gaps = 97/385 (25%)
Query: 15 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFT---FNDLKLATRNFRPE- 70
T+R + +S+ TT++ + + L + +V S L K+ DL P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 71 -SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 127
S++ E + W N K T + ++ L + + L+ V F
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCD---KLTTIIESSLNVLEPAEYRKMFDRLS-V-FPPS 384
Query: 128 LVHLN---LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184
H+ L + I+ D ++V + +E ++ +P SI +++ +
Sbjct: 385 -AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP-SIYLEL-KVKLEN 441
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTY 241
LH ++D YN + P D+ +H+
Sbjct: 442 EYALH---------------RSIVDH-YNIPKTFDSDDLIPPYLDQYFYSHI-------- 477
Query: 242 GYAAPEYVMTGHLTS--RSDVYS-FGVVLLEMLTGRRSMD-KNRPNGEHNLVEWARPHLG 297
G+ HL + + + F +V L+ R ++ K R + + +
Sbjct: 478 GH---------HLKNIEHPERMTLFRMVFLDF----RFLEQKIRHDSTAWNASGSILNTL 524
Query: 298 ERRRFYR----LIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-A 346
++ +FY+ DP+ E F K L ++ A
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPK--------IEENLICSKYTD-----LLRIA 571
Query: 347 LKPLPNLKDMASSSYYFQTMQAERI 371
L MA F+ +A +
Sbjct: 572 L--------MAEDEAIFE--EAHKQ 586
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 54/247 (21%), Positives = 83/247 (33%), Gaps = 76/247 (30%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 129
+G+G FG V +N AVK + N + E + L +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 130 HL-----NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 172
+ N+VK G C+ E L +YE + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIE 137
Query: 173 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA----------------- 214
+ K L +L + + + + D K NILL D +
Sbjct: 138 DIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 215 -------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVV 266
KL DFG A + + ++TR Y APE V+ S D++SFG V
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCV 248
Query: 267 LLEMLTG 273
L E+ TG
Sbjct: 249 LAELYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 422 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.52 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.33 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.17 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.86 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.4 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.11 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.77 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.72 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.61 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.56 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.3 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.02 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.57 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.41 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.76 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.71 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.56 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 85.67 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 81.59 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=461.51 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=205.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+++|++|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 589999999999999999999876 7889999999765433 34578999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
++.+|||||||+||+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999999654 456899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|+..... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..... +... .... .
T Consensus 172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~---i~~~--~ 241 (350)
T 4b9d_A 172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLK---IISG--S 241 (350)
T ss_dssp ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH---HHHT--C
T ss_pred ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH---HHcC--C
Confidence 9876422 122344689999999999999999999999999999999999999997653211 1111 1110 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+ +.+ +...+.++.+||.+||+.||.+|||+.|++++
T Consensus 242 ~-----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 F-----PPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp C-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-----CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 111 12345789999999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-62 Score=456.44 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=219.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|+++++||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+++|++|+|||||++++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 469999999999999999999877 78899999997532 234567899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++.+|||||||+||+|.+++.+. +.+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 999999999999999999999654 57999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|+..............+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+... +... ......
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~---i~~~~~- 251 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAK---IIKLEY- 251 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHTCC-
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHcCCC-
Confidence 998765444444556899999999999999999999999999999999999999997643211 1111 111110
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhCCCCCCCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE--ALKPLPNLKDMAS 358 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--~L~~~~~~~~~~~ 358 (422)
. ++...+.++.+||.+||+.||.+|||+.|++. .|..+++++++.+
T Consensus 252 -------~----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 252 -------D----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp -------C----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -------C----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 1 11233568999999999999999999999753 3566777766543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=454.52 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=212.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
..|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 579999999999999999999876 78899999997665555677899999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.+|||||||+||+|.+++.+ ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCcee
Confidence 99999999999999999864 36999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+..... .........
T Consensus 220 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~-------- 286 (346)
T 4fih_A 220 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNL-------- 286 (346)
T ss_dssp CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSS--------
T ss_pred cCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCC--------
Confidence 644322 2345789999999999999999999999999999999999999997643221 111111100
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.+. .....+.++.+||.+||+.||.+|||+.|++++
T Consensus 287 --~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 287 --PPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --CCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01110 112345789999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-60 Score=445.83 Aligned_cols=261 Identities=26% Similarity=0.458 Sum_probs=206.5
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+..++|++.++||+|+||+||+|.+.. .||||+++.... ...+.|.+|+.+|++++|||||+++++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 445788899999999999999998643 599999875432 334679999999999999999999998
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+. ++.++||||||++|+|.++|......+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 101 MT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCC
T ss_pred EE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeec
Confidence 75 46789999999999999999777778999999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|+|+..............+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+...... +... .
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~---~ 250 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFM---V 250 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHH---H
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHH---H
Confidence 99987654444434455789999999999864 4699999999999999999999999976443211 1111 0
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... ...+.+ ...+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 251 ~~~-----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 251 GRG-----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp HTT-----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred hcC-----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 000 011111 112234567899999999999999999999999988754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-61 Score=449.54 Aligned_cols=263 Identities=30% Similarity=0.442 Sum_probs=215.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|.+.+.||+|+||+||+|.+.... ...+|..||||+++.......++|.+|+++|++++|||||+++|+|.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcc----cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 357888999999999999999875421 1126789999999877666667899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
+..+||||||++|+|.++|.+. ...+++..+..|+.||+.||+|||+++ ||||||||+||||+.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 9999999999999999999653 246999999999999999999999988 9999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 290 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 290 (422)
+.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .+..
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence 9999999999987544433333344679999999999999999999999999999999998 89999865322 1111
Q ss_pred hhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... .... ...+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 242 ~i~----~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 CIT----QGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHH----HTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----cCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1000 011223467899999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=451.96 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=208.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|.+.++||+|+||+||+|.+... ....+++.||||+++.......++|.+|+++|++++|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5678889999999999999987531 112267899999998766666678999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~ 210 (422)
..+||||||++|+|.+++.+.. .++++..++.|+.||+.||+|||+.+ ||||||||+||||+.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence 9999999999999999986532 45899999999999999999999988 999999999999999
Q ss_pred CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 014585 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 289 (422)
++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||...... ...
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI 270 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH
Confidence 99999999999987655444444455789999999999999999999999999999999999 89999764321 111
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.... .... + ..+..++.++.+|+.+||+.||++|||+.||+++|+.+.
T Consensus 271 ~~i~----~g~~------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 271 DCIT----QGRE------L----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHH----HTCC------C----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHH----cCCC------C----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 1111 1000 0 112234578999999999999999999999999997653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-60 Score=445.99 Aligned_cols=264 Identities=26% Similarity=0.371 Sum_probs=214.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++++.+.||+|+||+||+|.+.... ...+++.||||+++.... ...++|.+|+.++++++|||||+++|+|.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 45677889999999999999874311 112678999999975433 3356799999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
+..+||||||++|+|.++|... ...+++..+..|+.||+.||+|||+++ ||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 9999999999999999999543 235899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 287 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 287 (422)
+.++.+||+|||+|+.....+........+||+.|||||++.++.|+.++|||||||+||||+| |..||.+.... .
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---H
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987644433334455789999999999999999999999999999999998 89999765421 2
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
+..... .... ...+..++.++.+|+.+||+.||.+||++.+|++.|+.+.+
T Consensus 256 ~~~~i~----~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 VVEMIR----NRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHHHH----TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHHHH----cCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222111 1100 01223456789999999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=446.15 Aligned_cols=252 Identities=24% Similarity=0.243 Sum_probs=208.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+.|++.++||+|+||+||+|++.. +|+.||||+++.... ..+|+.+|++|+|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 468888899999999999999876 788999999976533 247999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEEeeccCcc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAK 223 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl~DFG~a~ 223 (422)
.+|||||||+||+|.++|.+. +.+++..+..++.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999999654 47999999999999999999999998 99999999999999988 59999999998
Q ss_pred cCCCCCcc---ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 224 DGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 224 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
........ ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.. ...
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~ 273 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------EPP 273 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------SCC
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------CCC
Confidence 76543221 122346899999999999999999999999999999999999999987654433221111 100
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.+. .++..++.++.+||.+||+.||.+|||+.||+++|..
T Consensus 274 ~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 274 PIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 000 1222445789999999999999999999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=457.03 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=212.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+.|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 579999999999999999999876 78899999998776666677999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceE
Confidence 99999999999999999854 35999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+..... ........
T Consensus 297 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~--------- 362 (423)
T 4fie_A 297 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDN--------- 362 (423)
T ss_dssp CCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS---------
T ss_pred CCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcC---------
Confidence 644322 2345789999999999999999999999999999999999999997643221 11111110
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+.+. .....+.++.+||.+||+.||.+|||+.|++++
T Consensus 363 -~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 363 -LPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -CCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001110 111335789999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-59 Score=430.65 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=194.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.+|++.+.||+|+||+||+|.+.. +|+.||||++..... .....+.+|+++|++++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 589999999999999999999876 788999999975432 23457899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++.+||||||| +|+|.+++.++ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 999999999999 78999998654 57999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
|+...... .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.... .+.... .....
T Consensus 159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i---~~~~~ 229 (275)
T 3hyh_A 159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNI---SNGVY 229 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCC
T ss_pred CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HcCCC
Confidence 98754332 2334789999999999998876 57999999999999999999999754321 111111 11110
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ++...+.++.+||.+||+.||++|||+.|++++
T Consensus 230 --------~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 --------T----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --------C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --------C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 111235788999999999999999999999984
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-59 Score=432.76 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=199.9
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe--
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 142 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 142 (422)
|++.++||+|+||+||+|.+.. +|..||||++..... ...+.|.+|+++|++|+|||||+++++|.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 3667789999999999999876 788999999965432 234568999999999999999999999875
Q ss_pred --cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc-CCCCeEEeec
Q 014585 143 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDF 219 (422)
Q Consensus 143 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~-~~~~~kl~DF 219 (422)
++.+|||||||+||+|.+++.+ ...+++..+..|+.||+.||+|||+++ .+||||||||+||||+ .+|.+||+||
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeC
Confidence 3457999999999999999965 457999999999999999999999976 4599999999999997 4799999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....... .+..... ..
T Consensus 177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~----~~ 245 (290)
T 3fpq_A 177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT----SG 245 (290)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT----TT
T ss_pred cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHH----cC
Confidence 999864322 2345789999999998865 69999999999999999999999997543211 1111110 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..+.+ +...+.++.+||.+||+.||.+|||+.|++++
T Consensus 246 ~-----~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 246 V-----KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp C-----CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-----CCCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011 11223578999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=438.03 Aligned_cols=262 Identities=27% Similarity=0.337 Sum_probs=204.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++++.||+|+||+||+|++..+.. +++.||||++...... ....+.+|+++|++++|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSD------ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTT------TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCC------CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 579999999999999999998754322 6889999999754322 23468899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++.+|||||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999999654 47999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
+....... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+... .... ......
T Consensus 174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~---i~~~~~-- 243 (304)
T 3ubd_A 174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTM---ILKAKL-- 243 (304)
T ss_dssp EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCCC--
T ss_pred eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHH---HHcCCC--
Confidence 86543222 2345789999999999999999999999999999999999999998643221 1111 111110
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHhCCCCCCCCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDM 356 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~~~~~ 356 (422)
.++...+.++.+||.+||+.||.+||++. +.++.+..++++.+.
T Consensus 244 ----------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 244 ----------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ----------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 11223457899999999999999999853 223333345555443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=443.21 Aligned_cols=272 Identities=28% Similarity=0.385 Sum_probs=220.3
Q ss_pred chhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCC-Ccc
Q 014585 56 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVH-LNL 133 (422)
Q Consensus 56 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~ni 133 (422)
....|++..++|++.+.||+|+||+||+|.+...+. ..+++.||||++...... ..+.|.+|+++|.++.| |||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence 344566677899999999999999999999865322 225678999999765443 34579999999999965 899
Q ss_pred eeeEeEEEec-CceEEEEEecCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014585 134 VKLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197 (422)
Q Consensus 134 v~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~ii 197 (422)
|+++|+|.+. +.++||||||++|+|.++|... ...+++..+..++.||+.||+|||+++ ||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii 207 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 207 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence 9999999764 5689999999999999999643 234899999999999999999999998 99
Q ss_pred eccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCC
Q 014585 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 276 (422)
Q Consensus 198 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 276 (422)
||||||+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..|
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 999999999999999999999999997755544444556789999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 277 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 277 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
|.+...... +... +....+ + ..+..++.++.+|+.+||+.||.+|||+.+|+++|+.+
T Consensus 288 f~~~~~~~~--~~~~----i~~g~~------~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 288 YPGVKIDEE--FCRR----LKEGTR------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp STTCCCSHH--HHHH----HHHTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHH--HHHH----HHcCCC------C----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 986543211 1111 111100 1 11223457899999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=421.07 Aligned_cols=268 Identities=26% Similarity=0.311 Sum_probs=200.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|.+.++||+|+||+||+|.+ +|+.||||++..... ....+..|+..+.+++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 5688889999999999999987 577999999965421 1122345777778899999999999998764
Q ss_pred ----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCcEEEcCCCCeE
Q 014585 145 ----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 145 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----~~~iiHrDlkp~Nill~~~~~~k 215 (422)
.+|||||||++|+|.+++... .+++..+..++.|++.||+|||++. .++||||||||+||||+.++.+|
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 579999999999999999654 5899999999999999999999861 23499999999999999999999
Q ss_pred EeeccCcccCCCCCcc--ceeeccccCccccCCCcccCC------CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 216 LSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
|+|||+|+........ ......+||+.|||||++.+. .++.++|||||||+||||+||.+||..........
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 9999999875433322 122346899999999998764 46789999999999999999988875433211100
Q ss_pred --------hHHhhhhhhhcccccccccCcccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 288 --------LVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 288 --------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.......... ....++.+... ....++..+.+|+.+||+.||.+|||+.||++.|+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTSCSSCCHHHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0000000000 01112222211 12356778999999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=417.77 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=189.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+++|++|+|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 468999999999999999999876 7889999999765433 345689999999999999999999999765
Q ss_pred Cc------------eEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 144 DQ------------RLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 144 ~~------------~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
+. +|||||||++|+|.+++.... ...++..++.|+.||+.||+|||+++ |+||||||+||||+
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEEC
Confidence 43 689999999999999996543 23566778999999999999999998 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccc----------eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 279 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 279 (422)
.+|.+||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999999999998764432211 1234689999999999999999999999999999999996 6643
Q ss_pred CCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 280 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ........ ... ..+ + ......+..+.+||.+||+.||.+|||+.|++++
T Consensus 230 ~~-----~~~~~~~~-~~~-~~~-----p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 230 QM-----ERVRTLTD-VRN-LKF-----P----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH-----HHHHHHHH-HHT-TCC-----C----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc-----HHHHHHHH-Hhc-CCC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 11110000 000 000 0 0112334567899999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=427.80 Aligned_cols=268 Identities=23% Similarity=0.303 Sum_probs=204.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+.+++|+++|++|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 579999999999999999999876 7889999999755432 24568899999999999999999998764
Q ss_pred ------cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 143 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 143 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
.+.+|||||||+ |+|.+++.+ ...+++..+..++.||+.||.|||+++ ||||||||+|||++.+|.+||
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence 367899999995 689999854 457999999999999999999999999 999999999999999999999
Q ss_pred eeccCcccCCCCC--ccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 217 SDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 217 ~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+|||+|+...... ........+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+.......+....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998764322 12223457899999999998875 56999999999999999999999998754322211111100
Q ss_pred hhhhcc----------cccccccCcccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGER----------RRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~----------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... ......+.+.... ......+.++.+||.+||..||.+|||+.|+|++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0000000000000 0011235688999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=410.65 Aligned_cols=204 Identities=25% Similarity=0.330 Sum_probs=174.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
..++|++.++||+|+||+||+|+++.+ ..+++.||||.+.... ...++.+|+++|+.+ .|||||++++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 457899999999999999999987642 1267899999986543 345688999999998 6999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~~kl~DFG 220 (422)
+.+.+|||||||+||+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999999883 4899999999999999999999999 9999999999999877 899999999
Q ss_pred CcccCCCCCcc--------------------------ceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhC
Q 014585 221 LAKDGPEGDKT--------------------------HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 273 (422)
Q Consensus 221 ~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg 273 (422)
+|+........ ......+||+.|||||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432111 112335799999999999875 589999999999999999999
Q ss_pred CCCCCCCC
Q 014585 274 RRSMDKNR 281 (422)
Q Consensus 274 ~~pf~~~~ 281 (422)
+.||....
T Consensus 244 ~~Pf~~~~ 251 (361)
T 4f9c_A 244 RYPFYKAS 251 (361)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCC
Confidence 99996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=436.63 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=214.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++++.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3689999999999999999999876 7889999999877655567789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC--CCeEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~--~~~kl~DFG~ 221 (422)
+.+|||||||+||+|.++|.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999999999999777778999999999999999999999998 9999999999999754 8999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+...... ..... .....
T Consensus 304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i~---~~~~~ 374 (573)
T 3uto_A 304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVK---SCDWN 374 (573)
T ss_dssp CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHH---TTCCC
T ss_pred eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHH---hCCCC
Confidence 99875433 23446899999999999999999999999999999999999999986533211 11110 00000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
++.... ...+.++.+||.+||+.||.+||++.|+++|
T Consensus 375 ----~~~~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 ----MDDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----CCSGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCcccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111 1235788999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=430.53 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=203.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHH---HHHHHHhcccCCCcceeeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW---LAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~~~ 137 (422)
.++|+++++||+|+||+||+|++.. +|+.||||++.+... .....+ ..++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 4679999999999999999999876 888999999964321 112223 3456778888999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
++|.+.+.+|||||||+||+|.++|.+. +.+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEec
Confidence 9999999999999999999999999654 57999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||+|+...... ....+||+.|||||++. +..|+.++|||||||++|||++|.+||.+........+... ..
T Consensus 335 DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~ 407 (689)
T 3v5w_A 335 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL 407 (689)
T ss_dssp CCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HH
T ss_pred ccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hc
Confidence 999998764432 23478999999999997 46899999999999999999999999976443322111111 11
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 345 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~ 345 (422)
... .. ++...+.++.+||.+||+.||.+|++ +.||++
T Consensus 408 ~~~--------~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 408 TMA--------VE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HCC--------CC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCC--------CC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111 11 12234578999999999999999998 566654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=387.78 Aligned_cols=283 Identities=40% Similarity=0.694 Sum_probs=239.2
Q ss_pred cchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcce
Q 014585 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV 134 (422)
Q Consensus 55 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv 134 (422)
+.+.++....++|++.+.||+|+||.||+|.+. +|..||||++........+.+.+|+.+++.++||||+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 98 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLV 98 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEe
Confidence 344444556789999999999999999999853 4678999998877666677899999999999999999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
++++++...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175 (321)
T ss_dssp CEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTT
T ss_pred eEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCC
Confidence 99999999999999999999999999986543 35899999999999999999999988 9999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........+
T Consensus 176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 99999999999875443333333445689999999999989999999999999999999999999987766655555554
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
..... ....+...+++.+........+..+.+++.+||+.||.+||++.+++++|+.+.
T Consensus 256 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 256 AVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp THHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 43222 223445566677777778899999999999999999999999999999997653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=380.05 Aligned_cols=291 Identities=40% Similarity=0.727 Sum_probs=237.0
Q ss_pred hhccccchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc
Q 014585 50 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL 128 (422)
Q Consensus 50 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l 128 (422)
.....+++.++....++|++.+.||+|+||.||+|.+. +|+.||||++...... ....+.+|+.+++.+
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMA 84 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence 34567889999999999999999999999999999643 4678999999765432 233689999999999
Q ss_pred CCCcceeeEeEEEecCceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 129 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
+||||+++++++...+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+....+|+||||||+|
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 9999999999999999999999999999999999654 2349999999999999999999999811129999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--CC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR--PN 283 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~--~~ 283 (422)
||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred EEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 9999999999999999987644332 22344569999999999998899999999999999999999999996321 11
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.......+..... .......+.+..+...+....+..+.+++.+||+.||.+|||+.+++++|+....
T Consensus 244 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 244 DDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp SCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred cchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 1122233332222 2334455666677777888899999999999999999999999999999986433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=373.83 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=210.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.++++++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4689999999999999999998766 7889999999766656667899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++|+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999999999999998654 5899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ . .... .
T Consensus 165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~---~~~~--~ 234 (297)
T 3fxz_A 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---A---TNGT--P 234 (297)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H---HHCS--C
T ss_pred ecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H---hCCC--C
Confidence 7644322 233467999999999999999999999999999999999999999754321110000 0 0000 0
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ..+...+..+.+|+.+||+.||.+||++.+++++
T Consensus 235 ~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 EL-------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CC-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC-------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0112345678999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=378.48 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=215.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.++||+|+||+||+|.+.. +|..||+|++........+.+.+|+.++++++||||+++++++.++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 3679999999999999999999876 6789999999776656667899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccce
Confidence 9999999999999999999877778999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccc------------eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 224 DGPEGDKTH------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 224 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
......... ......||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 754332211 11145799999999999999999999999999999999999999876543222110000
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
. ...+.. .+..++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 237 -~----------~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 237 -R----------GFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -H----------HHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -h----------cccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000000 11123457889999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=387.80 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=215.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+..... ....++..||||++...... ..+.+.+|+.+++++ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34789999999999999999998754221 12225678999999765432 345789999999999 899999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
...+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999996543 34889999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 284 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 284 (422)
||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999987654433333334567899999999999999999999999999999999 999997643221
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
...... .. .....+..++.++.+||.+||+.||.+||++.++++.|+.+
T Consensus 314 ---~~~~~~----~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 ---LFKLLK----EG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ---HHHHHH----TT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHh----cC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 00 00111223457899999999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=379.00 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=208.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..+|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4689999999999999999999876 788999999975432 23456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999999999998554 46999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+........ ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||....... ... .......
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~~~~ 231 (328)
T 3fe3_A 161 SNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE---RVLRGKY 231 (328)
T ss_dssp CGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCC
T ss_pred ceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCC
Confidence 987544322 3346899999999999988775 79999999999999999999997643211 111 1111100
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ++...+.++.+|+.+||..||.+|||+.+++++
T Consensus 232 ~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 R------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 111235688999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=378.71 Aligned_cols=274 Identities=26% Similarity=0.340 Sum_probs=210.0
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+..++|++.++||+|+||+||+|.+ .++.||||++.... ........|+.++++++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL-----------LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE-----------TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEE-----------CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 3457899999999999999999987 46789999996543 22345667999999999999999999998
Q ss_pred ecCc----eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEeccCCCCcEE
Q 014585 142 EDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE----------AERPVIYRDFKTSNIL 207 (422)
Q Consensus 142 ~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~----------~~~~iiHrDlkp~Nil 207 (422)
.... .++||||+++|+|.+++... .+++..++.++.||+.||.|||+. + |+||||||+|||
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nil 163 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVL 163 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEE
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEE
Confidence 8553 69999999999999999653 499999999999999999999998 7 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-----CCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999999999876544333333446799999999998863 556789999999999999999999986544
Q ss_pred CCcchhHHhhhh--hhhc--ccccccccCcccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 283 NGEHNLVEWARP--HLGE--RRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 283 ~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
............ .... .........+.+... .....+.++.+||.+||+.||.+|||+.++++.|+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 322211111000 0000 000000111111111 112456779999999999999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=376.56 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=212.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...+|++.+.||+|+||.||+|.+...+. .+..||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34689999999999999999999875332 455699999976533 33457899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCc
Confidence 999999999999999999999777678999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 222 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 222 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... ..
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~----~~ 270 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVE----EG 270 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH----TT
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cC
Confidence 9876543222 12223456889999999998999999999999999999999 999997543211 111111 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.....+..++..+.+|+.+||..||.+||++.++++.|+.+.
T Consensus 271 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 ----------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001112234578999999999999999999999999997653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=376.30 Aligned_cols=250 Identities=30% Similarity=0.362 Sum_probs=207.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++++.||+|+||+||+|.+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 3679999999999999999999876 78899999996532 23346788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...+..++||||++||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999988543 47999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .... .......
T Consensus 151 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~~ 222 (337)
T 1o6l_A 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEEI 222 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCC
T ss_pred chhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---HHHcCCC
Confidence 9986432221 234468999999999999999999999999999999999999999754321 1111 1111110
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
.++...+.++.+||.+||+.||.+|| ++.+++++
T Consensus 223 ------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223357889999999999999999 88888864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=372.54 Aligned_cols=255 Identities=26% Similarity=0.364 Sum_probs=206.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3689999999999999999999876 6789999999654432 23568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 999999999999999999985 4456999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
...............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+....
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~------ 225 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK------ 225 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTC------
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccc------
Confidence 87644333333445689999999999987765 7899999999999999999999976543211 111111100
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+ ....+..+.+|+.+||+.||.+||++.|++++
T Consensus 226 --~~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 --TYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TTSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccCCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000 11234678899999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=376.76 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=208.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccCCCcceeeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ..+.+.+|+.+|++++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 4689999999999999999999876 7889999999765432 346789999999999999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC----C
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 213 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~----~ 213 (422)
+++.+.+..++||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 999999999999999999999999954 457999999999999999999999998 99999999999998877 7
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+||+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ......
T Consensus 158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i~ 231 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANIT 231 (361)
T ss_dssp EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 99999999987654322 234679999999999999999999999999999999999999997643211 111100
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... +++... ...+..+.+||.+||..||.+||++.+++++
T Consensus 232 ---~~~~~----~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 ---AVSYD----FDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ---TTCCC----CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---hcCCC----CCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 000001 1234678999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=371.99 Aligned_cols=254 Identities=19% Similarity=0.258 Sum_probs=210.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||.||+|.+.. +|..||+|.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4689999999999999999999876 78899999997543 3345688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC--CCCeEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~--~~~~kl~DFG~ 221 (422)
+..++|||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 9999999999999999999776668999999999999999999999998 999999999999987 78999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ......
T Consensus 151 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i---~~~~~~ 221 (321)
T 1tki_A 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENI---MNAEYT 221 (321)
T ss_dssp CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HHTCCC
T ss_pred CeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHH---HcCCCC
Confidence 987654332 334679999999999999889999999999999999999999997643211 11111 000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
+ +.... ...+.++.+|+.+||..||.+|||+.|++++-
T Consensus 222 ~----~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 222 F----DEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp C----CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred C----Chhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 0 00000 02346889999999999999999999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=365.77 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=209.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 4689999999999999999999876 6789999998654332 245688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999999554 47999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 157 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~- 228 (294)
T 4eqm_A 157 IAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS- 228 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-
T ss_pred Cccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-
Confidence 9987643322 122345799999999999999999999999999999999999999976432110 00000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNL 353 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~~~~ 353 (422)
.+..........+..+.+++.+||+.||.+|| ++.++++.|+.+...
T Consensus 229 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 229 ------VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ------CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ------CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 00000111223457899999999999999999 899999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=381.22 Aligned_cols=273 Identities=28% Similarity=0.387 Sum_probs=218.0
Q ss_pred cchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCc
Q 014585 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLN 132 (422)
Q Consensus 55 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~n 132 (422)
+....+.+..++|++.+.||+|+||.||+|.+.... ...+++.||||++...... ..+.+.+|++++.++ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 345556667789999999999999999999865421 1236789999999765433 345689999999999 7999
Q ss_pred ceeeEeEEEecCc-eEEEEEecCCCChhhhhccCCC--------------------------------------------
Q 014585 133 LVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSL-------------------------------------------- 167 (422)
Q Consensus 133 iv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------- 167 (422)
|+++++++.+.+. .++||||+++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999987554 8999999999999999965432
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 168 ---------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 168 ---------------------~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 1899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
............||+.|+|||++.+..++.++|||||||++|||++ |..||........ ...... ...
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~----~~~----- 313 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLK----EGT----- 313 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHH----HTC-----
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHH----cCC-----
Confidence 5444444445678999999999999999999999999999999998 9999976543211 111110 000
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
....+...+.++.+++.+||+.||.+||++.+++++|+.+
T Consensus 314 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 314 -----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0011112346889999999999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=377.15 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=211.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++..........+.+|+.++++++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 3689999999999999999999876 7889999999876555556789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC--CCCeEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~--~~~~kl~DFG~ 221 (422)
+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999999999999776667999999999999999999999998 999999999999974 57899999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... ....
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i~---~~~~- 267 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVK---RCDW- 267 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH---HCCC-
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHHH---hCCC-
Confidence 987654322 233579999999999999999999999999999999999999997643211 111110 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+.. .....+.++.+||.+||+.||.+||++.+++++
T Consensus 268 ---~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 ---EFDED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---CCCSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCCcc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111 111335789999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=358.45 Aligned_cols=282 Identities=37% Similarity=0.619 Sum_probs=226.6
Q ss_pred ccccchhHHHHHhcCCCCC------CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC----cccHHHHHHH
Q 014585 52 LRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE 121 (422)
Q Consensus 52 ~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E 121 (422)
...|++.++...+++|... +.||+|+||.||+|.+ ++..||||++.... ....+.+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence 4567888888888887776 8999999999999986 45689999986532 2234678999
Q ss_pred HHHhcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 014585 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 199 (422)
Q Consensus 122 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHr 199 (422)
+.++++++||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 157 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR 157 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence 99999999999999999999999999999999999999998633 456999999999999999999999998 9999
Q ss_pred cCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 014585 200 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 279 (422)
Q Consensus 200 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 279 (422)
||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999999987654433333444679999999998765 588999999999999999999999986
Q ss_pred CCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 280 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.........+ ..........+...++..+ .......+..+.+++.+||+.||.+||++.+++++|+.+.
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 237 HREPQLLLDI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TBSSSBTTHH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred CcchHHHHHH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 5443321111 1111111122222333322 2345678889999999999999999999999999997653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=379.45 Aligned_cols=251 Identities=28% Similarity=0.391 Sum_probs=201.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhccc-CCCcceeeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 137 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~ 137 (422)
+..++|++.++||+|+||+||+|++.. +|+.||||++.... ......+.+|..++..+ .||||++++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~ 90 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEE
Confidence 345789999999999999999999876 78899999997542 12345678999999988 799999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+++.+.+..||||||++||+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.+|.+||+
T Consensus 91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEc
Confidence 9999999999999999999999998554 46999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ... ....
T Consensus 167 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~ 238 (353)
T 3txo_A 167 DFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---AILN 238 (353)
T ss_dssp CCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH
T ss_pred cccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH---HHHc
Confidence 999998643322 22344689999999999999999999999999999999999999997653211 111 1111
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVE 345 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~ell~ 345 (422)
... .++...+.++.+||.+||+.||.+||++ .++++
T Consensus 239 ~~~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DEV------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCC------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 110 1112234678999999999999999998 66665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=370.21 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=203.8
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+...+|++.+.||+|+||+||+|.+ +|..||||++...... ..+.+.+|+.++++++||||++++++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4457899999999999999999976 5678999999765433 23568899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+...+..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEEC
Confidence 9999999999999999999999965432 3899999999999999999999976 459999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ..
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~~~~~~-~~ 255 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---VAAVGF-KC 255 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HHHHHH-SC
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-cC
Confidence 999997643321 122346799999999999999999999999999999999999999976432111 110000 00
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. ...++...+..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus 256 ~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 256 K------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp C------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred C------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 001122345688999999999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=361.14 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=206.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++...... ....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 579999999999999999999876 7789999999755432 23678899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+++ +|.+.+......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 9999999999965 777777666778999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc---
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 298 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 298 (422)
+....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .............
T Consensus 149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCT
T ss_pred eecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCCh
Confidence 87643222 223457899999999998765 899999999999999999998886433221 1111111100000
Q ss_pred --cccccccc---------CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 --RRRFYRLI---------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 --~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+.... ............+..+.+|+.+||+.||.+|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000 0000111222345788999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=363.22 Aligned_cols=271 Identities=23% Similarity=0.263 Sum_probs=214.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||+||+|.+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 4679999999999999999999876 678999999975432 335678899999999999999999999987
Q ss_pred cC--ceEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE----cCCCCe
Q 014585 143 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNA 214 (422)
Q Consensus 143 ~~--~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill----~~~~~~ 214 (422)
.+ ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence 65 7799999999999999996543 33999999999999999999999998 9999999999999 778889
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCccc--------CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 286 (422)
||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|..||.........
T Consensus 156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 9999999987654332 23357999999999886 578899999999999999999999999754432221
Q ss_pred -hhHHhhhhhhhcc--c--------ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 287 -NLVEWARPHLGER--R--------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 287 -~~~~~~~~~~~~~--~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
..........+.. . .+...........+....+..+.+|+.+||+.||.+||++.|++++...
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 1111111100000 0 0000001112234567888999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=384.00 Aligned_cols=262 Identities=25% Similarity=0.404 Sum_probs=213.0
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEe
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
+.+..++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|++++++++||||+++++
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 179 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34456789999999999999999999875 6779999998754322 2346889999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++...+..++||||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 180 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~D 256 (377)
T 3cbl_A 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISD 256 (377)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECc
Confidence 999999999999999999999999766667999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~---- 329 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVE---- 329 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHH----
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----
Confidence 999986543222111122345778999999998899999999999999999998 999997643211 111110
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... .. ..+..++..+.+||.+||+.||.+||++.++++.|+.+
T Consensus 330 ~~~---~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 330 KGG---RL-------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TTC---CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---CC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 000 00 11223457889999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=375.10 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=207.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++.... ......+.+|+.+|+.++|||||++++++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4679999999999999999999876 78899999986432 23346788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||+.||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccc
Confidence 999999999999999999999854 457999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
+++...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.................
T Consensus 161 ~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--- 234 (384)
T 4fr4_A 161 IAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--- 234 (384)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---
T ss_pred eeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---
Confidence 998764332 2344689999999999873 4689999999999999999999999986544332222211111
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVE 345 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~ 345 (422)
.. ..++...+..+.+||.+||+.||.+||+ +.++++
T Consensus 235 ~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TV------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cc------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 0112233578999999999999999998 666654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=365.21 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=204.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++++.||+|+||+||+|.+. +|+.||||++...... ....+.+|+.++++++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 468999999999999999999873 4678999999754332 2456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||++ ++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcC
Confidence 9999999999996 5888888777777999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-h---
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-L--- 296 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~--- 296 (422)
++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...... .
T Consensus 166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 987643222 2233578999999999876 56899999999999999999999999876544322211110000 0
Q ss_pred -hcccc-------cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 -GERRR-------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 -~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... .................+.++.+||.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 000000000000111234688999999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=364.46 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=207.5
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCce
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 146 (422)
|...+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+.++++++|+||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 6667799999999999999865 6789999999877666677899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCC
Q 014585 147 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226 (422)
Q Consensus 147 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 226 (422)
++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence 999999999999998853 36999999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 227 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ..
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~----------~~ 257 (321)
T 2c30_A 193 KDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRD----------SP 257 (321)
T ss_dssp SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH----------SS
T ss_pred cCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhc----------CC
Confidence 4322 1234679999999999999999999999999999999999999997543211 1111110 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.+. .....+..+.+++.+||+.||.+||++.+++++
T Consensus 258 ~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 258 PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01110 011234678999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=367.84 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=207.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccCCCcceeeEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
++|++.+.||+|+||.||+|.+.. +|..||+|++...... ..+.+.+|+.++++++||||+++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 81 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 569999999999999999999876 7889999999754332 3567899999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC----Ce
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NA 214 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~----~~ 214 (422)
++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCE
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCE
Confidence 99999999999999999999999854 457999999999999999999999998 99999999999998887 79
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 158 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~- 230 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS- 230 (326)
T ss_dssp EECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH-
T ss_pred EEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH-
Confidence 9999999987643322 234579999999999999999999999999999999999999997543211 111000
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.....+ .... ....+..+.+||.+||+.||.+||++.+++++
T Consensus 231 --~~~~~~----~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 231 --AVNYEF----EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --HTCCCC----CHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --hcCCCc----Cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 0000 01234678999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=374.37 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=202.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhccc-CCCcceeeEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIG 138 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (422)
..++|+++++||+|+||+||+|++.. +++.||||++...... ....+..|..++.++ +||||+++++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 120 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEE
Confidence 34689999999999999999999876 7889999999754322 234578999999887 8999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++.+.+..+|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|
T Consensus 121 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 121 CFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEee
Confidence 999999999999999999999998654 47999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc--hhHHhhh-hh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWAR-PH 295 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~-~~ 295 (422)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... ....... ..
T Consensus 197 FGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i 274 (396)
T 4dc2_A 197 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274 (396)
T ss_dssp CTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred cceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence 99998643222 2234578999999999999999999999999999999999999999754322110 0111111 11
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 340 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 340 (422)
..... .++...+.++.+||.+||+.||.+||++
T Consensus 275 ~~~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 275 LEKQI------------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHCCC------------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hcccc------------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11110 1122345788999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=375.37 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=205.9
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhccc-CCCcceee
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKL 136 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~ 136 (422)
....++|++.+.||+|+||+||+|.+.. +|+.||||++.... ......+..|..++..+ +||||+++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l 83 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcE
Confidence 3456789999999999999999999876 78899999997542 12345678899999887 99999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
++++.+.+..|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||
T Consensus 84 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 84 FCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEE
Confidence 99999999999999999999999998553 46999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ...... .
T Consensus 160 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~ 231 (345)
T 1xjd_A 160 ADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSI---R 231 (345)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---H
T ss_pred eEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH---H
Confidence 99999986433221 234568999999999999999999999999999999999999999764321 111111 0
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 345 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~ 345 (422)
... +. ++...+.++.+||.+||..||.+||++. ++++
T Consensus 232 ~~~--------~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 232 MDN--------PF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HCC--------CC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred hCC--------CC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 010 11 1122357889999999999999999987 5543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=367.44 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=206.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||+||+|.+.. +|+.||+|++.... ....+.+.+|+.+++.+.||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 3679999999999999999999876 78899999996532 13346688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||++||+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecC
Confidence 9999999999999999999999554 47999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ...........
T Consensus 152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~ 220 (318)
T 1fot_A 152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAEL 220 (318)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCCC
T ss_pred cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC
Confidence 99875432 23467999999999999999999999999999999999999999754321 11111111111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
. ++...+.++.++|.+||..||.+|| ++.+++++
T Consensus 221 ~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 R------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1 1122347889999999999999999 77777753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=377.92 Aligned_cols=270 Identities=27% Similarity=0.387 Sum_probs=217.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+..++|++.+.||+|+||.||+|.+..... .....+..||||++...... ....+.+|+++++++ +||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 445789999999999999999999764221 11225568999999765433 346788999999999 99999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
+...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 999999999999999999999996543 35999999999999999999999998 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 283 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 283 (422)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433333444567899999999999999999999999999999999 99999754321
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 353 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 353 (422)
....... ... .. ..+..++.++.+|+.+||+.||.+||++.++++.|+.+...
T Consensus 301 ---~~~~~~~----~~~------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 301 ---ELFKLLK----EGH------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ---HHHHHHH----TTC------CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHH----cCC------CC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 000 00 11123357899999999999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=357.21 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=213.3
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+++.+|+.++++++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4578999999999999999999774 356799999976543 34678999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999999999776667999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
......... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||........ ..... ...
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~~~- 222 (268)
T 3sxs_A 152 RYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKVS----QGH- 222 (268)
T ss_dssp EECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHH----TTC-
T ss_pred eecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---HHHHH----cCC-
Confidence 876543322 2233456788999999998899999999999999999999 9999975432111 11000 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.... +...+..+.+++.+||+.||.+||++.+++++|+.+..
T Consensus 223 --~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 223 --RLYR-------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CCCC-------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CCCC-------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0111 11224678999999999999999999999999998765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=375.32 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=201.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...+|++.+.||+|+||.||+|.+..... ++..||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSK------KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTS------CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCC------CceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34689999999999999999998763221 567899999976533 23457999999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence 999999999999999999999777778999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 222 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 222 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ....... ..
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~----~~ 266 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVD----EG 266 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHH----TT
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cC
Confidence 98764432211 1122345788999999999999999999999999999998 99999754321 1111111 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ....+..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 267 ~----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 Y----------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp E----------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0 0011123457899999999999999999999999998765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=359.32 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=211.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ChhhceeeheecCCCccEEEEEEec----------CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3468999999999999999999875 35579999997654 344679999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999999999777778999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... ..
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~----~~-- 223 (269)
T 4hcu_A 154 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIS----TG-- 223 (269)
T ss_dssp GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH----TT--
T ss_pred ccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh----cC--
Confidence 8654321 112223457888999999999999999999999999999999 999997543211 111111 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... .+...+..+.+++.+||+.||.+||++.+++++|+.+
T Consensus 224 -~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 224 -FRLY-------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -CCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccCC-------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0001 1112346789999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=364.26 Aligned_cols=262 Identities=19% Similarity=0.171 Sum_probs=212.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+|+.+++++ .|+||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 4689999999999999999999866 788999999875532 24688999999999 99999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC-----eEEe
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKLS 217 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-----~kl~ 217 (422)
.+..++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999999 99999999776678999999999999999999999998 999999999999998887 9999
Q ss_pred eccCcccCCCCCccc-----eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 218 DFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 218 DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||...............
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 999998754332211 123468999999999999999999999999999999999999999876543332222211
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
...... .....+ ....+ ++.+|+..||+.||.+||++.+|++.|+.+.
T Consensus 233 ~~~~~~------~~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 233 GDTKRA------TPIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHHH------SCHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred Hhhhcc------CCHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 100000 000000 00123 8999999999999999999999999887553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=379.59 Aligned_cols=263 Identities=26% Similarity=0.386 Sum_probs=209.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||+||+|.+.... ...++..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 467999999999999999999965321 112678999999975432 334568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC---C
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 213 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~---~ 213 (422)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 999999999999999999996532 45899999999999999999999998 99999999999998555 5
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i 299 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV 299 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999975422222222334568999999999999999999999999999999998 99999764321 111111
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. .. ....+..++..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 300 ~~----~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TS----GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HT----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hc----CC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 10 00 0011123356789999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=370.07 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=206.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||+||+|.+...+.. ....||+|.+.... ....+++.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 46799999999999999999998663221 22357888886443 2345679999999999999999999999986
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
. ..++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence 5 478999999999999999887778999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~- 236 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE- 236 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC-
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC-
Confidence 87654443333344567889999999999999999999999999999999 999997654322111111 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
....+..++.++.+|+.+||+.||.+||++.+++++|+.+.
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111233468899999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=383.53 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=212.8
Q ss_pred chhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCc
Q 014585 56 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLN 132 (422)
Q Consensus 56 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~n 132 (422)
.+.++.+..++|++.++||+|+||+||+|.+.. +|+.||||++..... .....+.+|+.++..++|||
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~ 135 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTT
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCC
Confidence 344555667899999999999999999999876 788999999964321 11234789999999999999
Q ss_pred ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 133 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
|++++++|.+.+..+||||||+||+|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|
T Consensus 136 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNG 212 (437)
T ss_dssp BCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred EEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCC
Confidence 999999999999999999999999999999776678999999999999999999999998 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
.+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|..||..........
T Consensus 213 ~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 291 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291 (437)
T ss_dssp CEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence 999999999987644322 2233468999999999987 5678999999999999999999999998643221111
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 346 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~ell~~ 346 (422)
.+ +.... ...-+.... ..+.++.+||++||..+|.+ ||++.|++++
T Consensus 292 ~i------~~~~~---~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 292 KI------MNHKE---RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HH------HTHHH---HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hh------hhccc---cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11 00000 000011111 23478899999999888888 9999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=369.27 Aligned_cols=270 Identities=25% Similarity=0.351 Sum_probs=209.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||+||+|.+... ...+|+.||||++........+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTT-----CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecc-----cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 347899999999999999999986421 122788999999987665556789999999999999999999999865
Q ss_pred --cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 143 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 143 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
....++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCc
Confidence 35689999999999999999777667999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC---------CcchhHH
Q 014585 221 LAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN---------GEHNLVE 290 (422)
Q Consensus 221 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~---------~~~~~~~ 290 (422)
++......... .......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 99876443221 1222345788899999999999999999999999999999999988642110 0000000
Q ss_pred hhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
....... .......+..++.++.+|+.+||+.||.+||++.++++.|+.+
T Consensus 240 ~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 240 HLIELLK----------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHH----------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHh----------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000000 0011112234457899999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=379.83 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=207.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 35689999999999999999999876 7889999999765533 235688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc---CCCCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~---~~~~~kl~ 217 (422)
.+.+..++|||||+||+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999999999998654 46999999999999999999999998 99999999999998 56889999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... .
T Consensus 156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~---~ 227 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIK---A 227 (444)
T ss_dssp CCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH---H
T ss_pred cCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHH---h
Confidence 9999987654322 223467999999999999999999999999999999999999999754321 1111110 0
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ....+ .. ...+.++.+||.+||+.||.+||++.+++++
T Consensus 228 ~~~---~~~~~-~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 228 GAY---DFPSP-EW----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TCC---CCCTT-TT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC---CCCcc-cc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 01111 11 1235789999999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=372.18 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=207.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|..||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34679999999999999999999876 7889999999765432 345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC---CCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~---~~~kl~ 217 (422)
.+.+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence 999999999999999999998854 457999999999999999999999998 9999999999999765 459999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... .
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~---~ 244 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIK---A 244 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---H
T ss_pred ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---h
Confidence 9999987653322 23467999999999999999999999999999999999999999764321 1111110 0
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ....+ .. ...+.++.+||.+||+.||.+||++.+++++
T Consensus 245 ~~~---~~~~~-~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 GAY---DYPSP-EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TCC---CCCTT-GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCC---CCCcc-cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000 00 1234688999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=358.80 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=199.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--------------------------cHHH
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE 117 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~~~~ 117 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 3689999999999999999999876 7889999999754321 1246
Q ss_pred HHHHHHHhcccCCCcceeeEeEEEe--cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 014585 118 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 195 (422)
Q Consensus 118 ~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~ 195 (422)
+.+|+.++++++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.||+.||.|||+.+
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8899999999999999999999987 567899999999999988763 346999999999999999999999998
Q ss_pred eEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCC---CCchhhhhhHHHHHHHHHh
Q 014585 196 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLT 272 (422)
Q Consensus 196 iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ellt 272 (422)
|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 99999999999999999999999999987644322 233467999999999998665 3788999999999999999
Q ss_pred CCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 273 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 273 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
|..||...... ............ .. .. ...+.++.+||.+||+.||.+||++.+++++
T Consensus 236 g~~pf~~~~~~------~~~~~~~~~~~~---~~---~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 236 GQCPFMDERIM------CLHSKIKSQALE---FP---DQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSCSSCCSSHH------HHHHHHHHCCCC---CC---SS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCCCccHH------HHHHHHhcccCC---CC---Cc----cccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999754211 111000000000 00 01 1234688999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=356.38 Aligned_cols=256 Identities=29% Similarity=0.533 Sum_probs=207.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-------HHHHHHHHHHhcccCCCcceee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVKL 136 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~ 136 (422)
.++|++.+.||+|+||+||+|.+.. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 4689999999999999999999876 67899999986544322 1578899999999999999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC---
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--- 213 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~--- 213 (422)
++++.+.. ++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCS
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCc
Confidence 99986544 7999999999999999777778999999999999999999999976 45999999999999988776
Q ss_pred --eEEeeccCcccCCCCCccceeeccccCccccCCCccc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 214 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 214 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
+||+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||............
T Consensus 166 ~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp CCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred eeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 99999999985432 133467999999999984 556789999999999999999999999765432211111
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... ......++..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 241 ~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIRE--------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHH--------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHhc--------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1000 0011112223457899999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=371.30 Aligned_cols=263 Identities=26% Similarity=0.416 Sum_probs=209.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||+||+|.+...+.. ....||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 46899999999999999999998763221 22348888885443 223356789999999999999999999886
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcc
Confidence 56789999999999999999776668999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...............||..|+|||++.+..++.++|||||||++|+|++ |..||...........+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~-- 235 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-----ER-- 235 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-----CB--
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----CC--
Confidence 98765544444455678889999999999999999999999999999999 99999865433221111100 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.. .+..++.++.+|+.+||..||.+||++.+++++|+.+..
T Consensus 236 ---~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 ---LA-------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CC-------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CC-------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 011123467799999999999999999999999976643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=373.68 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=205.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-----cccHHHHHHHHHHhcccCCCcceeeEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
.++|++.+.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3579999999999999999999876 78899999985321 123567899999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 213 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-- 213 (422)
++.+++..++|||||++++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCC
Confidence 999999999999999999998887543 345899999999999999999999998 999999999999986654
Q ss_pred -eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 214 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 -~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i 244 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI 244 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH
Confidence 99999999987654322 23346799999999999999999999999999999999999999975321 111110
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... ..+.... ..+.++.+||.+||..||.+||++.+++++
T Consensus 245 ---~~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 245 ---IKGKYK----MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ---HHTCCC----CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HcCCCC----CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 0000001 224688999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=370.81 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=205.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++++.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4689999999999999999999876 78899999996432 23346788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccc
Confidence 9999999999999999999999654 46999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ... .......
T Consensus 187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~i~~~~~ 255 (350)
T 1rdq_E 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYE---KIVSGKV 255 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCC
T ss_pred cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHH---HHHcCCC
Confidence 99875432 234679999999999999999999999999999999999999997543211 111 1111100
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 345 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~ 345 (422)
.++...+.++.+||.+||+.||.+||+ +.++++
T Consensus 256 ------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 011233578899999999999999998 666665
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=370.10 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=205.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..+|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3689999999999999999999876 788999999864321 2235788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...+..++||||+ +|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 9999999999999 78999988554 46999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+
T Consensus 154 ~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------- 220 (336)
T 3h4j_B 154 LSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------- 220 (336)
T ss_dssp CTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------
T ss_pred cceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------
Confidence 9987644322 234679999999999988776 68999999999999999999999764322111000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ...++...+.++.+||.+||+.||.+|||+.|++++
T Consensus 221 ------~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 ------NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ------CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ------HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 001122335788999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=371.15 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=215.1
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
....++|++.+.||+|+||.||+|.+..... ..+++.||||++...... ..+.+.+|+.++++++||||++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456789999999999999999999864211 125678999999765433 34568999999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPV 196 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~i 196 (422)
+.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 999999999999999999999996532 56999999999999999999999998 9
Q ss_pred EeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCC
Q 014585 197 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275 (422)
Q Consensus 197 iHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~ 275 (422)
+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999976533222222334568999999999999999999999999999999999 999
Q ss_pred CCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 276 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 276 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
||...... ....... .. .. ...+..++..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 276 p~~~~~~~---~~~~~~~----~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 276 PYYGMAHE---EVIYYVR----DG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTTSCHH---HHHHHHH----TT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCChH---HHHHHHh----CC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 99754321 1111110 00 00 01122345789999999999999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=362.56 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=191.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++++.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 4689999999999999999998866 7889999999755432 34678899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
++..++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence 999999999996 5999888543 245899999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-- 294 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-- 294 (422)
|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987543221 1233578999999999876 4689999999999999999999999976543211111100000
Q ss_pred ------hhhcccc------------cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 ------HLGERRR------------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ------~~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....... +...+.+.. ....+.++.+||.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000 000000111 11234689999999999999999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=370.88 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=205.1
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhccc-CCCcceeeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 137 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~ 137 (422)
...++|++.++||+|+||+||+|.+.. +|+.||||++.... ....+.+..|..++..+ .||||++++
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~ 87 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence 345789999999999999999999876 67899999997542 23346688999999988 899999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+++.+.+..|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+
T Consensus 88 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEE
Confidence 9999999999999999999999998654 46999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .... ....
T Consensus 164 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~ 235 (353)
T 2i0e_A 164 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIME 235 (353)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH
T ss_pred eCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHH---HHHh
Confidence 9999986432221 234468999999999999999999999999999999999999999764321 1111 1111
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVE 345 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~ell~ 345 (422)
... .++...+.++.+||.+||..||.+||++ .++++
T Consensus 236 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 HNV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCC------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 110 1122345789999999999999999964 55554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=359.47 Aligned_cols=265 Identities=17% Similarity=0.166 Sum_probs=214.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+|+.+++.+ .|+|++++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 35689999999999999999999865 78899999986543 234578999999999 8999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC-----eEE
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKL 216 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-----~kl 216 (422)
.....++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEE
Confidence 999999999999 99999999877677999999999999999999999988 999999999999987776 999
Q ss_pred eeccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 217 SDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 999999876443221 122346799999999999999999999999999999999999999987554333222221
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
....... ... +.+. ..++.++.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 233 ~~~~~~~-~~~-----~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 233 IGEKKQS-TPL-----RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHHHHH-SCH-----HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhhccC-ccH-----HHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 1110000 000 0001 1234789999999999999999999999999986643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=370.86 Aligned_cols=268 Identities=24% Similarity=0.376 Sum_probs=214.3
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+..++|++.+.||+|+||.||+|.+.... ...++..||||++..... ...+.+.+|+.+++++ .||||++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45578999999999999999999974321 122667899999975432 2346789999999999 99999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVI 197 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~qi~~al~~LH~~~~~~ii 197 (422)
+...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 194 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 194 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 9999999999999999999999965432 3789999999999999999999998 99
Q ss_pred eccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCC
Q 014585 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 276 (422)
Q Consensus 198 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 276 (422)
||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654443333444668899999999999999999999999999999998 9999
Q ss_pred CCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 277 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 277 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
|........ ...... .. .....+...+.++.+|+.+||..||.+||++.+++++|+.+..
T Consensus 275 ~~~~~~~~~--~~~~~~----~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 275 YPGIPVDAN--FYKLIQ----NG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp STTCCCSHH--HHHHHH----TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cccCCcHHH--HHHHHh----cC----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 976543211 111111 00 0011112335789999999999999999999999999976543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=376.46 Aligned_cols=261 Identities=26% Similarity=0.318 Sum_probs=205.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHH-hcccCCCcceeeEeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNF-LGDLVHLNLVKLIGY 139 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~~~~~ 139 (422)
.++|+++++||+|+||+||+|++.. +++.||||++...... ....+..|..+ ++.++||||++++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 3679999999999999999999876 7789999999765432 23456677776 577899999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+.+.+..|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+||
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999999999998553 46899999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... +.........
T Consensus 184 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~ 255 (373)
T 2r5t_A 184 GLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKP 255 (373)
T ss_dssp CBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSC
T ss_pred ccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcc
Confidence 9998633222 1234578999999999999999999999999999999999999999754321 1111111110
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCCCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 357 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 357 (422)
. . ++...+..+.+||.+||+.||.+||++.+.++.+..++++....
T Consensus 256 ~--------~----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 256 L--------Q----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp C--------C----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred c--------C----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 0 0 11123468899999999999999999877777777777765543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=364.40 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=202.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.++.++ +||||++++++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 3579999999999999999999876 7889999999765332 234578999999988 89999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+.+.+..++||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+||
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999998543 46999999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc--hhHHhhhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHLG 297 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~ 297 (422)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||......... ...........
T Consensus 155 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 155 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp GGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred cccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 99986432221 234468999999999999999999999999999999999999999753221110 00111110110
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 340 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 340 (422)
.. .. .++...+.++.+||.+||+.||.+||++
T Consensus 233 ~~-------~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 EK-------QI----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HC-------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cC-------CC----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 00 00 1122345789999999999999999996
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=364.13 Aligned_cols=265 Identities=28% Similarity=0.406 Sum_probs=215.0
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
...++|.+.+.||+|+||.||+|.+.... ...++..||||++..... ...+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34578999999999999999999875421 112567899999975432 3346788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~ii 197 (422)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 99999999999999999999996543 23889999999999999999999998 99
Q ss_pred eccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCC
Q 014585 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 276 (422)
Q Consensus 198 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p 276 (422)
||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654443333334567889999999999899999999999999999999 9999
Q ss_pred CCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 277 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 277 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
|...........+ . ... ....+..++..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 253 ~~~~~~~~~~~~~---~----~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 253 YPGIPPERLFNLL---K----TGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp STTCCGGGHHHHH---H----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHh---h----cCC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9765432211111 0 000 0011123457899999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=358.17 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=202.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||+||+|.+ . +|+.||||++...... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-N---------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-T---------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEc-C---------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 5799999999999999999987 3 5778999999755432 23678899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccc
Confidence 9999999999965 999998776678999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 293 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------- 293 (422)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 76532211 1233578999999999876 468999999999999999999999997643211111000000
Q ss_pred hhhhccccc---ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRF---YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.......+ .....+.....+....+.++.+||.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 00000000011112345788999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=359.15 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=200.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||.||+|.+...+. .+..||+|.+...... ..+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 85 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-
Confidence 45789999999999999999999865322 4667999998764332 345688999999999999999999997
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.++..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 86 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence 456789999999999999999777667999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||........ ..... ...
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~----~~~ 234 (281)
T 1mp8_A 163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIE----NGE 234 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHH----TTC
T ss_pred ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHH----cCC
Confidence 9876443221 1223457889999999999999999999999999999996 9999976543211 11110 000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
....+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 235 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 ----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011223457889999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=381.03 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=188.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|+++++||+|+||+||+|.+.. +|+.||||++..... ...+.+.+|+.+|++++|+|||++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 3689999999999999999999876 788999999965432 23457889999999999999999999985
Q ss_pred ec-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 142 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 142 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
.. ..+|+||||+ +++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEee
Confidence 43 5689999998 679999884 4457999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCcc-------------------------ceeeccccCccccCCCcc-cCCCCCchhhhhhHHHHHHHH
Q 014585 217 SDFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEM 270 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el 270 (422)
+|||+++........ ......+||+.|+|||++ .+..|+.++||||||||+|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999875432111 122346789999999976 466799999999999999999
Q ss_pred Hh-----------CCCCCCCCCCCCc-----------------chhHHhhhhhhhcc-------------ccccccc---
Q 014585 271 LT-----------GRRSMDKNRPNGE-----------------HNLVEWARPHLGER-------------RRFYRLI--- 306 (422)
Q Consensus 271 lt-----------g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~-------------~~~~~~~--- 306 (422)
++ |.++|.+...... .+........++.. ..+...+
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 6666654331100 00000000000000 0000000
Q ss_pred -CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 307 -DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 307 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+... ....+.++.+||.+||..||.+|||+.|++++
T Consensus 358 ~~~~~~~~-~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 358 EGTDLAER-FPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCCGGGG-STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHH-CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000111 11235789999999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=371.77 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=201.1
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 149 (422)
.+.||+|+||.||+|.+.. +|+.||+|++........+.+.+|+.++++++||||+++++++...+..+||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999999876 7889999999876655667899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE--cCCCCeEEeeccCcccCCC
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill--~~~~~~kl~DFG~a~~~~~ 227 (422)
|||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999998776667999999999999999999999998 9999999999999 5678999999999987654
Q ss_pred CCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccC
Q 014585 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 307 (422)
Q Consensus 228 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (422)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... ....... +.
T Consensus 242 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~---i~~~~~~----~~ 308 (373)
T 2x4f_A 242 REK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNN---ILACRWD----LE 308 (373)
T ss_dssp TCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHHTCCC----SC
T ss_pred ccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhccCC----CC
Confidence 332 223569999999999999999999999999999999999999997653211 1110 1100000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 308 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 308 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ...+.++.+||.+||+.||.+||++.+++++
T Consensus 309 ~~~~----~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 309 DEEF----QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhh----ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001 1234789999999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=366.81 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=196.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++++.||+|+||+||+|.+.. +|+.||||++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 3689999999999999999999876 788999999976543 236688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--eEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~--~kl~DFG~ 221 (422)
+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 9999999999999999998543 46999999999999999999999998 999999999999987765 99999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||............ .........
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~ 239 (361)
T 3uc3_A 165 SKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKY 239 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCC
T ss_pred cccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCC
Confidence 97543222 1233579999999999988887665 89999999999999999999865433221111 111111000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+ . .....+.++.+||.+||+.||.+|||+.+++++
T Consensus 240 ~~---~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SI---P-------DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC---C-------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC---C-------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 0 001234688999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=368.56 Aligned_cols=265 Identities=24% Similarity=0.382 Sum_probs=195.3
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeE
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
+.+..++|++.+.||+|+||.||+|.+...+. ....||||++.... ....+.+.+|+.++++++||||++++
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 91 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhh
Confidence 33456789999999999999999998865321 22379999997653 23356789999999999999999999
Q ss_pred eEEEecCce------EEEEEecCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 138 GYCIEDDQR------LLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 138 ~~~~~~~~~------~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
+++...... ++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NI 168 (323)
T 3qup_A 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNC 168 (323)
T ss_dssp EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceE
Confidence 999877655 9999999999999998532 225899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 014585 207 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 285 (422)
Q Consensus 207 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 285 (422)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999999999987654443333334567889999999999999999999999999999999 8999976543221
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ..... . . ....+...+.++.+|+.+||+.||.+||++.++++.|+.+
T Consensus 249 ~---~~~~~---~-~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 Y---NYLIG---G-N----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp H---HHHHT---T-C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHhc---C-C----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11100 0 0 0011123447899999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=378.86 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=209.6
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcc
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 133 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni 133 (422)
+.++....++|++.++||+|+||+||+|.+.. +|+.||+|++..... .....+.+|+.+++.++||||
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~I 131 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTB
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCC
Confidence 34445567899999999999999999999876 788999999864221 122457899999999999999
Q ss_pred eeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 134 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 134 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
|++++++.+.+..|||||||+||+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.
T Consensus 132 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred CeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCC
Confidence 99999999999999999999999999998643 5899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCC----CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .
T Consensus 207 ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~ 282 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y 282 (410)
T ss_dssp EEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H
T ss_pred EEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---H
Confidence 99999999987644322 2233578999999999998665 88999999999999999999999976432211 1
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 346 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~ell~~ 346 (422)
... +.....+ .. +. . ...+.++.+||.+||..+|.+ ||++.||+++
T Consensus 283 ~~i---~~~~~~~-~~--p~-~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 283 SKI---MNHKNSL-TF--PD-D----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH---HTHHHHC-CC--CT-T----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHH---Hhccccc-cC--CC-c----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111 0000000 00 00 0 123478999999999999988 9999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=360.93 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=208.1
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+++.+|++++++++|+||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 34578999999999999999999774 456799999976543 3467999999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999776667999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... ..
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~- 237 (283)
T 3gen_A 167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA----QG- 237 (283)
T ss_dssp GGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH----TT-
T ss_pred ccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHHHh----cc-
Confidence 986543211 11223456788999999998999999999999999999998 999997643211 111110 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... ..+...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 238 -----~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 238 -----LRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp -----CCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cCC----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 01112246889999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=364.36 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=216.0
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
...++|++.+.||+|+||.||+|.+... ....+++.||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 3457899999999999999999986431 1223678999999976543 2346789999999999 99999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 202 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlk 202 (422)
+...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 9999999999999999999999975532 4899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCC
Q 014585 203 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 281 (422)
Q Consensus 203 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 281 (422)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987765544333444568889999999999999999999999999999999 999997654
Q ss_pred CCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... ...... .. ... ..+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 253 ~~~~--~~~~~~----~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 253 VDSK--FYKMIK----EG------FRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SSHH--HHHHHH----HT------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhH--HHHHhc----cC------CCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 3211 111110 00 000 01112357899999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=376.80 Aligned_cols=264 Identities=21% Similarity=0.240 Sum_probs=210.4
Q ss_pred chhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCc
Q 014585 56 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLN 132 (422)
Q Consensus 56 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~n 132 (422)
.+.+..+..++|++.++||+|+||+||+|++.. +|+.||||++..... .....+.+|..++..++|+|
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~ 122 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTT
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCC
Confidence 344555667899999999999999999999876 788999999965321 12234789999999999999
Q ss_pred ceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 133 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 133 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
|+++++++.+.+..||||||++||+|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|
T Consensus 123 Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199 (412)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred eeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCC
Confidence 999999999999999999999999999999766667999999999999999999999998 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCccc-------CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 285 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 285 (422)
.+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|..||........
T Consensus 200 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp CEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999987644322 1223468999999999987 35789999999999999999999999976432211
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEA 346 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~ell~~ 346 (422)
...+... ... ...+.. ....+.++.+||.+||. +|.+| |++.+++++
T Consensus 279 ~~~i~~~----~~~-----~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 YGKIVHY----KEH-----LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHTH----HHH-----CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHhc----ccC-----cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111000 000 000111 11235789999999999 99998 588888764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=363.04 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=205.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||.||+|.+...+.. ....||+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 46899999999999999999998763321 12346888876443 3346789999999999999999999999986
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
. ..++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp S-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred C-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 5 488999999999999999877778999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~- 236 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE- 236 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC-
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC-
Confidence 87654443333344567889999999999999999999999999999999 999997654322111111 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
....+..++.++.+|+.+||..||.+||++.++++.|+.+..
T Consensus 237 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 ---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 001112234678999999999999999999999999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=383.76 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=216.5
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.+...+|++.+.||+|+||.||+|.+.. ++..||||++.... ...+++.+|+.+|++++||||+++++++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3455678999999999999999999876 67799999997654 3467899999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
...+..+|||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence 9999999999999999999999754 456999999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
|+++...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...... .
T Consensus 363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~ 434 (495)
T 1opk_A 363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----K 434 (495)
T ss_dssp TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----T
T ss_pred ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence 9998764332 122223456789999999999999999999999999999999 999997654221 111111 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. .....+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 435 ~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 D----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C----------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 0111122345789999999999999999999999999987753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=362.09 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=199.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3579999999999999999999876 6789999999754433 34678999999999999999999999876
Q ss_pred cCc---------------------------------------------------------eEEEEEecCCCChhhhhccC
Q 014585 143 DDQ---------------------------------------------------------RLLVYEFMPRGSLENHLFRR 165 (422)
Q Consensus 143 ~~~---------------------------------------------------------~~lv~e~~~~g~L~~~l~~~ 165 (422)
... .++|||||++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 542 78999999999999999654
Q ss_pred C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCcc----------ce
Q 014585 166 S--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----------HV 233 (422)
Q Consensus 166 ~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~----------~~ 233 (422)
. ...++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 3 23567778999999999999999998 999999999999999999999999999876543211 12
Q ss_pred eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCC
Q 014585 234 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH 313 (422)
Q Consensus 234 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (422)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+... ...... ... .. ...
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~-~~~-~~---------~~~ 293 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITD-VRN-LK---------FPL 293 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHH-HHT-TC---------CCH
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHH-hhc-cC---------CCc
Confidence 23357999999999999999999999999999999999987654210 000000 000 00 000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 314 FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 314 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.....+..+.+|+.+||+.||.+||++.+++++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 112344678999999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=360.23 Aligned_cols=248 Identities=25% Similarity=0.258 Sum_probs=197.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
..++|++.++||+|+||+||+|.+.. +|+.||||++...... ....+..|+..+.++ .|+||++++++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~ 125 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 34679999999999999999999876 6789999998654332 233455666666655 89999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+.+.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 126 WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCC
T ss_pred EEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccc
Confidence 99999999999999 77999998777778999999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..+|.... . .... ..
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~-~~~~----~~- 266 (311)
T 3p1a_A 202 GLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G-WQQL----RQ- 266 (311)
T ss_dssp TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H-HHHH----TT-
T ss_pred eeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H-HHHH----hc-
Confidence 9998764332 2233569999999998876 79999999999999999999977664321 0 0000 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....+.+ ....+.++.+|+.+||+.||.+||++.+++++
T Consensus 267 ----~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 267 ----GYLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----TCCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cCCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0000111 11234789999999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=354.60 Aligned_cols=263 Identities=27% Similarity=0.473 Sum_probs=198.9
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEe
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
++...+|++.+.||+|+||.||+|.+.. .||||++...... ..+.+.+|+.++++++|+||+++++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence 3445789999999999999999997633 5999999755432 3456899999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++ ..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 88 YS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp EE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred ec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEcc
Confidence 65 566789999999999999999777778999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
||++................||+.|+|||++. +..++.++|||||||++|+|++|..||....... .......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~-- 239 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVG-- 239 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHH--
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhc--
Confidence 99998654433333334467999999999986 6678999999999999999999999997643221 1111111
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.. ...+. .......++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 240 --~~-----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 --RG-----SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --HT-----SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --cc-----ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00 00010 11112234578999999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=372.36 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=195.5
Q ss_pred cCCCCC-CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcc-cCCCcceeeEeEEEe
Q 014585 65 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD-LVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 142 (422)
++|.+. ++||+|+||+||+|.+.. +|+.||||++... ..+.+|+.++.+ .+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 467666 689999999999999876 7889999999632 467788888754 489999999999876
Q ss_pred ----cCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCCe
Q 014585 143 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 214 (422)
Q Consensus 143 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~~ 214 (422)
.+.+|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCE
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccE
Confidence 567899999999999999997653 46999999999999999999999988 999999999999987 7899
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR 293 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~ 293 (422)
||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ......
T Consensus 204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 999999998754322 2234679999999999999999999999999999999999999998654432211 111110
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
. .. .....+. ....+.++.+||.+||..||.+||++.+++++-
T Consensus 281 ~---~~---~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 281 M---GQ---YEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp H---TC---CCCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c---Cc---ccCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 00 0000110 112357899999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=360.03 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=208.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||+||+|.+...+... ...+..||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYG--QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGG--CEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccc--cccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 468999999999999999999987632100 001257999999776656667899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--------eE
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AK 215 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~--------~k 215 (422)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999776666999999999999999999999998 999999999999998887 99
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+....... ....
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~---- 229 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQ---- 229 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH----
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHH----
Confidence 9999998764321 23468999999999987 779999999999999999999655443221110 1111
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.......+ .. ..+.++.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 230 ~~~~~~~~----~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYEDRHQL----PA--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHTTCCC----CC--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HhhccCCC----CC--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00111111 01 113467899999999999999999999999998765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=363.48 Aligned_cols=253 Identities=27% Similarity=0.362 Sum_probs=197.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
.++|++.+.||+|+||.||+|++.... .+|+.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGA------NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSST------TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccC------CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 467999999999999999999875321 2788999999976532 223457899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeC
Confidence 99999999999999999999998543 46899999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... .....
T Consensus 166 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~---i~~~~ 237 (327)
T 3a62_A 166 GLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDK---ILKCK 237 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HHHTC
T ss_pred CcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHhCC
Confidence 9997643222 1233467999999999999999999999999999999999999999764321 11111 11110
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
. .++...+.++.+||.+||..||.+|| ++.+++++
T Consensus 238 ~------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 L------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp C------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 01122357889999999999999999 77788774
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=352.26 Aligned_cols=254 Identities=30% Similarity=0.489 Sum_probs=196.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc----cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
..+|++.+.||+|+||.||+|.+ +|..||||++...... ..+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 46899999999999999999987 4678999998754322 24678899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC--------C
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--------D 211 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~--------~ 211 (422)
+...+..++||||+++++|.+++. ...+++..++.++.|++.||.|||+.+..+|+||||||+|||++. +
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999999999999884 346999999999999999999999987444889999999999986 7
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
+.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........ ..
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~- 224 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---AY- 224 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HH-
T ss_pred cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-
Confidence 789999999998654322 2235789999999999999999999999999999999999999975432110 00
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
..... ......+..++..+.+++.+||+.||.+||++.+++++|+.+
T Consensus 225 --~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 --GVAMN----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --HHHTS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --hhhcC----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00000 011111223457899999999999999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=381.17 Aligned_cols=250 Identities=30% Similarity=0.369 Sum_probs=197.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC---CcccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.++||+|+||.||+|.+.. +|+.||||++... .......+.+|+++++.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 4679999999999999999999876 7889999999743 223345678999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
...+..+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+||
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999999988544 479999999999999999999998 78 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .....
T Consensus 294 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~---i~~~~ 365 (446)
T 4ejn_A 294 GLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILMEE 365 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCC
T ss_pred CCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHH---HHhCC
Confidence 99986433221 2334689999999999999999999999999999999999999997543211 1111 11111
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
.. ++...+.++.+||.+||+.||.+|| ++.+++++
T Consensus 366 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 IR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11 1122347889999999999999999 99998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=358.01 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=216.3
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEe
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
++.+..++|++.+.||+|+||.||+|.+.. ++..||+|++.... ...+.+.+|+.++++++||||+++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344556889999999999999999999876 67899999997653 34567899999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence 999999999999999999999999754 456999999999999999999999999 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||........ ......
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~~-- 227 (288)
T 3kfa_A 154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEK-- 227 (288)
T ss_dssp CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHT--
T ss_pred cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhc--
Confidence 9999987654322 22334567889999999999999999999999999999999 9999976543221 111110
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. .....+..++..+.+|+.+||..||.+||++.++++.|+.+
T Consensus 228 --------~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 228 --------D----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --------T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------c----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0 00111123357899999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=366.62 Aligned_cols=278 Identities=23% Similarity=0.284 Sum_probs=215.0
Q ss_pred hhccccchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC
Q 014585 50 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 129 (422)
Q Consensus 50 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 129 (422)
.....+++.+.....++|++.++||+|+||+||+|.+.. +|+.||||++.... .....+..|+.+++.+.
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~ 89 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQ 89 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTC
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhc
Confidence 345567777777888999999999999999999999876 67899999997432 33456778999998886
Q ss_pred -----CCcceeeEeEEEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 014585 130 -----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 203 (422)
Q Consensus 130 -----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 203 (422)
|+||+++++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 90 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp 165 (360)
T 3llt_A 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKP 165 (360)
T ss_dssp CCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred ccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCc
Confidence 999999999999999999999999 999999997653 45999999999999999999999998 99999999
Q ss_pred CcEEEcC-------------------------CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchh
Q 014585 204 SNILLDA-------------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS 258 (422)
Q Consensus 204 ~Nill~~-------------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 258 (422)
+|||++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~ 240 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSS 240 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTH
T ss_pred ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCcc
Confidence 9999975 789999999999865432 2345789999999999999999999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc----------ccc-----ccccCcccCC-----------
Q 014585 259 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER----------RRF-----YRLIDPRLEG----------- 312 (422)
Q Consensus 259 DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~-----~~~~~~~~~~----------- 312 (422)
|||||||++|+|++|..||...........+.......+.. ... .....+....
T Consensus 241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 320 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred chHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence 99999999999999999997654322111111111000000 000 0000000000
Q ss_pred --CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 313 --HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 313 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+....+..+.+||.+||+.||.+|||+.|++++
T Consensus 321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000112678899999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=364.70 Aligned_cols=253 Identities=25% Similarity=0.291 Sum_probs=192.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 45689999999999999999999876 67799999997543 33568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCCeEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~~kl~DF 219 (422)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999999999999999854 456999999999999999999999998 999999999999975 889999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ....
T Consensus 196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i---~~~~ 267 (349)
T 2w4o_A 196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI---LNCE 267 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH---HTTC
T ss_pred ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH---HhCC
Confidence 9998754322 2234679999999999999999999999999999999999999997543211 011100 0000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .... ......+.++.+||.+||+.||.+||++.+++++
T Consensus 268 ~---~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 Y---YFIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp C---CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---ccCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 1112345788999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=376.93 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=207.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..+|.+.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4689999999999999999999876 788999999965321 2345788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
...+..++||||+++|+|.+++.+ ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999999999954 457999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ....... ...
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~---~~~ 232 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKIC---DGI 232 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHH---TTC
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHh---cCC
Confidence 9987654322 234679999999999988766 78999999999999999999999764321 1111110 000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..+...+.++.+||.+||..||.+||++.+++++
T Consensus 233 ------~------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 ------F------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------C------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------c------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 0111234678999999999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.59 Aligned_cols=269 Identities=19% Similarity=0.223 Sum_probs=206.6
Q ss_pred hcCCCCCCccccc--cCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 64 TRNFRPESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 64 ~~~y~~~~~lg~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
..+|+++++||+| +||.||+|.+.. +|+.||||++..... ...+.+.+|+.++++++|||||+++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 4689999999999 999999999876 788999999975432 223568889999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999999999998654 356999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCcc-----ceeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 219 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 219 FG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.......... ..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~ 249 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EK 249 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HH
Confidence 9988654222111 11122478999999999987 679999999999999999999999997654332211 00
Q ss_pred hhhhhhc---c-----cc-------------ccccc---------CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014585 292 ARPHLGE---R-----RR-------------FYRLI---------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341 (422)
Q Consensus 292 ~~~~~~~---~-----~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 341 (422)
....... . .. +...+ .......+....+.++.+||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 0000000 0 00 00000 00000012233457899999999999999999999
Q ss_pred HHHHH
Q 014585 342 EVVEA 346 (422)
Q Consensus 342 ell~~ 346 (422)
+++++
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=354.47 Aligned_cols=262 Identities=26% Similarity=0.375 Sum_probs=201.2
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcc--cCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||+||+|.+ +|+.||||++... ....+..|.+++.. ++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 346899999999999999999987 5678999998643 33455566666655 7999999999987
Q ss_pred Eec----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCCcEEE
Q 014585 141 IED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 141 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~~~~iiHrDlkp~Nill 208 (422)
... ...++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILV 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEE
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEE
Confidence 653 457899999999999999943 46999999999999999999999 777 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccc--eeeccccCccccCCCcccCC------CCCchhhhhhHHHHHHHHHhC-------
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTG------- 273 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg------- 273 (422)
+.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 999999999999997654332211 12234799999999999876 455799999999999999999
Q ss_pred ---CCCCCCCCCCCcchhHHhhhhhhhcccccccccCccc-CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 274 ---RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 274 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
..||............... ...... ..+.+ ...+....+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRK--VVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHH--HHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhH--HHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 7888655433321111100 000000 00111 111233567899999999999999999999999999865
Q ss_pred C
Q 014585 350 L 350 (422)
Q Consensus 350 ~ 350 (422)
+
T Consensus 300 i 300 (301)
T 3q4u_A 300 I 300 (301)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=374.84 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=207.4
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+..++|++.+.||+|+||.||+|.+ .|..||||+++... ..+.+.+|+.+|++++||||+++++++.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-----------cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 4457899999999999999999987 45689999998654 4467999999999999999999999988
Q ss_pred ecC-ceEEEEEecCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 142 EDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 142 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
..+ ..+|||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeC
Confidence 765 78999999999999999976543 4799999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
|+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||...........+ . .
T Consensus 334 G~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~----~ 401 (450)
T 1k9a_A 334 GLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---E----K 401 (450)
T ss_dssp TTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---H----T
T ss_pred CCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----c
Confidence 9998643221 12357889999999999999999999999999999998 99999865433221111 1 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. ....+..++..+.+||.+||+.||.+||++.++++.|+.+
T Consensus 402 ~~----------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 402 GY----------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 0111223457899999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=364.46 Aligned_cols=271 Identities=26% Similarity=0.414 Sum_probs=215.2
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceee
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKL 136 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~ 136 (422)
+++.+..++|++.+.||+|+||.||+|.+... ....++..||||.+...... ....+.+|+.++++++|+||+++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 34445567899999999999999999987631 01115678999999755432 34568899999999999999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 999999999999999999999999986421 45789999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 286 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 286 (422)
++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 247 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--- 247 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---
Confidence 99999999999999986543322222333567899999999999999999999999999999999 88998754321
Q ss_pred hhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
....... .. .. ...+..++..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 248 ~~~~~~~----~~-~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 QVLRFVM----EG-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHH----TT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHH----cC-Cc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111110 00 00 00112345788999999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=358.02 Aligned_cols=268 Identities=25% Similarity=0.320 Sum_probs=201.1
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHhccc---CCCcc
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDL---VHLNL 133 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~ni 133 (422)
...++|++.+.||+|+||+||+|.+.. +|+.||||++..... .....+.+|+.+++.+ .||||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni 76 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence 456799999999999999999998766 788999999864321 1234566777777766 49999
Q ss_pred eeeEeEEEecC-----ceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 134 VKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 134 v~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
+++++++.... ..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil 152 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 152 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 99999998765 4789999995 69999986553 34999999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 229 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999987543222 234679999999999999999999999999999999999999997654322111
Q ss_pred hHHhhhhhhhcccccccc-------cCcc---cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 288 LVEWARPHLGERRRFYRL-------IDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+...... .....+... +.+. .........+..+.+||.+||+.||.+|||+.|++++
T Consensus 230 ~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 230 KIFDLIGL-PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHCC-CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCC-CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11000000 000000000 0000 0000111234788999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=361.53 Aligned_cols=267 Identities=27% Similarity=0.414 Sum_probs=202.6
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCccee
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~ 135 (422)
.++.+..++|.+.+.||+|+||.||+|.+..... ++..||||++...... ..+.+.+|+.++++++||||++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG------TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS------CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCC------ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence 3444556889999999999999999998765322 5678999999755432 3456889999999999999999
Q ss_pred eEeEEEecC-----ceEEEEEecCCCChhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 136 LIGYCIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 136 ~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
+++++...+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 177 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 999998755 35999999999999998842 3456999999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 284 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 284 (422)
||++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 9999999999999999987654433333334567889999999999999999999999999999999 888997653321
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ...... . .... .+..++..+.+|+.+||..||.+||++.+++++|+.+
T Consensus 258 ~---~~~~~~---~-------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 258 M---YDYLLH---G-------HRLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp H---HHHHHT---T-------CCCC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHHc---C-------CCCC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111100 0 0001 1123346899999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=365.10 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=197.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCC--CcceeeEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVH--LNLVKLIG 138 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~ 138 (422)
..++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.+++++.| +||+++++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 76 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence 3567999999999999999999863 4678999999755432 23568899999999976 99999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++..++..+||||+ .+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 77 YEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp EEECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred eEeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEee
Confidence 99999999999995 488999999654 57999999999999999999999998 99999999999997 67899999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccC-----------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
||+++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---- 226 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 226 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----
Confidence 999987655443333445689999999999865 67899999999999999999999999753211
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
..... ..+++.....++...+.++.+|+.+||+.||.+||++.+++++.
T Consensus 227 -~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 227 -ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHHHH----------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11110 11111111112222346789999999999999999999999763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=368.27 Aligned_cols=274 Identities=22% Similarity=0.259 Sum_probs=214.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||+||+|.+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 4689999999999999999999876 688999999975432 335678899999999999999999999987
Q ss_pred cC--ceEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE----cCCCCe
Q 014585 143 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNA 214 (422)
Q Consensus 143 ~~--~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill----~~~~~~ 214 (422)
.+ ..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence 65 7799999999999999996542 33999999999999999999999998 9999999999999 777889
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc-
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 285 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~- 285 (422)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999998764432 2234679999999998865 5678899999999999999999999975433222
Q ss_pred chhHHhhhhhhhc----------ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 286 HNLVEWARPHLGE----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 286 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
...........+. ...+....+......+....+..+.+++.+||+.||++||++.++++.++.+..
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111111110000 000000001112234567888999999999999999999999999998876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=366.69 Aligned_cols=275 Identities=19% Similarity=0.243 Sum_probs=209.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHhcccCCC
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGDLVHL 131 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~ 131 (422)
..++|++.+.||+|+||.||+|.+..... ...++.||||++........ ..+..|+..++.+.|+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 34689999999999999999998865322 12467899999876542111 1245667778888999
Q ss_pred cceeeEeEEEec----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 132 NLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 132 niv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
||+++++++... ...+|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil 184 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL 184 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence 999999998875 4589999999 99999999877678999999999999999999999998 999999999999
Q ss_pred Ec--CCCCeEEeeccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Q 014585 208 LD--ADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280 (422)
Q Consensus 208 l~--~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 280 (422)
++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98 8899999999999765432211 1113356999999999999999999999999999999999999999853
Q ss_pred CCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.... .......... ...+..++++.+.. ..++.++.+|+..||..||.+||++.+|++.|+.+..
T Consensus 265 ~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 265 LKDP--KYVRDSKIRY--RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TTCH--HHHHHHHHHH--HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCH--HHHHHHHHHh--hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 3221 1111111111 01111222221110 1234789999999999999999999999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=357.46 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=196.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++....... ...+.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 4689999999999999999999876 78899999997654332 34688999999999999999999998
Q ss_pred EecCce----EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 141 IEDDQR----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 141 ~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
...... ++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 876544 9999999999999998544 46999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 217 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~ 231 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQH 231 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHH
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHH
Confidence 999999875443221 222335799999999999999999999999999999999999999976432111 0001
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
....... .... ....+.++.+|+.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~----~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 232 VREDPIP----PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHCCCCC----HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred hcCCCCC----cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1010000 0000 0123467899999999999999997776654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=361.23 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=181.5
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 148 (422)
.+.||+|+||.||+|.+.. +|+.||||++... ....+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 4789999999999999876 7889999999643 3456889999999997 9999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC---CeEEeeccCcccC
Q 014585 149 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 225 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~---~~kl~DFG~a~~~ 225 (422)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999654 57999999999999999999999998 99999999999997765 7999999999865
Q ss_pred CCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhhhhhccccccc
Q 014585 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYR 304 (422)
Q Consensus 226 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 304 (422)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ............
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----- 232 (325)
T 3kn6_A 160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----- 232 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-----
T ss_pred CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-----
Confidence 43322 2234578999999999999999999999999999999999999998654321111 111111000000
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+........+.++.+||.+||..||.+||++.+++++
T Consensus 233 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 233 ---FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp ---CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ---CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000000011235789999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=362.69 Aligned_cols=268 Identities=25% Similarity=0.396 Sum_probs=213.8
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+..++|++.+.||+|+||.||+|.+..... ....++..||||++..... .....+.+|+.+++++ +||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 345789999999999999999999864221 1223677899999976543 2345688999999999 89999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
+...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 999999999999999999999996543 24899999999999999999999998 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 283 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 283 (422)
|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654433333334567889999999998899999999999999999999 99999754321
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
....... ... .. ..+..++..+.+++.+||..||.+||++.++++.|+.+.
T Consensus 267 ---~~~~~~~----~~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 ---ELFKLLK----EGH------RM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp ---HHHHHHH----HTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHh----cCC------CC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111110 000 00 111234578999999999999999999999999997653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=366.00 Aligned_cols=279 Identities=27% Similarity=0.335 Sum_probs=215.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
.++|++.+.||+|+||.||+|.+... ...++..||||++........+.+.+|++++++++|+||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 46899999999999999999986431 122788999999987766666779999999999999999999999874
Q ss_pred -cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
....++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence 55688999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ . ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~-~~~~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-C-ERDVPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-c-ccccccHH
Confidence 98765433221 223356888999999999999999999999999999999999998643210000000 0 00000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.....+........+..++..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0001111111112233446789999999999999999999999999987644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=372.36 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=194.3
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccC-CCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~ 139 (422)
..++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++++. |+||++++++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 45789999999999999999999876 788999999865422 33456889999999997 9999999999
Q ss_pred EEecC--ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 140 CIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 140 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+...+ ..|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence 98654 6899999996 689988855 36899999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCC-------------------ccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCC
Q 014585 218 DFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 218 DFG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf 277 (422)
|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999998653211 1112234689999999999986 67999999999999999999999999
Q ss_pred CCCCCCCcchhHHhhhhhhhcc--cccccc------------------cCcccCCCC------------CHHHHHHHHHH
Q 014585 278 DKNRPNGEHNLVEWARPHLGER--RRFYRL------------------IDPRLEGHF------------SIKGAQKAAQL 325 (422)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~------------~~~~~~~l~~l 325 (422)
.+.........+. ..+... ..+..+ ........+ ...++.++.+|
T Consensus 232 ~~~~~~~~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 308 (388)
T 3oz6_A 232 PGSSTMNQLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308 (388)
T ss_dssp CCSSHHHHHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred CCCCHHHHHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence 8654321111110 000000 000000 000000000 00234678999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 014585 326 AAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 326 i~~~l~~dp~~Rps~~ell~~ 346 (422)
|.+||+.||.+|||+.|++++
T Consensus 309 l~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 309 LDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhhccCcccCCCHHHHhCC
Confidence 999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=349.09 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=207.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 4679999999999999999999876 678999999865432 334678899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999999999999854 457999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
................||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-----~~ 226 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK-----KT 226 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT-----CT
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc-----cc
Confidence 86543332223344679999999999987665 7899999999999999999999976543211 11111100 00
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... .....+..+.+|+.+||+.||.+||++.+++++
T Consensus 227 ---~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 ---YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---ccC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000 011234678999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=364.39 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=203.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+|+.++.++ .||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 4679999999999999999999876 788999999976543 235788888888 79999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC----CCeEEee
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSD 218 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~----~~~kl~D 218 (422)
.+..|+|||||+||+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999999999999854 457999999999999999999999998 9999999999998443 3599999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+...... .
T Consensus 164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---~ 238 (342)
T 2qr7_A 164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---G 238 (342)
T ss_dssp CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH---C
T ss_pred CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc---C
Confidence 999987543322 22346799999999999888899999999999999999999999976432222122111110 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .+...+....+.++.+||.+||..||.+||++.+++++
T Consensus 239 ~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 239 KF--------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CC--------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred Cc--------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 01111112345789999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=361.08 Aligned_cols=273 Identities=28% Similarity=0.397 Sum_probs=217.7
Q ss_pred cchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCc
Q 014585 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLN 132 (422)
Q Consensus 55 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~n 132 (422)
+....+....++|++.+.||+|+||.||+|.+.... ...+++.||||++...... ..+.+.+|+.++.++ +|||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 444555566789999999999999999999875311 1236789999999765433 345688999999999 7999
Q ss_pred ceeeEeEEEecC-ceEEEEEecCCCChhhhhccCCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 014585 133 LVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKIALGAAKGLAFLHEEAERPV 196 (422)
Q Consensus 133 iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~qi~~al~~LH~~~~~~i 196 (422)
|+++++++...+ ..++||||+++++|.+++...... +++..++.++.||+.||.|||+.+ |
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 999999988755 489999999999999999654332 889999999999999999999998 9
Q ss_pred EeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCC
Q 014585 197 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 275 (422)
Q Consensus 197 iHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~ 275 (422)
+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987655443333444678999999999999999999999999999999998 999
Q ss_pred CCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 276 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 276 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
||........ ...... ... ... .+...+..+.+++.+||+.||.+||++.+++++|+.+
T Consensus 250 p~~~~~~~~~--~~~~~~----~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 250 PYPGVKIDEE--FCRRLK----EGT------RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SSTTCCCSHH--HHHHHH----HTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccchhHH--HHHHhc----cCc------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9976543211 111110 000 000 1112346889999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=375.46 Aligned_cols=264 Identities=23% Similarity=0.267 Sum_probs=198.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++++.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 4789999999999999999999876 78899999997542 223456889999999999999999999997
Q ss_pred ecC------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
..+ ..||||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 653 56999999965 57666632 4899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 293 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-- 293 (422)
|+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+....
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998754322 2334689999999999999999999999999999999999999998654221111100000
Q ss_pred --------------hhhhcc-----cccccccCcccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 --------------PHLGER-----RRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 --------------~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... ..+...+...+. .......+.++.+||.+||..||.+|||+.|++++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000001100000 00111236789999999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=358.59 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=207.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccCCCcceeeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++++.||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 4579999999999999999999876 7889999999754332 356799999999999999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC----C
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 213 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~----~ 213 (422)
+++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999999999999954 457899999999999999999999998 99999999999999888 7
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~ 231 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANIT 231 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence 99999999987654322 234579999999999999999999999999999999999999997543211 111000
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ..++... ...+..+.+||.+||..||.+||++.+++++
T Consensus 232 ---~~~~----~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 ---SVSY----DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---TTCC----CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---hccc----ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0000000 1234678999999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.08 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=210.8
Q ss_pred cccchhHHHHHhcCCCCC-CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhccc-
Q 014585 53 RKFTFNDLKLATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL- 128 (422)
Q Consensus 53 ~~~~~~~~~~~~~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l- 128 (422)
.+..+.......++|.+. +.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.++..+
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~ 86 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc
Confidence 445556666777888888 899999999999999876 68899999987543 23356789999999999
Q ss_pred CCCcceeeEeEEEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 014585 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 129 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nil 207 (422)
.||||+++++++...+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl 163 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNIL 163 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEE
Confidence 5699999999999999999999999999999998643 467999999999999999999999998 999999999999
Q ss_pred EcC---CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC
Q 014585 208 LDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 284 (422)
Q Consensus 208 l~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 284 (422)
++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 987 78999999999987643321 233579999999999999999999999999999999999999997643211
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ...... ... ..........+..+.+||.+||+.||.+||++.+++++
T Consensus 241 ~---~~~i~~---~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 241 T---YLNISQ---VNV--------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp H---HHHHHH---TCC--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred H---HHHHHh---ccc--------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1 100000 000 00111112345788999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=362.00 Aligned_cols=264 Identities=24% Similarity=0.406 Sum_probs=205.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...+|++.+.||+|+||.||+|.+...+. ..+..||||++...... ....+.+|+.++++++||||+++++++.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 34678889999999999999998865321 13456999999765432 3456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999999999777778999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 222 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 222 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ....... ..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~----~~ 266 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAIN----DG 266 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TT
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----CC
Confidence 9876433221 11222456889999999999999999999999999999999 99999754321 1111111 10
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.. ...+..++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 267 ~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 FR----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CC----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred Cc----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 0011234578999999999999999999999999987653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=355.79 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=202.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++....... .+.+.+|+.++++++||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 689999999999999999999876 68899999986654322 3567899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 999999999999988888774 4457999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh------
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH------ 295 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------ 295 (422)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 87643222 1234578999999999876 67899999999999999999999999765432221111110000
Q ss_pred --hhccccc--ccccCcccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 --LGERRRF--YRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 --~~~~~~~--~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.....+ ..+.++..... .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00001000000 001235678999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.01 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=206.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||.||+|.+.. ++..||+|++........+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4679999999999999999999876 6778999999876556677899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE---cCCCCeEEeecc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFG 220 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill---~~~~~~kl~DFG 220 (422)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999999999999988554 46999999999999999999999998 9999999999999 788999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++........ .....||+.|+|||++.+. ++.++|||||||++|+|++|..||....... ...... ....
T Consensus 155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~---~~~~ 224 (277)
T 3f3z_A 155 LAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKIR---EGTF 224 (277)
T ss_dssp TCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HCCC
T ss_pred cceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---hCCC
Confidence 9987644322 2335799999999988654 8999999999999999999999997643211 111000 0000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+ ..... ...+..+.+|+.+||+.||.+||++.+++++
T Consensus 225 ~~----~~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 TF----PEKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CC----CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CC----Cchhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 0134688999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.05 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=187.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 579999999999999999999866 678999999964321 22467889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 999999999999999999999776678999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ .
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~----- 225 (278)
T 3cok_A 159 ATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------V----- 225 (278)
T ss_dssp CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------C-----
T ss_pred eeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------h-----
Confidence 9875432221 22357899999999999989999999999999999999999999764432111000 0
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+.. .+...+.++.+|+.+||+.||.+||++.+++++
T Consensus 226 ---~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 226 ---LADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---SSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---hcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00000 111234688999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=380.78 Aligned_cols=255 Identities=31% Similarity=0.417 Sum_probs=210.2
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
..++|++.++||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+|+.++|||||+++++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 45679999999999999999999876 78899999996432 1234568899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+.+.+..+|||||++||+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999986543 35999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||+++....... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... ...
T Consensus 330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~ 404 (576)
T 2acx_A 330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEV 404 (576)
T ss_dssp CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHC
T ss_pred cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcc
Confidence 999987654322 234589999999999999999999999999999999999999998654332211111110 000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
. ..++...+.++.+||.+||+.||.+|| ++.|++++
T Consensus 405 --------~----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --------P----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------c----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 111223457899999999999999999 67888764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=358.88 Aligned_cols=269 Identities=29% Similarity=0.393 Sum_probs=210.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.... ..+|+.||||++..... .....+.+|+.++++++|+||+++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTS-----SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEcccc-----CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 356899999999999999999854321 12788999999975432 345678999999999999999999999987
Q ss_pred c--CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 143 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 143 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
. ...++||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence 6 6689999999999999999776678999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------CCCcchhHHh
Q 014585 221 LAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR--------PNGEHNLVEW 291 (422)
Q Consensus 221 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~--------~~~~~~~~~~ 291 (422)
++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+.... +.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 99876544322 22334568889999999999999999999999999999999999864321 0000000000
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
..... ........+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 252 ~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 252 LVNTL----------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHH----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 00000 01111112234457899999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.25 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=197.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccC--CCcceeeEeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV--HLNLVKLIGY 139 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~ 139 (422)
..+|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|+++. |+||++++++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 356999999999999999999864 367899999976543 23467899999999996 5999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+...+..+|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+||
T Consensus 125 ~~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 125 EITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp EECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCC
T ss_pred EecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEec
Confidence 999999999999 5588999999654 47899999999999999999999988 99999999999995 589999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccC-----------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----- 273 (390)
T 2zmd_A 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----- 273 (390)
T ss_dssp SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----
T ss_pred CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----
Confidence 99987654433333445689999999999865 46899999999999999999999999753211
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... .++++.....++...+.++.+||.+||+.||.+||++.+++++
T Consensus 274 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111 1111111111111224678999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=379.16 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=212.6
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEe
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
.+.+..++|++.+.||+|+||.||+|.+. .+..||||++.... ...+.+.+|+.+|++++||||+++++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~ 250 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 250 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 34456678999999999999999999874 35679999997654 45678999999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
++. .+..+|||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEEC
T ss_pred EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEe
Confidence 986 66789999999999999999644 236889999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||+++...... ........+++.|+|||++....++.++|||||||++|||++ |..||...... .......
T Consensus 327 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~--- 399 (454)
T 1qcf_A 327 DFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE--- 399 (454)
T ss_dssp STTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH---
T ss_pred eCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---
Confidence 999998754321 111223456789999999998999999999999999999999 99999764321 1111111
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
... ... .+..++.++.+||.+||..||.+||++.+|++.|+.+..
T Consensus 400 -~~~---~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 400 -RGY---RMP-------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -HTC---CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -cCC---CCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 000 010 112345789999999999999999999999999988754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=364.27 Aligned_cols=266 Identities=25% Similarity=0.372 Sum_probs=213.3
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
...++|++.+.||+|+||.||+|.+...+.. ..+..||+|.+..... ...+.+.+|+.+++++ +||||++++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKE----DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSS----CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcc----cchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3457899999999999999999998653221 1345899999976543 2345689999999999 89999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
+...+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 99999999999999999999998643 345899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 014585 207 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 285 (422)
Q Consensus 207 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 285 (422)
|++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999986544333333344567889999999999999999999999999999998 9999976533211
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
........ .. ...+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 276 --~~~~~~~~----------~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 --FYKLVKDG----------YQ----MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --HHHHHHHT----------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHhcC----------CC----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111100 00 001112346889999999999999999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=363.56 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=204.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458899999999999999999866 7889999999765432 2356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.++..++||||+. |+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999996 6888888666678999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+...... ....||+.|+|||++. ...++.++|||||||++|||++|..||....... ... .....
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~---~~~~~ 268 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY---HIAQN 268 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHHS
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHH---HHHhc
Confidence 9875432 2357999999999984 5678999999999999999999999997543211 110 00000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
. .+.. .....+..+.+||.+||+.||.+||++.+++++.
T Consensus 269 ~-------~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 269 E-------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp C-------CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred C-------CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0 0000 0112346789999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=352.85 Aligned_cols=262 Identities=26% Similarity=0.293 Sum_probs=201.3
Q ss_pred cCCCCC-CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 65 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
++|++. ++||+|+||.||+|.+.. +|+.||||++..........+.+|+.++.++ .||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 578885 789999999999998765 6789999999876656677899999999985 79999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC---eEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~---~kl~DF 219 (422)
.+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred CCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 99999999999999999999654 46899999999999999999999998 999999999999988776 999999
Q ss_pred cCcccCCCCCc-----cceeeccccCccccCCCcccC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 220 GLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 220 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
|++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99876532211 111223569999999999875 56889999999999999999999999865433211000
Q ss_pred --------HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 290 --------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 290 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........... ..... ... ...+..+.+||.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~i~~~~--~~~~~-~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGK--YEFPD-KDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp --CCHHHHHHHHHHHHHCC--CCCCH-HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhHHHHHHHHHhccC--cccCc-hhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000000 00000 000 0134688999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=352.69 Aligned_cols=260 Identities=26% Similarity=0.363 Sum_probs=207.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||.||+|.+..... ++..||||.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKG------EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTC------CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCC------CcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 34689999999999999999998765321 456799999976532 33567899999999999999999999976
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+ +..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence 4 5678999999999999999776677999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+......... ......|++.|+|||++.+..++.++|||||||++|+|++ |..||........ ...... ..
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~----~~ 231 (281)
T 3cc6_A 160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEK----GD 231 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHH----TC
T ss_pred Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhc----CC
Confidence 9876443221 1233457889999999998999999999999999999998 9999975433221 111110 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. .. .+..++..+.+++.+||..||.+||++.++++.|+.+
T Consensus 232 ~------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 R------LP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp C------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------CC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0 00 1112346789999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=348.74 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=205.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+ .|..||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-----------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-----------CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 46799999999999999999987 466899999976543 23456899999999999999999999998
Q ss_pred ec--CceEEEEEecCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 142 ED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 142 ~~--~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+. +..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEe
Confidence 87 788999999999999999976543 5899999999999999999999865 4599999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCc---hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|..||........ .. ..
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~---~~ 223 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---GM---KV 223 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---HH---HH
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---HH---HH
Confidence 988765322 2246899999999998765544 89999999999999999999975432111 00 00
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
... ...+ .++...+..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 224 ~~~------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 224 ALE------GLRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHS------CCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred Hhc------CCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 000 0111 112234578999999999999999999999999997654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.89 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=202.5
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC-----CcccHHHHHHHHHHhcccCCCcce
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGDLVHLNLV 134 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv 134 (422)
+....++|++.+.||+|+||.||+|.+.. ++..||+|++... .....+.+.+|+.++++++||||+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 34456789999999999999999999876 7789999998643 223456789999999999999999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccC---------------------------------------CCCCCHHHHH
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------------SLPLPWSIRM 175 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~ 175 (422)
++++++.+.+..++||||+++|+|.+++... ...+++..++
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 9999999999999999999999999988421 1124677888
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC--CeEEeeccCcccCCCCCc--cceeeccccCccccCCCcccC
Q 014585 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT 251 (422)
Q Consensus 176 ~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 251 (422)
.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 99999999999999998 99999999999998776 899999999986432211 112234679999999999875
Q ss_pred --CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHc
Q 014585 252 --GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 329 (422)
Q Consensus 252 --~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 329 (422)
..++.++|||||||++|||++|..||........ .. ........ ...+. ....+.++.+||.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~~~~~~~~---~~~~~-----~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT---IS---QVLNKKLC---FENPN-----YNVLSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHCCCC---TTSGG-----GGGSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH---HH---HHHhcccc---cCCcc-----cccCCHHHHHHHHHH
Confidence 6889999999999999999999999976432111 11 11111000 00010 012346889999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 014585 330 LSRDPKARPLMSEVVEA 346 (422)
Q Consensus 330 l~~dp~~Rps~~ell~~ 346 (422)
|+.||.+||++.+++++
T Consensus 315 l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 315 LNRNVDERFDAMRALQH 331 (345)
T ss_dssp SCSCTTTSCCHHHHHHS
T ss_pred cCCChhHCCCHHHHhcC
Confidence 99999999999999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=374.34 Aligned_cols=264 Identities=22% Similarity=0.235 Sum_probs=211.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC-CcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||.||+|.+.. +|+.||||++...... ..+.+|+.+++.|.| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4689999999999999999999876 6789999998755432 457899999999977 556666667777
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE---cCCCCeEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill---~~~~~~kl~DF 219 (422)
.+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeC
Confidence 88889999999 99999999766778999999999999999999999998 9999999999999 68899999999
Q ss_pred cCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 220 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 220 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.................
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 999876543321 112256799999999999999999999999999999999999999987654433222221111
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.... ..... +.. .++.++.+|+..||+.||.+||++.+|++.|+.+..
T Consensus 231 ~~~~-~~~~~-----l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 231 KKVA-TSIEA-----LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHH-SCHHH-----HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cccc-ccHHH-----Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1000 00000 001 224689999999999999999999999999876644
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=350.59 Aligned_cols=263 Identities=21% Similarity=0.231 Sum_probs=210.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEE-Ee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-IE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+|+.+++.+.|++++..+.++ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 4689999999999999999999866 788999999876543 24688999999999988876666555 55
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE---cCCCCeEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill---~~~~~~kl~DF 219 (422)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 67789999999 99999999766778999999999999999999999998 9999999999999 48899999999
Q ss_pred cCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 220 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 220 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 999876543321 112346799999999999999999999999999999999999999987554333222221111
Q ss_pred -hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 295 -HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 295 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
..... .+.+. ...+.++.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 233 ~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 233 KKMSTP-------IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHSC-------HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cccCCc-------hHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 00000 00001 1234688999999999999999999999999986644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=349.04 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=210.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred chhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3468999999999999999999875 356899999986543 34679999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999999999777778999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
....... ........|+..|+|||++.+..++.++||||||+++|+|++ |..||....... ...... ...
T Consensus 152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~----~~~- 222 (267)
T 3t9t_A 152 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIS----TGF- 222 (267)
T ss_dssp GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH----TTC-
T ss_pred ccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHh----cCC-
Confidence 8653321 111223457889999999998999999999999999999999 899997543211 111110 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... .+...+..+.+++.+||+.||.+||++.+++++|+.+
T Consensus 223 --~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 223 --RLY-------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCC-------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 1112346889999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.40 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=203.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.++++++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 4679999999999999999999876 677999999864321 2245688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999999999998554 46999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........ ..... ..
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~---~~-- 222 (279)
T 3fdn_A 155 WSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRIS---RV-- 222 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHH---HT--
T ss_pred ccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHHHH---hC--
Confidence 986643322 2345789999999999999999999999999999999999999975432111 11000 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .++...+..+.+|+.+||+.||.+||++.+++++
T Consensus 223 ------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 ------EF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ------CC----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ------CC----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 1111234678999999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=360.23 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=204.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHhcccCCCccee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVK 135 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~ 135 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.++++++||||++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 93 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred ccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence 4689999999999999999999876 7889999999765421 2235778999999999999999
Q ss_pred eEeEEEecCceEEEEEecCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 136 LIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
+++++.+.+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 169 (335)
T 3dls_A 94 VLDIFENQGFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTI 169 (335)
T ss_dssp EEEEEECSSEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcE
Confidence 999999999999999999776 9999884 4457999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 170 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------- 236 (335)
T 3dls_A 170 KLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------- 236 (335)
T ss_dssp EECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------
T ss_pred EEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------
Confidence 9999999987654332 233579999999999988877 88999999999999999999999642110
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .... .+...+.++.+||.+||+.||.+||++.+++++
T Consensus 237 --~~------~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --VE------AAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TT------TCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --Hh------hccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000 011134688999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=351.24 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=199.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||+|+||.||+|.+.. +|..||+|++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 579999999999999999999876 678999999875432 3457789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE---cCCCCeEEe
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLS 217 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill---~~~~~~kl~ 217 (422)
+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence 9999999999999999988542 467999999999999999999999998 9999999999999 556889999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||..............
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------ 239 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------ 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------
Confidence 999998654322 223457999999999875 5789999999999999999999999976432111100000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... .. ... ..+..+.+|+.+||+.||.+||++.|++++
T Consensus 240 ~~~~~-~~----~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 KEPNY-AV----ECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC-CC------C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCccc-cc----ccC----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 000 124678899999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=378.63 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=211.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.++||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4689999999999999999999876 788999999965322 2345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
...+..|+||||++||+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence 9999999999999999999988653 346999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ........
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~ 407 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLE 407 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHH
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhh
Confidence 9999987654322 1234689999999999999999999999999999999999999998654322111 11111111
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhCCCCCCCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE-VVEALKPLPNLKDM 356 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e-ll~~L~~~~~~~~~ 356 (422)
... .++...+..+.+||.+||+.||.+||++.+ -.+.+..++++...
T Consensus 408 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 408 QAV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ccc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 110 112234578899999999999999997633 12233344554443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.66 Aligned_cols=270 Identities=23% Similarity=0.345 Sum_probs=203.0
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcc--cCCCcce
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLV 134 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv 134 (422)
........++|++.+.||+|+||.||+|.+ +|+.||||++... ....+..|..++.. ++|+||+
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~ 94 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENIL 94 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCee
Confidence 333344567899999999999999999987 4678999998643 22344555555554 4999999
Q ss_pred eeEeEEEec----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEeccCC
Q 014585 135 KLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE--------AERPVIYRDFK 202 (422)
Q Consensus 135 ~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~~~~iiHrDlk 202 (422)
++++++... ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+|||||
T Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dik 169 (337)
T 3mdy_A 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLK 169 (337)
T ss_dssp CEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCC
T ss_pred eEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccc
Confidence 999999887 6889999999999999999543 589999999999999999999988 6 9999999
Q ss_pred CCcEEEcCCCCeEEeeccCcccCCCCCccc--eeeccccCccccCCCcccCCCCCch------hhhhhHHHHHHHHHhC-
Q 014585 203 TSNILLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSR------SDVYSFGVVLLEMLTG- 273 (422)
Q Consensus 203 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg- 273 (422)
|+|||++.++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 999999999999999999997654332211 1124579999999999987766654 9999999999999999
Q ss_pred ---------CCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014585 274 ---------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343 (422)
Q Consensus 274 ---------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el 343 (422)
..||............. ...... ....+.+... ....++.++.+|+.+||+.||.+||++.++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDPSYEDM--REIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHH--HHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CcccccccccccHhhhcCCCCchhhh--HHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 55655433322111100 000000 0011111111 112678889999999999999999999999
Q ss_pred HHHhCCCCC
Q 014585 344 VEALKPLPN 352 (422)
Q Consensus 344 l~~L~~~~~ 352 (422)
+++|+.+..
T Consensus 323 l~~L~~l~~ 331 (337)
T 3mdy_A 323 KKTLAKMSE 331 (337)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999986544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=352.49 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=205.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|++.++||+|+||+||+|.+..... .+..||+|.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 4679999999999999999998765322 445789999876433 234678899999999999999999998654
Q ss_pred -cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccc
Confidence 56789999999999999999777778999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcc--ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||............ .. .
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---~~---~ 248 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQ---G 248 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH---HT---T
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---hc---C
Confidence 9876433211 12233567889999999999999999999999999999999 55666554332211111 00 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ... .+...+..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 249 ~----~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 249 R----RLL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C----CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000 1112346799999999999999999999999998765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=360.30 Aligned_cols=266 Identities=22% Similarity=0.319 Sum_probs=199.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++....... ...+.+|+.++++++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 579999999999999999999876 67899999997543222 12456899999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||++ |+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999996 5999999777778999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...... .....+
T Consensus 149 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~ 225 (324)
T 3mtl_A 149 AKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT-PTEETW 225 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTS
T ss_pred cccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChHhc
Confidence 6543221 2233578999999999876 67899999999999999999999999765432211111100000 000000
Q ss_pred cccc---------CcccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLI---------DPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~---------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... .+.... ......+.++.+||.+||+.||.+|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 000000 0011234678999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=350.27 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=209.6
Q ss_pred hcCCCCCC-ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|.+.+ .||+|+||.||+|.+... .++..||||++..... ...+.+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 35676776 999999999999987532 1567899999976533 3356789999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence 566799999999999999999777777999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 222 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 222 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~----~~ 229 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----QG 229 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHH----TT
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHh----cC
Confidence 9876443322 11223457899999999998899999999999999999998 999997654321 111111 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ...++..++..+.+++.+||..||.+||++.+++++|+.+
T Consensus 230 ~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 230 K----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0111223457899999999999999999999999998755
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=357.72 Aligned_cols=271 Identities=18% Similarity=0.206 Sum_probs=202.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-----------HHHHHHHHHHhcccCCCc
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGDLVHLN 132 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~n 132 (422)
.++|++.+.||+|+||.||+|.+...+. ++..||||++....... ...+.+|+.+++.+.|+|
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 4689999999999999999999875322 46689999997654221 123668889999999999
Q ss_pred ceeeEeEEEe----cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 133 LVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 133 iv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
|+++++++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 184 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence 9999999988 67889999999 999999996554 7999999999999999999999998 9999999999999
Q ss_pred cCCC--CeEEeeccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 014585 209 DADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281 (422)
Q Consensus 209 ~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 281 (422)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8887 9999999999865332111 11134579999999999999999999999999999999999999996432
Q ss_pred CCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
.... ........... .+...+..... ....+.++.+++.+||..||.+||++.+|++.|+.+..
T Consensus 265 ~~~~--~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPV--AVQTAKTNLLD--ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHH--HHHHHHHHHHH--TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccH--HHHHHHHhhcc--cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 2111 01100000000 00000000000 00234689999999999999999999999999987644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.38 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=195.7
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHhcccCCCcc
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNL 133 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni 133 (422)
...++|.+.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 456789999999999999999999876 788999999865321 112347899999999999999
Q ss_pred eeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC--
Q 014585 134 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-- 211 (422)
Q Consensus 134 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-- 211 (422)
+++++++. .+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 99999975 5568999999999999998854 457999999999999999999999998 9999999999999654
Q ss_pred -CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 212 -YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 212 -~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
+.+||+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-- 352 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-- 352 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence 459999999998764322 2334679999999999863 6788999999999999999999999976433221
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........ .. .. .+.... ..+..+.+||.+||+.||.+||++.+++++
T Consensus 353 ~~~~i~~~---~~---~~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 353 LKDQITSG---KY---NF-IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHHHTT---CC---CC-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcC---CC---CC-Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111000 00 00 000000 134688999999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=351.53 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=206.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..|.+.++||+|+||+||+|.+..... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eEEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 356677999999999999999765322 445799999976443 2346788999999999999999999999876
Q ss_pred Cce-EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+.. ++||||+.+|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 655 9999999999999999777778999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCc--cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCC-CCCCCCcchhHHhhhhhhhcc
Q 014585 223 KDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD-KNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 223 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~-~~~~~~~~~~~~~~~~~~~~~ 299 (422)
+....... ........|++.|+|||.+.+..++.++|||||||++|+|++|..||. ...... ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~---- 244 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQG---- 244 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTT----
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcC----
Confidence 86543221 112233567899999999999999999999999999999999665543 322211 11111100
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 245 ~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 245 R----------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0001112346899999999999999999999999998765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.21 Aligned_cols=201 Identities=28% Similarity=0.385 Sum_probs=168.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|++++|+||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 4689999999999999999999876 788999999975432 23467899999999999999999999998
Q ss_pred ec-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 142 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 142 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
.. ...|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 76 57899999995 699999854 457999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCcc--------------------ceeeccccCccccCCCcc-cCCCCCchhhhhhHHHHHHHHHhCCC
Q 014585 217 SDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRR 275 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~ 275 (422)
+|||+++........ ......+||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876433211 112457899999999986 46679999999999999999998655
Q ss_pred CCC
Q 014585 276 SMD 278 (422)
Q Consensus 276 pf~ 278 (422)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.49 Aligned_cols=266 Identities=21% Similarity=0.281 Sum_probs=195.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||+||+|.+.. +|+.||||++....... ...+.+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3579999999999999999999876 78899999997554322 345789999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc-----CCCCeEE
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKL 216 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~-----~~~~~kl 216 (422)
+++..++||||++ |+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999996 5999998554 46999999999999999999999998 99999999999994 4556999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.... .
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~ 255 (329)
T 3gbz_A 179 GDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-G 255 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-C
T ss_pred CcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-C
Confidence 99999986532211 22335789999999999874 58999999999999999999999997653221111110000 0
Q ss_pred hhcccc---------c----ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGERRR---------F----YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~~~~---------~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... + .......+...+....+.++.+||.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000 0 00000000000011134788999999999999999999999973
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=348.46 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=207.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEE-E
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-I 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~ 141 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+|+.+++.+.|++++..+..+ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 34789999999999999999999866 7889999987654322 3578999999999988877666655 5
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE---cCCCCeEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill---~~~~~~kl~D 218 (422)
..+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEec
Confidence 677789999999 99999999766778999999999999999999999998 9999999999999 7889999999
Q ss_pred ccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 219 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 219 FG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 9999876443221 12234679999999999999999999999999999999999999998765443322222111
Q ss_pred h-hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 294 P-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 294 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. ..... .+.... ..+.++.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~-------~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 232 EKKMSTP-------IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHHSC-------HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cccccch-------hhhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 1 10000 000001 124689999999999999999999999999986644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=348.50 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=206.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+.. +|..||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4689999999999999999999876 678999999965432 23456889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC---eEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~---~kl~D 218 (422)
..+..++||||+++++|.+.+... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence 999999999999999999888554 46999999999999999999999998 999999999999976655 99999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... .
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~---~ 222 (284)
T 3kk8_A 152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKA---G 222 (284)
T ss_dssp CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH---T
T ss_pred ceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHHHHh---c
Confidence 999987644322 233579999999999999999999999999999999999999997543211 1111100 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ....+ . ....+.++.+|+.+||+.||.+||++.+++++
T Consensus 223 ~~---~~~~~-~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 223 AY---DYPSP-E----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CC---CCCTT-T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cc---cCCch-h----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 00000 0 11234678999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=356.34 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=207.2
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 45789999999999999999999866 678999999976655556778999999999999999999999873
Q ss_pred ----cCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 143 ----DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 143 ----~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
....++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEE
Confidence 3477899999999999998865 3567999999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccc-------eeeccccCccccCCCcccCCC---CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 014585 216 LSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 285 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 285 (422)
|+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 254 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence 99999987643211100 011245799999999987654 68899999999999999999999953211100
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. ..... .... .. ......+..+.+||.+||+.||.+||++.+++++|+.+..
T Consensus 255 ~-~~~~~----~~~~---~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 255 S-VALAV----QNQL---SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C-HHHHH----HCC-----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-hhHHh----hccC---CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 00000 0000 00 0111234689999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.89 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=204.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcE--EEEEEecCCC-cccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
++|++.+.||+|+||.||+|.+.. +|.. ||||.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 689999999999999999999876 5554 4999987532 23345689999999999 999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 99999999999999999999996543 46999999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 284 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 284 (422)
||++.++.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 99999999999999999753221 11223457889999999998899999999999999999998 999997643211
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.... +... . ....+...+..+.+|+.+||..||.+||++.+++++|+.+.
T Consensus 250 ---~~~~----~~~~------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 250 ---LYEK----LPQG------Y----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp ---HHHH----GGGT------C----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHH----hhcC------C----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111 0000 0 00112234578999999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=362.85 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=198.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
..|++.++||+|+||.||+|.+..... .+..||||.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 457778899999999999998764221 345789999875432 345679999999999999999999998765
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence 56789999999999999999777777999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcc--ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 223 KDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 223 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
+........ .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+ . ..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~----~~ 312 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---L----QG 312 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---H----TT
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---H----cC
Confidence 865432211 11233467889999999999999999999999999999999 67777655433221111 1 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. .... +..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 313 ~---~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 313 R---RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp C---CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0011 112346899999999999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=358.71 Aligned_cols=266 Identities=25% Similarity=0.318 Sum_probs=201.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-----HHHHHHHHHHhcccCCCcceeeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+.++++++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 45789999999999999999998866 68899999997543221 24688999999999999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+++.+.+..++||||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999965 899988777777999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........ ........
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~ 229 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETL 229 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHH
T ss_pred ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHc
Confidence 9999987643222 2234578999999999875 4589999999999999999999999976532211 11111000
Q ss_pred hc-----ccccccccCc---ccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GE-----RRRFYRLIDP---RLEGH-----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~-----~~~~~~~~~~---~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ........+. ..... .....+.++.+||.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000000000 00000 012235789999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=351.87 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=204.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++..........+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 4679999999999999999999876 6789999999866544556788999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE---cCCCCeEEeecc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFG 220 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill---~~~~~~kl~DFG 220 (422)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999999999988554 46899999999999999999999998 9999999999999 788999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~---~~~~ 224 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIK---EGYY 224 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH---HCCC
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---cCCC
Confidence 997643321 22356899999999999999999999999999999999999999754321 1111110 0000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ....+....+.++.+||.+||..||.+||++.+++++
T Consensus 225 ---~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 ---E-----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---C-----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---C-----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0111112345789999999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=356.52 Aligned_cols=267 Identities=26% Similarity=0.388 Sum_probs=202.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++.+.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 589999999999999999999876 68899999986554332 3457899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence 99999999999998888776 44457999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 293 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------- 293 (422)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 76543221 22335789999999999875 78999999999999999999999997654321111110000
Q ss_pred hhhhcccccccccCcccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+.....+.....+.+.... ....+..+.+||.+||+.||.+||++.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000001111111111 11335789999999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=357.38 Aligned_cols=269 Identities=24% Similarity=0.308 Sum_probs=204.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.+|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 689999999999999999999876 7889999998654332 24568899999999999999999999987
Q ss_pred --------cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 143 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 143 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
.+..++||||++ ++|.+.+......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp C--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred cccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 346899999996 4888888777678999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCc--cceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 215 KLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999987543221 122234678999999999876 5689999999999999999999999986543221111111
Q ss_pred hhhhhhc-----c--cccccccCcccCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 ARPHLGE-----R--RRFYRLIDPRLEGHFSI-------KGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 ~~~~~~~-----~--~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....... . ......+.......... ..+..+.+||.+||+.||.+||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1000000 0 00000000000000000 013568899999999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.91 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=191.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 141 (422)
...+|++.++||+|+||.||+|.+.. +|+.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 44689999999999999999999876 67899999997665555677899999999996 999999999995
Q ss_pred e--------cCceEEEEEecCCCChhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 142 E--------DDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 142 ~--------~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
. ....++||||++ |+|.+++.. ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTT
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCC
Confidence 3 334789999995 799988854 3557999999999999999999999875 459999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccc----------eeeccccCccccCCCcc---cCCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 014585 212 YNAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMD 278 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~ 278 (422)
+.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998764432211 11135689999999998 56778999999999999999999999997
Q ss_pred CCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 279 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
....... .. ... .. .. ....+..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 255 ~~~~~~~---~~-------~~~---~~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 255 DGAKLRI---VN-------GKY---SI---PP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------------C---CC---CT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhHHHh---hc-------Ccc---cC---Cc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5432110 00 000 00 00 01112457899999999999999999999999976644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.18 Aligned_cols=273 Identities=31% Similarity=0.422 Sum_probs=208.6
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec-
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 143 (422)
.|++++.||+|+||+||++.+... ...+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPT-----NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSC-----C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHhhhheecCCCCeEEEEEEEccC-----CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 349999999999999999876432 223788999999986543 2345689999999999999999999999884
Q ss_pred -CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
...++||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence 5678999999999999999654 4899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 223 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 223 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
......... .......||..|+|||++.+..++.++|||||||++|+|++|..||........ ....+..... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~ 259 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM-TVLR 259 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH-HHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch-hHHH
Confidence 876544322 223345688899999999999999999999999999999999999864311000 0000000000 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
+...+........+..++.++.+||.+||+.||.+||++.++++.|+.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0111111111122234457899999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=358.15 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=203.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.... ...++..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 468999999999999999999854311 112678999999975432 334568899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 213 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~ 213 (422)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 999999999999999999997543 45899999999999999999999998 999999999999984 446
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH
Confidence 99999999975433332223334568999999999999999999999999999999998 99999754321 111111
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. .. .. ..+..++..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 259 ~~----~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TS----GG------RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HT----TC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hc----CC------CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 00 00 01123356889999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=363.21 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=205.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||.||+|.+.. +|..||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 35689999999999999999999876 6789999999765332 3456899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECC
Confidence 999999999999999999999554 4699999999999999999999985 7 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh-h---
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-L--- 296 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~--- 296 (422)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.................. .
T Consensus 178 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 178 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp CCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred CCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 98653211 123357999999999999999999999999999999999999999764321110000000000 0
Q ss_pred ------------------hcccc----cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 ------------------GERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ------------------~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... ...+.............+.++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000 000000000000111235689999999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=351.24 Aligned_cols=259 Identities=27% Similarity=0.376 Sum_probs=205.7
Q ss_pred HhcCCCCCC-ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 63 ATRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
..++|++.+ .||+|+||.||+|.+... .+++.||||++...... ..+++.+|+.+++.++||||++++++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 346788888 999999999999976432 15678999999765432 24678999999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+ ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 8 667889999999999999999654 46999999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 220 GLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 220 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|++.......... ......|++.|+|||++.+..++.++|||||||++|+|++ |..||....... ......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~---- 234 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE---- 234 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----
Confidence 9998765433221 1222456789999999998889999999999999999999 999997643211 111110
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... ...++..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 235 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 235 KGE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 0111223457899999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=350.99 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=199.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..+|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++++++|+||+++++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3579999999999999999999876 678999999975432 2345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEE
Confidence 999999999999999999998854 3567999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 179 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~---- 251 (310)
T 2wqm_A 179 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE---- 251 (310)
T ss_dssp CC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHH----
T ss_pred eccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhh----
Confidence 9999986543221 12335789999999999999999999999999999999999999975432111 1111000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
. ..+ .+.. ....+.++.+|+.+||..||.+||++.++++.|+.+..
T Consensus 252 ~-~~~----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 252 Q-CDY----PPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp T-TCS----CCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-ccC----CCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0 000 0000 11234689999999999999999999999999976644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=351.13 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=202.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++... ..+.+.+|+.+++++. |+||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 3689999999999999999999876 6789999999743 3467899999999997 9999999999988
Q ss_pred --cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEEeec
Q 014585 143 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 219 (422)
Q Consensus 143 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl~DF 219 (422)
....++||||+++++|.+++. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 667899999999999999884 3889999999999999999999998 99999999999999776 8999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
|+++....... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...........
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~ 250 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGT 250 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCC
Confidence 99987644332 233578999999999887 6789999999999999999999999964432111 00000000000
Q ss_pred --------------------------ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 --------------------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 --------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+..... .......+.++.+||.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH----SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC----TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhcc----ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000111 11111245789999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=370.71 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=206.8
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+.+..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++++||||++++++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34456789999999999999999998853 3579999997654 345689999999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
+.+ +..+|||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECC
Confidence 865 7789999999999999999653 356899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 324 fG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~---- 395 (452)
T 1fmk_A 324 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVE---- 395 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----
T ss_pred CccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----
Confidence 999987643221 12223457889999999999999999999999999999999 999997543211 111110
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
... . ...+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 396 ~~~---~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 396 RGY---R-------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp TTC---C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cCC---C-------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 000 0 01122345789999999999999999999999999987754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=346.99 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=203.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccCCCcceeeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ..+.+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 3579999999999999999999876 6789999998754322 356799999999999999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC----C
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 213 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~----~ 213 (422)
+++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence 999999999999999999999999854 346999999999999999999999998 99999999999998877 8
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~ 224 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTNIS 224 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH
T ss_pred eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHHhH
Confidence 99999999987643321 233568999999999999999999999999999999999999997643211 111000
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... .+.... ...+..+.+|+.+||..||.+||++.+++++
T Consensus 225 ---~~~~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 225 ---AVNYD----FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---TTCCC----CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---hcccC----Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00000 000000 1224678999999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=357.24 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=206.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4689999999999999999999876 678999999875432 2345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 999999999999999999998854 347999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .......
T Consensus 187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~~~~ 258 (335)
T 2owb_A 187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYL---RIKKNEY 258 (335)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHHTCC
T ss_pred CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHhcCCC
Confidence 9987643222 1234579999999999999999999999999999999999999997543111 100 0000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ++...+..+.+||.+||+.||.+||++.+++++
T Consensus 259 --------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --------S----IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --------C----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --------C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 111234678899999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=359.77 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=198.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+++++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 3689999999999999999999876 7889999999654322 2456889999999999999999999998
Q ss_pred ecC------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
..+ ..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEE
Confidence 653 459999999 8899999865 46899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999875432 234578999999999887 7899999999999999999999999986543211111100000
Q ss_pred h--------hhc--c----cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 H--------LGE--R----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~--------~~~--~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. +.. . ..+.......+. ......+..+.+|+.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 000 0 000000001111 1112345789999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=348.05 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=209.3
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEe
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
++.+..++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.++++++||||+++++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEE
Confidence 34455678999999999999999999864 35679999997654 34577999999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
++. .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 76 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 76 VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp EEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred EEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEEC
Confidence 876 556899999999999999986432 36899999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .......
T Consensus 152 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~--- 224 (279)
T 1qpc_A 152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLE--- 224 (279)
T ss_dssp CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH---
T ss_pred CCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHh---
Confidence 9999987654322 12223457889999999998899999999999999999999 89999754321 1111110
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. ... ..+...+..+.+|+.+||..||.+||++.++++.|+.+
T Consensus 225 -~~------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 225 -RG------YRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -TT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cc------cCC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 00 000 11123357899999999999999999999999988754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=346.73 Aligned_cols=260 Identities=23% Similarity=0.267 Sum_probs=201.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+.++++++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 3689999999999999999999876 67899999997543322 35688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..++..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999999999998654 46999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++......... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... . .........
T Consensus 180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~---~~~~~~~~~ 251 (309)
T 2h34_A 180 IASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----V---MGAHINQAI 251 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----H---HHHHHHSCC
T ss_pred cCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----H---HHHHhccCC
Confidence 99775433211 223457899999999999999999999999999999999999999754211 1 011111100
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPN 352 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~~~ 352 (422)
... .......+.++.+|+.+||+.||.+|| ++.++++.|+.+..
T Consensus 252 ~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 252 PRP--------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CCG--------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CCc--------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 000 011123346789999999999999999 99999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=355.75 Aligned_cols=259 Identities=17% Similarity=0.172 Sum_probs=205.0
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC---CCcceee
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKL 136 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~ 136 (422)
+.+..++|.+.++||+|+||+||+|.+.... ...+++.||||++.... ..++..|+++++.+. |+||+++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3445678999999999999999999643211 11267899999997653 346667777777665 9999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC--
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-- 210 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-- 210 (422)
++++...+..+||||||++|+|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccc
Confidence 9999999999999999999999999964 3567999999999999999999999988 999999999999988
Q ss_pred ---------CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 014585 211 ---------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281 (422)
Q Consensus 211 ---------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 281 (422)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999976433233334455789999999999999999999999999999999999999986432
Q ss_pred CCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCC
Q 014585 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 350 (422)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~ 350 (422)
.... .....+.. + .....+.+++..||+.+|.+|+ ++.++.+.|+.+
T Consensus 290 ~~~~---------------~~~~~~~~-----~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 290 GGEC---------------KPEGLFRR-----L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp TTEE---------------EECSCCTT-----C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred CCce---------------eechhccc-----c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 2100 00001100 0 1245778999999999999995 778887777643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=350.50 Aligned_cols=253 Identities=31% Similarity=0.479 Sum_probs=197.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||.||+|.+ .++.||||++... ...+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 71 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-----------RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-- 71 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred HhHeeeeeEeecCCCceEEEEEE-----------CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 35789999999999999999987 4568999999654 33467899999999999999999999876
Q ss_pred CceEEEEEecCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC-eEEeecc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFG 220 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-~kl~DFG 220 (422)
+..++||||+++|+|.+++..... .+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 72 NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence 458999999999999999965432 4789999999999999999999933233999999999999998887 7999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... ..
T Consensus 152 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~--- 220 (307)
T 2eva_A 152 TACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NG--- 220 (307)
T ss_dssp C-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TT---
T ss_pred cccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cC---
Confidence 99765322 1234689999999999999999999999999999999999999975432211 0111000 00
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
..+... ...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 221 -----~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 221 -----TRPPLI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -----CCCCCB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -----CCCCcc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 001111 123467899999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=373.32 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=200.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++++.||+|+||+||+|.+.. ++..||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3579999999999999999999876 778999999976532 23467899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCCeEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~~kl~D 218 (422)
+.+..++|||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 999999999999999999988554 46999999999999999999999998 999999999999976 45599999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||........ ..... ..
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~---~~ 252 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LRKVE---KG 252 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---HT
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH---hC
Confidence 99998764332 223467999999999876 5699999999999999999999999976533211 11110 00
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .. +..... ..+..+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~---~~-~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KY---TF-DSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CC---CC-CSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CC---CC-Cchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00 00 111111 234688999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=364.00 Aligned_cols=265 Identities=20% Similarity=0.249 Sum_probs=206.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC--------CCcce
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--------HLNLV 134 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv 134 (422)
..++|++.++||+|+||+||+|.+.. +|+.||||++.... ...+.+.+|+.+++.+. |+||+
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 45789999999999999999998876 78899999997542 33466889999999985 78899
Q ss_pred eeEeEEE----ecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEE
Q 014585 135 KLIGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILL 208 (422)
Q Consensus 135 ~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill 208 (422)
++++++. .....++||||+ +++|.+.+... ...+++..++.++.||+.||.|||++ + |+||||||+||||
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll 180 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILL 180 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEE
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeE
Confidence 9999988 456789999999 66776666544 36799999999999999999999998 8 9999999999999
Q ss_pred cCCC-------------------------------------------------CeEEeeccCcccCCCCCccceeecccc
Q 014585 209 DADY-------------------------------------------------NAKLSDFGLAKDGPEGDKTHVSTRVMG 239 (422)
Q Consensus 209 ~~~~-------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~g 239 (422)
+.++ .+||+|||++...... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 8775 7999999999875432 233578
Q ss_pred CccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHH---hhhhhhhc------------------
Q 014585 240 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE---WARPHLGE------------------ 298 (422)
Q Consensus 240 t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~---~~~~~~~~------------------ 298 (422)
|+.|+|||++.+..++.++|||||||++|||++|..||............. ........
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 999999999999999999999999999999999999998665433221111 01000000
Q ss_pred ccccccccCccc---------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+..+.+... ...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000000 012356778899999999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=380.37 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=203.8
Q ss_pred CCCCCC-ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 66 NFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++.+.+ .||+|+||.||+|.+.... ++..||||+++.... ...+++.+|+++|++++|||||++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSS-------CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCC-------CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 334444 7999999999999876421 456799999976543 346789999999999999999999999875
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..+|||||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 6789999999999999999777777999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 224 DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 224 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...... ...
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~----~~~- 556 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE----QGK- 556 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHH----TTC-
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCC-
Confidence 76433221 11222346789999999999999999999999999999998 999998654321 111111 100
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
...++..++.++.+||.+||..||.+||++.+|++.|+.+
T Consensus 557 ---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0112223457899999999999999999999999988643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.20 Aligned_cols=242 Identities=18% Similarity=0.202 Sum_probs=191.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHH---HHhcccCCCcceeeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEV---NFLGDLVHLNLVKLI 137 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~niv~~~ 137 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+ +++++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4679999999999999999999865 68899999997432 23456788999 556666899999998
Q ss_pred -------eEEEecCc-----------------eEEEEEecCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHH
Q 014585 138 -------GYCIEDDQ-----------------RLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAF 187 (422)
Q Consensus 138 -------~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~ 187 (422)
+++...+. .+|||||+ +|+|.+++.... ..+++..++.|+.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 66665542 78999999 689999996532 123358888999999999999
Q ss_pred HHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-----------CCCc
Q 014585 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----------HLTS 256 (422)
Q Consensus 188 LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ 256 (422)
||+.+ |+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 99998 99999999999999999999999999986322 2334578 999999999877 8999
Q ss_pred hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCC
Q 014585 257 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 336 (422)
Q Consensus 257 ~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 336 (422)
++|||||||++|||++|..||...........+ ... .. ..+.++.+||.+||+.||.+
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~~--~~----~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FRS--CK----NIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GSS--CC----CCCHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hhh--cc----CCCHHHHHHHHHHcCCCchh
Confidence 999999999999999999999764432211110 000 01 22468899999999999999
Q ss_pred CCCHHHHHHH
Q 014585 337 RPLMSEVVEA 346 (422)
Q Consensus 337 Rps~~ell~~ 346 (422)
||++.+++++
T Consensus 351 Rpt~~e~l~h 360 (377)
T 3byv_A 351 RLLPLQAMET 360 (377)
T ss_dssp CCCHHHHHTS
T ss_pred CCCHHHHhhC
Confidence 9999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=374.52 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=206.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.++||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4679999999999999999999876 788999999965432 3456799999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE---cCCCCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill---~~~~~~kl~ 217 (422)
.+.+..++|||||.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999999999998854 457999999999999999999999998 9999999999999 567899999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||+++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .......
T Consensus 172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~--- 241 (484)
T 3nyv_A 172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEK--- 241 (484)
T ss_dssp CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH---
T ss_pred eeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHc---
Confidence 9999987644322 233579999999998876 69999999999999999999999998653221 1111100
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ...+ . ....+..+.+||.+||+.||.+|||+.+++++
T Consensus 242 ~~~~---~~~~-~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 242 GKYT---FELP-Q----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCC---CCSG-G----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC---CCCc-c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000 0000 0 01235788999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=372.85 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=203.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.++||+|+||+||+|.+.. +|+.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 3579999999999999999999876 78899999986432 234567899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc---CCCCeEEee
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSD 218 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~---~~~~~kl~D 218 (422)
+.+..++|||||.+|+|.+.+... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999999999988554 46999999999999999999999998 99999999999994 556799999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||+++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ...... ..
T Consensus 168 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~---~~ 237 (486)
T 3mwu_A 168 FGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVE---TG 237 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HT
T ss_pred CCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---hC
Confidence 99998654332 2234579999999998876 59999999999999999999999997643211 111110 00
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... .+... ....+.++.+||.+||+.||.+|||+.+++++
T Consensus 238 ~~~----~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 KYA----FDLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCC----SCSGG----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCC----CCCcc----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000 01234688999999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=347.79 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=205.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+.++++++|+||+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 3679999999999999999999876 67899999986432 12345788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ... .....
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~~-- 227 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THR---RIVNV-- 227 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHTT--
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHH---HHhcc--
Confidence 987654322 233578999999999999999999999999999999999999997543211 110 00000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+. .++...+..+.++|.+||+.||.+||++.+++++
T Consensus 228 ------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 ------DL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ------CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ------cc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 00 1112234688999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=386.17 Aligned_cols=261 Identities=24% Similarity=0.315 Sum_probs=209.5
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhccc-CCCcceeeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 137 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~ 137 (422)
....+|+++++||+|+||.||+|.+.. +|+.||||++.... ....+.+..|..++..+ .|+||++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 456789999999999999999999876 77899999997432 22345688999999988 799999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+++.+.+.+||||||++||+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.+|.+||+
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence 9999999999999999999999999654 46999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.. ....
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~~ 556 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIME 556 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHS
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHH---HHHh
Confidence 9999986433222 234578999999999999999999999999999999999999999764321 1111 1111
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-HHHHHHhCCCCCCCC
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-SEVVEALKPLPNLKD 355 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~ell~~L~~~~~~~~ 355 (422)
... .++...+.++.+||.+||+.||.+||++ .+-.+.+..++++..
T Consensus 557 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 557 HNV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp SCC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 110 1222345789999999999999999987 222333334444444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=348.83 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=206.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.+.|+||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4689999999999999999999876 677999999865432 2345688999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 999999999999999999998854 347999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ... .......
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~~~~~ 232 (294)
T 2rku_A 161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYL---RIKKNEY 232 (294)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHTTCC
T ss_pred CceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHhhccC
Confidence 9987543222 1233578999999999999899999999999999999999999997543211 000 0000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ++...+..+.+++.+||+.||.+||++.+++++
T Consensus 233 --------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --------S----IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --------C----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --------C----CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 111234678999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=354.55 Aligned_cols=269 Identities=25% Similarity=0.357 Sum_probs=212.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||.||+|.+... ...+|+.||||++........+.+.+|+.++++++|+||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTT-----SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccc-----cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 46799999999999999999986321 1227889999999876655667899999999999999999999998765
Q ss_pred C--ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 144 D--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 144 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+ ..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence 4 789999999999999999877677999999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC---------CCcchhHHh
Q 014585 222 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP---------NGEHNLVEW 291 (422)
Q Consensus 222 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~---------~~~~~~~~~ 291 (422)
+.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||..... .........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98765433221 12234578889999999988899999999999999999999998863210 000000000
Q ss_pred hhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... .+........+..++.++.+||.+||+.||.+||++.++++.|+.+
T Consensus 272 ~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 LIE----------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHH----------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----------HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 0000000111223457899999999999999999999999988754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=361.22 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=199.7
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
....++|++.+.||+|+||+||+|.+.. +|+.||||++..... ...+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhhee
Confidence 3456789999999999999999999876 788999999865432 234799999999999999999998
Q ss_pred Eec--------------------------------------CceEEEEEecCCCChhhhhc---cCCCCCCHHHHHHHHH
Q 014585 141 IED--------------------------------------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIAL 179 (422)
Q Consensus 141 ~~~--------------------------------------~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~ 179 (422)
... ...++||||++ |+|.+.+. .....+++..++.++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 543 34789999997 58777764 3456799999999999
Q ss_pred HHHHHHHHHHhcCCCCeEeccCCCCcEEEc-CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCch
Q 014585 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSR 257 (422)
Q Consensus 180 qi~~al~~LH~~~~~~iiHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 257 (422)
||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.+
T Consensus 149 qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~ 222 (383)
T 3eb0_A 149 QLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPS 222 (383)
T ss_dssp HHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcc
Confidence 9999999999988 99999999999997 689999999999987644332 2335789999999998865 58999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh--h------h-h--cccccccccCcccCCCCCHHHHHHHHHHH
Q 014585 258 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--H------L-G--ERRRFYRLIDPRLEGHFSIKGAQKAAQLA 326 (422)
Q Consensus 258 ~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~------~-~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li 326 (422)
+|||||||++|||++|..||.+.........+..... . . . ....+.......+...++...+.++.+||
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence 9999999999999999999986543221111100000 0 0 0 00001111111111112333457899999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 014585 327 AHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 327 ~~~l~~dp~~Rps~~ell~~ 346 (422)
.+||+.||.+|||+.|++++
T Consensus 303 ~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=372.75 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=203.0
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHhcccC
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLV 129 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 129 (422)
..++|+++++||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+.++++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999999999876 778999999975432 22457889999999999
Q ss_pred CCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 130 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
||||+++++++.+.+..++|||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence 999999999999999999999999999999988554 46999999999999999999999998 99999999999998
Q ss_pred CCC---CeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 014585 210 ADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286 (422)
Q Consensus 210 ~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 286 (422)
.++ .+||+|||++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.......
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 254 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-- 254 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 776 699999999987644322 23457999999999876 568999999999999999999999998653221
Q ss_pred hhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....... ... ..+..... ..+.++.+||.+||+.||.+|||+.+++++
T Consensus 255 -~~~~i~~---~~~----~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 255 -IIKKVEK---GKY----YFDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -HHHHHHH---CCC----CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHc---CCC----CCCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111100 000 00000001 234689999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=350.30 Aligned_cols=265 Identities=24% Similarity=0.367 Sum_probs=189.1
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
.+..++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+++.+|+.++++++||||++++++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 81 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence 3456799999999999999999998765 677999999865432 234568899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
+...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 158 (303)
T 2vwi_A 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDG 158 (303)
T ss_dssp EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCC
Confidence 9999999999999999999999863 3456999999999999999999999998 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCc---cceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 213 NAKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 236 (303)
T 2vwi_A 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-- 236 (303)
T ss_dssp CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--
T ss_pred CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--
Confidence 999999999876543221 111234579999999999875 57899999999999999999999999765432111
Q ss_pred HHhhhhhhhcccccc-cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFY-RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... ....... ...++.... ..+.++.+|+.+||+.||.+||++.+++++
T Consensus 237 -~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 237 -MLTLQ--NDPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -HHHHT--SSCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHhc--cCCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000 0000000 001111111 234678999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=351.30 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=203.0
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+.. +|..||+|++........+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 34689999999999999999999876 678999999987766667889999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999999998766677999999999999999999999998 999999999999999999999999987
Q ss_pred ccCCCCCccceeeccccCccccCCCcc-----cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYV-----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
..... .........||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ... ....
T Consensus 165 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~ 236 (302)
T 2j7t_A 165 AKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLL---KIAK 236 (302)
T ss_dssp HHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHH
T ss_pred ccccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH---HHhc
Confidence 53211 01112235689999999988 36778999999999999999999999997543211 110 0000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .... ..+...+..+.+|+.+||..||.+||++.+++++
T Consensus 237 ~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 237 SD--PPTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SC--CCCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cC--Cccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 0000 0112234688999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=346.97 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=207.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+.|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.+++++.|+||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 579999999999999999998865 678999999976543 3457789999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999999999999853 46999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ..
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~----- 233 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLI----PK----- 233 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HH-----
T ss_pred ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHh----hc-----
Confidence 7543221 1234578999999999999999999999999999999999999997543211 11100 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
...+.+.. ..+..+.+|+.+||..||.+||++.+++++.
T Consensus 234 -~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 234 -NNPPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -SCCCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -CCCCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00111112 2346789999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=348.55 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=203.6
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...++|++.+.||+|+||.||+|.+.. +|+.||||++.... ..+.+.+|+.+++++.||||+++++++.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 345789999999999999999999866 68899999997653 3467899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999999756678999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... ...
T Consensus 172 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~---~~~-- 241 (314)
T 3com_A 172 AGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFMIP---TNP-- 241 (314)
T ss_dssp CEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH---HSC--
T ss_pred chhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHh---cCC--
Confidence 976543221 1234578999999999999999999999999999999999999997543211 000000 000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.+ ..+...+..+.+|+.+||..||.+||++.+++++
T Consensus 242 -----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 242 -----PPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -----CCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----Cccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 0111234688999999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=358.65 Aligned_cols=259 Identities=27% Similarity=0.351 Sum_probs=205.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----ccHHHHHHHHHHhccc-CCCcceeeEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIG 138 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~ 138 (422)
.++|++.+.||+|+||.||+|.+.... .+|+.||||++..... ...+.+.+|+.+++++ .|+||+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccC------CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 367999999999999999999885321 2788999999875321 2335577899999999 6999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++...+..+|||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEee
Confidence 999999999999999999999999654 46999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+ .....
T Consensus 203 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~ 279 (355)
T 1vzo_A 203 FGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL 279 (355)
T ss_dssp SSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH
T ss_pred CCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHh
Confidence 999987543222 22334679999999999985 35789999999999999999999999754432221111 11111
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 347 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~L 347 (422)
.. .+. ++...+..+.+||.+||..||.+|| ++.+++++.
T Consensus 280 ~~--------~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 KS--------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HC--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cc--------CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 011 1223346789999999999999999 899998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=345.56 Aligned_cols=252 Identities=22% Similarity=0.267 Sum_probs=200.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC----cccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.++++++|+||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 4689999999999999999998866 77899999996532 2234678999999999999999999999
Q ss_pred EE--ecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 140 CI--EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 140 ~~--~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
+. ..+..++||||++++ |.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence 84 456789999999776 76766543 457999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
+|||++................||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ......
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i-- 225 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENI-- 225 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH--
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHH--
Confidence 9999998765433333344567999999999987654 378999999999999999999999754211 111100
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... .. ++..++..+.+|+.+||..||.+||++.+++++
T Consensus 226 -~~~~--------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 -GKGS--------YA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHCC--------CC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hcCC--------CC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00 111234678899999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=343.95 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=201.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
.+|....+||+|+||.||+|.+.. ++..||||.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 345566699999999999999876 67899999998766555678999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-CCCeEEeeccC
Q 014585 145 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGL 221 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-~~~~kl~DFG~ 221 (422)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999999999997653 34678999999999999999999998 999999999999987 89999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
+........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... .........
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~--- 241 (295)
T 2clq_A 170 SKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMF--- 241 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHHH---
T ss_pred ccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhccc---
Confidence 987543221 123457899999999987643 8899999999999999999999996432111 000000000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+. ++...+.++.+|+.+||+.||.+||++.+++++
T Consensus 242 -----~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 -----KVHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -----CCCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -----ccccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111 122345788999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=344.02 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=200.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 3568888999999999999998876 678999999875432 23456889999999999999999999987
Q ss_pred e----cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc-CCCCeEE
Q 014585 142 E----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKL 216 (422)
Q Consensus 142 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~-~~~~~kl 216 (422)
. ....++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEE
Confidence 6 34578999999999999999543 46899999999999999999999976 4599999999999997 7899999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
+|||++....... .....||+.|+|||++. +.++.++|||||||++|+|++|..||....... .......
T Consensus 174 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~--- 243 (290)
T 1t4h_A 174 GDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT--- 243 (290)
T ss_dssp CCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT---
T ss_pred eeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHh---
Confidence 9999997654322 23357999999999876 458999999999999999999999997543211 1111000
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... .... +....+.++.+||.+||+.||.+||++.+++++
T Consensus 244 -~~~-----~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 244 -SGV-----KPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -TTC-----CCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccC-----Cccc----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 0000 111123578999999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=361.52 Aligned_cols=254 Identities=13% Similarity=0.029 Sum_probs=185.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhccc--CCCcceeeE--
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL--VHLNLVKLI-- 137 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l--~h~niv~~~-- 137 (422)
..|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.| +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~ 132 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------C
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhcee
Confidence 458999999999999999999876 7889999999876542 234567775444444 699987755
Q ss_pred -----eEEEecC-----------------ceEEEEEecCCCChhhhhccCCCCCCHHHH------HHHHHHHHHHHHHHH
Q 014585 138 -----GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIR------MKIALGAAKGLAFLH 189 (422)
Q Consensus 138 -----~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~qi~~al~~LH 189 (422)
+++...+ ..+|||||++ |+|.+++......+++..+ +.++.||+.||+|||
T Consensus 133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 5554433 3799999997 8999999765445566666 788899999999999
Q ss_pred hcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC--CCCCchhhhhhHHHHH
Q 014585 190 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVL 267 (422)
Q Consensus 190 ~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 267 (422)
+++ |+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 998 999999999999999999999999999875321 113457799999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 268 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 268 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
|||++|+.||....+......... . .................+..+.+||.+||+.||.+||++.++++
T Consensus 284 ~elltg~~Pf~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGSWKRP---S------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTCCCBC---C------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHhCCCCCCCcCcccccchhhh---h------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999987643321110000 0 00000000110111134578999999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=346.74 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=198.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..++|++.+.||+|+||.||+|.+ +|..||||++.... ..+.+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 347899999999999999999987 46789999997553 44678999999999999999999999765
Q ss_pred c-CceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 143 D-DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 143 ~-~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
. +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecc
Confidence 4 47899999999999999996543 23889999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... ..
T Consensus 163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~----~~ 230 (278)
T 1byg_A 163 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KG 230 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----TT
T ss_pred ccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cC
Confidence 998653321 22357889999999999999999999999999999998 999997543211 111110 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. ....+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 231 ------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 231 ------Y----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------C----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0 0111223457899999999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=349.99 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=200.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+..... .+..||||++..... ...+.+.+|++++++++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCC------ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 4689999999999999999998754211 334699999875432 3356789999999999999999999998
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.... .++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccc
Confidence 8654 88999999999999999776667999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 221 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 221 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
++.......... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...... ...... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~---~~~ 240 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKE 240 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTS
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHH---Hcc
Confidence 998765433221 2233567889999999998889999999999999999999 99999764321 111110 000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.. .. ......+..+.+++.+||..||.+||++.++++.|+.+.
T Consensus 241 ~~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 241 GE------RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC------CC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00 00 011234578999999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=378.78 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=212.1
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEe
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 138 (422)
.+.+..++|++.++||+|+||.||+|.+.. +..||||++.... ...+++.+|+++|++++|+||+++++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344556789999999999999999998853 3579999998654 34578999999999999999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
++.+ +..+|||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEc
Confidence 9865 7789999999999999999653 346899999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||+++...... ........++..|+|||++.+..++.++|||||||+||||++ |..||...... .......
T Consensus 406 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i~--- 478 (535)
T 2h8h_A 406 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVE--- 478 (535)
T ss_dssp CTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHHH---
T ss_pred ccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---
Confidence 999998754321 111223456889999999999999999999999999999999 89999754321 1111111
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
... . ...+..++..+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 479 -~~~---~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 479 -RGY---R-------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -TTC---C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -cCC---C-------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 000 0 01122345789999999999999999999999999987754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.04 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=199.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+..+..+ .||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 4679999999999999999999876 678999999976433 2345688999999999 999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC------
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------ 211 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~------ 211 (422)
.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence 9999999999999999999999653 256999999999999999999999998 9999999999999844
Q ss_pred -------------CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCC
Q 014585 212 -------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 212 -------------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf 277 (422)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 479999999998764322 23589999999999865 6678999999999999999998876
Q ss_pred CCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ....... .. .+.+ +...+..+.+|+.+||+.||.+||++.+++++
T Consensus 232 ~~~~-----~~~~~~~------~~-----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 232 RNGD-----QWHEIRQ------GR-----LPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSSH-----HHHHHHT------TC-----CCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cchh-----HHHHHHc------CC-----CCCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 4321 1111000 00 0111 11234788999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=355.00 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=207.4
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHhccc-
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDL- 128 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l- 128 (422)
........+|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 157 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 3344556789999999999999999999865 6889999998755321 134578999999999
Q ss_pred CCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 129 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
.||||+++++++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~ 233 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILL 233 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 8999999999999999999999999999999998543 46999999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
+.+|.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 234 ~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 310 (365)
T 2y7j_A 234 DDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310 (365)
T ss_dssp CTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999987654322 234679999999998863 3688999999999999999999999975432
Q ss_pred CCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 283 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ....... ..... ...+. .. ..+..+.+||.+||+.||.+||++.+++++
T Consensus 311 ~---~~~~~i~---~~~~~---~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 I---LMLRMIM---EGQYQ---FSSPE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H---HHHHHHH---HTCCC---CCHHH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H---HHHHHHH---hCCCC---CCCcc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1111110 00000 00000 00 124678999999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=342.70 Aligned_cols=250 Identities=27% Similarity=0.351 Sum_probs=198.3
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+++.++||||++++++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 34689999999999999999999875 67899999986432 2234578899999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCC
T ss_pred EecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999999999998554 46899999999999999999999999 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
|++........ .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||...... ....... ..
T Consensus 156 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~---~~ 226 (276)
T 2h6d_A 156 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIR---GG 226 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HC
T ss_pred ccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhh---cC
Confidence 99987644321 233568999999999987765 68999999999999999999999753211 1111110 00
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. . ++...+..+.+++.+||+.||.+||++.+++++
T Consensus 227 ~~--------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VF--------Y----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC--------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cc--------c----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 0 111234678999999999999999999999984
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=346.14 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=205.9
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
...+|++.+.||+|+||.||+|.+.. +|+.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 45679999999999999999999875 67899999997653 456789999999999999999998864
Q ss_pred ----------------cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 143 ----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 143 ----------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
....++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N 152 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSN 152 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHH
Confidence 44578999999999999999654 357999999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 285 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 285 (422)
||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 153 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 224 (284)
T 2a19_B 153 IFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----- 224 (284)
T ss_dssp EEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----
T ss_pred EEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----
Confidence 9999999999999999987644322 23356899999999999999999999999999999999999887421
Q ss_pred chhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 286 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
..... .+ ....+.. ..+..+.+++.+||..||.+||++.+++++|+.+..
T Consensus 225 ---~~~~~-~~---------~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 ---SKFFT-DL---------RDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp ---HHHHH-HH---------HTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ---HHHHH-Hh---------hcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00000 00 0111111 234678899999999999999999999999876544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=346.32 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=204.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3679999999999999999999876 6789999999765432 3456889999999999999999999886
Q ss_pred e--cCceEEEEEecCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCcEEEcCCCCe
Q 014585 142 E--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 142 ~--~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~--~~~iiHrDlkp~Nill~~~~~~ 214 (422)
. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 56789999999999999998643 345999999999999999999999976 2349999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
||+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~- 229 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR- 229 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHh-
Confidence 9999999987543221 122357899999999999999999999999999999999999999764321 1111110
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.. .. + .++...+.++.+++.+||+.||.+||++.++++++..
T Consensus 230 ---~~-~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 230 ---EG-KF-----R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---HT-CC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---hc-cc-----c----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 00 00 0 1112345789999999999999999999999987643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=344.73 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=188.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-H-HHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H-KEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++....... . +.+.++...++.+.||||+++++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~ 75 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence 35789999999999999999999876 78899999997653322 2 2344555568889999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
.+.+..++||||++ |+|.+++.. ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEB
T ss_pred eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999996 588777643 456799999999999999999999997 8 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcc----cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+|||++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|..||........ ....
T Consensus 152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~-- 225 (290)
T 3fme_A 152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQ-- 225 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHH--
T ss_pred eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHH--
Confidence 99999987543322 2234689999999996 566789999999999999999999999975322110 0000
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
..... .+ .......+.++.+|+.+||+.||.+||++.++++
T Consensus 226 --~~~~~-------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 226 --VVEEP-------SP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --HHHSC-------CC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HhccC-------CC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00000 00 0011123568899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=363.29 Aligned_cols=200 Identities=22% Similarity=0.337 Sum_probs=173.7
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc------CCCcceee
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL------VHLNLVKL 136 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~ 136 (422)
...+|++.++||+|+||.||+|.+.. +++.||||++.... .....+.+|+++++.+ .|+||+++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 34679999999999999999999876 78899999997542 2335577788887776 57799999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 213 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-- 213 (422)
++++...+..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCC
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcc
Confidence 999999999999999995 69999886653 45999999999999999999999998 999999999999999987
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 281 (422)
+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||....
T Consensus 241 vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999764332 223578999999999999999999999999999999999999997654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=364.95 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=197.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|++.++||+|+||.||+|.+.. +|+.||||++.... ....+|+++|+.++|+|||++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEecc
Confidence 3479999999999999999999876 67899999986543 2234799999999999999999998642
Q ss_pred C------ceEEEEEecCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CC
Q 014585 144 D------QRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YN 213 (422)
Q Consensus 144 ~------~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~ 213 (422)
+ ..++||||+++ +|.+++. .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~ 195 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAV 195 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTE
T ss_pred CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCe
Confidence 2 36799999965 6666553 34567999999999999999999999988 9999999999999965 56
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...... +....
T Consensus 196 ~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~ 270 (420)
T 1j1b_A 196 LKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII 270 (420)
T ss_dssp EEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 89999999987644322 2335789999999998764 799999999999999999999999986532211 11111
Q ss_pred hhhhhc---------cc-----ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 RPHLGE---------RR-----RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~~~~~~---------~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .+.. .. .+..+....+...+....+.++.+||.+||+.||.+||++.|++++
T Consensus 271 ~-~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 271 K-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp H-HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H-HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0000 00 0000000001111222345789999999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.97 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=196.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHH--HHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+..| +..+..+.|+||+++++.+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 46899999999999999999976 56799999996432 2334444 44455689999999998665
Q ss_pred e-----cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEeccCCCCcEE
Q 014585 142 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---------AERPVIYRDFKTSNIL 207 (422)
Q Consensus 142 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~~~~iiHrDlkp~Nil 207 (422)
. ....++||||+++|+|.+++... ..++..++.++.||+.||.|||+. + |+||||||+|||
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 3 22568999999999999999654 358899999999999999999998 7 999999999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCc------cceeeccccCccccCCCcccC-------CCCCchhhhhhHHHHHHHHHhCC
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLTGR 274 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~ 274 (422)
++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999987543221 112224579999999999986 45667899999999999999998
Q ss_pred CCCCCCCCCCcc-hhHHhhhhhhhcccc-----cccccCcccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 275 RSMDKNRPNGEH-NLVEWARPHLGERRR-----FYRLIDPRLEGH--FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 275 ~pf~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.||......... ............... ......+.+... .....+..+.+||.+||+.||.+|||+.++++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 776543322111 100000000000000 000001111111 123467789999999999999999999999999
Q ss_pred hCCCC
Q 014585 347 LKPLP 351 (422)
Q Consensus 347 L~~~~ 351 (422)
|+.+.
T Consensus 313 L~~ll 317 (336)
T 3g2f_A 313 MAELM 317 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=355.00 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=195.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 3689999999999999999999876 788999999975432 23456889999999999999999999998
Q ss_pred ecC------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
..+ ..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence 665 6799999996 57888874 35899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh----
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW---- 291 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~---- 291 (422)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998654321 22346799999999999999999999999999999999999999976532111000000
Q ss_pred -----h-------hhhhhcccc-----cccccCccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 -----A-------RPHLGERRR-----FYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 -----~-------~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ......... +...+.... ........+..+.+||.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 000000000 000000000 000112346789999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=346.06 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=199.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHhcccCCCcce
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNLV 134 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv 134 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++++++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 34679999999999999999999876 788999999975432 1123478999999999999999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC-
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN- 213 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~- 213 (422)
++++++..+ ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 79 KIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp CEEEEEESS-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred eEeeEEcCC-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 999998765 48999999999999998854 457999999999999999999999998 999999999999987654
Q ss_pred --eEEeeccCcccCCCCCccceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 214 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 214 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ .
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~ 228 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L 228 (322)
T ss_dssp CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H
T ss_pred CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H
Confidence 9999999998764321 123357999999999874 56789999999999999999999999976543221 1
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... .... ..+.... ..+..+.+|+.+||..||.+||++.+++++
T Consensus 229 ~~~~~~---~~~~----~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITS---GKYN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHH---TCCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHh---Cccc----cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111100 0000 0000001 224688999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.26 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=186.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++++.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3689999999999999999998876 788999999975432 23457889999999999999999999987
Q ss_pred ec------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
.. ...++|||++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEE
Confidence 54 5679999999 7899998854 46999999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999875322 234579999999999886 6889999999999999999999999976543211111100000
Q ss_pred h--------hhc--ccccccccCcccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 H--------LGE--RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~--------~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. +.. ...+...+....... .....+..+.+||.+||..||.+|||+.+++++
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 000000000000000 001234678999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.54 Aligned_cols=273 Identities=22% Similarity=0.290 Sum_probs=200.6
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-----------cHHHHHHHHHHh
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFL 125 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l 125 (422)
+.++....++|++.+.||+|+||.||+|.+. .|..||||++...... ..+.+.+|+.++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 5566778899999999999999999999864 4678999998643221 126789999999
Q ss_pred cccCCCcceeeEeEEEec-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 014585 126 GDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 200 (422)
Q Consensus 126 ~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrD 200 (422)
++++||||+++++++... ...++||||++ |+|.+++......+++..++.++.||+.||.|||+.+ |+|||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 159 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecC
Confidence 999999999999998653 35799999996 6898888777778999999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 014585 201 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDK 279 (422)
Q Consensus 201 lkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~ 279 (422)
|||+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999997543322 2233578999999999886 7789999999999999999999999986
Q ss_pred CCCCCcchhHHh-hh------------hhhhcc-cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 280 NRPNGEHNLVEW-AR------------PHLGER-RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 280 ~~~~~~~~~~~~-~~------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
.........+.. .. ...... ...................+..+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 542211111000 00 000000 0000000000000011123467899999999999999999999997
Q ss_pred H
Q 014585 346 A 346 (422)
Q Consensus 346 ~ 346 (422)
+
T Consensus 317 h 317 (362)
T 3pg1_A 317 H 317 (362)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=351.36 Aligned_cols=255 Identities=28% Similarity=0.392 Sum_probs=199.4
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
....++|++.+.||+|+||.||+|.+.. +|+.||||++.... .....+.+|+.+++++ .||||++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 3356789999999999999999999876 67899999997553 3346789999999999 89999999999
Q ss_pred EEe------cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC
Q 014585 140 CIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212 (422)
Q Consensus 140 ~~~------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~ 212 (422)
+.. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 987 46789999999999999999754 356999999999999999999999998 99999999999999999
Q ss_pred CeEEeeccCcccCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 213 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 167 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-- 242 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-- 242 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred CEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--
Confidence 999999999986543211 123357899999999987 56789999999999999999999999975432111
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... .. ....... ....+..+.+||.+||..||.+||++.+++++
T Consensus 243 -~~~~----~~-~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 -LFLI----PR-NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HHHH----HH-SCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHh----hc-CccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00 0000010 11234688999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.07 Aligned_cols=269 Identities=22% Similarity=0.331 Sum_probs=185.4
Q ss_pred cCCCC-CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 65 RNFRP-ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 65 ~~y~~-~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
+.|++ .++||+|+||+||+|.+... .+++.||||++..... ...+.+|+.+|++++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 34666 45899999999999997532 1577899999975532 3568899999999999999999999965
Q ss_pred -cCceEEEEEecCCCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE----c
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----D 209 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill----~ 209 (422)
....+|||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||| +
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC
Confidence 668899999995 5888877421 234999999999999999999999998 9999999999999 6
Q ss_pred CCCCeEEeeccCcccCCCCCcc-ceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc--
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 285 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-- 285 (422)
.++.+||+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 7799999999999876432211 22234679999999999987 4589999999999999999999999976543210
Q ss_pred ----chhHHhhhhhhhc--ccccccc------------cCcccCCCCC---------HHHHHHHHHHHHHcccCCCCCCC
Q 014585 286 ----HNLVEWARPHLGE--RRRFYRL------------IDPRLEGHFS---------IKGAQKAAQLAAHCLSRDPKARP 338 (422)
Q Consensus 286 ----~~~~~~~~~~~~~--~~~~~~~------------~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rp 338 (422)
..........+.. ...+..+ +......... ...+..+.+||.+||+.||.+||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 0111111000000 0000000 0000000000 01145788999999999999999
Q ss_pred CHHHHHHH
Q 014585 339 LMSEVVEA 346 (422)
Q Consensus 339 s~~ell~~ 346 (422)
|+.|++++
T Consensus 327 ta~e~L~h 334 (405)
T 3rgf_A 327 TSEQAMQD 334 (405)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=378.28 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=198.6
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEecCceEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 148 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 148 (422)
+.||+|+||.||+|.+... .+++.||||+++.... ...+++.+|+.+|++++|||||++++++. .+..+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence 4799999999999976532 1567899999975432 23567999999999999999999999986 456899
Q ss_pred EEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 149 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999999954 457999999999999999999999998 999999999999999999999999999876543
Q ss_pred Ccc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 229 DKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 229 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
... .......||+.|+|||++.+..++.++|||||||++|||++ |..||....... ...... ..
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~----~~------- 588 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLE----KG------- 588 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TT-------
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC-------
Confidence 321 22233457889999999999999999999999999999998 999997653321 111111 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.....+..++.++.+||.+||+.||.+||++.+|++.|+.
T Consensus 589 ---~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 589 ---ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0011122345789999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.02 Aligned_cols=265 Identities=27% Similarity=0.395 Sum_probs=206.8
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcc--cCCCcceeeEe
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIG 138 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~ 138 (422)
....++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|++++.. ++||||+++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 44567899999999999999999987 4678999999643 34567788888877 79999999999
Q ss_pred EEEecC----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCCcE
Q 014585 139 YCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNI 206 (422)
Q Consensus 139 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~~~~iiHrDlkp~Ni 206 (422)
++.... ..++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +.+ |+||||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 998876 789999999999999999653 5899999999999999999999 767 99999999999
Q ss_pred EEcCCCCeEEeeccCcccCCCCCccc--eeeccccCccccCCCcccCC------CCCchhhhhhHHHHHHHHHhC-----
Q 014585 207 LLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTG----- 273 (422)
Q Consensus 207 ll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----- 273 (422)
|++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999997654333211 12345799999999998865 234689999999999999999
Q ss_pred -----CCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 014585 274 -----RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347 (422)
Q Consensus 274 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 347 (422)
..||.......... ..+... ... ....+.+... ....++..+.+|+.+||+.||.+||++.+++++|
T Consensus 259 ~~~~~~~p~~~~~~~~~~~-~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSV-EEMRKV-VCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCH-HHHHHH-HTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCccccCcCcccH-HHHHHH-HHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 67776543322111 111110 000 0111111111 1236678899999999999999999999999999
Q ss_pred CCCC
Q 014585 348 KPLP 351 (422)
Q Consensus 348 ~~~~ 351 (422)
+.+.
T Consensus 332 ~~i~ 335 (342)
T 1b6c_B 332 SQLS 335 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=351.78 Aligned_cols=264 Identities=19% Similarity=0.341 Sum_probs=203.7
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceee
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKL 136 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~ 136 (422)
++.+..++|++.+.||+|+||.||+|.+.. .||+|++..... ...+.+.+|+.++++++|+||+++
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEE
Confidence 334456789999999999999999998743 499999875432 223567899999999999999999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
++++...+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l 170 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVI 170 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEE
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEE
Confidence 99999999999999999999999999776667999999999999999999999998 99999999999998 689999
Q ss_pred eeccCcccCCCCC---ccceeeccccCccccCCCcccC---------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC
Q 014585 217 SDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMT---------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 284 (422)
Q Consensus 217 ~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 284 (422)
+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999987643211 1111223568999999999864 457899999999999999999999997543211
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCCCC
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 354 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 354 (422)
...... .. ..+... ....+.++.+|+.+||..||.+||++.++++.|+.+....
T Consensus 251 ---~~~~~~----~~------~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 251 ---IIWQMG----TG------MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ---HHHHHH----TT------CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ---HHHHhc----cC------CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111000 00 000000 0112357889999999999999999999999999887643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=349.84 Aligned_cols=268 Identities=23% Similarity=0.296 Sum_probs=203.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|++++.||+|+||.||+|.+.. ++..||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 4689999999999999999999876 7789999999754332 23678899999999999999999999976
Q ss_pred c-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 143 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 143 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
. ...++||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEE
Confidence 5 36899999996 5999988543 5999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCcc-ceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 218 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 218 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
|||++......... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||...........+......
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999875432211 1123457999999999876 456899999999999999999999999875443322111100000
Q ss_pred hh-c---------cccc-ccccCccc--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LG-E---------RRRF-YRLIDPRL--EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~-~---------~~~~-~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. . ...+ ........ ...+....+.++.+||.+||+.||.+||++.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 0000 00000000 000011234678999999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=352.94 Aligned_cols=272 Identities=18% Similarity=0.226 Sum_probs=206.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCccee--------
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK-------- 135 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 135 (422)
.++|++.+.||+|+||.||+|.+...... .....++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 46899999999999999999998652110 00013678999998754 46889999999999999887
Q ss_pred -------eEeEEEe-cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 014585 136 -------LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 206 (422)
Q Consensus 136 -------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Ni 206 (422)
+++++.. ++..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999999765 367999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEeeccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 014585 207 LLDADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 279 (422)
Q Consensus 207 ll~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 279 (422)
|++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999875432211 111335799999999999999999999999999999999999999986
Q ss_pred CCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 280 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
...... .............. .+.+.... ....+.++.+|+.+||..||.+||++.++++.|+.+..
T Consensus 271 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVDKPG---PFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GTTCHH-HHHHHHHHHHHSCC---CEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcCHH-HHHHHHHhccCChh---hhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 542211 11111111111111 11110000 00124789999999999999999999999999976543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=342.28 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=204.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---------ccHHHHHHHHHHhcccC-CCcc
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGDLV-HLNL 133 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~ni 133 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.+++++. ||||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 4689999999999999999999876 788999999975531 11345789999999995 9999
Q ss_pred eeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 134 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 134 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
+++++++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 99999999999999999999999999998553 47999999999999999999999998 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCccc------CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
+||+|||++........ .....|++.|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 236 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--- 236 (298)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred EEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---
Confidence 99999999987644322 23357899999999885 4568899999999999999999999997543211
Q ss_pred hHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
..... ..... ....+ .....+..+.+|+.+||+.||.+||++.++++
T Consensus 237 ~~~~~---~~~~~---~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 MLRMI---MSGNY---QFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHH---HHTCC---CCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHH---hcCCc---ccCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11100 00000 00000 01133578999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=350.54 Aligned_cols=260 Identities=18% Similarity=0.271 Sum_probs=205.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-----------------HHHHHHHHHHhc
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFLG 126 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~ 126 (422)
.++|++.+.||+|+||.||+|.+ +|+.||||++....... .+.+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999987 46799999986432211 177999999999
Q ss_pred ccCCCcceeeEeEEEecCceEEEEEecCCCChhhh------hccC-CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 014585 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIY 198 (422)
Q Consensus 127 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiH 198 (422)
+++||||+++++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ .+ |+|
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H 175 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH 175 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence 99999999999999999999999999999999998 5442 5679999999999999999999999 88 999
Q ss_pred ccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCc-hhhhhhHHHHHHHHHhCCCC
Q 014585 199 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTS-RSDVYSFGVVLLEMLTGRRS 276 (422)
Q Consensus 199 rDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~p 276 (422)
|||||+|||++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875432 23446799999999999877 6766 99999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhhhccccccc----ccC---cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 277 MDKNRPNGEHNLVEWARPHLGERRRFYR----LID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 277 f~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
|...... .......... ...+.. ... ...........+.++.+|+.+||+.||.+||++.+++++
T Consensus 252 f~~~~~~--~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 252 FSLKISL--VELFNNIRTK---NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCCSSCS--HHHHHHHTSC---CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCcH--HHHHHHHhcc---CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9865431 1111111100 000000 000 000000112345789999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=357.17 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=195.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
..+|++.++||+|+||+||+|.+.. ++ .||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 3579999999999999999998864 33 488888764432 223799999999999999999999765
Q ss_pred Cc------eEEEEEecCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc-CCCC
Q 014585 144 DQ------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYN 213 (422)
Q Consensus 144 ~~------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~-~~~~ 213 (422)
+. .++||||++++ |.+.+. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~ 180 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGV 180 (394)
T ss_dssp SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCc
Confidence 43 78999999764 444332 23567999999999999999999999998 99999999999998 7999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+...
T Consensus 181 ~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp EEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999987644332 2345789999999998764 5899999999999999999999999865422111110000
Q ss_pred h--------hhhhc---ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 R--------PHLGE---RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~--------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..... ...+.......+...+....+.++.+||.+||+.||.+||++.+++++
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 00000 000001111111111222345789999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=347.49 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred cchhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccC--C
Q 014585 55 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLV--H 130 (422)
Q Consensus 55 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h 130 (422)
+.++.+.+..++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.+++++. |
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 87 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGC
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccC
Confidence 444445556788999999999999999999863 4678999999754332 3467889999999997 5
Q ss_pred CcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC
Q 014585 131 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210 (422)
Q Consensus 131 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~ 210 (422)
+||+++++++...+..++|||+ .+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 88 ~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 162 (313)
T 3cek_A 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD 162 (313)
T ss_dssp TTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET
T ss_pred CceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC
Confidence 9999999999999999999995 588999999654 47899999999999999999999998 999999999999964
Q ss_pred CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccC-----------CCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 014585 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDK 279 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~ 279 (422)
+.+||+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 163 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 163 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp -TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 8999999999987654433333344679999999999875 4788999999999999999999999975
Q ss_pred CCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 280 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ...... ..++.....++...+.++.+|+.+||+.||.+||++.+++++
T Consensus 242 ~~~~-----~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 242 IINQ-----ISKLHA----------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CCSH-----HHHHHH----------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH-----HHHHHH----------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 4321 111110 111111111111224688999999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=341.07 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=196.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 4679999999999999999999866 67899999996432 334678899999999999999999998865
Q ss_pred ------------cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC
Q 014585 143 ------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210 (422)
Q Consensus 143 ------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~ 210 (422)
.+..++||||+++++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcC
Confidence 35678999999999999999777667889999999999999999999998 999999999999999
Q ss_pred CCCeEEeeccCcccCCCCCc------------cceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCC
Q 014585 211 DYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf 277 (422)
++.+||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999987543210 1112345789999999999864 78999999999999999998 44
Q ss_pred CCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ........... ....+...+....+..+.+|+.+||+.||.+||++.+++++
T Consensus 229 ~~~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 229 STGM-----ERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp SSHH-----HHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCch-----hHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 3210 11111100000 01111222333445778999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=348.81 Aligned_cols=268 Identities=26% Similarity=0.340 Sum_probs=191.2
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
...++|++.+.||+|+||.||+|.+.. +|+.||||++.... .....+.+|++.+..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 445789999999999999999999876 67899999986543 22346778888899999999999999997
Q ss_pred ecCc-------eEEEEEecCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeccCCCCcEEEc
Q 014585 142 EDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH--EEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 142 ~~~~-------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~LH--~~~~~~iiHrDlkp~Nill~ 209 (422)
..+. .++||||+++ +|.+.+. .....+++..++.++.|++.||.||| +.+ |+||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVN 165 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEe
Confidence 6544 7899999965 5555443 34567899999999999999999999 877 99999999999999
Q ss_pred C-CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 014585 210 A-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287 (422)
Q Consensus 210 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 287 (422)
. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 7 89999999999987654322 2345789999999998765 48999999999999999999999998654321111
Q ss_pred hHHhhh--------hhhhcccccccccC------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 288 LVEWAR--------PHLGERRRFYRLID------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 288 ~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+.... ..+..........+ ...........+.++.+||.+||+.||.+||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 110000 00000000000000 000011122356789999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=343.35 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=205.5
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc------ceee
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVKL 136 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~ 136 (422)
..++|++.+.||+|+||.||+|.+... +|+.||||++.... ...+.+.+|+.+++.+.|++ |+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKA--------GGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCC--------CCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 457899999999999999999987431 67899999997542 33456889999998887654 9999
Q ss_pred EeEEEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-----
Q 014585 137 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----- 210 (422)
Q Consensus 137 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~----- 210 (422)
++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEE
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccc
Confidence 99999999999999999 889999986653 46899999999999999999999998 999999999999987
Q ss_pred --------------CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCC
Q 014585 211 --------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 276 (422)
Q Consensus 211 --------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 276 (422)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 678999999999875432 2335789999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhhhhc-------ccccc------------------cccCc-ccCCCCCHHHHHHHHHHHHHcc
Q 014585 277 MDKNRPNGEHNLVEWARPHLGE-------RRRFY------------------RLIDP-RLEGHFSIKGAQKAAQLAAHCL 330 (422)
Q Consensus 277 f~~~~~~~~~~~~~~~~~~~~~-------~~~~~------------------~~~~~-~~~~~~~~~~~~~l~~li~~~l 330 (422)
|...........+.......+. ..... ....+ ..........+.++.+||.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 9765432211111111000000 00000 00000 0000122356788999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 014585 331 SRDPKARPLMSEVVEA 346 (422)
Q Consensus 331 ~~dp~~Rps~~ell~~ 346 (422)
+.||.+||++.|++++
T Consensus 314 ~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 314 EYDPAKRITLREALKH 329 (339)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred CcCcccccCHHHHhcC
Confidence 9999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.13 Aligned_cols=268 Identities=24% Similarity=0.307 Sum_probs=196.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEE--
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-- 141 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 4689999999999999999999876 78899999998766556678899999999999999999999874
Q ss_pred ------------ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 142 ------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 142 ------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
.....++||||++ |+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 3467899999996 699998843 46899999999999999999999998 99999999999997
Q ss_pred -CCCCeEEeeccCcccCCCCCc-cceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 014585 210 -ADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286 (422)
Q Consensus 210 -~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 286 (422)
.++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567999999999987543211 111233567999999998875 78899999999999999999999999865432111
Q ss_pred hhHHhhhhhhh--ccccccccc----CcccC------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 287 NLVEWARPHLG--ERRRFYRLI----DPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 287 ~~~~~~~~~~~--~~~~~~~~~----~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+....+... ....+...+ ..... .......+.++.+||.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11000000000 000000000 00000 00011235789999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=342.44 Aligned_cols=255 Identities=27% Similarity=0.349 Sum_probs=181.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHH-HhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVN-FLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+..|+. +++.+.||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 4789999999999999999999876 6889999999765432 2345566666 778889999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
..+..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEE
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEE
Confidence 99999999999965 88777742 256799999999999999999999998 8 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcc----cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||........ ..
T Consensus 168 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~ 239 (327)
T 3aln_A 168 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL 239 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred ccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH
Confidence 99999987543221 2234689999999998 466789999999999999999999999975432110 00
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... .....+.+........+..+.+|+.+||..||.+||++.+++++
T Consensus 240 ~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 TQV-------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCC-------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHH-------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000 00001111111111235789999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=377.18 Aligned_cols=264 Identities=24% Similarity=0.376 Sum_probs=210.0
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeE
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
++.+..++|++.+.||+|+||.||+|.+...+. .+..||||.+...... ..+.+.+|+.++++++||||++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 457 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 334456789999999999999999999865322 4668999998764332 346789999999999999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
+++. ++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 458 ~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEE
Confidence 9984 56789999999999999999777667999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .......
T Consensus 534 DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~--- 606 (656)
T 2j0j_A 534 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE--- 606 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH---
T ss_pred ecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH---
Confidence 99999876443221 2233457889999999999999999999999999999997 99999764321 1111111
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... .. ..+..++..+.+|+.+||..||.+||++.++++.|+.+
T Consensus 607 -~~~------~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 607 -NGE------RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -HTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCC------CC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 000 00 11223457899999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=346.88 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=198.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 3689999999999999999999876 7889999999765432 2456889999999999999999999998
Q ss_pred ecCce------EEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
..+.. ++||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 77655 99999995 68888773 34999999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999865332 234578999999999887 7899999999999999999999999976532211110000000
Q ss_pred h--------hhc--ccccccccCcccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 H--------LGE--RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~--------~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. +.. ...+...+....... .....+..+.+||.+||+.||.+||++.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000 000000000000000 011235789999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=342.01 Aligned_cols=266 Identities=25% Similarity=0.334 Sum_probs=202.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhccc---CCCcceeeE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLI 137 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~ 137 (422)
..++|++.+.||+|+||.||+|.+... +|+.||||++..... .....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC--------CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 347899999999999999999998531 577899999864322 1223466777777666 899999999
Q ss_pred eEEE-----ecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC
Q 014585 138 GYCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 211 (422)
Q Consensus 138 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~ 211 (422)
+++. .....++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 156 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence 9987 4567899999996 69999986643 45999999999999999999999998 9999999999999999
Q ss_pred CCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 212 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 212 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...
T Consensus 157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~ 230 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGK 230 (326)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH
T ss_pred CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH
Confidence 999999999998654221 22346789999999999999999999999999999999999999986542211 111
Q ss_pred hhhhhh--ccccccc----------ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 ARPHLG--ERRRFYR----------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 ~~~~~~--~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...... ....+.. .........+....+..+.+|+.+||..||.+||++.+++++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 110000 0000000 000000011222345788999999999999999999999963
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=347.71 Aligned_cols=267 Identities=24% Similarity=0.288 Sum_probs=200.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4689999999999999999999876 7889999999654322 24568899999999999999999998876
Q ss_pred c-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEe
Q 014585 143 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217 (422)
Q Consensus 143 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~ 217 (422)
. ...++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 4 67899999996 699998855 36999999999999999999999998 9999999999999999999999
Q ss_pred eccCcccCCCCCccc--------eeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 218 DFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 218 DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998764322111 1123578999999998764 7889999999999999999999999986532111000
Q ss_pred HHhhhhhhhcc---------------cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGER---------------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.......... ..+.......+ .......+.++.+||.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 00000000000 00011335788999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=348.35 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=201.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-----------CCc
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLN 132 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 132 (422)
..+|++.+.||+|+||+||+|.+.. +|+.||||++.... .....+.+|+.+++++. |+|
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 4689999999999999999999876 78899999997542 23456889999998886 899
Q ss_pred ceeeEeEEEecC----ceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcE
Q 014585 133 LVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNI 206 (422)
Q Consensus 133 iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Ni 206 (422)
|+++++++...+ ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+. + |+||||||+||
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI 163 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 163 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence 999999998754 788999999 88999998764 45699999999999999999999997 8 99999999999
Q ss_pred EEc------CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Q 014585 207 LLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 280 (422)
Q Consensus 207 ll~------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 280 (422)
|++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 4457999999999875432 22357899999999999999999999999999999999999999865
Q ss_pred CCCCcch---hHHhhhhhhhc------------------ccccccccCc---------ccCCCCCHHHHHHHHHHHHHcc
Q 014585 281 RPNGEHN---LVEWARPHLGE------------------RRRFYRLIDP---------RLEGHFSIKGAQKAAQLAAHCL 330 (422)
Q Consensus 281 ~~~~~~~---~~~~~~~~~~~------------------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l 330 (422)
....... ........+.. ...+..+... .....++...+.++.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 4322111 11000000000 0000000000 0011245677899999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 014585 331 SRDPKARPLMSEVVEA 346 (422)
Q Consensus 331 ~~dp~~Rps~~ell~~ 346 (422)
+.||.+||++.|++++
T Consensus 319 ~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNH 334 (373)
T ss_dssp CSSTTTCBCHHHHHTC
T ss_pred ccCccccCCHHHHhhC
Confidence 9999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=347.55 Aligned_cols=208 Identities=24% Similarity=0.277 Sum_probs=174.7
Q ss_pred hhHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CC----
Q 014585 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL---- 131 (422)
Q Consensus 57 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~---- 131 (422)
+.......++|++.+.||+|+||+||+|.+.. +|+.||||++.... .....+..|+++++.+. |+
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~ 115 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMK 115 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGG
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccc
Confidence 33344456799999999999999999999876 77899999997442 23456778888888774 44
Q ss_pred -cceeeEeEEEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 132 -NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 132 -niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
+|+++++++...+..+|||||++ ++|.+++.... ..+++..+..++.||+.||.|||.+. .+|+||||||+|||++
T Consensus 116 ~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 116 YYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLC 193 (382)
T ss_dssp GGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEES
T ss_pred eeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEe
Confidence 49999999999999999999995 59999987653 56999999999999999999999532 2399999999999994
Q ss_pred --CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 014585 210 --ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281 (422)
Q Consensus 210 --~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 281 (422)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 194 ~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 194 NPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp STTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4788999999999876432 233578999999999999999999999999999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=335.82 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=203.2
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 34689999999999999999999865 678999999865432 3456789999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC---CCeEEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 217 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~---~~~kl~ 217 (422)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence 9999999999999999999988554 46999999999999999999999998 9999999999999654 469999
Q ss_pred eccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 218 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 218 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ....... .
T Consensus 167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~---~ 236 (287)
T 2wei_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE---T 236 (287)
T ss_dssp STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---H
T ss_pred ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---c
Confidence 9999986543321 223468999999998865 4899999999999999999999999764321 1111110 0
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... .+.... ...+.++.+++.+||..||.+||++.+++++
T Consensus 237 ~~~~----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 GKYA----FDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCC----CCSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCC----CCchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000 000000 1234688999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=341.43 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=174.7
Q ss_pred hcCCCCCC-ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.+ +||+|+||.||+|.+.. +|+.||||++.... ....+....++.+.|+||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 36888855 69999999999999876 68899999996431 222223334566799999999999876
Q ss_pred ----cCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCCe
Q 014585 143 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 214 (422)
Q Consensus 143 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~~ 214 (422)
....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCE
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceE
Confidence 445899999999999999997653 46999999999999999999999998 999999999999976 4559
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--- 243 (336)
T 3fhr_A 171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--- 243 (336)
T ss_dssp EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---
Confidence 999999998654322 2335789999999999888999999999999999999999999976543221100000
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... .............+.++.+||.+||+.||.+||++.+++++
T Consensus 244 ~~~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 244 RIRL-------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhc-------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 00000000111335789999999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.71 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=199.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 3689999999999999999999876 7889999999764332 2456889999999999999999999998
Q ss_pred ecCc------eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
..+. .++||||++ ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEE
T ss_pred cccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEE
Confidence 7654 499999996 68888773 24899999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999865322 233578999999999886 6889999999999999999999999986542211110000000
Q ss_pred --------hhhcc------cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 --------HLGER------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 --------~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.+... ..+.......+ .......+.++.+||.+||..||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 00000000011 11122446789999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=341.38 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=202.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc------cee
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVK 135 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~ 135 (422)
...++|++.+.||+|+||+||+|.+... .+..||||++.... ...+.+.+|+.+++++.|++ ++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3457899999999999999999998652 23689999997542 33456888999999987765 899
Q ss_pred eEeEEEecCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE------
Q 014585 136 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL------ 208 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill------ 208 (422)
+++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccc
Confidence 999999999999999999 667777775543 57999999999999999999999988 9999999999999
Q ss_pred -------------cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCC
Q 014585 209 -------------DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 275 (422)
Q Consensus 209 -------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 275 (422)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 56789999999999864332 233579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHHhhhhhhhc----cccccc---------------------ccCc-ccCCCCCHHHHHHHHHHHHHc
Q 014585 276 SMDKNRPNGEHNLVEWARPHLGE----RRRFYR---------------------LIDP-RLEGHFSIKGAQKAAQLAAHC 329 (422)
Q Consensus 276 pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------------------~~~~-~~~~~~~~~~~~~l~~li~~~ 329 (422)
||...........+.......+. ...... ...+ ..........+..+.+||.+|
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 99865422111111111000000 000000 0000 000011224567899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 014585 330 LSRDPKARPLMSEVVE 345 (422)
Q Consensus 330 l~~dp~~Rps~~ell~ 345 (422)
|+.||.+|||+.++++
T Consensus 318 L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 318 LEFDPAQRITLAEALL 333 (355)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred hcCChhhCcCHHHHhc
Confidence 9999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=340.10 Aligned_cols=244 Identities=26% Similarity=0.419 Sum_probs=193.8
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc------HHHHHHHHHHhccc----CCC
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------HKEWLAEVNFLGDL----VHL 131 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l----~h~ 131 (422)
...++|++.+.||+|+||.||+|.+.. +|+.||||++....... ...+.+|+.++.++ .|+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 345789999999999999999998766 67899999997654321 23356799999888 899
Q ss_pred cceeeEeEEEecCceEEEEEe-cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc-
Q 014585 132 NLVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD- 209 (422)
Q Consensus 132 niv~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~- 209 (422)
||+++++++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 999999999999999999999 7899999999654 46999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
.++.+||+|||++....... .....|+..|+|||++.+..+ +.++|||||||++|+|++|+.||.... ..
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~ 245 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI 245 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH
Confidence 88999999999998765432 234568999999999887666 458999999999999999999996421 00
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .... .++...+..+.+||.+||+.||.+||++.+++++
T Consensus 246 ~-------~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 L-------EAEL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H-------HTCC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred h-------hhcc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 0112234678999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=342.79 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=201.3
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccC--CCc
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLN 132 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~n 132 (422)
....++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.+++++. |+|
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 109 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence 3456789999999999999999998876 7789999999754322 1234678999999996 599
Q ss_pred ceeeEeEEEecCceEEEEEecCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc-C
Q 014585 133 LVKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-A 210 (422)
Q Consensus 133 iv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~-~ 210 (422)
|+++++++...+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .
T Consensus 110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185 (320)
T ss_dssp BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence 99999999999999999999976 899999855 347899999999999999999999998 99999999999999 7
Q ss_pred CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhH
Q 014585 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 289 (422)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------- 253 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------- 253 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------
Confidence 8999999999998764322 233579999999999987665 788999999999999999999996421
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... .... .. ....+.++.+||.+||+.||.+||++.+++++
T Consensus 254 ~~~----~~~~----~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 EII----RGQV----FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHH----HCCC----CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhh----cccc----cc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000 00 11234688999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=334.59 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=183.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-H-HHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H-KEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++.+.||+|+||.||+|.+.. +|+.||||++....... . +.+.++..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 4679999999999999999999876 67899999997654322 2 23445556788889999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
..+..++||||+ ++.+..+.......+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999 6566666655466799999999999999999999995 8 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... ..... ..
T Consensus 171 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~---~~ 242 (318)
T 2dyl_A 171 ISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLT---KV 242 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH---HH
T ss_pred CchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHH---HH
Confidence 997654322 123356899999999984 567889999999999999999999999753221 11111 11
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... +.+.. ....+.++.+|+.+||+.||.+||++.+++++
T Consensus 243 ~~~~~-------~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 243 LQEEP-------PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHSCC-------CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred hccCC-------CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11100 00000 01234688999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.12 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=187.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 143 (422)
+.|.+.++||+|+||+||.+.. . +|+.||||++... ..+.+.+|+.+++++ +|||||++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~---------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-F---------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-S---------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEE-E---------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 4566678899999999986533 2 5789999998643 235678999999886 899999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC------
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------ 211 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~------ 211 (422)
+..+||||||+ |+|.+++...... ..+..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccc
Confidence 99999999995 6999999654321 123345789999999999999998 9999999999999654
Q ss_pred -------CCeEEeeccCcccCCCCCccc--eeeccccCccccCCCcccC-------CCCCchhhhhhHHHHHHHHHh-CC
Q 014585 212 -------YNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GR 274 (422)
Q Consensus 212 -------~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~ 274 (422)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 489999999998765432211 1234579999999999875 678999999999999999999 99
Q ss_pred CCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 275 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 275 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.||....... ..... ..... +..........+.++.+||.+||+.||.+||++.+++++
T Consensus 238 ~Pf~~~~~~~----~~i~~----~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 238 HPFGDKYSRE----SNIIR----GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp CTTCSTTTHH----HHHHH----TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCchhhH----HHHhc----CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 9996543211 00000 00000 111112234677899999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=346.42 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=189.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
..+|.+.++||+|+||+||.... . +|+.||||++...... .+.+|+++|+.+ +|||||++++++.+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~---------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-F---------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-S---------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-e---------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 45789999999999999654322 2 5779999999754432 356899999999 89999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-----CCCeEEe
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLS 217 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-----~~~~kl~ 217 (422)
....+||||||+ |+|.+++......+.+..++.++.||+.||.|||+.+ |+||||||+|||++. ...+||+
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 999999999995 6999999776666666677899999999999999998 999999999999943 2357899
Q ss_pred eccCcccCCCCCcc-ceeeccccCccccCCCccc---CCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 014585 218 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 218 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 292 (422)
|||+++........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||....... ....
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~ 241 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANIL 241 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHH
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHH
Confidence 99999876543211 2233467999999999997 4577889999999999999999 888985432111 1000
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..... ... ......+..+.+||.+||+.||.+||++.+++++
T Consensus 242 ~----~~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 242 L----GACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp T----TCCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred h----ccCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 00000 000 0112456678999999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=358.98 Aligned_cols=258 Identities=27% Similarity=0.361 Sum_probs=199.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
.+|++.+.||+|+||.||+|.+.. +|..||||++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 689999999999999999998765 678999999876432 234568899999999999999999998765
Q ss_pred -----cCceEEEEEecCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC--
Q 014585 143 -----DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 213 (422)
Q Consensus 143 -----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~-- 213 (422)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 677899999999999999996543 36899999999999999999999988 999999999999987765
Q ss_pred -eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 214 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 -~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...|.
T Consensus 162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~ 233 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWH 233 (676)
T ss_dssp EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSS
T ss_pred eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhh
Confidence 89999999987644332 2346799999999999999999999999999999999999999975311 01110
Q ss_pred hh-------------hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014585 293 RP-------------HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 344 (422)
Q Consensus 293 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 344 (422)
.. .......+... ......+....+..+.+|+.+||..||.+||++.+++
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00 00000000000 0112234455788999999999999999999997743
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=316.55 Aligned_cols=231 Identities=14% Similarity=0.092 Sum_probs=185.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
..+|++.+.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+.++.+++|+||+++++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 4689999999999999999999866 68899999997654332 36789999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+++..|+||||++|++|.+++.. + .....+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+++|
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~-~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADT-S--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTT-C--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EECCcEEEEEEecCCCCHHHHHhc-C--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence 999999999999999999999843 2 355678899999999999999998 9999999999999999999998543
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
|++ .++.++|||||||++|||++|+.||............. .......
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~ 222 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQP 222 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSCB
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccCC
Confidence 333 36889999999999999999999998754432110000 0000000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. .........+.++.+||.+||+.||.+| |+.++++.|+.+
T Consensus 223 ~--------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 223 I--------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp C--------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred C--------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0 0000111235779999999999999999 999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.76 Aligned_cols=240 Identities=25% Similarity=0.397 Sum_probs=193.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.++||+|+||.||+|.+... +|+.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 447899999999999999999998641 467899999865432 33456889999999999999999999999
Q ss_pred ecCc-----eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 142 EDDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 142 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
..+. .||||||++|++|.+++.. .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.+ .+||
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEE
Confidence 8766 7999999999999987743 6999999999999999999999998 9999999999999875 8999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.........
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------- 285 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------- 285 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------
Confidence 999999876432 3357999999999887654 88999999999999999999888642211100
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 348 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L~ 348 (422)
........+..+.+||.+||+.||.+||+ +.++...|.
T Consensus 286 --------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 --------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp --------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00011123467899999999999999995 555555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=339.99 Aligned_cols=240 Identities=18% Similarity=0.177 Sum_probs=183.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc---cHHHHHHHHHHhcccCC-Ccc-------
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVH-LNL------- 133 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~ni------- 133 (422)
..|...++||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+.+++.+.| .|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 457788899999999999999876 7889999998743322 24678999999999977 221
Q ss_pred --eeeE------------eEEEe-----cCceEEEEEecCCCChhhhhc------cCCCCCCHHHHHHHHHHHHHHHHHH
Q 014585 134 --VKLI------------GYCIE-----DDQRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLAFL 188 (422)
Q Consensus 134 --v~~~------------~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~qi~~al~~L 188 (422)
+..+ .++.. ....+++|+++ +++|.+++. .....+++..++.++.||+.||+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1111 11111 22457778876 789999883 2244578889999999999999999
Q ss_pred HhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcc----------cCCCCCchh
Q 014585 189 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----------MTGHLTSRS 258 (422)
Q Consensus 189 H~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~ 258 (422)
|+.+ |+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++
T Consensus 228 H~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 228 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 9998 999999999999999999999999998864322 334578 999999999 555688899
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014585 259 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338 (422)
Q Consensus 259 DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 338 (422)
|||||||++|||++|+.||.......... .++.. .. ..+..+.+||.+||+.||.+||
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~--~~----~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS--CK----NIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS--CC----CCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh--cc----cCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999997643221111 01110 00 1236899999999999999999
Q ss_pred CHHHHHH
Q 014585 339 LMSEVVE 345 (422)
Q Consensus 339 s~~ell~ 345 (422)
++.++++
T Consensus 357 t~~~~l~ 363 (413)
T 3dzo_A 357 LPLQAME 363 (413)
T ss_dssp CHHHHTT
T ss_pred CHHHHHh
Confidence 9999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=317.11 Aligned_cols=227 Identities=21% Similarity=0.283 Sum_probs=180.2
Q ss_pred cCCCCC-CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHh-cccCCCcceeeEeEEEe
Q 014585 65 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~-~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~ 142 (422)
.+|.+. ++||+|+||.||+|.+.. +|+.||||++.. ...+.+|+.++ +.+.||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567776 789999999999999876 678999999863 24677899888 55699999999999987
Q ss_pred ----cCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCCe
Q 014585 143 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 214 (422)
Q Consensus 143 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~~ 214 (422)
....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence 677899999999999999997653 46999999999999999999999998 999999999999988 7899
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
||+|||++.... +..++.++|||||||++|+|++|..||............
T Consensus 160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~----- 210 (299)
T 3m2w_A 160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----- 210 (299)
T ss_dssp EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-----
T ss_pred EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-----
Confidence 999999986532 235678999999999999999999999754322110000
Q ss_pred hhhcccccccccCcccCCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFS----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. .+... ...++ ...+.++.+|+.+||+.||.+||++.+++++
T Consensus 211 --~~-----~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 211 --KT-----RIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --CC-----SSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HH-----HHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00 00000 00011 1235789999999999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=327.22 Aligned_cols=244 Identities=16% Similarity=0.152 Sum_probs=186.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHhcccC------
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLV------ 129 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 129 (422)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 46799999999999999999987 567999999976532 23367889999888885
Q ss_pred ---CCcceeeEeEEE------------------------------ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHH
Q 014585 130 ---HLNLVKLIGYCI------------------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 176 (422)
Q Consensus 130 ---h~niv~~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 176 (422)
|+|||++.+++. ..+..+||||||++|++.+.+.+ ..+++..++.
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~ 165 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS 165 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence 777777777643 26789999999999987777644 4689999999
Q ss_pred HHHHHHHHHHHHH-hcCCCCeEeccCCCCcEEEcCCC--------------------CeEEeeccCcccCCCCCccceee
Q 014585 177 IALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY--------------------NAKLSDFGLAKDGPEGDKTHVST 235 (422)
Q Consensus 177 i~~qi~~al~~LH-~~~~~~iiHrDlkp~Nill~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~ 235 (422)
++.||+.||.||| +.+ |+||||||+||||+.++ .+||+|||+|+.....
T Consensus 166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 888 99999999999999887 8999999999865321
Q ss_pred ccccCccccCCCcccCCCCCchhhhhhHHHH-HHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCC
Q 014585 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 314 (422)
Q Consensus 236 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (422)
..+||+.|+|||++.+.. +.++||||||++ .++++.|..||... .........+.... ..........
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~~~~~~ 304 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM----TFKTKCNTPA 304 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC----CCSSCCCSHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh----ccCcccchhh
Confidence 247999999999998766 899999998777 77888898888421 00000000000000 0011111112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HH
Q 014585 315 SIKGAQKAAQLAAHCLSRDPKARPLMSEVV-EA 346 (422)
Q Consensus 315 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell-~~ 346 (422)
....+.++.+||.+||+.| |+.|++ ++
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 3467889999999999977 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=296.33 Aligned_cols=186 Identities=18% Similarity=0.107 Sum_probs=130.8
Q ss_pred cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc----------cHHHHHHHHHHhccc-CCCcceeeEeEEE
Q 014585 73 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDL-VHLNLVKLIGYCI 141 (422)
Q Consensus 73 lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 141 (422)
++.|++|.+..++... .|+.||+|++...... ..++|.+|+.+|+++ .|+||+++++++.
T Consensus 242 ~~~~~~~~h~~~rr~~---------fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e 312 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYF---------FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE 312 (569)
T ss_dssp -C--------CCEEEE---------ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE
T ss_pred cccCCccccccccccc---------ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Confidence 3445555554443333 6788999999754321 234689999999999 7999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..||||||++|++|.++|.+ .+++++. .|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+
T Consensus 313 d~~~~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 313 NAQSGWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp CSSEEEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeeccc
Confidence 99999999999999999999954 4567764 47899999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCC
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 277 (422)
|+....... .....+||+.|||||++.+ .+..++|+|++|+++++|.++..++
T Consensus 386 Ar~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 386 IVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp EESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 987644322 2344789999999998875 4677899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=264.80 Aligned_cols=185 Identities=18% Similarity=0.233 Sum_probs=145.9
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc--------HHHHHHHHHHhcccCCCcceeeEeE
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
...++||+|+||.||+|.. .+..+++|......... .+++.+|++++++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 4467899999999999954 46689999875433211 2347899999999999999966666
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+...+..+|||||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEEC
Confidence 6678888999999999999999854 5689999999999999998 999999999999998 9999999
Q ss_pred cCcccCCCCCccc-----eeeccccCccccCCCcccC--CCCCchhhhhhHHHHHHHHHhCCCCC
Q 014585 220 GLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 220 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf 277 (422)
|+++......... .....+||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999875432211 1235789999999999986 67888999999999998888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=216.18 Aligned_cols=147 Identities=14% Similarity=0.068 Sum_probs=117.8
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------------------cHHHHHHHHHH
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNF 124 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~ 124 (422)
....|.+.+.||+|+||.||+|.+ . +|+.||||+++..... ....+.+|+.+
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~ 157 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred CCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence 345566779999999999999998 4 6789999999643221 23468899999
Q ss_pred hcccCCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 125 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
+++++ | +++.+++. .+..++||||++|++|.+ +.. .....++.||+.||.|||+.+ |+||||||+
T Consensus 158 l~~l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp HHHTT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHhcc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 99999 4 66666543 356799999999999998 421 124579999999999999998 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCccc
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 250 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 250 (422)
|||++ ++.+||+|||+++. +..++|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999 99999999999864 33578888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-23 Score=188.90 Aligned_cols=137 Identities=18% Similarity=0.049 Sum_probs=106.4
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcE--EEEEEecCCCccc------------------------HHHHHH
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDGLQG------------------------HKEWLA 120 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~--vavK~~~~~~~~~------------------------~~~~~~ 120 (422)
|.+.+.||+|+||.||+|.+.. +|+. ||||+++...... ...+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 6788999999999999998854 6778 9999975432110 125789
Q ss_pred HHHHhcccCCCcc--eeeEeEEEecCceEEEEEecCC-C----ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hcC
Q 014585 121 EVNFLGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEA 192 (422)
Q Consensus 121 E~~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ 192 (422)
|+.+|.++.|++| ..++++ +..+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999988764 444442 367899999942 3 56555422 234567889999999999999 888
Q ss_pred CCCeEeccCCCCcEEEcCCCCeEEeeccCcccC
Q 014585 193 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225 (422)
Q Consensus 193 ~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~ 225 (422)
|+||||||+|||++. .++|+|||+|...
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-19 Score=172.80 Aligned_cols=136 Identities=14% Similarity=0.097 Sum_probs=100.6
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--------------cHHH--------HHHHHH
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKE--------WLAEVN 123 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------~~~~--------~~~E~~ 123 (422)
-|.+.+.||+|+||.||+|.+. +|+.||||+++..... .... ..+|+.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 3899999999999999999863 5789999997632110 0011 235777
Q ss_pred HhcccCCCcce--eeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 014585 124 FLGDLVHLNLV--KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 201 (422)
Q Consensus 124 ~l~~l~h~niv--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 201 (422)
.|.++.+.++. ..+++ ...+|||||++|+.|.++... .....++.||+.+|.|||+.+ ||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g---IVHrDL 231 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG---LIHGDF 231 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 77777555442 22322 234799999999888765421 123567899999999999998 999999
Q ss_pred CCCcEEEcCCC----------CeEEeeccCcccC
Q 014585 202 KTSNILLDADY----------NAKLSDFGLAKDG 225 (422)
Q Consensus 202 kp~Nill~~~~----------~~kl~DFG~a~~~ 225 (422)
||.|||++++| .+.|+||+-+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999998776 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.1e-14 Score=129.74 Aligned_cols=143 Identities=15% Similarity=-0.000 Sum_probs=111.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 142 (422)
...|++...++.|+++.||++.. .|..+++|+...........+.+|+.+++.+. +..+.++++++..
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 35688888899999999999864 34589999986532222345889999999884 6778899999998
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------ 192 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~------------------------------ 192 (422)
.+..|+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 8899999999999999876421 1223467889999999999811
Q ss_pred --------------------------CCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 193 --------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 193 --------------------------~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1339999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=2.8e-12 Score=117.01 Aligned_cols=137 Identities=17% Similarity=0.046 Sum_probs=98.9
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc--ceeeEeEEEec
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIED 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~ 143 (422)
.|.+..+.+.|..+.||++... +|..+++|+.... ....+..|+.+++.+.+.+ +.+++++....
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3444333345667999998642 3567999997654 2245778999998885544 55688888888
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 192 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~------------------------------- 192 (422)
+..++||||++|.+|. ... .. ...++.++++.|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 8899999999998884 211 11 2356778888888888743
Q ss_pred ------------------------CCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 193 ------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 193 ------------------------~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
+..++|+|++|.|||++.++.+.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776667999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.33 E-value=6.9e-12 Score=120.40 Aligned_cols=142 Identities=15% Similarity=0.195 Sum_probs=106.3
Q ss_pred CCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEec--CCCc-ccHHHHHHHHHHhcccC--CCcceeeEeEEEec
Q 014585 69 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGL-QGHKEWLAEVNFLGDLV--HLNLVKLIGYCIED 143 (422)
Q Consensus 69 ~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 143 (422)
..+.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3567899999999998752 3468888876 3321 22346788999999986 45678899988766
Q ss_pred ---CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 014585 144 ---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---------------------------- 192 (422)
Q Consensus 144 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---------------------------- 192 (422)
+..|+||||++|..+.+.. -..++......++.+++..|..||+..
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 4589999999998885422 224678888899999999999999831
Q ss_pred ---------------------------CCCeEeccCCCCcEEEcCCCC--eEEeeccCccc
Q 014585 193 ---------------------------ERPVIYRDFKTSNILLDADYN--AKLSDFGLAKD 224 (422)
Q Consensus 193 ---------------------------~~~iiHrDlkp~Nill~~~~~--~kl~DFG~a~~ 224 (422)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987753 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.3e-11 Score=115.65 Aligned_cols=183 Identities=20% Similarity=0.207 Sum_probs=121.6
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCc--ceeeEeEEEecC--
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLN--LVKLIGYCIEDD-- 144 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~-- 144 (422)
++.++.|....||++. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 4568999999999862 25889986533 2345688999999888 3333 445555443333
Q ss_pred -ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 014585 145 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 192 (422)
Q Consensus 145 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~------------------------------- 192 (422)
..|+|||+++|..|.+... ..++......++.+++..|..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 3479999999988875432 24677778888889999999988621
Q ss_pred ------------------------CCCeEeccCCCCcEEEcC--CCCeEEeeccCcccCCCCCccceeeccccCccc---
Q 014585 193 ------------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY--- 243 (422)
Q Consensus 193 ------------------------~~~iiHrDlkp~Nill~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y--- 243 (422)
...++|+|+++.||+++. ++.+.|+||+.+......... .....+
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~ 239 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEE 239 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTS
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccc
Confidence 124899999999999988 456789999988653221100 000011
Q ss_pred cCCCcccC-----CCC---------CchhhhhhHHHHHHHHHhCCCCC
Q 014585 244 AAPEYVMT-----GHL---------TSRSDVYSFGVVLLEMLTGRRSM 277 (422)
Q Consensus 244 ~aPE~~~~-----~~~---------~~~~DvwslG~il~elltg~~pf 277 (422)
..|+.... +.. ..-.+.|++|.++|.+.+|..+|
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12221110 011 12368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=4e-08 Score=89.99 Aligned_cols=136 Identities=17% Similarity=0.081 Sum_probs=95.8
Q ss_pred ccccccCc-EEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEEecCceEEE
Q 014585 72 LLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 72 ~lg~G~fg-~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 149 (422)
.+..|..| .||+..... .+..+++|+-... ....+.+|..+|+.+. +--|.++++++.+.+..++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34556555 689876543 4557889986533 2356788999998884 34477889999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------------- 192 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 192 (422)
||+++|.++.+..... ......+..++...|.-||...
T Consensus 99 me~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999998877654221 1223345566666666666431
Q ss_pred ------------------CCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 193 ------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 193 ------------------~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01279999999999999877677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=5.3e-08 Score=93.02 Aligned_cols=86 Identities=5% Similarity=-0.060 Sum_probs=56.1
Q ss_pred CCcc-ccccCcEEEEEEecc--CCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccC-C--CcceeeEeEE
Q 014585 70 ESLL-GEGGFGCVFKGWIEE--NGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLV-H--LNLVKLIGYC 140 (422)
Q Consensus 70 ~~~l-g~G~fg~Vy~~~~~~--~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~ 140 (422)
.+.| +.|....+|+..... ++. ..+..+++|+..... ......+.+|+.+++.|. + ..+.+++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~-----~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGR-----SIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTE-----EEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEECCCCCccceEEEEEEecccCCC-----CCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 3567 788889999886530 000 014578899865432 111245778888888884 2 3567888877
Q ss_pred Eec---CceEEEEEecCCCChhh
Q 014585 141 IED---DQRLLVYEFMPRGSLEN 160 (422)
Q Consensus 141 ~~~---~~~~lv~e~~~~g~L~~ 160 (422)
.+. +..++||||++|..+.+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCCB
T ss_pred cCCCccCCceEEEEecCCCChhh
Confidence 654 35689999999877754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.5e-07 Score=87.95 Aligned_cols=136 Identities=21% Similarity=0.148 Sum_probs=94.5
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCC---cceeeEeEEE-ecCc
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCI-EDDQ 145 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~ 145 (422)
.+.++.|....||+. |..+++|+... ......+..|+++|+.|.+. .|.+++.++. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 456888888899987 12478888532 12345688999999999652 3567777764 4556
Q ss_pred eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 014585 146 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------------- 192 (422)
Q Consensus 146 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------------------------------- 192 (422)
.++||||++|..|.+.... .++......++.++...|..||+..
T Consensus 88 ~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 7899999999888663211 2345555556666666666666432
Q ss_pred ------------------------CCCeEeccCCCCcEEEcC---CCCe-EEeeccCccc
Q 014585 193 ------------------------ERPVIYRDFKTSNILLDA---DYNA-KLSDFGLAKD 224 (422)
Q Consensus 193 ------------------------~~~iiHrDlkp~Nill~~---~~~~-kl~DFG~a~~ 224 (422)
+..++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999987 4565 7999998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=3.8e-07 Score=88.38 Aligned_cols=76 Identities=13% Similarity=0.045 Sum_probs=49.7
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHhcccCC--C-cceeeEeE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLVH--L-NLVKLIGY 139 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~ 139 (422)
.+.||.|.++.||++.... .+..|+||....... ....++..|.++++.+.. + .+.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4579999999999996543 356799998653211 123456788888887732 3 34456543
Q ss_pred EEecCceEEEEEecCCC
Q 014585 140 CIEDDQRLLVYEFMPRG 156 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g 156 (422)
+.+..++|||++++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.1e-06 Score=81.00 Aligned_cols=139 Identities=15% Similarity=0.191 Sum_probs=78.6
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC--CcceeeEe------EEEe
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIG------YCIE 142 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~------~~~~ 142 (422)
+.|+.|..+.||++... +..+++|+.... ...+..|+.+++.|.. -.+.+++. +...
T Consensus 38 ~~l~gG~~n~~~~v~~~-----------~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~ 102 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-----------SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH 102 (346)
T ss_dssp EECC----CEEEEEEET-----------TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred eeccccccCcEEEEEeC-----------CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence 34666778999998652 235889998752 2344455555555531 12333332 1234
Q ss_pred cCceEEEEEecCCCChhh--------------hhcc--CCC--C---------CCHHH----------------------
Q 014585 143 DDQRLLVYEFMPRGSLEN--------------HLFR--RSL--P---------LPWSI---------------------- 173 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~--------------~l~~--~~~--~---------~~~~~---------------------- 173 (422)
.+..++||||++|..+.. .++. ... + ..|..
T Consensus 103 ~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 182 (346)
T 2q83_A 103 GSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKED 182 (346)
T ss_dssp TTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred CCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCC
Confidence 667889999999875530 0111 000 0 11211
Q ss_pred ---------HHHHHHHHHHHHHHHHh--------c--CCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 174 ---------RMKIALGAAKGLAFLHE--------E--AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 174 ---------~~~i~~qi~~al~~LH~--------~--~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
...+..++..++.+|+. . .+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 183 PFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223445666653 1 234599999999999998888999999997753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.4e-06 Score=77.96 Aligned_cols=75 Identities=19% Similarity=0.122 Sum_probs=59.2
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC---CCcceeeEeEEEecCce
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 146 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~ 146 (422)
.+.|+.|.+..+|+... .+..+++|+.... ....+..|+..|+.|. ...+.++++++...+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 45789999999999864 3457889987643 2456888999998884 35688899988888889
Q ss_pred EEEEEecCCCCh
Q 014585 147 LLVYEFMPRGSL 158 (422)
Q Consensus 147 ~lv~e~~~~g~L 158 (422)
++||||++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.1e-05 Score=78.79 Aligned_cols=76 Identities=14% Similarity=0.170 Sum_probs=45.9
Q ss_pred CCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeecccc--CccccCCCcccCC---CCCchhhhhhHHHHHH
Q 014585 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTG---HLTSRSDVYSFGVVLL 268 (422)
Q Consensus 194 ~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il~ 268 (422)
..++|+|+++.|||++.++ ++|+||+.+......... ..... ...|++|+..... .-....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4499999999999998876 999999988753211000 00011 1245666544311 1122345557777777
Q ss_pred HHHhC
Q 014585 269 EMLTG 273 (422)
Q Consensus 269 elltg 273 (422)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77664
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=5.2e-05 Score=69.78 Aligned_cols=80 Identities=19% Similarity=0.138 Sum_probs=57.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC---CcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~ 141 (422)
....-++.+|.|..+.||+.... +|+.|++|+...........+..|+..|+.|.- .-+.+++++.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-
T ss_pred CCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-
Confidence 34555677999999999999764 577899998765544444567889999988842 2345565542
Q ss_pred ecCceEEEEEecCCCCh
Q 014585 142 EDDQRLLVYEFMPRGSL 158 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L 158 (422)
..++||||++++..
T Consensus 84 ---~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 ---DRTLAMEWVDERPP 97 (288)
T ss_dssp ---TTEEEEECCCCCCC
T ss_pred ---CceEEEEeecccCC
Confidence 34789999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.90 E-value=5.4e-05 Score=70.75 Aligned_cols=140 Identities=13% Similarity=0.102 Sum_probs=76.7
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc--ceeeEeE------EEe
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY------CIE 142 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~ 142 (422)
+.|+.|....+|+.... .| .+++|+..... ....+..|+.+++.|...+ +.+++.. ...
T Consensus 28 ~~i~~G~~n~~~~v~~~----------~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT----------KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEECC---EEEEEEEES----------SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eccCCCcccceEEEEeC----------Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 34667888899998652 22 58899887531 1234566777776663222 2333321 123
Q ss_pred cCceEEEEEecCCCChhhh--------------hccC----CCC----CC---HHHHHH------------HHHHHHHHH
Q 014585 143 DDQRLLVYEFMPRGSLENH--------------LFRR----SLP----LP---WSIRMK------------IALGAAKGL 185 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~--------------l~~~----~~~----~~---~~~~~~------------i~~qi~~al 185 (422)
.+..++||+|++|..+... ++.. ... .. |...+. +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 4567899999988664320 1110 000 11 111000 001134455
Q ss_pred HHHHhc----CCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 186 AFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 186 ~~LH~~----~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
..++.. .+..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 555532 12459999999999999877656899998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.77 E-value=4.1e-05 Score=71.03 Aligned_cols=136 Identities=9% Similarity=0.035 Sum_probs=75.7
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~l 148 (422)
.+.|+.|....+|++ . .+++|+....... .....+|+.+++.+...++ .+++++ +.+.-++
T Consensus 23 i~~l~gG~tN~~~~~---~------------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---G------------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---T------------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---e------------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 678999999999998 1 4888988653211 1123468877777743333 355543 3445678
Q ss_pred EEEec-CCCChhhh------------------hccCCCCC----CH-HHHHHHHH--------------HHHHHHH----
Q 014585 149 VYEFM-PRGSLENH------------------LFRRSLPL----PW-SIRMKIAL--------------GAAKGLA---- 186 (422)
Q Consensus 149 v~e~~-~~g~L~~~------------------l~~~~~~~----~~-~~~~~i~~--------------qi~~al~---- 186 (422)
|+||+ +|.+|... ++.....+ .. ..+..+.. .+...+.
T Consensus 85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 99999 66555321 01111101 11 11111110 0111111
Q ss_pred HHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 187 FLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 187 ~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
.|.. ..+..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1111 12234899999999999 5667889999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00013 Score=69.83 Aligned_cols=148 Identities=16% Similarity=0.119 Sum_probs=84.0
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc-ceeeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l 148 (422)
++.|..|-...+|++....... .....+..|++|+.... ......+.+|.++++.|.-.+ ..++++++.. .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 3467778888999987632100 00113467999986432 234556779999998884333 3566665532 39
Q ss_pred EEEecCCCChhhh-h----------------ccC----CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 014585 149 VYEFMPRGSLENH-L----------------FRR----SLPLP--WSIRMKIALGAAK-------------------GLA 186 (422)
Q Consensus 149 v~e~~~~g~L~~~-l----------------~~~----~~~~~--~~~~~~i~~qi~~-------------------al~ 186 (422)
||||++|..|..- + +.. ..... +..+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665421 0 111 11122 3445555544322 233
Q ss_pred HHH----hc-CCCCeEeccCCCCcEEEcCC----CCeEEeeccCccc
Q 014585 187 FLH----EE-AERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 224 (422)
Q Consensus 187 ~LH----~~-~~~~iiHrDlkp~Nill~~~----~~~kl~DFG~a~~ 224 (422)
.|. .. .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 21 12349999999999999876 7899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.72 E-value=9.5e-05 Score=72.19 Aligned_cols=81 Identities=19% Similarity=0.120 Sum_probs=51.0
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~l 148 (422)
.+.|+.|....||++........ ....+..+++|+..... ....+..|+.+++.|...++ .++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 45678888899999976421000 00124678999884321 12456689999988854444 56676543 2 38
Q ss_pred EEEecCCCCh
Q 014585 149 VYEFMPRGSL 158 (422)
Q Consensus 149 v~e~~~~g~L 158 (422)
||||++|..|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00026 Score=69.57 Aligned_cols=74 Identities=14% Similarity=0.036 Sum_probs=46.8
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv 149 (422)
+.|+.|-...+|++.... .+..+++|+..... ...-....|+.+++.|...++ .++++++. + .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence 467778889999987632 23678899875432 111122588888888865554 56777652 2 359
Q ss_pred EEecCCCCh
Q 014585 150 YEFMPRGSL 158 (422)
Q Consensus 150 ~e~~~~g~L 158 (422)
|||++|..|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987655
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00014 Score=63.02 Aligned_cols=99 Identities=15% Similarity=0.073 Sum_probs=66.6
Q ss_pred ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeec
Q 014585 157 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236 (422)
Q Consensus 157 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 236 (422)
+|.++|...+.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------------
Confidence 7889998888999999999999999999877622110 11233457899999999998764 1111
Q ss_pred cccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhC
Q 014585 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 273 (422)
Q Consensus 237 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 273 (422)
.....+.|||... ...+.+.=|||||+++|..+--
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123467888653 3446788899999999999853
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00025 Score=66.35 Aligned_cols=140 Identities=15% Similarity=0.106 Sum_probs=79.1
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCC--cceeeEeE-----EEec
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLIGY-----CIED 143 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~ 143 (422)
..|+ |....||++... .|..+++|+..... .....+..|+.+++.|... .+.+++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 3566 888899987542 35568999986432 2345667788888777422 23444432 2234
Q ss_pred CceEEEEEecCCCChhh----h----------hcc----C----CCCCCHHHH----HHH---------------HHHHH
Q 014585 144 DQRLLVYEFMPRGSLEN----H----------LFR----R----SLPLPWSIR----MKI---------------ALGAA 182 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~----~----------l~~----~----~~~~~~~~~----~~i---------------~~qi~ 182 (422)
+..++||+|++|..+.. . ++. . ...+..... ..+ ...+-
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 56688999998755421 0 110 0 011221111 001 01111
Q ss_pred HHHHHHHhc----CCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 183 KGLAFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 183 ~al~~LH~~----~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..+..+... .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222333221 234489999999999998 4 899999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00026 Score=66.51 Aligned_cols=32 Identities=31% Similarity=0.378 Sum_probs=27.5
Q ss_pred CCeEeccCCCCcEEEcCC----CCeEEeeccCcccC
Q 014585 194 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDG 225 (422)
Q Consensus 194 ~~iiHrDlkp~Nill~~~----~~~kl~DFG~a~~~ 225 (422)
..++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999874 67899999988653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00022 Score=68.04 Aligned_cols=83 Identities=10% Similarity=0.046 Sum_probs=45.2
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc-ceeeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l 148 (422)
.+.|+.|....+|++........ ..+..+..+++|+..... ........|+.+++.+...+ +.++++.. . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 34677888899999876320000 000123578888875432 11112457888888774334 34666543 2 378
Q ss_pred EEEecCCCCh
Q 014585 149 VYEFMPRGSL 158 (422)
Q Consensus 149 v~e~~~~g~L 158 (422)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0016 Score=61.28 Aligned_cols=31 Identities=13% Similarity=0.153 Sum_probs=27.3
Q ss_pred CCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 194 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 194 ~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.011 Score=57.34 Aligned_cols=82 Identities=12% Similarity=0.042 Sum_probs=48.6
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCc-ceeeEeEEEecCceEE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 148 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l 148 (422)
++.|..|-...+|+......... ....+..|++++..... ...-...+|.++++.+...+ ..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 34577788889999986421100 00125689999875432 11223457888888874333 34566533 2 378
Q ss_pred EEEecCCCCh
Q 014585 149 VYEFMPRGSL 158 (422)
Q Consensus 149 v~e~~~~g~L 158 (422)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.033 Score=53.53 Aligned_cols=29 Identities=28% Similarity=0.319 Sum_probs=24.6
Q ss_pred eEeccCCCCcEEE------cCCCCeEEeeccCccc
Q 014585 196 VIYRDFKTSNILL------DADYNAKLSDFGLAKD 224 (422)
Q Consensus 196 iiHrDlkp~Nill------~~~~~~kl~DFG~a~~ 224 (422)
++|+|+.+.|||+ +++..+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999988754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.76 E-value=0.98 Score=38.88 Aligned_cols=116 Identities=8% Similarity=0.023 Sum_probs=78.5
Q ss_pred CCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEE
Q 014585 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 208 (422)
Q Consensus 129 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill 208 (422)
.||+++.. .+-.+++.+.+.++.-+ +...+- .-..++....++++.+|+....+++. =+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 57888866 45556666555555433 233322 12346788999999999988766654 5788899999999
Q ss_pred cCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 014585 209 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 278 (422)
Q Consensus 209 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 278 (422)
+.++.+++.-.|+-... +|. .++...=+-.+=|++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999877754322 222 12222335567889999999988775
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.71 E-value=0.69 Score=39.99 Aligned_cols=115 Identities=10% Similarity=0.084 Sum_probs=75.9
Q ss_pred CCCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeccCCCCcEE
Q 014585 129 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA-FLHEEAERPVIYRDFKTSNIL 207 (422)
Q Consensus 129 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~-~LH~~~~~~iiHrDlkp~Nil 207 (422)
.||++ -..+-.+++.+.+.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 57777 344446667766666654333222222 24678889998888887666 5544 678889999999
Q ss_pred EcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 014585 208 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 278 (422)
Q Consensus 208 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 278 (422)
++.++.++|.-.|+-.. ++|.- ++..-=+-.+=|++..++.++..|.
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987775432 33331 1222224467788888988877664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.56 E-value=0.1 Score=51.07 Aligned_cols=63 Identities=8% Similarity=0.090 Sum_probs=18.9
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEE------EEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV------KTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
.+.+.|| ||.||+|.+.. ....||| |....... +....+.+|..+++.++|+|+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~---------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK---------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhcccccc---------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 4566777 99999998854 2236777 66654322 223467889999999999999999988
Q ss_pred EEe
Q 014585 140 CIE 142 (422)
Q Consensus 140 ~~~ 142 (422)
...
T Consensus 213 ~~~ 215 (463)
T 3cxl_A 213 KVH 215 (463)
T ss_dssp EEE
T ss_pred EEe
Confidence 654
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=85.67 E-value=4.6 Score=40.51 Aligned_cols=82 Identities=12% Similarity=0.086 Sum_probs=50.9
Q ss_pred eeeEeEEEecCceEEEEEecCCCChhhhhc----------cCCCC------CCHHHHHHHHHHHH--HHHHHHHhcCCCC
Q 014585 134 VKLIGYCIEDDQRLLVYEFMPRGSLENHLF----------RRSLP------LPWSIRMKIALGAA--KGLAFLHEEAERP 195 (422)
Q Consensus 134 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----------~~~~~------~~~~~~~~i~~qi~--~al~~LH~~~~~~ 195 (422)
++.|.+........| .|++++.++.+.+. +.... ..+..+..++..++ ..+.|+=..
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi---- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV---- 476 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence 445555555555444 57777655554442 21110 12455566666654 345666432
Q ss_pred eEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 196 VIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 196 iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+|=.++||||+.+|++.=+|||.+-
T Consensus 477 ---gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 ---GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp ---CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred ---cCCCCcceeEcCCCCEeeeehHHhh
Confidence 5778999999999999999999874
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=81.59 E-value=10 Score=38.71 Aligned_cols=81 Identities=15% Similarity=0.137 Sum_probs=49.3
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccCC----------C----CC--CHHHHHHHHHHHH--HHHHHHHhcCCCCe
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------L----PL--PWSIRMKIALGAA--KGLAFLHEEAERPV 196 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~----~~--~~~~~~~i~~qi~--~al~~LH~~~~~~i 196 (422)
+.|.+........| .|+++..+|.+++.+.+ . .+ ....+..++..++ ..+.|+=.
T Consensus 477 ~~Y~Vipls~~~GL-IE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YILG------ 549 (696)
T 2x6h_A 477 TPYKVLATSSKHGF-LQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLLG------ 549 (696)
T ss_dssp CCCCEEESSTTCEE-EECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHHT------
T ss_pred eccEEEeccCCCCe-eeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHcc------
Confidence 44455544444444 46666555555543221 1 11 1244555665554 34566633
Q ss_pred EeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 197 IYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 197 iHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
=+|=.++||||+.+|.+.-+|||.+-
T Consensus 550 -lGDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 550 -VGDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp -CCCCCTTTEEECTTSCEEECCCCSCT
T ss_pred -CCCCCCcceEEeCCCCEEEEeehhhh
Confidence 36889999999999999999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 422 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-76 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-69 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 1e-76
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 33/290 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 123
+G G FG V+KG VAVK LN Q + + EV
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
L H+N++ +GY Q +V ++ SL +HL + IA A+
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
G+ +LH + +I+RD K++NI L D K+ DFGLA +H ++ G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 244 AAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300
APE + + +SDVY+FG+VL E++TG+ P N + +G
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGY 226
Query: 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
L ++ + + +L A CL + RPL +++ +++ L
Sbjct: 227 LSPDL--SKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (560), Expect = 2e-69
Identities = 73/309 (23%), Positives = 127/309 (41%), Gaps = 38/309 (12%)
Query: 55 FTFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 105
FTF D A R F E ++G G FG V G ++ G + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 106 TLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 164
TL + +++L+E + +G H N++ L G + +++ EFM GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 165 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224
+ + G A G+ +L + ++RD NIL++++ K+SDFGL++
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 225 GPEGDKTHVSTRV---MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281
+ T + APE + TS SDV+S+G+V+ E+++ R
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----R 232
Query: 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341
P + + I+ + QL C +D RP
Sbjct: 233 PYWDMTNQDV-----------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 342 EVVEALKPL 350
++V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 1e-68
Identities = 85/326 (26%), Positives = 136/326 (41%), Gaps = 36/326 (11%)
Query: 40 SKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 99
S L EL A + + L + +F ++G G FGCV+ G + +N G
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIV---HF--NEVIGRGHFGCVYHGTLLDND------GKK 55
Query: 100 LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGS 157
+ AVK+LN G ++L E + D H N++ L+G C+ + L+V +M G
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 158 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 217
L N + + + L AKG+ FL + ++RD N +LD + K++
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 172
Query: 218 DFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 275
DFGLA+D E D H T + A E + T T++SDV+SFGV+L E++T
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 276 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 335
P + N + L + RL+ P ++ C +
Sbjct: 233 -----PPYPDVNTFDITVYLL----QGRRLLQPEYC-------PDPLYEVMLKCWHPKAE 276
Query: 336 ARPLMSEVVEALKPLPNLKDMASSSY 361
RP SE+V + + Y
Sbjct: 277 MRPSFSELVSRISAI--FSTFIGEHY 300
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 3e-68
Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 31/285 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+G G FG V G+ VA+KT+ ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
L H LV+L G C+E LV+EFM G L ++L + + + L +G+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
A+L E VI+RD N L+ + K+SDFG+ + + D+ ST +A+
Sbjct: 115 AYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWAS 170
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PE +S+SDV+SFGV++ E+ + + +NR N E +VE +RL
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI-------STGFRL 221
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
PRL + Q+ HC P+ RP S ++ L +
Sbjct: 222 YKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-68
Identities = 56/284 (19%), Positives = 107/284 (37%), Gaps = 31/284 (10%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 124
++ LG G FG V G VA+K + E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184
+ +L H LV+L G C + ++ E+M G L N+L +++ +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
+ +L + ++RD N L++ K+SDFGL++ + D+ S ++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304
PE +M +S+SD+++FGV++ E+ + + + N E
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAE 212
Query: 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
I L + ++K + C RP ++ +
Sbjct: 213 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-66
Identities = 67/313 (21%), Positives = 125/313 (39%), Gaps = 43/313 (13%)
Query: 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 118
++L +F S LG G G VFK +GL +A K ++ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 119 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
+ E+ L + +V G D + + E M GSL+ L + +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 238
+ KGL +L E+ +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR----------------------- 275
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 276 ---SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 332
+ + +RP + +++ S + + CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 333 DPKARPLMSEVVE 345
+P R + +++
Sbjct: 285 NPAERADLKQLMV 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 4e-66
Identities = 69/299 (23%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 53 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 112
++ ++ + + LG G +G V++G V LTVAVKTL D +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTM 55
Query: 113 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPW 171
+ +E+L E + ++ H NLV+L+G C + ++ EFM G+L ++L + +
Sbjct: 56 EV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 114
Query: 172 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 231
+ + +A + + +L + + I+RD N L+ ++ K++DFGL++ GD
Sbjct: 115 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 170
Query: 232 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291
+ APE + + +SDV++FGV+L E+ T S +
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------ 224
Query: 292 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
Y L++ +K +L C +P RP +E+ +A + +
Sbjct: 225 ----------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-66
Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 33/286 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+ LG G FG V+ G+ VAVK+L +LAE N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 184
L H LV+L + ++ E+M GSL + L S + L + + +A A+G
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
+AF+ E R I+RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWT 177
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304
APE + G T +SDV+SFG++L E++T R P E + R YR
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNL----ERGYR 228
Query: 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
++ P + ++ QL C P+ RP + L+
Sbjct: 229 MVRPD---NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-65
Identities = 68/304 (22%), Positives = 130/304 (42%), Gaps = 30/304 (9%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 119
++ + ++G G FG V+KG ++ + + VA+KTL + + ++L
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57
Query: 120 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVM 238
G A G+ +L ++RD NIL++++ K+SDFGL++ + + T+ ++
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
+ APE + TS SDV+SFG+V+ E++T N E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL----PNLK 354
+ I+ + QL C ++ RP +++V L L +LK
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
Query: 355 DMAS 358
+A
Sbjct: 279 TLAD 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-65
Identities = 70/307 (22%), Positives = 113/307 (36%), Gaps = 46/307 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 124
N +LG G FG V K G + VAVK L +E ++E+
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 125 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------- 167
+ L H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 168 ------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221
L + + A AKG+ FL + ++RD N+L+ K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 281
A+D V + APE + G T +SDV+S+G++L E+ + +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 341
P + FY+LI + ++ + C + D + RP
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 342 EVVEALK 348
+ L
Sbjct: 316 NLTSFLG 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-65
Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 31/310 (10%)
Query: 59 DLKLATRNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 116
L L N + LG G FG V +G + VA+K L + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54
Query: 117 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
E + E + L + +V+LIG C + + +LV E G L L + +P S +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 235
+ + G+ +L E + ++RD N+LL + AK+SDFGL+K G + +
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295
+ APE + +SRSDV+S+GV + E L+ + +P + E
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE----- 220
Query: 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-PLPNLK 354
I+ + + L + C + RP V + ++ +L
Sbjct: 221 ------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 355 DMASSSYYFQ 364
++
Sbjct: 275 SKVEGHHHHH 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 77/314 (24%), Positives = 117/314 (37%), Gaps = 46/314 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 124
LG G FG V + +K +TVAVK L +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 125 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------S 166
L L H+N+V L+G C L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 167 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 226
L L + + AKG+AFL + I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 227 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286
V + APE + T SDV+S+G+ L E+ + S P
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 287 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346
FY++I + + C DP RP ++V+
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 347 LKPLPNLKDMASSS 360
++ K ++ S+
Sbjct: 302 IE-----KQISEST 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 3e-64
Identities = 71/318 (22%), Positives = 116/318 (36%), Gaps = 47/318 (14%)
Query: 57 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 115
L+ N +GEG FG VF+ + VAVK L +
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 116 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-------- 167
++ E + + + N+VKL+G C L++E+M G L L S
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 168 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212
PL + ++ IA A G+A+L E R ++RD T N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
K++DFGL+++ D + PE + T+ SDV+++GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 273 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 332
+ E ++ + R G L L C S+
Sbjct: 238 YGLQPYYGMAHEE--VIYYVRD--GNILACPENCPLEL------------YNLMRLCWSK 281
Query: 333 DPKARPLMSEVVEALKPL 350
P RP + L+ +
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-64
Identities = 70/313 (22%), Positives = 119/313 (38%), Gaps = 35/313 (11%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 124
R + +G+G FG V++G G VAVK + + AE+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50
Query: 125 LGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
L H N++ I +D+ Q LV ++ GSL ++L R + +K+AL
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALS 108
Query: 181 AAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HV 233
A GLA LH E + + +RD K+ NIL+ + ++D GLA T
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 234 STRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRR----SMDKNRPN 283
+GT Y APE + R+D+Y+ G+V E+ D P
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 343
+ + + + + +L S + + A++ C + AR +
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 344 VEALKPLPNLKDM 356
+ L L + +
Sbjct: 289 KKTLSQLSQQEGI 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 6e-64
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 39/286 (13%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 124
+ + +G+G FG V G G VAVK + +D + +LAE +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 125 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAA 182
+ L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+ + +L ++RD N+L+ D AK+SDFGL K+ T
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302
+ APE + +++SDV+SFG++L E+ + R P L + R
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------PRV 213
Query: 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
+ ++ +C D RP ++ E L+
Sbjct: 214 EKGYKMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-63
Identities = 76/288 (26%), Positives = 119/288 (41%), Gaps = 29/288 (10%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 121
++ R LG+G FG V +G + G ++VAVK L D L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
VN + L H NL++L G + ++ V E P GSL + L + + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGT 240
A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 241 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300
+ + APE + T + SD + FGV L EM T + P N + E
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGE 232
Query: 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
R PR E Q + C + P+ RP + + L
Sbjct: 233 RL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-62
Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 33/296 (11%)
Query: 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGD 127
+ LG G FG V KG+ + TVAVK L ++ E LAE N +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 128 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 187
L + +V++IG C E + +LV E G L +L + + +++ + G+ +
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 122
Query: 188 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 246
L E ++RD N+LL + AK+SDFGL+K + T + AP
Sbjct: 123 LEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 247 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306
E + +S+SDV+SFGV++ E + + +P E ++
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAML 223
Query: 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYY 362
+ ++ L C + D + RP + V L+ D+ + ++
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDVVNEGHH 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-62
Identities = 72/308 (23%), Positives = 123/308 (39%), Gaps = 47/308 (15%)
Query: 64 TRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 117
TR+ PE LG+G FG V+K T + A K ++ + ++
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55
Query: 118 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 177
++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
L +LH + +I+RD K NIL D + KL+DFG++ +
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 238 MGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292
+GT + APE VM ++DV+S G+ L+EM P+ E N +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVL 224
Query: 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV-------VE 345
+ L P +S CL ++ AR S++ V+
Sbjct: 225 LKIA--KSEPPTLAQPS---RWS----SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
Query: 346 ALKPLPNL 353
+ KP+ L
Sbjct: 276 SNKPIREL 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-62
Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 26/285 (9%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 125
F+ +LG G FG V+KG G + VA+K L + +KE L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
+ + ++ +L+G C+ +L + + MP G L +++ + + + AKG+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
+L + R +++RD N+L+ + K++DFGLAK +K + + + A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
E ++ T +SDV+S+GV + E++T P E +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 225
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
++ + C D +RP E++ +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-62
Identities = 68/296 (22%), Positives = 112/296 (37%), Gaps = 45/296 (15%)
Query: 53 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 112
R++ D F LG+G FG V+ + + +A+K L L
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 44
Query: 113 ---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 169
+ EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KF 103
Query: 170 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 229
A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 104 DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
Query: 230 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289
+T + GT Y PE + + D++S GV+ E L G+ P +
Sbjct: 161 RTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQ 210
Query: 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
E + F + A L + L +P RP++ EV+E
Sbjct: 211 ETYKRISRVEFTFPDFVTE------------GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-62
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 53/318 (16%)
Query: 50 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 109
+ +ND+K + ++GEG FG V K I+++G + A+K +
Sbjct: 2 TIYPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKE 47
Query: 110 DGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 167
H+++ E+ L L H N++ L+G C L E+ P G+L + L + +
Sbjct: 48 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 107
Query: 168 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 212
L + A A+G+ +L + + I+RD NIL+ +Y
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 164
Query: 213 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 272
AK++DFGL++ K T + A E + T+ SDV+S+GV+L E+++
Sbjct: 165 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 273 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 332
+ P E Y + + + L C
Sbjct: 222 LGGT-----PYCGMTCAEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 265
Query: 333 DPKARPLMSEVVEALKPL 350
P RP ++++ +L +
Sbjct: 266 KPYERPSFAQILVSLNRM 283
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-61
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 33/286 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+ R E LG+G FG V+ G VA+KTL + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKG 184
L H LV+L ++ +V E+M +GSL + L L + +A A G
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
+A++ ++RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWT 181
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304
APE + G T +SDV+SFG++L E+ T R N E
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD 225
Query: 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
++ + + L C ++P+ RP + L+
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 9e-61
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 30/282 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 124
++ LGEG +G V V T VAVK ++ + + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184
L H N+VK G+ E + + L E+ G L + + +P + G
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT Y
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 245 APEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
APE + + DV+S G+VL ML G D+ + + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YS 217
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ + + K L L +P AR + ++ +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-60
Identities = 61/289 (21%), Positives = 111/289 (38%), Gaps = 37/289 (12%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 123
++ +G G +G K + G + K L++ + + ++EVN
Sbjct: 5 DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSIRMKIA 178
L +L H N+V+ I+ L V E+ G L + + + + L +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 179 LGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
L H + V++RD K +N+ LD N KL DFGLA+ T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
+GT Y +PE + +SD++S G +L E+ P + E A
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227
Query: 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ R+ +S + ++ L+ RP + E++E
Sbjct: 228 EGKF-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-59
Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 38/288 (13%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 122
R + + +G G F V+KG + T + VA L L + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 123 NFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
L L H N+V+ +LV E M G+L+ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWC 118
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRV 237
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 119 RQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
+GT + APE + DVY+FG+ +LEM T + + +
Sbjct: 174 IGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------- 221
Query: 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ R+ F + ++ C+ ++ R + +++
Sbjct: 222 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-59
Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 124
+GEG FG V +G L VA+KT + +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 184
+ H ++VKLIG ++ ++ E G L + L R L + + A +
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 185 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 244
LA+L + ++RD N+L+ ++ KL DFGL++ + + +++ +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWM 176
Query: 245 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-GERRRFY 303
APE + TS SDV+ FGV + E+L +P + GER
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERLPMP 231
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
P L L C + DP RP +E+ L +
Sbjct: 232 PNCPPTL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 5e-59
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 43/289 (14%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 120
+ F +G G FG V+ VA+K +++ G Q +++W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
EV FL L H N ++ G + + LV E+ + + + PL + G
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHG 123
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 240
A +GLA+LH +I+RD K NILL KL DFG A + +GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 174
Query: 241 YGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPHL 296
+ APE ++ G + DV+S G+ +E+ + + + N + +++ + P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-- 232
Query: 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
GH+S + CL + P+ RP +++
Sbjct: 233 -----------ALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-58
Identities = 74/309 (23%), Positives = 129/309 (41%), Gaps = 37/309 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 124
LG+G FG V++G VK VA+KT+N ++ E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 125 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPLPWSIRM 175
+ + ++V+L+G + L++ E M RG L+++L P S +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
++A A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295
+ + + +PE + G T+ SDV+SFGVVL E+ T + N +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------- 243
Query: 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL--PNL 353
R + +L C +PK RP E++ ++K P
Sbjct: 244 ------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 354 KDMASSSYY 362
+++ S YY
Sbjct: 298 REV--SFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-57
Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 36/302 (11%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 123
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
+ + + N+V + + D+ +V E++ GSL + + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQ 127
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
L FLH VI+RD K+ NILL D + KL+DFG + ++GT +
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
APE V + D++S G++ +EM+ G P N +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA--TNGTP 234
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-----ALKPLPNLKDMAS 358
L +P S CL D + R E+++ KPL +L + +
Sbjct: 235 ELQNPE---KLS----AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287
Query: 359 SS 360
++
Sbjct: 288 AA 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 1e-56
Identities = 82/303 (27%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 124
+ LG G FG V + K T TVAVK L H+ ++E+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 125 LGDLVH-LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SL 167
L + H LN+V L+G C + L ++ EF G+L +L +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 168 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227
L + + AKG+ FL R I+RD NILL K+ DFGLA+D +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 228 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 287
+ APE + T +SDV+SFGV+L E+ + S P
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241
Query: 288 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 347
+ E L E R R + + + Q C +P RP SE+VE L
Sbjct: 242 IDEEFCRRLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 348 KPL 350
L
Sbjct: 292 GNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-56
Identities = 75/302 (24%), Positives = 118/302 (39%), Gaps = 38/302 (12%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 124
LGEG FG V E G KP VAVK L D + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 125 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------------- 168
+ + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 169 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228
L + A A+G+ +L + I+RD N+L+ D K++DFGLA+D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 229 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288
D +T + APE + T +SDV+SFGV+L E+ T S P E
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245
Query: 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
++L+ + + C P RP ++VE L
Sbjct: 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 349 PL 350
+
Sbjct: 293 RI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-54
Identities = 59/289 (20%), Positives = 99/289 (34%), Gaps = 34/289 (11%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 117
K +F+ +LGEG F V + T A+K L +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54
Query: 118 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 177
E + + L H VKL +D++ + G L ++ + +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFY 113
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
L +LH + +I+RD K NILL+ D + +++DFG AK K +
Sbjct: 114 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
+GT Y +PE + SD+++ G ++ +++ G P N + +
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIK 224
Query: 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346
F P KA L L D R E+
Sbjct: 225 LEYDFPEKFFP------------KARDLVEKLLVLDATKRLGCEEMEGY 261
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (458), Expect = 8e-54
Identities = 61/282 (21%), Positives = 98/282 (34%), Gaps = 31/282 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
++ LG G FG V + + TG A K + + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
L H LV L +D++ +++YEFM G L + + ++ KGL
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
+H E ++ D K NI+ + KL DFGL V GT +
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 191
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
AAPE + +D++S GV+ +L+G P G N E R
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMD 245
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ ++ L DP R + + +E
Sbjct: 246 DSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (456), Expect = 2e-53
Identities = 70/344 (20%), Positives = 126/344 (36%), Gaps = 38/344 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+ LG G FG V + V+ TG K +N E++ +
Sbjct: 30 YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
L H L+ L + + +L+ EF+ G L + + + + + A +GL
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
+H E +++ D K NI+ + + K+ DFGLA + T +
Sbjct: 141 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
AAPE V + +D+++ GV+ +L+G P + +E + F
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFD 248
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKP-LPNLKDMASSS 360
+ +A + L ++P+ R + + +E LK NL SS
Sbjct: 249 EDAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300
Query: 361 YYFQTMQ--AERIGSSPNTRNGIR--AQGGSLSRNGQRSLSIPN 400
Y + Q E+ P + I A SL ++ + I +
Sbjct: 301 RYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (429), Expect = 2e-50
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 36/290 (12%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 123
+ +LG GG V VAVK L D + + + E
Sbjct: 9 YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
L H +V + + +V E++ +L + + P+ +++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIA 118
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 238
A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+ + V+
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
GT Y +PE + +RSDVYS G VL E+LTG P + V A H+ E
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE 229
Query: 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 347
L + + L+++P+ R +E+ L
Sbjct: 230 DPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (432), Expect = 8e-50
Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 39/280 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 122
+F ++G GGFG V+ K TG A+K L+ + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 123 N---FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 179
+ +V + D+ + + M G L HL + + +R A
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAA 114
Query: 180 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 239
GL +H R V+YRD K +NILLD + ++SD GLA D + +G
Sbjct: 115 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 167
Query: 240 TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
T+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--- 224
Query: 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
L FS + L L RD R
Sbjct: 225 --------AVELPDSFS----PELRSLLEGLLQRDVNRRL 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 9e-50
Identities = 57/350 (16%), Positives = 124/350 (35%), Gaps = 45/350 (12%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+ LG G FG V + V+ + T K + G E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
H N++ L ++ ++++EF+ + + + L + + L
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
FLH + + D + NI+ ++ K+ +FG A+ GD + + Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 303
APE +++ +D++S G ++ +L+G P + + F
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFD 223
Query: 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EALKPLPN--LKD 355
+ + +A L ++ K+R SE + + ++ + ++
Sbjct: 224 EEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
Query: 356 MASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYAS 405
+ YY ++ + R + GG++ Q+ +S+ AS
Sbjct: 276 LKHRRYYHTLIKKDLNMVVSAAR---ISCGGAIRS--QKGVSVAKVKVAS 320
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (424), Expect = 1e-49
Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 46/296 (15%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 116
N+ P+ +LG G V + + T AVK ++ G + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 117 EWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 175
L EV+ L + H N+++L + LV++ M +G L ++L + L
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 113
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 235
KI + + LH+ +++RD K NILLD D N KL+DFG + G+K
Sbjct: 114 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167
Query: 236 RVMGTYGYAAPEYVMTGHL------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 289
V GT Y APE + D++S GV++ +L G P +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQM 221
Query: 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
R + +F + L + L P+ R E +
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 4e-49
Identities = 52/298 (17%), Positives = 94/298 (31%), Gaps = 33/298 (11%)
Query: 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 118
+L++ R +R +G G FG ++ G G VA+K H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49
Query: 119 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
E + + I +C + ++ + SLE+ S + +A
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGD-----K 230
+ ++H + I+RD K N L + DFGLAK +
Sbjct: 110 DQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 231 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 290
+ + GT YA+ + + R D+ S G VL+ G + + E
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 291 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348
+ L + + A C S +P S + + +
Sbjct: 227 R------ISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 1e-48
Identities = 55/280 (19%), Positives = 94/280 (33%), Gaps = 28/280 (10%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 125
+ +LG G F V T VA+K + L+G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
+ H N+V L L+ + + G L + + + ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAV 120
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 245
+LH+ + LD D +SDFGL+K D V + GT GY A
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVA 177
Query: 246 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305
PE + + D +S GV+ +L G P + N + L F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSP 231
Query: 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
+ + A H + +DP+ R + ++
Sbjct: 232 YWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 5e-48
Identities = 70/277 (25%), Positives = 102/277 (36%), Gaps = 37/277 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 122
+F +LG+G FG VF T A+K L D + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 123 NFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L H L + + V E++ G L H+ S A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEI 112
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD GT
Sbjct: 113 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
Y APE ++ D +SFGV+L EML G+ P + E +
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPF 221
Query: 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
+ R ++ A L R+P+ R
Sbjct: 222 YPRWLEKE------------AKDLLVKLFVREPEKRL 246
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 32/308 (10%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 123
NF+ +GEG +G V+K TG VA+K + D + E++
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
L +L H N+VKL+ +++ LV+EF+ + + +P + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ + V+ +
Sbjct: 114 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYR 169
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 293
A + + ++ D++S G + EM+T R + G + V W
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 294 P-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EA 346
+ + + + + + L + L DP R + +
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
Query: 347 LKPLPNLK 354
KP+P+L+
Sbjct: 290 TKPVPHLR 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-46
Identities = 67/290 (23%), Positives = 110/290 (37%), Gaps = 31/290 (10%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 126
LGEG F V+K T VA+K + K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 127 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
+L H N++ L+ LV++FM LE + SL L S L +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 246
+LH+ +++RD K +N+LLD + KL+DFGLAK ++ + T + T Y AP
Sbjct: 115 YLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 247 EYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHNLVEWARPH 295
E + + D+++ G +L E+L + + G +W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
++ H L +P AR ++ ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 4e-46
Identities = 69/277 (24%), Positives = 108/277 (38%), Gaps = 39/277 (14%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 121
++F+ LG G FG V G A+K L + + K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 122 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 181
L + H ++++ G + Q ++ +++ G L R+S P + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 182 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
L +LH + +IYRD K NILLD + + K++DFG AK P+ T GT
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165
Query: 242 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301
Y APE V T D +SFG+++ EML G P + N ++ L R
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELR 219
Query: 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
F + L + ++RD R
Sbjct: 220 FPPFFNE------------DVKDLLSRLITRDLSQRL 244
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (399), Expect = 8e-46
Identities = 44/295 (14%), Positives = 86/295 (29%), Gaps = 34/295 (11%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+++ +GEG FG +F+G VA+K + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 126 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 185
L + + Y ++ ++ + SLE+ L A +
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGD-----KTHVST 235
+HE + ++YRD K N L+ + + DFG+ K +
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 236 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295
+ GT Y + + + R D+ + G V + L G + E
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--- 228
Query: 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350
+ L F ++ + + + A P + +
Sbjct: 229 ---GEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-45
Identities = 68/315 (21%), Positives = 115/315 (36%), Gaps = 37/315 (11%)
Query: 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 118
A + + + +GEG +G VFK +NG G VA+K + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56
Query: 119 -LAEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWS 172
+A + L H N+V+L C LV+E + + +P
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 173 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 232
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 170
Query: 233 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 289
T V+ T Y APE ++ + D++S G + EM + + + +
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 290 -------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 342
+W R R+ F+ +E + + L CL+ +P R
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 343 VVEA--LKPLPNLKD 355
+ + L K+
Sbjct: 290 ALSHPYFQDLERCKE 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-45
Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 30/300 (10%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 122
+ S +GEG +G V + + VA+K ++ Q + + L E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 123 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALG 180
L H N++ + + ++ + L++ ++ L
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMG 239
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T +
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 240 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298
T Y APE ++ ++S D++S G +L EML+ R + N + +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 299 RRRFYRLIDPRLEGHFSIKGAQK-------------AAQLAAHCLSRDPKARPLMSEVVE 345
+ S+ K A L L+ +P R + + +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-45
Identities = 60/289 (20%), Positives = 100/289 (34%), Gaps = 40/289 (13%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 120
+ LG G F V K + TGL A K + + + ++
Sbjct: 12 YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 121 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 180
EV+ L ++ H N++ L +L+ E + G L + L + L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 121
Query: 181 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVSTR 236
G+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
+ GT + APE V L +D++S GV+ +L+G P E
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVS 229
Query: 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
F + A L +DPK R + + ++
Sbjct: 230 AVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-44
Identities = 78/281 (27%), Positives = 105/281 (37%), Gaps = 36/281 (12%)
Query: 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 118
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 119 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 177
+ E L + H L L D+ V E+ G L HL R
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFY 110
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 237
L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 238 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297
GT Y APE + D + GVV+ EM+ GR P + L
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILM 219
Query: 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 338
E RF R + P +A L A L +DPK R
Sbjct: 220 EEIRFPRTLSP------------EAKSLLAGLLKKDPKQRL 248
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 2e-43
Identities = 60/293 (20%), Positives = 110/293 (37%), Gaps = 28/293 (9%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 123
+ +GEG +G V+K G T A+K + + + E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
L +L H N+VKL + +LV+E + L+ L L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
G+A+ H+ R V++RD K N+L++ + K++DFGLA+ + + ++ +
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYR 167
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 293
A + + ++ D++S G + EM+ G G N W
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 294 -PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
L + + + +P F + L + L DP R + +E
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-43
Identities = 61/289 (21%), Positives = 99/289 (34%), Gaps = 50/289 (17%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 120
++ LLG GGFG V+ G ++ L VA+K + D + E
Sbjct: 6 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 121 EVNFLGDL--VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
EV L + +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRV 237
+ + H V++RD K NIL+D + KL DFG K V T
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 169
Query: 238 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
GT Y+ PE++ RS V+S G++L +M+ G + + ++
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRG----- 219
Query: 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
S + L CL+ P RP E+
Sbjct: 220 ----------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-42
Identities = 68/322 (21%), Positives = 113/322 (35%), Gaps = 47/322 (14%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
++ ++G G FG V++ +G VA+K + D + E+ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67
Query: 126 GDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKI 177
L H N+V+L + ++ LV +++P H R LP
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 178 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTR 236
+ LA++H + +RD K N+LLD D KL DFG AK G+ +
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296
+ Y A TS DV+S G VL E+L G+ + + +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 297 GE-----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR-------- 337
+F ++ F + +A L + L P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 338 -PLMSEVVEALKPLPNLKDMAS 358
E+ + LPN +D +
Sbjct: 303 HSFFDELRDPNVKLPNGRDTPA 324
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 55/283 (19%), Positives = 93/283 (32%), Gaps = 39/283 (13%)
Query: 72 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 130
+LG G G V + T A+K L + EV
Sbjct: 19 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 131 LNLVKLIGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGL 185
++V+++ L+V E + G L + + R +I + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 186 AFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYG 242
+LH + +RD K N+L + KL+DFG AK+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178
Query: 243 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302
Y APE + D++S GV++ +L G H L R
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQ 233
Query: 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
Y +P S ++ L + L +P R ++E +
Sbjct: 234 YEFPNPEWS-EVS----EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 7e-40
Identities = 63/307 (20%), Positives = 105/307 (34%), Gaps = 40/307 (13%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 123
+ + +G+G FG VFK TG VA+K + + + L E+
Sbjct: 11 KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 124 FLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWSIRM 175
L L H N+V LI C LV++F S
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIK 120
Query: 176 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS- 234
++ GL ++H +++RD K +N+L+ D KL+DFGLA+ + +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 235 -TRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 289
T + T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 290 ----------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ-LAAHCLSRDPKARP 338
L E+ + +++ A L L DP R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 339 LMSEVVE 345
+ +
Sbjct: 298 DSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 8e-39
Identities = 60/294 (20%), Positives = 102/294 (34%), Gaps = 28/294 (9%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 123
+ +GEG +G VFK T VA+K + D L E+
Sbjct: 3 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 124 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 183
L +L H N+V+L D + LV+EF + + I K
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112
Query: 184 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 243
GL F H R V++RD K N+L++ + KL++FGLA+ + + S V+ +
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYR 168
Query: 244 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLVEWA 292
++ D++S G + E+ R + G +W
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 293 R-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
L + + + + K L + L +P R E ++
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (347), Expect = 1e-37
Identities = 68/314 (21%), Positives = 108/314 (34%), Gaps = 42/314 (13%)
Query: 31 SNAESNSSTSKLEEELKVASR--LRKFTFNDLKLATRN-FRPESLLGEGGFGCVFKGWIE 87
+ A+ S ++E L A L+K+ A + F LG G FG V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV--- 60
Query: 88 ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDD 144
+G A+K L+ + K+ L E L + LVKL ++
Sbjct: 61 ------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204
+V E++ G + +HL R A +LH +IYRD K
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 264
N+L+D +++DFG AK T + GT APE +++ D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 265 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 324
V++ EM G P ++ + + RF
Sbjct: 226 VLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSS------------DLKD 267
Query: 325 LAAHCLSRDPKARP 338
L + L D R
Sbjct: 268 LLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 66/323 (20%), Positives = 113/323 (34%), Gaps = 42/323 (13%)
Query: 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 124
+R +G G +G V V TG VA+K L K E+
Sbjct: 20 YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 125 LGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 178
L + H N++ L+ D+ LV FM G+ L + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127
Query: 179 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 238
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ ++ V+
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVV 180
Query: 239 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--------- 289
+ A + T D++S G ++ EM+TG+ + + +
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 290 EWARPHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
E+ + + + Y P LE + A L L D + R E +
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
Query: 346 A--LKPLPNLKDMASSSYYFQTM 366
+ L + +D Y +
Sbjct: 301 HPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-36
Identities = 73/326 (22%), Positives = 118/326 (36%), Gaps = 33/326 (10%)
Query: 51 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 110
R T + K+ NF +LG G +G VF TG A+K L
Sbjct: 10 RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKA 63
Query: 111 GL----QGHKEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 165
+ + + E L + LV L + + L+ +++ G L HL +R
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
Query: 166 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 225
L LH+ +IYRD K NILLD++ + L+DFGL+K+
Sbjct: 124 E-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 226 PEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 283
+ + GT Y AP+ V G D +S GV++ E+LTG
Sbjct: 180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDG 236
Query: 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSE 342
+++ E +R L + + + A L L +DPK R
Sbjct: 237 EKNSQAEISRRILKSEPPYPQEMSA------------LAKDLIQRLLMKDPKKRLGCGPR 284
Query: 343 VVEALKPLPNLKDMASSSYYFQTMQA 368
+ +K + + + + A
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVPA 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 1e-33
Identities = 53/305 (17%), Positives = 99/305 (32%), Gaps = 47/305 (15%)
Query: 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 125
+++ LG G + VF+ + V VK L K+ E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83
Query: 126 GDL-VHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 182
+L N++ L + R LV+E + + L
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEIL 139
Query: 183 KGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 241
K L + H +++RD K N+++D + +L D+GLA+ G + + +
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193
Query: 242 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLV 289
+ PE ++ D++S G +L M+ + N G +L
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQK---------AAQLAAHCLSRDPKARPLM 340
++ + E + I R + A L D ++R
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 341 SEVVE 345
E +E
Sbjct: 314 REAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-32
Identities = 60/313 (19%), Positives = 106/313 (33%), Gaps = 51/313 (16%)
Query: 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 122
+ ++ +G G G V + VA+K L+ K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 123 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSY 123
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
+ G+ LH +I+RD K SNI++ +D K+ DFGLA+ T
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 177
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSMDKN 280
+ T Y APE ++ D++S G ++ EM+ + +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 281 RPNGEHNLVEWARPHLGERRRFYRLIDPRL--------EGHFSIKGAQKAAQLAAHCLSR 332
P L R ++ R ++ L P+L + + A +A L + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 333 DPKARPLMSEVVE 345
DP R + + ++
Sbjct: 298 DPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-30
Identities = 65/330 (19%), Positives = 120/330 (36%), Gaps = 40/330 (12%)
Query: 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 121
++ S +G G +G V + TGL VAVK L+ K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 122 VNFLGDLVHLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 176
+ L + H N++ L+ +E+ + + + L N + + L
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125
Query: 177 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 236
+ +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 237 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN----------RPNGEH 286
+ A + H D++S G ++ E+LTGR R G
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
Query: 287 NLVEWARPHLGERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEV 343
+ R + + + + +F+ I A L L D R ++
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
Query: 344 VEA--LKPLPNLKDMASSSYYFQTMQAERI 371
+ + D + Y Q+ ++ +
Sbjct: 299 LAHAYFAQYHDPDDEPVADPYDQSFESRDL 328
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 3e-27
Identities = 56/336 (16%), Positives = 103/336 (30%), Gaps = 63/336 (18%)
Query: 56 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 115
+ D + + LG G F V+ N T VA+K + D +
Sbjct: 9 PYKDAR-----YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-T 53
Query: 116 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---------------EFMPRGSLEN 160
+ E+ L + + K +LL + E + L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 161 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 219
+P +I+ GL ++H +I+ D K N+L++ D L
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 279
+A G T + T Y +PE ++ +D++S ++ E++TG +
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
Query: 280 NRPNGEHNLVEWAR------------------------PHLGERRRFYRLIDPRLEG--- 312
+ + + G R +L LE
Sbjct: 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291
Query: 313 ---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345
FS A++ + + L DP+ R +V
Sbjct: 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.5 bits (177), Expect = 2e-15
Identities = 25/158 (15%), Positives = 50/158 (31%), Gaps = 16/158 (10%)
Query: 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 130
L+GEG VF + E+ G VK + K + G +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 131 LNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 186
L KL G + + ++ E + L ++ + +A
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 187 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224
+ R +++ D N+L+ + + DF + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 422 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.53 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.91 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-59 Score=430.07 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=208.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 579999999999999999999876 7889999999765432 345689999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..|||||||++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 99999999999999999995 4457999999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
..............+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... ..... ....
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~~~-----~~~~ 225 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKE-----KKTY 225 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHHHT-----TCTT
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHHhc-----CCCC
Confidence 7654444444455789999999999988776 578999999999999999999997654322111 11000 0000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 226 ---~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 ---L------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---S------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---C------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0011234688999999999999999999999763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-58 Score=427.88 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=211.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 579999999999999999999876 78899999998665566678999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..|||||||+||+|.+++.+. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhee
Confidence 999999999999999987543 5999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 304 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (422)
...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+..... ..... ..... ..
T Consensus 166 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~---~~~~~--~~ 235 (293)
T d1yhwa1 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLI---ATNGT--PE 235 (293)
T ss_dssp CCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---HHHCS--CC
T ss_pred eccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHHH---HhCCC--CC
Confidence 644322 2344689999999999999999999999999999999999999997543211 11100 00000 00
Q ss_pred ccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 305 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+ ..+...+.++.+||.+||+.||.+|||+.|++++
T Consensus 236 ~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 L-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp C-------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred C-------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1112345789999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=427.03 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=205.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC--cccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
+..++|++.+.||+|+||+||+|.+.. .||||+++... ....+.|.+|+.+|++++|||||+++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 445789999999999999999997532 59999997543 2345679999999999999999999998
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+. ++..+||||||++|+|.+++......+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCC
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccc
Confidence 75 46789999999999999999777778999999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
|+|+...............||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+....... .....
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~--- 223 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVG--- 223 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHH---
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHh---
Confidence 99987655444444455789999999999864 45899999999999999999999999865432111 11110
Q ss_pred hcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 297 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. ...+. ....+..++.++.+|+.+||+.||.+|||+.+|+++|+.+
T Consensus 224 -~~-----~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 224 -RG-----YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp -HT-----SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cC-----CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00 00010 0112223457899999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=424.12 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=208.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 469999999999999999999876 78899999986432 233467889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..+||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999999999999544 46999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|+...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..... ..... ....
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i---~~~~-- 220 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRI---SRVE-- 220 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HTTC--
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHH---HcCC--
Confidence 98754332 234679999999999999999999999999999999999999997643211 11110 0000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ++...+.++.+||.+||+.||.+|||+.|++++
T Consensus 221 ------~~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 ------FT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 01 122345789999999999999999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-58 Score=427.75 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=211.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+.|++++.||+|+||+||+|.+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999999876 78899999998776666778999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..+||||||++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 999999999999999998776778999999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCccceeeccccCccccCCCccc-----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
.... .......+||+.|+|||++. +..|+.++|||||||++|||++|..||...........+ . ...
T Consensus 160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i---~---~~~ 231 (288)
T d2jfla1 160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---A---KSE 231 (288)
T ss_dssp CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH---H---HSC
T ss_pred cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH---H---cCC
Confidence 4321 11223467999999999984 456899999999999999999999999865432211110 0 000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
...+ ..+...+.++.+||.+||+.||.+|||+.|++++
T Consensus 232 --~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 --PPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 1112345789999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=430.42 Aligned_cols=261 Identities=23% Similarity=0.277 Sum_probs=211.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 579999999999999999999876 78899999986432 233467899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..|||||||+||+|.+++... +.+++..++.++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccc
Confidence 999999999999999999988544 57999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|+..............+||+.|+|||++.+..|+.++|||||||++|||++|..||...+... .... .....
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~---i~~~~-- 226 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQK---IIKLE-- 226 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHTTC--
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHH---HHcCC--
Confidence 988755444444455789999999999999999999999999999999999999998643211 1110 01100
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hCCCCCCCCC
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKDM 356 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~--L~~~~~~~~~ 356 (422)
.. ++...+.++.+||.+||+.||.+|||+.|++.+ +..++++.+.
T Consensus 227 ------~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 227 ------YD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp ------CC----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ------CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 01 122335788999999999999999999997643 4455555443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-58 Score=427.63 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=216.6
Q ss_pred HHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 60 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 60 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
|++..++|++.+.||+|+||+||+|.+.. +|+.||||+++... ...+++.+|+++|++++|||||+++++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCcc
Confidence 33445789999999999999999999876 78899999997654 345789999999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
|.+++..+||||||++|+|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcc
Confidence 99999999999999999999998654 567999999999999999999999988 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
||+|+....... .......|++.|+|||++.+..|+.++|||||||++|||++|..||...... ........ .
T Consensus 159 FG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~----~ 231 (287)
T d1opja_ 159 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLE----K 231 (287)
T ss_dssp CCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHH----T
T ss_pred ccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHh----c
Confidence 999987654322 2233456899999999999999999999999999999999977766433221 11111111 0
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 352 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 352 (422)
......+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 232 ----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 232 ----------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111222345789999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=420.79 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=197.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999999876 7889999999766433 23568899999999999999999999875
Q ss_pred --cCceEEEEEecCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEeccCCCCcEEEcCCCCeE
Q 014585 143 --DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAE--RPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 143 --~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~--~~iiHrDlkp~Nill~~~~~~k 215 (422)
++.+|||||||++|+|.+++.+ ....+++..++.++.||+.||.|||+.+. .+|+||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 4568999999999999999864 34679999999999999999999998651 3499999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
|+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|..||...... .......
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~-- 227 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR-- 227 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH--
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHH--
Confidence 999999987644322 233468999999999999999999999999999999999999999764321 1111111
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..+ +. ++...+.++.+||.+||+.||.+|||+.|++++
T Consensus 228 --~-~~~-----~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 228 --E-GKF-----RR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --H-TCC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --c-CCC-----CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 000 01 122345789999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=416.87 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=200.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++.+.||+|+||+||+|.+. ++..||||+++... ...+++.+|++++++++|||||+++|++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 57889999999999999999874 35679999997654 44578999999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..+||||||++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhee
Confidence 999999999999999999777778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCC-CCCCCCCCCcchhHHhhhhhhhcccccc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR-SMDKNRPNGEHNLVEWARPHLGERRRFY 303 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (422)
....... ......||+.|+|||++.+..|+.++|||||||++|||+|+.. ||..... ......... ..
T Consensus 151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~----~~--- 219 (263)
T d1sm2a_ 151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIST----GF--- 219 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHH----TC---
T ss_pred ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHh----cC---
Confidence 6543322 2233578999999999999999999999999999999999654 4443211 111111111 00
Q ss_pred cccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 304 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... .+..++.++.+|+.+||+.||++|||+++|+++|+.+
T Consensus 220 ~~~-------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 220 RLY-------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 1122357899999999999999999999999999765
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.8e-57 Score=429.77 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=212.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 589999999999999999999876 78899999998776555677899999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc--CCCCeEEeeccCc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYNAKLSDFGLA 222 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~--~~~~~kl~DFG~a 222 (422)
..|||||||+||+|.+++.+....+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 999999999999999999777778999999999999999999999998 99999999999995 4688999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
+...... ......||+.|||||++.+..|+.++|||||||++|||++|..||.+..... ..... ......
T Consensus 174 ~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i---~~~~~~- 243 (350)
T d1koaa2 174 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNV---KSCDWN- 243 (350)
T ss_dssp EECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHTCCC-
T ss_pred eeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCCCC-
Confidence 8765433 2334689999999999999999999999999999999999999997643211 11111 000000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
++. ......+.++.+||.+||+.||.+|||+.|++++
T Consensus 244 ---~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ---MDD----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---SCC----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CCc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001 1111235788999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=429.56 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=207.6
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|+++++||+|+||+||+|++.. +|+.||+|+++...... ...+.+|+.+|++++|||||+++++|.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 35689999999999999999999876 78899999997654333 457899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
+++..+||||||+||+|.+++.+. ..+++..++.++.||+.||.|||+ ++ |+||||||+||||+.+|.+||+|||
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCC
Confidence 999999999999999999999654 469999999999999999999997 47 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh-hhhhhhc-
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPHLGE- 298 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~- 298 (422)
+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. .......
T Consensus 151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 99864321 22346899999999999999999999999999999999999999976543211000000 0000000
Q ss_pred -----------------c---cc----cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 -----------------R---RR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 -----------------~---~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. .. .................+.++.+||.+||+.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00 000000000000001124688999999999999999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-57 Score=422.42 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=202.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||+||+|.+...+. ....||||.+...... ..++|.+|+++|++++|||||++++++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 3568888999999999999999875322 2346899998755433 34679999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..++|||||++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccc
Confidence 99999999999999999998777778999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccce---eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 223 KDGPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 223 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+.......... .....||+.|||||++.++.++.++|||||||++|||+| |..||...... ....... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~----~ 248 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE----Q 248 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----T
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c
Confidence 87654322211 122468999999999999999999999999999999998 89999765322 1111111 1
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.. ....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 249 ~~----------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 249 DY----------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC----------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00 0112224567899999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-56 Score=428.39 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=213.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++..........+.+|+.+|++++|||||++++++.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 579999999999999999999876 78899999998766555667889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc--CCCCeEEeeccCc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYNAKLSDFGLA 222 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~--~~~~~kl~DFG~a 222 (422)
.+|||||||+||+|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999999999999988777778999999999999999999999998 99999999999997 6789999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
+...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+..... ...... ...
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~---~~~--- 244 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVK---RCD--- 244 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH---HCC---
T ss_pred eecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---hCC---
Confidence 8875433 2334679999999999999999999999999999999999999997643221 111110 000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..+........+.++.+||.+||+.||.+|||+.|++++
T Consensus 245 -----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 -----WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -----CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111122345788999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-57 Score=422.00 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=194.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
.++|++.++||+|+||+||+|.+.. +|+.||||++....... ...+.+|+.+|++++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4679999999999999999999876 78899999997654332 3457899999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc---CCCCeEEeec
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDF 219 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~---~~~~~kl~DF 219 (422)
++..|||||||+||+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+||
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 9999999999999999999954 457999999999999999999999998 99999999999994 5789999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+..... ...... ...
T Consensus 155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~---~~~ 225 (307)
T d1a06a_ 155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQIL---KAE 225 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH---TTC
T ss_pred ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHh---ccC
Confidence 9998654332 2334679999999999999999999999999999999999999997643211 111111 000
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ..........+.++.+||.+||+.||.+|||+.|++++
T Consensus 226 ~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 Y--------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C--------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 01111122345789999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-56 Score=406.84 Aligned_cols=255 Identities=22% Similarity=0.379 Sum_probs=214.2
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.++||+|+||+||+|+++ ++..||||+++.... ..+++++|+.++++++|||||++++++.++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 368999999999999999999974 466899999987653 457899999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++||||+++|+|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhe
Confidence 9999999999999999998777778999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ...... ...
T Consensus 149 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~----~~~-- 218 (258)
T d1k2pa_ 149 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA----QGL-- 218 (258)
T ss_dssp BCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH----TTC--
T ss_pred eccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHH----hCC--
Confidence 76543322 2334679999999999999999999999999999999998 799997654221 111111 100
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
... .+..++.++.+||.+||+.||++|||+.+|+++|..+
T Consensus 219 -~~~-------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 -RLY-------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCC-------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCC-------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111 1123347899999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=411.08 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=199.0
Q ss_pred CCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe--
Q 014585 67 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 142 (422)
Q Consensus 67 y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 142 (422)
|++.++||+|+||+||+|.+.. +++.||+|++..... ...+.+.+|+++|++++|||||++++++.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 3667789999999999999876 788999999875432 234568999999999999999999999875
Q ss_pred --cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc-CCCCeEEeec
Q 014585 143 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDF 219 (422)
Q Consensus 143 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~-~~~~~kl~DF 219 (422)
+..++||||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++ .+|+||||||+||||+ +++.+||+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence 34578999999999999999554 47999999999999999999999876 4599999999999996 5799999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||....... .+..... ..
T Consensus 160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~----~~ 228 (270)
T d1t4ha_ 160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT----SG 228 (270)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT----TT
T ss_pred CcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHH----cC
Confidence 999864332 2234689999999998865 69999999999999999999999997543211 1111110 00
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
. ....+ +...+.++.+||.+||+.||++|||+.|++++
T Consensus 229 ~-----~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 V-----KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp C-----CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C-----CCccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0 00111 11224578999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=425.73 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=212.1
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
..++|++.++||+|+||+||+|.+...+. ...+..||||.+..... .....+.+|+.+|.++ +|||||++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 44689999999999999999999875322 11345799999865432 3345789999999998 899999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 198 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiH 198 (422)
.+.+..+||||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ |+|
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 99999999999999999999996543 34889999999999999999999988 999
Q ss_pred ccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCC
Q 014585 199 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 277 (422)
Q Consensus 199 rDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf 277 (422)
|||||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |..||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655444444455678999999999999999999999999999999997 89999
Q ss_pred CCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 278 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
.+...... +..... .. .....+..++.++.+||.+||+.||++|||+.||+++|.
T Consensus 268 ~~~~~~~~--~~~~~~----~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDAN--FYKLIQ----NG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHH--HHHHHH----TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHH--HHHHHh----cC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 76543221 111111 10 011122234578999999999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-56 Score=412.96 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=208.7
Q ss_pred cCCCCCCc-cccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~-lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|.+.+. ||+|+||+||+|.+...+ ++..||||+++..... ..++|.+|+++|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666664 999999999999875421 4568999999765433 35679999999999999999999999864
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..+||||||++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence 5689999999999999998777778999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcc-ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 223 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 223 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+........ .......||+.|+|||++.++.++.++|||||||++|||+| |..||...... ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~----~~~ 229 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGK 229 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----TTC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCC
Confidence 876543322 22234578999999999999999999999999999999998 89999865432 1111111 100
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.+ ..+..++.++.+||.+||+.||++||++.+|++.|+.
T Consensus 230 ------~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 230 ------RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 01 1222445789999999999999999999999998864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-56 Score=418.80 Aligned_cols=247 Identities=26% Similarity=0.373 Sum_probs=203.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
+.|++++.||+|+||+||+|.+.. +|+.||||++....... .+.+.+|+.+|++++|||||++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 358999999999999999999876 78899999997655432 356889999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..|||||||++|+|..++ .....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCEEEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccc
Confidence 999999999999999887665 34457999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
|+.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||....... .... ....
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---~~~~---i~~~ 229 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH---IAQN 229 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH---HHHS
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhC
Confidence 987533 223579999999999864 468999999999999999999999997543211 1110 0000
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. +.+ .+...+.++.+||.+||+.||.+|||+.|++++
T Consensus 230 --~~-----~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 --ES-----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --CC-----CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CC-----CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 00 000 111235789999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=413.37 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=207.0
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
++..++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.++++++|||||++++++
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 344578999999999999999999874 45689999997654 3457799999999999999999999987
Q ss_pred EecCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
. ++..+||||||++|+|.+++... ...+++..++.|+.||++||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 78 ~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred c-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence 5 46679999999999999987543 336999999999999999999999988 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcc
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 299 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 299 (422)
|+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ........ ..
T Consensus 154 Gla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~----~~ 226 (272)
T d1qpca_ 154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE----RG 226 (272)
T ss_dssp TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----TT
T ss_pred cceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----hc
Confidence 99987654322 2233467899999999999999999999999999999999976555432211 11111111 10
Q ss_pred cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 300 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
..+. .+..++.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus 227 ------~~~~----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 227 ------YRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCC----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 0111 112345789999999999999999999999998864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=413.08 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=208.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc------ccHHHHHHHHHHhcccCCCcceeeE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGDLVHLNLVKLI 137 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~ 137 (422)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|+.+|++++|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3689999999999999999999876 788999999965432 2356799999999999999999999
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC----C
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 213 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~----~ 213 (422)
+++.+++..|||||||++|+|.+++.+. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred EEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence 9999999999999999999999998554 47999999999999999999999998 99999999999998776 4
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||.+...... .....
T Consensus 156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~ 229 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVS 229 (293)
T ss_dssp EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HHHHH
Confidence 99999999987654332 2346799999999999999999999999999999999999999986432211 11100
Q ss_pred hhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.....+ ........+.++.+||.+||+.||.+|||+.|++++
T Consensus 230 ---~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 230 ---AVNYEF--------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---TTCCCC--------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hcCCCC--------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 000011234688999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=418.17 Aligned_cols=250 Identities=30% Similarity=0.365 Sum_probs=208.7
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++++.||+|+||+||+|++.. +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence 3579999999999999999999876 78899999997532 23456788999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+++.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecc
Confidence 9999999999999999999998554 47999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+... +.. .......
T Consensus 151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~---~i~~~~~ 222 (337)
T d1o6la_ 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILMEEI 222 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCC
T ss_pred cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHH---HHhcCCC
Confidence 9987543222 2344789999999999999999999999999999999999999998654211 111 1111111
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 346 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~~ 346 (422)
. ++...+.++.+||.+||+.||.+|++ +.+++++
T Consensus 223 --------~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 --------R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------C----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 12234578899999999999999995 6677653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=407.69 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=199.0
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEecCceEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 148 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 148 (422)
++||+|+||+||+|.+... .+++.||||+++..... ..+++.+|+++|++++|||||+++++|.. +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 4699999999999987542 15678999999754332 24579999999999999999999999864 56789
Q ss_pred EEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCCC
Q 014585 149 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 228 (422)
Q Consensus 149 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 228 (422)
|||||++|+|.+++.+ ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 vmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 9999999999999854 457999999999999999999999988 999999999999999999999999999876543
Q ss_pred Cccc-eeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccccccccc
Q 014585 229 DKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 306 (422)
Q Consensus 229 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (422)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.... ....... ...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~----~~~------ 227 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLE----KGE------ 227 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----TTC------
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHH----cCC------
Confidence 3322 2234578999999999999999999999999999999998 89999864321 1111111 100
Q ss_pred CcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhC
Q 014585 307 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 348 (422)
Q Consensus 307 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 348 (422)
....+..++.++.+|+.+||+.||.+|||+.+|++.|+
T Consensus 228 ----~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 228 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ----CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 01112234578999999999999999999999998775
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=409.20 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=204.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
+.|++.++||+|+||+||+|.+...+.. ....||||++....... ..+|++|+.++++++|||||+++|++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---C-----CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCE-----EEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 5688899999999999999998753211 23479999997554332 35689999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..++|||||.+++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999999988777788999999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCc-cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
....... ........||+.|+|||++.++.++.++|||||||++|||++|..||...... ........ ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~----~~--- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIN----DG--- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH----TT---
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHh----cc---
Confidence 7644322 22233456899999999999999999999999999999999976665433211 11111111 10
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.....+..++.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus 230 -------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11112223457899999999999999999999999988754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=408.48 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=202.4
Q ss_pred HhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-HHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 63 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 63 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
..++|++.+.||+|+||.||+|.+...+. .+..||||.+....... .+.+.+|+.+|++++|||||++++++.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34689999999999999999999875332 45679999986544333 456899999999999999999999985
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence 56789999999999999998777778999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||........ ..... ...
T Consensus 155 a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~----~~~ 226 (273)
T d1mp8a_ 155 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIE----NGE 226 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHH----TTC
T ss_pred heeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCC
Confidence 987644322 22334678999999999999999999999999999999998 8899976543221 11111 000
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.+ .++..++.++.+||.+||+.||.+|||+.+|+++|+.+
T Consensus 227 ------~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 227 ------RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00 12223457899999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-55 Score=410.71 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=206.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++++.||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 579999999999999999999876 78899999996432 234567899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+++..|+|||||+||+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 99999999999999999988854 457899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ . ........
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~i~~~~~- 218 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---Y---EKILNAEL- 218 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHHCCC-
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---H---HHHHcCCC-
Confidence 9876432 2346899999999999999999999999999999999999999976432111 1 11111110
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~ 346 (422)
.++...+.++.+++.+||..||.+|+ ++.+++++
T Consensus 219 -----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11123346889999999999999996 78888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=402.18 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=209.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++++.||+|+||+||+|.+.. +|+.||||+++.... ....+.+|+++|+.++|||||++++++.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3689999999999999999999876 788999999976543 334688999999999999999999999999
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC--CCeEEeeccC
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAKLSDFGL 221 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~--~~~kl~DFG~ 221 (422)
+.+|||||||+||+|.+++......+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccch
Confidence 9999999999999999999777668999999999999999999999998 9999999999999854 5899999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
++...... ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||........ .... ......
T Consensus 151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~~~i---~~~~~~ 221 (321)
T d1tkia_ 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENI---MNAEYT 221 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH---HHTCCC
T ss_pred hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---HHHH---HhCCCC
Confidence 98764433 23346799999999999999999999999999999999999999976532211 1110 000000
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+ +.... ...+.++.+||.+||..||.+|||+.|++++
T Consensus 222 ~----~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 F----DEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp C----CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----Chhhc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000 0234678999999999999999999999984
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=410.09 Aligned_cols=260 Identities=23% Similarity=0.387 Sum_probs=207.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.+|+++++||+|+||+||+|.+..++.. ....||+|.+.... ....+++.+|+.++++++|||||+++++|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~- 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4699999999999999999998763221 23469999986543 3446789999999999999999999999976
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
+..+++|||+.+|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 4677889999999999999888888999999999999999999999988 9999999999999999999999999999
Q ss_pred cCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 224 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 224 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
...............||+.|+|||++.++.|+.++|||||||++|||+| |..||...........+ . ...+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~----~~~~- 231 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---E----KGER- 231 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---H----HTCC-
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---H----cCCC-
Confidence 8765544444445678999999999999999999999999999999998 78888765432211111 1 0000
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
...+..++.++.+|+.+||+.||.+|||+.+|+++|+.+
T Consensus 232 ---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 011223457899999999999999999999999988654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-54 Score=412.85 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=206.2
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 579999999999999999999876 78899999986432 233467899999999999999999999999
Q ss_pred ecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 142 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 142 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
+.+..++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999999999998554 47999999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 301 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 301 (422)
|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|..||.+..... .... .....
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~---i~~~~-- 254 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEK---IVSGK-- 254 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCC--
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHH---HhcCC--
Confidence 9876432 234679999999999999999999999999999999999999997643211 1111 11110
Q ss_pred cccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014585 302 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVE 345 (422)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~ 345 (422)
.. ++...+.++.+||.+||+.||.+|+ ++.++++
T Consensus 255 ------~~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ------VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CC----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01 1123357889999999999999994 7888875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.3e-54 Score=396.90 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=203.3
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---HHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||+||+|.+.. +|+.||||++....... ...+.+|+++++.++|||||++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 4679999999999999999999876 78899999997654432 34688999999999999999999999
Q ss_pred EecCc----eEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 141 IEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 141 ~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
...+. .|||||||+|++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcccccee
Confidence 87543 78999999999999988544 47999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCc-cceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 217 SDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 217 ~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
+|||.+........ .......+||+.|+|||++.+..++.++|||||||++|||++|..||....... .....
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~ 226 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQH 226 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHH
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHH
Confidence 99999876543222 222344689999999999999999999999999999999999999997643211 11111
Q ss_pred hhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhCCC
Q 014585 296 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 350 (422)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~ell~~L~~~ 350 (422)
.......... .....+.++.+||.+||+.||.+|| +++++++.|.++
T Consensus 227 ~~~~~~~~~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 227 VREDPIPPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHCCCCCGGG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhcCCCCCch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1111111011 1112357899999999999999999 899998887643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-53 Score=410.58 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=201.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHH---HHHHHHhcccCCCcceeeEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW---LAEVNFLGDLVHLNLVKLIG 138 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~~~~ 138 (422)
++|+++++||+|+||.||+|++.. +|+.||||++..... .....+ .+|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 579999999999999999999876 788999999864321 112223 34577888889999999999
Q ss_pred EEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 139 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 139 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
++.+++..|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999999999999554 57899999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 219 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 219 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
||+|+...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..........+... ...
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~ 223 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT 223 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSS
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccc
Confidence 99998764432 234579999999999874 5789999999999999999999999986543322111111 000
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 345 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~ 345 (422)
. ... ++...+.++.+||.+||+.||.+||+ +.++++
T Consensus 224 ~--------~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 M--------AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C--------CCC----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C--------CCC----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 011 11123578999999999999999998 567765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=406.99 Aligned_cols=270 Identities=28% Similarity=0.371 Sum_probs=204.7
Q ss_pred hHHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCccee
Q 014585 58 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVK 135 (422)
Q Consensus 58 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~ 135 (422)
..+++..++|++.++||+|+||.||+|.+..... ..+++.||||++...... ..+.+.+|..++.++ +|+|||.
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 3444555789999999999999999999865322 236778999999754432 345688888888887 6889999
Q ss_pred eEeEEEec-CceEEEEEecCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 014585 136 LIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 199 (422)
Q Consensus 136 ~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHr 199 (422)
+++++... ...++|||||++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 99998764 4689999999999999998643 234889999999999999999999988 9999
Q ss_pred cCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCC-CCCC
Q 014585 200 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RSMD 278 (422)
Q Consensus 200 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~ 278 (422)
||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765544444444568999999999999999999999999999999999875 5776
Q ss_pred CCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 279 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
....... ..... .... .+. .+..++.++.+||.+||+.||.+|||+.|++++|+.+
T Consensus 239 ~~~~~~~--~~~~~----~~~~------~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 239 GVKIDEE--FCRRL----KEGT------RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp TCCCSHH--HHHHH----HHTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHHH--HHHHH----hcCC------CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 5432211 11111 1100 011 1123356899999999999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-54 Score=406.78 Aligned_cols=266 Identities=25% Similarity=0.376 Sum_probs=213.7
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
...++|++.+.||+|+||+||+|++... ....++..||||++...... ..+++.+|+.+|++++||||+++++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3457899999999999999999987542 11226678999999765433 345799999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 197 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~ii 197 (422)
...+..++||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+.+ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999985322 24889999999999999999999988 99
Q ss_pred eccCCCCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCC-CC
Q 014585 198 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RS 276 (422)
Q Consensus 198 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p 276 (422)
||||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998654444444445577899999999999999999999999999999999986 56
Q ss_pred CCCCCCCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 277 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 277 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
|....... ...... ... . +. .+..++.++.+|+.+||+.||++|||+.||++.|+++.
T Consensus 243 ~~~~~~~e---~~~~v~----~~~-~-----~~----~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEE---VIYYVR----DGN-I-----LA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHH---HHHHHH----TTC-C-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHH---HHHHHH----cCC-C-----CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 76543221 111111 110 0 11 12234468999999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=401.36 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=202.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|++.+.||+|+||+||+|.+.. +..||||++.... ...+.|.+|+.++++++|+|||++++++. +
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 4679999999999999999998853 3579999997554 44578999999999999999999999985 5
Q ss_pred CceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
+..++|||||++|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||++
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence 6689999999999999888643 356999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccccc
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 302 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (422)
+....... .......||+.|+|||++.++.++.++|||||||++|||++|..||...... ......... .
T Consensus 161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~----~--- 230 (285)
T d1fmka3 161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER----G--- 230 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT----T---
T ss_pred hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHh----c---
Confidence 87643322 2233467899999999999999999999999999999999976666443221 111111110 0
Q ss_pred ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 303 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.. ...+..++.++.+||.+||+.||++||++.+|++.|+...
T Consensus 231 ---~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 231 ---YR----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ---CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CC----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 01 1122234578999999999999999999999999988643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.6e-54 Score=396.73 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=206.9
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc---------HHHHHHHHHHhcccC-CCcce
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLV-HLNLV 134 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv 134 (422)
++|++.+.||+|+||+||+|++.. +|+.||||++....... .+.+.+|+.+++++. |||||
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 689999999999999999999876 78899999997653221 235789999999996 99999
Q ss_pred eeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 135 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 135 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
++++++.+++..|||||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 999999999999999999999999999965 447999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccC------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 288 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 288 (422)
||+|||+++....... ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+......
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--- 223 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--- 223 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---
Confidence 9999999987654332 234679999999998853 4578899999999999999999999986542111
Q ss_pred HHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 289 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... ...... .........++++.+|+.+||+.||.+||++.|++++
T Consensus 224 ~~~i---~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 224 LRMI---MSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHH---HHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHH---HhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 111000 0111112345789999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=404.55 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=201.6
Q ss_pred cCCCCCC-ccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhccc-CCCcceeeEeEEEe
Q 014585 65 RNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~-~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 142 (422)
++|.+.+ +||+|+||+||+|.+.. +|+.||||++.. ...+.+|+.++.++ +|||||+++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 5788875 69999999999999876 788999999864 25678899987655 89999999999875
Q ss_pred ----cCceEEEEEecCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCCe
Q 014585 143 ----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 214 (422)
Q Consensus 143 ----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~~ 214 (422)
+..+|||||||+||+|.+++.+. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCE
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccc
Confidence 46689999999999999999765 356999999999999999999999998 999999999999975 5679
Q ss_pred EEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 215 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
||+|||+|+....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+..
T Consensus 154 Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~--- 227 (335)
T d2ozaa1 154 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--- 227 (335)
T ss_dssp EECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred cccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---
Confidence 9999999987654332 2346799999999999999999999999999999999999999976543222111100
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ......+........+.++.+||.+||+.||.+|||+.|++++
T Consensus 228 ----~i---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 ----RI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----CC---CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HH---hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 0000001111112456789999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=400.36 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=200.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc---ccHHHHHHHHHHhcccCCCcceeeEeEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 140 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 140 (422)
.++|++.+.||+|+||.||+|.+..... .+..||||++..... ...+++.+|+.+|++++|||||+++|++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCC------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3679999999999999999998765321 345799999875432 2346789999999999999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+ +..++|||||++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence 65 5778999999999999988777778999999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCccce-eeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhc
Q 014585 221 LAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 298 (422)
Q Consensus 221 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 298 (422)
+++.......... .....|+..|+|||++.+..++.++|||||||++|||++ |..||.+..... ...... ..
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~---~~ 230 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---KE 230 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TS
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHH---hC
Confidence 9998755433222 233567889999999999999999999999999999998 899997543221 111111 11
Q ss_pred ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 299 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.. .+ ..+..++.++.+|+.+||..||++|||+.+|++.|++
T Consensus 231 ~~------~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 GE------RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC------CC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 00 01 1122345789999999999999999999999998864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=406.29 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=204.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC---cccHHHHHHHHHHhc-ccCCCcceeeEeEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLG-DLVHLNLVKLIGYC 140 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~ 140 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++.... ....+.+..|..++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999999876 78899999996432 223456677777765 68999999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeecc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 220 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG 220 (422)
.+++..|||||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence 999999999999999999999854 447999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
+++....... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...... .... ...
T Consensus 149 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i---~~~-- 218 (320)
T d1xjda_ 149 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSI---RMD-- 218 (320)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HHC--
T ss_pred hhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH---HcC--
Confidence 9987543322 23346899999999999999999999999999999999999999986532211 1111 001
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 345 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~ 345 (422)
.+. ++...+.++.+||.+||+.||.+||++. ++++
T Consensus 219 ------~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 011 1123357899999999999999999985 6654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=396.93 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=202.0
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++++.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 479999999999999999999876 7889999999654322 24678999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..|+||||+.++.+..........+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|
T Consensus 73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcc
Confidence 99999999999654444343445667999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 293 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------- 293 (422)
+....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 150 ~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 150 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 87543322 223357999999999887655 5889999999999999999999997643211111000000
Q ss_pred hhhhcccccccccCcccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PHLGERRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.................... .....+.++.+|+.+||..||.+|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000000000000000 011234788999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=396.36 Aligned_cols=262 Identities=23% Similarity=0.262 Sum_probs=197.3
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCccc-----HHHHHHHHHHhcccCCCcceeeEeEEEecC
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 144 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 144 (422)
+++||+|+||+||+|++.. +|+.||||+++...... .+.+.+|+.+|++++|||||++++++..++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 5689999999999999876 78899999997543322 246889999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 145 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 145 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..|||||||.++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 999999999887666555 55667999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-----hhhc
Q 014585 225 GPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-----HLGE 298 (422)
Q Consensus 225 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~ 298 (422)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||...........+..... ....
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 6543222 234679999999999874 5689999999999999999999999976543221111100000 0000
Q ss_pred ccccccccCcccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 RRRFYRLIDPRLEGH-----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 ~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.........-..... .....+.++.+||.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000000000 011235789999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=392.28 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=198.1
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEe-
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 142 (422)
.++|++.+.||+|+||.||+|.+ .|..||||+++... ..+.+.+|++++++++|||||+++|++.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-----------~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-----------CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 35788899999999999999987 45689999997543 34679999999999999999999999865
Q ss_pred cCceEEEEEecCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccC
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 221 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~ 221 (422)
.+.+++||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccc
Confidence 466899999999999999996542 35899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhhhhhccc
Q 014585 222 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 300 (422)
Q Consensus 222 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 300 (422)
++..... .....+|..|+|||++.+..++.++|||||||++|||++ |.+||...... ........ .
T Consensus 150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~----~- 216 (262)
T d1byga_ 150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK----G- 216 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT----T-
T ss_pred ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----C-
Confidence 9865332 223468999999999999999999999999999999998 67777654322 12221111 0
Q ss_pred ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 301 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
..+ .++...+.++.+||.+||+.||.+|||+.+|+++|+.+
T Consensus 217 -----~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 217 -----YKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 011 12223457899999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=399.43 Aligned_cols=267 Identities=27% Similarity=0.387 Sum_probs=210.3
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+..++|++++.||+|+||.||+|++...... ...++..||||+++..... ...++.+|+..+.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 3457899999999999999999987653221 1224568999999765543 346788999999888 89999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 204 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 204 (422)
|.+++..++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 999999999999999999999996442 35899999999999999999999998 999999999
Q ss_pred cEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 014585 205 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 283 (422)
Q Consensus 205 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 283 (422)
|||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999987655444444455679999999999999999999999999999999998 68888654321
Q ss_pred CcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 284 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
...... .... .+. .+...+.++.+||.+||+.||.+|||+.||++.|+.+
T Consensus 245 ---~~~~~i----~~~~------~~~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFKLL----KEGH------RMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHH----HTTC------CCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHH----HcCC------CCC----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111111 1110 111 1123357899999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=397.80 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=214.9
Q ss_pred HHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc-cHHHHHHHHHHhccc-CCCcceeeEeE
Q 014585 62 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 139 (422)
Q Consensus 62 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~ 139 (422)
+..++|++.++||+|+||.||+|.+... .+..+++.||||+++..... ...++.+|+.+++++ +|||||+++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3457899999999999999999987542 12237789999999765433 345689999999999 69999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 202 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlk 202 (422)
+.+.+..+||||||++|+|.+++.... ..+++..+..++.||+.||+|||+++ ++|||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLK 172 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccc
Confidence 999999999999999999999986432 35899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhC-CCCCCCCC
Q 014585 203 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNR 281 (422)
Q Consensus 203 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~ 281 (422)
|+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+|+ .+||....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999987665555555567899999999999999999999999999999999995 55554433
Q ss_pred CCCcchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCC
Q 014585 282 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 349 (422)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 349 (422)
.... ....... ......+...+.++.+||.+||+.||.+|||+.+|++.|++
T Consensus 253 ~~~~--~~~~i~~--------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 253 VDSK--FYKMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp SSHH--HHHHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH--HHHHHhc--------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2211 1111110 00111112335789999999999999999999999998864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=396.65 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=204.1
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCc--EEEEEEecCCC-cccHHHHHHHHHHhccc-CCCcceeeEeEE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 140 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 140 (422)
++|++.++||+|+||+||+|.+.. +|. .||||.+.... ....+.+.+|+++|.++ +|||||++++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 578899999999999999999876 444 47888875433 23456799999999999 799999999999
Q ss_pred EecCceEEEEEecCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 014585 141 IEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 205 (422)
Q Consensus 141 ~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 205 (422)
.+++..++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~N 157 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 157 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccce
Confidence 9999999999999999999998643 357999999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCC-CCCCCCCCC
Q 014585 206 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR-SMDKNRPNG 284 (422)
Q Consensus 206 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~ 284 (422)
||++.++.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......
T Consensus 158 IL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~- 233 (309)
T d1fvra_ 158 ILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 233 (309)
T ss_dssp EEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred EEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986533221 223568999999999999999999999999999999999765 56543211
Q ss_pred cchhHHhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 285 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.+..... ... .+ ..+..++.++.+||.+||+.||++|||+.||+++|+.+.
T Consensus 234 --~~~~~i~----~~~------~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 234 --ELYEKLP----QGY------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp --HHHHHGG----GTC------CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHH----hcC------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111111 100 01 112234578999999999999999999999999987653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=391.65 Aligned_cols=269 Identities=23% Similarity=0.281 Sum_probs=202.6
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhccc---CCCcceeeEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLIG 138 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~ 138 (422)
.++|++++.||+|+||+||+|++... +++.||||++..... .....+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 47899999999999999999998652 356799999864322 2223466777776665 7999999999
Q ss_pred EEEe-----cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCC
Q 014585 139 YCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 213 (422)
Q Consensus 139 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~ 213 (422)
+|.. ....+++|||++++.+..........+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 9863 34678999999887776666566778999999999999999999999998 999999999999999999
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 293 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 293 (422)
+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+....
T Consensus 155 ~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 155 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 999999998865332 23345789999999999999999999999999999999999999998654322111111000
Q ss_pred hh-----hhccc----ccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 294 PH-----LGERR----RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 294 ~~-----~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. ..... .............+....+..+.+||.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000 0000000000111222345788999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=391.07 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=204.8
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCC-cccHHHHHHHHHHhcccCCCcceeeEeEEEe-cCceE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRL 147 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 147 (422)
.++||+|+||+||+|.+...+. +...||||+++... ....++|.+|+++|++++|||||+++|++.. ++..+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 5789999999999999865321 34479999997533 3345679999999999999999999999876 45789
Q ss_pred EEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCcccCCC
Q 014585 148 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 227 (422)
Q Consensus 148 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 227 (422)
+|||||++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999999877778899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCcc--ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhcccccccc
Q 014585 228 GDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 305 (422)
Q Consensus 228 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (422)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|..||....... ........ . . +.
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~---g-~---~~ 253 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ---G-R---RL 253 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT---T-C---CC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc---C-C---CC
Confidence 3222 12233578999999999999999999999999999999999888876533211 11111110 0 0 01
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 306 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.. +..++.++.+||.+||+.||++||++.||+++|+.+.
T Consensus 254 ~~-------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 254 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 1233578999999999999999999999999997663
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=395.11 Aligned_cols=267 Identities=26% Similarity=0.394 Sum_probs=213.3
Q ss_pred HHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeE
Q 014585 61 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGY 139 (422)
Q Consensus 61 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 139 (422)
++..++|++.+.||+|+||+||+|.+.... +..++..||||+++.... .....+.+|+.++++++|||||+++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 344578999999999999999999885311 111456899999975433 233468999999999999999999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 210 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~ 210 (422)
+..++..++|||||++|+|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||||+.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence 99999999999999999999988532 235789999999999999999999988 999999999999999
Q ss_pred CCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCC-CCCCCCCCCCcchhH
Q 014585 211 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLV 289 (422)
Q Consensus 211 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~ 289 (422)
++++||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +||....... ..
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~ 245 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VL 245 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 9999999999998765444433444567999999999999999999999999999999999985 6665432211 11
Q ss_pred HhhhhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCCC
Q 014585 290 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 351 (422)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 351 (422)
.... .... + ..+..++..+.+||.+||+.||++|||+.+|++.|+...
T Consensus 246 ~~i~----~~~~------~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 246 RFVM----EGGL------L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHH----TTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHH----hCCC------C----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1110 1000 0 011233478999999999999999999999999998653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=386.07 Aligned_cols=242 Identities=23% Similarity=0.382 Sum_probs=198.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------cHHHHHHHHHHhcccC--CCccee
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNLVK 135 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~ 135 (422)
.++|++.++||+|+||+||+|.+.. +|+.||||++...... ...++.+|+.+|++++ |||||+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 3689999999999999999999876 7889999998754221 1234678999999996 899999
Q ss_pred eEeEEEecCceEEEEEecCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCC-CC
Q 014585 136 LIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YN 213 (422)
Q Consensus 136 ~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~-~~ 213 (422)
+++++.+++..++||||+.+ +++.+++.+ ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCe
Confidence 99999999999999999976 577777744 457999999999999999999999998 9999999999999854 79
Q ss_pred eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 214 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 214 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
+||+|||+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ...
T Consensus 150 vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~--- 217 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII--- 217 (273)
T ss_dssp EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH---
T ss_pred EEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh---
Confidence 9999999998754322 334679999999999987665 677999999999999999999996421 000
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.... . +.. ..+.++.+||.+||+.||.+|||+.|++++
T Consensus 218 ----~~~~----~----~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 ----RGQV----F----FRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----HCCC----C----CSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hccc----C----CCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 0 111 234789999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=387.60 Aligned_cols=268 Identities=26% Similarity=0.308 Sum_probs=200.0
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 143 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 143 (422)
.++|.+.+.||+|+||.||+|++ +|+.||||++..... .......|+..+.+++|||||++++++.+.
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~ 69 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence 35688889999999999999986 577999999964421 112234466666788999999999999875
Q ss_pred C----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCcEEEcCCCCe
Q 014585 144 D----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 144 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----~~~iiHrDlkp~Nill~~~~~~ 214 (422)
+ ..++|||||++|+|.+++.+. .+++..++.++.|++.||+|||+.. .++|+||||||+||||+.++.+
T Consensus 70 ~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 70 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 4 578999999999999999654 5899999999999999999999741 1349999999999999999999
Q ss_pred EEeeccCcccCCCCCccc--eeeccccCccccCCCcccCCC------CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 014585 215 KLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 286 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 286 (422)
||+|||+++......... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999998764433221 223467999999999987543 577999999999999999999888543322111
Q ss_pred h--------hHHhhhhhhhcccccccccCcccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 287 N--------LVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 287 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
. .......... ....++.+... ........+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~-----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHT-----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhcccccchHHHHHHHHh-----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0 0010110000 01112222111 1234567899999999999999999999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-51 Score=382.42 Aligned_cols=266 Identities=22% Similarity=0.300 Sum_probs=200.7
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|+++++||+|+||+||+|.+. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 58999999999999999999874 5678999999765432 24679999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
++..+++|||+.++.+..+. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence 99999999999765555544 55678999999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh-------
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP------- 294 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------- 294 (422)
........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 87543222 1233568999999999875 4569999999999999999999999976432211111000000
Q ss_pred -hhhccccc---ccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 -HLGERRRF---YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 -~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........ .....+.....+....+.++.+||.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00000000111122345788999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=377.59 Aligned_cols=269 Identities=23% Similarity=0.297 Sum_probs=198.4
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc--ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+|+.+|++++|+||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 689999999999999999999876 788999999865432 234678899999999999999999999865
Q ss_pred --------cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCe
Q 014585 143 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 214 (422)
Q Consensus 143 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~ 214 (422)
.+..++||||+.++.+. .+......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp ----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred ccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 34689999999766554 44455668999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCcccCCCCCcc--ceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 014585 215 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 291 (422)
Q Consensus 215 kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 291 (422)
||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+..
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999765433221 122335799999999998765 789999999999999999999999976433222111111
Q ss_pred hhhhhhcc-------cccccccCcccCCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 292 ARPHLGER-------RRFYRLIDPRLEGHFS-------IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 292 ~~~~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
........ ................ ...+..+.+||.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11000000 0000000000000000 1124577899999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=385.16 Aligned_cols=262 Identities=25% Similarity=0.319 Sum_probs=196.7
Q ss_pred CCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcceeeEeEEEec--
Q 014585 66 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 143 (422)
Q Consensus 66 ~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 143 (422)
+|+..++||+|+||+||+|++.. +|+.||||++..... .+.+|+.+|++++|+|||+++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 58888999999999999999876 788999999976542 234799999999999999999998643
Q ss_pred ----CceEEEEEecCCCChhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEE
Q 014585 144 ----DQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKL 216 (422)
Q Consensus 144 ----~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl 216 (422)
.+++||||||+++.+..+.. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence 24689999997654333321 34567999999999999999999999988 99999999999999775 8999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh---
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--- 292 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~--- 292 (422)
+|||+++....... ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|..||...........+...
T Consensus 165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999987644332 234679999999998875 57899999999999999999999999765422111111000
Q ss_pred ------hhhhh--cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 293 ------RPHLG--ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 293 ------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
..... ....+.......+........+.++.+||.+||..||.+|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0000111111111111222345789999999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-50 Score=374.38 Aligned_cols=260 Identities=20% Similarity=0.206 Sum_probs=202.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcce-eeEeEEEec
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIED 143 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~ 143 (422)
++|++.+.||+|+||+||+|.+.. +|+.||||++..... ..++..|+++++.++|+|++ .+.+++.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 579999999999999999999876 788999999876532 24578999999999877654 555666778
Q ss_pred CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC---CCCeEEeecc
Q 014585 144 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFG 220 (422)
Q Consensus 144 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~---~~~~kl~DFG 220 (422)
+..++||||+ +++|.+.+......+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence 8889999999 67888877777778999999999999999999999998 999999999999854 5579999999
Q ss_pred CcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh-hh
Q 014585 221 LAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 294 (422)
Q Consensus 221 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~ 294 (422)
+|+........ .......||+.|||||++.+..++.++|||||||++|||++|..||............... ..
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 99876543321 1233468999999999999999999999999999999999999999875543332221111 10
Q ss_pred hhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 295 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... ..+.+. ..++.++.+|+.+||+.||++||++.++.+.|+.+
T Consensus 232 ~~~~-------~~~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 232 KMST-------PIEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHS-------CHHHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cCCC-------ChhHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 000011 12347889999999999999999999988877654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-50 Score=374.97 Aligned_cols=262 Identities=17% Similarity=0.168 Sum_probs=210.4
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC-CcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 142 (422)
.++|+++++||+|+||+||+|.+.. +|+.||||++..... ...+.+|+++++.|.| +||+.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 4689999999999999999999876 788999999865432 2457788999999865 899999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcC-----CCCeEEe
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLS 217 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~-----~~~~kl~ 217 (422)
+...++||||+ +++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEc
Confidence 99999999999 78999999877778999999999999999999999998 999999999999964 5789999
Q ss_pred eccCcccCCCCCcc-----ceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 014585 218 DFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 292 (422)
Q Consensus 218 DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 292 (422)
|||+|+........ ......+||+.|||||++.+..++.++|||||||++|||++|..||.+.............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 99999876433211 1233468999999999999999999999999999999999999999865544332222111
Q ss_pred hhhhhcccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhCCC
Q 014585 293 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 350 (422)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 350 (422)
.... ...... .+.. .++.++.+++..|+..+|++||++..+.+.|+.+
T Consensus 229 ~~~~-~~~~~~-----~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 229 GEKK-QSTPLR-----ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHH-HHSCHH-----HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Hhcc-CCCChH-----HhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1100 000000 0111 2346789999999999999999999988877654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=382.69 Aligned_cols=269 Identities=21% Similarity=0.286 Sum_probs=198.8
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc-ccHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
..+|++++.||+|+||+||+|.+.. +|+.||||++..... ...+.+++|+.+|++++||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 3579999999999999999999876 788999999975443 234578899999999999999999999976
Q ss_pred cC----ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEee
Q 014585 143 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 218 (422)
Q Consensus 143 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~D 218 (422)
.. ..+++++|+.+|+|.+++... .+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred ccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcc
Confidence 53 234555666699999999543 5999999999999999999999998 99999999999999999999999
Q ss_pred ccCcccCCCCCcc-ceeeccccCccccCCCccc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhh
Q 014585 219 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 296 (422)
Q Consensus 219 FG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 296 (422)
||+++........ ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||...................
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999875433221 1223467999999999985 5677999999999999999999999997654321111110000000
Q ss_pred hcc----------cccccccCcccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 297 GER----------RRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 297 ~~~----------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... ............ .......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000000000 00011224678999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=382.06 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=196.9
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++++.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+++|++++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999999876 7889999999754332 2456889999999999999999999998
Q ss_pred ecC------ceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeE
Q 014585 142 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 215 (422)
Q Consensus 142 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~k 215 (422)
..+ .+|+||||| +.+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 655 469999999 6677776643 36999999999999999999999998 99999999999999999999
Q ss_pred EeeccCcccCCCCCccceeeccccCccccCCCcccC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 014585 216 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 294 (422)
Q Consensus 216 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 294 (422)
|+|||+|+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...............
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 9999999876432 234679999999999876 4568999999999999999999999976532211111000000
Q ss_pred hh--------h------cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 295 HL--------G------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 295 ~~--------~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
.. . ....+.......+. ......+.++.+||.+||..||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0 00000000000010 1112335678999999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=368.50 Aligned_cols=265 Identities=23% Similarity=0.276 Sum_probs=206.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|++++.||+|+||+||+|++.. +|+.||||+++..... ....+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 579999999999999999999876 7889999999755432 34678999999999999999999999999
Q ss_pred cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCc
Q 014585 143 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 222 (422)
Q Consensus 143 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a 222 (422)
.+..++|||++.+++|..++ ...+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchh
Confidence 99999999999888887766 55568999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccceeeccccCccccCCCcccCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhhc---
Q 014585 223 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 298 (422)
Q Consensus 223 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 298 (422)
+........ .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||....... ............
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCCh
Confidence 876543322 22345788999999987654 6899999999999999999999975433211 111111000000
Q ss_pred -----------ccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 299 -----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 299 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
....................+..+.+|+.+||+.||.+|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000011111222345788999999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-49 Score=375.26 Aligned_cols=259 Identities=19% Similarity=0.243 Sum_probs=199.8
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeEeEEEe-
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE- 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~- 142 (422)
++|+++++||+|+||+||+|++.. +|+.||||+++.. ..+++.+|+.+|+++. ||||+++++++..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 589999999999999999999876 7889999999754 3467889999999995 9999999999985
Q ss_pred -cCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCC-CeEEeecc
Q 014585 143 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG 220 (422)
Q Consensus 143 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~-~~kl~DFG 220 (422)
....++|||||++++|..+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccc
Confidence 45689999999999997764 35899999999999999999999999 99999999999998655 68999999
Q ss_pred CcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-H-Hhh-----
Q 014585 221 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-V-EWA----- 292 (422)
Q Consensus 221 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~-~~~----- 292 (422)
+|+....... ....+||+.|+|||.+.+. .++.++||||+||++|||++|..||........... + ...
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 9987654332 3346789999999998765 579999999999999999999999976543211100 0 000
Q ss_pred ----h-hhhhcccccccccC--------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014585 293 ----R-PHLGERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 345 (422)
Q Consensus 293 ----~-~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 345 (422)
. ........+..... ...........+.++.+||.+||..||.+|||++|+|+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000000000 00011111223568899999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=378.32 Aligned_cols=256 Identities=27% Similarity=0.350 Sum_probs=205.5
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCc----ccHHHHHHHHHHhcccCC-CcceeeEeE
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVH-LNLVKLIGY 139 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~niv~~~~~ 139 (422)
++|++++.||+|+||+||+|.+.... .+|+.||||++..... ...+.+.+|+++|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccC------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 56999999999999999999885532 2788999999865422 234568899999999976 799999999
Q ss_pred EEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEEeec
Q 014585 140 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 219 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl~DF 219 (422)
+.+....++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred eccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeec
Confidence 99999999999999999999998544 46789999999999999999999998 999999999999999999999999
Q ss_pred cCcccCCCCCccceeeccccCccccCCCcccCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhhhh
Q 014585 220 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 297 (422)
Q Consensus 220 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 297 (422)
|+++........ ......|++.|+|||.+.+. .++.++|||||||+||+|++|..||...........+.... ..
T Consensus 174 G~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~ 250 (322)
T d1vzoa_ 174 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK 250 (322)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH
T ss_pred cchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--cc
Confidence 999876443222 23346799999999999754 46889999999999999999999998765544322221111 00
Q ss_pred cccccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014585 298 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 345 (422)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~ell~ 345 (422)
. .+. ++...+.++.+|+.+||+.||.+||+ ++|+++
T Consensus 251 ~--------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 S--------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C--------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 011 12234578999999999999999995 677765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=375.54 Aligned_cols=263 Identities=23% Similarity=0.300 Sum_probs=193.3
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEEe
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 142 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 142 (422)
++|+++++||+|+||+||+|++.. +|+.||||++...... ...++.+|+.+|++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 689999999999999999999876 7889999999765432 23468899999999999999999999964
Q ss_pred c------CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 143 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 143 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
. ...|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|+
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred ccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 3 6789999999664 444442 35899999999999999999999999 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHH------
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE------ 290 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~------ 290 (422)
+|||+++...... .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999988754432 2344679999999999999999999999999999999999999997653221111000
Q ss_pred ---hhh-------hhhhcc-----cccccccCccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 291 ---WAR-------PHLGER-----RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 291 ---~~~-------~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
+.. ...... ........... ........+.++.+||++||..||++|||++|+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000000 00000111111 111223457889999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=367.60 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=197.5
Q ss_pred hcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc--cHHHHHHHHHHhcccCCCcceeeEeEEE
Q 014585 64 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 141 (422)
Q Consensus 64 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 141 (422)
.++|++++.||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+++|++++|+|||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999999876 7889999999765432 3356889999999999999999999986
Q ss_pred ec-----CceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEcCCCCeEE
Q 014585 142 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 216 (422)
Q Consensus 142 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~~~~~~kl 216 (422)
.. ...++||+|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+|+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccc
Confidence 43 344677778889999998843 36999999999999999999999998 999999999999999999999
Q ss_pred eeccCcccCCCCCccceeeccccCccccCCCcccCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhHHhhhhh
Q 014585 217 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 295 (422)
Q Consensus 217 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 295 (422)
+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999764322 2346789999999987765 5689999999999999999999999765432211111100000
Q ss_pred hhc----------c----cccccccCcccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014585 296 LGE----------R----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 346 (422)
Q Consensus 296 ~~~----------~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 346 (422)
... . ..+.......+.. .....+.++.+||.+||..||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 0 0000000000000 001234678999999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-43 Score=339.44 Aligned_cols=264 Identities=21% Similarity=0.229 Sum_probs=192.6
Q ss_pred cCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-----------CCcc
Q 014585 65 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLNL 133 (422)
Q Consensus 65 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni 133 (422)
.+|+++++||+|+||+||+|++.. +|+.||||+++.... ..+.+.+|+++++.+. |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 469999999999999999999876 788999999976532 2356788998888775 5789
Q ss_pred eeeEeEEEe--cCceEEEEEecCCCChhhh--hccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEE
Q 014585 134 VKLIGYCIE--DDQRLLVYEFMPRGSLENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILL 208 (422)
Q Consensus 134 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~Nill 208 (422)
+++++++.. ....+++|+++..+..... .......+++..++.++.||+.||+|||+ .+ |+||||||+||||
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence 999998865 3456677777655443222 22345678999999999999999999997 77 9999999999999
Q ss_pred cCCCC------eEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 014585 209 DADYN------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 282 (422)
Q Consensus 209 ~~~~~------~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~ 282 (422)
+.++. ++|+|||.+...... ....+||+.|+|||++.+..++.++||||+||++++|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 76654 899999999865432 2346799999999999999999999999999999999999999976543
Q ss_pred CCcchhHHhhh---hhhhc--------c---------cccccccCc----------ccCCCCCHHHHHHHHHHHHHcccC
Q 014585 283 NGEHNLVEWAR---PHLGE--------R---------RRFYRLIDP----------RLEGHFSIKGAQKAAQLAAHCLSR 332 (422)
Q Consensus 283 ~~~~~~~~~~~---~~~~~--------~---------~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~ 332 (422)
........... ..+.. . ......+.. .....+....+.++.+||.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 22111110000 00000 0 000000000 001124456788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 014585 333 DPKARPLMSEVVEA 346 (422)
Q Consensus 333 dp~~Rps~~ell~~ 346 (422)
||.+|||++|+|++
T Consensus 315 dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 315 DPRKRADAGGLVNH 328 (362)
T ss_dssp STTTCBCHHHHHTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=9.2e-27 Score=202.23 Aligned_cols=169 Identities=15% Similarity=0.114 Sum_probs=119.4
Q ss_pred CCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcc------------------cHHHHHHHHHHhcccC
Q 014585 68 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNFLGDLV 129 (422)
Q Consensus 68 ~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~ 129 (422)
.+.++||+|+||+||+|.+. +|+.||||+++..... .......|+..+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 45789999999999999873 5779999987532110 0122456889999999
Q ss_pred CCcceeeEeEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEEc
Q 014585 130 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 209 (422)
Q Consensus 130 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~Nill~ 209 (422)
|.+++..+++. ..++||||+++..+.+ ++...+..++.|++.+|.|||+++ |+||||||+|||++
T Consensus 73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~ 137 (191)
T d1zara2 73 GLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 137 (191)
T ss_dssp TSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeee
Confidence 99999888653 2479999998765543 233445678999999999999998 99999999999998
Q ss_pred CCCCeEEeeccCcccCCCCCccceeeccccCccccCCCcccCCCCCchhhhhhHHHHH
Q 014585 210 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 267 (422)
Q Consensus 210 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 267 (422)
++ .++|+|||+|...............+.. + .+ +....|+.++|+||+.--+
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~---~-~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGWREILERDVRN---I-IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTHHHHHHHHHHH---H-HH-HHHHHHCCCCCHHHHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCcHHHHHHHHHH---H-HH-HHcCCCCCcccHHHHHHHH
Confidence 65 4899999999775433211100000000 0 01 1235678899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.87 E-value=5.4e-09 Score=93.13 Aligned_cols=149 Identities=15% Similarity=0.010 Sum_probs=101.0
Q ss_pred HHHHHhcCCCCCCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccC-CCcceeeE
Q 014585 59 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLI 137 (422)
Q Consensus 59 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 137 (422)
+++.....|++.+..+.++.+.||+... .+..++||+...........+.+|...+..+. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 3444456777776655555678998754 34567889886544333445778888887773 44467888
Q ss_pred eEEEecCceEEEEEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC------------------------
Q 014585 138 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE------------------------ 193 (422)
Q Consensus 138 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~------------------------ 193 (422)
.+...++..++||++++|..+.+...... ....++.++++.+..||+...
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred EEEecCCceEEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence 88888889999999999988765442111 122344555566666664320
Q ss_pred --------------------------------CCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 194 --------------------------------RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 194 --------------------------------~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1179999999999998776667999997753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.24 E-value=4.6e-06 Score=73.08 Aligned_cols=129 Identities=19% Similarity=0.112 Sum_probs=82.7
Q ss_pred cccccC-cEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC--CcceeeEeEEEecCceEEE
Q 014585 73 LGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQRLLV 149 (422)
Q Consensus 73 lg~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv 149 (422)
+..|.. +.||+.... .|..+++|....... ..+..|...++.+.. -.+.+++++..+++..++|
T Consensus 18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 344543 678988653 455688898765433 346677777777643 3366788888888899999
Q ss_pred EEecCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 014585 150 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE--------------------------------------- 190 (422)
Q Consensus 150 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------- 190 (422)
|++++|.++.+.. .... .++.++.+.|.-||.
T Consensus 85 ~~~i~G~~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (255)
T d1nd4a_ 85 LGEVPGQDLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 155 (255)
T ss_dssp EECCSSEETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEeeecccccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhh
Confidence 9999887664421 1111 112223333333332
Q ss_pred ------------cC----CCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 191 ------------EA----ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 191 ------------~~----~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
.. +..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 156 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 1127999999999999887667799998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.13 E-value=4.2e-06 Score=78.58 Aligned_cols=78 Identities=14% Similarity=0.080 Sum_probs=49.5
Q ss_pred CCccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCC------C-cccHHHHHHHHHHhcccC-C--CcceeeEeE
Q 014585 70 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGDLV-H--LNLVKLIGY 139 (422)
Q Consensus 70 ~~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-h--~niv~~~~~ 139 (422)
.+.||.|....||++.... .|+.|+||.-... . .....+...|+..|+.+. + ..+.+++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 3468999999999997654 4668999975321 1 112345567888877662 2 345566654
Q ss_pred EEecCceEEEEEecCCCCh
Q 014585 140 CIEDDQRLLVYEFMPRGSL 158 (422)
Q Consensus 140 ~~~~~~~~lv~e~~~~g~L 158 (422)
+.+..++|||++++..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 45667899999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.53 E-value=0.00018 Score=67.18 Aligned_cols=81 Identities=19% Similarity=0.129 Sum_probs=53.2
Q ss_pred CccccccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc-eeeEeEEEecCceEEE
Q 014585 71 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 149 (422)
Q Consensus 71 ~~lg~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv 149 (422)
+.|+.|-.-.+|++....... +....+..|.+++.... .......+|..+++.+.-.++ .++++++. -.+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceE
Confidence 568888888999998765321 11224456777777532 233456789999988853344 47777663 2689
Q ss_pred EEecCCCChh
Q 014585 150 YEFMPRGSLE 159 (422)
Q Consensus 150 ~e~~~~g~L~ 159 (422)
|||++|..|.
T Consensus 120 ~efi~g~~l~ 129 (395)
T d1nw1a_ 120 EEYIPSRPLS 129 (395)
T ss_dssp ECCCCEEECC
T ss_pred EEEeccccCC
Confidence 9999876553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.29 E-value=0.00039 Score=62.91 Aligned_cols=134 Identities=14% Similarity=0.083 Sum_probs=75.7
Q ss_pred CcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCCCcc--eeeE-----eEEEecCceEEEE
Q 014585 78 FGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL--VKLI-----GYCIEDDQRLLVY 150 (422)
Q Consensus 78 fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~ 150 (422)
--.||++... +|..|++|+.+... ....++..|+..+..|...+| +..+ ..+...+..+.|+
T Consensus 35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 4589998653 57789999986543 345667888888877743222 1111 1223466778899
Q ss_pred EecCCCChhhh----h----------cc--------CCCCCCH-------------------H---HHHHHHHHHHHHHH
Q 014585 151 EFMPRGSLENH----L----------FR--------RSLPLPW-------------------S---IRMKIALGAAKGLA 186 (422)
Q Consensus 151 e~~~~g~L~~~----l----------~~--------~~~~~~~-------------------~---~~~~i~~qi~~al~ 186 (422)
++++|..+... + +. .....+. . .....+.++...+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 99976543210 0 00 0011111 1 11222233333222
Q ss_pred HH-HhcCCCCeEeccCCCCcEEEcCCCCeEEeeccCccc
Q 014585 187 FL-HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 224 (422)
Q Consensus 187 ~L-H~~~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~~ 224 (422)
-+ ....+..+||+|+.+.|||++.+ ..++||+-+..
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 22 12223458999999999999743 45899997764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.91 E-value=0.0034 Score=56.00 Aligned_cols=155 Identities=14% Similarity=-0.003 Sum_probs=80.5
Q ss_pred chhHHHHHhcCCCCCCccc-----cccCcEEEEEEeccCCCCCCCCCCCcEEEEEEecCCCcccHHHHHHHHHHhcccCC
Q 014585 56 TFNDLKLATRNFRPESLLG-----EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 130 (422)
Q Consensus 56 ~~~~~~~~~~~y~~~~~lg-----~G~fg~Vy~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 130 (422)
+-+++.....+|.+.++.. .|---+.|+....+ ..+++|++.... ...++..|+.++..|..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-----------g~yVLri~~~~~--~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-----------DPLILTLYEKRV--EKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-----------CCEEEEEECC-----CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-----------CcEEEEEcCCCC--CHHHHHHHHHHHHhhhh
Confidence 3455555667787765543 55557889887632 358899986432 22345566666666643
Q ss_pred Cc-----ceeeE---eEEEecCceEEEEEecCCCChhhhh--------------c----cCC----CCCCH---------
Q 014585 131 LN-----LVKLI---GYCIEDDQRLLVYEFMPRGSLENHL--------------F----RRS----LPLPW--------- 171 (422)
Q Consensus 131 ~n-----iv~~~---~~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~~~----~~~~~--------- 171 (422)
.+ .+... .+....+....++.++.+......- + ... .....
T Consensus 71 ~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (316)
T d2ppqa1 71 KGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDK 150 (316)
T ss_dssp TTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHH
T ss_pred ccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhH
Confidence 22 11110 0122344556677777665442211 0 000 00000
Q ss_pred ---------HHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCcEEEcCCCCeEEeeccCcc
Q 014585 172 ---------SIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 223 (422)
Q Consensus 172 ---------~~~~~i~~qi~~al~~LH~~-~~~~iiHrDlkp~Nill~~~~~~kl~DFG~a~ 223 (422)
......+..+...+.-.+.. -+.++||+|+.+.||+++.+...-|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 151 SEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00112222223333333221 13459999999999999988777899999875
|